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Abstract  
 This	 thesis	 investigates	 the	 fundamental	 aspects	 of	 regulation	 of	 expression	 of	 the	 surface	antigen,	 Fraction	 1	 (F1),	 of	 the	 plague	 pathogen	Yersinia	pestis.	 	 F1	 contains	 a	 single	 subunit,	Caf1,	 polymerised	 into	 a	 flexible	 fibrillar	 structure.	 It	 is	 a	 key	 diagnostic	 tool	 and	 a	 primary	component	 of	 older	 whole	 cell	 plague	 vaccines	 and	 newer	 subunit	 ones	 under	 development.	Caf1	is	encoded	by	the	caf	gene	cluster,	comprising	caf1R,	an	AraC/XylS	family	regulator	and	the	chaperone/usher	caf1MA1	operon.	Despite	considerable	research	on	its	assembly	and	role	as	a	vaccine	constituent	there	is	virtually	no	information	on	how	the	expression	of	this	key	antigen	is	regulated.				Availability	of	a	spontaneous	Caf1R	point	mutation	(E98G)	that	virtually	abolished	F1	assembly	stimulated	initial	 interest	 in	regulation.	Modelling	of	Caf1R	revealed	location	of	E98	within	the	DNA	binding	helix-6	and	its	involvement	in	a	novel	‘bridge-type’	DNA-protein	interaction	linking	DNA	backbone	bound	R62	(helix-4)	to	helix-6.	It	is	proposed	that	this	interaction	may	be	critical	for	 the	 correct	 spatial	orientation	of	 the	base-binding	 residues	Q93	and	R97	within	 the	major	DNA	 groove.	 Site-specific	 mutagenesis	 supported	 this	 model	 and	 defined	 the	 requirement	 of	other	 Caf1R	 residues	 modeled	 as	 interacting	 with	 DNA	 backbone	 or	 specific	 nucleotides.	Promoter-lacZ	 fusions	 identified	 a	 Caf1R	 dependent	 class	 II	 promoter	 (PM)	 controlling	expression	of	 the	caf1MA1	operon	and	2	potential	promoters	upstream	of	caf1R	(PR2	and	PRK).		PR2	promoter,	also	a	class	II	promoter,	was	autoactivated	by	Caf1R.	Provision	of	Caf1R	in	trans	from	 a	 PBAD	 promoter,	 identified	 thermosensing	 within	 the	 caf	 locus	 is	 via	 5′	 UTR	 of	 Caf1R.	Potential	RNA	 thermometer	 (RNAT)	 structures	were	predicted	 from	 the	5′	UTR	of	 transcripts	from	both	promoters.	The	longer	and	more	stable	5′	UTR	from	PRK	and	the	higher	level	of	Caf1R	independent	 transcription	 from	 this	 promoter	would	 be	 consistent	with	 an	 RNAT	within	 this	transcript	controlling	early	expression	of	caf1R	in	response	to	temperature.	Five	potential	Caf1R	binding	 sites	 (repeat	 motifs)	 were	 identified	 within	 the	 caf1R-caf1M	 intergenic	 region,	 R1-3	upstream	 of	 caf1R	 and	 R3′	 and	 R4′	 upstream	 of	 caf1M,	 with	 the	 consensus	 sequence	TGCRCBS1RAMWAGCWARDBS2.	An	electrophoretic	mobility	shift	assay	(EMSA)	confirmed	specific	binding	 of	 Caf1R	 to	R4′.	 Several	 tagged	 approaches	were	 taken	 for	 purification	 of	 Caf1R.	 Low	levels	 of	 soluble	 hCaf1R	 were	 recovered	 using	 the	 PBAD	promoter.	 Using	 the	 pET28a+	vector,	hCaf1RT	 was	 mainly	 recovered	 in	 inclusion	 bodies	 but	 low	 levels	 of	 soluble	 hCaf1RT	 were	recovered	using	 codon	optimisation	 and	 induction	with	 glucose	plus	 IPTG.	 Solubility	 of	 Caf1R	was	 greatly	 enhanced	 with	 MBPCaf1R	 expressed	 in	 E.	 coli-K12	 2508.	 While	 isolated	 Caf1R	showed	some	activity	in	EMSA,	comparison	with	activity	in	crude	lysed	cell	fractions	suggested	either	inactivation	of	Caf1R	during	isolation	or	loss	of	an	activating	factor.		Thus	this	study	has	identified	the	fundamental	features	controlling	transcription	within	the	caf	locus	 for	 subsequent	 expression	 of	 F1.	 This	 is	 the	 first	 example	 of	 AraC/XylS	 type	 regulator,	directly	linked	to	a	CU	system	of	ϒ3-fimbriae/pili	family.	Working	models	are	presented	that	can	be	used	as	a	basis	to	further	clarify	autoregulation	of	Caf1R	including	activation,	the	possibility	of	repression	and	thermoregulation.	This	study	has	provided	the	fundamental	 information	and	tools	 for	 in-depth	understanding	of	expression	of	F1	 in	Y.	pestis	and	 its	applications	 in	vaccine	development.
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1.1 An overview on Yersinia pestis and its F1 antigen  
	
Yersinia	pestis,	 the	causative	agent	of	plague,	has	been	one	of	 the	most	devastating	diseases	 in	human	history.	Y.	pestis	belongs	to	the	Enterobacteriaceae	family	of	Gram-negative	bacteria	and	possesses	 a	 rod	 like	 structure	 of	 1-3	 μm	 in	 length	 and	 0.5-0.8	 μm	 in	 diameter,	 which	 is	surrounded	by	a	unique	capsular	material	known	as	surface	antigen,	F1	(Fig.	 1.1)	 (MacIntyre,	2004;	Miller	 et	 al.,	 1998;	Runco	 et	 al.,	 2008).	 F1	 is	 encoded	by	 the	 caf	 locus	 (consist	 of	 caf1R	regulator	and	caf1MA1	operon)	of	the	Y.	pestis	specific	virulence	plasmids,	pFra		(also	known	as	pMT1).	The	typical	size	of	this	plasmid	is	≈100	kb;	96.21	kb	for	pFra	from	Y.	pestis	CO92	(Hu	et	al.,	1998)	and	100.98	kb	for	pMT1	from	Y.	pestis	KIM5	(Filippov	et	al.,	1990;	Lindler	et	al.,	1998;	Prentice	et	al.,	2001).	Y.	pestis	evolved	from	its	progenitor	species	Y.	pseudotuberculosis,	around	15,00-20,000	years	ago	via	several	distinct	genetic	gain	and	losses,	resulting	in	a	very	different	mode	of	pathogenicity	and	transmission	(Achtman	et	al.,	1999;	Morelli	et	al.,	2010;	Reuter	et	al.,	2014;	 Skurnik	 et	 al.,	 2000).	 Y.	 pseudotuberculosis	 is	 transmitted	 by	 the	 faecal-oral	 route	 and	causes	mild	 and	 self-limiting	 gastroenteritis;	 	 in	 contrast,	Y.	pestis	 is	 transmitted	 by	 flea	 bites	directly	into	subcutaneous	tissues	causing	bubonic	or	septicemic	plague	or	by	aerosols	resulting	to	 pneumonic	 plague	 (Perry	 and	 Fetherston,	 1997).	 Genomic	 analysis	 indicates	 that	 Y.	 pestis	shares	 ≥	 97%	 nucleotide	 identity	 in	 about	 75%	 of	 their	 genes	 with	 Y.	 pesudotuberculosis	(Achtman	et	al.,	1999;	Reuter	et	al.,	2014;	Skurnik	et	al.,	2000).			
	
 
Figure 1.1| India ink stained Y. pestis smear, indicating F1 capsular antigen on the cell surface.  
Picture taken from (Amies, 1951).   	F1	is	a	key	detection	tool	(WHO	manual)	and	extensive	research	has	been	carried	out	over	the	last	20-25	years	using	F1	as	a	primary	component	of	both	subunit	and	whole	cell	 (attenuated	and	killed)	vaccines	to	combat	plague	(Derbise	et	al.,	2012;	Hart	et	al.,	2012;	Rocke	et	al.,	2008;	Titball	et	al.,	1997).	F1	is	unique	to	Y.	pestis,	likely	to	be	required	for	transmission	from	the	flea	vector	to	the	mammalian	hosts	and	thus	establishment	of	infection	in	a	mouse	model	of	bubonic	pelage	 (Sebbane	et	al.,	2009).	Because	of	 its	uniqueness	 to	Y.	pestis	 it	 is	being	used	 to	 identify	bacterium	 and	 monitoring	 anti-F1	 antibodies	 from	 the	 recovering	 patients	 of	 plagues	 or	 the	ancient	 human	 remains	 of	 plague	 (Bianucci	 et	 al.,	 2007;	 Chanteau	 et	 al.,	 2000).	 F1	 in	 concert	with	 Type	 three	 secretion	 system	 (T3SS)	 protects	 Y.	 pestis	 from	 the	 host	 immune	 by	 its	antiphagocytic	property,	as	shown	by	comparison	of	native	EV76	strain-mediated	resistance	to	phagocytosis	 in	 the	 macrophage-like	 cell	 line	 J774	 to	 the	 reduced	 level	 of	 phagocytosis	 by	mutant	 strain	 carrying	 in-frame	deletion	 in	 the	caf1M	chaperone	gene	(Du	et	 al.,	 2002).	 It	has	been	always	arguable	that	F1	role	in	virulence	is	not	critical	as	naturally	occurring	F1	negative	
	 3	
‘virulent’	 strains	 are	 known	 and	 these	 strains	 along	 with	 strains	 carrying	 genetically	 defined	nonpolar	mutations	in	the	caf1	structural	gene	retained	their	virulence	for	mice	and	nonhuman	primates	 (Friedlander	 et	 al.,	 1995).	 African	 green	monkeys	 following	 ‘aerosol’	 exposure	 to	 F1	positive	and	negative	strain	(CO92	and	CO91-C12,	respectively)	all	died	between	4	to	10	days	of	exposure	 and	 had	 lesions	 consistent	with	 primary	 pneumonic	 plague,	 suggesting	 F1	 is	 not	 an	essential	 virulence	 factor	 (Davis	 et	 al.,	 1996).	 A	 recombinant	 subunit	 vaccine	 composed	 of	 F1	and	V	antigens	(rF1+V)	had	been	shown	to	protect	mice	against	bubonic	and	pneumonic	plague,	and	also	shown	to	give	a	better	protection	than	F1	or	V	antigen	alone	carrying	vaccines	against	the	 F1	 positive	 strains	 only	 (Heath	 et	 al.,	 1998).	 These	 results	 indicate	 a	 requirement	 of	designing	new	vaccines	 to	 protect	 from	 the	 F1	negative	 virulent	 strains	 and	 suggest	 F1	 alone	can’t	 be	 an	 efficient	 target	 to	 boost	 immune	 response	 albeit	 antibodies	 to	 F1	 contributes	 to	protection.	 Likewise,	 in	 one	 another	 study,	 F1	 negative	 strains	 were	 found	 fully	 virulent	 in	animal	 models	 (BALB/c	 mice)	 of	 bubonic	 and	 pneumonic	 plague	 and	 broke	 the	 immune	responses	generated	with	live-attenuated	strains	or	F1	subunit	vaccines	(Quenee	et	al.,	2008).	In	a	 relatively	new	study,	 intranasal	 instillation	of	 guinea	pigs	by	 fully	 virulent	 strain	of	Y.	pestis	CO92	 showed	 that	 expression	 of	 the	 F1	was	 not	 required	 for	 development	 of	 the	 pneumonic	plague;	however,	it	appeared	to	be	essential	for	establishment	of	the	bubonic	plague	(Quenee	et	al.,	 2011).	 Immunisation	 of	 guinea	 pigs	with	 recombinant	 subunit	 vaccine,	 carrying	 F1	 and	 V	antigens	(rF1+V),	generated	robust	humoral	immune	responses	in	contrast	to	vaccines	carrying	either	V	or	F1	antigen	alone,	partial	protection	by	V	antigen	carrying	vaccine	against	pneumonic	plague	and	no	protection	by	recombinant	F1	carrying	vaccine	(Quenee	et	al.,	2011).	Again	these	results	 suggest	 F1	 is	 not	 a	 required	 virulence	 factor;	 however,	 it	 should	 be	 considered	 that	virulence	may	also	be	dependent	on	the	animal	models	used	in	these	studies	hence,	it	is	not	so	clear	that	the	F1	could	fulfil	the	requirement	of	molecular	Koch’s	postulates	(Falkow,	1988).		
1.2 Historical perspective of plague its transmission and prevention 
1.2.1 Plague history 	Plague	 has	 been	 responsible	 for	 millions	 of	 deaths	 over	 the	 last	 15	 centuries	 and	 today	approximately	1000-3000	cases	of	plague	arise	each	year	(Ninh,	2011).	Three	main	pandemics	of	plague	are	documented,	Justinian	plague	(6th	century	A.	D.),	Black	Death	(14th	century	A.	D.)	and	 bubonic	 plague	 (1665-till	 date),	 causing	 an	 estimated	 137	 million	 deaths	 worldwide	reviewed	 in	 (Butler,	 2009;	MacIntyre,	 2004;	Morelli	 et	 al.,	 2010).	 The	 19th	 century	 pandemic	(originating	in	1855	in	Yunnan	province,	China)	killed	over	12	million	people	in	India	and	China	alone	(Cohn,	2003),	together	with	continued	20th	century	plague	outbreaks	reported	from	India,	Madagascar	and	Africa,	suggest	that	plague	is	not	a	disease	of	the	past	and	will	remain	a	threat	in	 the	 future,	 hence	 requiring	 continued	 study	 (Butler,	 2009).	 Despite	 attempts	 to	 eradicate	plague	 it	 is	still	endemic	 in	certain	regions	of	 the	world.	Australia	and	European	countries	are	currently	plague-free	but	regions	in	Africa,	Asia	and	the	America	have	experienced	epidemics	in	recent	decades	(Ninh,	2011).	The	most	recent	presumptive	positive	case	of	plague	was	reported	by	California	Department	of	Public	Health	 (USA),	 involving	a	person	 from	Georgia	who	visited	Yosemite	National	Park,	California,	USA	in	August,	2015	(Botelho,	2015).	According	to	the	World	Health	 Organisation	 (WHO),	 the	 most	 recent	 outbreak	 of	 plague	 was	 reported	 in	 China	 (July	2014)	 where	 a	 man	 died	 of	 bubonic	 plague	 and	 30,000	 residents	 of	 Yumen	 City	 were	
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quarantined	 from	 the	 outside	world.	 In	 2013,	 a	 plague	 outbreak	was	 reported	 in	Madagascar	with	84	reported	plague	cases	and	32	deaths	(Associated	Press	in	Antananarivo,	2013).	In	2012,	there	were	256	cases	of	plague	and	60	deaths	reported	in	Madagascar	(BBC,	2013).	In	the	same	year	 (July	 2012),	 The	 Guardian	 newspaper	 reported	 an	 Oregon	 State	 citizen	 recovering	 from	plague	after	contracting	the	disease	while	trying	to	take	a	mouse	from	the	jaw	of	a	choking	cat	(Quinn,	2012).	In	2010,	the	Ministry	of	Health,	Peru	reported	17	cases	of	plague	of	which	4	were	pneumonic,	 12	 were	 bubonic	 and	 one	 was	 septicemic.	 During	 this	 investigation,	 10	 distinct	clones	 of	Y.	 pestis	were	 isolated	 from	 rodents	 and	 domestic	 cats	 as	 well	 as	 from	 humans	(Haensch	et	al.,	 2010).	Albeit	 recent	plague	cases	are	 relatively	 low	 in	numbers,	Y.	pestis	is	 an	organism	of	high	concern	due	to	the	fact	it	is	so	virulent,	the	emergence	of	multi-drug	resistant	strains	 (Welch	 et	 al.,	 2007)	 and	potential	misuse	 as	 a	 bioterrorist	weapon	 combined	with	 the	continued	fear	of	this	bacterial	disease	(MacIntyre,	2004;	Rollins	et	al.,	2003).	Taking	these	facts	into	 account,	 the	 Center	 for	 Disease	 Control	 and	 prevention	 (CDC)	 classified	 Y.	 pestis	 as	 an	‘A’	class	pathogen	requiring	high	attention	(Inglesby	et	al.,	2000).		
1.2.2 Life cycle of Y. pestis and transmission of plague  
	
Y.	 pestis	 is	 a	 zoonotic	 pathogen,	 primarily	 transmitted	 to	 humans	 and	 animals	 by	 an	 infected	flea-vector	 bites	 (for	 example	 bite	 from	 the	 rat	 flea,	 Xenopsylla	 cheopis)	 (Chouikha	 and	Hinnebusch,	 2012;	 Hinnebusch,	 2003,	 2005;	 Sebbane	 et	 al.,	 2009;	 Stenseth	 et	 al.,	 2008)	 as	depicted	 in	 Fig.	 1.2a.	 Briefly,	 once	 fleas	 acquire	 Y.	 pestis	 through	 their	 blood	 meal	 from	 the	infected	 mammalian	 host,	 the	 bacterium	 establishes	 in	 the	 flea	 midgut	 where	 it	 expresses	selected	 colonisation	 factors	 such	 as	 the	 biofilm	 generating	Hemin	 storage	 locus	 (Hms)	and	 a	phospholipase	D	(Ymt)	(Chouikha	and	Hinnebusch,	2012;	Hinnebusch,	2003,	2005;	Zhou	et	al.,	2012).	 The	 biofilm	 extends	 into	 the	 proventriculus	 and	 oesophagus,	 and	 blocks	 the	 digestive	tract.	This	blockage	forces	the	flea	to	regurgitate	the	contaminated	blood	meal	when	feeding	on	the	 next	 host,	 thus	 transmitting	 Y.	 pestis	 to	 a	 new	 host	 (Chouikha	 and	 Hinnebusch,	 2012;	Hinnebusch,	 2003,	 2005).	 With	 every	 attempt	 to	 feed	 about	 25,000-100,000	 bacteria	 are	regurgitated	 into	 the	 host	 skin	 (Reed	 et	 al.,	 1970).	 During	 plague	 epizootics,	 many	 rodents	including	rats	die,	causing	Y.	pestis	loaded	hungry	fleas	to	seek	an	alternate	source	of	blood	meal.	As	a	result	of	this,	humans	or	animals	in	close	proximity	are	at	high	risk	of	being	infected	from	the	flea	bites	(CDC,	2012).	Following	Y.	pestis	 loaded	flea	bite(s),	bacteria	are	transmitted	from	cutaneous	 lymphatics	 to	 the	 regional	 lymph	 nodes	 and	multiply	 quickly.	 Once	 established	 in	lymphoid	tissues	bacteria	replicate	primarily	extracellularly	within	necrotic	lesions	or	abscesses	and	 resist	 host	macrophages	 and	 neutrophil	mediated	 phagocytosis	 (Pujol	 and	 Bliska,	 2005).	During	 the	 very	 early	 stage	 of	 infection,	Y.	pestis	 enters	 into	macrophages	 and	neutrophils	 by	active	invasion	or	by	passive	phagocytosis	(Lukaszewski	et	al.,	2005).	Neutrophils	normally	kill	the	bacterial	cells	but	Y.	pestis	can	survive	within	macrophages	by	subverting	some	macrophage	functions	for	example	inhibition	of	production	of	Nitric	oxide	(Pujol	and	Bliska,	2005).	Invasion	of	 Y.	 pestis	 into	 nonprofessional	 phagocytes	 or	 epithelial	 cells	 is	mediated	 by	 expression	 and	binding	 of	 adhesive	 factors,	 reviewed	 in	 (Ke	 et	 al.,	 2013).	 These	 include,	 the	 chromosomally	encoded	outer	membrane	protein,	Ail	 (attachment-invasion	 locus)	 (Miller	et	al.,	2001),	 the	9.5	kb	pPCP1	plasmid	encoded	Plasminogen	activator	(Pla,	 	a	17.5	kDa	outer	membrane	protein	of	the	omptin	family	of	proteases)	(Kukkonen	and	Korhonen,	2004;	Lahteenmaki	et	al.,	2001),	the	chromosomally	encoded	pH6	antigen,	Psa	(Bartra	et	al.,	2008;	Huang	and	Lindler,	2004)	and	a	
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chromosomally	encoded	adherence	 factor,	yadBC	(Forman	et	al.,	2008;	Sha	et	al.,	2008).	Upon	entering	into	macrophages,	Y.	pestis	express	an	alternate	set	of	virulence	factors.		These	include	the	 pCD1	 plasmid	 (≈70	 kb)	 encoded	 type	 3-secretion	 machinery	 (T3SS),	 Yersinia	 effector	proteins	(Yops)	and	the	low-calcium	response	V	antigen,	LcrV	(Pettersson	et	al.,	1999;	Plano	and	Schesser,	 2013).	 Expression	 of	 T3SS	 genes	 is	 enhanced	 by	 low	 calcium	 (Bi	 et	 al.,	 2009)	 and	controlled	 by	 the	 AraC/XylS-like	 regulator	 LcrF	 (Plano	 and	 Schesser,	 2013).	 During	 the	intracellular	 phase,	 the	 pFra	 plasmid	 encoded	 F1	 is	 initially	 expressed	 (Fukuto	 et	 al.,	 2010).	After	multiplying	within	macrophages,	Y.	pestis	escapes	from	the	cells	and	develops	resistance	to	phagocytosis.	T3SS	injects	Yops	through	a	needle	like	injectisome	into	neutrophils,	macrophages	and	 dendritic	 cells	 leading	 to	 cytokine	 activation	 and	 apoptosis	 (Marketon	 et	 al.,	 2005).	 The	antiphagocytic	ability	of	Y.	pestis	has	been	attributed	to	 the	expression	of	F1,	pH6	antigen	and	Yops	of	T3SS	(Benedek	et	al.,	2004;	Du	et	al.,	2002;	Ke	et	al.,	2013).	This	allows	the	bacteria	to	exist	and	multiply	rapidly	in	the	extracellular	environment.		Following	infection,	 the	host	 immune	response	destroys	most	bacterial	cells;	however	survival	of	some	Y.	pestis	cells	within	macrophage	and	migration	to	the	regional	 lymph	nodes,	causes	a	remarkably	tender	inflammation	in	the	lymphatic	tissues.	These	inflammations	are	round	oval-shaped	structures,	known	as	buboes	(Fig.	1.2b	(i)),	and	the	plague	caused	from	these	buboes	is	known	 as	 bubonic	 plague,	 the	 most	 common	 primary	 manifestation	 (Inglesby	 et	 al.,	 2000).	Bursting	of	buboes	causes	bleeding	under	 the	skin	and	organs	and	release	of	Y.	pestis	 into	 the	blood	where	it	multiplies.	This	form	of	plague	is	known	as	septicemic	plague.	The	symptoms	of	septicemic	plague	are	similar	to	those	of	the	bubonic	form	with	an	additional	necrosis	leading	to	blackness	on	the	fingers	(Fig.	1.2b	(ii)).	Septicemic	plague	has	an	even	higher	rate	of	mortality.	When	bacteria	from	septicemic	stage	infect	lungs	and	cause	pneumonia	then	this	form	of	plague	is	known	as	pneumonic	plague	(Fig.	1.2b	 (iii)).	 	Pneumonic	plague	is	the	most	contagious	and	devastating	form	of	plague	as	it	can	be	communicated	via	Y.	pestis	charged	respiratory	droplets	from	person	to	person	(Fig.	1.2a).	Pneumonic	plague	is	thought	to	lead	to	100%	mortality	rate	if	left	untreated.	The	pneumonic	route	of	plague	is	the	route	that	has	been	of	concern	with	respect	to	its	potential	use	as	a	bioweapon	(Fig.	1.2a)	(Morelli	et	al.,	2010).			
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Figure 1.2| Life cycle and transmission of Y. pestis along with three types of plagues. 
a) Arrows indicate flea and mammalian stages of life cycle and transmission of Y. pestis. Pictures adapted from 
(Chouikha and Hinnebusch, 2012; Cole and Buchrieser, 2001). b) Three forms of plague caused by Y. pestis in 
human. i). Bubonic plague, indicated by buboes on thigh. ii) Septicemic plague, an Oregon patient recovering 
from plague. iii). Pneumonic plague, an X-ray picture of pneumonic plague infected lungs. Pictures, i) and iii) 
taken from CDC image library ii) is taken from The Guardian newspaper (Quinn, 2012).   
1.2.3 Preventive measures  	In	the	early	stage	of	infection,	plague	can	be	controlled	by	antibiotics.	Streptomycin	has	been	the	most	 commonly	 used	 and	 effective	 antibiotic	 against	 Y.	 pestis.	 	 Gentamycin,	 tetracycline,	chloramphenicol,	 or	 combinations	 of	 antibiotics	 have	 alternatively	 been	 used.	 More	 recently,	levafloxacillin,	 ciprofloxin	and	doxycycline	have	also	been	 recommended	 to	 treat	plague	 cases	(CDC,	2015).	However,	once	 infection	 is	established	antibiotics	are	 less	successful.	 In	addition,	isolation	 of	 multi-drug	 resistant	 strains	 of	 Y.	 pestis,	 there	 is	 concern	 over	 excessive	 use	 of	antibiotics	associated	with	re-emergence	of	plague	(Galimand	et	al.,	1997;	Guiyoule	et	al.,	2001).	To	 control	 plague,	 live	 attenuated	 and	 killed	 whole	 cells	 vaccines	 were	 used	 in	 the	 past	(Feodorova	and	Motin,	2012;	MacIntyre,	2004;	Titball	and	Williamson,	2001).	But	a	number	of	local	 and	 systemic	 side	 effects	were	 observed	with	 both	 types	 of	 vaccine,	 for	 example,	 strong	pain	at	 the	site	of	 injection,	swelling,	 regional	 lymphadenopathy,	malaise,	headache,	giddiness,	anorexia,	weakness	 and	mild	 fever	 (Feodorova	 and	Motin,	 2012;	MacIntyre,	 2004;	Titball	 and	Williamson,	 2001).	 In	 addition,	 killed	 whole	 cell	 vaccine	 is	 unable	 to	 protect	 against	 the	pneumonic	 form	of	 plague	 and	 both	 live	 attenuated	 and	 killed	whole	 cell	 vaccines	 require	 an	annual	booster.	Hence,	there	has	been	a	strong	focus	on	development	of	less	reacto-genic,	safe,	stable	 and	 efficient	 vaccines	 to	 combat	 plague	 (Feodorova	 and	Motin,	 2012).	 There	 has	 been	particular	 focus	 on	 subunit	 vaccines	 and	 safe	 designed	 attenuated	 vaccines.	 Subunit	 vaccines	have	 been	 primarily	 focused	 on	 2	major	 antigens,	 F1	 capsular	 antigen	 and	 LcrV,	 produced	 as	recombinant	 proteins.	 Both	 have	 been	 shown	 to	 induce	 a	 protective	 immune	 response	when	used	 individually	 and	 a	 synergistic	 response	 when	 combined	 (Titball	 and	Williamson,	 2001).	The	recombinant	F1-V	 fusion	(rF1-V)	provides	stronger	protection	 than	killed	whole	cells	and	live	attenuated	vaccines,	when	used	in	mice	(Rocke	et	al.,	2008).	Additionally,	the	rF1-V	fusion	
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vaccine	is	being	evaluated	in	Phase	2b	human	clinical	trials	(Hart	et	al.,	2012).	Several	other	new	strategies	 are	 being	 developed	 in	 order	 to	 produce	 a	 successful	 vaccine,	 such	 as	 using	heterologous	bacterial,	viral	and	plant	delivery	systems	(Del	Prete	et	al.,	2009;	Feodorova	and	Corbel,	 2009).	 Among	 these	 Salmonella	 is	 the	 most	 characterised	 bacteria,	 used	 as	 a	heterologous	 live	 carrier	 platform.	 Attenuated	 Salmonella	 enteritica	 Serovars	 Minnesota,	
Typhimurium,	 and	 Typhi	 have	 been	 used	 to	 express	 F1,	 LcrV	 and	 a	 combination	 of	 both	(Andrews	et	al.,	1996;	Motin	et	al.,	1994).	A	study	 from	Carniel	and	coworkers	suggests	 that	a	single	dose	of	live	attenuated	Y.	pseudotuberculosis	V674F1,	expressing	recombinant	Y.	pestis	F1,	gives	protection	against	pneumonic	plague	 (Derbise	et	 al.,	 2012).	As	plague	 is	 still	 endemic	 in	some	 parts	 of	 the	 world	 and	 can	 be	 used	 as	 a	 bioweapon,	 there	 is	 continued	 interest	 in	 the	development	of	next-generation	vaccines	including	live	attenuated	and	subunit	vaccines.			
1.3 F1 capsular antigen  
1.3.1 F1 encoding caf locus and regulation of F1 expression  	Initial	sequencing	identified	that	the	pFra	plasmid	encoded	caf	locus	(5.128	kb)	(Fig.	1.3a)	has	three	 genes,	 caf1M	(777	 bp),	 caf1A	(2502	 bp)	 and	 caf1	(513	 bp),	organised	 into	 two	 possible	transcriptional	units	(in	the	same	orientation),	one	for	caf1M	and	caf1A,	and	the	other	for	caf1	alone	(Galyov	et	al.,	1990).	These	genes	code	for	a	periplasmic	chaperone,	Caf1M	(26.3	kDa),	an	outer	membrane	 usher	 protein,	 Caf1A	 (90.5	 kDa),	 both	 required	 for	 F1	 assembly,	 and	 the	 F1	structural	 subunit,	 Caf1	 (15.5	 kDa)	 (Chapman	 et	 al.,	 1999).	 Further	 an	 additional	 divergently	orientated	transcriptional	unit	of	924	bp	was	identified	at	327	bp	upstream	from	the	caf1M	start	codon	(Karlyshev	et	al.,	1992).	This	encodes	a	protein	of	301	amino	acids	with	homology	to	the	AraC/XylS	 family	of	DNA-binding	 transcriptional	 regulators	and	was	shown	to	be	required	 for	F1	assembly.	Hence,	 it	was	named	caf1R,	 encoding	Caf1R	regulator	 (36.04	kDa).	Bioinformatic	analysis	of	Caf1R	identified	two	domains;	a	DNA-binding	domain	(DBD,	1-112	amino	acids)	and	a	C-terminal	domain	(113-301	amino	acids).	Unlike	many	AraC/XylS	family	proteins,	Caf1R-DBD	constitutes	 the	 N-terminal	 half	 rather	 than	 the	 C-terminal	 half	 of	 the	 protein	 (Schuller	 et	 al.,	2012).	Two	different	start	sites	have	been	annotated	for	Caf1R,	one	start	from	ATG	(Met)	codon	and	codes	for	a	301	amino	acid	long	product	(Fig.	 1.3b)	of	36.05	kDa	(Karlyshev	et	al.,	1992).	The	second	start	site	was	annotated,	six	codons	upstream,	starting	at	the	rare	start	codon	TTG	(Leu	 or	 fMet)	 (Fig.	 1.3b).	 This	 would	 encode	 a	 307	 amino	 acid	 long	 product	 of	 36.82	 kDa	(Parkhill	et	al.,	2001;	Prentice	et	al.,	2001;	Song	et	al.,	2004;	Zhou	et	al.,	2004).	Three	possible	promoters	and	two	inverted	repeat	motifs	(IR1	and	IR2)	were	identified	(Karlyshev	et	al.,	1992)	within	the	caf1R-caf1M	intergenic	region	(Fig.	1.3b).	The	-10	and	-35	elements	of	two	predicted	promoters	were	 located	upstream	of	caf1M,	suggesting	 that	either	of	 these	could	be	 the	active	promoter	for	caf1M	or	caf1MA1	transcription.	The	third	promoter	was	a	predicted	promoter	for	
caf1R	 (Fig.	 1.3b).	 A	 distinct	 transcriptional	 unit	 for	 caf1	 alone	 was	 predicted	 (Galyov	 et	 al.,	1990)	 and	 it	was	 speculated	 that	 the	 small	 intergenic	 region	 (80	bp)	 between	 caf1A	 and	 caf1	might	be	an	additional	regulatory	site	of	the	caf	locus	controlling	the	high	level	of	F1	production	(Galyov	et	al.,	1990;	MacIntyre,	2004).	There	has	been	little	specific	focus	on	the	regulation	of	F1	expression.	 However,	 it	 has	 been	 well	 documented	 that	 production	 of	 F1	 is	 temperature	regulated,	 a	 high	 level	 at	 35-37°C	 and	 none	 at	 lower	 temperature	 of	 26°C,	 correlating	 with	production	 in	mammalian	hosts	but	not	 in	 the	 flea	 vector	 (Simpson	et	 al.,	 1990).	More	 recent	
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transcriptomic	 studies	 have	 confirmed	 upregulation	 of	 the	 caf	 genes	 at	 37°C	 and	 the	 fold	increase	upon	temperature	transition	was	highest	for	caf1	in	the	entire	genome	(Chauvaux	et	al.,	2007;	Han	et	al.,	2007;	Li	et	al.,	2011;	Motin	et	al.,	2004;	Simpson	et	al.,	1990).	A	transcriptome	analysis	 of	 Y.	 pestis	 grown	 under	 different	 conditions	 found	 upregulation	 of	 caf	 genes	 in	 the	presence	of	 low	Mg2+	concentration,	nutrient	deficiency	and	 low	pH,	conditions	mimicking	 life	inside	 a	 macrophage	 (Han	 et	 al.,	 2007)	 and	 analysis	 of	 Y.	 pestis	 mRNA	 expression	 inside	 a	macrophage,	revealed	a	time	dependant	induction	of	caf	mRNA	(Fukuto	et	al.,	2010).		
 
 
Figure 1.3| Organisation of the caf locus and caf1R gene. 
a) Y. pestis pFra plasmid (≈100 kb) encoded caf locus (5.128 kb), solid red arrow indicates proposed activation 
of caf genes by Caf1R and dotted red arrow indicates speculation that Caf1R might also influence expression 
from the caf1A-caf1 intergenic region. Proposed and putative promoter for caf1R, caf1M and caf1 are indicated 
by PR, PM and P1, respectively. b) The intergenic region between caf1R-caf1M and the coding sequence of caf1R 
with deduced amino acids is depicted. Thick lines indicate inverted repeat (IR) motifs and dashed lines represent 
the predicted -10 and -35 elements of putative caf1R and caf1M promoters. Red arrows indicate the assigned 
start sites for caf1R and caf1M. Two different start sites, ATG (Met or M) (PubMed ID 1633857) together with 
SD sequence (underlined) (Karlyshev et al., 1992) and TTG (Leu or fM) (PubMed ID 11586360) (Parkhill et al., 
2001) are indicated with red bent arrows, which encode 301 and 307 amino acid long product with a calculated 
molecular weight of 36.05 and 36.82 kDa, respectively.  
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1.3.2 F1 structure and assembly  	F1	has	a	capsular	appearance	as	it	excludes	India	ink,	but	it	actually	consists	of	a	mesh	of	very	thin	fibres,	collapsing	together	to	act	as	a	protective	coat	surround	the	cell	(Fig.	1.4a).	 	F1	is	a	high	molecular	weight	(0.5-1.0	×103	kDa)	thin	fibrillar	polymer,	made	of	thousands	of	repeating	Caf1	subunits	(MacIntyre,	2004;	MacIntyre	et	al.,	2001;	Zavialov	et	al.,	2003).	A	high-resolution	crystal	 structure	 of	 two	 Caf1	 subunits	 bound	 to	 Caf1M	 chaperone	 (Caf1M-Caf1’-Caf1’’)	 was	solved	(Zavialov	et	al.,	2003)	and	this	together	with	earlier	mutagenic	studies	(MacIntyre	et	al.,	2001;	 Zavialov	 et	 al.,	 2002)	 demonstrated	 the	 structural	 basis	 of	 these	 long	 polymers.	 Each	subunit	within	the	polymer	is	linked	together	by	a	non-covalent	donor	strand	complementation	interaction.	 Based	 on	 the	 assumption	 that	 the	 subunit-subunit	 orientation	 is	 retained	throughout	the	F1	polymer,	the	polymer	was	modelled	as	a	thin	extended	linear	fibre	of	nearly	20	Å	diameter,	wound	in	an	open	right-handed	helical	structure	(Fig.	1.4b).	The	modelled	fibre	has	 a	wavy	 appearance	with	 a	 rise	 of	~47	Å	 per	 subunit	 (roughly	 the	 length	 of	 a	 single	 Caf1	subunit)	and	~2.7	subunits/turn.			
		
Figure 1.4| F1 capsular and molecular architecture. 
a) Transmission electron micrograph of recombinant E. coli expressing F1 capsular antigen, made up of thin 
fibers (indicated in red circles). F1-labeled with anti-F1 antibody and gold labeled anti IgG (MacIntyre, S., 
unpublished data). b) F1 fibre, modelled on the crystal structure of periplasmic chaperone (Caf1M, blue)-subunit 
(Caf1’, red)-subunit (Caf1’’, yellow) complex, generated by assuming same orientation between successive 
subunits (Caf1’’’ to Caf16 in picture). An orange colored string indicates donor β-strand. Image taken from 
(Zavialov et al., 2003).	  
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F1	is	assembled	by	a	bacterial	chaperone-usher	(CU)	pathway	(Di	Yu	et	al.,	2012;	MacIntyre	et	al.,	 2001;	 Zavialov	 et	 al.,	 2003;	 Zavialov	 et	 al.,	 2002),	 one	 of	 the	 most	 common	 assembly	mechanisms	of	pili	in	bacteria	belonging	to	the	Enterobacteriaceae	family	(Busch	and	Waksman,	2012;	 Choudhury	 et	 al.,	 1999;	 Drummelsmith	 and	Whitfield,	 2000;	 Phan	 et	 al.,	 2011).	 Briefly,	following	 synthesis	 of	 the	 F1	 subunit	 (Caf1)	 in	 the	 bacterial	 cytoplasm,	 the	 subunit	 is	transported	 across	 the	 inner	 membrane	 via	 the	 Sec	 pathway	 and	 enters	 the	 periplasm	 (Fig.	
1.5a,	 iia).	 The	 newly	 synthesised	 subunits	 would	 be	 predicted	 to	 have	 an	 incomplete	immunoglobulin	(Ig)-like	fold	of	only	six	β-strands	instead	of	the	seven	required	to	complete	the	fold.	This	would	lead	to	an	exposed	hydrophobic	groove	or	cleft	in	the	subunit.	On	this	account	the	 subunits	 on	 their	 own	 are	 very	 unstable,	 tend	 to	 aggregate	 (misfold)	 and	 are	 rapidly	degraded	 (Fig.	 1.5a,	 iib).	 To	 avoid	 degradation	 and	 assists	 in	 stabilisation	 of	 Caf1	 subunit,	Caf1M	 chaperone	 interacts	 selectively	with	Caf1	 and	donates	 its	G1	 β-strand	via	 a	mechanism	known	as	donor	strand	complementation	(DSC)	(Choudhury	et	al.,	1999;	Zavialov	et	al.,	2003)	
(Fig.	1.5a,	 iii).	This	capture	of	subunit	by	Caf1M	prevents	aggregation	of	nascent	Caf1,	helps	in	correct	 folding	 of	 Caf1	 and	 is	 involved	 in	 targeting	 the	 correctly	 folded	 subunits	 to	 the	 outer	membrane	usher,	Caf1A	(Fig.	1.5a,	iii-iv)	(Chapman	et	al.,	1999;	MacIntyre	et	al.,	2001;	Yu	et	al.,	2012).			Caf1A	 usher	 forms	 a	 transmembrane	 β-barrel	 with	 four	 additional	 functional	 domains,	 an	 N-terminal	domain	(NTD),	a	middle	or	plug	domain	(Huang	et	al.,	2009;	Remaut	et	al.,	2008;	Yu	et	al.,	2009)	and	two	C-terminal	domains	(CTD1	and	CTD2)	(Dubnovitsky	et	al.,	2010;	Ford	et	al.,	2010;	 Phan	 et	 al.,	 2011).	 The	 Caf1ANTD	 selectively	 interacts	with	 Caf1	 loaded	 chaperone	 (Fig.	
1.5a,	iii)	(Yu	et	al.,	2012),	positioning	the	incoming	subunit	correctly	for	donor	strand	exchange	with	 a	 C-terminal	 bound	 Caf1:Caf1M	 complex	 and	 fibre	 elongation	 (polymerisation).	 During	donor	 strand	 exchange,	 the	 N-terminal	 extension	 (GD	 strand)	 of	 the	 incoming	 Caf1	 subunit	displaces	 the	Caf1M	chaperone	G1	 strand	and	occupies	 the	hydrophobic	 cleft	 of	 the	preceding	Caf1	 subunit	 in	 the	 polymer.	 Thus	 by	 exchanging	 the	 chaperone	 G1	 strand	 for	 a	 subunit	 GD	strand,	 the	 Caf1-Caf1	 subunits	 are	 sequentially	 interlocked	 and	 form	 F1	 capsule	 at	 the	 cell	surface	(Fig.	1.5a,	iv).	Selective	binding	of	loaded	chaperone	(Caf1M-Caf1)	to	the	Caf1A	usher	is	a	consequence	of	allosteric	changes	in	the	surface	of	the	chaperone.	In	free	or	unloaded	Caf1M,	two	 invariant	Proline	residues	(Pro103	and	Pro104)	at	 the	end	of	 the	F1	strand	create	a	sharp	kink	 at	 the	 beginning	 of	 the	 subunit-binding	 loop,	 causing	 a	 condensed	 conformation	 of	 the	Caf1A-binding	surface	(Fig.	1.5b,	i).	During	DSC	the	interaction	of	Caf1M	with	Caf1	stretches	the	F1-G1	 loop	 altering	 the	 position	 of	 Pro103	 and	 Pro104	 thus	 opening	 this	 ‘proline	 lock’	 and	generating	a	hydrophobic	pocket	into	which	an	absolutely	conserved	F4	residue	of	Caf1A	can	fit.	This	interaction	is	key	to	stabilising	the	binding	of	Caf1M-Caf1	binary	complex	to	Caf1ANTD	(Fig.	
1.5b,	 iii).	Prior	to	elongation	of	Caf1	polymer	through	Caf1A	usher,	a	central	plug	of	the	usher	must	be	displaced	to	permit	docking	of	a	subunit	in	the	central	usher	pore	(Eidam	et	al.,	2008;	Yu	 et	 al.,	 2009).	 A	 high-resolution	 crystal	 structure	 of	 the	 Fim	 translocon	 complex	 revealed	details	 of	 the	 chaperone:	 subunit:	 adhesin	 complex	 docked	 on	 the	 C-terminus	 of	 FimD	 usher	(Phan	et	al.,	2011).	Based	on	the	facts	that	chaperone:	subunit	complex	binds	both	N-terminus	(Di	 Yu	 et	 al.,	 2012)	 and	 C-terminus	 (Dubnovitsky	 et	 al.,	 2010)	 of	 Caf1A,	Mycroft,	 Z.	 proposed	possible	mechanisms	 of	 Caf1A	 opening	 (Mycroft,	 2011).	 In	 one	model,	 binding	 of	 Caf1M-Caf1	binary	complex	or	Caf1M-Caf1-Caf1	ternary	complex	to	Caf1ANTD	was	sufficient	to	open	the	pore	
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and	 in	 the	 case	 of	 ternary	 complex	 docking	 of	 one	 subunit	 within	 the	 pore.	 This	 would	 be	accompanied	by	transfer	of	the	chaperone	subunit	complex	to	the	C-terminus,	positioning	it	for	polymerisation	with	an	incoming	Caf1ANTD	bound	binary	subunit:	chaperone	complex.	The	other	model	 involved	 opening	 of	 the	 pore	 upon	 direct	 binding	 of	 the	 ternary	 complex	 to	 the	 C-terminus.	 This	 would	 then	 also	 be	 appropriate	 for	 polymerisation	 with	 an	 incoming	 binary	complex.		However,	it	is	still	elusive	what	activates	opening	of	the	Caf1A	pore.		
 
 	
Figure 1.5| F1 Assembly. 
a) Schematic presentation of F1 assembly.  F1 subunit (Caf1) is transported into the periplasm via the sec 
pathway (iia). In the periplasm, chaperone (Caf1M) aids folding of subunit by donating its G1 strand (i) and edge 
strand interactions by a process known as donor strand complementation (DSC). The chaperone:subunit complex 
is then targeted to the outer membrane usher (iii) where the subunit is incorporated into the growing fiber as 
chaperone: subunit interaction is exchanged for subunit: subunit interaction in a process known as donor strand 
exchange. This leads to translocation through the Caf1A outer membrane usher (iv), forming a capsular like 
structure of F1 on the cell surface. b) Selective targeting of Caf1M-Caf1 binary complex to Caf1ANTD via 
opening of a proline lock at Caf1M-P103/P104. Caf1M-Caf1 interaction during DSC leads to shortening of the 
chaperone F1-G1 binding loop. Repositioning of Pro104 results in opening of a hydrophobic pocket into which 
the Phe4 residue of Caf1A can fit. This stabilises the Caf1ANTD interaction specifically with loaded chaperone. 
Turquoise, Caf1M chaperone; royal blue, Caf1M G1 and F1 strands or dashed line F1-G1 loop; yellow spheres, 
Pro103 and Pro104 magenta, Caf1 subunit; orange, Caf1AN, red line Caf1A unstructured N-terminal 1-24 
residues. Picture (a) is taken from (MacIntyre, 2004) and (b) from (Di Yu et al., 2012).  
 
1.4 Transcription regulation in bacteria 
	To	protect	 from	the	adverse	environment	and	ensure	energy	economy,	bacterial	cells	 respond	quickly	and	regulate	gene	expression	by	making	the	right	products	in	the	correct	amount	at	the	appropriate	time	E.	coli	has	served	as	model	organism	to	understand	bacterial	gene	regulation.	The	 key	 steps	 to	 regulate	 gene(s)	 lie	 in	 the	 initiation	 of	 transcription	 or	 RNA-transcript	formation.	The	central	component	of	transcription	initiation	is	DNA-dependent	RNA	polymerase	(RNAP),	a	multi-subunit	holoenzyme,	which	is	composed	of	2α,	β,	β′,	σ	and	ω	subunits	(Ebright,	2000).	Active	site	for	RNAP,	the	determinant	for	the	binding	of	both	template	DNA	and	the	RNA	
a!
b! i) ii) iii) 
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product,	 is	 made	 up	 from	 the	 large	 β	 and	 β′	 subunits.	 Each	 of	 the	 two	 identical	 α	 subunits	contains	 two	 independently	 folded	 domains,	 a	 larger	 amino-terminal	 domain	 (αNTD)	 and	 a	smaller	 carboxy-terminal	 domain	 (αCTD),	which	 are	 joined	by	 flexible	 linker	 (Korzheva	 et	 al.,	2000).	The	αNTD	dimerises	and	is	responsible	for	the	assembly	of	the	β	and	β′	subunits	while	αCTD	is	a	DNA-binding	module	has	an	important	role	at	certain	promoters	(Gourse	et	al.,	2000).	No	direct	role	in	transcription	has	been	assigned	for	the	ω	subunit	but	it	seems	to	function	as	a	chaperone	 to	 assist	 the	 folding	 of	 the	 β′	 subunit	 (Mathew	 and	 Chatterji,	 2006).	 To	 begin	transcription	at	a	particular	promoter,	the	core	RNAP	(made	up	of	2α,	β,	β′	and	ω	subunits)	must	first	interact	with	σ	subunit	to	form	the	holoenzyme.	The	σ	subunit	has	3	main	functions,	1)	to	ensure	the	recognition	of	specific	promoter	elements,	2)	to	position	the	RNAP	holoenzyme	at	a	target	promoter	and	3)	to	facilitate	unwinding	of	the	DNA	duplex	near	the	transcript	start	site	(Wosten,	1998).	Most	bacteria	contain	multiple	σ	 factors,	enabling	 the	recognition	of	different	set	of	promoters.	With	an	exception	of	σ54	(Merrick,	1993),	all	σ	factors	share	common	features,	which	 are	 multi-domain	 proteins,	 consist	 of	 up	 to	 4	 different	 domains	 joined	 by	 linkers	(Campbell	 et	 al.,	 2002).	 Domains	 (regions)	 2,	 3	 and	 4	 are	 known	 to	 be	 involved	 in	 promoter	recognition,	whereas	the	function	of	domain	(region)	1	is	not	understood	(Browning	and	Busby,	2004).			Transcription	 initiation	 requires	 the	 interaction	 of	 RNAP	 holoenzyme	 with	 promoter	 DNA	 to	form	an	open	complex,	in	which	unwinding	of	duplex	DNA	begins	near	the	transcript	start-site	(deHaseth	et	al.,	1998).	Following	this,	synthesis	of	DNA	template-directed	RNA	starts,	with	the	formation	 of	 the	 first	 phosphodiester	 bond	 between	 the	 initiating	 and	 adjacent	 nucleoside	triphosphate.	 After	 the	 initiation	 stage,	 RNAP	 is	 moved	 into	 the	 elongation	 stage	 and	 thus	extension	 of	 RNA-chain	 occurs.	 A	 crucial	 step	 in	 transcription	 initiation	 is	 the	 promoter	recognition	 by	RNAP	 and	 the	 different	DNA	 elements	 recognised	 by	RNAP	 have	 been	 studied	extensively	 (Busby	 and	 Ebright,	 1994).	 Four	 DNA	 elements	 have	 been	 identified.	 	 The	 two	principal	 elements	 are	 -10	 and	 -35,	 with	 a	 consensus	 of	 TATAAT	 (-10)	 and	 TTGACA	 (-35),	located	at	10	and	35	bp	upstream	from	the	transcription	start	site	(TSS).	The	-10	elements	are	recognised	by	domain	2	and	-35	elements	by	domain	4	of	the	σ	subunit	(Murakami	et	al.,	2002).	The	 remaining	 two	DNA	elements	 are	 the	 extended	 -10	 (by	3-4	bp)	 and	 the	UP-element	 (≈20	bp),	located	upstream	of	the	-35	element.		The	extended	-10	elements	are	recognised	by	domain	3	of	the	σ	subunit	whereas	UP-elements	are	recognised	by	αCTD	(Murakami	et	al.,	2002;	Ross	et	al.,	 2001).	 Following	 initial	 binding	 of	 RNAP	 with	 promoter	 DNA	 (closed	 complex),	 the	 DNA	strands	from	approximately	-10	to	+2	(relative	to	TSS)	are	unwound	and	form	the	open	complex	(Tsujikawa	et	al.,	2002)	and	thus	permitting	transcription.			To	 ensure	 transcription	 at	 the	 correct	 promoter	 when	 required,	 productive	 distribution	 of	RNAP,	 promoter	 sequence,	 σ	 factors,	 small	 ligands,	 transcription	 factors	 and	 the	 folded	chromosome	 structure	 all	 have	 critical	 roles,	 as	 elegantly	described	by	Busby	 and	 co-workers	(Browning	 and	 Busby,	 2004).	 A	 brief	 overview	 on	 how	 different	 transcriptional	 factors	(regulators)	control	 transcription	 is	described	here.	 In	E.	coli	K-12,	304	genes	are	predicted	to	encode	 regulators	 to	 regulate	 (up	and	down)	 transcription	of	almost	half	of	 the	 total	 genes	 in	this	bacterium	(Perez-Rueda	et	al.,	2015).	About	60%	of	these	regulators	contain	two-domains,	30%	have	single	domain,	and	10%	contain	3	and	4	structural	domains.	The	most	frequent	DNA-
	 13	
binding	domains	correspond	to	the	winged	helix-turn-helix	motifs.	Most	of	these	regulators	are	predicted	 to	 bind	 specifically	 to	 the	 promoter	 DNA.	 Some	 of	 these	 regulators	 are	 global	 and	hence	 control	 expression	 of	 large	 number	 of	 genes	 whereas	 some	 are	 dedicated	 regulators	controlling	expression	of	one	or	two	genes	or	an	operon.	On	the	basis	of	sequence	analysis	and	predicted	 structures,	 these	 regulators	 are	 grouped	 in	 different	 families	 correspond	 to	 well-studied	families,	LacI,	AraC,	LysR,	CRP	and	OmpR	(Perez-Rueda	et	al.,	2015).				Transcriptional	 regulators	 controlling	 the	 expression	 of	 genes	 in	 response	 to	 environmental	signals	 must	 be	 regulated	 either	 by	 controlling	 their	 activity	 or	 their	 expression.	 Several	mechanisms	are	utilised	to	achieve	this.	First,	the	DNA	binding	affinity	of	the	regulators	can	be	modulated	by	small	 ligands,	nutrient	availability	or	stress	signal.	A	well-characterised	example	of	this	is	LacI	repressor	whose	DNA-binding	affinity	is	modulated	by	allolactose,	in	the	presence	of	lactose	(Daber	et	al.,	2007).	Second,	the	activity	of	some	regulators	is	modulated	by	covalent	modification	and	such	regulators	are	known	as	response	regulators.	For	example,	NarL,	which	binds	to	its	target	DNA	only	once	it	is	phosphorylated	by	the	cognate	sensor	kinase	such	as	NarX	and	 NarQ,	 which	 are	 activated	 by	 binding	 to	 extracellular	 nitrite	 or	 nitrate	 ions	 (Stock	 et	 al.,	2000).	Third,	the	concentration	of	regulators	inside	the	cell	controls	their	activity.	In	such	cases	concentration	 is	 determined	 either	 by	 the	 rate	 of	 expression	 or	 by	 proteolysis.	 For	 examples,	SoxS	(AraC-type	regulator)	whose	transcription	is	controlled	by	SoxR,	which	in	is	turn	regulated	by	 interaction	with	oxidizing	 ligands	(Demple,	1996)	and	enhanced	proteolysis	of	RovA	global	regulator	 (SlyA/Hor	 family)	 of	 Y.	 pestis	 at	 37°C	 (Quade	 et	 al.,	 2012).	 Fourth,	 a	 less	 common	mechanism	 for	 regulating	 the	 effective	 concentration	 of	 transcriptional	 regulator	 is	sequestration	by	a	regulatory	protein	to	which	it	binds	(Plumbridge,	2002).			When	a	transcriptional	regulator	binds	to	its	cognate	promoter,	it	can	either	activate	or	repress	transcription.	Although,	 some	regulators	 function	solely	as	activators	or	repressors	others	can	function	 as	 both	 activator	 and	 repressor	 according	 to	 the	 target	 promoter	 (Perez-Rueda	 and	Collado-Vides,	2000).	Activators	enhance	the	performance	of	the	target	promoter	by	improving	its	 affinity	 to	RNAP.	Hence,	 it	 is	 quite	 likely	 that	most	 activators	 first	 bind	 to	 target	promoter	before	binding	to	RNAP.	Although,	some	regulators	first	interact	with	free	RNAP	and	then	scan	the	 sequence	 of	 target	 promoter	 DNA,	 examples	 include,	MarA	 and	 SoxS	 (Martin	 et	 al.,	 2002;	Shah	 and	 Wolf,	 2004).	 Different	 mechanisms	 have	 been	 documented	 to	 express	 genes	 in	response	to	changing	environment.	Although	each	mechanism	has	variation	in	the	level	of	gene	expression	which	 is	 known	as	 fine-tuning	but	 there	 are	 some	exception	which	do	not	 require	fine-tuning	such	as	expression	of	 the	 fimbrial	gene.	DNA	segment	containing	 the	promoter	 for	the	fimbrial	genes	can	be	switched	from	one	orientation	in	which	transcription	of	fimbrial	gene	occurs,	 to	 the	 opposite	 orientation	 in	 which	 promoter	 is	 directed	 away	 and	 thus	 creating	 an	effective	 ON/OFF	 switch	 (Blomfield,	 2001).	 Transcription	 activation	 at	 many	 promoters	 is	simple	and	thus	involves	contribution	of	a	single	activator.	Three	basic	mechanisms	are	utilised	for	simple	activation,	class	I,	class	II	and	activator-mediated	conformational	change	of	the	target	promoter,	 enabling	 interactions	 of	 RNAP	 with	 -10	 and	 -35	 recognition	 elements.	 The	 class	 I	activation	require	regulator	binding	to	the	target	promoter	sequence	located	upstream	of	the	-35	element	and	 thus	 recruit	RNAP	by	 interacting	with	αCTD	of	RNAP.	Example	of	 this	kind	of	activation	 is	 the	 action	 of	 cAMP	 receptor	 protein	 (CRP)	 at	 lac	 promoter	 (Ebright,	 1993).	
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Regulators	 function	 in	 class	 I	 manner	 can	 bind	 at	 several	 locations	 upstream	 of	 promoters,	which	 is	 accompanied	 by	 flexible	 linker	 joining	 the	 αCTD	 and	 αNTD	 of	 RNAP.	 The	 class	 II	activation	 requires	 activator	 binding	 to	 the	 target	 sequence,	 which	 overlaps	 -35	 element	 and	thus	 contacts	 αCTD	 and	 region	 4	 of	 σ	 subunit	 of	 the	 RNAP	 (Dove	 et	 al.,	 2003).	 The	 third	mechanism	of	activation,	which	is	by	conformational	change	of	the	target	promoter	by	activator,	requires	 activators	 binding	 at	 or	 close	 to	 the	 promoter	 elements	 (Sheridan	 et	 al.,	 2001).	Promoters	 activated	by	MerR	 family	 regulators	 are	 examples	 of	 this	 kind	of	 activation,	where	spacing	between	 -10	and	 -35	 is	not	optimum	for	 the	binding	of	RNAP.	Activators	belonging	 to	MerR	family	bind	to	the	-10	and	-35	spacer	sequence	and	twist	the	DNA	to	reorientate	-10	and	-35	elements	in	such	a	way	that	they	can	be	bound	by	RNAP	σ	subunit	(Brown	et	al.,	2003).			Like	transcription	activation,	repression	of	transcription	by	repressor	proteins,	which	decreases	the	 rate	 of	 transcription	 by	 binding	 to	 the	 target	 promoter	 is	 also	 simple	 and	 thus	 involves	 a	single	 repressor.	 Three	 mechanisms	 have	 been	 illustrated	 for	 transcription	 repression,	 first,	steric	hindrance	of	RNAP	binding	to	the	target	promoter.	In	this	case,	repressor-binding	site	are	located	 in	 or	 close	 to	 -10	 and	 -35	 elements,	 example	 include	 repression	 by	 LacI	 repressor	 by	binding	to	lac	promoter	(Daber	et	al.,	2007).	Second,	repressor	might	not	prevent	RNAP	binding	but	 might	 interfere	 with	 post	 recruitment	 step	 of	 transcription	 initiation	 (Muller-Hill,	 1998).	Third	 mechanism	 of	 repression	 involves	 DNA	 looping,	 where	 multiple	 repressor	 molecules	binds	to	promoter	distal	sites,	causing	loop	formation	and	thus	shuts	off	transcription	initiation.	The	 best-characterised	 example	 of	 transcription	 repression	 by	 DNA-looping	 is	 regulation	 of	
araBAD	 operon	 by	 AraC,	 discussed	 in	 later	 sub	 section.	 Unlike	 activation,	 complex	 cases	 of	repression	also	have	been	characterised	where	repressor	acts	as	an	anti-activator.	For	example,	CytR-repressed	promoters	those	are	dependent	on	activation	by	CRP,	which	in	turn	is	mediated	by	CytR	direct-interaction	with	CRP	(Shin	et	al.,	2001).	CytR	recognises	tandom-bound	CRP	and	the	 bound	 CRP	 confers	 the	 specificity	 for	 CytR-mediated	 repression	 (Valentin-Hansen	 et	 al.,	1996).	 It	 has	 been	 documented	 that	 CRP,	 FNR,	 IHF,	 Fis,	 ArcA,	 NarL	 and	 Lrp	 transcription	regulators	control	50%	of	all	regulated	genes,	whereas	about	60	other	transcription	regulators	control	 only	 a	 single	 promoter	 (Martinez-Antonio	 and	 Collado-Vides,	 2003).	 A	 descriptive	survey	 of	 CU	 pathway	 assembled	 fimbriae/pili	 regulation	 mechanisms	 and	 more	 specifically	regulation	 by	 AraC/XylS	 family	 of	 transcriptional	 regulators	 is	 discussed	 in	 the	 following	subsections.		
1.4.1 Regulation of expression of CU pathway assembled pili/fimbriae  	To	 establish	 an	 infection,	 attachment	 of	 bacterial	 pathogens	 to	 specific	 host	 cells	 is	 often	 a	crucial	 step.	 This	 is	 often	 mediated	 by	 surface-exposed	 adhesive	 structures	 known	 as	 pili	 or	fimbriae,	assembled	by	the	CU	pathway	(Sauer	et	al.,	2004;	Soto	and	Hultgren,	1999;	Thanassi	et	al.,	 1998;	 Zavialov	 et	 al.,	 2007).	 Genes	 involved	 in	 the	 biogenesis	 of	 the	 pili	 or	 fimbriae	 are	clustered	into	operons.	These	operons	always	contain	a	gene	for	the	major	structural	subunit	or	pilin,	 a	 periplasmic	 chaperone	 and	 an	 outer	 membrane	 usher	 protein.	 	 Often,	 these	 operons	contain	 additional	 genes	 encoding	 structural	 proteins	 such	 as	 genes	 for	 minor	 subunits	 and	adhesins	located	at	the	tip	of	the	pilus	and	sometimes	the	locus	includes	additional	chaperones	and	regulatory	protein(s)	(Fig.	1.6).			
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Figure 1.6| Gene clusters/operons of some FGL and FGS group fimbriae. 
Colored arrows indicate the orientation of each gene in the cluster/operon; black (regulator/s), blue (periplasmic 
chaperone), orange (outer membrane usher), red (adhesin and structural subunit/s), yellow (subunit/s with 
unknown function), green (protein/s with putative function) and pink (protein/s of unknown function). Numbers 
inside the colored arrows designate the molecular weight in kDa of the corresponding protein. Black asterisks (*) 
indicate CU loci known to be controlled by an AraC/XylS family regulator, AggR (29.4 kDa), AfrR (32 kDa), 
Caf1R (36 kDa), LdaA (36 kDa) and Rns (32 kDa). AggR and Rns (*, not indicated) are global regulators. AggR 
controls expression of agg, agg-3 and aaf fimbriae (Morin et al., 2013; Nataro et al., 1994). Rns controls the 
expression of cs1-4, cs14, cs17 and cs19 fimbriae (Bodero et al., 2008; Caron et al., 1989). Picture modified 
from (Zav'yalov et al., 2010). 
1.4.2 Diversity of CU pathway assembled pili/fimbriae 	The	CU	class	was	initially	divided	into	two	structurally	and	functionally	distinct	groups,	FGS	and	FGL	(Fig	1.6),	where	the	assembly	of	pili	or	fibrillar	structures	is	assisted	either	by	a	short	(S)	or	a	long	(L)	F1-G1	loop	of	the	periplasmic	chaperone	(Hung	et	al.,	1996).	A	well-studied	example	of	CU	pathway	from	the	FGL	group	is	the	assembly	of	Y.	pestis	F1	capsular	antigen.	Most	of	the	FGL	group,	like	the	Caf	system	assemble	simple,	thin	and	flexible	fibres	of	only	one	or	two	subunits.		The	pili	belonging	to	 the	very	 large	FGS	group	are	generally	 thick	and	rigid	pili	also	known	as	adhesive	 fimbriae.	These	 fimbriae/pili	have	a	more	complex	 structure	with	a	major	 structural	subunit	 (fimbrin/pilin)	making	up	 the	shaft	of	 the	pilus,	 several	additional	 subunits	 forming	a	thin	flexible	tip	fibrillum	and	a	single	specialised	adhesin	with	both	pilin	and	adhesin	domains	
caf 
psa 
mif 
afa-8 
afa-3 
daa 
dafa 
dra 
agg-3 
agg 
aaf 
nfa 
cs3 
saf 
sef 
cs6-1 
cs6-2 
** 
** 
* 
* 
** 
atf 
pef 
aciad 
f17a 
acu 
fim/fha 
fas 
csw 
fot 
afr 
hif 
haf 
mrk 
lpf 
pmf 
foc 
stf 
fim 
sfp 
ral 
sfa 
mrp 
lda 
fae 
mrf 
pap 
* 
FGL Group fimbriae 
FGS Group fimbriae 
* 
* 
	 16	
on	 the	 tip	 of	 pilus	 (Hung	 et	 al.,	 1996)	 unlike	 F1	 (MacIntyre,	 2004;	 Zavialov	 et	 al.,	 2003).	Phylogenetically,	 FGS	 group	 is	 much	 more	 diverse	 and	 is	 subdivided	 into	 several	 clades	including,	β-,	γ1-,	γ2-,	γ4-,	κ-	and	π-fimbriae	(Nuccio	and	Baumler,	2007).	Unlike	FSG,	FGL	 is	a	small	monophyletic	group	having	only	one	clade,	γ3.			Expression	 of	 pili/fimbriae	 from	 both	 groups	 is	 often	 tightly	 controlled	 to	 avoid	 expression	when	 not	 needed.	 Different	 mechanisms	 used	 to	 regulate	 expression	 of	 CU	 systems,	 either	belonging	 to	 FGS	 or	 FGL	 group.	 Well-studied	 examples	 of	 both	 the	 assembly	 and	 the	 gene	regulation	of	fimbriae/pili	from	the	FGS	group	are	Type	1	and	Pap	fimbriae	of	E.	coli	(Blomfield,	2001;	Busch	and	Waksman,	2012;	Choudhury	et	al.,	1999;	Drummelsmith	and	Whitfield,	2000;	El-Labany	et	al.,	2003;	Fernandez	and	Berenguer,	2000;	Hernday	et	al.,	2002;	Phan	et	al.,	2011;	Schwan,	 2011;	 Sohanpal	 et	 al.,	 2004;	 Sohanpal	 et	 al.,	 2007).	 An	 overview	 of	 regulatory	mechanisms	 controlling	 expression	 of	 the	 Type	 1	 fimbriae	 and	 Pap	 pilus	 (FGS	 group),	 and	regionably	well-studied	examples	from	the	FGL	group	are	described	below.			
1.4.3 Regulatory mechanisms of FGS group: Type 1 and Pap fimbriae/pili   
i)	 Regulation	of	Type	1	fimbriae	expression:	promoter	inversion			Type	1	 fimbriae	of	uropathogenic	E.	coli	are	 synthesised	 from	a	 chromosomally	 encoded	gene	cluster	known	as	 the	 fim	 locus.	This	 locus	 is	 composed	of	9	 genes,	 fimB,	 fimE,	 fimA,	 fimI,	 fimC,	
fimD,	fimF,	fimG	and	fimH	(Fig.	1.7a),	encoding	two	regulatory	proteins,	FimB	and	FimE;	a	major	subunit	 pilin,	 FimA;	 two	 assembly	 proteins,	 a	 periplasmic	 chaperone,	 FimC	 and	 an	 outer	membrane	 usher,	 FimD;	 two	 tip	 associated	 fibrillum	 subunits,	 FimF	 and	 FimG;	 the	mannose-binding	terminal	adhesin,	FimH;	and	FimI,	a	subunit	responsible	 for	anchoring	the	pilus	to	the	cell	 surface.	Regulation	of	expression	of	 the	 fim	 locus	 is	mediated	by	Phase	variation,	which	 is	accompined	by	an	 invertible	DNA	fragment	(314	bp),	known	as	 fimS,	flanked	by	9	bp	inverted	repeats,	IRL	and	IRR	(5’TTGGGGCCA3’)	(Fig.	1.7b).	A	promoter	located	on	fimS	is	responsible	for	transcription	of	major	fimbrial	subunit	(FimA)	encoding	gene,	fimA.	Switching	the	orientation	of	
fimS	 is	 responsible	for	 transcription	of	 fimA,	 forward	orientation	 lead	 to	 transcription	 (Phase-	ON,	pilliated	state)	wherease	in	opposite	orientation	of	fimS,	no	transcription	is	possible	(Phase-OFF,	 non-pilliated	 state).	 The	 regulatory	proteins,	 FimB	and	FimE	 influence	 the	 orientation	of	
fimS.	 They	 are	 site-specific	 recombinases,	 share	 48%	 amino	 acid	 identity	 and	 both	 contain	 a	tetrad	 of	 conserved	 amino	 acids	 (Arg47,	 His141,	 Arg144	 and	 Tyr176;	 in	 FimB	 and	 Arg41,	His136,	Arg139	and	Tyr171;	 in	FimE),	which	has	been	shown	 to	be	essential	 for	 recombinase	activity	 (Blomfield,	2001;	Burns	et	al.,	 2000;	Dorman	and	Higgins,	1987;	Schwan,	2011;	Smith	and	Dorman,	1999).	FimB	can	bind	to	fimS	in	both	states,	Phase-ON	and	Phase-OFF	with	a	slight	bias	 toward	 the	 Phase-OFF	 state	 (Schwan,	 2011).	 In	 contrast,	 FimE	 primilarly	 mediates	 the	inversion	 of	 fimS	 from	 ON	 to	 OFF	 state	 (Fig.	 1.7b).	 The	 mechanism	 and	 factors	 influencing	orientation	and	recombination	of	the	fimS	element	are	clearly	complicated	and	are	influenced	by	the	concentrations	of	both	FimB	and	FimE,	as	well	as	other	factors.	Three	promoters	have	been	identified	for	 fimB	expression	(Donato	et	al.,	1997;	Schwan	et	al.,	1994)	while	for	 fimE	a	single	promoter	has	been	identified	(Olsen	and	Klemm,	1994).			
	 17	
At	least	20	additional	auxiliary	genes	are	known	to	influence	the	expression	of	Type	1	fimbriae	
(Fig.	1.7c).		The	product	of	pilG,	an	allele	of	the	hns	gene,	was	reported	to	influence	inversion.	A	mutation	 in	 the	pilG	was	shown	 to	 increase	 inversion	of	 fimS	up	 to	100-fold	using	a	 fimA-lacZ	fusion	(Spears	et	al.,	1986).	The	global	regulatory	protein,	H-NS,	represses	transcription	of	both	
fimB	 and	 fimE	 genes	by	binding	 to	promoters	of	both	with	high	specificity	 (Olsen	and	Klemm,	1994;	Olsen	et	al.,	1998;	Schwan	et	al.,	2002).	H-NS	may	also	directly	affect	inversion	by	binding	to	 sequences	 adjacent	 to	 the	 fimS	DNA	 fragment	 (Donato	 and	 Kawula,	 1999;	 Schwan	 et	 al.,	2002).	 In	 addition	 to	H-NS,	 integration	host	 factor	 (IHF)	 and	 leucine-responsive	protein	 (Lrp)	also	affect	Phase	variation	(Brinkman	et	al.,	2003;	Dorman	and	Higgins,	1987;	Eisenstein	et	al.,	1987).	Both	IHF	and	Lrp	cause	sharp	bends	in	the	DNA	structure,	introducing	hairpin	loops	that	facilitate	recombination.	Other	site-specific	recombinases	(HbiF,	IpuA,	IpuB	and	IpbA)	have	been	identified	 as	 possibly	 influencing	 inversion	 of	 fimS	 (Xie	 et	 al.,	 2006).	 There	 is	 also	 cross	 talk	between	regulators	of	different	pili	systems	in	E.	coli.	Both	PapB,	a	regulatory	protein	of	the	Pap	fimbriae	locus,	and	SfaB	from	the	S	pili	locus,	can	influence	the	orientation	of	fimS	by	inhibiting	the	Phase-OFF	to	the	Phase-ON	switch	(Holden	et	al.,	2006;	Holden	et	al.,	2001;	Xia	et	al.,	2000).	The	ppGpp	alarmone	also	appears	to	be	required	for	optimum	expression	of	Type	1	fimbriae	and	the	ppGpp	alarmone	along	with	RNA	polymerase-binding	protein,	DksA	was	shown	to	stimulate	transcription	 of	 fimB	 from	 the	 P2	 promoter	 (Paul	 et	 al.,	 2005;	 Schwan,	 2011).	 Environmental	factors	such	as	temperature	and	pH	also	play	a	crucial	role	in	the	expression	of	type	1	fimbriae.	Several	 studies	have	shown	 that	 the	Phase	switching	 from	OFF	 to	ON	state	 increases	at	 lower	temperature	 (Dorman	 and	 Ni	 Bhriain,	 1992;	 Gally	 et	 al.,	 1993;	 Olsen	 et	 al.,	 1998).	 Under	conditions	of	 low	pH,	proteins	such	as	SlyA	or	RcsB	may	activate	 fimB	and	prevent	H-NS	 from	binding	thus	promoting	Type	1	fimbriae	synthesis	(Schwan,	2011).			
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Figure 1.7| Regulation of Type 1 fimbriae expression. 
a) The fim locus indicating key features, role of each gene, promoters and invertible fimS DNA element flanked 
by inverted repeats IRL and IRR, responsible for Phase ON/OFF states.  b) FimB and FimE mediated inversion 
of fimS DNA element. Fim B influences ON state and piliated bacteria. FimB and FimE both bind to influence 
switch to non-piliated bacteria. c) Role of 20 auxiliary proteins in regulation of Type 1 fimbriae.  Invertible 
motifs, IRL and IRR are indicated in open boxes. IHFs (I-II) and Lrp (1-3) binding sites are also represented as 
open boxes. The fimB, fimE and fimA are displayed in black boxes. All identified promoters are shown as bent 
black arrows. Dark and light gray arrows correspond to FimB and FimE, respectively. Black arrows signify 
effect on fimS. Confirmed and presumed binding associated with stimulatory effects is presented by solid and 
dashed green arrows, respectively; whereas confirmed and presumed binding associated with repressing effects 
are shown by solid and dashed red arrows, respectively. Picture (a) modified from (Fernandez and Berenguer, 
2000; Schwan, 2011) and pictures, (b) and (c) were modified and provided by Bill Schwan (Schwan, 2011).  
 
ii)	 Regulation	of	Pap	pili	expression:	methylation/epigenetic	switch			Genes	encoding	Pap	pilus	are	clustered	on	a	chromosomally	encoded	pap	 locus	which	contains	11	genes,	papI,	papB,	papA,	papH,	papC,	papD,	papJ,	papK,	papE,	papF	and	papG.	The	role	of	each	gene	product	 is	depicted	 in	Fig.	 1.8a.	PapB	and	PapI,	are	 regulatory	proteins	essential	 for	 the	expression	 Pap	 pilus.	 PapA	 is	 the	 major	 pilin,	 while	 PapK,	 PapE	 and	 PapF	 code	 for	 the	 tip	fibrillum,	PapG	is	a	galactose-binding	adhesion	and	PapH	is	the	pilus	anchor.	The	other	two	gene	
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products	 PapD	 and	 PapC	 are	 the	 two	 assembly	 proteins,	 a	 periplasmic	 chaperone,	 and	 outer	membrane	usher,	respectively	(Fernandez	and	Berenguer,	2000;	Sauer	et	al.,	2004).	Regulation	of	expression	of	the	pap	locus	is	also	mediated	by	Phase	variation	but	in	a	different	way	to	that	of	Type	1	 fimbriae.	Phase	variation	 in	Pap	 is	determined	by	binding	of	Lrp	 to	2	different	Dam	methylation	sites	within	 the	promoter	 region.	This	prevents	methylation	of	 the	site	 leading	 to	either	 activate	 (Phase-ON)	 or	 repress	 (Phase-OFF)	 transcription	 of	 the	 pap	 gene	 cluster	(Blomfield,	2001),	as	depicted	in	Fig.	1.8b-c.	The	regulatory	proteins,	PapI	(8	kDa)	and	PapB	(12	kDa)	 positively	 control	 expression	 of	 the	 pap	 gene	 cluster	 in	 association	 with	 the	 global	regulatory	proteins,	Lrp,	CAP	and	H-NS	(Hernday	et	al.,	2002;	White-Ziegler	et	al.,	1998;	White-Ziegler	et	al.,	2000).	The	intergenic	regulatory	region	(416	bp)	between	papI	and	papB	contains	6	Lrp-binding	sites	(1-6),	which	control	transcription	of	both	papA	and	papB	(Fig.	1.8b).	Within	this	there	are	two	DNA	methylase	(Dam)	sites,	GATCprox	and	GATCdist	located	within	Lrp-binding	sites	2	 and	5,	 respectively	 (Fig.	 1.8b-c).	 	When	accessible	 these	 sites	 are	methylated	 at	 the	A	base	of	the	GATC	motif,	but	when	Lrp	is	bound	methylation	of	the	sites	is	blocked.	Lrp-binding	proximal	 to	papBA	 promoter	 inhibits	 transcription	whereas	 binding	 at	 the	 distal	 site	 permits	methylation	 at	 site	 2	 and	 activates	 transcription	 of	 papBA	 (ON	 state).	 Lrp	 binds	 with	 higher	affinity	 to	 1-3	 sites	 than	 4-6	 (Braaten	 et	 al.,	 1994;	 Nou	 et	 al.,	 1995;	 Nou	 et	 al.,	 1993).	 The	regulator	 PapI	 promotes	 binding	 of	 LRP	 to	 sites	 3-5	 rather	 than	1-3,	 promoting	 the	ON	 state.	Transcription	is	also	under	control	of	catabolite	repression	thus	requiring	binding	of	cAMP-CAP	complex	60	bp	upstream	of	the	Lrp-binding	site	(Baga	et	al.,	1985;	Goransson	et	al.,	1989;	Hung	et	al.,	2001;	Weyand	et	al.,	2001).			As	with	regulation	of	expression	of	Type	1	fimbriae,	expression	of	Pap	pili	is	also	controlled	by	a	number	 of	 environmental	 stimuli	 (Baga	 et	 al.,	 1985;	 White-Ziegler	 et	 al.,	 2000).	 Pap	 pili	transcription	 is	 significantly	 repressed	during	 growth	 at	 lower	 temperatures	 (<26°C)	 in	 Luria	broth	(Goransson	et	al.,	1990;	Goransson	and	Uhlin,	1984;	White-Ziegler	et	al.,	2000).	In	addition	to	environmental	factors,	proteins	not	belonging	to	the	pap	locus	have	been	shown	to	contribute	to	 positive	 regulation	 of	 Pap	 pilus	 transcription.	 For	 example,	 the	 two-component	 sensor-regulator	CpxAR	appears	to	be	activated	by	misfolded	Pap	subunits	in	the	periplasm	as	well	as	on	 binding	 of	 Pap	 pilus	 to	 solid	 surfaces.	 This	 initiates	 a	 phosphotransfer	 relay	 from	CpxA	 to	CpxR,	which	in	turn	upregulates	transcription	of	a	number	of	genes,	 including	degP	and	pap.	 It	has	also	been	shown	that	when	CpxAR	system	is	activated,	the	transcription	of	papI	and	papBA	is	enhanced	2-fold	(Otto	and	Silhavy,	2002).				
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Figure 1.8| Regulation of Pap pilus expression.   
a) The pap locus, indicating key features. Genes encoding regulatory proteins, PapI and PapB; pilus assembly 
proteins, PapH, PapC and PapD; tip fibrillum proteins, PapJ, PapK, PapE and PapK; and adhesin protein, PapG 
are indicated by different shaded boxes and labeled accordingly. b) Regulatory network of pap locus. Regulatory 
region of divergently transcribed papBA and papI promoters is depicted. Dam methylation sites, GATCprox and 
GATCdist are located within Lrp binding sites 2 and 5 as indicated. Legends for PapB, CAP and Lrp binding sites 
along with -10 and -35 elements are indicated on left side of the figure. Orientation of Lrp sites with consensus 
sequence 5’Gnn(n)TTTt3’ are indicated with arrows above the sequence. Mutations (substitution, deletion and 
insertion) shown below the wild type sequence switch the phenotype of mutants is indicated in parentheses. c) 
DNA-methylation states of Phase-ON and Phase-OFF cells. DNA methylation of the GATC sites is blocked by 
Lrp-binding at 4-6 sites in Phase-ON cells and at 1-3 sites in Phase-OFF cells. Picture (a) is taken from 
(Fernandez and Berenguer, 2000) and (b) and (c) are taken from (Hernday et al., 2002) with permission. 
 
 
1.4.4 Regulation of expression of FGL group CU systems 	Within	the	FGL	(Υ3)	group	of	CU	loci,	the	regulatory	mechanisms	of	expression	of	only	few	loci	have	been	studied	and	understanding	is	very	limited	when	compared	to	the	detailed	knowledge	of	regulation	of	expression	of	Type	1	and	Pap	pili	of	E.	coli.	One	system	which	has	been	studied	in	 some	 detail	 is	 expression	 of	 the	 chromosomally	 located	 psa	 locus	 which	 encodes	 the	 pH6	fibrillar	 antigen	 of	 Y.	 pestis	 and	 is	 closely	 related	 to	 the	myf	 locus	 of	 Y.	 pseudotuberculosis)	(Iriarte	 and	 Cornelis,	 1995;	 Zavialov	 et	 al.,	 2007;	 Zhang	 et	 al.,	 2013).	 The	 pH6	 antigen	 is	expressed	at	low	pH	and	inside	macrophage	(Huang	and	Lindler,	2004)	hence	its	name.		The	psa	locus	 is	 composed	of	 five	genes,	psaE,	psaF,	psaA,	psaB	and	psaC	(Fig.	 1.6).	PsaE	(24	kDa)	and	
a 
b 
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PsaF	 (18	 kDa)	 are	 regulators	 both	 located	 within	 the	 inner	 membrane	 and	 required	 for	expression	 of	 pH6	 fibrillum.	 PsaE	 contains	 a	 cytosolic	 N-terminal	 DNA-binding	 domain	 with	homology	 to	 PhoB	 and	OmpR	 of	E.	 coli,	ToxR	 of	Vibrio	 and	HilA	 of	 S.	 typhimurium	 (Yang	 and	Isberg,	 1997).	 The	 C-terminal	 domain	 of	 PsaE	 lies	 in	 the	 periplasm	 and	 interacts	 with	 the	periplasmic	domain	of	PsaF	(Yang	and	Isberg,	1997).	The	central	regulator,	RovA	(18	kDa)	has	been	shown	to	interact	with	promoter	regions	of	psaE	and	psaA	(Cathelyn	et	al.,	2006).	A	recent	study	 from	 Zhang	 et	 al.,	 demonstrated	 that	 PhoP	 and	 RovA	 recognise	 the	 promoter-proximal	regions	 of	psaEF	 and	psaABC	(Zhang	 et	 al.,	 2013).	RovA	 activated	psaEF	and	psaABC,	whereas	PhoP	 repressed	 both	 psaEF	 and	 psaABC	 by	 an	 involvement	 of	 direct	 association	 between	RovA/PhoP	and	the	target	promoter	regions.	It	was	suggested	that	this	reciprocal	regulation	of	
psa	genes	by	PhoP	and	RovA	could	contribute	to	the	tight	regulation	of	pH6	antigen	expression	during	infection	(Zhang	et	al.,	2013).	Expression	of	the	Afa-3	and	-8	fimbriae	of	E.	coli,	controlled	by	two	regulatory	proteins,	AfaF	(10	kDa)	and	AfaA	(12	kDa).	AfaF	and	AfaA	are	homologous	to	the	 regulatory	 proteins,	 PapI	 and	 PapB	 of	 the	 Pap	 pilus,	 which	 suggests	 that	 these	 fimbriae	might	have	 a	 similar	 kind	of	Phase	 switching	mechanism	 to	 regulate	 their	 expression	 (Servin,	2005).	 Gene	 cluster	 of	 Sef	 fimbriae	 of	 S.	 enteritidis	 contains,	 sefABC	 genes,	which	 encode	 a	structural	subunit	(SefA	fimbrin),	a	periplasmic	chaperone	(SefB)	and	an	outer	membrane	usher	(SefC)	 to	 assemble	 Sef	 fimbriae	 (Clouthier	 et	 al.,	 1993).	 The	 regulatory	 mechanism	 of	 Sef	fimbriae	 is	mediated	by	 two	stem	 loop	mRNA	secondary	structure,	a	class	of	 rho-independent	transcription	terminator,	located	in	between	sefA	and	sefB	genes	(Clouthier	et	al.,	1993).			Expression	 of	Agg	 and	Aaf	 fimbriae	 of	 enteroaggregative	E.	coli	 is	 controlled	 by	 an	AraC/XylS	family	 regulator,	 AggR	 (29.4	 kDa),	which	 is	 encoded	 on	 a	 60	MDa	 plasmid	 and	 located	 9	 kbp	upstream	 from	 the	 agg	 locus	 (Gallegos	 et	 al.,	 1993;	 Nataro	 et	 al.,	 1994).	 	 AggR	 was	 recently	shown	 to	 act	 as	 a	 global	 regulator	 (Morin	 et	 al.,	 2013).	 Forty-four	 additional	 AggR	 targets,	including	genes	encoding	dispersin	surface	protein	(Aap),	dispersin	 translocator	(Aat)	and	Aai	type-VI	 secretion	 system	 were	 identified.	 AggR	 was	 found	 to	 activate	 the	 expression	 of	 Agg	fimbriae	 in	 response	 to	 temperature,	 oxygen	 tension,	 and	 osmolality	 as	 well	 as	 the	 medium	composition	(Nataro	et	al.,	1994).	Similarly,	gene	cluster	of	chromosomally	encoded	CS1-3	pili	of	enterotoxigenic	E.	coli	is	also	regulated	by	an	AraC/XylS	family	regulator,	Rns	(32	kDa)	(Munson	and	Scott,	1999,	2000).	Rns	is	encoded	on	a	plasmid,	unlinked	to	any	CU	system,	and	is	flanked	by	transposases	on	one	side	and	pseudogenes	on	the	other	side	(Caron	et	al.,	1989;	Munson	and	Scott,	1999,	2000).	A	detailed	description	of	gene	regulation	by	Rns	is	discussed	in	section	1.5.5.			Many	pathogens	undergo	a	temperature	transition	during	their	life-cyle	to	establish	an	infection	in	 the	 host.	 In	 such	 cases,	 expression	 of	 virulence	 factors	 is	 frequently	 under	 thermo-control.	Temperature-dependent	 expression	 of	 a	 number	 of	 virulence	 factors	 including	 the	 caf	 locus	(Chauvaux	et	al.,	2007;	Han	et	al.,	2007;	Li	et	al.,	2011;	Motin	et	al.,	2004;	Simpson	et	al.,	1990),	has	 been	 identified	 in	 Y	 pestis,	 but	 the	 basis	 of	 temperature	 regulation	 of	 F1	 expression	 has	never	been	 investigated.	 	As	mentioned	earlier	 (section	1.3.1),	Caf1R	 is	also	a	 regulator	of	 the	AraC/XylS	 family,	 but	 despite	 the	 fact	 that	 this	 regulator	 controls	 expression	 of	 a	 major	virulence	component	of	Y	pestis,	there	has	been	no	further	characterisation	of	this	regulator	or	its	action	on	the	caf	locus.			
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In	conclusion,	many	very	different	mechanisms	of	regulation	have	been	co-opted	by	CU	systems	to	control	 the	expression	of	 fimbriae.	Despite	the	common	nature	of	CU	assembly	pathways	of	both	FGS	and	FGL	groups	of	fimbriae,	even	closely	related	systems	such	as	psa	and	caf	loci	may	use	very	different	methods	of	regulation.		
1.4.5 Regulation via AraC/XylS family protein-regulators  	Regulators	 belonging	 to	 AraC/XylS	 family	 are	 widespread	 among	 Gram-negative	 and	 Gram	positive	 bacteria,	 controlling	 expression	 of	 genes	 involved	 in	 varied	 biological	 processes	including	carbon	metabolism,	stress	responses	and	pathogenesis	(Gallegos	et	al.,	1997;	Ibarra	et	al.,	 2008;	 Martin	 and	 Rosner,	 2001;	 Schuller	 et	 al.,	 2012).	 Proteins	 of	 this	 family	 are	characterised	by	having	a	conserved	DNA-binding	domain	(DBD,	≈100	amino	acids	long),	most	frequently	located	at	the	C-terminus	and	a	highly	variable	sensing	or	oligomersiation	N-terminal	domain	(100-200	amino	acids	long)	(Gallegos	et	al.,	1997;	Ibarra	et	al.,	2008;	Martin	and	Rosner,	2001;	Schuller	et	al.,	2012).	A	 few	examples	of	 this	 family	of	 regulators	 contain	only	 the	DBD,	including	MarA	and	SoxS,	which	have	been	characterised	(Griffith	et	al.,	2004;	Griffith	and	Wolf,	2002).	 DBD	 binds	 to	 the	 promoter/operator	 region	 of	 target	 operon(s)	 and	 often	 activates	expression	although	some	may	act	as	both	activator	and	repressor	(Gallegos	et	al.,	1997;	Ibarra	et	al.,	2008;	Martin	and	Rosner,	2001;	Schuller	et	al.,	2012).	DBD	contains	a	conserved	tertiary	structure	 composed	 of	 7	 α-helices,	 including	 two	 helix-turn-helix	 (HTH)	 motifs,	 which	 are	connected	by	a	central	α-helix	or	turn	(Ibarra	et	al.,	2008;	Schuller	et	al.,	2012).			A	 recent	 bioinformatic	 analysis	 of	 putative	 and	 characterised	 DBDs	 of	 62	 AraC/XylS-type	regulators	 grouped	 Caf1R-DBD	 with	 regulators	 controlling	 metabolic	 processes	 (Fig.	 1.9).	Unexpectedly,	 it	 was	 aligned	 very	 distantly	 to	 AggR	 and	 VirF,	 regulators	 of	 virulence	 factors	including	fimbriae	(Schuller	et	al.,	2012).	Caf1R	was	most	closely	aligned	with	XylR	regulator	of	
E.	coli	K-12,	which	is	essential	for	transcription	of	genes	required	for	the	utilisation	of	D-xylose	and	 L-arabinose	 (Ni	 et	 al.,	 2013).	 Whether	 this	 relationship	 to	 XylR	 and	 other	 regulators	 of	metabolic	 processes	 is	 an	 indication	 of	 metabolic	 processe(s)	 regulated	 by	 Caf1R	 or	 is	 an	indication	of	small	molecule	sensing	by	Caf1R	remains	to	be	seen.			Despite	 the	 very	 large	 size	 of	 the	AraC/XylS	 family	 (about	 1900	members),	 only	 a	 very	 small	number	 of	 regulators	 belonging	 to	 this	 family	 have	 been	 characterised	 experimentally	 and	among	 these	 so	 far	only	 two	regulators,	MarA	and	Rob	of	E.	coli	 have	been	cocrystalized	with	their	cognate	promoter	DNA	(Kwon	et	al.,	2000;	Rhee	et	al.,	1998).	An	overview	of	transcription	activation	by	some	well-characterised	regulators	of	this	family	is	described	below.				
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Figure 1.9| Caf1R-DBD closely related to metabolic regulator, XylR of E. coli.	
A dendrogram of DNA binding domains (DBDs) from 62 AraC/XylS family regulators. Functional category and 
biological process controlled by each each regulator is indicated by different colors schemes, on left. Caf1R is 
indicated in red box. Picture kindly provided by Francisco Melo (Schuller et al., 2012).  	
i)	 Transcription	activation	by	AraC:	a	sugar	responsive	regulator			AraC	 regulator	 is	 one	 of	 the	 best-characterised	 regulators	 of	 AraC/XylS	 family.	 It	 regulates	expression	of	 the	araBAD	operon	of	E.	coli	 for	 the	catabolism	of	arabinose	(Bustos	and	Schleif,	1993;	 Schleif,	 2010).	 	 It	 acts	 as	 both	 activator	 and	 repressor	 in	 the	 presence	 and	 absence	 of	arabinose	inducer,	respectively	(Bustos	and	Schleif,	1993;	Schleif,	2010).	AraC	is	a	homodimeric	protein	 (60	 kDa),	 where	 each	 monomer	 binds	 to	 a	 single	 molecule	 of	 L-arabinose	 prior	 to	activating	transcription	of	the	araBAD	operon	(Bustos	and	Schleif,	1993;	Schleif,	2010).	Genetic	and	 biochemical	 studies	 showed	 that	 a	 short	 N-terminal	 arm	 (residues	 7-17)	 of	 AraC	 plays	 a	critical	role	in	both	activation	and	repression	(Rodgers	et	al.,	2009;	Saviola	et	al.,	1998).	It	does	this	via	differential	contact	with	either	DBD	or	L-arabinose,	a	process	termed	the	‘Light-switch’	mechanism	(Schleif,	2000,	2010)	(Fig.	1.10).	According	to	this	mechanism,	in	the	absence	of	L-arabinose	(-),	the	NTD-arm	region	binds	the	DBD	limiting	flexibility	of	the	two	domains.	The	N-terminal	domains	of	2	monomers	interact	and	the	DBDs	of	these	monomer	bind	at	two	distantly	spaced	sites,	araO2	and	araI1,	repressing	the	transcription	of	araBAD	operon.	Induction	occurs	in	 the	presence	of	L-arabinose,	which	binds	 the	N-terminal	domain	and	 the	arm	releasing	 the	
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constraint	 on	 the	 DBD.	 During	 this	 state	 (L-arabinose	 bound),	 the	 NTD	 and	 DBD	 are	 flexibly	connected	and	adopt	a	 conformation	where	both	DBDs	bind	 to	closely	 spaced	half	 sites,	araI1	and	araI2	on	the	araBAD	promoter	(PBAD)	region	activating	transcription.			
		
Figure 1.10| Light-switch mechanism of AraC. 
In the absence (-) of L-arabinose, the arm region of AraCNTD interacts with CTDDBDs and the DBDs binds to 
araO2 and araI1 sites. In the presence (+) of L-arabinose, the arm region of AraCNTD bends over L-arabinose 
and thus releases the DBDs. DBDs from both monomers bind.  Picture modified from (Schleif, 2000). 
 
ii)	 Transcription	activation	by	MarA:	conferring	multiple	antibiotic	resistance		MarA	(15	kDa)	of	E.	coli	is	a	global	regulator	within	the	Enterobacteriaceae	family	and	regulates	transcription	 of	more	 than	 40	 genes,	 involved	 in	 conferring	 resistance	 to	multiple	 antibiotics,	toxic	compounds,	acidic	pH	and	antimicrobial	peptides	 (Duval	and	Lister,	2013).	 In	particular,	MarA	 activates	 expression	 of	 the	 multidrug	 efflux	 pump,	 AcrAB-TolC	 and	 the	 porin	 OmpF	leading	 to	decreased	permeability	of	 the	outer	membrane	and	a	multiple	 antibiotic	 resistance	phenotype	 (Okusu	 et	 al.,	 1996).	 MarA	 is	 encoded	 within	 the	 chromosomally	 located	marRAB	operon	(Cohen	et	al.,	1993).	The	function	of	marB	is	largely	unknown.	It	was	shown	to	somehow	increase	 the	 level	of	marA	message	and	also	contains	a	predicted	periplasmic	signal	sequence,	suggesting	a	role	at	the	posttranscriptional	level	(Vinue	et	al.,	2013).	Another	report	suggested	a	role	in	transcriptional	regulation	of	inaA,	one	of	the	MarA	regulated	genes	(Lee	et	al.,	2012).	The	first	gene	of	the	marRAB	operon,	marR	encodes	a	transcriptional	repressor,	MarR	that	functions	as	an	autorepressor	of	the	marRAB	operon.	 	 It	 forms	a	dimer	and	contains	a	winged-type	HTH	motif	(Alekshun	et	al.,	2001)	that	promotes	highly	specific	binding	to	two	palindromic	sequence	motifs	 (P1	 and	 P2),	 located	within	 promoter	 region	 (marO)	 upstream	 of	 the	marRAB	 operon	(Alekshun	et	al.,	2001),	 repressing	 transcription	(Fig.	 1.11a).	Binding	of	MarR	 is	abolished	on	binding	of	antibiotics	such	as	chloramphenicol	and	tetracycline	(Hachler	et	al.,	1991)	or	phenolic	compounds	such	as	sodium	salicylate,	2,	4-dinitrophenol	or	2,	3-dihydroxybenzoate	(Martin	and	Rosner,	 1995).	 In	 the	 absence	 of	 MarR	 binding,	 MarA	 activates	 transcription	 of	 the	marRAB	operon	and	other	genes	within	the	mar	regulon.	(Barbosa	and	Levy,	2000).			MarA	activates	 transcription	at	both	class	 I	and	class	 II	promoters	 (Martin	et	al.,	1999;	Martin	and	Rosner,	2002).	These	promoter	classes	are	defined	according	to	the	orientation	and	location	of	DNA-binding	site,	relative	to	-35	and	-10	promoter	elements,	recognised	by	RNAP	(Martin	et	al.,	 1999;	 Martin	 and	 Rosner,	 2002).	 In	 majority	 of	 the	 class	 I	 promoters,	 transcriptional	regulators	 bind	 around	 7-27	 bp	 upstream	 of	 -35	 element,	 to	 a	 DNA	 motif	 oriented	 in	 the	backward	(←)	direction.	In	class	II	promoters,	the	DNA-binding	site	of	the	regulators	is	oriented	in	the	forward	(→)	direction	and	often	overlaps	with	-35	element.	Examples	of	class	I	promoters	
L-arabinose (-) L-arabinose (+) 
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include,	 MarA/Rob/Sox	 activated	 mar,	 zwf	 and	 map	 promoters	 (Duval	 and	 Lister,	 2013),	although	 zwf	 and	map	 are	 exceptions	 with	 forward	 (→)	 oriented	 binding	 sites.	 Examples	 of	MarA/Rob/SoxS	 activated	 class	 II	 promoters	 include	 fumC	 and	micF	(Duval	 and	Lister,	 2013).	The	 consensus	 DNA	 binding	 motif	 for	 MarA/Rob/SoxS	 regulators	 is	AGRGCACRWWNNRYYAAAGN	 (R=A/G,	 Y=C/T,	 W=A/T	 and	 N=A/T/C/G)	 and	 contains	 two	binding	 sites,	 BS1	 (RGCAC)	 and	BS2	 (NRYYAAA),	 identified	by	DNase	 I	 foot	 printing	 of	MarA-DNA	binding	(Martin	et	al.,	1996)	and	analysis	of	the	cocrystal	structure	of	mar-MarA	complex	(Rhee	 et	 al.,	 1998).	 	 BS1	 is	 recognised	 by	 MarA	 helix-3	 and	 BS2	 by	 helix-6.	 Other	 class	 II	promoters	include,	pur	and	hdeA	promoters,	but	both	are	repressed	by	MarA/Rob/SoxS	(Duval	and	 Lister,	 2013).	 Two	 different	 orientations	 and	 locations	 of	 MarA	 binding	 site	 imply	 two	configurations	of	ternary	complex	(MarA-RNAP-DNA)	formation	to	activate	transcription.	NMR	studies	 of	 MarA-DNA-RNAP	 complexes	 (Dangi	 et	 al.,	 2004)	 showed	 that	 class	 I	 promoter,	transcriptional	activation	requires	MarA	 interaction	with	 the	CTD	of	 the	α-subunit	 from	RNAP	whereas	class	II	promoters,	transcription	activation	requires	MarA	interaction	with	both	α-CTD	and	region	4	of	σ70	subunit	of	the	RNAP	(Dangi	et	al.,	2004;	Martin	et	al.,	1999).		MarA	 activates	 its	 own	 transcription	 by	 binding	 (as	 a	monomer)	 to	 a	 20	 bp	motif	 (mar	 box),	located	 upstream	 of	 the	 -35	 promoter	 element	 in	 the	 promoter	 region	 of	 marRAB	 operon	(Martin	et	al.,	1996).	MarA	is	rapidly	degraded	by	Lon	protease	and	has	an	extremely	short	half-life	 (about	 3	min)	 that	 ensures	 rapid	 removal	 of	 the	 response	 cascade	 as	 the	 stress	 signal	 is	removed.	Thus	in	the	absence	of	a	stress	signal	the	level	of	MarA	is	drastically	low	(Griffith	et	al.,	2004).	Fis	(Factor	for	inversion	stimulation),	a	small	DNA-binding	and	bending	protein	that	has	been	 shown	 to	 activate	 the	 transcription	 of	 the	 marRAB	 operon	 by	 binding	 to	 the	 marO	promoter	region	(Martin	and	Rosner,	1997).	Fis-mediated	activation	of	marRAB	operon	requires	the	presence	of	MarA	or	 the	auxiliary	proteins,	 SoxS	or	Rob	 (Martin	and	Rosner,	1997).	MarA	contains	 only	 DBD	 (127	 amino	 acids	 long).	 It	 lacks	 the	 effector	 domain,	 although	 MarR	effectively	act	as	a	sensor	for	MarA	(Duval	and	Lister,	2013).				The	3D	cocrystal	structure	of	mar-MarA	complex	(PDB-1bl0)	showed	that	MarA	is	composed	of	seven	α-helices	(1-7)	and	a	long	C-terminal	loop	(Fig.	1.11b).	The	α-helices	are	folded	into	two	structurally	identical	subdomains	(SD1	and	SD2),	encompassing	residues,	10-61	(SD1)	and	62-110	(SD2).	Residues	from,	31-52	and	79-102	form	two	HTH	motifs,	HTH1	and	HTH2,	comprised	of	helices,	2-3	and	5-6.		The	two	HTH	motifs	are	connected	by	a	flexible	linker,	helix-4	(Rhee	et	al.,	 1998).	 Each	HTH	motif	 contains	 a	 recognition	helix,	 helix-3	 in	HTH1	and	helix-6	 in	HTH2,	both	of	which	bind	to	adjacent	major	grooves	of	the	mar	DNA.	Binding	involves	bending	of	the	DNA	(≈	35°)	and	makes	base	specific	contacts	in	the	major	grooves	(Rhee	et	al.,	1998).	Alanine-scanning	 mutagenesis	 (Gillette	 et	 al.,	 2000)	 and	 the	 solved	 cocrystal	 structure	 of	mar-MarA	complex	(Rhee	et	al.,	1998)	has	identified	the	amino	acid	residues	of	both	S1	and	S2	subdomains	of	MarA,	which	are	involved	in	the	mar	DNA-binding.	A	schematic	representation	of	interactions	of	SD1	and	SD2	with	cognate	mar	DNA	base(s)	is	shown	in	(Fig.	1.11c).		In	the	recognition	helix-3	and	6,	amino	acid	residues	R46	and	R96	protrude	 into	 the	adjacent	major	groove	and	make	hydrogen	bonds	(interatomic	distance	<	3.5Å)	with	G-20,	G-30,	C-31	bases	(with	R46	of	helix-3)	and	A-9,	G-10,	G-40	bases	 (with	R96	of	helix-6).	 In	addition,	T93	of	 recognition	helix-6	makes	water	mediated	sequence-specific	hydrogen	bonds	with	C-41	and	T-42	bases	of	mar	DNA	(Rhee	
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et	 al.,	 1998).	Moreover,	W42	 of	 recognition	 helix-3	 and	Q92	 of	 recognition	 helix-6	may	make	sequence-specific	hydrogen	bonds	with	corresponding	C-32	and	T-7	bases	of	mar	DNA	(Rhee	et	al.,	1998).	It	was	suggested	that	the	overall	specificity	of	protein-DNA	interactions	in	mar-MarA	complex	 is	provided	by	hydrogen	bonds	and	 the	shape	complementarity	of	 the	MarA	residues	within	the	recognition	helices	and	the	mar	DNA	bases	of	the	adjacent	major	grooves	(Rhee	et	al.,	1998).			
		
Figure 1.11| Transcription activation by MarA. 
a) MarA regulon, in the absence of sensing signal (phenolic compounds/antibiotics), MarR binds (as a dimer) to 
S1 and S2 sites on the marO promoter region, repressing the mar regulon. In presence of a sensing signal, the 
signaling compound binds MarR and inactivates it. Release of MarR leads to derepression of the operon, 
production of MarA, which binds to the mar box and thus activating transcription of genes in the mar regulon. b) 
mar-MarA cocrystal structure complex (PDB-1bl0). MarA subdomain 1 and 2 are encircled. Specificity 
determining residues, R46 (in recognition helix-3) and R96 (in recognition helix-6) are shown as red balls. W42 
(in helix-3) and Q92 and T93 (in helix-6) were also suggested to provide sequence specific interactions. The mar 
DNA used in the cocrystal structure is indicated underneath. Binding site (BS) 1 and 2 for corresponding helix-3 
and 6 interactions are shown in red text. c) DNA-protein interactions mediated by residues from SD1 and SD2 
with mar DNA. Amino acid residues in the corresponding helix (α) are encircled while DNA bases are boxed. 
Recognition helices, 3 and 6 are indicated as α-3 and α-6. Van der Waal interactions (interatomic distance < 4Å) 
are indicated by solid lines whereas hydrogen bonds (interatomic distance < 3.5Å) are indicated by dashed lines. 
Water molecule (W) involved in SD2 binding are encircled. DNA bases buried by MarA binding are shaded in 
grey. DNA bases (T-8 and C-32), which may contribute sequence specificity are indicated in black boxes. 
Picture (a) is adapted from (Duval and Lister, 2013), pictures (b) and (c) are adapted from  (Rhee et al., 1998).  
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iii)	 Transcription	activation	by	Rob:	conferring	resistance	to	heavy	metals		Rob	 (33.1	 kDa)	 of	 E.	 coli	 is	 also	 a	 global	 regulator	 within	 the	 Enterobacteriaceae	 family	 and	regulate	 transcription	 of	 more	 than	 40	 genes,	 conferring	 resistance	 to	 antibiotics,	 organic	solvent	 and	heavy	metals	 (Duval	 and	Lister,	 2013).	 The	homologous	proteins,	MarA	 and	 SoxS	can	 also	 activate	 the	 same	 set	 of	 genes	 albeit	 the	 level	 of	 activation,	 differs	 among	 these	regulators	 (Duval	 and	 Lister,	 2013).	 Transcription	 activation	 of	 these	 genes	 occurs	 by	 Rob	binding	 (as	 a	monomer)	 to	 a	highly	degenerate	 sequence	motif,	 located	either	upstream	of	or	within	the	promoter	of	the	target	gene	(Jair	et	al.,	1996b;	Tanaka	et	al.,	1997).	Rob	transcription	has	been	shown	to	be	repressed	by	SoxS,	MarA	and	by	itself	(Chubiz	et	al.,	2012;	McMurry	and	Levy,	2010;	Michan	et	al.,	2002;	Schneiders	and	Levy,	2006).	Rob	 is	 synthesised	constitutively	unlike	 MarA	 and	 SoxS	 whose	 expression	 requires	 inducing	 signals	 (Rosenberg	 et	 al.,	 2003).	However,	 being	 abundant	 inside	 the	 cell,	 a	 major	 fraction	 of	 Rob	 remains	 inactive	 due	 to	 its	sequestration	in	inclusion	bodies	(Azam	et	al.,	2000).			Unlike	 MarA	 and	 SoxS,	 Rob	 is	 a	 longer	 protein	 (289	 amino	 acids)	 and	 contains	 a	 C-terminal	sensing	domain	(residues,	121-289),	which	interacts	with	bile	salts	or	dipyridyl	to	activate	Rob	(Griffith	et	al.,	2009;	Rosenberg	et	al.,	2003;	Rosner	et	al.,	2002)	as	depicted	in	Fig.	1.12a.		Like	MarA,	 the	 N-terminal	 DBD	 (residues,	 1-120)	 contains	 seven	 α-helices	 with	 two	 HTH	 motifs	(HTH1;	 residues,	 26-46,	 (α2-T-α3)	 and	 HTH2;	 residues,	 73-96	 (α5-T-α6)),	 joined	 by	 a	 linker	helix	 (helix-4),	 which	 fixes	 their	 relative	 orientation.	 The	 C-terminal	 sensing	 domain	 of	 Rob	contains	a	pair	of	α-helices	and	10	antiparallel	β-strands,	organised	in	such	a	way	that	eight	β-strands	are	sandwiched	between	this	pair	of	α-helices.	The	remaining	two	β-strands	are	present	at	 the	 C-terminus	 (Kwon	 et	 al.,	 2000).	 The	 interface	 between	DBD	 and	 CTD	 is	 composed	 of	 a	triad	of	hydrophobic	residues,	V64,	L68,	W109	(from	DBD)	and	L149,	I152,	W244	(from	CTD),	and	an	electrostatic	 interaction	between	E108	and	R288	of	DBD	and	CTD,	respectively.	The	N-terminal	 DBD	 of	 Rob	 shares	 51%	 identity	 and	 71%	 similarity	 with	 MarA	 (Duval	 and	 Lister,	2013).	 In	 the	 3D	 cocrystal	 structure	 of	 micF-Rob	 complex	 (PDB-1d5y),	 unlike	 mar-MarA	complex	 (PDB-1bl0),	 only	 one	 HTH	 motif	 (HTH1)	 of	 DBD	 protrudes	 into	 the	 adjacent	 major	groove	of	the	micF	DNA		(Fig.	1.12b)	and	makes	sequence	specific	contacts	(Kwon	et	al.,	2000).	The	second	HTH	motif	(HTH2)	interacts	with	the	DNA	backbone	instead	of	protruding	into	the	adjacent	major	groove	of	DNA	and	as	a	result	of	this	the	micF	DNA	appears	unbent	(Fig.	1.12b)	(Kwon	et	al.,	2000).	In	this	structure,	the	amino	acid	residues	within	HTH1	motif,	interact	with	conserved	A-box	(relative	to	recognition	α-helix	3)	of	the	micF	DNA	major	groove	includes,	W36,	Q39	and	R40.		W36	and	Q39	make	van	der	Waals	interactions	with	C-7	base	whereas	R40	makes	hydrogen	 bond	 with	 G-6	 base	 within	 the	 A-box	 of	 the	micF	 DNA.	 Unlike	mar-MarA	 cocrystal	structure,	 no	 specific	 interactions	 were	 observed	 within	 HTH2	motif	 and	 the	 adjacent	 major	groove	 of	 the	micF	 DNA	 (Kwon	 et	 al.,	 2000;	 Rhee	 et	 al.,	 1998).	 Although	 some	 non-specific	interactions	 were	 observed,	 formed	 by	 R90	 and	 K94	with	 phosphate	 group	 of	 the	micF	DNA	backbone	(Kwon	et	al.,	2000).	The	micF-Rob	interactions	at	the	A-box	are	analogous	to	the	mar-MarA	 complex	 interactions	 at	 the	 recognition	 helix-3. Recently,	 micF-Rob	 interactions	 from	HTH2	motif	with	the	B-box	of	micF	DNA	(relative	to	recognition	helix-6)	have	been	confirmed	by	
in	vivo	epigenetic	and	mutagenesis	studies	(Taliaferro	et	al.,	2012).	This	suggests	that	absence	of	HTH2	motif	interaction	with	B-box	of	micF	DNA	in	the	cocrystal	structure	of	micF-Rob	complex	
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could	 be	 an	 artifact.	 Recently	 it	 has	 also	 been	 shown	 that	 class	 II	 promoters	 directed	transcription,	 activated	by	Rob-DBD	 interaction	with	 region	4	of	 σ70	 subunit	 of	RNAP	and	 the	CTD	does	not	substantially	alter	this	mode	of	interaction	(Taliaferro	et	al.,	2012).			
		
Figure 1.12| Transcription activation by Rob. 
a) Rob regulon, in the absence of sensing signal (bile salt), Rob is sequestered in the intracellular foci and 
remains in the inactive form. Once the cell comes in contact with sensing signals then the sequestered form of 
Rob is released from the intracellular foci and Rob becomes active and binds (as monomer) to the Rob box, 
located at the upstream promoter region. The activated Rob then activates the expression of other genes in its 
regulon. b) Rob-micF DNA cocrystal structure complex (PDB-1d5y). N-terminal DNA binding domain (DBD) 
and C-terminal sensing domain are indicated in different colors. Specific interactions from HTH1 residues, W36, 
Q39 and R40 with G-6 and C-7 bases of micF DNA and non-specific interaction from HTH2 residues, R90 and 
K94 with phosphate group of micF DNA backbone are indicated in different color balls. The micF DNA bound 
in the cocrystal structure is indicated underneath with corresponding helix-3 and 6 binding sites as box A and 
box B.  Picture (a) is adapted from (Duval and Lister, 2013) whereas pictures (b) is adapted from (Kwon et al., 
2000).    
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iv)	 Transcription	activation	by	SoxS:	a	stress	response	regulator		SoxS	 (12.9	 kDa)	 is	 a	 global	 regulator	 that	 regulates	more	 than	40	 genes	 involved	 in	 oxidative	stress	and	protection	of	bacterial	cells	from	the	oxidative	stresses.	This	is	governed	by	binding	to	a	highly	degenerate	 ‘soxbox’	DNA	motif,	 (ANVGCACWWWNKRHCAAAHN	consensus,	where	N:	A/T/G/C,	V:	A/C/G,	W:	A/T,	K:	G/T,	R:	A/G,	H:	A/C/T	and	bold	letters	represent	two	binding	sites),	 located	 upstream	of	 promoter	 region	 in	 the	 chromosomally	 encoded	 soxR-soxS	 regulon	(Duval	 and	 Lister,	 2013).	 	 SoxS	 is	 the	 smallest	 member	 (107	 amino	 acids)	 of	 the	 AraC/XylS	family	and	closely	related	 to	MarA,	having	41%	identity	and	67%	similarity	(Duval	and	Lister,	2013).	Like	MarA,	SoxS	activates	transcription	at	both	class	I	and	class	II	promoters	by	binding	as	 a	monomer	 (Duval	 and	Lister,	 2013).	 In	 soxR-soxS	 regulon,	 soxR	encodes	 SoxR	 regulator	 (a	member	 of	 MerR	 family)	 whose	 expression	 is	 divergently	 transcribed	 from	 a	 promoter	embedded	in	the	soxS	structural	gene	(Amabile-Cuevas	and	Demple,	1991).	In	the	absence	of	an	oxidative	 stress	 signal,	 SoxR	binds	 to	 the	 soxS	promoter	 region	 as	 a	 homodimer	 and	prevents	transcription	(Hidalgo	et	al.,	1998).	 	Due	to	the	inactivity	of	Lon	and	FtsH	proteases	on	SoxR	a	very	 low	 level	 of	 SoxS	 is	 synthesised,	 in	 the	 absence	 of	 inducing	 stress	 signal	 (Griffith	 et	 al.,	2004).	Once	SoxR	is	oxidized,	it	becomes	an	activator	of	soxS	transcription	and	synthesises	SoxS	(Nunoshiba	 et	 al.,	 1992).	 When	 SoxS	 is	 synthesised	 optimally	 it	 is	 able	 to	 repress	 its	 own	transcription,	 in	 addition	 to	 the	 repression	medicated	 by	MarA	 and	 Rob	 (Chubiz	 et	 al.,	 2012;	Nunoshiba	et	al.,	1993).	SoxS	regulon	shows	a	remarkable	degree	of	overlap	with	MarA	regulon	albeit	different	degree	of	affinities	for	different	promoters	and	the	methods	of	activation	(Duval	and	 Lister,	 2013;	 Pomposiello	 et	 al.,	 2001).	 Therefore,	 SoxS	 is	 the	 first	 to	 respond	 to	 any	oxidative	stress	and	MarA	is	the	first	to	deal	with	antibiotic	assaults	(Duval	and	Lister,	2013).			A	comprehensive	alanine	scanning	mutagenesis	of	SoxS	identified	amino	acid	residues,	required	for	transcription	activation	at	both	class	I	(zwf	and	fpr)	and	class	II	(fumC	and	micF)	promoters	and	DNA-binding	(Griffith	and	Wolf,	2002).	 It	was	demonstrated	that	the	predicted	N-terminal	HTH	motif	(HTH1,	residues	25-46)	of	SoxS	interacts	with	highly	conserved	region	of	the	‘soxbox’	assigned	 as	 recognition	 element	 1	 (RE1,	 GCAC	 consensus)	 and	 the	 predicted	 C-terminal	 HTH	motif	 (HTH2,	 residues	73-96)	 interacts	with	 less	 conserved	 region	of	 the	 ‘soxbox’	assigned	 as	recognition	 element	 2	 (RE2,	 CAAA	 consensus).	 It	 has	 been	 shown	 that	 Ala	 substitution	 of	predicted	 surface	 exposed	 residues	 of	 recognition	 helices,	 3	 and	 6	 of	 SoxS	 were	 more	detrimental	 to	DNA-binding	 than	 the	substitutions	of	 residues	predicted	 to	make	base	specific	contacts	 (Griffith	and	Wolf,	2002).	 Substitution	of	many	 residues	within	predicted	 recognition	helix-6,	which	is	assumed	to	make	base	specific	contact	with	RE2	had	a	relatively	small	effect	on	DNA-binding,	 suggesting	 the	 possibility	 of	 alternate	 protein-DNA	 interactions	 than	 those	inferred	 from	 the	 cocrystal	 structure	 of	 the	 mar-MarA	 complex	 (PDB-1bl0).	 Furthermore,	mutant	 SoxSK30A	 failed	 to	 activate	 transcription	 at	 both	 class	 of	 the	 promoters.	 A	 similar	phenotype	was	observed	upon	substitution	of	putatively	surface-exposed	surrounding	residues,	H3A,	K5A,	D9A,	S31A	and	V45A	mutants,	suggesting	surface	generated	by	H3,	K5,	D9,	K30,	S31	and	V45	residues	is	essential	for	the	interactions	with	RNAP	and	transcription	activation	at	both	classes	of	SoxS-dependent	promoters.	 In	contrast,	 the	Ala	substitutions	of	F74,	D75,	M78,	D79	and	 Q85	 residues	 appeared	 to	 create	 a	 surface	 for	 RNAP	 interactions	 and	 transcription	activation	only	at	class	II	promoters	(Griffith	and	Wolf,	2002).		
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v)	 Transcription	activation	by	Rns:	a	fimbrial	regulator		Rns	 (32	 kDa)	 or	 its	 closest	 homolog	 CfaD/CfaR	 (95%	 amino	 acid	 identity)	 activates	 the	expression	 of	 several	 pili/fimbriae	 from	 enterotoxigenic	 E.	 coli	 (ETEC)	 (Bodero	 et	 al.,	 2008;	Caron	et	al.,	1989;	Caron	and	Scott,	1990).	About	25	different	fimbriae	have	been	identified	thus	far	 in	various	strains	of	ETEC,	although	most	strains	express	only	 two	or	 three	 types	 (Gaastra	and	 Svennerholm,	 1996;	 Grewal	 et	 al.,	 1997;	 Peruski	 et	 al.,	 1999;	 Pichel	 et	 al.,	 2000).	 Most	commonly	 expressed	 fimbriae	 are,	 CS1-CS6	 and	 CFA/I	 (Evans	 et	 al.,	 1975),	 out	 of	 which	 the	regulation	mechanisms	of	CS1,	CS2	and	CFA/I	are	reasonably	well	 studied	 (Caron	et	al.,	1989;	Caron	and	Scott,	1990).	Fimbriae	whose	expression	is	activated	by	Rns	include,	CS1-CS4,	CS14,	CS17	and	CS19	(Bodero	et	al.,	2008;	Caron	et	al.,	1989).	Expression	of	CFA/I	fimbriae	is	activated	by	Rns	homologs;	CfaD/CfaR,	which	 are	 functionally	 interchangeable	with	Rns	 and	 recognises	the	same	binding	sites	as	Rns	(Caron	and	Scott,	1990).	In	addition	to	activation	of	the	expression	of	 fimbrial	genes,	Rns	positively	regulates	 its	own	gene	(rns)	expression	by	binding	(direct)	at	three	sites,	centered	at	-227,	+43	and	+82	(relative	to	transcription	start	site	(TSS)	(Froehlich	et	al.,	1994).	Position	of	uncommon	downstream	binding	sites	(at	+43	and	+82)	is	often	associated	with	transcription	repression.	However,	it	has	been	shown	that	activation	of	rns	requires	at	least	one	of	the	two	downstream	binding	sites	along	with	the	upstream	binding	site	(Froehlich	et	al.,	1994).	 Rns	 activates	 the	 expression	 of	 several	 other	 putative	 virulence	 genes	 (Munson	 et	 al.,	2002;	Pilonieta	et	al.,	2007).			A	DNaseI	footprinting	analysis	revealed	that	Rns	binding	site	is	located	immediately	upstream	of	-35	 element	 of	 Pcoo	promoter	 (required	 for	 the	 expression	 of	 CfaA,	 CS1	 fimbriae)	 and	 other	promoters	of	CS17,	CS19	and	PCFO71	 fimbriae	(Bodero	et	al.,	2008;	Munson	and	Scott,	1999),	suggesting	Rns	may	activate	 transcription	by	direct	 contact	with	RNAP.	 In	addition	 to	binding	site	near	-35	promoter	element,	a	second	binding	site	was	identified	at	all	the	promoter	regions	of	these	fimbriae	(at	-88	in	CfaA,	at	-144	in	CS1,	at	-109.5	in	CS17	and	PCFO71	and	at	-108.5	in	CS19)	(Bodero	et	al.,	2008;	Munson	and	Scott,	1999).	Each	site	showed	an	additive	effect	on	Rns-dependent	transcription	activation	and	thus	required	for	Rns	full	activation	(Bodero	et	al.,	2008;	Munson	 and	 Scott,	 1999).	 Rns	 homologs	 have	 been	 identified	 in	 several	 strains	 of	 ETEC	 and	other	 enteric	 bacterial	 pathogens.	 Proteins	 having	 strong	 homology	 to	 Rns	 include	 CsvR	 and	FapR	from	ETEC	(De	Haan	et	al.,	1991;	Klaasen	and	de	Graaf,	1990),	PerA	of	enteropathogenic	E.	
coli	(Tobe	 et	 al.,	 1996),	 AggR	 of	 enteroaggregative	E.	coli	(Nataro	 et	 al.,	 1994),	 ToxT	 of	Vibrio	
cholerae	(Lowden	et	al.,	2010)	and	VirF	of	Shigella	(Sakai	et	al.,	1986).	Among	these,	AggR,	CsvR,	PerA	and	ToxT	regulate	the	expression	of	fimbrial	genes	(De	Haan	et	al.,	1991;	Klaasen	and	de	Graaf,	1990;	Lowden	et	al.,	2010;	Nataro	et	al.,	1994;	Tobe	et	al.,	1996).	VirF	of	Shigella	activates	the	expression	of	icsA	and	virB	genes,	having	roles	in	invasion	and	cell-to-cell	spread	of	bacteria	in	the	host	epithelial	cells,	respectively	(Sakai	et	al.,	1988).			Transcription	activation	by	Rns	and	its	homologs	is	thermo-sensitive,	which	is	repressed	by	H-NS	at	low	temperatures	(Munson	and	Scott,	2000).	Like	most	AraC/XylS	family	regulators,	Rns	is	also	a	two	domain	protein,	a	NTD	(largely	unknown	function)	and	a	conserved	C-terminal	DBD	with	 two	 predicted	 HTH	 motifs	 (Mahon	 et	 al.,	 2010).	 A	 mutagenesis	 study	 (pentapeptide	insertion)	 demonstrated	 that	 Rns	 uses	 both	 HTH	 motifs	 to	 make	 DNA	 contacts	 and	 thereby	
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activates	 the	expression	of	CS1	 fimbrial	 genes	 (Mahon	et	al.,	 2010).	 In	 support	of	 this	a	uracil	interference	study	by	Munson	et.	al.,	showed	that	Rns	contacts	two	major	grooves	of	the	DNA	in	order	to	activate	transcription	(Munson	and	Scott,	1999,	2000).	Like	DBD	of	several	AraC/XylS	family	 regulators,	 Rns	DBD	 is	 believed	 to	 be	 involved	 in	making	RNAP	 contacts,	 although	 the	region	 involved	 in	making	such	contacts	has	not	been	 identified	yet	 (Munson	and	Scott,	1999,	2000).	Comparatively,	the	role	of	Rns-NTD	is	largely	unknown.	It	is	not	clearly	known	whether	Rns	acts	primarily	as	a	monomer	or	dimer	as	previous	studies	regarding	this	are	contradictory	to	each	other	(Basturea	et	al.,	2008;	Mahon	et	al.,	2012).	Moreover,	there	is	no	evidence	that	Rns	responds	to	any	effector	molecules	(Basturea	et	al.,	2008).	The	N-terminal	deletion	mutagenesis	showed	that	Rns-NTD	is	essential	for	transcription	activation	both	in	vivo	and	in	vitro	(Basturea	et	 al.,	 2008).	 A	 truncated	 version	 of	 Rns	 (first	 61	 amino	 acids	 deleted)	 has	 also	 shown	 the	complete	 loss	of	DNA-binding	 and	 transcription	 activation	or	 repression	 at	 the	 corresponding	promoter	 regions	 (Basturea	 et	 al.,	 2008).	 Rns-NTD	 motif	 from	 I12-M18	 is	 highly	 conserved	among	the	closest	homologs,	sharing	about	74%	amino	acid	identity	compared	to	26%	identity	in	 the	 overall	 NTDs,	 suggesting	 a	 crucial	 role	 of	 this	 motif	 in	 the	 overall	 function	 of	 Rns.	 In	support	of	this,	Munson	et.	al.,		isolated	two	random	mutants	(I14T	and	N16D)	of	Rns-NTD	and	found	 their	 activities	 were	 decreased	 dramatically	 at	 the	 rns	 promoter,	 indicating	 the	importance	 of	 I14	 and	 N16	 residues	 in	 transcription	 activation	 (Basturea	 et	 al.,	 2008).	Additionally,	it	was	found	that	the	I14T	and	N16D	mutations	have	disparate	effects	at	other	Rns	regulated	promoters	and	suggested	 that	 these	residues	may	 interact	with	DBD	 in	a	manner	 to	activate	transcription	(Basturea	et	al.,	2008).																					 	
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Aim and objectives: 	Fraction	1	(F1)	is	a	key	antigen	of	Y.	pestis,	encoded	by	virulence	plasmid	(pFra	or	pMT1)	borne	
caf	 locus	and	 is	 used	 in	 both	 plague	 detection	 and	 vaccine	 design.	 A	 wealth	 of	 knowledge	 is	available	 on	 its	 structure	 and	 assembly	 by	 the	 chaperone	 usher	 (CU)	 system.	 Despite	 that,	virtually	no	information	is	available	on	regulation	of	the	caf	locus.	Understanding	the	regulation	of	expression	of	key	antigens	 from	a	bacterial	pathogen	 is	one	strategy	 to	design	antibacterial	therapeutics.	With	respect	to	F1,	this	might	be	ensuring	optimum	production	of	F1	in	attenuated	vaccines	or	heterologous	vaccines	expressing	native	F1.	Initial	sequencing	identified	Caf1R	is	a	transcriptional	 activator	 of	 the	 caf	 locus,	 belonging	 to	 an	 AraC/XylS	 family	 of	 bacterial	transcriptional	 regulators	 that	 contain	 a	 conserved	 DNA	 binding	 domain	 (DBD).	 Additionally,	production	 of	 F1	 is	 known	 to	 be	 temperature	 regulated	 and	 transcriptomic	 studies	 have	provided	 some	 relevant	 data,	 but	 there	 is	 no	 further	 study	 on	 Caf1R	 itself	 or	 on	 the	mode	 of	regulation	within	the	caf	locus.	Regulation	of	CU	systems	is	very	diverse	and,	unlike	the	wealth	of	knowledge	available	on	regulation	of	E.	coli	 fim	and	pap	operons,	AraC/XylS-type	regulators	controlling	 expression	 of	 CU	 systems	 remain	 poorly	 characterised.	 A	 detailed	 molecular	characterisation	 of	 Caf1R	would	 provide	 useful	 information	 of	 relevance	 to	 other	 CU	 systems	using	 the	 same	mechanism	 of	 regulation.	 F1	 is	 naturally	 expressed	 from	 a	 low	 copy	 number	plasmid.	 Expression	 of	 the	 caf	 locus	 from	 the	 native	 promoter	 on	 high	 copy	 number	recombinant	plasmids	can	be	a	metabolic	burden	on	the	cell,	leading	to	deletions	and	mutations	that	reduce	expression.	Previous	studies	in	the	laboratory	identified	a	single	spontaneous	point	mutation	 (E98G)	 in	 Caf1R-DBD	 that	 lead	 to	 a	 dramatic	 reduction	 in	 F1	 expression	 (Lopez-Tolman,	A.;	unpublished).	Understanding	the	impact	of	this	mutation	on	Caf1R	function	was	the	starting	point	of	this	study,	which	focused	on	a	detailed	study	of	Caf1R-DBD	and	its	function	as	an	activator	of	caf	transcription.	The	main	objectives	were	as	follows:		
• To	characterise	the	N-terminal	DBD	of	Caf1R,	identify	key	DNA	binding	residues	and	explain	the	impact	of	the	Caf1R-E98G	mutation	on	Caf1R	function	and	assembly	of	F1.		
• To	create	and	compare	tagged	Caf1R	constructs,	optimise	the	expression	and	purification	of	tagged	Caf1R	for	use	in	a	DNA-protein	interaction	study.	
• To	localise	active	promoters	within	the	caf	 locus	and	monitor	the	 impact	of	Caf1R	on	their	activity,	in	order	to	define	Caf1R	binding.		
• Analysis	of	thermoregulation	in	the	caf	locus.				
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2.1 Introduction 	This	 chapter	 covers	 all	 the	materials,	methods,	 tools	 and	 software	 used	 routinely.	 In	 the	 case	where	additional	explanation	of	detail	or	method	is	required	this	is	dealt	with	in	the	appropriate	chapter.		
2.1.1 Bacterial strains and culture conditions 	Details	 of	E.	 coli	 bacterial	 strains	 used	 in	 this	 research	 are	 listed	 in	 Table	 2.1.	 	 Bacteria	were	grown	at	26°C	or	37°C	in	Luria	Bertani	broth	(LB)	(1%	(w/v)	trypton,	0.5%	(w/v)	yeast	extract,	0.09	M	NaCl;	 pH	 7.0)).	 For	 overnight	 (15-24	 h)	 growth	 0.6%	 (w/v)	 glucose	was	 added	 in	 LB	along	with	appropriate	antibiotic(s),	when	required.	All	bacterial	 cultures	 (in	LB)	were	grown	with	 shaking	 at	 225	 rpm.	 The	 additional	 details	 of	 culture	 conditions	 are	 discussed	 in	 the	respective	 section.	 Bacterial	 strains	 and	 transformants	 carrying	 confirmed	plasmid	 constructs	were	 stocked	 in	 LB	 supplemented	with	 15%	 (w/v)	 glycerol	 at	 -80°C.	 Luria	 Bertani	 agar	 (LA)	(1%	 (w/v)	 tryptone,	 0.5%	 (w/v)	 yeast	 extract,	 0.09	M	NaCl,	 1.5%	 (w/v)	 agar;	 pH	 7.0)),	with	appropriate	 antibiotic(s)	 was	 used	 throughout	 for	 culture	 of	 transformants.	 Antibiotic	 stocks	(mg/ml)	 used	 in	 this	 study	 were	 Ampicillin	 (Amp-100	 mg/ml),	 Chloramphenicol	 (Cm-50	mg/ml)	and	Kanamycin	(Kan-50	mg/ml)	with	final	working	concentrations,	100,	10-34	and	30	μg/ml,	 respectively.	 All	 antibiotic	 stocks	 were	 kindly	 provided	 by	 Hanson,	 K.	 (a	 senior	 lab	technician	for	Knight	building).		
Table 2.1| E. coli strains used in this study 
Strain		 Description		 Genotype	 Source	
TOP10		(*R1120)	 General	cloning	and	expression	studies	of	pBADHisA,	pRS415	and	pRS550	plasmid	based	constructs.	
Feature:	Keeps	constant	level	of	L-arabinose	during	growth.			
F-	mcrA	Δ(mrr-hsdRMS-mcrBC)	ϕ80lacZΔM15	ΔlacΧ74	recA1	
araD139	Δ(ara-leu)7697	galU	
galK	rpsL	(StrR)	endA1	nupG	λ-	
Invitrogen	Cat	No.	C4040-10	
DH5α	(R1023)	 General	cloning	and	expression	studies	of	pACYCDuet-I	based	constructs.		
F–	endA1	hsdR17(rk-	mk+)	supE44	
thi	-1	recA1	gyrA	(Nalr)	relA1	Δ(lacIZYA-	argF)U169	deoR	(ϕ80dlacΔ(lacZ)M15)		
(Sambrook	and	Russell,	2001);	Lab	stock.		
Stellar™		 Culturing	of	Infusion	mixtures.			
Feature:	Enhanced	ability	to	repair	nicks	in	the	infused	DNA	fragment.			
F–	endA1	supE44	thi-1	recA1	relA1	
gyrA96	phoA	Φ80d_lac	ZΔM15	
Δ(lacZYA-	argF)U169	Δ(mrr-	
hsdRMS	-	mcrBC)	ΔmcrA	λ–		
Clontech		Cat	No.	636763	
BL21(DE3)	(R837)		 His6-	and	MBP-tagged	Caf1R	overexpression	from	pET28a+	and	pMALc2x	plasmids	based	constructs.		
Feature:	General	expression	strain	of	λDE3	lysogen	contains	a	chromosomal	copy	of	T7	
F–	ompT	gal	dcm	lon	hsdSB	(rB-	mB-)	λ(DE3)			 (Studier	and	Moffatt,	1986);	Lab	stock.						
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RNAP	gene	under	the	control	of	lacUV5	promoter.			 	
BL21	StarTM	
(DE3)pLysS	
His6-tagged	Caf1R	overexpression	from	pET28a+	plasmid	based	constructs	
Feature:		BL21(DE3)	derivative,	provides	enhanced	mRNA	stability	with	low	proteins	background	expression.			
F-ompT	hsdSB	(rB-,	mB-)	gal	dcm	
rne131	(DE3)	pLysS	(CmR)	 Life	Technologies	Cat.	No.	C6020-03		
Rosetta-
gamiTM		
2(DE3)	
His6-tagged	Caf1R	overexpression	from	pET28a+	plasmid	based	constructs.	
Feature:		
i)	BL21	(DE3)	derivative	with	combined	properties	of	Rosetta	2	and	Origami	2	strains.		
ii)	Alleviate	codon	bias	by	supplying	7	rare	tRNAs	codons	(AUA,	AGG,	AGA,	CUA,	CCC,	GGA	and	CGG)	from	pRARE2	plasmid.					
iii)	Enhance	disulfide	bond	formation	in	cytoplasm.		
	
Δ(ara-leu)7697	ΔlacX74	ΔphoA	
PvuII	phoR	araD139	ahpC	galE	
galK	rpsL	(DE3)	F′[lac+	lacIq	pro]	
gor522::Tn10	trxB	pRARE2	(CmR	StrR		TetR)	
Novagen®	Cat.	No.	71351		
LOBSTR-
BL21(DE3)		
His6-tagged	Caf1R	overexpression	from	pET28a+	plasmid	based	constructs.	
Feature:		
i)	BL21	(DE3)	derivative.				
ii)	Deficient	in	major	E.	coli	contaminants,	ArnA	(74.3	kDa)	and	SlyD	(21	kDa)	(Robichon	et	al.,	2011).		
F-	ompT	hsdSB(rB-,	mB-)	gal	dcm	(DE3)	araA-	slyD-	
	
(Andersen	et	al.,	2013);	Kerafast	Cat.	No	EC1001				
LOBSTR-
BL21(DE3)-
RIL	
His6-tagged	Caf1R	overexpression	from	pET28a+	plasmid	based	constructs.	
Feature:		
i)	LOBSTR-BL21	(DE3)	derivative.	
ii)	Contains	extra	copies	of	genes	coding	for	argU,	ileY,	and	leuW	tRNA.		
F-	ompT	hsdSB(rB-,	mB-)	gal	dcm	(DE3)		araA-	slyD-	araU	ileY		leuW	(CmR)		
(Andersen	et	al.,	2013);	Kerafast	Cat.	No	EC1002				
K12-
ER2508		
MBP-tagged	Caf1R	overexpression	from	pMALc2x	based	constructs.			
Feature:	
i)	RR1	derivative	with	lon-	mutation.	
ii)	Deficient	in	major	ATP-dependent	protease.		
iii)	Improves	stability	of	heterologous	proteins	in	cytoplasm.	
F-	ara-14	leuB6	fhuA2	Δ(argF-
lac)U169	lacY1	
lon::miniTn10(TetR)	glnV44	galK2	
rpsL20(StrR)	xyl-5	mtl-5	Δ(malB)	
zjc::Tn5(KanR)	Δ(mcrC-mrr)HB101	
NEB;	Cat	no.	E4127	
	 36	
	
SHuffle®	T7		
	
His6-tagged	Caf1R	overexpression	from	pET28a+	plasmid	based	constructs.	
Feature:		
i)	K12	derivative		
ii)	Expresses	DsbC	chaperone	in	cytoplasm	that	enhances	cytoplasmic	disulfide	bonds	formation.			
F´	lac,	pro,	lacIQ	/	Δ(ara-leu)7697	
araD139	fhuA2	lacZ::T7	gene1	
Δ(phoA)PvuII	phoR	ahpC*	galE	(or	
U)	galK	λatt::pNEB3-r1-cDsbC	(SpecR,	lacIq)	ΔtrxB	rpsL150(StrR)	
Δgor	Δ(malF)3	
NEB	Cat.	No.	C3026H	
* Assigned stock number 
2.1.2 Plasmids and their respective constructs 	A	descriptive	list	of	all	vectors	used	and	plasmids	constructed	during	this	study	is	tabulated	in	Table	2.2.			
Table 2.2| Plasmid constructs used and designed during this study 
Plasmid	 Description	 Source	pFMA1	 Contains	only	caf1M,	caf1A	and	caf1	genes	of	the	caf	locus	under	the	control	of	IPTG-inducible	Ptrc	promoter.		AmpR		 (MacIntyre	et	al.,	2001);	Lab	stock	pBADHisA	(*R638)		 Low	copy	number,	pBR322-derived	expression	plasmid	vector	(4.1	kb)	contains	N-terminal	His6-tag	and	L-arabinose	inducible	PBAD	promoter.	AmpR			
Invitrogen;	(Lab	stock)		pBADhCaf1RE98G		(R1110)	 pBADHisA	based	plasmid	construct	contains	gene	for	mutated	Caf1RE98G,	suncloned	from	pFS2	plasmid	between	SacI	and	BglII	restriction	sites.			
Lopez-Tolman,	A.	(Lab	stock)		pBADhCaf1R	(R1117)	(hCaf1R,	40.9	kDa)		
Derivative	of	pBADhCaf1RE98G	with	repaired	E98G	mutation	(G98E,	wild	type).		 Lopez-Tolman,	A.	(Lab	stock)		pBADΔhCaf1R	(R1121/R1119)				
Derivative	of	pBADhCaf1R	with	deleted	His6-tag	and	Enterokinase	cleavage-site	fragment.	Sequence	confirmed	for	two	transformants,	4	(R1121)	and	8	(R1119),	both	stocked	and	number	4	(R1121)	was	used.			
This	study		
pACYCDuet-I	 Medium	copy	number	(10-12),	P15A-derived	cloning	and	expression	plasmid	vector	(4.0	kb),	contains	two	multiple	cloning	sites	(MCS)	preceded	by	IPTG	inducible	T7	promoter.	Genes	cloned	into	MCS1	can	be	sequenced	by	ACYCDuetUP1	and	DuetDOWN1	primers	whereas	for	MCS2	cloned	gene	DuetUP2	and	T7	terminator	primers	can	be	used.	CmR		
Novagen®	(Lab	stock)		
pACYCF1SpM	(R1101b)		 pACYCDuet-I	based	plasmid	construct	contains	spontaneous	mutant	caf	locus	(5.128	kb)	with	188	and	175	bp	flanking	ends	(relative	to	caf1R	and	caf1	stop	codon).	Complete	fragment	was	subcloned	(in	between	NcoI/SacI	of	MCS1)	from	pFS2	plasmid	(Drozdov	et	al.,	1995;	Galyov	et	al.,	1990)	under	native	regulatory	system	(caf1R-caf1M	intergenic	region	and	mutant	Caf1RE98G	regulator).			
Leonard,	M.	(Lab	stock)		
	pACYC-MA1		 Derivative	of	pACYCF1SpM	with	deleted	Caf1RE98G.	Expression	of	caf	MA1	is	controlled	by	caf1R-caf1M	intergenic	region.	 This	study	
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Sequence	confirmed	transformant	5	was	used.	pACYC-RE98G		 Derivative	of	pACYCF1SpM	with	deleted	cafMA1;	caf1R	expression	is	controlled	by	caf1R-caf1M	intergenic	region.	Sequence	confirmed	two	transformants,	1	and	5	were	stocked	and	1	was	used.			
This	study	
pACYCF1	(R1122b)			 Derivative	of	pACYCF1SpM	with	repaired	Caf1RE98G.			 This	study			pACYC-R		 Derivative	of	pACYCF1	with	deleted	cafMA1;	caf1R	expression	is	controlled	by	caf1R-caf1M	intergenic	region.	Sequence	confirmed	two	transformants,	1	and	5	were	stocked	and	5	was	used.			
This	study	
pACYC-RE98K		 Derivative	of	pACYC-R,	with	Caf1RE98K	substitution.	Sequence	confirmed	two	transformants,	2	and	4	were	stocked	and	number	2	was	used.			
This	study	
ΔPM_pACYCF1		 Derivative	of	pACYCF1	with	TAAAAT	to	GCCGGC	substitution	in	-10	element	of	visually	identified	PM	promoter.	Sequence	confirmed	three	transformants,	1,	2	and	3	were	stocked	and	used	all.			
This	study	
Site-specific	substitution	mutations	in	caf1R	of	pACYCF1		
	
Helix-2		
	pACYCF1-RI31A			 I31A.	Sequence	confirmed	four	transformants,	2-5	were	stocked	and	number	3	was	used.			 This	study	pACYCF1-RD32A			 D32A.	Sequence	confirmed	two	transformants,	1	and	2	were	stocked	and	number	1	was	used.			 This	study	pACYCF1-RC33A			 C33A.	Sequence	confirmed	ten	transformants,	3-12	were	stocked	and	number	6	was	used.			 This	study	
Loop	between	Helix-2	and	3	
	pACYCF1-RF40A		 F40A.	Sequence	confirmed	four	transformants,	1-4	were	stocked	and	number	4	was	used.			 This	study	
Helix-3	
	pACYCF1-RR42A		 R42A.	Sequence	confirmed	transformant	number	4	was	stocked	and	used.			 	This	study	pACYCF1-RR43A			 R43A.	Sequence	confirmed	four	transformants,	1-4	were	stocked	and	number	4	was	used.			 	This	study	pACYCF1-RY44A		 Y44A.	Sequence	confirmed	four	transformants,	1-4	were	stocked	and	number	3	was	used.			 	This	study	
Helix-4	
	pACYCF1-RR62A			 R62A.	Sequence	confirmed	three	transformants,	1-3	were	stocked	and	number	3	was	used.		 	This	study	pACYCF1-RR62S			 R62S.	Sequence	confirmed	three	transformants,	1,	2	and	4,	were	stocked	and	number	4	was	used.		 	This	study	
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Helix-6	
	pACYCF1-RQ93A		 Q93A.	Sequence	confirmed	four	transformants,	1-4	were	stocked	and	number	1	was	used.			 This	study	pACYCF1-RR97A		 R97A.	Sequence	confirmed	three	transformants,	1-3	were	stocked	and	number	2	was	used.				 This	study	pACYCF1-RE98K	
	
E98K.	Obtained	during	the	repair	of	Caf1RE98G	in	pACYCF1SpM.		Sequence	confirmed	transformants,	7,	11	and	14	were	stocked	and	number	7	was	used.			
This	study	
pACYCF1-RE98A			 E98A.	Sequence	confirmed	three	transformants,	1,	2	and	4,	were	stocked	and	number	4	was	used.			 This	study	pACYCF1-RE98T	 E98T.	Sequence	confirmed	two	transformants,	1	and	2	were	stocked	and	number	1	was	used.			 This	study	
Loop	between	Helix-6	and	7	
	pACYCF1-RT106A	 T106A.	Sequence	confirmened	transformant	number	3	was	was	stocked	and	used.			 This	study	
Helix-7	
	pACYCF1-RR108A			 R108A.	Sequence	confirmed	three	transformants,	1-3	were	stocked	and	number	1	was	used.				 This	study	pACYCF1-RQ109A	 Q109A.	Sequence	confirmened	transformant	number	3	was	was	stocked	and	used.		 This	study	
Constructs	used	for	tagged	Caf1R	expression	and	purification	
	pMAL-c2x	 Medium	copy	number	(~20),	pMB1-derived	expression	plasmid	vector	(6.646	kb),	contains	N-terminal	maltose-binding	protein	(MBP)-tag	and	ptac	promoter.	Specific	for	over-expression	of	cytoplasmic	protein,	induction	by	IPTG;	AmpR		
NEB		
pMALc2-Caf1R			(MBPCaf1R,	79.3	kDa)	 pMAL-c2x	based	plasmid	construct,	contains	N-terminally	MBP-tagged	wild	type	native	Caf1R	(MBPCaf1R).	Sequence	confirmed	three	transformants,	23,	24,	and	26	were	stocked	and	number	23	was	used.			
This	study	
pMALc2-Caf1RN		(MBPCaf1RN,	57.3	kDa)	 pMAL-c2x	based	plasmid	construct,	contains	N-terminally	MBP-tagged	DBD	of	wild	type	native	Caf1R	(MBPCaf1RN).	Sequence	confirmed	three	transformants,	L1-L3	were	stocked	and	L1	was	used.			
This	study	
pET28a+	 High	copy	number	(~40),	pBR322-derived	expression	plasmid	vector	(5.369	kb),	contains	N-terminal	His6-tag	and	T7	promoter,	induction	by	IPTG;	KanR		
Novagen	
pEThCaf1R	(hCaf1RT,	40	kDa)	 pET28a+	based	plasmid	construct,	contains	N-terminally	His6-tagged	wild	type	native	Caf1R.	Sequence	confirmed	two	transformants,	6	and	8	were	stocked	and	number	8	was	used.			
This	study	
pEThCaf1RN	(hCaf1RTN,	16.4	kDa)	 pET28a+	based	plasmid	construct,	contains	N-terminally	His6-tagged	DBD	of	wild	type	native	Caf1R.	Sequence	confirmed	eight	transformants,	1-8	were	stocked	and	8th	was	used.			
This	study	
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pEThCaf1Rgs		(hCaf1RTgs,	38.5	kDa)		 pET28a+	based	plasmid	construct,	contains	N-terminally	His6-tagged	synthetic	codon-optimised	Caf1R;	subcloned	in	between	EcoRI	and	NheI	sites.			
GenScript,	USA	
pEThCaf1RgsE98G	(hCaf1RTgsE98G,		38.5	kDa)		
Derivative	of	pEThCaf1Rgs	with	Caf1RE98G	mutation.			 GenScript,	USA	
pBADhCaf1Rgs	(hCaf1Rgs,	37.5	kDa)	 Derivative	of	pEThCaf1Rgs,	contains	N-terminally	His6-tagged	synthetic	codon-optimised	wild	type	Caf1R	in	the	pBADHisA	plasmid;	subcloned	in	between	NheI	and	EcoRI	sites.		
This	study	
pMALc2-Caf1Rgs	(MBPCaf1Rgs,	78.9	kDa)	 Derivative	of	pEThCaf1Rgs,	contains	N-terminally	MBP-tagged	synthetic	codon-optimised	wild	type	Caf1R	in	pMALc2x	plasmid.				
This	study	
pRS415	
				 Multicopy	number,	pNK678	derived	transcription	fusion	plasmid	vector	(10.752	kb),	contains	promoter	less	lacZ.	AmpR			
(Simons	et	al.,	1987)			
pRS415	plasmid	based	promoter-lacZ	fusion	constructs	to	localise	caf1R	promoter(s)	and	
Caf1R	binding	upstream	of	caf1R	
	pRScaf1M′-R′-lacZ		 Contains	reverse	complement	of	complete	caf1R-caf1M	intergenic	region	(327	bp)	plus	192	and	158	bp	from	the	5′	of	caf1R	(ATG	start)	and	caf1M,	respectively.	Complete	fragment	was	amplified	from	pACYCF1SpM	and	subcloned	in	between	EcoRI	and	BamHI	sites	(upstream	of	lacZ)	of	pRS415	plasmid.		
Qahtani,	A.	and	Pereira,	I.	(Lab	stock)	
Contains			–xxx	bp		to		+192	bp	from	Caf1R	start	(ATG),	Infused	upstream	of	promoter	less	lacZ	
	pRScaf1R′-137+192-lacZ								 -137	bp,	contains	R1,	R2	and	R3	potential	Caf1R	binding	repeats,	and	all	three	predicted	promoters,	PR1,	PR2	and	PRK	for	caf1R	transcription.	Sequence	confirmed	transformant	number	7	was	stocked	and	used.			
This	study	
pRScaf1R′-114+192-lacZ			 -114	bp,	possesses	R1	and	R2	repeat	motifs	and	all	three	predicted	promoters,	PR1,	PR2	and	PRK	for	caf1R.	Sequence	confirmed	transformant	number	7	was	stocked	and	used.			
This	study	
pRScaf1R′-70+192-lacZ									 -70	bp,	possesses	only	R1	repeat	and	two	predicted	promoters,	PR1	and	PR2	for	caf1R.	Sequence	confirmed	transformant	number	8	was	stoked	and	used.			
This	study	
pRScaf1R′-65+192-lacZ			 -65	bp,	possesses	only	half	of	the	R1	repeat	and	two	predicted	promoters,	PR1	and	PR2	for	caf1R.	Sequence	confirmed	transformant	number	8	was	stocked	and	used.			
This	study	
pRScaf1R′-46+192-lacZ			 -46	bp,	possesses	no	repeat	but	contains	partial	sequence	of	both	PR1	and	PR2	promoters.	Sequence	confirmed	transformant	number	8	was	stocked	and	used.			
This	study	
pRS550			 Multicopy	number	pNK678	derived	transcription	fusion	plasmid	(12.459	kb)	contains	promoter	less	lacZ	gene.	Identical	to	pRS415	plasmid	except	reverse	orientation	of	EcoRI	and	BamHI	cloning	site.	AmpR	and	KanR		
(Simons	et	al.,	1987)		
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pRS550	plasmid	based	promoter-lacZ	fusion	constructs	to	localise	caf1M	promoter(s)	and	
Caf1R	binding	upstream	of	caf1M	
	pRScaf1R′-M′-lacZ			 Contains	complete	caf1R-caf1M	intergenic	region	(327	bp)	plus	192	and	158	bp	from	the	5′	of	caf1R	(ATG	start)	and	
caf1M,	respectively.		Complete	fragment	was	amplified	from	pACYCF1SpM	and	subcloned	in	between	BamHI	and	EcoRI	sites	(upstream	of	lacZ)	of	pRS550	plasmid.		
Qahtani,	A.	and	Pereira,	I.	(Lab	stock)	
Contains			–xxx	bp		to		+158	bp	from	Caf1M	start	(ATG),	Infused	upstream	of	promoter	less	lacZ		pRScaf1M′-270+158-lacZ			 -270	bp,	possesses	R1,	R2,	R3,	R3′	and	R4′	potential	Caf1R	binding	repeats,	and	all	three	predicted	promoters,	PM,	PMB	and	PMK1-2	for	caf1M	transcription.		Sequence	confirmed	transformant	number	1	was	stocked	and	used.			
This	study	
pRScaf1M′-197+158-lacZ										 -197	bp,	possesses	R3′	and	R4′	repeats,	and	all	three	predicted	promoters,	PM,	PMB	and	PMK1-2	for	caf1M.	Sequence	confirmed	transformant	const1col2_3	was	stocked	and	used.		
This	study	
pRScaf1M′-184+158-lacZ			 -184	bp,	possesses	only	R4′	repeat	but	all	three	predicted	promoters,	PM,	PMB	and	PMK1-2	for	caf1M.	Sequence	confirmed	transformant	number	3	was	stocked	and	used.			
This	study	
pRScaf1M′-169+158-lacZ										 -169	bp,	possesses	part	of	R4′	repeat	but	all	three	predicted	promoters,	PM,	PMB	and	PMK1-2	for	caf1M.	Sequence	confirmed	transformant	number	2	was	stocked	and	used.			
This	study	
pRScaf1M′-141+158-lacZ			 -141	bp,	possesses	no	repeat	but	has	-35	element	of	PM	and	complete	PMB	and	PMK1-2	predicted	promoters	for	caf1M.		Sequence	confirmed	transformant	number	3	was	stocked	and	used.			
This	study	
pRScaf1M′-102+158-lacZ										 -102	bp,	possesses	no	repeat	motifs	but	has	only	PMK1-2	predicted	promoter	for	caf1M.	Sequence	confirmed	transformant	number	1	was	stocked	and	used.			
This	study	
pRS550	plasmid	based	promoter-lacZ	fusion	constructs	to	localise	caf1	promoter(s)	and	to	
test	Caf1R	binding	upstream	of	caf1	
	
Contains			–xxx	bp			to		+88	bp	(relative	to	caf1	ATG	start),	Infused	upstream	of	promoter	less	lacZ		pRScaf1A′-1′-lacZ		 -259,	possesses	179	bp	of	caf1A	3′	end	(relative	to	TGA	stop	codon),	complete	caf1A-caf1	intergenic	region	(80	bp)	and	88	bp	of	caf1	(relative	to	ATG	start).	Sequence	confirmed	transformant	Inf_3	was	stocked	and	used.			
This	study	
pRScaf1′-181+88-lacZ			 -181	bp,	possesses	R1c,	R2a	and	R2b	repeats,	and	P11,	P12,	P1B	and	-35	element	of	P13	predicted	promoters	for	caf1	transcription.	Sequence	confirmed	transformant	number	1	was	stocked	and	used.				
This	study	
pRScaf1′-158+88-lacZ								 -158	bp,	possesses	R1b,	R1c,	R2a	and	R2b	repeats,	and	P11,	P12	and	P1B	predicted	promoters	for	caf1.	Sequence	confirmed	transformant	number	1	was	stocked	and	used.			
This	study	
pRScaf1′-61+88-lacZ			 -61	bp,	possesses	R1c,	R2a	and	R2b	repeat	motifs,	and	P11	and		P1B	predicted	promoters	for	caf1.		Sequence	confirmed	transformant	number	2	was	stocked	and	used.			
This	study	
		 		 		
	 41	
pRScaf1′-38+88-lacZ			 -38	bp,	possesses	R1c,	R2a	and	R2b	repeats,	and	P1B	and	-10	element	of	P11	predicted	promoters	for	caf1.	Sequence	confirmed	transformant	number	1	was	stocked	and	used.			
This	study	
Contains			–259	bp			to		-xx	bp	(relative	to	caf1	ATG	start),	Infused	upstream	of	promoter	less	lacZ	
	pRScaf1′-259-61-lacZ								 -61	bp,	possesses	R1a	and	R1b	repeats,	and	P13	and	P12	predicted	promoters	for	caf1.	Sequence	confirmed	transformant	number	2	was	stocked	and	used.			
This	study	
pRScaf1′-259-22-lacZ			 -22	bp,	possesses	R1a	and	R1b	and	part	of	R2a	repeats,	and	P13,	P12,	P11	and	-35	of	P1B	predicted	promoters	for	caf1.	Sequence	confirmed	transformant	number	1	was	stocked	and	used.			
This	study	
pRS550	plasmid	based	promoter-lacZ	fusion	constructs	to	test		Caf1R	binding		(cis-
orientation	of	caf1R)	at	caf1R	or	caf1M	promoter(s)	
	pRScaf1RE98G-M′-lacZ			 Contains	mutant	caf1R	(E98G)	and	wild	type	caf1R-caf1M	intergenic	region	plus	159	bp	of	caf1M	(relative	to	ATG).	Complete	fragment	was	amplified	from	pACYCF1SpM	and	subcloned	in	between	BamHI	and	EcoRI	sites	(upstream	of	
lacZ)	of	pRS550	plasmid.	Sequence	confirmed	transformant	9b2	was	used	and	stocked.			
	Qahtani,	A.	and	Pereira,	I.		(Lab	stock)	
pRScaf1RE98K-M′-lacZ			 Derivative	of	pRScaf1RE98G-M′-lacZ	containing	caf1R	with	G98K	mutation.	Sequence	confirmed	4_2	was	stocked	and	used.			
This	study	
pRScaf1R-M′-lacZ				 Derivative	of	pRScaf1RE98K-M′-lacZ	containing	wild	type	caf1R.	Sequence	confirmed	transformants	11	and	16	were	stocked	and	11	(Q5-E98_11)	was	used.			
This	study	
	* Assigned stock number.				 	
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2.1.3 Chemicals and enzymes 	Chemicals	used	in	this	study	were	of	Molecular	biology	grade	or	higher	and	were	sourced	from	Sigma-Aldrich,	 Melford	 Laboratories	 and	 Thermo	 Fisher	 Scientific.	 Restriction	 enzymes	 were	sourced	from	NEB	and	Thermo	Scientific.	DNA	polymerases	were	sourced	from	Takara	Clontech,	Bioline,	 NEB	 and	 Agilent	 Technologies.	 All	 enzymes	 were	 used	 according	 to	 manufacturer’s	specification	with	the	appropriate	buffer(s).	
2.1.4 Centrifuges  	For	 all	 centrifugation	 steps	 involving	 volumes	 ≤	 1.5	 ml,	 a	 benchtop	 eppendorf	 centrifuge	(Eppendorf,	Germany)	was	used.	For	volumes	1.5-50	ml	and	centrifugation	speeds	≤	4000	rpm,	a	 benchtop	 Megafuge1.OR	 centrifuge	 was	 used.	 For	 larger	 volumes	 (50-1000	 ml)	 and	centrifugation	speed	≤	18,000	rpm,	a	SorvallTM	 centrifuge	was	used	with	appropriate	 rotor(s).	For	 ultra-centrifugation	 (50,000	 rpm	 =	 134877.8×g)	 a	 benchtop	 Beckman	 Optima	 TLX	ultracentrifuge	was	used	with	TLA-100.3	rotor.	
2.2 In vitro DNA techniques 
2.2.1 Preparation of plasmid DNA  	Plasmid	DNA	was	routinely	prepared	(using	Qiagen	mini-prep	kit)	from	5	ml	culture,	grown	at	37°C	for	15-18	h	with	shaking	(225	rpm).	For	temperature-dependent	plasmid	construct(s)	such	as	 pACYCF1	 and	 pACYCF1-R	 mutants,	 culture(s)	 were	 grown	 at	 26°C	 for	 at	 least	 24	 h	 with	shaking	(225	rpm)	to	avoid	unwanted	mutation(s)	in	the	caf	 locus	by	metabolic	burden	due	to	fast	growth	rate	at	37°C.	DNA	was	routinely	eluted	 into	35	μl	nH2O	 followed	by	quantification	and	storage	at	-20°C.		
2.2.2 Quantification of plasmid DNA  
i)	 Nanodrop	spectrophotometer		An	estimation	of	plasmid	DNA	concentration	was	routinely	carried	out	from	2	μl	sample,	using	a	Nanodrop	spectrophotometer-ND1000	(Thermo	Scientific).	It	gives	concentration	in	ng/μl	with	an	indication	of	purity	from	the	ratio	of	OD260/OD280.		
ii)	 Agarose	gel	electrophoresis		Quality	and	concentration	of	DNA	was	routinely	confirmed	by	agarose	gel	electrophoresis	(AGE)	using	a	horizontal	agarose	gel	electrophoresis	system	(BioRad).	Regularly	DNA	fragments	were	resolved	on	0.75-0.8%	(w/v)	agarose	gels	(Melford	Labs),	prepared	in	TAE	buffer	(40	mM	Tris-HCl,	1	mM	EDTA,	pH	8.0).	Samples	were	applied	with	1×	DNA	loading	buffer	blue	(Bioline)	and	electrophoresed	 at	 80	 volts	 for	 90	min	 at	 room	 temperature	 (RT).	 One	 Kilobase	 (1	 kb)	 DNA	HyperLadder™	 I	 (Bioline,	Fig.	 2.1)	was	 used	 throughout,	 as	 a	 size	marker.	 Nucleic	 acid	 stain,	GelRed	 (Cambridge	Bioscience)	was	 added	 to	 the	 gel	 (1:20000)	 to	 stain	 the	DNA.	DNA	bands	were	visualised	under	ultraviolet	light	using	G-Box	(Syngene).	Gel	pictures	were	saved	in	.tif	and	.sgd	 formats.	 	 If	 required,	DNA	 concentration	was	 also	 calculated	using	 the	 .sgd	 file	 of	 the	 gel	picture	by	GeneTool,	a	DNA/protein	band	quantification	software	(Syngene).	 	DNA	quantity	 in	band	of	interest	was	generally	quantified	by	comparing	with	20	ng	of	HyperLadderTM	I	(Fig.	2.1).		
	 43	
			
	
 
Figure 2.1| DNA HyperLadder ITM (Bioline). 
The molecular size (bp) and quantity (ng) of each separated band is shown from a 5 µl sample, on 1% agarose 
gel in 1× TAE.  
 
2.2.3 Oligonucleotide primers 	Oligonucleotide	primers	listed	in	Table	2.3	were	purchased	from	Eurofins-Genomics	(Germany)	and	routenly	resuspended	in	nH2O	to	a	stock	concentration	of	200	pmol/μl.	Designing	strategies	for	deletion,	Infusion,	mutagenesis	and	sequencing	primers	were	different.			For	deletion	primers,	the	length	was	kept	ideally	between	18-33	nucleotides	(nt)	with	a	melting	temperature	 (Tm)	 range	 of	 59-67°C	 and	%GC	 content	 about	 42-66%.	 Both	 Tm	 and	%GC	were	calculated	by	primer	properties	scan	tool	(Eurofins-Genomics).	Tm	difference	between	forward	and	reverse	primers	was	kept	at	≤	4°C	to	obtain	optimal	amplification.	One	to	three	guanine	(G)	or	cytosine	(C)	were	included	at	the	3′	end	of	each	primer.	A	unique	restriction	enzyme	site	was	inserted	at	the	5′	end	of	each	primer	with	some	upstream	nt	for	optimal	action	of	the	respective	restriction	enzyme.			Infusion	primers	were	designed	using	Clontech	primer	design	tool	with	the	following	features:		The	5′	end	of	each	primer	was	taken	from	15	bases	of	the	linearised	plasmid	vector	(linearised	either	 by	 restriction	 digestion	 or	 inverse	 PCR).	 The	 3′	 end	 of	 each	 primer	was	 insert	 specific	with	 a	 length	of	18-25	bases,	GC-content	40-60%	and	Tm	58-65°C.	The	Tm	difference	between	forward	and	reverse	primers	was	kept	≤	4°C	and	1-3	G	or	C	were	included	at	the	3′	end	of	each	primer.	 Complementarity	 within	 each	 primer	was	 avoided	 to	 prevent	 hairpin	 structures,	 and	primer	dimer	formation	between	primer	pairs.			Mutagenesis	primers	were	designed	according	to	QuikChange	Site-Directed	mutagenesis	XLII	kit	(Agilent)	 and	 Q5®	 Site-Directed	 mutagenesis	 kit	 (NEB)	 with	 following	 considerations.	 For	QuikChange	 Site-Directed	 mutagenesis,	 desired	 mutation(s)	 was	 added	 by	 incorporating	 the	desired	nucleotide	change(s)	in	the	middle	of	the	forward	primer.	On	either	side	of	incorporated	
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mutation(s),	 12-15	 bases	 were	 kept	 gene-specific.	 Reverse	 primer	 was	 obtained	 by	 reverse	complementing	the	forward	primer.	Primer	length	was	kept	≤	45	bases	with	Tm	≥	78°C.	The	Tm	was	calculated	by	following	formula:		Tm	=	81.5	+	0.41(%GC)	–	675/N	–	%	mismatch	N,	total	number	of	bases			For	 Q5®	 Site-Directed	 mutagenesis,	 desired	 mutation	 was	 added	 near	 the	 5′	 end	 of	 forward	primer	and	3′	was	extended	up	to	20	bases	from	the	site	of	mutation.	Thus	forward	mutagenic	primer	was	generated	with	a	total	length	of	about	25-30	bases.	Reverse	primer	had	no	mutation.	and	thus	was	gene-specific.	It	was	designed	in	such	a	way	that	the	5′	ends	of	both	forward	and	reverse	primers	anneal	back-to-back.	NEB	Tm	calculator	(http://tmcalculator.neb.com/#!/)	was	used	to	calculate	Tm	of	each	primer.			Most	sequencing	primers	were	used	from	on-site	sequencing	services.	When	there	was	need	of	additional	sequencing	primers	these	were	designed	according	to	standard	features	such	as	18-25	bases	in	length,	which	are	homologous	to	the	gene	of	interest	and	having	55-58°C	Tm	with	40-60%	GC-content.		
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Table 2.3| Oligonucleotide primers used in PCR reactions 
																																																								1Nucleotides	in	small	letters	indicate	the	change(s)	to	make	desired	restriction	sites.			2	Nucleotides	from	vector	ends	are	indicated	in	bold	capital	text	and	Tm	is	shown	only	from	gene	specific	part,	according	to	the	Infusion	method	(Clontech).						
	
Construct		
	
Primer		
											
				Sequence	(5′-3′)	
	
GC	(%)	 		Tm	(°C)	
Inverse	PCR	primers	
	pACYC-MA1	 Invcaf1Rfor	 ACCCatgg1CAAAATAATAGCATTCT
AGATAGTG NcoI		
 
36.4	 64.5	
Invcaf1Rrev	 TCCcAtgGCAGGAGTCGCATAAGG NcoI		
 
58.3	 66.1	
pΔhBADCaf1R	 dhCaf1Rfor	 TATCCATGGCGCTCATTTGGGTTATA
TTCATGC NcoI		
 
42.4	 67.0	
dhCaf1Rrev	 CGATGCCATGGTTAATTCCTCCTGTT
AG 
 
46.4	 65.1	
pACYC-R	and			pACYC-RE98G	 pACYCcaf1Rf	 GCCTAACCCTCGAGCTCG SacI		 66.7	 60.5	pACYCcaf1Rr		 GCTTgAgCTCCTTACGGAATG SacI	 52.4	 59.8	
Infusion	primers2	
 pEThCaf1R	 pETCaf1Rf	 CAGCCATATGGCTAGCAAGGCTAGCT
GGGGATCCGAGCTCATTTG NheI			 57.7	 68.0	pETCaf1Rr		 GACGGAGCTCGAATTCTTCGAATTCCCATATGGTACCAGC EcoRI			 50.0	 60.3	pEThCaf1RN	 pETCaf1RNf*	 CAGCCATATGGCTAGCTCCGAGCTCA
TTTGGGTTATATTC  
 
41.7	 59.3	
pETCaf1RNr*	 GACGGAGCTCGAATTCTTAAAAGGAC
CAAAAAGGGATCATC TTA-Stop			 36.0	 58.1	pMALc2-Caf1R	 pMALcaf1Rf	 AAGGATTTCAGAATTCGTTGAATTCA
TGCTAAAACAGATG EcoRI		 33.3	 55.9	pMALcaf1Rr	 CGACTCTAGAGGATCCTATGGATCCA
GCTGCAGATC BamHI		 50.0	 57.3	pMALc2-Caf1RN	(L1)	 pMALCaf1RNifF	 AAGGATTTCAGAATTCTCCGAGCTCA
TTTGGGTTATATTC 
 
41.7	 59.3	
pMALCaf1RNinfR	 CGACTCTAGAGGATCCTTAAAAGGAC
CAAAAAGGGATCATC TTA-Stop			 36.0	 58.1	pMALc2-Caf1Rgs	 pMALCaf1R_GSf	 AAGGATTTCAGAATTCATGCTGAAAC
AAATGACCGTGAAC 	 41.7	 59.3	pMALCaf1R_GSr	 CGACTCTAGAGGATCCTTATGATTTC
GGCAGACCCAGCGT 
50.0	 62.7	
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  	pRScaf1R′-137+192-lacZ			 Delta7f	 TGGGGATCGGAATTTTGCGCAAATAGCTAATTTTG 
 
33.3	 52.0	
Deltapcaf1Rr	 CGGTTGTCCGGATCCAGCAGCTCTAC
TAGCCC  
 
61.1	 58.2	
pRScaf1R′-114+192-lacZ			 Delta6f	 TGGGGATCGGAATTATTGATGCGCGTGCACAAATAG 
 
45.5	 58.4	
Deltapcaf1Rr	 CGGTTGTCCGGATCCAGCAGCTCTAC
TAGCCC 
 
61.1	 58.2	
pRScaf1R′-70+192-lacZ		 Delta5f	 TGGGGATCGGAATTTGCGCAAATAGCTAAGTCCC 
 
50.0	 57.3	
Deltapcaf1Rr	 CGGTTGTCCGGATCCAGCAGCTCTAC
TAGCCC 
 
61.1	 58.2	
pRScaf1R′-65+192-lacZ			 Delta16f	 TGGGGATCGGAATTAAATAGCTAAGTCCCGGC 
 
52.6	 56.7	
Deltapcaf1Rr	 CGGTTGTCCGGATCCAGCAGCTCTAC
TAGCCC 
 
61.1	 58.2	
pRScaf1R′-46+192-lacZ			 Delta17f	 TGGGGATCGGAATTCCGGCCCACTATCTAGAATG 
 
55.0	 59.3	
Deltapcaf1Rr	 CGGTTGTCCGGATCCAGCAGCTCTAC
TAGCCC 
 
61.1	 58.2	
pRScaf1M′-270+158-lacZ		 pRSDeltaFor	 CAGGAATTGGGGATCAGCTATTTGCGCATACCCAG  
 
50.0	 57.3	
pRS550(13-17)R		 GTCCGGATCGGAATTCTAACGGGTATATGATCCTACTCTC 
 
44.0	 61.3	
pRScaf1M′-197+158-lacZ			 pRS550(13-16)F;	Delta1for		 CAGGAATTGGGGATCTGCGCAACAAGCAAGTGGAGTG 
 
50.0	 62.7	
pRS550(13-16)R	 GTCCGGATCGGAATTCTAACGGGTAT
ATGATCCTACTCTC 
 
44.0	 61.3	
pRScaf1M′-184+158-lacZ		 Delta	15F	 CAGGAATTGGGGATCAGTGGAGTGCG
C  
 
66.7	 40.0	
Delta	550R	 GTCGGATCGGAATTCTAACGGGTATA
TGATCC 
  
44.4	 51.4	
pRScaf1M′-169+158-lacZ			 Delta	14F	 CAGGAATTGGGGATCAAGCTAAACTTTGTGTG  
 
35.3	 45.5	
Delta	550R	 GTCGGATCGGAATTCTAACGGGTATA
TGATCC 
 
44.4	 51.4	
pRScaf1M′-141+158-lacZ			 Delta4for	 CAGGAATTGGGGATCAAAATTGTTCTCAGTGAGGCTG 
 
40.9	 56.5	
pRS550(13-16)R	 GTCCGGATCGGAATTCTAACGGGTAT
ATGATCCTACTCT 
44.0	 61.3	pRScaf1M′-102+158-lacZ			 pRS550(13-17)F	or	Delta2	 CAGGAATTGGGGATCTCCCCTTCATTTGTTACCCACC  
 
44.4	 51.4	
pRS550(13-16)R	 GTCCGGATCGGAATTCTAACGGGTAT
ATGATCCTACTCTC 
44.0	 61.3	
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																																																								3	Desired	mutation(s)	in	the	sequence	are	indicated	by	bold	text	with	desired	change(s)	in	small	letter(s)	and			Tm,	according	to	QuikChange	II	XL	site-directed	mutagenesis	(Agilent).		
 pRScaf1A′-1′-lacZ	 pRS(11-12)infF			 CAGGAATTGGGGATCCTGGCATTGTC
GGAGATAATAGCG  
 
50.0	 62.7	
pRS(11-12)infR				 GTCGGATCGGAATTGCAGTGGTGCTT
GCAGTTAAATC 
 
47.8	 60.6	
pRScaf1′-181+88-lacZ			 Delta11f	 CAGGAATTGGGGATCAGAGATAAAAATCAATC 
 
23.5	 40.7	
Deltapcaf1r	 GTCCGGATCGGAATTGCAGTGGTGCT 
TGCAG  
 
62.5	 54.3	
pRScaf1′-158+88-lacZ			 Delta10f	 CAGGAATTGGGGATCATCTAATGTAGTTCTACC 
 
36.8	 50.2	
Deltapcaf1r	 GTCCGGATCGGAATTGCAGTGGTGCT
TGCAG 
 
62.5	 54.3	
pRScaf1′-61+88-lacZ			 Delta9f	 CAGGAATTGGGGATCCAGGACACAAGCCCTCT 
 
63.2	 61.0	
Deltapcaf1r	 GTCCGGATCGGAATTGCAGTGGTGCT
TGCAG  
 
62.5	 54.3	
pRScaf1′-38+88-lacZ			 Delta8f	 CAGGAATTGGGGATCATTTGTTCGTGGATTGG 
   
44.4	 51.4	
Deltapcaf1r	 GTCCGGATCGGAATTGCAGTGGTGCT
TGCAG  
 
62.5	 54.3	
pRScaf1′-259-61-lacZ		 Deltapcaf1f	 CAGGAATTGGGGATCCTGGCATTGTC
GGAG 
 
60.0	 50.6	
Delta12r	 GTCCGGATCGGAATTGAAATAAACAT
CCGTTTC 
 
33.3	 46.9	
pRScaf1′-259-22-lacZ			 Deltapcaf1f	 CAGGAATTGGGGATCCTGGCATTGTCGGAG  
 
60.0	 50.6	
Delta13r	 GTCCGGATCGGAATTCCAATCCACGA
ACAAATTCG 
 
45.0	 55.2	
Mutagenesis	primers3	
 pACYC-RE98K	 pRS550(8-10)Lys98for											 CCAAATATTTTCTTAAATTtTCTGGTGAATGTCTGTTGCGAATC 
 
31.8	 76.9	
pRS550(8-10)Lys98rev	 GATTCGCAACAGACATTCACCAGAaAATTTAAGAAAATATTTGG 
 
31.8	 76.9	
ΔPM_pACYCF1	 	Pcaf1M_2f		  CTTTGTGTGCATTTTTAAAGCCGCCT
GTTCTCAGTGAGGCTGTGC 
 
	48.9	 	73.2	
Pcaf1M_2r	 GCACAGCCTCACTGAGAACAGGCGGC
TTTAAAAATGCACACAAAG 
 
48.9	 73.2	
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pRScaf1R-M′-lacZ		 G98Efor	 CTTAAATTcTCTGGTGAATGTCTGTTGCG 
 
44.4	 63.9		G98Erev	 AAAATATTTGGTTATACCCCACGGCA
G 
 
40.7	 61.9	
pACYCF1	 Caf1RG98Efor	 GCAACAGACATTCACCAGAgAATTTA
AGAAAATATTTGGTTATAC  
 
31.1	 67.6	
Caf1RG98E	rev	 GTATAACCAAATATTTTcTTAAATTC
TCTGGTGAATGTCTGTTGC  
 
31.1	 67.6		pACYCF1-RI31A	 Caf1R-I31Af	 CGAAATTCATTAACgcTGACTGTTTG
GTTTTG 
 
37.5	 69.5	
Caf1R-I31Ar	 CAAAACCAAACAGTCAgcGTTAATGA
ATTTCG 
 
37.5	 69.5	
pACYCF1-RD32A	 Caf1R-D32Af	 GTCGAAATTCATTAACATTGcCTGTT
TGGTTTTGTATTC 
 
33.3	 75.2	
Caf1R-D32Ar	 GAATACAAAACCAAACAGgCAATGTT
AATGAATTTCGAC  
 
33.3	 75.2	
pACYCF1-RC33A	 Caf1R-C33Af*					 GAAATTCATTAACATTGACgcTTTGG
TTTTGTATTCAGGATTCA 
  
33.3	 75.7	
Caf1R-C33Ar*				 CTGAATCCTGAATACAAAACCAAAgc
GTCAATGTTAATGAATTTC 
 
33.3	 75.7	
pACYCF1-RF40A	 Caf1R-F40Afor	 GGTTTTGTATTCAGGAgcCAGCAGAA
GGTATTTGCAAATTTCC 
 
41.9	 78.3	
Caf1R-F40Arev	 GGAAATTTGCAAATACCTTCTGCTGg
cTCCTGAATACAAAACC 
 
41.9	 78.3	
pACYCF1-RR42A	 Caf1R-R42Afor	 GGTTTTGTATTCAGGATTCAGCgcAA
GGTATTTGCAAATTTCC 
 
39.5	 77.3	
Caf1R-R42Arev	 GGAAATTTGCAAATACCTTgcGCTGA
ATCCTGAATACAAAACC 
 
39.5	 77.3	
pACYCF1-RR43A	 Caf1R-R43Afor	 GGTTTTGTATTCAGGATTCAGCAGAgcGTATTTGCAAATTTCC 
 
39.5	 77.3	
Caf1R-R43Arev	 GGAAATTTGCAAATACgcTCTGCTGA
ATCCTGAATACAAAACC  
 
39.5	 77.3	
pACYCF1-RY44A	 Caf1R-Y44Afor	 GGTTTTGTATTCAGGATTCAGCAGAA
GGgcTTTGCAAATTTCC  
 
41.9	 78.3	
Caf1R-Y44Arev	 GGAAATTTGCAAAgcCCTTCTGCTGA
ATCCTGAATACAAAACC 
  
41.9	 78.3	
pACYCF1-RR62A	 R62Afor				 GCCTATTGGAACATATATTcgAGTTA
GAAGGGCTAGTAGAGCGC  
 
44.4	 80.2	
R62Arev				 GCAGCTCTACTAGCCCTTCTAACTcg
AATATATGTTCCAATAGGC  
44.4	 80.2		pACYCF1-RR62S	 R62Sfor			 GCCTATTGGAACATATATTAGcGTTA
GAAGGGCTAGTAGAGCTGC  
 
44.4	 82.4	
R62Srev	 GCAGCTCTACTAGCCCTTCTAACgCT
AATATATGTTCCAATAGGC  
 
44.4	 82.4	
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pACYCF1-RQ93A	 Caf1R-Q93Af	 TGATTCGCAAgcGACATTCACCAGAG  50.0	 68.3		Caf1R-Q93Ar	 CTCTGGTGAATGTCgcTTGCGAATCA  50.0	 68.3		pACYCF1-RR97A	 Caf1R-R97Af					 GCAACAGACATTCACCgcAGAATTTA
AGAAAATATTTGG 
 
35.9	 73.7	
Caf1R-R97Ar	 CCAAATATTTTCTTAAATTCTgcGGT
GAATGTCTGTTGC 
 
35.9	 73.7	
pACYCF1-RE98A	 E98Afor	 CAGACATTCACCAGAGcATTTAAGAA
AATATTTGGTTATACCCC 
 
36.4	 78.8	
E98Arev	 GGGGTATAACCAAATATTTTCTTAAA
TgCTCTGGTGAATGTCTG 
 
36.4	 78.8	
pACYCF1-RE98T	 E98Tfor	 CAGACATTCACCAGAacATTTAAGAA
AATATTTGGTTATACCCC 
  
34.1	 75.6	
E98Trev	 GGGGTATAACCAAATATTTTCTTAAA
TgtTCTGGTGAATGTCTG 
 
34.1	 75.6	
pACYCF1-RT106A	 Caf1R-T106Af	 GAAAATATTTGGTTATgCCCCACGGC
AGTATAGG  
 
44.1	 76.7	
Caf1R-T106Ar	 CCTATACTGCCGTGGGGcATAACCAA
ATATTTTC  
 
44.1	 76.7	
pACYCF1-RR108A		 Caf1R-R108Af	 GGTTATACCCCAgcGCAGTATAGGATGATCC  
 
51.6	 74.4	
Caf1R-R108Ar				 GGATCATCCTATACTGCgcTGGGGTA
TAACC 
 
51.6	 74.4	
pACYCF1-RQ109A	 Caf1R-Q109Af	 GGTTATACCCCACGGgcGTATAGGAT
GATCC  
 
54.8	 75.7	
Caf1R-Q109Ar	 GGATCATCCTATACgcCCGTGGGGTA
TAACC  
 
54.8	 75.7	
	
Sequencing	Primers	
	
To	confirm		
	
	Deletion	of	His6-tag	plus	enterokinase	cleavage-site	from	pBADhCaf1R.		
pBADF	 ATGCCATAGCATTTTTATCC  35.0	 58.0	pBADR	 GATTTAATCTGTATCAGG  33.0	 45.0	
Repair	and	generated	mutation	in	caf1R	in	pACYCF1SpM	or	pACYCF1	or	pRScaf1R-M′-lacZ	or	pRScaf1RE98K-M′-lacZ.	
	
F1_1		 ATGTTGGGTCGAACATAAATCG 40.9	 56.5	
caf1R	and	caf1R-caf1M	intergenic	region	from	pACYCF1SpM	or	pACYCF1	and	pACYC-R	or		pACYC-RE98G	or		pACYC-RE98K.		
ACYCDuetUp1	 GGATCTCGACGCTCTCCCT  
 
63.0	 55.0	
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2.2.4 PCR amplification 	An	 Eppendorf	 mastercycler	 machine	 was	 used	 for	 all	 PCR	 amplification	 reactions.	 	 The	 PCR	amplification	 products	 were	 routinely	 analysed	 by	 AGE	 and	 where	 required,	 were	 either	purified	 using	 Qiagen	 PCR	 purification	 kit	 or	 gel-excised	 and	 purified	 using	 GeneJET	 Gel	Extraction	kit	(Thermo	Scientific),	according	to	manufacturer’s	protocol.			Four	types	of	PCR	amplification	were	carried	out	during	this	study,	1)	Simple	PCR,	to	amplify	a	gene	 or	 a	 segment	 of	 a	 gene	 to	 be	 used	 for	 subsequent	 cloning,	 2)	 Colony	 PCR,	 to	 screen	 for	insertion	 of	 desired	 gene	 or	 gene	 fragment	 in	 the	 plasmid	 vector	 of	 choice,	 by	 direct	amplification	from	single	bacterial	colonies	transformed	with	respective	ligation	or	Infusion	mix,	3)	Inverse	PCR,	to	delete	a	particular	region	from	the	desired	plasmid	and	4)	Mutagenic	PCR,	to	introduce	the	desired	mutation(s)	into	the	target	plasmid(s).		PCR	reaction(s)	and	conditions	for	each	were	as	follows:		
i)	 Subcloning	or	Infusion	PCR			Gene	or	gene-fragment	to	be	used	for	Infusion	or	ligation	were	amplified	by	this	PCR	type.	PCR	reaction	mixture	(25	μl)	contained	50	ng	plasmid	DNA	template,	0.5	pmol	of	each	forward	and	reverse	primer	and	12.5	μl	of	2×	CloneAmpHiFi	PCR	Premix	(Clontech)	containing	proof	reading	CloneAmpHiFi	 DNA	 polymerase,	 optimised	 dNPTs	 mix	 and	 reaction	 buffer.	 The	 reaction	mixtures	 were	 always	 prepared	 on	 ice.	 	 The	 PCR-cycles	 used	 were	 routinely:	 98°C/1	 sec,	followed	by	35	cycles	of	98°C	for	10	sec,	55°C	for	15	sec	and	72°C	for	5	sec/kb.				
caf1R	and	caf1R-caf1M	intergenic	region	from		pACYC-R	or	pACYC-RE98G	or		pACYC-RE98K.		
DuetDown1	 GATTATGCGGCCGTGTACAA  
 
50.0	 52.0	
caf1R-caf1M	intergenic	region.	
	
F1_6	 CCTTCTGCTGAATCCTGAATAC 45.0	 53.0	
caf1A-caf1	intergenic	region.	 F1for11		 GTGGATCCCTGGCATTGTCGGAGATAATAGCG  53.0	 62.7	F1rev12	 CGGAATTCGCAGTGGTGCTTGCAGTT
AAATC 
  
54.0	 60.6	
caf1R,	caf1RN	in	pET28a+	plasmid.	 T7F		 TAATACGACTCACTATAGGG   40.0	 48.0	T7R	 GCTAGTTATTGCTCAGCGG  
 
53.0	 51.0	
caf1R,	caf1RN	and	caf1Rgs	in	pMALc2x	plasmid.		 malE	for	 GGTCGTCAGACTGTCGATGAAGCC   58.0	 61.0	
lacZ-fusion	constructs	and	
caf1R	and	its	derivatives	in	pMALc2x	plasmid		
M13F	 TGTAAAACGACGGCCAGT  
 
50.0	 48.0	
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ii)	 Colony	PCR		In	order	 to	 identify	positive	recombinant	clones	within	a	 large	number	of	bacterial	 colonies,	a	short	 fragment	 (≈	 1	 kb)	 was	 routinely	 amplified	 from	 10-35	 single	 individual	 colonies	 using	appropriate	 primer	 pairs.	 The	 individual	 colonies	 were	 picked	 with	 a	 sterile	 pipette	 tip	 and	mixed	 into	 10	 µl	 of	 sterile	 nH2O	 in	 an	 eppendorf	 tube.	 	 Five	 microliters	 of	 this	 colony	 re-suspension	was	mixed	 into	15	µl	 of	 PCR	 reaction	mixture,	 containing	1.25	units	 of	DreamTaq	DNA	polymerase	(Thermo	Scientific),	2	mM	dNTPs	(5	μl,	0.2	mM	of	each),	appropriate	forward	and	reverse	primer	(10	pmol	of	each),	10×	DreamTaq	buffer	(5	μl)	in	a	final	reaction	volume	of	50	μl.	 PCR	 cycles	were	 as	 follows:	 95°C/1	min	 (initial	 denaturation),	 followed	by	30	 cycles	 of	95°C	 for	 30	 sec	 (denaturation),	 Tm	 −5°C	 for	 30	 sec	 (annealing)	 and	 72°C	 for	 1	 min/kb	(extension).	The	final	extension	was	carried	out	at	72°C	for	5	min	with	a	single	cycle.	Following	colony	 PCR,	 the	 remaining	 5	 µl	 colony	 re-suspension	 was	 added	 to	 100	 µl	 sterile	 LB	 and	incubated	at	37°C	until	positive	clone(s)	were	 identified	by	AGE.	Positive	colonies,	 in	LB	were	then	inoculated	into	10	ml	selective	LB	and	incubated	overnight	at	37°C	with	shaking	at	225	rpm	for	plasmid	DNA	isolation	and	screening	by	restriction	digestion	and/or	sequencing.		
iii)	 Inverse	PCR	for	fragment	deletion			Inverse	 PCR	was	 carried	 out	 using	 BIO-X-ACTTM	 short	DNA	polymerase	 (Bioline)	 and	Q5	HiFi	DNA	 polymerase	 (NEB).	 The	 PCR	 reaction	 mixtures	 and	 cycle	 conditions	 for	 each	 were	 as	follows:	
a) BIO-X-ACTTM	short	DNA	polymerase		BIO-X-ACTTM	 enzyme	 (Bioline)	was	 used	 to	 delete	 the	His6-tag	 and	 enterokinase	 cleavage	 site	from	the	pBADhCaf1R	plasmid	in	order	to	design	pBADΔhCaf1R	plasmid	construct.	PCR	reaction	mixture	was	prepared	by	adding	62	ng	of	pBADhCaf1R	template,	10×	Opti	buffer	(5	μl),	50	mM	MgCl2	 (2	 μl),	100	 mM	 dNTPs	(2.5	 μl),	 Hi	 space	 additive	 (2.5	 μl),	 dhCaf1Rfor	 and	 dhCaf1Rrev	primers	 (20	pmol	 of	 each,	 2	 μl)	 and	 one	 unit	 (1	 μl)	 of	 Bio-X-ACTTM	DNA	polymerase	 in	 a	 final	reaction	 volume	 of	 50	 μl.	 	 The	 PCR	 cycles	were	 as	 follows:	 95°C/3	min	 (initial	 denaturation),	followed	by	30	cycles	of	94°C	for	30	sec	(denaturation),	57.5°C	for	30	sec	(annealing)	and	72°C	for	5	min	(extension).	The	final	extension	was	carried	out	at	72°C	for	10	min	with	a	single	cycle.	
b) Q5	HiFi	DNA	polymerase		Q5	HiFi	enzyme	(NEB)	was	used	to	delete	both	the	caf1R	and	caf1MA1	genes	from	the	pACYCF1SpM	and	pACYCF1	plasmid	templates	in	order	to	construct	pACYC-MA1,	pACYC-R	and	pACYC-RE98G.		
i) pACYC-MA1	construction			PCR	 reaction	 mixture	 and	 cycles	 to	 prepare	 pACYC-MA1	 were	 as	 follows:	 pACYCF1SpM	 DNA	template	 (50	 ng,	 1.65	 μl)	 was	 mixed	 with	 5×	 Q5	 reaction	 buffer	 (5	 μl),	 Invcaf1Rfor	 and	Invcaf1Rrev	primers	(12.5	pmol	of	each,	1.25μl	from	10	pmol/μl	stock),	5×	Q5	High	GC	enhancer	and	one	unit	of	Q5	HiFi	DNA	polymerase	in	a	final	reaction	volume	25	μl.	The	PCR	cycles	were	as	follows:	 98°C/30	 sec	 (initial	 denaturation)	 followed	 by	 25	 cycles	 of	 98°C	 for	 5	 sec	
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(denaturation),	55.1	and	60.8°C	for	15	sec	(annealing)	and	72°C	for	6	min	(extension).	The	final	extension	was	carried	out	at	72°C	for	2	min	with	a	single	cycle.	
ii) pACYC-R	and	pACYC-RE98G	construction		PCR	 reaction	 mixture	 and	 cycles	 to	 design	 pACYC-RE98G	 and	 pACYC-R	 from	 pACYCF1SpM	 and	pACYCF1	 templates	were	 as	 follows:	 pACYCF1SpM	 or	 pACYCF1	plasmid-DNA	 template	 (100	ng,	1.5	μl)	was	mixed	with	5×	Q5	reaction	buffer	(5	μl),	pACYCcaf1Rf	and	pACYCcaf1Rr	primers	(10	pmol	of	each,	1.0	μl	from	10	pmol/μl	stock),	5×	Q5	High	GC	enhancer	(5.0	μl)	and	one	unit	of	Q5	HiFi	DNA	polymerase	 (NEB)	 in	a	 final	 reaction	volume	25	μl.	The	PCR	cycles	were	as	 follows:	98°C/30	sec	(initial	denaturation),	followed	by	25	cycles	of	98°C	for	5	sec	(denaturation),	59.9°C	for	 15	 sec	 (annealing)	 and	72°C	 for	 4	min	 (extension).	 The	 final	 extension	was	 carried	 out	 at	72°C	for	2	min	with	a	single	cycle.	
iv)	 Mutagenic	PCR		Three	 kinds	 of	mutagenic	 PCRs	were	 used	 to	 add	 the	 desired	 substitution	mutation(s)	 in	 the	plasmid(s)	of	interest.	First,	by	using	QuikChange	site-directed	mutagenesis	(QC-SDM)	II	XL	kit	(Agilent)	second,	by	using	KOD	Hot-Start	DNA	Polymerase®	(Novagen)	and	 third	by	using	Q5®	site-directed	mutagenesis	(Q5®-SDM)	kit	(NEB).	PCR	reaction	mixture	and	cycles	for	each	were	as	follows:	
a) QC-SDM	II	XL			QC-SDM	XLII	 kit	was	used	 to	 add	 site-specific	mutantion(s)	 in	 caf1R	of	 the	pACYCF1	 and	 also	used	to	construct	ΔPM-pACYCF1	and	pACYC-RE98K	mutants.	 	PCR	reaction	for	QC-SDM	II	XL	was	set	up	as	follows:	5	μl	of	10×	reaction	buffer,	50	ng	of	corresponding	plasmid-DNA	template,	125	ng	of	each	forward	and	reverse	mutagenic	primers,	1	μl	of	dNTPs	mix,	3	μl	of	Quik	solution	and	one	unit	(1	μl)	of	Pfu-Ultra	HF	enzyme	in	a	final	reaction	volume	of	50	μl.		The	PCR	cycles	were	as	 follows:	 95°C/1	 min	 (initial	 denaturation),	 followed	 by	 18	 cycles	 of	 95°C	 for	 50	 sec	(denaturation),	 60°C	 for	 15	 sec	 (annealing)	 and	 68°C	 for	 1	 min/kb	 (extension).	 The	 final	extension	was	carried	out	at	68°C	 for	7	min	with	a	single	cycle.	Mutagenic	PCR	products	were	routinely	digested	(25	μl)	with	0.5	μl	DpnI	(from	kit,	unless	otherwise	stated)	at	37°C	for	25	min	or	 unless	 otherwise	 specified	 to	 remove	methylated	 template	 from	newly	 synthesised	mutant	strands.	 	Following	DpnI	treatment,	2	μl	of	 treated	PCR	product	was	transformed	into	50	μl	of	competent	DH5α	or	Top10	cells.		
b) KOD	Hot-Start	DNA	Polymerase®		The	plasmid	construct	pRScaf1RE98K-M′-lacZ	was	designed	using	KOD	Hot-Start	DNA	polymerase	(Novagen).	PCR	reaction	and	cycles	were	as	follows:	70	ng	of	pRScaf1RE98G-M′-lacZ	plasmid-DNA	template,	 5	 μl	 of	 10×	 reaction	 buffer,	 10	 pmol	 of	 each	 pRS550(8-10)Lys98for	 and	 pRS550(8-10)Lys98rev	primers,	3	μl	of	 	50	mM	MgCl2,		1	μl	of	 	10	mM	dNTPs	mix	and	one	unit	 (1	μl)	of		KOD	 Hot-Start	 DNA	 polymerase	 in	 final	 reaction	 volume	 of	 50	 μl.	 	 The	 PCR	 cycles	 were	 as	follows:	 94°C/2	 min	 (initial	 denaturation),	 followed	 by	 18	 cycles	 of	 98°C	 for	 10	 sec	(denaturation),	57°C	for	30	sec	(annealing)	and	68°C	for	6.0	min	(extension).		
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c) Q5®-SDM		The	 plasmid	 construct	 pRScaf1R-M′-lacZ	 was	 designed	 using	 Q5-SDM	 kit	 (NEB).	 PCR	 reaction	and	cycles	were	as	 follows:	50	ng	of	pRScaf1RE98K-M′-lacZ	plasmid-DNA	template,	12.5	μl	of	2×	Q5	Hot-Start	HF	master	mix,	12.5	pmol	of	each	G98Efor	and	G98Erev	primers	in	a	final	reaction	volume	 of	 25	 μl.	 	 The	 PCR	 cycles	 were	 as	 follows:	 98°C/30	 seconds	 (initial	 denaturation),	followed	by	25	cycles	of	98°C	for	10	sec	(denaturation),	65°C	for	20	sec	(annealing)	and	72°C	for	6.23	min	(extension).	The	final	extension	was	carried	out	at	72°C	for	2	min	with	a	single	cycle.	Following	PCR,	the	PCR	product	was	treated	with	an	enzyme	mixture	containing	Kinase,	Ligase	and	DpnI	(KLD)	at	RT	for	5	min	and	then	5	μl	of	KLD	treated	PCR	product	transformed	into	50	μl	of	competent	Top10	cells.		
2.2.5 Restriction digestion 	Restriction	 endonuclease	 enzymes	 used	 to	 digest	 either	 PCR	 product(s)	 or	 plasmid(s)	 were	purchased	 from	either	NEB	or	Thermo	Scientific.	 For	 restriction	digestion,	100-700	ng	of	PCR	product	 or	 plasmid-DNA	 was	 combined	 with	 10	 units	 of	 desired	 restriction	 enzyme	 in	 the	presence	of	1×	enzyme-specific	buffer.	The	final	reaction	volume	was	adjusted	to	25	μl	by	adding	autoclaved	 nH2O.	 Reaction	 mixtures	 were	 then	 incubated	 at	 37°C	 for	 15-60	 min	 (dependent	upon	 enzyme	manufacturer).	 In	 case	 of	 simultaneous	 digestion	 by	 two	 restriction	 enzymes,	 5	units	of	each	enzyme	were	used	and	an	appropriate	buffer	was	selected	to	ensure	compatibility	of	both	enzymes	with	maximum	activity.		
2.2.6 Clean-up of restriction digestion reactions 	This	procedure	was	carried	out	using	QIAquick	PCR	Purification	Kit	(Qiagen,	0.1-15	kb	product	size),	according	to	the	manufacturer’s	instructions.	The	purified	digested	products	were	eluted	using	sterile	nH2O	and	then	stored	at	-20°C.		
2.2.7 Purification of DNA from agarose gel slice 	DNA	to	be	used	for	cloning	or	Infusion	was	routinely	purified	from	an	agarose	gel,	using	GenJET	gel	 extraction	 kit	 (Thermo	 Scientific)	 according	 to	 the	 manufacturer’s	 protocol.	 The	 purified	DNA	was	typically	eluted	in	35	μl	of	sterile	nH2O.		
2.2.8 Molecular cloning techniques 	Two	kinds	of	cloning	procedures	were	used	during	this	study.	One	based	on	T4	DNA-ligase,	known	as	ligation,	and	the	other	was	Infusion,	which	is	independent	of	DNA-ligase.	
i) Ligation		T4	 DNA	 ligase	 (Thermo	 Scientific,	 UK)	 was	 used	 throughout	 for	 ligation	 of	 Inverse	 PCR	product(s).	The	digested	and	purified	PCR	products	(50-100	ng)	were	combined	with	5	units	of	T4	DNA	ligase	in	the	presence	of	1×	T4	DNA	ligase	buffer	and	the	reaction	volume	was	adjusted	to	20	μl	with	autoclaved	nH2O.	Reaction	mixtures	were	then	incubated	at	room	temperature	for	30	min	in	order	to	allow	ligation.			
	 54	
ii) Infusion		Ligation	 sometimes	 produces	 recombinant	 clones	 in	 the	 wrong	 orientation	 when	 a	 single	restriction	 enzyme	 is	 used	 to	 digest	 the	 PCR	 product	 and	 the	 destination	 plasmid	 vector.	 To	avoid	this,	either	digestion	of	both	PCR	product	and	destination	plasmid	vector	can	be	carried	out	using	two	restriction	enzymes	or	another	procedure	such	as	Infusion	cloning	can	be	used	to	generate	 seamless	 clones	 with	 confirmed	 correct	 orientation.	 Hence,	 Infusion	 was	 used	 to	prepare	 all	 promoter-lacZ	 fusion	 constructs	 in	 pRS415	 and	 pRS550	 plasmids.	 In	 addition,	Infusion	was	also	used	to	fuse	caf1R	or	caf1RN	into	both	the	pET28a+	and	pMALc2x	plasmid.	For	this	purpose	the	Infusion®	HD	Cloning	kit	(Clontech,	Takara)	was	utilised	throughout	to	set	up	the	 Infusion	 reaction(s).	 Briefly,	 the	 destination	 plasmid	 vectors	 were	 digested	 by	 two	restriction	 enzymes	 such	 as	 EcoRI	 and	 BamHI	 in	 case	 of	 pRS415,	 pRS550	 and	 pMALc2x	plasmids,	and	EcoRI	and	NheI	in	case	of	pET28a+	plasmid.	The	digested	plasmids	were	purified	using	the	Qiagen	PCR	purification	kit	and	eluted	into	nH2O,	whereas	the	PCR	products	were	gel-excised,	purified	by	GeneJET	gel	extraction	kit	(Thermo	Scientific)	and	eluted	into	nH2O.	To	set	up	an	Infusion	reaction,	50	ng	of	purified	PCR	products	were	combined	with	200	ng	of	linearised	destination	plasmid	vector	 in	 the	presence	of	5×	 Infusion	HD	enzyme	pre-mix	(2	μl).	The	 final	reaction	volume	was	adjusted	to	10	μl	with	autoclaved	nH2O	and	the	Infusion	reaction	mixtures	were	 incubated	 at	 50°C	 for	 15	 min.	 Routinely,	 2.5	 μl	 of	 Infusion	 reaction	 mixture(s)	 was	transformed	in	50	μl	Stellar™	competent	cells	(Clontech).	A	complete	overview	of	this	procedure	for	one	example	of	plasmid	construct,	pMALc2-Caf1Rgs	is	depicted	in	Fig.	2.2.		
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Figure 2.2| An example of plasmid construct designing by Infusion cloning method.  
Picture modified from Infusion® HD cloning kit manual (Clontech) for pMALc2-Caf1R designing. 
  
2.2.9 Transformation 
i)	 Preparing	chemically	competent	cells			The	 E.	 coli	 cells	 were	 routinely	 made	 competent	 using	 the	 classical	 CaCl2	method	 (Hanahan,	1983;	Hanahan	et	al.,	1991).	The	desired	E.	coli	strains	were	grown	overnight	(~15	h)	in	10	ml	LB	(no	glucose)	at	37°C	with	shaking	at	225	rpm.	Next	day,	50	ml	LB	(no	glucose)	was	inoculated	(1/100)	with	overnight	grown	culture	and	incubated	at	37°C	with	shaking	(225	rpm)	to	0.3-0.5	OD600.	Cells	were	recovered	by	centrifugation	at	4000	rpm	for	20	min	at	4°C.	The	pelleted	cells	were	 resuspended	 in	 15	 ml	 of	 ice-cold	 RF1	 buffer	 (160.9	 mM	 KCl,	 50.5	 mM	MnCl2,	30.5	 mM	Potassium	 acetate,	 10.2	 mM	 CaCl2,	 60%	 glycerol;	 pH	 5.8)	 and	 incubated	 on	 ice	 for	 15	 min.	Following	incubation	on	ice,	the	cell	suspension	was	centrifuged	at	4000	rpm	for	10	min	at	4°C	and	the	RF1	treated	cells	were	then	resuspended	into	5	ml	of	ice-cold	RF2	buffer	(20.1	mM	KCl,	74.8	mM	CaCl2,	500	mM	MOPS,	60%	glycerol;	pH	6.8)	and	incubated	on	ice	for	30	min.	After	30	
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min	 incubation	 on	 ice,	 the	 RF2	 treated	 cell	 suspension	 was	 aliquoted	 (50	 μl)	 into	 ice-cold	eppendorf	tubes	then	snap	frozen	in	liquid	nitrogen.	All	aliquots	were	stored	at	-80°C.		
ii)	 Transformation	of	chemically	competent	E.	coli	cells		An	aliquot	of	competent	cells	was	thawed	on	 ice	and	up	to	3	μl	of	plasmid	DNA	(10-50	ng/μl)	was	 added	 to	 50	 µl	 cells.	 The	 tube	was	 then	 gently	 flicked	 in	 order	 to	mix	 the	DNA	with	 the	competent	cells,	incubated	on	ice	for	30	min,	and	then	heat	shocked	at	42°C	for	45	sec	followed	by	 incubation	on	 ice	 for	a	 further	2	min.	Pre-warmed	(at	37°C)	500	μl	LB	(with	0.6%	glucose)	was	then	added	and	incubated	at	37°C	for	1	h	with	shaking	at	225	rpm.	Cells	were	then	spreaded	onto	 selective	 LA	plates	 containing	 appropriate	 antibiotic(s).	 Plates	were	usually	 incubated	 at	37°C	overnight	except	pACYCF1	and	pACYCF1-R	plasmids	which,	where	were	always	incubated	at	26°C	 for	at	 least	48	h.	 Infusion	mixtures	were	transformed	 into	specialized	competent	cells,	StellarTM	(Clontech),	otherwise	homemade	competent	DH5α	and/or	Top10	cells	were	used.	
ii) Co-transformation	or	complementation		Co-transformation	was	done	for	a	combination	of	pACYC+pBAD	or	pACYC+pRS	based	plasmids.	Equimolar	concentrations	of	each	plasmid	(20-25	ng)	were	mixed	and	transformed	into	50	μl	of	competent	cells	of	choice.	The	co-transformation	mixture	was	spreaded	on	LA	plates	containing	two	corresponding	selective	antibiotics	and	0.6%	glucose.	Plates	were	often	 incubated	at	37°C	overnight,	unless	otherwise	stated.		
2.2.10 DNA sequencing 	Following	transformation,	several	individual	colonies	of	each	kind	of	transformant	were	picked	and	 either	 screened	 by	 Colony	 PCR	 and/or	 the	 plasmid-DNA	 was	 directly	 isolated	 for	subsequent	 screening	 by	 restriction	 digestion	 and/or	 confirmation	 by	 sequencing.	 Routinely,	50-100	ng/μl	of	plasmid-DNA	was	sent	either	to	Source	Bioscience,	Oxford	or	Eurofin-Genomic	(Germany),	 along	 with	 the	 required	 concentration	 of	 desired	 sequencing	 primers	 (if	 not	available	onsite).	Whenever	plasmid	DNA	was	not	 in	 the	 required	 range,	 then	onsite	 template	amplification	 service	 from	 Source	 Bioscience,	 Oxford	 was	 used.	 Sequencing	 results	 were	provided	 as	 .ab1	 and	 .seq	 files	 from	 Source	 Bioscience,	 Oxford,	 while	 from	 Eurofin-Genomic	(Germany)	sequencing	 files	were	obtained	 in	 .scf,	 .seq	and	 .pdf	 format.	The	sequencing	results	from	.seq	and	.scf	files	were	analysed	by	DNADynamo	and	FinchTV,	sequence	analysis	software.		
2.3 Transcriptional fusions and β-galactosidase assay  
2.3.1 Construction of promoter-lacZ fusion plasmids 	Two	transcriptional	fusion	vectors	pRS415	and	pRS550	(Simons	et	al.,	1987)	(Appendix	1)	were	used	to	identify	promoter	activity	within	the	caf	locus.	In	these	two	vectors,	a	promoterless	lacZ	gene,	 with	 its	 own	 RBS	 and	 start	 codon,	 is	 located	 downstream	 from	 the	 EcoRI	 and	 BamHI	cloning	sites.	Insertion	in	pRS550	was	used	to	test	promoter	activity	upstream	of	caf1M	and	caf1	whereas	 insertion	 in	pRS415	was	used	 to	 test	promoter	activity	of	 the	 complementary	 strand	and	to	identify	caf1R	promoter.	Initial	constructs	with	the	caf1R-caf1M	intergenic	region	cloned	in	 pRS415	 (pRScaf1M′-R′-lacZ)	 and	 pRS550	 (pRScaf1R′-M′-lacZ),	 respectively,	 were	 already	available	and	were	used	to	test	promoter	activity	upstream	of	caf1R	and	caf1M.	To	test	promoter	
	 57	
activity	 upstream	 of	 caf1,	 pRScaf1A′-1′-lacZ	 was	 constructed	 by	 Infusion	 using	 the	 pACYCF1	template	 and	 PCR	 amplification/Infusion	 primers,	 pRS(11-12)infF	 and	 pRS(11-12)infR	 to	amplify	a	347	bp	fragment	encompassing	the	caf1A-caf1	intergenic	region	(80	bp),	88	bp	of	caf1	and	 179	 bp	 of	 caf1A.	 The	 pRS550	 plasmid	 was	 linearised	 with	 EcoRI/BamHI	 and	 column	purified.	 Insert	 and	 vector	 were	 then	 Infused	 and	 transformed	 to	 generate	 pRScaf1A′-1′-lacZ.	Three	 promoter-lacZ	 fusion	 constructs,	 pRScaf1R-M′-lacZ,	 pRScaf1RE98G-M′-lacZ	 and	pRScaf1RE98K-M′-lacZ	 containing	 the	 same	 DNA	 fragment	 as	 in	 pRScaf1R′-M′-lacZ	 plus	 the	complete	wild	 type	caf1R,	caf1R	with	E98G	and	E98K	substitutions,	 respectively,	were	used	 to	test	 the	 impact	of	wild	 type	and	mutant	caf1R	on	caf1M	transcription,	 in	a	cis	orientation.	The	wild	 type	 pRScaf1R-M′-lacZ	was	 difficult	 to	make	 so	 initially	 the	 pRScaf1RE98K-M′-lacZ	 mutant	was	 constructed	by	using	previously	designed	pRScaf1RE98G-M′-lacZ	mutant	template	 and	 then	pRScaf1RE98K-M′-lacZ	was	used	 as	 template	 to	 create	wild	 type	pRScaf1R-M′-lacZ	(section	2.2.4	(iv)	(c)).	A	pACYCF1SpM	plasmid	fragment	(1519	bp)	encompassing	mutant	caf1R	(E98G),	caf1R-
caf1M	 intergenic	 region	 and	 the	 first	 158	 bp	 of	 caf1M	was	 previously	 subcloned	 in	 between	EcoRI/BamHI	 sites	 of	 the	 pRS550	 plasmid	 and	 thus	 constructed	 pRScaf1RE98G-M′-lacZ.	 The	remaining	two	constructs,	pRScaf1RE98K-M′-lacZ	and	pRScaf1R-M′-lacZ	were	constructed	by	site-specific	 mutagenesis	 of	 pRScaf1RE98G-M′-lacZ	 and	pRScaf1RE98K-M′-lacZ	 templates,	 respectively	(section	2.2.4	(iv)	b	and	c).	Constructs	used	to	test	progressively	smaller	fragments	for	promoter	activity	 were	 constructed	 by	 PCR	 amplification	 and	 Infusion,	 using	 the	 corresponding	 PCR	amplification/Infusion	 primers	 and	 linearized	 pRS415	 or	 pRS550	 as	 required.	 Sequences	 of	insert	for	all	constructs	were	confirmed	by	sequencing	with	the	M13F	primer	for	both	pRS415	and	pRS550	based	constructs.	The	sequence	of	caf1R	in	pRScaf1R-caf1M′-lacZ	and	pRScaf1RE98K-
M′-lacZ	was	additionally	confirmed	with	F1_1	sequencing	primer.	
2.3.2 Monitoring β-galactosidase activity 	In	order	to	quantify	the	strength	of	predicted	promoters	(identified	within	the	intergenic	region	of	the	caf	locus)	and	to	monitor	the	impact	of	Caf1R	on	their	activity,	the	β-galactosidase	activity	of	each	promoter-lacZ	fusion	construct	was	measured	±	Caf1R	(expressed	from	pACYC-R)	from	three	individual	colonies	as	follows:	
i)	 Growth	curve	and	sample	collection		Single	 colonies	 of	 freshly	 transformed	 E.	 coli	 Top10	 cells,	 carrying	 promoter-lacZ	 fusion	construct	 ±	 pACYC-R	were	 inoculated,	 in	 triplicate,	 into	 10	ml	 LB	 containing	 100	 µg/ml	 Amp	(+10	 µg/ml	 Cm	 for	 cells	 also	 carrying	 pACYC	 Duet-I	 vector	 or	 pACYC-R/pACYC-RE98G/pACYC-RE98K).	Cells	were	grown	for	24	h	at	26°C	with	shaking	at	225	rpm.	On	the	following	day,	OD600	was	measured	and	one	sample	of	cells	equivalent	to	0.5	OD	unit	was	harvested	by	centrifugation	(13,000	rpm	-	10	min),	as	0	time	sample.	A	second	sample	equivalent	to	0.5	OD	unit	was	added	into	50	ml	pre-warmed	(at	37°C)	selective	LB	(100	µg/ml	Amp	±	10	µg/ml	Cm)	in	250	ml	sterile	flasks	and	incubated	at	37°C	with	shaking	at	225	rpm	for	24	h.	OD600	was	monitored	and	0.5	OD	unit	of	culture	harvested	every	2	h	until	cultures	reached	stationary	phase	(10	h).	A	final	sample	was	harvested	at	24	h.	During	sampling,	all	samples	were	kept	on	ice	to	halt	growth	while	OD600	was	measured.	All	recovered	cell	pellets	were	immediately	frozen	at	-20°C	until	required	for	the	measurement	of	β-galactosidase	activity.		
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ii)	 Cell	lysis	and	β-galactosidase	assay		Frozen	pelleted	cells	were	resuspended	in	100	μl	of	Bugbuster	master	mix	(Novagen®)	solution	and	 incubated	 at	 37°C	 for	 20	 min	 with	 gentle	 shaking.	 The	 cell	 lysate	 was	 then	 centrifuged	(13,000	rpm	-	5	min)	and	the	supernatant	transferred	to	another	sterile	1.5	ml	eppendorf	tube.	Lysed	samples	were	stored	on	ice,	processed	the	same	day	to	measure	β-galactosidase	activity,	and	 were	 never	 refrozen.	 Four	 microliter	 lysate	 samples	 were	 loaded	 into	 a	 96-well	 plate	(Grainer	BIO-ONE,	flat	bottom)	and	196	μl	of	reactant	solution4	was	added	using	a	multichannel	pipettor	 immediately	 before	 inserting	 the	 plate	 into	 a	 SpectraMax	 Plus	 Microplate	 reader	(Molecular	Devices	corps)	and	to	begin	recording.	SoftMaxT	program	was	used	to	measure	the	reaction	rate	(Vmax)	across	each	well	of	the	plate,	for	an	hour	at	30°C	with	readings	at	OD420		at	30	sec	 intervals.	 The	 Vmax	 values	 and	 plot	 of	 each	 plate	 was	 exported	 as	 .pdf	 file	 and	 used	 to	calculate	the	β-galactosidase	activity	as	Abs420	min-1	OD-1	of	cells,	as	follows:					β-galactosidase	activity	=	Vmax	=	1000	×	ΔAbs420	min-1			ΔAbs420	min-1		=	Vmax/1000																																																																			ΔAbs420	min-1	OD-1	=	(Vmax		×	25	×	2)/1000																																																																										=	Vmax/20	(for	undiluted	sample)																																											=		Abs420	min-1	OD-1	(Units)																				Factor	25	is	from	100/4:	4	μl	of	the	100	μl	Bugbuster	lysed	cells	used	to	test	activity		Factor	2	is	from	1/0.5:		To	calculate	activity	per	OD	and	take	account	of	0.5	OD	cells	used	in	the	assay.		
2.4 In vitro protein techniques 
2.4.1 F1 analysis in whole cell 	To	analyse	F1	expression	in	whole	cells,	a	single	bacterial	colony	or	glycerol	stock	culture	of	an	individual	colony	was	inoculated	in	10	ml	selective	LB	(containing	0.6%	glucose	and	appropriate	antibiotic/s)	 and	 incubated	 at	 26°C	 for	 22	 h	with	 shaking	 at	 225	 rpm.	 Next	 day,	 1	ml	 of	 this	overnight	culture	was	pelleted	by	centrifugation	(13,000	rpm-10	min)	and	washed	with	fresh	LB	(no	glucose)	by	re-suspension	and	re-centrifugation	(13,000	rpm-10	min).	This	pellet	was	then	resuspended	in	10	ml	selective	LB	(containinig	only	appropriate	antibiotics)	and	grown	at	37°C	for	6	h,	unless	otherwise	stated.	After	4	and	6	h	thermo-induction	(26	to	37°C),	1	ml	sample	was	recovered	 by	 centrifugation	 (13,000	 rpm-	 20	 min)	 and	 the	 pelleted	 cells	 mixed	 in	 200	 μl	PBS/OD600,	unless	otherwise	specified.	 	On	some	occasions,	pelleted	cells	were	mixed	in	100	μl	PBS/OD600	 as	 stated	 in	 the	 corresponding	 result	 sections.	 F1,	 from	 the	 co-transformed	constructs,	was	extracted	after	induction	with	L-ara	(0.02%)	at	37°C	for	4-6	h.	During	F1	sample	preparation	extreme	care	was	taken	to	remove	the	culture	supernatant	(LB)	 from	the	pelleted																																																									4	1.0	mM	MgSO4.7H2O,	10	mM	KCl,	60	mM	Na2HPO4.2H2O,	40	mM	NaH2PO4.2H2O,	14.9	mM	ONPG,	24.9	mM	DTT,	8.85%	PBS;	pH	7.5.					
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cells,	 ensuring	 no	 loss	 of	 fluffy	 F1,	 on	 the	 surrounded	 cell	 surface.	 The	 recovered	 cells	were	stored	at	-20°C	for	further	use.	
2.4.2 F1 extraction from cell surface   	To	 extract	 F1	 from	 the	 cell	 surface,	 PBS	 mixed	 cell	 suspensions	 (section	 2.4.1)	 were	 heat-shocked	 at	 57°C	 for	 1	 h	 with	 intermittent	 mixing	 every	 10-15	 min	 to	 detach	 F1	 from	 the	associated	 Caf1M	 chaperone	 (Chapman	 et	 al.,	 1999;	 MacIntyre	 et	 al.,	 2001).	 Following	 heat	shocking,	cells	were	removed	by	centrifugation	at	13,000	rpm	for	10	min	and	the	F1	containing	supernatant	 was	 recovered	 (Zavialov	 et	 al.,	 2003).	 Samples	 were	 stored	 at	 -20°C	 for	 further	analysis.		
2.5 Expression and purification of tagged Caf1R  	Caf1R	was	overexpressed	and	purified	from	its	native	and	synthetic	codon	optimised	sequence	in	three	expression	plasmids,	pBADHisA,	pET28a+	and	pMALc2x.	A	brief	overview	of	expression	and	purification	of	tagged	Caf1R	was	as	follows:			
2.5.1 Expression, sampling and lysis of recombinant caf1R constructs in E. coli 	Ten	 ml	 (small-scale)	 or	 40-500	 ml	 (large-scale)	 LB,	 containing	 the	 appropriate	 selective	antibiotic	 and	0.6%	glucose,	was	 inoculated	with	 either	 a	 single	 fresh	 transformant	 or	 from	 a	glycerol	 stocked	 culture	of	 the	 construct	 of	 interest.	 Cultures	were	 grown	at	37°C	on	 a	 rotary	shaker	(225	rpm)	for	16-17	h.	Next	day,	cells	from	1-5	ml	culture	were	pelleted-down	(13,000	rpm/5	min),	washed	by	mixing	in	fresh	LB	(no	glucose)	and	re-centrifuged	(13,000	rpm/5	min).	The	washed	 cells	were	 then	 resuspended	 in	 the	 same	original	 volume	of	 LB	 (no	 glucose)	 and	subcultured	 (1/100)	 in	 selective	 LB	 (containing	 the	 appropriate	 antibiotic	 ±	 1.0%	 glucose)5.		Small-scale	(10	ml)	preparations	were	carried	out	in	20	ml	universals	while	large-scale	(40-500	ml)	preparations	were	 in	250	ml	to	2-liter	Erlenmeyer	flasks.	Subcultured	cells	were	grown	at	37°C	on	a	rotary	shaker	(225	rpm)	until	about	0.5	OD600.		At	 this	point	cells	were	 induced	with	either	 a	 range	 of	 IPTG	 concentrations	 (pET28a+	 and	 pMALc2x	 based	 constructs)	 or	 L-ara	(pBADHisA	based	constructs)	as	specified.	During	induction,	cultures	were	grown	at	37°C,	or	at	an	 alternate	 temperature	 as	 metioned,	 and	 samples	 taken	 at	 the	 time	 points	 indicated.	 	 For	small-scale	 analysis	 of	 expression	 directly	 in	whole	 cells,	 cells	 (1	 OD	 unit)	were	 recovered	 at	13,000	 rpm/5	 min	 at	 RT	 and	 directly	 mixed	 routinely	 into	 100	 μl	 of	 4×	 SDS-PAGE	 sample	buffers.	 For	 preparative	 large-scale	 procedures,	 cells	were	 recovered	 at	 4,000	 rpm/20	min	 at	4°C	 (large-scale)	 and	 resuspended	 directly	 in	 the	 lysis	 buffer	 of	 choice	 (100	 μl/OD,	 unless	otherwise	stated).	When	lysis	was	followed	by	affinity	purification,	cells	were	generally	lysed	in	the	appropriate	column	buffer.	To	small	screens,	Bug	buster	was	often	used.	Use	of	other	 lysis	buffers	 are	 indicated	 in	 the	 respective	 Results	 section.	 For	 pBADHisA	 and	 pET28a+	 based	construct,	 EDTA-free	 and	 for	 pMALc2x	 based	 constructs	 EDTA-plus	 proteases	 inhibitor	 was	added	during	lysis.	Cells	were	lysed	by	sonication	or	French	press,	directly	or	following	storage	at	 -20°C,	 as	described	below.	Cells	mixed	 in	Bug	buster	master	mix	 (Novagen)	do	not	 require	sonication	or	French	press.																																																										5	After	confirming	IPTG-mediated	toxicity	pEThCaf1Rgs	or	pEThCaf1RgsE98G	plasmid	containing	cells	were	always	grown	in	LB	containing	1.0%	glucose	throughout	irrespective	of	induction.		
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2.5.2 Cell lysis 	Cells	 were	 routinely	 lysed	 either	 by	 Bug	 buster	 master	 mix	 (Novagen)	 or	 sonication	 or	French	press	followed	by	mixing	into	appropriate	lysis	buffer.	Bug	buster	master	mix	was	used	to	 lyse	 pelleted	 cells	 harvested	 from	 500	 μl	 to	 5	ml	 culture.	 Bug	 buster	master	mix	 contains	protein	extraction	reagents,	benzonase	nuclease	and	rLysozyme™	in	one	convenient	formulation	allowing	gentle	disruption	of	 the	E.	coli	cell	wall	 to	 liberate	active	proteins	without	 the	use	of	any	mechanical	methods	 of	 cells	 lysis	 i.e.	 French	 press	 or	 sonication.	 To	 lyse	 cells	 using	 Bug	buster	master	mix,	recovered	cells	were	regularly	mixed	in	100	μl/OD600	of	Bug	buster	master	mix,	unless	otherwise	stated,	and	incubated	at	RT	with	gentle	shaking	for	about	15-20	min.	The	unlysed	cells	were	then	removed	by	centrifugation,	as	described	 in	the	subsequent	section.	To	lyse	cells	by	sonication,	Sonic	VibraTM	sonicator	(Sonics)	was	used	to	lyse	cell-suspensions	from	500	 μl	 to	 10	 ml.	 Samples	 were	 always	 kept	 on	 ice	 and	 cells	 were	 routinely	 lysed	 with	appropriate-sized	probe	for	about	3-5	min,	with	10	sec	pulse	ON/OFF	mode	at	amplification-1,	50%	energy	setting.		To	lyse	40-50	ml	of	cell	suspension,	prepared	in	the	affinity	column	binding	buffer	 supplemented	 with	 EDTA-free	 proteases	 inhibitor	 (Pierce),	 a	 French	 press	 (Thermo	Scientific)	with	pre-chilled	(at	4°C)	45	ml	cell	was	regularly	used	to	at	12,000	psi,	4×.	
2.5.3 Clarification of cell lysates: preparation of soluble and insoluble fractions  	Unless	otherwise	specified,	 following	cell-lysis,	 lysates	were	centrifuged	at	15-20,000	rpm/15-20	min	 in	 an	 Eppendorf	 or	MSE	bench	 top	 centrifuge	 to	 remove	 any	 remaining	 unlysed	 cells,	cells	 debris	 (membranes)	 and	 inclusion	 bodies	 (pellet,	 insoluble	 fraction)	 from	 the	 soluble	protein	 fraction	 (supernatant).	 Where	 indicated,	 lysates	 were	 clarified	 by	 ultracentrifugation	(50,000	 rpm6/60	 min	 at	 4°C)	 using	 a	 Beckman	 Optima	 TLX	 ultracentrifuge	 with	 TLA-100.3	rotor.	 This	 should	 remove	 all	 aggregates,	 leaving	 soluble	 protein	 in	 the	 supernatant	 fraction.	Lysates	to	be	used	in	subsequent	protein	purification	were	always	ultracentrifuged	to	obtain	the	soluble	fraction.	After	separation	of	supernatant,	pelleted	cells	were	resuspended	in	the	volume	of	 buffer	 used	 for	 lysis.	 	 Pellet	 and	 supernatant	 fractions	 were	 analysed	 by	 SDS-PAGE	 using	12.5%	acrylamide	for	all	MBP-tagged	constructs	and	14%	acrylamide	for	His-tagged	constructs.			
2.5.4 Purification 	Affinity-chromatography	based	methods	were	used	to	purify	His6-tagged	and	MBP-tagged	Caf1R	using	an	AKTA	purifier10	(GE	Healthcare)	at	15-18°C.	For	purification	of	tagged	Caf1R,	soluble	fractions	were	 always	 prepared	 by	 ultracentrifugation	 (50,000	 rpm/60	min	 at	 4°C)	 to	 ensure	removal	of	all	insoluble	aggregates.			
i)	 Purification	of	hCaf1R/hCaf1RTgs	by	Ni2+	affinity	chromatography			His6-tagged	Caf1R	was	prepared	 from	250	or	100	ml	 culture	of	Top10/pBADhCaf1R	 (induced	with	0.02%	L-ara	at	30°C-6	h)	or	BL21(DE3)/pEThCaf1Rgs	(induced	with	0.35	mM	IPTG	at	37°C		for	 2	 h	 30	 min).	 Cells	 were	 resuspended	 in	 10-40	 ml	 of	 HisTrapFF	 column	 binding	 buffer	supplemented	 with	 1×	 EDTA-free	 protease	 inhibitor	 (Pierce)	 and	 lysed	 by	 French	 press																																																										6	50,000	rpm	=	134,877×g	or	rcf	
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(hCaf1R)	 or	 sonication	 (hCaf1RTgs)	 followed	 by	 ultracentrifugation.	 The	 clarified	 lysate	supernatants	(10-40	ml)	were	fractionated	using	a	pre-packed	1	ml	HisTrapFF	column	and	His	trap	buffer	kit	(GE	Healthcare).	The	column	was	pre-equilibrated	with	10-column	volume	(CV)	binding	 buffer	 (20	 mM	 NaPO4	buffer,	 500	 mM	 NaCl,	 5	 mM	 DTT,	 20	 mM	 imidazole;	 pH	 7.4).		Samples	were	 applied	 at	 a	 flow	 rate	of	 0.5	ml/min.	The	 column	was	 then	washed	with	10-CV	binding	buffer	at	a	speed	of	1	ml/min.	Flow-through	(FT)	and	wash	(W)	fractions	were	collected	to	 analyse	 unbound	 protein.	 Bound	 hCaf1R	 or	 hCaf1RTgs	 was	 eluted	 with	 20-CV	 of	 a	 linear	gradient	 of	 0-250	 mM	 imidazole	 in	 binding	 buffer,	 at	 a	 flow	 rate	 of	 1	 ml/min.	 Column	 was	washed	with	5	ml	binding	buffer	containing	250	mM	imidazole	(100%	B).	One	ml	fractions	were	collected	and	stored	on	ice	or	at	4°C	until	required.		
ii)	 Purification	of	MBPCaf1Rgs	by	Maltose	affinity	chromatography			Likewise	a	pre-packed	MBPTrapHP	column	(1	ml	size,	GE	Healthcare)	fitted	to	an	AKTA	purifier	was	 regularly	 used	 to	 purify	 MBPCaf1Rgs	 from	 the	 clarified	 lysate	 supernatant.	 Lysate-supernatant	 was	 prepared	 from	 the	 IPTG	 (0.3	 mM)	 induced	 culture	 of	 E.	 coli	 K-12	2508/pMALc2-Caf1Rgs	(500	ml),	recovered	after	5	h	at	25°C	post-induction.	Recovered	pelleted	cells	were	mixed	in	40	ml	of	MBPTrapHP	binding	buffer	(20	mM	Tris-HCl,	200	mM	NaCl,	1	mM	EDTA	 and	 10	 mM	 β-Mercaptoethanol;	 pH	 7.45)	 supplemented	 with	 1×	 protease	 inhibitor	(Pierce)	 followed	 by	 sonication	 and	 ultracentrifugation	 (50,000	 rpm/60	 min	 at	 4°C).	 Before	applying	the	clarified	 lysate	supernatant,	 the	column	was	equilibrated	with	10-CV	of	MBPTrap	column	buffer	(20	mM	Tris-HCl,	200	mM	NaCl,	1	mM	EDTA	and	10	mM	β-Mercaptoethanol;	pH	7.45).	The	sample	was	then	applied	at	a	rate	of	0.5	ml/min.	The	flow-through	(FT)	was	collected	and	the	column	washed	with	10-CV	of	column	buffer	at	1	ml/min.	Unbound	and	washed	samples	were	collected	for	analysis.	The	column-matrix	bound	MBPCaf1Rgs	was	eluted	with	12-CV	of	the	column	buffer	containing	maltose	over	a	linear	gradient	of	0-100%	10	mM	maltose,	collecting	12	fractions	(1	ml	each).	Eluted	fractions	were	kept	on	ice	and	analysed	by	SDS-PAGE.		
 
2.5.5 Solublisation of inclusion bodies by urea  	A	culture	(50	ml)	of	BL21(DE3)/pEThCaf1Rgs	was	 induced	with	0.1	mM	IPTG	at	37°C	 for	5	h.	Recovered	cells	(90	OD	units)	were	resuspended	in		2	ml	20	mM	Na2Po-4	,	500	mM	NaCl;	pH	7.4	(buffer	1)	and	 lysed	by	sonication	 (20	min	10	sec	ON/OFF	pulse).	Cell	 lysates	were	cleared	at	4000	 rpm/10	min/4°C	 to	 remove	 any	 unlysed	 cells	 and	 then	 centrifuged	 at	 low	 speed	 (3000	rpm/20	min	at	4°C)	to	pellet	inclusion	bodies.	This	pellet	was	resuspended	in	2	ml	solublisation	buffer	 2	 (20	 mM	 NaPo4-	 500	 mM	 NaCl,	 0.5%	 Triton-X;	 pH	 7.4),	 aliquoted	 (400	 µl	 ×5)	 and	centrifuged	 (2000×g/20	 min	 at	 4°C),	 to	 wash	 the	 pelleted	 protein	 (Hancock,	 2001).	 These	pellets	were	mixed	in	400	µl	of	buffer	1,	(control,	no	urea)	or	buffer	1	containing	4	M,	6M	or	8	M	urea	(500	mM	NaCl,	20	mM	NaPo4-	buffer;	pH	8.0)	and	sonicated	 for	1	min	40	sec	with	10	sec	ON/OFF	 pulse	 on	 ice.	 Supernatants	 (urea	 solubilised	 protein)	 and	 pellets	 (urea	 insoluble	protein)	were	separated	by	centrifugation	(14,000×g/30	min	at	RT)	and	kept	on	ice.	Resulting	final	 pellets	were	mixed	 in	 400	 µl	 of	 4×	 SDS-PAGE	 sample	 buffer	 and	 analysed	 by	 SDS-PAGE	along	with	final	supernatants.			
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2.6  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 	All	 protein	 samples	 were	 routinely	 analysed	 by	 discontinuous	 Sodium	 Dodecyl	 Sulphate	Polyacrylamide	Gel	Electrophoresis	(SDS-PAGE)	(Laemmli,	1970).	A	vertical	gel	electrophoresis	system,	mini-PROTEAN	 II	 (Bio-Rad)	was	 used	 throughout	with	 freshly	 prepared	 gels	 (see	 gel	making	procedure	in	section	2.6.1)	of	varying	acrylamide	concentration	(%)	in	the	resolving	gel.	The	most	 common	 concentrations	 of	 acrylamide	 used	were	 14	 or	 16%	 for	 F1	 subunit	 (Caf1)	analysis	and	12.5	or	14%	for	Caf1R	as	specified	 in	 respective	 result	 sections.	 	Before	analysis,	samples	were	mixed	with	an	appropriate	volume	of	4×	sample	buffer	(10%	(w/v)	glycerol,	62.5	mM	Tris-HCl	pH	6.8,	8%	(w/v)	SDS,	0.1	mg/ml	bromophenol	blue)	to	give	a	final	concentration	of	 ×1.	 For	 analysis	 of	 Caf1R,	 routinely	 DTT	 was	 added	 to	 the	 sample	 buffer	 to	 a	 final	concentration	of	50	mM.		Samples	were	heat-denatured	(97.5°C	for	10-15	min)	before	applying	to	gel	except	for	F1	polymer	analysis,	which	was	performed	using	unheated	samples.	Gels	used	were	of	0.75	mm	thick	and	routinely	run	at	200	volts	for	45	min	at	RT,	in	1x	SDS-PAGE	running	buffer	(0.25	M	Tris-HCl	base,	0.2	M	glycine,	0.1	(w/v)	SDS).			Following	SDS-PAGE,	the	resolved	proteins	were	either	stained	with	Coomassie	Brilliant	Blue	R-250	(CB)	stain	 (45%	(v/v)	methanol,	10%	(v/v)	glacial	acetic	acid	and	0.25%	(w/v)	CB	stain)	and/or	 processed	 for	 western	 immunoblotting	 (section	 2.7).	 	 For	 CB	 staining,	 gels	 were	submersed	in	CB	stain	in	a	plastic	box	and	kept	on	a	gentle	shaking	platform	for	about	an	hour	at	RT	 followed	by	de-staining	of	excess	CB	stain	by	 transferring	 the	gels	 into	another	plastic	box	containing	de-staining	solution	(40%		(v/v)	methanol,	10%	(v/v)	glacial	acetic	acid).	De-staining	was	at	RT	with	gentle	shaking	for	about	2	h	with	2-3	times	replacement	of	de-staining	solution.	Finally,	gels	were	equilibrated	with	nH2O	and	imaged	in	G-Box	(Syngene,	UK).	Gel	pictures	were	always	saved	in	.tif	and	.sgd	file	formats.	Sometimes,	gels	were	dried	between	cellophane	sheets	(Bio-Rad)	using	GelAir	dryer	system	(Bio-Rad)	for	storage.	
2.6.1 Preparation of discontinuous SDS-PAGE gel  	As	 the	 name	 suggests,	 discontinuous	 SDS-PAGE	 gels	 contain	 two	 different	 concentrations	 of	acrylamide	and	pH	on	a	single	gel	 to	resolve	proteins	according	to	 their	molecular	weight	and	charge.	 Hence,	 two	 gels,	 resolving	 (with	 varying	 concentration	 of	 acrylamide,	 pH	 8.8)	 and	stacking	(contains	5%	(w/v)	acrylamide,	pH	6.8)	were	prepared	one	after	the	other	and	a	single	SDS-PAGE	gel	was	made	by	combining	both	as	follows:		
i)	 Resolving	and	stacking	gel	preparation			Initially,	 the	 resolving	and	stacking	gel	buffers7	were	prepared	which	were	 then	used	 to	make	the	corresponding	gel.	An	example	of	a	14%	resolving	gel	(0.75	mm	thickness)	is	as	follows:	in	a	clean	 15	 ml	 Falcon®	 tube,	 the	 following	 components	 were	 added	 in	 the	 following	 order:	 4×	resolving	 gel	 buffer	 (950	 μl),	 30%	 (w/v)	 acrylamide	 (acrylamide:	 bisacrylamide,	 ratio	 37.5:1,	Severn	 Biotech	 Ltd)	 (1.68	 ml),	 nH2O	 (1.0	 ml),	 10%	 (w/v)	 APS	 (56	 μl)	 and	 TEMED	 (2.5	 μl).	Similarly	the	stacking	gels	were	prepared	by	adding	the	following	components	in	another	clean																																																									7	Resolving	gel	buffer	(4×):	1.5	M	Tris-HCl	(pH	8.8),	0.4%(w/v)	SDS							Stacking	gel	buffer	(4×):	0.5	M	Tris-HCl	(pH	6.8),	0.4%(w/v)	SDS	
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15	ml	size	Falcon®	tube:	 	4×	stacking	gel	buffer	(333	μl),	30%	acrylamide	(225	μl),	nH2O	(750	μl),	10%	(w/v)	APS	(21	μl)	and	TEMED	(2.5	μl).		
ii)	 Preparation	of	SDS-PAGE	gel			The	resolving	gel	mixture	was	mixed	and	poured	in	between	the	assembled	glass	plates	 in	the	Mini-PROTEN	II	gel	casting	apparatus	(Bio-Rad).	 	 Isopropanol	was	 layered	on	top	of	 the	gel	 in	order	 to	 exclude	 air	 bubbles	 and	 the	 gel	 was	 left	 to	 set	 for	 about	 20	 min	 at	 RT.	 After	 the	resolving	gel	had	set,	the	isopropanol	was	decanted	and	rinsed	with	nH2O.	Now	the	stacking	gel	was	 applied	 on	 top	 of	 the	 pre-set	 resolving	 gel	 and	 a	 plastic	 comb	 (Bio-Rad)	was	 inserted	 to	form	wells	in	the	stacking	gel.	The	gel	was	left	to	set	again	for	about	20	min	at	RT.	Routinely	a	coloring	 agent,	 bromphenol	 blue	 (1%	 (w/v))	 was	 added	 in	 the	 stacking	 gel	 to	 give	 a	 good	contrast.	
2.7 Western Immunoblotting  	Western	 Immunoblotting	 or	 WB	 (Towbin	 et	 al.,	 1979)	 was	 routenly	 used	 to	 detect	 the	 low	expression	 level	 or	 to	 confirm	 the	 identity	 of	 tagged	 Caf1R	 (from	 pBADHisA,	 pET28a+	 and	pMALc2x	 based	 Caf1R/Caf1RN	 encoding	 constructs)	 and	 F1	 subunit	 (Caf1)	 expression	 from	pACYCF1	(WT)	or	pACYCF1-RE98K	mutant.	All	WBs	were	carried	out	using	a	Mini-PROTEN	II	Mini	Trans-blot	 module	 (Bio-Rad).	 Following	 SDS-PAGE,	 the	 gels	 were	 equilibrated	 with	 ×1	electroblotting	 transfer	buffer	 (0.025	M	Tris-HCl,	0.2	M	glycine)	along	with	 two	 fiber	sponges,	four	pieces	of	adsorbent	Whatman’s	paper	and	an	electro	blotting	membrane	per	gel.	Two	types	of	 electroblotting	 membranes,	 Nitrocellulose	 (Amersham	 Biosciences)	 (NCM)	 and	 PVDF	(Thermo	 Scientific)	 both	 0.45	 μm	 pores	 size	were	 used.	 PVDF	membrane	was	 activated	with	95%	methanol	prior	to	equilibration	with	transfer	buffer,	unlike	NCM	that	does	not	need	such	activation.			The	 gel-membrane	 sandwich	was	 assembled	on	 the	 black	 side	 of	 the	 blotting	 cartridge	 in	 the	following	 order:	 equilibrated	 sponge,	 two	 Whatman’s	 filter	 paper,	 SDS-PAGE	 gel,	 blotting	membrane,	two	Whatman’s	paper	and	finally	the	second	sponge.	The	assembled	cartridge	was	placed	 into	 the	 gel	 tank	 (Bio-Rad)	 filled	with	 transfer	 buffer,	 along	with	 an	 ice	 container	 and	electrophoresed	at	36	volts	 for	90	min	at	RT.	Following	electrophoretic	 transfer,	 the	sandwich	was	disassembled	and	 the	membrane	 removed	and	 incubated	 face-side	up	 in	blocking	buffer8	for	 either	 an	 hour	 or	 overnight	 at	 4°C	 in	 order	 to	 prevent	 non-specific	 antibody	 binding.		Following	 blocking,	 the	membrane	was	 rinsed	with	 TBST	 and	 incubated	with	 protein-specific	primary	 antibody	 solution,	 prepared	 in	 the	TBST	 for	 an	hour	 at	RT	with	 gentle	 shaking.	After	probing	with	primary	antibody,	the	membrane	was	washed	with	TBST	for	15	min,	with	every	5	min	changing	of	TBST	on	a	shaking	platform.	Following	washing,	the	membrane	was	re-probed	with	HRP-conjugated	secondary	antibody	for	an	hour,	similar	to	primary	antibody	and	likewise	washed	 after	 that.	 For	 hCaf1R	 probing,	 a	 single	 antibody,	 monoclonal	 antiHis-HRP	 antibody	(Roche)	was	used	at	either	1	in	10,000	or	1	in	20,000	dilution	as	specified	in	the	corresponding	result	 sections.	 For	 Caf1,	 two	 antibodies	were	 used	 and	 each	 are	 stated	 in	 the	 corresponding																																																									8	5%	(w/v)	dried	milk	powder	(Marvel)	in	TBST	(0.05	M	Tris-HCl	(pH	7.5),	0.15	M	NaCl,	0.1%	(v/v)	Tween-20	
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result	 sections.	 The	 probed	 antibody/ies	 was/were	 visualised	 by	 a	 chemiluminescence	substrate,	 ChemiFast	 (Syngene)	 according	 to	 the	manufacturer’s	 protocol.	 Blotted	membranes	were	put	 in	between	a	plastic	 sheet	and	 imaged	using	G-box	 (Syngene,	UK).	Blot	 images	were	also	saved	as	.tif	and	.sgd	file	formats.		
2.8 Protein quantification 	After	determining	the	level	of	protein	purity	via	SDS-PAGE,	the	protein	was	quantified	from	the	solution	as	well	as	from	the	corresponding	band	on	SDS-PAGE	as	follows:	
2.8.1 Quantification from solution 	Nanodrop	ND-1000	spectrophotometer	(Fisher	Thermo	Scientific,	UK)	was	used	to	estimate	the	protein	 concentration	 in	 the	 purified	 tagged	 Caf1R	 samples	 (average	 of	 3	 ×2	 µl).	 	 It	 gave	concentration	values	in	mg/ml,	which	were	further	converted	into	pmol/μl	for	subsequent	use	in	DNA-Protein	binding	assay,	EMSA.	
2.8.2 Quantification from a band on SDS-PAGE 	This	 procedure	 was	 used	 for	 quantification	 of	 Caf1,	 either	 extracted	 from	 the	 cell	 surface	 or	directly	analysed	from	the	whole	cell	of	E.	coli	DH5α	expressing	either	pACYCF1	or	pACYCF1-R	mutants.	ImageJ	software	(Hartig,	2013)	was	used	to	quantitate	the	CB	stained	Caf1	bands	of	the	G-box	imaged	gels	saved	as	.tif	files.	ImageJ	calculates	the	peak	area	of	the	band	to	be	quantified,	in	grey	scale.	This	was	readily	identified	by	location	on	the	gel	and	can	be	easy	distinguish	from	background	 bands.	 The	 average	 area	 under	 the	 peak	 was	 calculated	 from	 3	 different	transformants	and	then	converted	into	relative	percentage	(%)	of	WT	Caf1	extracted	from	E.	coli	DH5α/pACYCF1,	following	growth	at	37°C	for	both	4	h	and	6	h.	For	quantification,	an	equal	OD	unit	of	the	cells	was	applied	to	gels	in	order	to	get	valid	comparison	between	samples.	
2.9 Protein characterisation procedure 
2.9.1 Concentration 	Following	purification	of	wild	type	His6-tagged	hCaf1R	or	hCaf1RT	and	MBP-tagged	MBPCaf1R,	the	 eluted	 fractions	 (1	 ml)	 that	 showed	 tagged-Caf1R	 in	 relatively	 high	 amount	 with	 less	background	 (checked	 by	 SDS-PAGE	 and	 confirmed	 by	 western	 blot)	 were	 selected	 for	subsequent	concentration.	 In	 this	 regard,	Fn-18	 from	hCaf1R	(30	μg/ml;	Fig.	 4.4),	Fn-10	 from	hCaf1RTgs	 (40	 μg/ml;	 Fig.	 4.21)	 and	 Fn-3	 from	 MBPCaf1Rgs	 (380	 μg/ml;	 Fig.	 4.25)	 were	concentrated	using	10	kDa	MWCO	Viva	spin	concentrators	(Vivaproducts).	Concentrators	were	pre-equilibrated	with	nH2O	for	5	min	at	RT	and	then	the	purified	fraction	of	choice	was	applied	(500	μl	×2)	on	 top	of	 the	 concentrator	membrane	 followed	by	 centrifugation	 (14,000	 rpm/30	min	at	RT).	Tenfold-concentrated	(1	ml	to	100	μl)	samples	were	remixed	and	carefully	removed	from	 the	 concentrator	 ensuring	 not	 to	 touch	 the	 membrane.	 Protease	 inhibitor	 (Thermo	Scientifie	Pierce,	UK)	was	added	to	each	concentrated	protein	sample	(EDTA-free	for	His-tagged	Caf1R	and	EDTA	plus	for	MBP-tagged	Caf1R)	and	all	were	stored	4°C.		
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2.9.2 Buffer exchange using viva spin concentrator 	Excess	 salt	 or	 imidazole	 from	 the	 concentrated	 hCaf1R	 was	 removed	 using	 a	 Viva	 spin	concentrator	 (1	ml	 size).	 The	 concentrated	 hCaf1R	 (100	 μl)	was	mixed	 in	 500	 μl	 of	 exchange	buffer	(50	mM	NaPO4	buffer,	150	mM	NaCl,	5	mM	DTT;	pH	7.0)	and	applied	to	the	concentrators,	which	had	been	pre-treated	with	nH2O.	The	concentrator	was	centrifuged	at	14,000	rpm/30	min	at	RT	and	200	μl	buffer	exchanged	hCaf1R	recovered.	After	exchanging	buffer,	50	μl	was	stored	at	4°C	(EDTA-free	proteases	inhibitor	added)	and	the	remaining	150	μl	(200	μg/ml)	was	directly	used	for	further	gel	filtration	chromatography.		
2.9.3 Buffer exchange using Mini D-tube dialyser 	Purified	 and	 concentrated	 hCaf1RTgs	 (250	 μg/ml)	 and	 MBPCaf1Rgs	 (750	 μg/ml)	 along	 with	purchased	 hCaf1RP	 (500	 μg/ml)	 were	 dialysed	 against	 20	 mM	 Tris,	 300	 mM	 NaCl,	 pH	 8.0;	adapted	 from	 (Lowden	 et	 al.,	 2010).	 Mini	 D-tube	 dialysers	 (Novagen®),	 with	 MWCO	 6-8	 kDa	were	used	for	this	purpose.	Prior	to	dialysis,	three	D-tubes	were	pre-treated	with	nH2O	(100	μl)	for	 20	min	 at	 RT.	 	 Protein	 samples	 (100	 μl)	 were	 then	 loaded	 into	 equilibrated	 Mini	 D-tube	dialysers	and	the	dialysers,	 inserted	into	a	Styrofoam	rack,	were	placed	in	a	beaker	containing	50	ml	dialysis	buffer	(20	mM	Tris,	300	mM	NaCl,	pH	8.0).	Samples	were	dialysed	for	at	least	12	h	at	4°C	with	2	changes	of	buffer.	Following	dialysis,	the	protein	samples	were	removed	(≈	90	μl)	from	the	D-tube	dialyser,	and	 the	protein	concentration	of	each	determined	using	a	Nanodrop	spectrophotometer	 (hCaf1RTgs,	 245	 μg/ml;	 MBPCaf1Rgs,	 740	 μg/ml;	 hCaf1RP,	 500	 μg/ml).	Samples	were	stored	at	4°C	after	adding	1×	proteases	 inhibitor	(Thermo	Scientifie	Pierce,	UK)	(EDTA-free	for	hCaf1RT	and	EDTA	plus	for	MBPCaf1Rgs).			
2.9.4 Size exclusion chromatography 	A	 pre-packed	 Superose™12	 10/300GL	 column	 (GE	 Healthcare),	 and	 AKTA	 purifier	 (GE	Healthcare)	was	used	to	estimate	oligomerisation	state	of	hCaf1R.	The	column	was	equilibrated	with	2-column	volumes	(CV)	of	elution	buffer	(50	mM	NaPO4,	150	mM	NaCl,	5	mM	DTT;	pH	7.0)	at	a	 rate	of	800	μl/min.	The	elution	profile	of	 four	protein	markers,	Blue	dextran	 (2000	kDa),	Albumin	(67	kDa)	Ovalbumin	(45	kDa)	and	Ribonuclease	A	(13.7	kDa)	from	GE	Healthcare,	(150	μl,	 1	 mg/ml	 each)	 were	 monitored	 individually.	 All	 four	 markers	 were	 then	 mixed	 at	 an	equimolar	concentration	and	150	μl	was	applied	 to	 the	column	 to	calibrate.	Concentrated	and	buffer	exchanged	hCaf1R	(150	μl)	was	applied	to	the	column	and	1	ml	fractions	were	collected	at	an	elution	rate	of	0.8	ml/min.	Position	of	hCaf1R	was	monitored	by	immunoblotting.		
2.10 Electrophoretic mobility shift assay (EMSA) 	EMSA	 has	 been	 used	 extensively	 for	 studying	 DNA-protein	 interactions	 (Carolina	 and	 Celso,	2012).	 Principally,	 this	 technique	 is	 based	 on	 the	 fact	 that	 DNA-protein	 complexes	 migrate	slower	than	non-bound	DNA	in	a	native	polyacrylamide	gel,	resulting	 in	a	shift	 in	migration	of	the	 labeled	 DNA	 band	 (Carolina	 and	 Celso,	 2012).	 A	 LightShift®	 Chemiluminescent	 EMSA	 kit	(Thermo	Scientific,	Pierce)	was	used	to	test	the	ability	of	binding	of	His6-	and	MBP	tagged	Caf1R	to	bind	specific	and	non-specific	caf	DNA	fragments.				
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2.10.1 Preparation of specific and non-specific caf DNA probes for use in EMSA 	Biotin-TEG	(at	3′)	 labelled,	HPLC	purified	oligonucleotides	 (47	bp)	of	both	strands	 for	specific	(F2-B/F2c-B)	 and	 non-specific	 (F1-B/F1c-B)	 DNA	 fragments	 were	 purchased	 from	 MWG,	Eurofin	 (Germany)	 (See	 Fig.	 5.14	 for	 details).	 F2	 oligonucleotides	 were	 also	 purchased	unlabeled	(F2/F2c).	Following	purchase,	each	strand	was	resuspended	in	nanopure	nH2O	to	give	a	 stock	of	200	pmol/μl	and	stored	at	–20°C.	For	 subsequent	use	 in	EMSA,	 the	 complementary	strands	of	 the	desired	probe	(Biotin	 labelled	F1-B/F1c-B	or	F2-B/F2c-B	or	unlabelled	F2/F2c)	were	annealed	by	mixing	20	μl	of	working	stock	(100	pmol/μl)	of	each	strand	in	a	final	volume	of	50	μl	annealing	buffer	 (10	mM	Tris-HCl,	pH	7.5,	100	mM	NaCl,	1	mM	EDTA).	Samples	were	incubated	at	Tm+10°C	 for	10	min	 in	an	Eppendorf	Mastercycler	PCR	machine	and	 then	cooled	down	at	RT	for	1	h.	A	dilution	series	of	each	annealed	probe	(40	pmol/μl,	ds	DNA)	was	prepared	in	 1×	 annealing	 buffer	 down	 to	 a	 concentration	 of	 5	 fmol/μl.	 Stock	 and	 diluted	 probes	 were	stored	at	-20°C,	for	up	to	one	year.	
2.10.2 Preparation of cell lysate for EMSA  	Overnight	 culture	 of	 E.	 coli	 BL21	 (DE3)	 carrying	 pEThCaf1Rgs,	 pEThCaf1RgsE98G	 or	 pET28a+	(negative	 control)	 or	 cultures	 of	 E.	 coli	 K12-ER2508	 carrying	 pMALc2-MBPCaf1Rgs,	 pMALc2-MBPCaf1RN	or	pMALc2x	plasmid	(negative	control),	were	subcultured	(1/100)	in	10	ml	LB	plus	kanamycin	 (30	 μg/ml)	 or	 ampicillin	 (100	 μg/ml),	 as	 appropriate	 and	 grown	 at	 37°C	 with	shaking	 at	 225	 rpm.	 At	 0.5	 OD600	 IPTG	 (0.30	 mM	 final	 concentration)	 was	 added	 to	 induce	expression	 of	 hCaf1RT	gs	or	 hCaf1RTgsE98G	 and	MBPCaf1Rgs	 or	MBPCaf1RN.	 Following	 a	 further	37°C/5.0	 h	 incubation	 (pET28a+	 plasmid	 based	 constructs)	 or	 2.5	 h	 incubation	 (pMALc2x	plasmid	 based	 constructs),	 1.0	 OD	 unit	 of	 induced	 cells	 were	 harvested	 by	 centrifugation	(13,000	rpm	–	5	min),	resuspended	in	500	μl	EMSA	lysis	buffer	(10	mM	Tris-HCl,	pH	7.5,	1	mM	EDTA,	100	mM	KCl,	5	mM	MgCl2,	1	mM	DTT,	10%	Glycerol	and	1×	EDTA-free	protease	inhibitor	(Pierce)	and	lysed	by	sonication	(on	ice)	for	3	min	with	25	sec	pulse	ON/OFF	mode.	Following	lysis,	the	cell	lysates	were	clarified	by	centrifugation	(21,000	rpm/15	min/4°C),	and	the	soluble	supernatant	fraction	used	directly	to	set	up	EMSA	binding	reactions.		
2.10.3 Purified, concentrated and dialysed protein samples used in EMSA 	From	 section	 2.9.1	 and	 2.9.3,	 purified,	 concentrated	 and	 dialysed	 hCaf1RTgs	 (40	 kDa),	MBPCaf1Rgs	(78.9	kDa)	and	hCaf1RP	(38.5	kDa)	protein	samples,	stored	at	4°C	with	1×	proteases	inhibitor	 (EDTA-free	 for	 hCaf1RTgs/hCaf1RP	 and	 EDTA	 plus	 for	 MBPCaf1Rgs)	 were	 used	 in	corresponding	final	concentration,	6.31,	9.37	and	12.87	nmol/ml.		
2.10.4 Setting up EMSA binding reaction 	Binding	reactions	were	set	up	in	1.5	ml	eppendorf	tubes	at	RT.	In	a	standard	20	μl	reaction,	the	reaction	components	were	added	in	the	following	order:	autoclaved	nanopure	nH2O	(xx	μl),	10×	binding	buffer9	(2	μl),	1	μg	Poly	dI.dC	(1	μl),	 freshly	prepared	cell	 lysate	(4	or	6	μl)	or	varying	amount	of	protein	sample	(0.10-55	pmol/μl),	3′	Biotin-labeled	F1-B	or	F2-B	caf	DNA	probe	(5	to	12.5	 fmol	 in	2	μl).	For	competition	reactions	100-fold	molar	excess	unlabeled	specific	 (F2)	caf																																																									9		100	mM	Tris,	500	mM	KCl,	10	mM	DTT;	pH	7.5	
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DNA	probe	(2	μl)	was	included,	prior	to	addition	of	purified	protein	or	lysate	sample	and	biotin-labeled	specific	(F2-B)	caf	DNA	probe.	After	adding	each	component,	the	reaction	mix	was	gently	mixed	by	pipetting	once	or	twice	and	then	incubated	at	RT	for	20	min.			Prior	to	running	the	gel,	5	μl	of	5×	 loading	buffer	(Thermo	Scientific	Pierce,	UK)	was	added	to	each	reaction.	Following	incubation	 all	 reactions	 were	 resolved	 on	 polyacrylamide	 DNA-retardation	 gels	 followed	 by	electro	transfer	on	positively	charged	Nylon	membrane,	and	detection	with	Streptavidin-HRP.			To	discriminate	binding	(shift)	of	tagged	Caf1R	from	lysate(s)	or	purified/dialysed	sample(s),	a	negative	control	of	binding	reaction	was	always	included	in	the	assay.	For	example,	the	negative	control	 for	 cell	 lysate(s)	 expressing	 tagged	Caf1R	was	 freshly	prepared	 cell	 lysate(s)	 from	 the	corresponding	 cells	 expressing	 the	 respective	 vector	 (pET28a+	 or	 pMALc2x)	 whereas	 the	negative	 control	 for	 binding	 reaction(s),	 set	 up	 by	 using	 purified/dialysed	 tagged	 Caf1R	 was	reaction	in	the	absence	of	Caf1R.		
2.10.5 Polyacrylamide Gel Electrophoresis and Streptavidin-HRP based detection 	BoltTM	Mini	DNA-retardation	gels	(6%	acrylamide	with	12	×25	μl	wells)	(Life	technologies)	were	used	to	monitor	gel	shift.	Gels	were	pre-run	at	100	volts	for	1	h	at	4°C	in	0.5×	TBE	buffer	(44.57	mM	 Tris-base,	 44.47	 mM	 Boric	 acid,	 0.025	 mM	 EDTA;	 pH	 8.0)	 using	 a	 BoltTM	 Mini	 gel	electrophoresis	system	(Life	 technologies).	The	entire	binding	reaction	was	directly	applied	 to	the	 pre-run	 gel	 and	 electrophoresis	 continued	 at	 4°C	 without	 changing	 buffer,	 until	 the	 blue	tracking	dye	was	0.5	cm	from	the	bottom	of	the	gel	(approximately	1	h	30	min).	DNA	was	then	electro-transferred	 to	 positively	 charged	 Nylon	 Hybond	 XL	 membrane	 (GE	 Healthcare)	 at	 30	volts	for	1	h	at	4°C	in	fresh	0.5×	TBE.		The	membrane	was	then	cross-linked	using	UV302nm	for	5	min	with	DNA	side	down	on	a	T-20	UVP	Dual-intensity	trans-illuminator.	After	UV	cross-linking,	the	membrane	was	blocked	in	EMSA	blocking	buffer	(20	ml)	for	15	min	at	RT	with	shaking,	then	transferred	 into	 a	 clean	 square	 petri	 dish.	 The	 membrane	 was	 submerged	 in	 20	 ml	 EMSA	blocking	buffer,	supplemented	with	streptavidin-HRP	conjugate	(1:300)	and	incubated	at	RT	for	15	 min	 with	 gentle	 shaking.	 The	 membrane	 was	 then	 rinsed	 with	 1×	 EMSA	 wash	 solution,	washed	four	times	(5	min	each)	with	1×	EMSA	wash	solution	(20	ml),	with	gentle	shaking.	The	membrane	was	 then	 carefully	 removed,	 the	 edge	 blotted	 on	 a	 paper	 towel	 to	 remove	 excess	buffer	 and	 then	 transferred	 to	 another	 clean	 plastic	 box	 containing	 30	 ml	 EMSA	 substrate	equilibration	buffer.		This	was	incubated	for	5	min	with	gentle	shaking.	In	the	mean	time	a	fresh	EMSA	substrate-working	solution	(1	ml/membrane)	was	prepared	by	mixing	an	equal	amount	(500	μl	each)	of	Luminol	enhancer	solution	and	stable	peroxidase	solution	in	1.5	ml	eppendorf	tubes,	keeping	the	substrate	in	the	dark.	The	membrane	was	removed,	the	edge	again	blotted	to	remove	excess	buffer	and	then	placed	onto	a	clean	plastic	sheet	face–up	(with	the	intense	dye-front	facing	up).	The	freshly	prepared	EMSA	substrate-working	solution	was	then	pipetted	over	the	 entire	 surface	 and	 the	membrane	 incubated	 for	5	min	 at	RT	 in	 the	dark,	without	 shaking.	Excess	 solution	was	 removed	by	blotting	 the	edge	of	membrane	on	a	paper	 towel.	 	The	moist	membrane	 was	 then	 placed	 between	 2	 clean	 transparent	 plastic	 sheets	 (Rexel,	 reinforced	polished	 plastic	 pockets	 –	 no	 12265),	 avoiding	 bubbles	 and	 imaged	 immediately	 using	 G-box	(Syngene)	 with	 automatic	 exposure	 time,	 under	 chemiluminescent	 substrate-specific	immunoblotting	image	setting.	The	images	were	saved	in	.tif	file	format.		
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2.11 Bioinformatic analysis 
2.11.1 DNA sequence(s) analysis, primers and constructs design  	Sequence	 analysis	 software,	 DNAdynamo	 (http://www.bluetractorsoftware.co.uk/	DNAdynamo/)	 was	 routinely	 used	 to	 design	 primers,	 plasmid-constructs	 or	 mutants	 and	analysis	 of	 sequencing	 results.	 Raw	 sequencing	 data	 (peaks	 chromatogram)	 were	 regularly	analysed	by	DNA	sequencing	data	viewer	tool,	FinchTV	(http://www.geospiza.com/	FinchTV/).		
2.11.2 Promoter prediction  	A	bioinformatic	and	visual	analysis	of	caf1R-caf1M	 (327	bb)	and	caf1A-caf1	 (80	bp)	 intergenic	region	was	carried	out	to	predict	promoter(s)	for	caf1R,	caf1M	and	caf1.	The	complete	intergenic	region	of	choice	with	a	few	hundred	bases	of	the	genes	on	either	side	joining	was	analysed	using	the	 bacterial	 promoter	 prediction	 program,	 BPROM	 (Solovyev,	 2011)	(http://www.softberry.com/berry.phtml/BPROM)	with	default	parameters	in	order	to	identify	-10	 and	 -35	 elements.	 BPROM	 identifies	 σ70	 type	 promoters	 (one	 of	 the	major	 class	 of	 E.	 coli	promoters)	based	on	a	linear	discriminant	function	(Korzheva	et	al.)	algorithm.	This	algorithm	is	based	on	nt	composition	of	the	predicted	-10	and	-35	elements	and	the	distance	between	them.	In	addition	to	identifying	-10	and	-35	elements,	BPROM	also	identifies	transcriptional	factor(s)	binding	 site(s),	 surrounding	 the	 predicted	 -10	 and	 -35	 elements.	 It	 has	 been	 suggested	 that	BPROM	identifies	-10	and	-35	elements	with	about	80%	accuracy	and	specificity,	when	tested	on	equal	 number	 of	 sequence	 sets	 containing	 promoter	 and	 non-promoter	 sequences	 (Solovyev,	2011).	 For	 visual	 prediction	 of	 promoters,	 upstream	 of	 caf1R,	 caf1M	 and	 caf1,	 the	 upstream	region	of	choice	was	initially	screened	for	-10	element	consensus	(TATAAT)	and	then	looked	for	sequence	 motif	 with	 highest	 similarity	 with	 -35	 element	 consensus	 (TTGACA),	 at	 16-22	 nt	upstream.	 The	 following	 criteria	 were	 used	 to	 identify	 optimum	 likely	 promoters	 with	 an	optimum	distance	(spacer)	between	-10	and	-35	elements,	17	nt	(from	the	end	of	-10	element	to	the	 start	 of	 -35	 element)	 using	 as	 a	 guide	 the	 consensus	 frequency	 percentage	 (%)	 for	 each	nucleotide	 within	 both	 elements	 as	 follows:	 T80%A95%T45%A50%A60%T96%	 (-10)	 and	T82%T84%G78%A65%C54%A48%	(-35)	(Lisser	and	Margalit,	1993).		
2.11.3 Identifying potential Caf1R binding sites 	The	 caf1R-caf1M	 and	 caf1A-caf1A	 intergenic	 region	 along	 with	 few	 hundred	 bases	 of	 the	adjoining	genes	was	 screened	 to	 identify	nucleotide-repeat	 sequences,	 using	 the	 repeat	 finder	program,	REPFIND	 (http://zlab.bu.edu/REPFIND/)	with	 default	 parameters.	 Identified	 repeat,	sequences	(3-7	nt	long)	were	further	analysed	visually	on	both	strands	to	increase	the	length	of	each	 repeat	 including	 mismatches.	 The	 direction	 of	 each	 repeat	 sequence	 was	 assigned	 with	respect	to	closeness	to	the	preceding	gene.		
2.11.4	 Prediction of potential Shine-Dalgarno sequence for caf1R, caf1M and caf1  	Identification	of	potential	Shine-Dalgarno	(SD)	sequences	or	ribosomal	binding	sites	(Quade	et	al.),	5-10	bp	upstream	of	 the	assigned	caf1R,	caf1M	 and	caf1	 translation	 initiation	codon	(ATG	(Met)	for	caf1M	and	caf1;	ATG	and	TTG	(fMet)	for	caf1R)	was	visually	analysed	for	the	sequence	
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motif	with	highest	degree	of	similarity	to	the	Y.	pestis	predicted	SD	consensus	motif,	AGGAGGT	(Karlyshev	et	al.,	1992;	Parkhill	et	al.,	2001;	Starmer	et	al.,	2006).			
2.11.5	Prediction of potential transcriptional start site for caf1R, caf1M and caf1  	After	localisation	of	an	active	promoter	for	the	corresponding	gene,	10th	base	downstream	from	start	of	the	identified	-10	element	of	each	promoter	was	assigned	as	+1.		
2.11.6 Prediction of RNA thermometers (RNATs) 	Nucleotides	from	assigned	+1	of	PR2,	PRK	and	PM	promoters	to	a	string	of	1-10	amino	acids	of	
caf1R	or	caf1M	was	screened	with	Mfold2.3	(Zuker,	2003)	at	different	temperatures	with	default	parameters.			
2.11.7 Physiochemical properties prediction of Caf1R  	Entrez	gene	database,	Prosite	database	and	ProtPram	were	used	to	confirm	gene	and	protein	entry	of	Caf1R	along	with	its	physiochemical	properties,	respectively.	
2.11.8 Caf1R homologs search and their multiple sequence alignment  	The	 NCBI	 accession	 number	 of	 full-length	 Caf1R	 (Q65AJ3,	 relative	 to	 TTG	 start	 codon)	 was	analysed	by	NCBI	protein-BLAST	(BLASTp)	server	(https://blast.ncbi.nlm.nih.gov)	against	non-redundant	 (nr)	 database	with	 an	 E-value	 threshold,	 1e-3	 and	 excluding	 the	Y.	pestis.	 The	 500	sequences	 were	 retrieved.	 Identical	 sequences	 were	 removed	 manually	 and	 the	 remianing	sequences	 were	 analysed	 from	 their	 genomic	 records	 and	 genome	 organisation	 in	 order	 to	identify	 regulators	 associated	 to	 CU	 system.	 Following	 this	 analysis,	 selected	 sequences	were	organised	 according	 to	 similarity	 percentage	 (most	 similar	 on	 top)	 using	 SIAS	 web	 server	(http://imed.med.ucm.es/Tools/sias.html)	and	 Jalview	2.9	 (Waterhouse	et	al.,	2009)	was	used	to	view	multiple	sequence	alignment.		
2.11.9 Caf1R secondary structure prediction 	The	amino	acid	sequence	of	Caf1R	(relative	to	TTG	start)	was	analysed	by	PSIPRED	(McGuffin	et	al.,	2000),	with	default	parameters,	in	order	to	predict	the	secondary	structure	of	the	full-length	Caf1R	and	DNA	binding	predicted	recognition	helix-6	with	E98G/A/T/K	mutations.			
2.11.10 Modelling of Caf1R and its DNA-binding domain (DBD) mutants  	The	amino	acid	sequences	of	Caf1R	(relative	to	TTG	start)	and	all	DBD	mutants	were	submitted	to	IntFOLD3.0	(McGuffin	et	al.,	2015;	Roche	et	al.,	2011).	In	each	case,	model	was	retrieved	from	the	lig2.pdb	file	(protein	model	associated	with	two	DNA	ligands).		This	in	turn	was	based	on	the	top	 scored	model	 with	 a	 quality	 score	 of	 ≥	 0.788	 over	 1.0,	 probability	 of	 incorrectness	 or	 P-value,	 ≤	 2.328E-4	 and	 reliability	 score,	 ‘CERTAIN’.	 Unless	 otherwise	 stated,	 almost	 all	 protein	models	 were	 based	 on	 the	 Rob	 protein	 template	 with	 two	 DNA	 ligands,	 one	 from	 cocrystal	structure	of	the	micF-Rob	complex	(PDB-1d5y)	(Kwon	et	al.,	2000)	and	the	other	from	cocrystal	structure	of	 the	mar-MarA	complex	 (PDB-1bl0)	 (Rhee	et	al.,	1998).	For	 further	analysis,	micF-DNA	was	removed	from	all	models	and	thus	kept	modelled	Caf1R	associated	only	with	the	mar	DNA	in	order	to	analyse	Caf1R-DNA	interactions.		
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	To	assess	the	impact	of	site	specific	mutation(s)	on	Caf1R-DNA	interactions,	modelled	mar	DNA-Caf1R	 complex	 and	 mutant	 model	 of	 interest	 (after	 removing	 both	 DNA	 ligands)	 were	superposed	by	TM	align	web	server	(Zhang	and	Skolnick,	2005).	Full-atom	superposition	for	the	entire	protein	chain	was	retrieved	to	analyse	DNA-Caf1R	interactions,	using	MacPyMOL1.3.		
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Chapter 3 
 Demonstration of Caf1R as a 
positive regulator of the caf locus  	 	
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3.1 Introduction 	Unlike	the	study	of	F1	assembly	via	classical	chaperone/usher	system	(Dubnovitsky	et	al.,	2010;	Kersley	et	al.,	2003;	Knight,	2007;	MacIntyre	et	al.,	2001;	Yu	et	al.,	2009;	Yu	et	al.,	2012;	Zavialov	et	 al.,	 2001;	 Zavialov	 et	 al.,	 2003)	 the	mechanisms	 controlling	 expression	 of	 F1	have	 received	very	 little	 attention.	 Sequencing	 of	 the	 caf	 locus	 (Karlyshev	 et	 al.,	 1992)	 and	 bioinformatic	analysis	of	AraC/XylS-like	 regulators	 identified	Caf1R	as	 a	member	of	 the	AraC/XylS	 family	of	transcription	regulators	(Gallegos	et	al.,	1997;	Ibarra	et	al.,	2008;	Schuller	et	al.,	2012).	But	there	have	been	no	studies	on	the	way	in	which	Caf1R	regulates	expression	of	the	caf	gene	cluster	or	
caf	 locus.	Transcriptional	control	via	Caf1R	regulator	 is	 likely	 to	be	 fundamental	 in	controlling	F1	expression.	Previous	studies	have	used	recombinant	plasmids,	pFS2	and	pFMA1	to	study	the	mechanism	of	F1	assembly	(Chapman	et	al.,	1999;	Di	Yu	et	al.,	2012;	Dubnovitsky	et	al.,	2010;	Kersley	et	al.,	2003;	MacIntyre	et	al.,	2001;	Yu	et	al.,	2009;	Yu	et	al.,	2012;	Zavialov	et	al.,	2003;	Zavialov	et	al.,	2005).	The	ptrc99	based	plasmid,	pFMA1	contains	caf1M,	caf1A	and	caf1	under	tight	 control	 of	 ptrc	 promoter	 (induction	 by	 IPTG).	 It	 produces	 a	 high-level	 of	 periplasmic	chaperone	(Caf1M),	which	 in	 turn	has	been	useful	 to	 trap	accumulated	F1	subunit,	Caf1	 in	 the	periplasm	in	assembly	defective	mutants	(Dubnovitsky	et	al.,	2010;	MacIntyre	et	al.,	2001;	Yu	et	al.,	 2009).	 	 However,	 high-level	 of	 production	 of	 the	 outer	membrane	 usher,	 Caf1A	 from	 this	plasmid	is	toxic	to	cells,	requiring	short	induction	times	(Chapman	et	al.,	1999;	MacIntyre	et	al.,	2001).	The	complete	caf	locus	was	originally	subcloned	from	Y.	pestis	pFra	plasmid	into	a	high-copy	number	plasmid,	pFS2	(Drozdov	et	al.,	1995;	Galyov	et	al.,	1990).	Spontaneous	 loss	of	F1	expression	was	observed	in	strains	carrying	this	plasmid	following	storage	at	-80°C	(Galyov	et	al.,	 1991;	Karlyshev	et	 al.,	 1992).	 In	order	 to	minimise	 spontaneous	 loss	 in	F1	expression	and	maintain	high	levels	of	production	of	F1	without	toxicity,	the	complete	caf	locus	from	pFS2	was	subcloned	 into	 a	 medium	 copy	 number	 plasmid,	 pACYCDuet-I	 (Novagen)	 to	 generate	 the	construct	pACYCF1	(Fig.	3.1).	A	surprisingly	low	level	of	F1	expression	was	observed	from	this	new	construct.	Sequencing	of	the	entire	caf	locus	in	both	the	pACYCF1	construct	and	the	original	pFS2	 plasmid	 identified	 a	 single	 nucleotide	 change	 (A⟶G)	 in	 caf1R,	 causing	 an	 amino	 acid	substitution	Glu98⟶Gly98	(E98G)	(Fig.	3.1)	within	the	N-terminus	of	Caf1R	(Lopez-Tolman,	A.;	unpublished	 data).	 It	 was	 concluded	 that	 this	 single	 Caf1RE98G	 mutation	 must	 have	 been	responsible	for	the	low	level	of	F1	in	both	plasmids.	Hence	this	pACYCF1	construct	was	assigned	the	name	pACYCF1SpM	to	reflect	that	it	has	a	spontaneous	mutation.			The	aim	of	this	first	chapter	was	to	unveil	the	impact	of	this	spontaneous	mutation	and	to	begin	to	 understand	 the	 properties	 of	 Caf1R	 and	 its	 role	 in	 regulation	 of	 F1	 expression.	 Different	approaches	 were	 employed	 including	 generation	 of	 a	 stable	 recombinant	 caf	 construct	 to	monitor	 Caf1R	 regulated	 F1	 expression,	 bioinformatic	 analysis	 of	 Caf1R	 to	 identify	 closest	homologs	and	in	particular	those	linked	to	chaperone/usher	systems,	modelling	the	structure	of	Caf1R-DNA	complex	to	address	the	impact	of	the	E98G	substitution	and	mutagenesis	to	identify	the	contribution	of	key	residues	including	E98	on	transcription	of	the	caf	locus	and	subsequent	assembly	of	the	F1.				
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Figure 3.1| Plasmid map of pACYCF1. 
The caf gene cluster 5128 bp plus 115 and 82 bp from the end of caf1R and caf1, respectively, PCR-amplified 
from pFS2 plasmid and subcloned into NcoI and SacI sites of pACYCDuet-I vector (Novagen). Encoded 
products include the positive regulator (Caf1R), chaperone (Caf1M), outer membrane usher (Caf1A) and 
structural subunit of F1 capsule (Caf1). Additional features include, chloramphenicol resistance marker (CmR), 
origin of replication (Ori-p15), T7 promoter (pT7) and T7 terminator (T7-term). Red and green arrowheads 
indicate primers used to create pACYC-R and pACYC-MA1. Black arrowheads indicate sequencing primers. 
Locations of the E98G spontaneous mutation and StuI site within caf1R are indicated. PR and PM, indicate 
proposed promoters for caf1R and caf1M, respectively. Putative promoter for caf1 (P1) is indicated by dotted 
arrow. Expression from the caf locus is controlled by Caf1R regulator and is under thermoregulation, ON at 
37°C and OFF at 26°C (see Chapter-6). 	
Results and Discussion 
3.2 Generation of a stable construct expressing recombinant caf locus 
3.2.1 Caf1RE98G mutation is complemented by co-expression with wild type Caf1R 	To	confirm	the	negative	impact	of	the	Caf1RE98G	mutation	on	F1	expression,	a	complementation	approach	was	taken.	The	hypothesis	was	that	the	mutated	regulator,	Caf1RE98G	encoded	within	pACYCF1SpM	could	be	complemented	by	wild	type	Caf1RG98E,	and	that	 this	would	restore	a	high	level	of	F1.	Therefore,	recombinant	E.	coli	Top10	cells	carrying	pACYCF1SpM	plasmid	(encoding	Caf1RE98G)	 were	 transformed	 with	 pBADhCaf1R,	 which	 encodes	 His6-tagged	 Caf1R	 (hCaf1R)	under	control	of	PBAD	promoter.	F1	expression	was	monitored	following	induction	of	expression	of	 hCaf1R	with	 0.02-2%	arabinose	 (L-ara)	 at	 37°C.	 Following	 induction,	 F1	 polymer	was	 heat	extracted	 at	 57°C	 from	 the	 cell	 surface	 of	 harvested	 cells	 (4.5	 OD	 units),	 	 (section	 2.4.2)	 and	analysed	by	SDS-PAGE	for	the	denatured	F1	subunit,	Caf1.	SDS-PAGE	analysis	confirmed	a	very	low	 level	 of	 Caf1	 from	 cells	 carrying	pACYCF1SpM	 and	pBADHisA	 vector	 (Fig.	 3.2a,	 lane	 2).	 A	dramatically	 enhanced	 level	 of	 F1	 from	 co-transformants	 carrying	 both	 pACYCF1SpM	 and	pBADhCaf1R	(Fig.	3.2a,	lane	3-4)	was	observed;	confirming	that	the	mutated	Caf1RE98G	encoded	in	 pACYCF1SpM	 had	 been	 successfully	 complemented	 with	 pBADhCaf1R	 encoded	 wild	 type	hCaf1R.	 No	 band	 at	 this	 position	 from	 the	 negative	 control,	 pBADHisA+pACYCDuet-I	 vectors	
(lane	 5)	 and	 a	 small	 amount	 from	 the	 Caf1	 positive	 control,	 pFMA1	 (MacIntyre	 et	 al.,	 2001)	
(lane	 1)	 confirmed	 identity	 of	 the	 Caf1	 band	 and	 the	 high	 level	 from	 pACYCF1.	 Induction	 of	hCaf1R	with	0.02%	L-ara	seemed	sufficient	 to	produce	an	optimum	 level	of	F1	 from	these	co-transformants.				It	was	possible	 that	 the	enhanced	 level	of	F1	 from	pACYCF1SpM+pBADhCaf1R	co-transformants	was	a	consequence	of	higher	levels	of	Caf1R	in	the	presence	of	2	copies	of	the	gene	and	that	L-ara	 induced	 expression	 had	 little	 to	 do	 with	 the	 E98G	 mutation	 of	 Caf1R.	 To	 clarify	 this,	 F1	expression	 was	 monitored	 from	 pACYCF1SpM,	 co-transformed	 with	 either	 pBADhCaf1RE98G	 or	
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with	pBADhCaf1R.	The	level	of	Caf1	produced	in	the	presence	of	complementing	wild	type	Caf1R	was	 much	 higher	 (Fig.	 3.2b,	 lane	 3)	 than	 that	 where	 complementation	 was	 with	 mutated	Caf1RE98G	(Fig.	 3.2b,	 lane	 2).	Thus	regain	of	F1	 in	pACYCF1SpM+pBADhCaf1R	co-transformants	could	not	simply	be	attributed	to	an	increase	in	copy	number	of	the	caf1R	gene.	This	highlighted	the	 loss-in-function	phenotype	of	 the	E98G	mutation	of	Caf1R	and	 indicated	a	possible	 critical	significance	of	residue	E98	to	Caf1R	structure	or	function.					
	
 
Figure 3.2| Caf1RE98G mutation is complemented by co-expression with wild type Caf1R.   
a) SDS-PAGE (14% acrylamide) analysis of heat denatured (98°C-15 min) F1 subunit Caf1 from cells carrying 
pACYCF1SpM (Caf1RE98G) complemented with pBADhCaf1R (WT Caf1R).  F1 was extracted in 100 µl PBS 
from the cell surface of 4.5 OD units culture of E. coli Top10 cells, expressing either pACYCF1SpM+pBADHisA 
(lane 2) or pACYCF1SpM+pBADhCaf1R (lanes 3 and 4).  Cells were harvested after 4 h induction (in LB 
containing 0.6% glucose) at 37°C with L-ara (2.0-0.02%), as indicated.  Lane 1, positive control for Caf1, E. coli 
BL21 (DE3)/pFMA1, induced with IPTG (0.5 mM) at 37°C for 1.5 h and processed for F1 extraction in similar 
way. Lane 5, negative control, Top10/pBADHisA+pACYCDuet-1 vectors. Sample equivalent to 0.225 OD units 
cells was applied in each lane. b) Cells carrying pACYCF1SpM complemented with either pBADhCaf1R (WT 
Caf1R) (lane 3) or pBADhCaf1RE98G (mutant Caf1R) (lane 2) or pBADHisA vector (lane 1). F1 prepared from 
1.0 OD unit cells harvested after 4 h induction with 0.02% L-ara at 37°C.  Sample equivalent to 0.05 OD units 
cells was applied in each lane.  
3.2.2 Caf1R regulator is an activator of F1 expression 	To	 confirm	 the	 requirement	 of	 Caf1R	 for	 expression	 of	 F1,	 the	 entire	 caf1R	 gene	was	 deleted	from	pACYCF1SpM	 and	 replaced	with	 an	NcoI	 site	 by	 Inverse	PCR	 (section	2.2.4(iii)(b)(i)).	 The	inverse	 PCR	 primers,	 Invcaf1Rfor	 and	 Invcaf1Rrev	 were	 used	 with	 Q5	 HiFi	 DNA	 polymerase	(NEB)	at	two	annealing	temperatures	(55.1	and	60.8	°C)	and	gave	products	of	the	expected	size	(≈	8.366	kb)	 (Fig.	 3.3a).	 Both	products	were	 gel-excised,	 column	purified,	 digested	with	NcoI	
(Fig.	3.3b)	and	then	religated	with	T4	DNA	ligase	(Thermo	Scientific)	prior	to	transformation	of	
E.	 coli	 DH5α.	 Seven	 individual	 transformants,	 3	 from	 the	 55.1°C	 PCR	 reaction	 and	 4	 from	 the	60.8°C	PCR	reaction	were	screened	by	NcoI	and	StuI	restriction	digestion.	 	NcoI	confirmed	the	correct	 linear	 size	 (8.366	 kb)	 of	 pACYC-MA1	 in	 all	 7	 transformants.	 Absence	 of	 StuI	 digestion	confirmed	deletion	of	caf1R,	as	StuI	is	a	unique	restriction	enzyme	site	within	caf1R	(Fig.	3.3c).		Retention	 of	 the	 intact	 and	 correct	 DNA	 sequence	 of	 the	 caf1R-caf1M	 intergenic,	 regulatory	region	was	confirmed	for	transformant	5,	which	was	then	tested	for	expression	of	F1	in	whole	
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cells.	 SDS-PAGE	 analysis	 showed	 that	 no	 CB	 stainable	 Caf1	 was	 detected	 from	 pACYC-MA1	following	4	h	growth	at	37°C	(Fig.	3.4,	 lane	2),	although	a	very	low	level	of	F1	expression	was	confirmed	 from	 pACYC-MA1	 by	 immunoblotting	 (data	 not	 shown).	 In	 contrast,	 caf1R	complemented	pACYC-MA1	(pBADhCaf1R+pACYC-MA1)	produced	a	very	high	level	of	Caf1	(Fig.	
3.4,	 lane	 4),	 confirming	gain-in-function	upon	supply	of	Caf1R	 regulator	 in	 trans.	 	Thus	 these	results	 confirm	 the	 role	 of	 Caf1R	 as	 an	 activator	 of	 expression	 from	 the	 caf	 locus.	 The	 role	 of	Caf1R	as	regulator	is	studied	in	depth	in	Chapter-5.		
	
 
Figure 3.3| Construction of pACYC-MA1.   
a) AGE (0.75% agarose) analysis of inverse PCR products (100 ng each) from 55.1°C (i) and 60.8°C (ii) 
annealing temperature from pACYCF1SpM template. UD, undigested and D, NcoI digested. b-c) Restriction 
digestion analysis of 7 pACYC-MA1 transformants with NcoI, StuI or undigested (UD). Transformants 1-3  and 
4-7 are from PCR reactions (i) and (ii), respectively.  L, DNA Hyper ladder-I (20 ng).  
 
		
Figure 3.4| F1 expression is abolished in pACYC-MA1.  
SDS-PAG (16% acrylamide) of F1 extracted in 100 µl PBS from 5 OD units culture of Top10 cells containing 
pACYC Duet-I empty plasmid (lane 1); pACYC-MA1 (lane 2); pACYC-MA1+pBADHisA (lane 3) and 
pACYC-MA1+pBADhCaf1R (lane 4) plasmids. Samples in lane 1 and 2 are from noninduced cultures while 
samples in lane 3 and 4 are from 0.02% L-ara induced cultures. Cells from both noninduced and induced 
cultures were harvested at 4 h post-induction at 37°C. The equivalent of 0.25 OD unit cells was applied to each 
lane. Arrowhead indicates denatured F1 subunit, Caf1.  
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3.2.3  Impact of N-terminal His6-tag on Caf1R function  	The	 His6-tag	 and	 enterokinase	 cleavage	 site	 were	 included	 at	 the	 N-terminus	 of	 Caf1R	 to	 aid	identification,	purification	and	subsequent	characterisation	of	Caf1R.	The	protease	cleavage	site	aids	 in	 subsequent	 cleavage	 of	 protein	 from	 the	 tag.	 On	 the	 other	 hand,	 addition	 of	 a	 His-tag	extension	 can	 interfere	 with	 the	 overall	 protein	 folding	 process	 if	 it	 is	 attached	 to	 a	 critical	region	involved	in	folding	(Halliwell	et	al.,	2001;	Ledent	et	al.,	1997;	Wu	and	Filutowicz,	1999),	for	 example,	 residues	 contributing	 to	 the	 hydrophobic	 core	 (Murphy	 et	 al.,	 2015).	 This	 can	destabilise	 the	 protein.	 hCaf1R	 expressed	 from	 pBADhCaf1R	was	 clearly	 functional	 (Fig	 3.4).	However,	as	the	construct	had	been	designed	for	purification	and	use	in	in	vitro	activity	studies,	activity	of	hCaf1R	was	compared	to	that	of	Caf1R	(without	the	His6-tag	and	enterokinase	site).			The	DNA	sequence	encoding	His6-tag	and	enterokinase	cleavage	site	was	deleted	by	Inverse	PCR	(section	 2.2.4(iii)(a))	 using	 pBADhCaf1R	 template,	 deletion	 primers,	 dhCaf1Rfor	 and	dhCaf1Rrev	and	Bio-X-ACT	short	DNA	polymerase	 (Bioline).	The	PCR	product	(Fig.	 3.5a)	was	digested	 with	 NcoI,	 purified	 by	 spin	 column	 purification,	 religated	 with	 T4	 DNA	 ligase	 and	transformed	 into	 Top10	 competent	 cells.	 Six	 transformants	 were	 screened	 by	 restriction	digestion	using	NcoI	and	SacI	enzymes	(Fig.	3.5b).	NcoI	was	used	to	determine	the	linear	size	of	pBADΔhCaf1R	 (5.5	 kb)	 and	 SacI	 to	 confirm	 the	 deletion	 of	 His6-tag	 and	 the	 enterokinase	cleavage	 site.	 A	 restriction	 site	 for	 SacI	 is	 present	 within	 the	 codons	 for	 the	 enterokinase	recognition	sequence,	thus	the	deletion	construct	should	no	longer	contain	SacI	site	and	should	remain	 supercoiled	 (2.8	 kb)	 in	 the	 presence	 of	 this	 enzyme.	 As	 expected,	 digestion	with	NcoI	produced	a	 single	band	at	 about	5.5	kb,	 except	 for	 transformant	1,	 for	which	 two	bands	were	observed,	at	5.5	kb	and	2.8	kb,	suggesting	partial	digestion.	SacI	as	expected	was	unable	to	digest	plasmid	 in	 all	 transformants	 tested	 (Fig.	 3.5b).	 The	 complete	 caf1R	 sequence	 and	 precise	deletion	 of	 the	 coding	 sequence	 for	 the	 His6-tag	 plus	 enterokinase	 site	 was	 confirmed	 for	transformants	 2	 and	 4	 by	 DNA	 sequencing	 using	 pBADF	 and	 pBADR	 primers.	 Both	transformants	were	stocked	and	number	4	was	used	to	test	expression.			
		
Figure 3.5| Construction of pBADΔhCaf1R.   
a) PCR product from inverse deletion PCR; undigested (1) and NcoI digested, purified (2, 250 ng), which was 
used for religation and transformation. b) Restriction digestion analysis (0.75% agarose) of plasmids from 
transformants 1-6; undigested (UD), NcoI or SacI digested (D), as indicated. DNA bands at about 5.5 and 2.8 kb 
indicate linear and supercoiled plasmid pBADΔhCaf1R. L, Hyper DNA ladder-I (20 ng).  
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The	 impact	 of	 presence/absence	 of	 the	His6-tag	 plus	 enterokinase	 site	 on	 Caf1R	 function	was	monitored	 by	 comparing	 F1	 expression	 in	 cells	 carrying	 the	 defective	 pACYCF1SpM	complemented	with	either	pBADhCaf1R	(His6-tagged	Caf1R)	or	pBADΔhCaf1R	(no	His6-tag).	F1	was	extracted	from	the	cell	surface	of	a	noninduced	and	a	0.02%	L-ara	induced	culture	of	each.	SDS-PAGE	 analysis	 of	 F1	 polymer	 (migrates	 in	 the	 stacking	 gel)	 and	 Caf1	 subunit	 (15.5	 kDa)	
(Fig.	 3.6)	 showed	 that	 upon	 induction	 the	 level	 of	 F1	 from	 cells	 carrying	pACYCF1SpM+pBADhCaf1R	 (H)	 was	 actually	 slightly	 better	 than	 F1	 in	 cells	 carrying	pACYCF1SpM+pBADΔhCaf1R	 (ΔH),	 suggesting	 that	 addition	 of	 the	 His6-tag	 extension	 does	 not	interfere	 with	 Caf1R-mediated	 activation	 of	 F1	 expression.	 F1	 was	 also	 produced	 in	 the	noninduced	samples	(no	L-ara)	consistent	with	a	high	basal	level	of	expression	in	the	absence	of	glucose	 induced	 catabolite	 repression.	 In	 these	 noninduced	 samples,	 H	 co-transformant	produced	 a	much	 higher	 level	 of	 Caf1	 than	 ΔH	 co-transformant	 (Fig.	 3.6).	 It	 is	 possible	 that	presence	of	the	N-terminal	His6-tag	extension	actually	stabilises	Caf1R	leading	to	slightly	better	levels	 of	 F1.	 Finally,	 it	was	 concluded	 that	hCaf1R	encoded	on	plasmid	pBADhCaf1R	was	 fully	functional	and	a	suitable	choice	for	subsequent	studies	involving	complementation	as	well	as	for	purification	of	hCaf1R.			
		
Figure 3.6| N-terminal His6-tag plus enterokinase cleavage site does not affect Caf1R function. 
SDS-PAGE (14% acrylamide) analysis of F1 polymer extracted in 100 µl PBS from 5 OD units culture of E. coli 
Top10 cells containing pACYCF1SpM complemented with either pBADhCaf1R (H; N-terminal His6-tag) or 
pBADΔhCaf1R (ΔH - N-terminal His6-tag plus enterokinase site deleted). For F1 polymer analysis (remains in 
stacking gel), an equal amount (10 µl) surface extracted F1 was mixed in SDS-PAGE sample buffer and applied 
directly to gel without heating. Denatured subunit (Caf1) was resolved following heat denaturation (97.5°C-15 
min) of samples in SDS-PAGE sample buffer. Induction with L-ara in LB (no glucose), as indicated. Cells from 
both noninduced and induced cultures were harvested at 4 h postinduction at 37°C. The equivalent of 0.25 OD 
unit cells was applied to each lane.  
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3.2.4 Repair of E98G mutation in pACYCF1SpM  	Results	 in	 earlier	 sections	 clearly	 demonstrated	 the	 requirement	 of	 wild	 type	 Caf1R	 for	 F1	expression	and	loss-of-function	with	the	E98G	spontaneous	mutation.	Therefore,	it	was	decided	to	repair	Caf1RE98G	in	 the	pACYCF1SpM	 template	 in	order	 to	generate	a	working	model	 to	study	the	 regulation	 of	 F1	 expression	 as	 well	 as	 for	 studies	 on	 the	 assembly	 of	 F1.	 Site-directed	mutagenesis	was	 applied	 to	 repair	 this	mutation	using	 the	Quikchange	Lightning	 kit	 (Agilent)	(section	 2.2.4	 (iv)	 (a))	 with	 the	 mutagenic	 primers,	 Caf1RG98Efor	 and	 Caf1RG98Erev.	 These	primers	introduce	a	single	nucleotide	change	in	Gly98	codon	(TCC	to	TTC)	to	revert	this	residue	to	wild	 type	 Glu98	 codon.	 Following	mutagenesis	methylated	 or	 hemimethylated	 pACYCF1SpM	template	 was	 removed	 by	 digestion	 with	 Fast-DpnI	 at	 37°C	 for	 5	 min	 according	 to	 the	manufacturer’s	protocol	(Agilent)	(Fig.	3.7)	and	3	µl	of	DpnI	treated	PCR	product	transformed	into	 competent	E.	coli	 Top10	 (50	 µl).	 Screening	 of	 transformant	 plasmids	 by	 sequencing	with	F1_1	 primer	 revealed	 a	 number	 of	 unwanted	mutations.	 Hence	DpnI	 treatment	was	 repeated	using	standard	DpnI	(Bioline)	 for	4	h	as	had	been	used	previously	 in	the	 lab.	The	E.	coli	strain	used	(Top10)	could	also	have	contributed	to	the	problem,	as	this	strain	has	lower	efficiency	of	repairing	 nicked	DNA	 and	 stabilising	 bigger	 plasmids	 as	 in	 the	 case	 of	 pACYCF1SpM	 (9.33	 kb).	Therefore,	the	PCR	product	digested	with	standard	DpnI	(Bioline)	was	transformed	into	E.	coli	DH5α.	 From	 this	 set	 of	 transformants,	 eight	 transformants	 (numbered	 15-22)	 were	 picked,	plasmids	 prepared	 and	 the	 DNA	 sequenced	with	 F1_1	 sequencing	 primer.	 Sequencing	 results	revealed	 that	 the	 TCC	 (G98)	 ⟶	 TTC	 (E98)	 repair	 was	 present	 in	 all	 8	 transformants.	 The	complete	caf1R;	caf1R-caf1M	and	caf1A-caf1	 intergenic	 regions	were	 confirmed	by	 sequencing	with	F1_1,	F1_6,	ACYCDuetUP1,	F1for11	and	F1rev12	primers	(Fig.	3.1)	from	transformants	16,	17,	19	and	20.	Strains	and	plasmid	DNA	of	all	were	stocked	and	transformant	17	was	assigned	as	pACYCF1	and	used	in	all	subsequent	studies.		
		
Figure 3.7| Site-directed mutagenesis of pACYCF1SpM.  
AGE (0.75% agarose) analysis of site-directed (Caf1RE98G) mutagenesis PCR products of pACYCF1SpM. 
Undigested (UD) and DpnI digested (D) products from two individual PCR reactions. UD (i and ii), ≈100 ng 
each from 50 and 100 ng of pACYCF1SpM template. D, Fast (i) and normal DpnI digested (ii) product (≈100 ng 
each) from 50 and 100 ng of pACYCF1SpM template. L, Hyper DNA ladder-I (20 ng).  					
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F1	expression	 from	 the	newly	 created	pACYCF1	plasmid,	 encoding	 the	 complete	wild	 type	caf	locus	was	 compared	 to	 expression	 from	 the	original	plasmid	pACYCF1SpM.	As	F1	expression	 is	known	 to	 be	 downregulated	 at	 lower	 temperatures	 (Cao	 et	 al.,	 2012;	 Simpson	 et	 al.,	 1990;	Straley	 and	 Perry,	 1995;	 Titball	 et	 al.,	 1997),	 all	 cultures	 containing	 pACYCF1	were	 grown	 at	26°C	until	induction	was	required.	For	induction,	the	growth	temperature	was	switched	to	37°C.	Production	of	F1	in	high	levels,	from	pFS2,	was	known	to	result	in	a	dense	capsule	of	F1	polymer	around	 the	 cells,	 making	 the	 cells	 less	 dense.	 Recovering	 these	 cells	 requires	 an	 extended	centrifugation	time	(13,000	rpm	for	20	min)	and	results	in	pellets	with	a	fluffy	white	appearance	(Moslehi,	 E.,	 and	 MacIntyre,	 S.,	 unpublished	 data).	 	 Therefore,	 following	 temperature	 upshift	from	 26	 to	 37°C,	 5	 OD	 units	 of	 E.	 coli	DH5α	 carrying	 either	 pACYCF1	 or	 pACYCF1SpM	 were	recovered	at	4	h	and	6	h	and	the	pelleted	cells	were	visually	inspected.	Cells	containing	pACYCF1	exhibited	 the	 typical	 fluffy	white	pellet	 (Fig.	 3.8a),	 indicating	a	high	 level	of	production	of	F1	polymer.	 	Gain-in-function	of	the	repaired	caf1R	 in	pACYCF1	was	confirmed	by	SDS-PAGE	(Fig.	
3.8b)	analysis	of	whole	cells	and	of	surface	extracted	F1,	as	described	in	section	2.4.			 	
	
	
Figure 3.8| Comparative analysis of F1 from repaired pACYCF1 to spontaneous mutant pACYCF1SpM.    
a) Visual analysis of pelleted (13,000 rpm-20 min) whole cells, recovered after 4 h thermoinduction at 37°C.  b) 
SDS-PAGE (16% acrylamide) analysis from whole cell (WC) (i) and from cell surface extract (CSE) (ii and iii) 
after 4 and 6 h thermoinduction at 37°C. C, Negative control, E. coli DH5α expressing pACYC Duet-1 vector; 
pACYCF1SpM, caf1RE98G; pACYCF1, caf1R (WT).  5 OD units cells, mixed in 100 µl PBS were processed for 
both (a) and (b). The equivalent of 0.25 OD unit cells was applied to each lane.					
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The	level	of	Caf1	subunit	was	quantified	(section	2.8.2)	by	imaging	coomassie	blue	(CB)	stained	acrylamide	(16%)	gels	of	a	lower	level	of	whole	cells	(1	OD	unit,	suspended	in	200	μl	PBS).	The	level	of	F1	from	three	individual	transformants	of	E.	coli	DH5α/pACYCF1SpM	(Caf1RE98G,	mutant)	and	of	E.	coli	DH5α/pACYCF1	(Caf1R,	WT)	was	monitored	after	4	and	6	h	thermoinduction	(Fig.	
3.9).	 	The	 level	of	F1	 increased	by	45%	in	cells	with	Caf1R	and	by	58%	in	cells	with	Caf1RE98G	between	4	h	and	6	h.		At	both	time	points	cells	expressing	Caf1RE98G	showed	a	marked	reduction	in	F1.	After	4	h	 induction,	 the	 level	of	Caf1/OD	cells	 in	 samples	expressing	Caf1RE98G	was	only	13.05%	±	0.62	of	 the	 level	 in	 cells	 expressing	wild	 type	Caf1R	 (100%	±	4.38).	While	after	6	h	induction,	the	level	for	the	Caf1RE98G	sample	was	14.16%	±	0.32	that	of	wild	type	Caf1R	samples	(100%	±	 3.09).	 These	 values	 highlight	 the	 extent	 of	 loss-in-function	 of	 the	mutated	 regulator	Caf1RE98G	 with	 respect	 to	 production	 of	 F1.	 	 The	 high	 level	 of	 F1	 production	 from	 wild	 type	pACYCF1	was	consistent	over	all	of	 these	tests,	 indicating	a	stable	working	model,	 to	study	F1	expression	and	assembly	under	the	native	thermoinducible	promoter.			
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Figure 3.9| Quantification of F1 in pACYCF1 (WT) and pACYCF1SpM (Caf1RE98G mutant).  
a) SDS-PAGE (16% acrylamide) analysis of F1 levels from three individual colonies of E. coli DH5α carrying 
pACYCF1 (WT) or pACYCF1SpM plasmid. Expression was monitored from whole cells after 4 and 6 h of 
thermoinduction at 37°C. Note: for quantification 1 OD unit of harvested cells were mixed and heated in 200 µl 
PBS + sample buffer and thus an equivalent of 0.04 OD unit sample applied to each lane. The average OD600 of 
cultures of the three replicates at 4 and 6 h was 1.27 and 1.52 (control; E. coli DH5α/pACYC Duet-1 vector); 
0.85 and 1.47 (WT); 1.15 and 1.34 (Caf1RE98G mutant), respectively.  b) Caf1 band quantification by imageJ as 
described in section 2.8.2. Value shown is the total peak area for the Caf1 band. Line at bottom of the peak, 
excluded background and unrelated proteins. c) The F1 peak area from the triplicate cultures of WT at 4 and 6 h 
were assigned as 100% and the relative recovery from the Caf1RE98G mutant calculated for both time points.  
Standard error on each bar is ±SEM.  
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3.2.5 Effect of Caf1RE98G on transcriptional activity of caf1R and caf1M promoter(s)  	Results	 in	 the	 earlier	 sections	 demonstrated	 that	 the	 Caf1RE98G	mutation	 is	 a	 loss-in-function	mutation,	resulting	in	a	dramatically	decreased	level	of	F1	production.	As	Caf1R	is	a	regulator	of	the	 AraC/XylS	 family	 many	 of	 which	 activate	 transcription	 by	 binding	 close	 to	 their	 cognate	operator/promoter	region	(Gallegos	et	al.,	1997),	 it	was	hypothesised	that	Caf1RE98G	was	most	likely	ineffective	in	activating	transcription	of	the	caf	gene	cluster	(caf	locus).	This	could	be	due	to	weak	 binding	 at	 the	 caf1M	 and/or	 the	 caf1R	promoter(s)	 leading	 to	 ineffective	 or	 reduced	activation	 of	 transcription.	 To	 test	 this	 hypothesis	 the	 region	 encompassing	 the	 caf1R-caf1M	intergenic	 region	 subcloned	 into	 the	 two	 transcriptional	 fusion	 plasmids,	 pRS415	 or	 pRS550	(Simons	 et	 al.,	 1987)	were	used	 to	monitor	 promoter	 activity	 (Section	2.3).	 pRScaf1M′-R′-lacZ	tests	 for	caf1R	promoter(s)	and	pRScaf1R′-M′-lacZ	tests	 for	 the	caf1M	promoter	as	depicted	 in	
Fig.	3.10a.	These	plasmids	carry	a	promoterless	 lacZ	gene,	hence	the	impact	of	mutated	Caf1R	was	 tested	 by	 complementation	 with	 pACYC-R	 encoded	 Caf1RE98G	 and	 monitoring	 β-galactosidase	activity	(promoter	activity	indicator).		To	 create	 pACYC-RE98G	 and	 the	 wild	 type	 control	 pACYC-R	 the	 DNA	 fragment	 containing	 the	complete	sequence	 for	caf1MA1	was	deleted	by	 inverse	PCR	from	pACYCF1SpM	and	pACYCF1	as	template.	 This	 left	 only	 caf1RE98G	 (or	 caf1R)	 and	 the	 caf1R-caf1M	 intergenic	 region.	 PCR	 was	performed	 using	 caf1MA1	deletion	 primers,	pACYCcaf1Rf	 and	 pACYCcaf1Rr	and	 Q5	 HiFi	 DNA	polymerase	 (NEB).	 The	 PCR	 products	 (5.9	 kb)	 (Fig.	 3.10b)	 were	 digested	 with	 SacI-HF	restriction	 enzyme	 (NEB),	 gel	 purified	 and	 ligated	 with	 T4	 DNA	 ligase	 (Thermo	 Scientific)	followed	 by	 transformation	 into	E.	 coli	 DH5α.	 Plasmid	 DNA	was	 isolated	 from	 five	 individual	transformants	of	each	and	analysed	by	AGE	(data	not	shown).	Based	on	AGE,	a	plasmid	from	a	single	 transformant	of	each,	pACYC-RE98G	 (transformant	1)	and	pACYC-R	(transformant	5)	was	digested	with	 BamHI	 (unique	 site)	 to	 confirm	 the	 linear	 size	 (~5.9	 kb)	 (Fig.	 3.10c).	 In	 these	pACYC-R	 constructs,	 caf1RE98G/caf1R	 is	 under	 native	 control	 from	 the	 caf1R-caf1M	 intergenic	region.	 Therefore,	 the	 complete	 sequence	 of	 caf1R	 and	 the	 caf1R-caf1M	 intergenic	 region	was	confirmed	 by	 sequencing	 using	 ACYCDuetUp1	 and	 DuetDown1	 sequencing	 primers.	 Both	transformants	were	stocked	and	used	for	complementation	studies.			
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Figure 3.10| Strategy to compare impact of wild type and mutant (E98G) Caf1R on transcription.   
a) Diagram depicting caf locus, promoter-lacZ fusion constructs, pRScaf1M′-R′-lacZ (contains caf1R 
promoter/s) and pRScaf1R′-M′-lacZ (contains caf1M promoter/s), and the complementing plasmids, pACYC-R 
and pACYC-RE98G, which encodes wild type and mutant (E98G) Caf1R, respectively. The caf locus regions 
indicated in between dotted lines were PCR amplified along with backbone plasmid pACYC, in case of pACYC-
R and pACYCE98G   or   subcloned in between EcoRI/BamHI sites at 5′ UTR of promoter less lacZ gene in the 
transcriptional fusion plasmids, pRS415 and pRS550 (Simons et al., 1987) to construct pRScaf1M′-R′-lacZ 
(contains – strand of caf locus) and pRScaf1R′-M′-lacZ  (contains + strand of caf locus), respectively. b) 
Construction of pACYC-R and pACYC-RE98G. AGE (0.8% agarose) of SacI-HF digested PCR products (1 µg 
each) of pACYC-RE98G (i) and pACYC-R (ii) along with one template (T), pACYCF1 (30 ng). c) Restriction 
digestion (D) analysis of (i) and (ii) with single cutter or unique BamHI enzyme along with undigested (50 ng) 
corresponding plasmid.   		The	 impact	on	caf1R	 transcription	was	tested	using	co-transformants	of	E.	coli	Top10	carrying	pACYC-RE98G+pRScaf1M′-R′-lacZ	(Caf1RE98G	mutant),	pACYC-R+pRScaf1M′-R′-lacZ	 (WT	Caf1R)	or	pACYC+pRScaf1M′-R′-lacZ	 (no	 Caf1R;	 control).	 Promoter	 activity	 from	 the	 Caf1RE98G	 co-transformants	was	only	1.2-	 (2	h),	1.9-	 (4	h)	and	1.5-	 (6	h)	 fold	 increased	over	 the	control.	 In	contrast,	activity	from	the	wild	type	co-transformants	was	enhanced	8.2-	(2	h),	10.9-	(4	h)	and	6.5-(6	 h)	 fold	 (Fig.	 3.11a).	 This	 corresponded	 to	 an	 average	 of	 5.6-fold	 reduction	 in	 Caf1R	mediated	 activation	 at	 the	 caf1R	 promoter(s)	 in	 the	 presence	 of	 Caf1RE98G.	 The	 impact	 on	promoter	activity	upstream	of	caf1M	was	similarly	studied	using	E.	coli	Top10	co-transformants	carrying	the	pRScaf1R′-M′-lacZ	promoter	fusion	combined	with	pACYC-RE98G,	pACYC-R	or	pACYC.	Activity	 in	 the	 presence	 of	 Caf1RE98G	 was	 3.0-	 (2	 h),	 5.2-	 (4	 h)	 and	 9.8-	 (6	 h)	 fold	 increased	compared	to	the	control;	whereas,	activity	in	the	presence	of	wild	type	was	enhanced	12.7-	(2	h),	24.5-	 (4	h)	and	40.0-fold	 (6	h)	(Fig.	 3.11a).	Again	 this	highlighted	a	 significant	 reduction	 (4.3	fold	average)	in	Caf1R-mediated	promoter	activation	with	the	E98G	mutation.	Thus	these	results	
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clearly	 show	 a	 negative	 effect	 of	mutated	 Caf1RE98G	 on	 the	 activation	 of	 transcription	 at	 both	
caf1R	 and	 caf1M	 promoter(s).	 The	 impact	 of	 this	mutation	 on	 the	 ability	 of	 Caf1R	 to	 bind	 at	
caf1R	and	caf1M	promoter(s)	 is	addressed	 in	Chapter-5.	 In	conclusion,	 the	reduced	 level	of	F1	from	pACYCF1SpM	can	be	explained	by	poor	transcriptional	activation	by	Caf1RE98G.			
	
 
Figure 3.11| Caf1RE98G lower the transcription activation at both caf1R and caf1M promoter(s). 
a) Effect of mutant Caf1RE98G cf wild type on the activity of caf1R promoter/s (PR). b) Effect of mutant 
Caf1RE98G cf wild type on the activity of caf1M promoter/s (PM).  Promoter or β-galactosidase activity from E. 
coli Top10 carrying the indicated commination of plasmids was monitored from cells recovered after 2, 4 and 6 
h growth at 37°C along with respective control. Standard error on the activity bars shows ± SEM of activity from 
three individual co-transformant of each. The range of OD600 (2-6 h) from E. coli Top10 carrying respective 
combination of plasmids is indicated underneath activity values. 	
3.3 Bioinformatic analysis of Caf1R  
3.3.1 Characterisation of Caf1R  	Annotations	 of	 Y.	 pestis	 caf	 locus	 identify	 two	 possible	 start	 sites	 for	 Caf1R.	 One	 encodes	 a	product	 of	 301	 amino	 acids	 (MWt	 36.04	 kDa),	 starting	 with	 ATG	 (Met)	 codon,	 having	 NCBI	accession	 number,	 CAA43969.1;	 structural	 organization	 of	 Y.	 pestis	 virulence-associated	plasmids	and	Caf1R	(Hu	et	al.,	1998;	Karlyshev	et	al.,	1992).	The	second	predicted	start	site	was	annotated	six	codons	upstream,	starting	at	the	rare	start	codon	TTG	(Leu	or	fMet)	and	encodes	a	product	 of	 307	 amino	 acids	 (MWt	 36.84	 kDa).	 This	 start	 site	 was	 used	 with	 NCBI	 accession	
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number	 CAB55263.1;	 genome	 sequence	 of	 Y.	 pestis,	 strain	 CO92	 (Parkhill	 et	 al.,	 2001)	 and	AAS58717.1,	genome	sequence	of	Y.	pestis,	biovar	Microtus	strain-91001	(Song	et	al.,	2004).	As	there	had	been	no	experimental	data	confirming	the	functional	start	site	of	Caf1R	and	the	larger	open	 reading	 frame	 (ORF)	 was	 predicted	 in	 the	 published	 genome	 sequences,	 bioinformatic	analysis	 was	 performed	 using	 this	 larger	 ORF	 (Swiss-Prot	 accession	 number,	 Q65AJ3).	 Initial	analysis	was	carried	out	using	the	ExPASy-ProtParam	tool	(http://web.expasy.org/protparam)	to	determine	relevant	physiochemical	properties.	The	theoretical	pI	of	Caf1R,	9.17,	 indicated	a	highly	basic	protein.	Furthermore,	Ile	and	Tyr	are	the	most	frequent	amino	acids	with	10.1	and	8.1%	 compositions,	 respectively.	 Total	 numbers	 of	 negatively	 charged	 amino	 acids	 (Asp+Glu)	are	32	whereas	the	total	numbers	of	positively	charged	amino	acids	(Arg+Lys)	are	43;	consistent	with	 it	being	a	positively	charged	protein	at	pH	7.0.	The	 instability	 index	was	computed	 to	be	50.34,	 which	 classifies	 Caf1R	 as	 an	 unstable	 protein.	 The	 PROSITE	 database	(http://expasy.org/prosite/)	 entry,	 PS01124	 of	 AraC/XylS	 family	 regulators	 confirms	 Caf1R	inclusion	within	 AraC/XylS	 family	 regulators	 as	 any	 proteins	with	 a	 score	 of	 12.52-30.74	 are	classified	 as	 a	 member	 of	 AraC/XylS	 regulator	 family	 and	 for	 Caf1R	 this	 score	 was	 28.810.	Analysis	 with	 Pfam	 tool	 (http://pfam.xfam.org/protein/Q65AJ3)	 shows	 that	 Caf1R	 is	 a	 two-domain	 protein,	 containing	N-terminal	 DNA-binding	 domain	 (DBD)	 encompassing	 residues	 1-112	 and	 a	 C-terminal	 GyrI-like	 domain,	 encompassing	 residues,	 131-270.	 The	 N-terminal	position	of	the	DBD	is	uncommon	(Gallegos	et	al.,	1997;	Ibarra	et	al.,	2008;	Schuller	et	al.,	2012)	but	 Caf1R	 is	 predicted	 to	 have	 the	 two	 characteristic	 helix-turn-helix	 (HTH)	 motifs,	encompassing	residues,	31-53	(HTH1)	and	80-103	(HTH2).	The	presence	of	a	GyrI-like	domain	suggests	 the	 possibility	 that	 Caf1R	 may	 bind	 small	 molecule(s)	 like	 other	 regulators	 of	AraC/XylS	 family	such	as	 the	sugar	metabolite	binding	of	AraC	(Schleif,	2010),	RhaS	and	RhaR	(Kolin	et	al.,	2008),	XylR	(Ni	et	al.,	2013),	XylS	(Gallegos	et	al.,	1996)	and	 	 fatty	acid	binding	of	ToxT	(Lowden	et	al.,	2010).		Seven	Cys	residues	(C33,	C129,	C137,	C148,	C164,	C269	and	C277)	were	 identified	 in	 the	 entire	 chain	 of	 Caf1R,	 this	 is	 quite	 unsual	 as	 the	 analysed	 regulators	belonging	to	AraC/XylS	family	contain	much	less	Cys	residues	(see	Fig.	3.15).	For	example,	the	DBD	of	Rob,	MarA	and	SoxS	don’t	contain	any	Cys	residue	(see	Fig.	3.17).	The	N-terminal	DBD	of	 Caf1R	 contains	 a	 single	 Cys	 residue	 (C33)	 whereas	 the	 remaining	 6	 were	 located	 in	 the	putative	C-terminal	GyrI-like	domain.		
3.3.2 Identification of Caf1R homologs   	AraC/XylS	 family	 contains	 regulators	 controlling	 the	 expression	 of	 genes	 or	 gene	 cluster(s),	involved	 in	 a	diverse	 range	of	 cellular	processes	 such	as	 carbon	metabolism,	 stress	 responses	and	virulence	in	both	Gram-negative	and	Gram-positive	bacteria	(Gallegos	et	al.,	1997;	Ibarra	et	al.,	 2008).	 In	Gram-negative	bacteria,	many	different	 surface	molecules	 and	 secretion	 systems	are	 critical	 to	 virulence,	 reviewed	 in	 (Costa	 et	 al.,	 2015)	 including	 fimbriae	or	pili	 (Busch	 and	Waksman,	2012;	Thanassi	et	al.,	2012).	A	review	of	the	literature	(Sections	1.4.1-4;	Fig.	1.6)	had	identified	 four	 different	 AraC/XlyS	 regulators	 controlling	 CU	 pathways,	 AfrR	 (Cantey	 et	 al.,	1999),	 AggR	 (Nataro	 et	 al.,	 1994),	 LdaA	 (Scaletsky	 et	 al.,	 2005)	 and	 Rns	 (Munson	 and	 Scott,	2000).	Pairwise	Blast	of	Caf1R	with	each	of	these	four	regulators	gave	E-values	of	3e-61	(AfrR),	4e-06	 (AggR),	 1e-68	 (LdaA)	 and	 3e-06	 (Rns).	 LdaA	 and	 AfrR	 shared	 121/276	 (44%)	 and	116/274	 (42%)	 identical	 amino	 acids	with	Caf1R	whereas	AggR	and	Rns	 shared	only	40/121	(41%)	and	22/56	(39%)	identical	amino	acids	to	Caf1R.	This	 indicates	that	LdaA	and	AfrR	are	
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likely	to	be	relatively	close	homologs	of	Caf1R	and	that	AggR	and	Rns	are	more	distantly	related.	Hence,	only	LdaA	and	AfrR	were	considered	in	further	sequence	analysis	with	Caf1R.				In	 order	 to	 investigate	 the	 closest	 relatives	 of	 Caf1R,	 initially	 Y.	 pestis	 entries	 to	 NCBI	 were	searched	for	homologs	of	full	length	Caf1R	(Q65AJ3,	the	longer	307	aa	predicted	protein),	using	the	 BLASTp	 server	 (http://blast.ncbi.nlm.nih.gov/Blast.cgi)	with	 an	 E-value	 threshold	 of	 1e-3.	All	 Caf1R	 regulator	 entries	were	 100%	 identical	 for	 full	 length	 Caf1R.	 After	 these	 the	 closest	entry	 was	 annotated	 as	 Rob	 (Accession	 no	WP_002209231.1,	 E-value	 4e-25,	 83/287	 identity	(29%)	and	45%	similarity).	Hence,	there	was	no	protein	closely	related	to	Caf1R	encoded	within	the	Y.	pestis	genome	or	associated	plasmids.		The	non-redundant	(nr)	protein	database	was	then	searched	 for	 all	 proteins	 related	 to	 Caf1R	 using	 the	 same	 parameters,	 but	 excluding	 Y	 pestis	entries.	The	BLASTp	output	for	Caf1R	showed	that	the	closest	homolog	(WP_042110517.1)	was	from	 a	 whole	 genome	 sequence	 (WGS)	 project,	 contig-2016	 of	 uropathogenic	 E.	 coli	 (UPEC),	strain-126	 (Salipante	 et	 al.,	 2015).	 This	 protein	 bears	 61%	 identity	 over	 87%	 of	 the	 Caf1R	sequence	with	an	E-value	of	4e-105.	The	second	homolog	(WP_001697817.1)	was	also	 from	a	WGS	project,	 contig-134	and	assigned	as	a	putative	F1	 regulator	 from	avian	pathogenic	E.	coli	(APEC),	strain-O08	(Rojas	et	al.,	2013).	This	exhibited	53%	identity	over	87%	of	 the	sequence	and	a	slightly	lower	E-value	(1e-79).			Analysis	 of	 the	 genomic	 context	 of	 the	 closest	 homolog	 (WP_042110517.1)	 revealed	 a	divergently	 transcribed	 gene	 annotated	 as	 a	 carbohydrate	 transporter	 approximately	 500	 bp	upstream	 of	 this	 Caf1R	 related	 regulator.	 Immediately	 upstream	 of	 this	 was	 a	 glycosyl	transferase.	 There	 was	 nothing	 encoded	 immediately	 downstream	 of	 the	 regulator,	 before	 a	small	hypothetical	protein	followed	by	a	gene	encoding	a	putative	plasmid	stabilisation	protein,	and	a	CopG	family	transcriptional	regulator	(Fig.	3.12a).	Thus,	this	closest	homolog	appeared	to	be	 linked	 to	 carbohydrate	 metabolism	 rather	 than	 a	 CU	 system.	 The	 second	 homolog	(WP_001697817.1)	was	on	a	small	contig	of	900	bp	and	hence	neighbouring	genes	could	not	be	identified	(Fig.	3.12b).	A	more	detailed	analysis	of	these	homologs	revealed	that	the	N-terminal	DBD	of	Caf1R	showed	a	particularly	close	similarity	to	these	proteins,	74%	and	67%	amino	acid	identity	 and	 82%	 and	 77%	 similarity	 with	 the	 first	 (WP_042110517.1)	 and	 the	 second	(WP_001697817.1)	homolog,	respectively.			The	 third	 top	 homolog	 (WP_024182496.1)	 was	 also	 from	 a	 WGS	 project,	 contig-11_1	 of	diarrheagenic	E.	coli,	strain-DEC11A	(Hazen	et	al.,	2012).	This	exhibited	44%	identity	over	89%	sequence	 coverage	 to	 Caf1R	 with	 an	 E-value	 of	 2e-68.	 The	 genomic	 context	 of	 this	 homolog	showed	 an	 associated	 CU	 system	 with	 four	 fimbrial	 subunits,	 three	 unassigned	 and	 one	annotated	as	K88-like	minor	fimbrial	subunit,	an	outer	membrane	usher,	annotated	as	FaeF	and	a	periplasmic	chaperone,	annotated	as	ClpE	(Fig.	3.13a).	Aside	from	the	associated	CU	system,	this	homolog	 is	surrounded	by	a	 few	hypothetical	proteins,	one	 transposase,	one	recombinase	and	one	additional	transcriptional	regulator	of	unknown	family	and	a	repFib	replication	protein	A	(Fig.	 3.13a).	 	After	excluding	 identical	entries,	 the	genomic	context	of	 the	remaining	entries	within	 the	 top	 500	 homologs	 were	 analysed.	 Twelve	 homologs	 of	 Caf1R,	 including	 LdaA	 and	AfrR,	associated	with	ORFs	belonging	to	a	complete	or	partial	CU	system,	were	identified.	LdaA	(AAX78184.1)	was	 identified	 as	 7th	 top	 homolog	 and	 AfrR	 (WP_032489301.1)	was	 present	 at	
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position	35.	 Sequence	 entries	 between	 the	3rd	 and	7th	 closest	 homolog	 and	many	others	were	hypothetical	 or	 unassigned	 regulators	 of	AraC/XylS	 family	 on	 short	 contigs	with	 a	 single	ORF	that	could	not	be	analysed.			The	 sequences	of	 all	12	CU	associated	 regulators	were	 retrieved	and	arranged	on	a	neighbor-joining	phylogenetic	tree	(based	on	%	identity)	along	with	AggR	and	Rns,	and	some	non	CU-type	regulators,	which	showed	≥	30%	amino	acids	identity	to	Caf1R	over	≥	85%	sequence	coverage	and	an	E.	value	cut	off,	≤	6e-32	(Fig.	3.14).	A	multiple	sequence	alignment	was	generated	from	the	12	CU-type	regulator	sequences	along	with	sequences	of	the	closest	two	(non-CU)	homologs	
(Fig.	3.15).	It	was	observed	that	the	putative	DBD	of	all	regulators	is	highly	conserved	with	an	equal	 distribution	 of	 hydrophobic	 and	 charged	 residues,	 which	 would	 be	 consistent	 with	 a	similar	 structure.	Within	 the	 HTHs	motifs,	 the	 sequence	 conservation	was	more	 pronounced;	HTH1	 has	 seven	 and	HTH2	 contains	 eight	 identical	 or	 highly	 similar	 amino	 acids.	 The	 highly	conserved	GxSSR	 in	HTH1	and	DSxQ	and	RE*FxK	 in	HTH2	(x,	variant	residue;	E*,	Glu98)	(Fig.	
3.15),	 suggest	 that	 these	 residues	may	 be	 essential	 for	 DNA-protein	 interactions.	 In	 addition,	this	 includes	 Glu98	 the	mutated	 residue	 in	 the	 poorly	 functioning	 Caf1R	 regulator.	 	 This	may	indicate	a	similar	mode	of	DNA	binding.			The	 sequence	 identity	 of	 these	 regulators	 over	 the	 GyrI-like	 domain	 of	 Caf1R	was	 lower.	 The	significance	of	this	domain	to	regulator	function	has	not	been	addressed	in	any	of	these	systems.		It	remains	to	be	seen	if	this	C-terminal	domain	is	involved	in	sensor	binding	or	dimerisation.	The	connecting	 region	 between	 the	 putative	 DBD	 and	 GyrI-like	 domain	 (113-130	 aa)	 was	 highly	variable,	consistent	with	a	linker	segment	although	unique	properties	of	each	regulator	should	not	be	excluded.	 	Conclusively,	12	CU-linked	AraC-like	 regulators	were	 identified	all	 sharing	a	high	 degree	 of	 similarity	with	 Caf1R	 although	 none	 of	 them	 seem	 to	 be	 linked	 to	 CU	 systems	from	FGL	class	(or	Υ3	family)	(Nuccio	and	Baumler,	2007;	Zav'yalov	et	al.,	2010;	Zavialov	et	al.,	2007)	 to	 which	 the	 caf	 locus	 belongs.	 The	 high	 degree	 of	 similarity	 indicates	 a	 common	underlying	regulatory	mechanism	among	these	regulators.			
		
Figure 3.12| Closest homologue of Caf1R is not associated with CU system. 
Genome context of closest 2 homologs of Caf1R.  a) Accession no WP_042110517.1 (closest NCBI entry) and 
b) Accession no WP_001697817.1 (second closest NCBI entry).  HP, hypothetical protein. 
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Figure 3.13| Identified Caf1R homologs associated with CU-system. 
Gene cluster of top third homolog, accession no WP_024182496.1 (a), AfrR (accession no WP_032489301.1) 
controlled AF/R1 fimbriae (Cantey et al., 1999) (b) and LdaA (accession no AAX78184.1) controlled lda locus 
(Scaletsky et al., 2005) (c) indicating the annotation, location and direction of each gene. Putative or assigned 
AraC/XylS family regulator of each is shown in between two vertical red lines.  
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Figure 3.14| Phylogenetic tree of Caf1R homologs from AraC/XylS family and CU-type regulators. 
NCBI accession number of each is indicated followed by regulator (if identified), name of organism and the 
sequence limit. Caf1R is boxed.  The E-value, query coverage and amino acid identity % to complete Caf1R for 
each are shown in parentheses. Non CU-type AraC/XylS family regulators are indicated by *. All others are 
associated with a CU system. Phylogenetic distance (0.3) is indicated by bar. APEC: Avian pathogenic E. coli 
and UPEC: uropathogenic E. coli. NCBI tree viewer1.6 program was used to construct phylogenetic tree from 
the multiple sequence alignment (by NCBI-COBALT program) of the retrieved sequences. Neighbor joining 
method with default parameters was used to construct tree.  		
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Figure 3.15| Multiple sequence alignment of selected Caf1R homologs. 
Sequences with respective NCBI accession number are organised according to similarity to Caf1R with a range 
of 61% (top) to 31% (bottom) amino acid identity to complete Caf1R (1-307 aa) and 74-44% to N-terminal DBD 
(1-112 aa). Black line, location of predicated DBD; red line, GyrI-like domain. Putative helix-turn-helix (HTH) 
motifs 1 and 2 are boxed. The conserved E98 residue is indicated with an arrow. Residues highlighted in 
different colors represent features of absolutely conserved (100% identical) and similar amino acid according to 
ClustalX color scheme (Livingstone and Barton, 1993) I, L, A, F: Hydrophobic; N, S, Q: Polar; G: Hydrophobic 
and small; R, K: Polar and positive charged; Y: Polar, hydrophobic and aromatic; P: Pro (small and nonpolar) 
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and D, E: Polar and negatively charged. (*), indicates residues assumed to contribute to the hydrophobic core of 
DBD, based on mar-MarA complex (PBD-1bl0). Similarity percentage % corresponds to complete Caf1R and 
N-terminal DBD alone is indicated in parentheses following description of each NCBI accession number. 
WP_042110517.1, uncharacterised regulator from uropathogenic E. coli, strain-126 (65/82); WP_001697817.1, 
putative F1 regulator from avian pathogenic E. coli, strain-O08 (58/78); WP_006816075.1, uncharacterised 
regulator from P. rustigianii (53/71); AAX78184.1, LdaA, regulator of locus for diffuse adherence of 
enteropathogenic E. coli (52/71); WP_024182496.1, uncharacterised regulator from Diarrheagenic E. coli, 
strain-DEC11A (52/71); WP_032226276.1, uncharacterised regulator from E. coli (51/71); WP_032346508.1, 
uncharacterised regulator from E. coli (48/69); WP_000920931.1, uncharacterised regulator from E. coli (50/72); 
WP_000159872.1, uncharacterised regulator from E. coli (49/65); WP_032489301.1, AfrR regulator from E. 
coli (49/72); WP_000149835.1, uncharacterised regulator from E. coli (48/69); WP_0001725754.1, 
uncharacterised regulator from E. coli (41/65); WP_046093264.1, uncharacterised regulator from S. enterica 
(40/61); WP_032428831.1, uncharacterised regulator from K. pneumoniae (38/55). Jalview2.9 (Waterhouse et 
al., 2009) was used to generate multiple sequence alignment and SIAS web server 
(http://imed.med.ucm.es/Tools/sias.html) used to calculate similarity (%) over complete and N-terminal DBD 
alone.   	
3.3.3 Identification of Caf1R homologs within PDB database  	The	 Caf1R	 accession	 number	 (Q65AJ3)	 was	 analysed	 against	 the	 protein	 data	 bank	 (PDB)	database	to	identify	the	closest	AraC/XylS	regulators	that	have	been	characterised	structurally.	Eleven	proteins	were	 found	 to	have	a	3D	 fold	 to	which	Caf1R	might	be	 similar.	Description	of	each	along	with	their	accession	number	is	shown	in	Table	3.1.	Out	of	11,	eight	of	these	proteins	belong	to	the	AraC/XylS	regulator	family	and	the	remaining	three	are	two-component	response	regulators.	Rob	protein	from	E.	coli-K12	gave	the	highest	score	(229,	E-value,	1.7e-21)	followed	by	E.	coli	MarA	(176,	E-value,	2.3e-15).	Although	the	amino	acid	identity	of	the	entire	Caf1R	with	Rob	was	only	27.5%,	the	two	proteins	(Caf1R	and	Rob)	shared	36.6%	identity	within	N-terminal	domains,	slightly	lower	than	the	identity	with	MarA,	which	was	37.3%.	MarA	contains	only	the	DBD.	This	can	explain	why	the	identity	with	MarA	was	highest,	while	the	highest	score	was	with	Rob,	which	like	Caf1R	has	a	C-terminal	domain.	The	score	from	XylR,	AraC	and	other	regulators	was	much	 lower	 than	of	Rob	or	MarA,	 suggesting	 that	 structures	of	Rob	and/or	MarA	are	 the	best	on	which	to	model	the	Caf1R	3D	structure.			Caf1R	secondary	structure	elements	(α-helix,	β-strand	and	turn)	were	predicted	(Fig.	3.16)	by	PSIPRED	(McGuffin	et	al.,	2000)	and	added	above	the	alignment.	Ten	α-helices	and	9	β-strands	were	predicted	in	the	complete	Caf1R.		Out	of	10	α-helices,	7	were	present	in	the	N-terminus	(1-112	 aa)	 and	 the	 remaining	 3	were	 located	 in	 the	 C-terminus	 (113-307	 aa).	 The	 β-strands	 (9)	were	 predicted	 only	 in	 the	 C-terminus	 (Fig.	 3.16).	 The	 result	 from	 this	 secondary	 structure	prediction	suggested	that	Caf1R	has	a	typical	AraC/XylS	type	regulator	fold	with	6	α-helices	 in	the	 N-terminal	 DBD,	 which	 are	 organised	 into	 two	 HTH	 motifs	 (α2-T-α3)	 and	 (α5-T-α6)	connected	 by	 a	 long	 linker	 (helix-4),	 and	 a	 pocket	 of	 antiparallel	 β-strands	 in	 the	 C-terminal	domain,	 essential	 for	 either	 sensing	 or	 dimerisation.	 Despite	 these	 common	 themes	 among	AraC/XylS-like	 regulators,	 the	 domain	 location	 within	 Caf1R	 (like	 Rob)	 is	 in	 the	 reverse	orientation	when	compared	to	most	AraC/XylS	regulators	(Gallegos	et	al.,	1997).	However,	this	N-terminal	DBD	is	common	to	all	CU-type	regulators	of	AraC/XylS	family,	analysed	above	except	AggR	and	Rns,	where	the	DBD	is	C-terminal.			 	
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Table 3.1| Predicted structural homologs of Caf1R identified in PDB database. 
                  Dark color shaded regulators represent AraC/XylS family regulators whereas 
histidine kinases/two-component response regulators are indicated by light 
color shade.  
UniProt	
Entry	
Protein	
name	
	
Description	 Score	
P0ACI0	 Rob	 Right	origin-binding	protein	from	E.	coli-K12	 E-value:	1.7E-21	Score:	229	Identity:	27.5%		P0ACH5	 MarA	 Multiple	antibiotic	resistance	protein	MarA	from	E.	coli-K12	 E-value:	2.3E-15	Score:	176	Identity:	37.3%		Q89YQ8	 Histidine	Kinase	 From	B.	thetaiotaomicron		 E-value:	1.4E-9	Score:	143	Identity:	31.6%		A9KJQ6	 AraC	type	regulator	 From	C.	phytofermentans		 E-value:	2.4E-9	Score:	138	Identity:	34.3%		P0ACI3	 XylR	 Xylose	operon	regulatory	protein	from	E.	coli-K12	 E-value:	22E-9	Score:	132	Identity:	36.2%		Q8RGT8	 YesN	 Two-component	response	regulator	from	F.	nucleatum		 E-value:	150E-9	Score:	124	Identity:	32.6%		Q7NTG7	 AraC	type	regulator	 From	C.	violaceum		 E-value:	190E-9	Score:	124	Identity:	30.4%		Q88H39	 AraC	type	regulator	 From	P.	putida		 E-value:	0.0000026	Score:	115	Identity:	28.7%		P0A9E0	 AraC	 Arabinose	operon	regulatory	protein	from	E.coli-K12	 E-value:	0.0000030	Score:	114	Identity:	28.3%		A9KIW7	 AraC	type	regulator	 Two	component	regulator	from	C.	phytofermentans		 E-value:	0.0000034	Score:	115	Identity:	33.0%		Q89YR8	 Histidine	kinase	 Two-component	sensor	histidine	kinase/response	from	
B.	thetaiotaomicron		 E-value:	0.000013	Score:	111	Identity:	29.7%		
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Figure 3.16| Caf1R secondary structure prediction by PSIPRED.  	
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To	fully	understand	the	function	of	AraC/XylS	type	regulators,	characterisation	of	DNA-protein	interactions	 is	 essential	 and	 in	 this	 regard	 only	 Rob	 and	MarA	 have	 been	 characterised	with	their	 cognate	 DNA	 (Kwon	 et	 al.,	 2000;	 Rhee	 et	 al.,	 1998).	 Therefore	 in	 further	 analysis,	 the	remaining	nine	proteins	were	excluded.	The	amino	acid	sequences	of	MarA,	the	N-terminal	DBD	of	Rob	and	the	N-terminal	DBD	of	Caf1R,	were	aligned	along	with	one	other	well-characterised	MarA	 homologue,	 SoxS	 (Griffith	 and	 Wolf,	 2002)	 to	 establish	 a	 structure-based	 functional	relationship	 for	 Caf1R	 (Fig.	 3.17).	 Following	 multiple	 sequence	 alignment,	 Caf1R	 residues	corresponding	 to	 residues	 of	mar-MarA	 DNA-protein	 complex	 (PDB-1bl0)	 involved	 in	 DNA-protein	 interactions	 were	 identified	 (Rhee	 et	 al.,	 1998).	 Within	 HTH1	 motif	 (α2-T-α3),	 five	amino	 acids	 of	 Caf1R,	 G39,	 S41,	 L45,	 Q46	 and	 F49	 shared	 identity	 with	MarA,	 Rob	 and	 SoxS	whereas	 in	HTH2	motif	 (α5-T-α6),	 eight	 amino	 acids,	 I80,	 S91,	Q92,	Q93,	T94,	R97,	 F100	 and	F103	shared	identity	to	MarA,	Rob	and	SoxS.	The	higher	amino	acid	conservation	of	HTH2	has	been	taken	as	an	indication	of	common	DNA	binding	features	within	AraC/XylS	regulators	and	the	greater	variation	 in	HTH1	as	a	possible	 indication	of	specificity	of	DNA-protein	 interaction	(Gallegos	et	al.,	1997).			
		
Figure 3.17| Multiple sequence alignment of Caf1R DBD with MarA, Rob and SoxS DBD. 
Secondary structure elements, α-helices (1-7; pink rods) and turn (black lines) indicated above Caf1R were 
predicted by PSIPRED (McGuffin et al., 2000). Putative Helix-turn-helix (HTH) motifs (HTH1, 31-53 aa and 
HTH2, 80-103 aa) assigned according to mar-MarA complex (Rhee et al., 1998) are indicated by black boxes. 
Alignment numbering is relative to Caf1R sequence. Colored asterisks below alignment indicate the assigned 
role of residues in mar-MarA complex (PDB-1bl0). *: Hydrophobic core residues; *: residues interacting with 
phosphate group of DNA backbone and *: residues interacting with DNA bases (see Chapter 1, section 1.5.2 for 
further detail). Jalview2.9 program (Waterhouse et al., 2009) was used for multiple sequence alignment with 
ClustalX color scheme (Livingstone and Barton, 1993). Residues highlighted in different colors represent 
features of absolutely conserved (100% identical) and similar amino acids. I, L, A, F: Hydrophobic; S, Q, T: 
Polar; G: Hydrophobic and small; R: Polar and positive charged; P: Pro (small and nonpolar) and Y: Polar, 
hydrophobic and aromatic. Arrowheads, location of site-specific mutations within Caf1R-DBD (Section 3.4 and 
onward). 
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3.3.4 Modelling of Caf1R 	In	order	to	 identify	the	 location	and	influence	of	Glu98	in	the	Caf1R	structure,	 the	structure	of	Caf1R	was	modelled.	 A	working	model	 of	 Caf1R	would	 also	 assist	 in	 identifying	 key	 residues	within	 the	 DBD,	 essential	 for	 activation	 of	 transcription.	 The	 amino	 acid	 sequence	 of	 Caf1R	(relative	 to	 TTG	 start	 codon)	 was	 submitted	 to	 a	 protein-modelling	 server,	 IntFOLD3.0	(McGuffin	 et	 al.,	 2015;	 Roche	 et	 al.,	 2011)	 that	 uses	 template	 based	method	 from	 the	 crystal	structures	 in	 PDB	 database,	 representing	 the	 correct	 folds.	 Following	 submission	 of	 Caf1R	 to	IntFold3.0,	103	models	were	predicted	and	almost	all	of	them	were	based	on	either	Rob	(PDB-1d5y)	 or	 MarA	 (PDB-1bl0)	 or	 both	 protein	 templates.	 This	 is	 supported	 by	 Caf1R	 analysis	against	 the	PDB	database	(discussed	earlier).	The	highest	scored	model	was	based	on	the	Rob	template	with	≥	70%	non-redundancy	(Fig.	 3.18a).	The	reliability	of	this	model	can	be	judged	by	 the	 score	 of	 modeling-confidence,	 which	 was	 categorised	 as	 ‘certain’	 with	 a	 P-value	(probability	 of	 incorrectness)	 of	 1.921E-4	 and	 an	 overall	 global	 model	 quality	 score	 of	0.8133/1.0.	 The	 high	 reliability	 of	 the	 model	 is	 also	 indicated	 by	 the	 excellent	 β-factor	represented	by	color	intensity	from	blue	(high	accuracy)	to	red	(low	accuracy)	(Fig.	3.18a).	The	N-terminal	 domain	 (DBD)	 is	 apparently	 a	well-predicted	model;	 this	was	 also	 reflected	 in	 the	low	level	of	intrinsic	disorder	and	residue	error	(in	Å).	The	prediction	for	the	C-terminal	domain	was	also	good,	aside	from	β-strands	4	and	5	(residues	173-206)	which	were	slightly	less	reliable	and	the	extreme	C-terminus	(residues	278-307),	which	was	unstructured.	This	can	be	seen	by	the	much	higher	peaks	and	histogram	bars	 for	 the	C-terminus,	compared	to	 the	N-terminus	 in	the	DISCOClust	disorder	prediction	plot	and	the	per	residue	error	plot	(Fig.	3.18d-e).			One	 advantage	 of	 the	 IntFOLD3.0	 server	 is	 that	 it	 also	 predicts	 ligand(s)	 associated	with	 the	submitted	protein	and	potential	binding	 site(s)	within	both	protein	and	 the	associated	 ligand.	Not	surprisingly,	the	2	DNA	ligands	from	the	solved	cocrystal	structures	of	mar-MarA	(Rhee	et	al.,	1998)	and	micF-Rob	(Kwon	et	al.,	2000)	DNA-protein	complexes	were	modelled	as	ligands	of	Caf1R.	However,	 the	micF	DNA	was	bound	to	 the	modelled	Caf1R	DBD	in	only	one	major	DNA	groove	via	Caf1R	helix-3	(Fig.	3.18b)	and	therefore	micF-Caf1R	model	was	not	used	further.	In	contrast,	modeling	with	mar	DNA	from	mar-MarA	complex,	generated	the	expected	interaction	of	 regulator	with	 two	major	grooves	within	 the	DNA.	 In	 the	mar	DNA-Caf1R	model,	 helix-3	of	Caf1R	 interacts	with	 one	major	 groove	 and	 helix-6	with	 the	 other	 (Fig.	 3.18c).	 This	 requires	bending	 of	 the	 DNA,	 as	 shown	 for	 MarA	 binding	 to	mar	 promoter	 (Rhee	 et	 al.,	 1998).	 Three	Caf1R	 residues	 were	 predicted	 to	 interact	 with	 the	 bound	mar	 DNA	 ligand;	 R43	 in	 helix-3	interacting	 with	 a	 G-base,	 and	 Q93	 and	 R97	 (both	 in	 helix-6)	 interacting	 with	 a	 T-base	 (Fig.	
3.18b-c).	 Residues	 in	 the	 positions	 corresponding	 to	 Caf1R-	 R43	 and	 R97	 are	 known	 to	 be	critical	 in	DNA	binding	of	MarA	(Rhee	et	al.,	1998),	Rob	(Kwon	et	al.,	2000)	and	SoxS	(Griffith	and	Wolf,	 2002).	 Therefore,	 R43,	 Q93	 and	 R97	 might	 reasonably	 be	 considered	 as	 key	 DNA	binding	residues	of	Caf1R.	Because	the	model	with	mar	DNA	is	consistent	with	current	evidence	of	 interaction	 of	 regulators	 with	 2	 binding	 sites,	 BS1	 and	 BS2	 adjacent	 to	 HTH1	 and	 HTH2,	respectively,	the	mar	DNA-Caf1R	model	was	used	as	a	working	model	for	analysis	of	Caf1R-DNA	interactions	and	designing	a	mutagenesis	strategy.				
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Figure 3.18| Caf1R modelling.   
a) Ribbon diagram of IntFOLD3.0 predicted model of full-length Caf1R, indicating quality of prediction by β-
factor color intensity. Predicted N-terminal DNA-binding domain (DBD) (helices, 1-7) and C-terminal GyrI-like 
domain (helices (8-9) and β-strands (1′-8′) are annotated.  b-c) Caf1R-DNA interaction with micF (b) and mar 
(c) DNA indicating modelled interactions of R43 (in helix-3) with a G-base in both cases and Q93 and R97 (in 
helix-6) with a T-base only with mar DNA. Caf1R model with micF DNA indicates helix-6 interaction with 
DNA backbone adjacent to a T-base. The retrieved micF and mar DNA-Caf1R models (from lig2.pdb file) were 
superposed by Tm align web server (Zhang and Skolnick, 2005) on the corresponding protein template (Rob and 
MarA) in order to show complementarity between modelled Caf1R and template. d) Disorder prediction and e) 
per-residue error in Å of the selected top scored Caf1R model based on Rob template. The default cut-off value 
(0.5) of good quality prediction is indicated by green dotted line in (d). A vertical black dotted line in (d) and (e) 
indicates division between N and C-terminal domains of Caf1R. MacPyMOL1.3 was utilised to visualise and 
generate the ribbon diagrams of Caf1R and Caf1R-DNA models.  	
3.4 Mutagenesis supports role of Glu98 in bridge interaction   
3.4.1 Impact of E/G98 residues on Caf1R structure 	The	repair	of	the	spontaneous	E98G	mutation	within	Caf1R	DBD	identified	E98	as	a	potentially	key	residue,	essential	for	high	levels	of	F1	production,	but	the	question	remained	why	was	this	residue	 so	 important?	 How	 and	 where	 does	 it	 interact,	 in	 a	 DNA-protein	 or	 protein-protein	interaction?	This	Glu98	is	highly	conserved	in	all	of	the	analysed	CU-type	regulators	(Fig.	3.15)	whereas	 in	 comparison	 to	 Rob,	 MarA	 and	 SoxS,	 this	 position	 is	 highly	 variable	 (Fig.	 3.17).	Therefore	the	modelled	mar	DNA-Caf1R	DBD	complex	was	analysed	with	respect	to	this	residue.	Glu98	appeared	to	be	involved	in	a	bridge-type	interaction	(Fig.	3.19a)	with	R62	(in	helix-4)	on	one	 side,	which	 in	 turn	 interacts	with	 the	DNA	backbone.	On	 the	other	 side	E98	 is	 located	on	helix-6	neighbouring	R97,	which	is	highly	conserved	in	all	of	these	AraC/XylS	regulators	(Figs.	
3.15	and	3.17).	 In	the	mar	DNA-Caf1R	model	R97	retains	the	interaction	with	a	T-base	in	the	DNA	major	groove,	adjacent	to	helix-6.	This	interaction	appears	to	be	stabilized	by	interaction	of	
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Q93	 (also	 in	 helix-6)	 with	 the	 same	 T-base	 in	 the	 major	 DNA	 groove.	 Thus,	 this	 bridge-type	interaction	 (DNA	backbone::R62-E98-R97-Q93::T-base),	 could	play	 a	 critical	 role	 in	 stabilising	the	overall	 Caf1R-DNA	 interactions	 and	also	 in	 correctly	orientating	helix-6	 and	 the	predicted	DNA	specific	binding	residues		R97	and	Q93.		In	 order	 to	 address	 the	 impact	 of	 the	G98	mutation	 on	 the	bridge	 interaction,	 the	 amino	 acid	sequence	 of	 Caf1RE98G	 was	 submitted	 to	 IntFOLD3.0	 and	 the	 top	 scored	 model	 retrieved	 for	analysis.	Caf1RE98G	was	modelled	on	two	templates,	micF-Rob	complex	(PDB-1d5y)	(Kwon	et	al.,	2000)	 and	 mar-MarA-RNAP	 ternary	 complex	 (PDB-1xs9)	 (Dangi	 et	 al.,	 2004).	 With	 E98G	substitution,	Intfold3.0	predicted	three	residues,	R43,	Y44	and	R97,	which	might	be	essential	for	DNA-Caf1R	 interactions.	Selection	of	 the	additional	 residue,	Y44	as	a	binding	residue	could	be	related	to	the	fact	that	the	Caf1RE98G	model	is	based	on	two	protein	templates	unlike	the	single	protein	template	(Rob)	on	which	the	wild	type	Caf1R	model	was	based.	This	extra	residue,	Y44	of	helix-3	was	predicted	with	a	possible	interaction	with	a	G-base	of	DNA.	Superposition	of	the	modelled	Caf1RE98G	structure	on	the	wild	type	model	of	Caf1R	indicated	no	change	in	position	of	helices	even	between	DNA	recognition	helix-3	and	helix-6	in	either	case.	Although	slight	changes	in	the	side	chains	of	 the	respective	amino	acids	were	observed	 in	both	cases,	 for	example	R43	and	Y44	(Fig.	 3.19b-c).	The	DNA-Caf1R	interactions	were	compared	by	superposing	Caf1RE98G	model	 on	 the	 mar	 DNA-Caf1R	 modelled	 complex.	 As	 would	 be	 expected,	 the	 bridge-type	interaction	was	disrupted	upon	substitution	of	E98	with	G98	(Fig.	3.19b).	The	small	size	of	the	Gly	 residue	 and	 absence	 of	 side	 chain	 abolishes	 the	 interaction	 with	 R62	 in	 the	mar	 DNA-Caf1RE98G	 modelled	 complex.	 The	 interaction	 of	 R97	 and	 Q93	 with	 predicted	 T-base	 was	unaffected	in	the	model,	however,	the	small	size	and	conformational	flexibility	of	Gly	means	that	it	 generally	 has	 a	 low	propensity	 for	 α-helix	 formation.	 Therefore,	 using	 PSIPRED	web	 server	(McGuffin	et	al.,	2000)	 the	secondary	structure	of	Caf1R	helix-6	was	predicted	with	E98	(wild	type)	 and	E98G	 substitution	 (Fig.	 3.19b-c).	 The	 E98G	 substitution	 gave	 a	 substantially	 lower	confidence	of	α-helix	formation	and	predicted	a	slightly	shorter	helix-6	(Fig.	3.19b-c).	Hence,	an	impact	of	the	Gly98	substitution	on	helix-6	length	and	stability	might	also	directly	affect	correct	spatial	 orientation	 of	 binding	 residues	 within	 helix-6	 as	 well	 as	 through	 loss	 of	 the	 R62	backbone	interaction.	
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Figure 3.19| Impact of E/G98 residues on Caf1R structure.   
a) Ribbon diagrams of the predicted Caf1R model with G98 substitution (grey-balls). Quality of prediction is 
indicated by β-factor color intensity (underneath). Model quality score was 0.806 with P-value of 2.054E-4 and 
‘certain’ reliability score. Modelled mar DNA-Caf1R (WT) (b) and mar DNA-Caf1RE98G (c) indicating 
interactions of Intfold3.0 predicted (R43, Y44, Q93 and R97) and visually identified (R62 and E/G98) residues 
of Caf1R to DNA-bases (G, G and T). To generate the mar DNA-Caf1RE98G complex, Tm align web server 
(Zhang and Skolnick, 2005) was used to superpose modelled structure of Caf1RE98G on WT modelled complex 
of mar DNA-Caf1R.  For clarity, only the N-terminal DBD is shown in both cases.  Using PSIPRED (McGuffin 
et al., 2000) secondary structure was predicted for helix-6 with E/G98 substitution as indicated. MacPyMOL1.3 
was utilised to visualize and generate the pictures.  
3.4.2 E98 bridges critical DNA binding residues, R62, Q93 and R97  	As	reviewed	in	section	1.5.2	and	Fig.	1.11,	the	corresponding	residues	of	Caf1R-	Q93	and	R97	in	MarA	(Q92	and	R96)	make	extensive	van	der	Waals	 interactions	and/or	hydrogen	bonds	with	the	 mar	 DNA	 bases	 in	 the	 cocrystal	 structure	 of	 mar-MarA	 complex.	 More	 so,	 alanine	substitution	of	MarA-R96	 showed	a	major	 impact	 on	 all	 six	MarA-regulated	promoters	 tested,	although	 substitution	 of	 MarA-Q92	 had	 less	 of	 an	 effect,	 only	 two	 of	 six	 MarA-regulated	promoters	 were	 affected	 (Gillette	 et	 al.,	 2000).	 From	 the	 modelled	mar	 DNA-Caf1R	 complex,	Caf1R-	 R62,	 Q93	 and	 R97	 appeared	 to	 be	 critical	 residues,	 linked	 together	 by	 a	 bridge-type	interaction	through	E98.	Therefore,	it	was	predicted	that	mutation	of	Q93	and	R97	would	have	a	major	impact	on	Caf1R	activity	and	that	substitutions	of	the	bridge	related	residues	R62	and	E98	would	destabilise	the	Caf1R-DNA	interaction	and	regulatory	impact	regulator	activity.		
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Initially,	Caf1R-R62	was	substituted	in	silico	to	the	smaller	and	non-polar	or	polar	residues,	Ala	and	Ser	whereas	Q93	and	R97	were	substituted	only	to	Ala	and	Caf1R	was	again	modelled	with	each	mutation.	Each	of	these	models	was	superposed	on	the	mar	DNA-Caf1R	complex	model	to	analyse	 the	 impact	 on	 the	 bridge-type	 interaction	 and	 interaction	 of	 the	 key	 helix-6	 residues	with	 DNA.	 Each	 substitution	 was	 found	 to	 be	 responsible	 for	 disruption	 of	 the	 bridge-type	interaction	and	would	be	predicted	to	destabilise	the	Caf1R-DNA	interaction	(Fig	3.20).			The	 impact	of	 each	of	 the	R62,	Q93	and	R97	substitutions	on	activation	of	F1	production	was	assessed	 following	 construction	 of	 site-specific	 mutations	 in	 pACYCF1.	 F1	 expression	 was	quantified	either	from	cell	surface	extracts	(pACYCF1-RR62A	and	pACYCF1-RR62S)	or	directly	from	whole	 cells	 (pACYCF1-RQ93A	 and	 pACYCF1-RR97A)	 from	 three	 transformants	 of	 each	 following	thermoinduction	 at	 37°C	 (Fig	 3.20).	 Following	 4	 h	 induction,	 cells	 carrying	 the	 mutated	plasmids,	pACYCF1-RR62A	or	pACYCF1-RR62S	produced	only	76.35%	±	3.86	and	58.85%	±	0.20	the	amount	of	F1	produced	with	wild	type	Caf1R	(Fig.	3.20a	(i-ii)).	At	6	h	post-induction,	the	level	was	 comparable	 to	 that	 of	wild	 type,	 96.55%	 ±	 1.27	 from	 pACYCF1-RR62A	 and	 92.97%	±	 2.94	from	pACYCF1-RR62S	(Fig.	3.20a	(i-ii)).	This	reduction	in	F1	expression	from	both	mutants	at	4	h	is	 consistent	with	 the	modelled	 loss	of	 interaction	of	 residue	A/S62	with	E98.	The	model	also	indicated	 loss	 of	 interaction	 of	 A/S62	 with	 the	 phosphate	 backbone.	 Both	 effects	 could	contribute	 to	 decreased	 activation	 of	 transcription	 by	 Caf1R	 (Fig.	 3.20a	 (iii-iv)).	 With	 the	mutation	 RQ93A,	the	 F1	 level	was	 very	 low	 at	 both	 time	 points	 tested,	 6.99%	 ±	 0.36	 (4	 h)	 and	33.90%	 ±	 1.77	 (6	 h)	 of	 wild	 type	 levels	 (Fig.	 3.20b	 (i-ii)).	 Similarly,	 the	 level	 of	 F1	 from	pACYCF1-RR97A	mutant	was	again	drastically	reduced	at	4	h	(4.79%	±	1.83)	although	there	was	more	 at	 6	h,	 86.53%	±	4.78	of	wild	 type	 levels	 (Fig.	 3.20b	 (i-ii)).	 The	dramatically	 enhanced	level	of	F1	at	6	h	from	pACYCF1-RR97A	mutant	appears	unusual	in	light	of	the	critical	role	of	this	conserved	Arg	 in	MarA	 (R96)	 (Gillette	et	 al.,	 2000;	Rhee	et	al.,	 1998).	The	 reduced	 level	of	F1	from	 each	 of	 these	 mutants	 (including	 R97A	 at	 4	 h)	 supports	 the	 involvement	 of	 these	 key	residues	in	optimising	Caf1R-DNA	interactions.		
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Figure 3.20| Caf1R- R62, Q93 and R97 are essential for bridge-type interaction and F1 production.  
 a) Effect of R62A and R62S substitution on F1 recovery and E98-mediated bridge-type interaction. (i-ii) SDS-
PAGE (16% acrylamide) analysis (i) and F1 subunit, Caf1 band (←) quantification (ii) following F1 recovery 
from the ‘cell surface’ of recombinant DH5α cells carrying pACYCF1-RR62A/S mutant plasmids (R62A or R62S) 
or wild type (WT), pACYCF1. F1 expression was monitored after 4 and 6 h of thermoinduction at 37°C and an 
equivalent of 0.04 OD unit sample of each was applied to gel following heat denaturation (97.5°C-15 min). 
Average of cell densities (OD600) of triplicate cultures from either WT or mutants plasmid carrying cells was 
similar at both selected time points, 0.96-1.05 (4 h) and 1.09-1.19 (6 h). Error bars are based on ± SEM of F1 
recovery from three transformants of each. (iii-iv) Effect of R62A and R62S substitutions on bridge-type 
interaction. Superposed model of Caf1RR62A (iii) and Caf1RR62S (iv) on modelled mar DNA-Caf1R complex 
indicating a gap (disruption of bridge) between R62A or R62S (in helix-4) and the E98 (in helix-6) as shown by 
colored spheres and labels.  b) Effect of Q93A and R97A substitution on F1 recovery and E98-mediated bridge-
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type interaction. (i-ii) SDS-PAGE analysis (i) and Caf1 band (←) quantitification (ii) following F1 recovery in 
‘whole cell’ of recombinant DH5α cells carrying either pACYCF1-RQ93A  (Q93A) or pACYCF1-RR97A  (R97A) 
mutant plasmid or wild type (WT), pACYCF1 were carried out as in (a). Average of cell densities (OD600) of 
triplicate cultures from either WT or mutants plasmid carrying cells at 4 and 6 h were 0.84 and 1.04 (WT), 0.96 
and 1.03 (Q93A), and 1.23 and 1.32 (R97A) (iii-iv). Effect of Q93A and R97A substitutions on E98-mediated 
bridge-type interaction. Superposed model of Caf1RQ93A (iii) and Caf1RR97A (iv) on modelled mar DNA-Caf1R 
complex indicating a gap (disruption of bridge) between R62 and the E98 in both cases as shown by colored 
spheres and labels. Note: Each mutant model was predicted on Rob protein template (PDB-1d5y) with model 
quality score ≥ 0.788/1.0, P-value ≤ 2.328E-4 and ‘certain’ reliability score.  
 
3.4.3 Effect of additional E98 substitutions on bridge interaction and F1 production  	The	evidence	from	modelled	Caf1R	and	mutagenesis	was	consistent	with	a	key	role	of	the	helix	6	residues	(Q93	and	R97)	in	binding	in	the	major	DNA	groove.	Binding	of	R62	was	also	important.	Therefore	to	further	explore	the	role	of	E98	as	a	bridge	between	these	key	residues,	additional	less	 drastic	 substitutions	 were	 made	 at	 residue	 98.	 E98	 was	 substituted	 with	 the	 analogous	residues	 present	 in	 Rob	 (A88)	 and	 MarA	 (T97)	 to	 create	 the	 plasmids	 pACYCF1-RE98A	 and	pACYCF1-RE98T.	 F1	 expression	 was	 monitored	 from	 cell	 surface	 extracts	 of	 three	 individual	transformants	as	above.	The	level	of	F1	from	cells	carrying	either	of	the	mutated	plasmids	was	substantially	 reduced	 in	 comparison	 to	 cells	 carrying	 WT	 pACYCF1	 plasmid.	 After	 4	 h	thermoinduction	at	37°C,	the	F1	level	was	58.85%	±	2.15	of	wild	type	with	pACYCF1-RE98A	and	67.38%	±	1.57	with	pACYCF1-RE98T.	After	6	h	thermoinduction,	the	F1	level	of	both	increased	in	comparison	 to	 wild	 type,	 95.24%	 ±	 3.24	 (with	 pACYCF1-RE98A)	 and	 73.12%	 ±	 2.44	 (with	pACYCF1-RE98T)	 (Fig.	 3.21a	 (i)	 and	 b).	 The	 reduced	 level	 of	 F1	 from	 both	 E98A	 and	 E98T	substitutions	 reflects	 loss	 of	 the	 E98-mediated	 bridge	 interaction	 with	 R62	 in	 the	 modelled	Caf1R	mutants	 (Fig.	 3.21c	 (i-ii)).	 Additionally,	 secondary	 structure	 prediction	 of	 helix-6	with	E98A	 and	 E98T	 substitutions	 showed	 a	 good	 score	 of	 helix-6	 propensity	 (Fig.	 3.21c	 (i-ii)),	suggesting	 that	 loss	 of	 the	 E98-mediated	 bridge	 interaction	 is	 responsible	 for	 destabilising	Caf1R-DNA	interactions	to	ensure	optimum	activation	of	transcription	and	F1	production.			These	results	were	 further	supported	by	an	 ‘unwanted’	mutation	 in	caf1R,	encoding	Caf1RE98K,	which	 led	 to	virtual	 complete	 loss	of	F1	production.	There	was	no	CB	stainable	Caf1	 in	whole	cells	 (Fig.	 3.21a	 (ii)).	 This	 was	 further	 confirmed	 by	 immunoblotting	 (Fig.	 3.21a	 (iii)).	Following	 co-transformation	 of	 pACYCF1-RE98K	 with,	 pBADhCaf1R	 (WT	 Caf1R),	 F1	 production	was	restored	to	wild	type	levels	(Fig.	3.21a	(ii)),	confirming	that	loss	of	F1	production	could	be	attributed	to	the	E98K	mutation	within	Caf1R.	In	the	IntFOLD3.0	generated	model	of	Caf1RE98K	
(Fig.	 3.21c	 (iii))	 a	 single	 base-amino	 acid	 (A-R43)	 interaction	 was	 predicted.	 Interactions	between	helix-6	and	DNA	were	no	longer	predicted.	Following	analysis	of	superposed	model,	the	proposed	bridge-type	interaction	was	completely	 lost	 in	Caf1RE98K	(Fig.	 3.21d	 (ii)).	This	could	be	 due	 to	 repulsive	 interactions	 between	 the	 positively	 charged	 R62	 and	 K98	 residues.	Additionally,	slight	displacement	of	both	Q93	and	R97	were	observed	in	the	Caf1RE98K	model	cf	wild	 type	 (Fig.	 3.21d	 (ii)),	 suggesting	 an	 additional	 impact	 on	base-specific	 interactions	with	helix-6	residues.	To	test	the	impact	of	the	E98K	mutation	on	transcription,	E.	coli	Top10	was	co-transformed	 with	 the	 promoter-lacZ	 fusion	 plasmids,	 pRScaf1M′-R′-lacZ	 (contains	 caf1R	promoter(s);	PR)	or	pRScaf1R′-M′-lacZ	(contains	caf1M	 promoter(s);	PM)	 together	with	pACYC-RE98K	and	promoter	activity	or	β-galactosidase	level	was	monitored	(Fig.	3.22).	There	was	very	low	 activity	 at	 both	 PM	and	PR	 promoter(s)	 upon	 transactivation	 by	 pACYC-RE98K	 compared	 to	
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transactivation	 by	 wild	 type	 pACYC-R.	 This	 is	 consistent	 with	 a	 much	 lower	 affinity	 of	 the	mutated	Caf1RE98K	for	the	caf	DNA	as	indicated	in	the	model.	The	effect	was	much	more	severe	at	the	 PM	 promoter(s)	 (32.62-fold	 reduction	 at	 10	 h)	 than	 at	 the	 PR	 (5.52-fold	 reduction)	promoter(s)	 (Fig.	 3.22,	 solid	 lines).	 There	was	 no	 dramatic	 change	 on	 the	 growth	 of	 cells	 in	either	 case	 (Fig.	 3.22,	 dotted	 lines).	 These	 results	 confirm	 that	 the	 dramatic	 reduction	 in	 F1	production	with	the	E98K	mutation	is	a	consequence	of	very	poor	activation	of	transcription	at	both	caf1R	and	caf1M	promoter(s)	of	the	caf	locus.			These	studies	support	the	hypothesis	of	a	role	for	E98	as	a	linker	residue	between	2	key	Caf1R-DNA	 interacting	 sites	 generating	 the	 DNA	 backbone::R62-E98-R97-Q93::T-base	 bridge	interaction.		This	bridge	interaction	would	be	predicted	to	ensure	optimum	spatial	orientation	of	the	key	DNA	binding	residues	and	stability	of	the	Caf1R-DNA	complex.				
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Figure 3.21| Caf1R- 98th residue is essential for bridge-type interaction and F1 production.  
a-b) Effect of Caf1R- E98A, E98T and E98K substitutions on F1 recovery. SDS-PAGE (16% acrylamide) 
analysis of F1 subunit, Caf1 (indicated by arrowheads) from pACYCF1-RE98A (E98A) and pACYCF1-RE98T 
(E98T) (i) and from pACYCF1-RE98K (E98K) (ii). F1 recovery in (i) was monitored and quantitated (b) from 
‘cell surface’ of recombinant DH5α cells carrying either mutant plasmids (E98A or E98T) or wild type 
pACYCF1 (WT) following 4 and 6 h of thermoinduction at 37°C. An equivalent of 0.04 OD unit sample of each 
was applied to gel following heat denaturation (97.5°C-15 min). Average of cell densities (OD600) of triplicate 
cultures from either WT or mutants plasmid carrying cells at corresponding 4 and 6 h were 0.84 and 1.04 (WT); 
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0.81 and 0.96 (E98A); 0.89 and 0.95 (E98T). Indicated error bars are in (b) are based on ±SEM of F1% from 
three biological replicates of each. ii) F1 expression from three individual co-transformants of 
Top10/pACYCF1-RE98K+pBADHis (E98K) and wild type Caf1R complemented Top10/pACYCF1-
RE98K+pBADhCaf1R (E98K+Caf1R). F1 expression was monitored from  ‘whole cell’ recovered from 5 OD 
units induced culture (0.02% L-ara arabinose, 4 h at 37°C induction), mixed in 100 µl PBS   and an equivalent of 
0.37 OD unit sample of each was applied to gel following heat denaturation (97.5°C-15 min). ii) Western blot 
(on NCM) analysis of F1 expression from pACYCF1-RE98K mutant along with negative (pACYC empty vector; 
C) and positive (pACYCF1; WT) control. F1 expression was monitored (37°C-4 h) from the ‘whole cell’ 
samples (5 OD units) of recombinant DH5α carrying pACYCF1-RE98K mutant plasmid or positive or negative 
control plasmid. Level of F1 expression (Caf1 subunit, from heat denatured 0.37 OD unit sample of each was 
detected by blotting with anti-Caf1sc (1:5000) primary antibody and anti-Rabbit IgG-HRP (1:40,000) secondary 
antibody. c) Effect of E98A, E98T and E98K substitutions on bridge-type interaction and helix-6 propensity. 
Superposed model of Caf1RE98A (i), Caf1RE98T (ii) and Caf1RE98K (iii) on modelled mar DNA-Caf1R complex 
indicating a gap (disruption of bridge) between R62 and the E98A and E98T substitution whereas no such effect 
in (iii) as indicated by colored spheres and labels. No dramatic effect was observed on helix-6 propensity upon 
E98A/T/K substitutions as indicated by identical length of helix and equal prediction score in each case. d) 
Bridge-type interaction analysis from another angle of modelled complex of wild type (WT) and mutant (E98K) 
Caf1R, indicate clear disruption of E98-mediated bridge-type interaction upon E98K substitution. For picture 
clarity DNA was hide in both cases.			 	
		
Figure 3.22| Caf1RE98K causes reduced transcription activation at both PM and PR promoter(s).   
β-galactosidase activity from recombinant Top10 cells carrying respective caf1M (PM) and caf1R promoters (PR) 
containing promoter-lacZ fusion constructs, pRScaf1R′-M′-lacZ  (PM) and pRScaf1M′-R′-lacZ (PR) was tested in 
presence of wild type pACYC-R (WT) and mutant pACYC-RE98K (E98K) as indicated. Standard error bars, on 
activity lines are based on ± SEM of activity from three biological replicates of each. Growth (OD600) of 
corresponding sample is indicated by dotted lines of identical color.   	 	
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3.5 Analysis of other key binding residues within N-terminal DBD of Caf1R  
3.5.1 Localisation of other key residues modelled as interacting with DNA  	The	requirement	for	Caf1R-	R62	(helix	4)	and	E98,	Q93	and	R97	(HTH2)	for	stable	DNA-protein	interaction	in	the	major	DNA	groove	was	addressed	in	earlier	sections.	In	order	to	identify	other	key	residues,	essential	for	DNA-protein	interactions,	the	modelled	mar	DNA-Caf1R	complex	was	analysed	for	all	residues,	which	appear	to	interact	with	the	mar	DNA	ligand	(Fig.	3.23).	In	HTH1	(H2-T-H3)	 I31,	 D32,	 C33,	 F40,	 R42,	 R43	 and	 Y44	 were	 identified	 as	 interacting	 with	 the	associated	DNA.	 	 I31,	D32	and	C33	are	 located	 in	helix-2,	F40	 is	within	 the	connecting	 loop	of	helix-2	and	3	and	residues,	R42,	R43	and	Y44	in	helix-3	(Fig.	3.23).	Only	R43	and	Y44	interact	with	nucleotides	in	DNA	binding	site,	BS1.	The	remaining	five	residues,	I31,	D32,	C33,	F40,	R42	of	HTH1	 interact	with	 the	DNA	backbone	(summarised	 in	Table	3.2).	This	 is	 in	contrast	 to	 the	
mar-MarA	crystal	structure	where	3	residues	W42,	Q45	and	R46	(corresponding	to	Caf1R-	R43,	Q46	 and	 I47)	 make	 extensive	 base	 specific	 interactions	 in	 BS1.	 In	 addition	 MarA-H43	(corresponds	 to	 Caf1R-Y44)	 interacted	 with	 the	 DNA	 backbone	 (Rhee	 et	 al.,	 1998).	 This	 one	shared	base-interacting	position	(R43	in	Caf1R	and	W42	in	MarA)	was	proposed	to	contribute	to	sequence	 specific	 interaction	within	 the	 AraC/XylS	 regulators	 (Rhee	 et	 al.,	 1998).	 Each	 of	 the	DNA	 backbone	 interactions	 corresponds	 to	 similar	 locations	 of	 interaction	 in	 the	mar-MarA	cocrystal	 structure.	 Close	 to	 HTH2,	 there	 were	 four	 additional	 DNA	 binding	 residues,	 K100,	T106,	 R108	 and	 Q109	 (Fig.	 3.23).	 K100	 is	within	 helix-6	while	 R108	 to	 Q109,	 lie	within	 the	predicted	helix-7	and	T106	is	located	in	the	connecting	loop	of	helix-6	and	7	(Fig.	3.23).	All	of	these	 residues	 are	 surface	 exposed.	 	 K100,	 R108	 and	 Q109	 would	 appear	 to	 have	 the	 same	function	as	the	corresponding	position	in	MarA,	where	they	interact	with	the	phosphate	group	of	the	DNA	backbone	in	mar-MarA	complex.		Caf1R-	T106	corresponds	to	MarA	(P105)	which	faces	away	from	the	DNA	in	the	mar-MarA	complex	(Rhee	et	al.,	1998).				
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Figure 3.23| Caf1R- DBD mutagenesis model in complex with DNA.   
IntFOLD3.0 modelled wild type Caf1RN (blue colored ribbons with indicated helices, 1-7) at 90° (a) and 180° 
(b) is shown in complex with mar DNA from MarA-DNA complex (PDB-1bl0). Ca1R residues from HTH1 
(H2-T-H3) and HTH2 (H5-T-H6) along with termini (Helix-7 and loop between helix 2 and 3), which seems to 
interact with associated DNA are shown in different colored balls and labeled. Residues presented by red dotted 
lines are screened in earlier sections. DNA bases interacting with R43 (G) and R97 (T) are indicated by grey 
colored balls and labeled. N & C and 5′ & 3′ show the termini of Caf1RN and DNA, respectively. 
MacPyMOL1.3 was used to generate the model picture.   	
3.5.2 Effect of predicted DNA binding residues of Caf1R-DBD on F1 expression  	Following	 identification	of	 putative	DNA-interacting	 residues	within	mar	 DNA-Caf1R	 complex,	each	 identified	 residue	was	mutated	 to	 the	 small	 and	 non-reactive	 alanine	 (A)	 residue	 in	 the	pACYCF1	 template.	 Following	 construction	 of	 this	 library	 of	 pACYCF1-R	 mutants	 by	 SDM		(section	2.2.4	(iv)	(a)),	the	level	of	F1	expression	was	monitored	by	SDS-PAGE	either	directly	in	whole	 cells	 or	 from	 the	 cell	 surface	 extract	 and	 the	 intensity	 of	 the	 F1	 subunit	 (Caf1)	 bands	quantitated	(Fig	3.24a-b)	as	described	in	sections	2.4.1	and	2.4.2.	The	level	of	F1	at	both	4	and	6	h	from	the	selected	mutants	of	DBD	is	presented	as	before,	as	percent	recovery	relative	to	wild	type	Caf1R	(Fig.	3.24).	The	data	is	summarised	in	Table	3.2.			It	was	observed	that	upon	alanine	substitution	of	the	2	nucleotide	contacting	residues	of	helix-3,	R43	 and	 Y44,	 the	 level	 of	 F1	 was	moderately	 reduced	 at	 both	 time	 points	 compared	 to	WT;	79.48%	±	4.02	and	66.35%	±	0.66	(4	h	and	6	h,	respectively,	pACYCF1-RR43A)	and	72.06%	±	1.39	and	76.44%	±	2.34	(4	h	and	6	h,	respectively,	pACYCF1-RY44A)	(Fig	3.24a	and	c).	This	provides	support	to	the	model	that	both	R43	and	Y44	of	Caf1R	are	equally	essential	residues	to	interact	with	DNA	bases.	Of	the	predicted	DNA	backbone	contacting	residues	of	HTH1,	I31,	D32,	C33,	F40	
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and	 R42	 four	 mutants,	 pACYCF1-RI31A,	 pACYCF1-RD32A,	 pACYCF1-RC33A	 and	 pACYCF1-RF40A	significantly	 affected	 F1	 production	 (Fig.	 3.24a	 and	 c).	 A	wild	 type	 phenotype	was	 observed	from	 pACYCF1-RR42A	 at	 both	 time	 points,	 suggesting	 no	 impact	 of	 R42A	 mutation	 on	 Caf1R	mediated	 transcription	 activation.	 Among	 the	 DNA-backbone	 interacting	 residues,	 F40A	substitution	had	the	biggest	effect;	producing	only	4.18%	±	0.33	the	 level	of	WT	F1	at	4	h	and	5.53%	±	 0.06	 at	 6	 h.	 F40	 is	 located	 in	 the	 loop	 region	 between	 helix-2	 and	 3.	 Aside	 from	 the	interaction	with	DNA	it	is	surface	exposed.	Hence,	the	impact	it	has	cannot	be	readily	explained	from	the	modelled	complex.	The	reduction	of	F1	production	also	from	pACYCF1-RI31A,	pACYCF1-RD32A	 and	 pACYCF1-RC33A	 mutants	 at	 4	 h	 suggests	 an	 importance	 of	 I31,	 D32	 and	 C33	 in	maintaining	protein-DNA	backbone	interactions	to	enable	efficient	activation	of	transcription.			Substitution	of	additional	DNA-backbone	interacting	residues	close	to	HTH2,	for	examples	T106	(present	in	connected	loop	of	helix-6	and	7)	and	Q109	(in	helix-7)	appeared	to	have	little	impact,	suggesting	a	negligible	impact	on	the	Caf1R-DNA	interaction.	 	 In	contrast,	substitution	of	R108	(in	 helix-7)	 led	 to	 about	 50%	 reduction	 in	 F1	 recovery	 at	 both	 4	 and	 6	 h.	 This	may	 reflect	 a	critical	 role	 in	anchoring	 the	HTH-2	motif	 in	place.	 	MarA-K99	corresponds	 to	Caf1R	K100	 (in	helix-6).		MarA	(K99A)	generated	a	substantial	impact	on	transcription	activation	(Gillette	et	al.,	2000).	 	But	attempts	 to	 construct	pACYCF1-RK100A	were	not	 successful	 therefore	 the	 impact	of	this	DNA	backbone	interacting	residues	could	not	be	assessed.			
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Figure 3.24| Quantification of F1 recovery from DH5α/pACYCF1-R mutants. 
a-b) SDS-PAGE (16% acrylamide) analysis of F1 expression from the selected Caf1R mutants. Samples for F1 
expression analysis were prepared either from ‘whole cell’ culture (1 ml) or cell surface extract of 5 OD units 
cells. Samples were harvested after 4 and 6 h of thermoinduction at 37°C, from an OD600 range 0.85-1.23 (4 h) 
and 0.95-1.46 (6 h). The recovered pelleted whole cells (from 1 ml culture) were mixed in 200 µl/OD PBS to 
give 5 OD units. Heat-denatured (97.5°C-15 min) 0.04 OD unit sample of each was analysed by SDS-PAGE. 
Arrowheads indicate F1 subunit, Caf1 band and expression level from respective mutant or wild type. Label of 
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each mutant is indicated on left. WT DH5α/pACYCF1. c) Caf1 band quantification by imageJ software (Hartig, 
2013). Relative recovery (%) with respect to 100% from corresponding WT was calculated from the average of 
three individual transformants (1-3) of each at 4 and 6 h of post-induction. Standard error on recovered F1 (%), 
added according to ± SEM of F1 recovery from three independent transformants of each.						
Table 3.2| Impact of Caf1R-DBD site-specific mutations on the expression of F1. 
The relative % of recovered F1 from 0.04 OD sample, either from cell surface extract (CSE) or in whole cell 
(WC) from each constructed mutant was calculated with respect to corresponding WT (100%) at 4 and 6 h of 
thermoinduction at 37°C. MacPyMOL1.3 predicted possible interaction(s) of each mutagenesis-targeted residue 
with associated DNA within modelled mar DNA-Caf1RN complex. Interatomic distance (Å; from center to 
center) between closest atom of DNA and the mutagenesis-targeted residue is calculated by PyMOL1.3. 	
pACYCF1-R	
mutant	
F1	recovery	(%)	
	
Location	of	
mutation	in	
Caf1RN	
Interaction(s)	in	
DNA-Caf1RN	
model		4	h	 6	h	
	WT	 100	±	1.32	(WC)	 100	±	1.57	(WC)	 Bridge-type;	DNA	backbone	::	R62-E98-R97-Q93	::	DT		WT	 100	±	5.33	(CSE)	 100	±	3.43	(CSE)	I31A		 33.92	±	1.31	(WC)	 73.22	±	1.16	(WC)	 Helix-2	 DNA	backbone;		(3.1Å)	D32A		 61.25	±	4.40						(WC)	 86.76	±	1.83	(WC)	 Helix-2	 DNA	backbone;		(3.5Å)	C33A	 59.50	±	7.84	(WC)	 96.20	±	9.44	(WC)	 Helix-2	 DNA	backbone;			(5.4Å)	F40A		 4.18	±	0.33	(CSE)	 5.53	±	0.06	(CSE)	 Connecting	loop,	2-3	 DNA	backbone;			(3.4Å)	R42A		 143.87	±	3.51	(CSE)	 85.19	±	1.77	(CSE)	 Helix-3	 DNA	backbone;		(4.9Å)		R43A		 79.48	±	4.02	(CSE)	 66.35	±	0.66	(CSE)	 Helix-3	 (DG	::	R43)	(Overlap)	Y44A		 72.06	±	1.39	(CSE)	 76.44	±	2.34	(CSE)	 Helix-3	 (DG	::	Y44)	Overlap	R62A	 76.33	±	3.66	(CSE)	 96.55	±	1.27	(CSE)	 Helix-4	 Bridge-type		R62S	 58.85	±	0.20	(CSE)	 92.97	±	2.94	(CSE)	 Helix-4	 Bridge-type	Q93A		 6.99	±	0.36	(WC)	 33.90	±	1.77	(WC)	 Helix-6	 Bridge-type	R97A		 4.79	±	1.83	(WC)	 86.53	±	4.78	(WC)	 Helix-6	 Bridge-type	E98G	 13.05	±	0.62	(CSE)	 14.16	±	0.32	(CSE)	 Helix-6	 Bridge-type	E98A	 58.85	±	2.15	(CSE)	 95.24	±	3.24	(CSE)	 Helix-6	 Bridge-type	E98T	 67.38	±	1.57	(CSE)	 73.12	±	2.44	(CSE)	 Helix-6	 Bridge-type	E98K	 00	(WC)	 00	(WC)	 Helix-6	 Bridge-type	T106A	 125.12	±	1.48	(WC)	 112.73	±	1.84	(WC)	 Connecting	loop,	6-7	 DNA	backbone;			(Overlap)	R108A	 57.22	±	2.17	(WC)	 49.05	±	0.63	(WC)	 Helix-7	 DNA	backbone;			(Overlap)	Q109A	 121.25	±	5.73	(WC)	 112.74	±	5.94	(WC)	 Helix-7	 DNA	backbone;			(3.6Å)			 	
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3.6 Conclusion 	Original	 cloning	and	 identification	of	 the	caf	 locus	 (Galyov	et	 al.,	 1990;	Karlyshev	et	 al.,	 1992)	had	 identified	 the	caf1R	 gene	 located	upstream	of	caf1M	 in	 the	opposite	orientation.	The	gene	product	 was	 known	 to	 be	 a	 regulator	 belonging	 to	 the	 AraC/XylS	 family	 of	 transcriptional	regulators	(Gallegos	et	al.,	1997)	and	is	required	for	the	biogenesis	of	F1.	Regulators	belonging	to	 this	 family	 have	 a	 conserved	 DNA	 binding	 domain	 (DBD)	 that	 is	 usually	 present	 at	 the	 C-terminus	of	 the	protein	 (Gallegos	et	al.,	1997;	 Ibarra	et	al.,	2008;	Schuller	et	al.,	2012).	Unlike	most	AraC/XylS	family,	the	putative	DBD	of	Caf1R	is	located	at	the	N-terminus	(Karlyshev	et	al.,	1992;	Schuller	et	al.,	2012).		Prior	to	this	study,	a	single	point	mutation	of	Caf1R-	E98G	leading	to	virtual	 loss	 of	 F1	 production	 was	 identified	 in	 a	 plasmid,	 pFS2	 encoding	 the	 complete	recombinant	 caf	 locus	 (unpublished).	 Spontaneous	 loss	 in	 F1	 expression	 in	 cells	 carrying	recombinant	native	caf	 locus	had	been	previously	noticed	(Galyov	et	al.,	1991;	Karlyshev	et	al.,	1992),	but	characterisation	of	mutations	leading	to	loss	of	F1	had	not	been	investigated.				In	this	study,	in	order	to	minimise	loss	of	F1	the	native	caf	locus	subcloned	into	a	medium-copy	number	 plasmid,	 pACYCF1,	 was	 used.	 Combined	 with	 temperature	 control	 of	 the	 caf	 genes,	expression	off	at	26°C	and	on	at	37°C	(Cao	et	al.,	2012;	Simpson	et	al.,	1990;	Straley	and	Perry,	1995;	Titball	et	al.,	1997),	this	permitted	study	of	stable,	controllable	expression	and	assembly	of	F1.	The	E98G	mutation	had	initially	been	subcloned	in	pACYCF1SpM.	Repair	of	 this	mutation,	together	with	 complementation	 studies	with	 pBADhCaf1R	 encoded	 Caf1R,	 confirmed	 that	 the	E98G	mutation	was	 solely	 responsible	 for	 the	 dramatic	 loss	 in	 F1	 production	 from	pACYCF1-	RE98G.	Furthermore,	the	E98G	mutation	had	a	dramatic	impact	on	transcription	activation	at	both	
caf1R	(PR)	and	caf1M	(PM)	proposed	promoters.			Secondary	structure	prediction	and	modelling	of	Caf1R	(on	Rob	 template	 (Kwon	et	al.,	2000))	showed	this	mutation	is	located	within	a	HTH	DNA	binding	motif,	more	specifically	within	DNA	recognition	 helix-6	 of	 HTH2.	 Analysis	 of	 the	 modelled	 Caf1R	 with	mar	 DNA,	 from	mar-MarA	complex	(Rhee	et	al.,	1998)	identified	a	potential	role	for	E98	as	a	bridging	residue,	interacting	with	R62	 (in	helix-4)	on	one	 side	and	with	Q93	and	R97	 (in	helix-6)	on	 the	other	 side.	 In	 the	modelled	DNA-Caf1R	 complex,	 R62	 interacts	with	 the	DNA-backbone.	 At	 the	 other	 end	 of	 the	bridge,	 Q93	 and	R97	were	 predicted	 by	 IntFold3.0	 to	 be	 base	 interacting	 residues	 and	 in	 the	model	 both	 interact	 with	 mar	 DNA	 base	 (T)	 in	 the	 major	 groove	 adjacent	 to	 helix-6.	 On	substitution	of	E98	with	a	Gly	residue,	the	bridge	interaction	is	modelled	as	disrupted	due	to	the	very	 small	 size	 of	 Gly.	 Superposition	 of	 wild	 type	 Caf1R	 model	 on	 Caf1RE98G	 mutant	 model	showed	 no	 structural	 difference,	 although	 the	 secondary	 structure	 prediction	 of	 helix-6	 with	E/G98	residue	indicated	a	substantial	decrease	in	helix	propensity	and	shortening	of	helix-6	by	G98.	Thus,	destabilisation	of	helix-6	in	Caf1RE98G,	combined	with	loss	of	the	bridge	interaction,	is		likely	to	have	a	synergistic	negative	effect	on	Caf1R	mediated	activation	of	transcription.			The	role	of	E98	as	a	bridging	residue	was	further	supported	by	E98	substitution	with	residues,	which	 showed	 a	 helix-6	 propensity	 score	 comparable	 to	 that	 of	wild	 type.	 For	 example	 E98T	(corresponding	 to	MarA	T97),	E98A	(corresponding	 to	Rob	A88)	and	E98K	(replaces	negative	with	 positive	 charge)	 substitutions.	Modelling	 of	 all	 3	mutated	 Caf1R	 protein-DNA	 complexes	
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showed	loss	of	a	bridge	interaction	with	R62	and	there	was	a	considerable	reduction,	of	33-42%	in	F1	production	from	the	2	mutated	plasmids,	pACYCF1-RE98A	and	pACYCF1-RE98T.	The	fact	that	E98K	virtually	abolished	F1	expression	can	be	explained	by	 location	of	 this	positively	charged	side	 chain	 between	 2	 positively	 charged	 Arg	 residues,	 R62	 and	 R97.	 This	 resulted	 in	displacement	of	the	key	base	 interacting	residues	R97	and	Q93,	as	well	as	 loss	of	the	E98-R62	interaction.	 This	 again	 highlights	 the	 strict	 requirement	 for	 optimal	 orientation	 of	 the	 base	interacting	residues	of	helix-6	within	BS2.			The	 role	of	R62	 in	 stabilising	 the	DNA-Caf1R	 complex	via	 a	 helix-4-DNA	backbone	 interaction	was	also	validated	by	R62A	and	R62S	substitutions.	The	significant	loss	in	recovery	of	F1	by	24-42%	reflected	the	modelled	loss	of	R62-DNA	backbone	interaction.		This	was	combined	with	loss	of	 E98	 interaction.	 	 Similarly,	 the	 critical	 role	 of	 the	 invariant	 base-binding	 residues,	Q93	 and	R97,	was	confirmed	by	the	drastic	reduction	of	66-95%	in	F1	production	following	independent	Ala	substitution	of	each	residue.	Thus,	these	results	provide	strong	evidence	that	Q93	and	R97	are	 key	 residues	 in	 specific	 base	 interaction	 at	 BS2,	 that	 R62-backbone	 DNA	 interaction	 is	important	 in	 stabilising	 the	 DNA-regulator	 interaction	 and	 that,	 in	 Caf1R,	 E98	 additionally	stabilises	the	complex	via	a	bridge	interaction	between	helix-6	and	R62	of	helix-4.		The	residue	corresponding	 to	 E98	 in	 the	MarA/	Rob/Sox	 family	 is	 highly	 variable.	 The	 importance	 of	 this	residue,	at	least	in	Caf1R,	is	most	likely	related	to	optimum	spatial	orientation	of	HTH2	residues	within	the	major	DNA	groove	to	ensure	efficient	activation	of	transcription	and	F1	expression.			Modelling	 and	mutagenesis	 also	 identified	 other	 key	 Caf1R	 residues	 interacting	with	 DNA.	 In	HTH1	(H2-T-H3),	both	R43	and	Y44	were	modelled	as	making	specific	DNA-base	interactions	in	BS1	and	alanine	substitution	of	these	2	residues	resulted	in	a	moderate	reduction	of	21-34%	in	F1	production	 from	pACYCF1.	Within	HTH1,	 I31,	D32,	C33,	F40	and	R42	were	all	 identified	as	residues	interacting	with	the	DNA	backbone.	Alanine	substitution	of	each	of	these	residues,	with	the	 exception	of	R42,	 affected	F1	production.	 F40A	was	notable	 in	 the	pronounced	effect	 that	this	 substitution	 had,	 reducing	 F1	 production	 by	 95%.	 Similarly,	with	 residues	 close	 to	HTH2	(H5-T-H6),	K100,	T106,	R108	and	Q109	were	all	modelled	as	being	involved	in	DNA	backbone	interactions	 close	 to	 BS2.	 	 Alanine	 substitution	 of	 these	 residues	 appeared	 to	 have	 less	 of	 an	impact.	T106A	and	Q109A	had	negligible	effect	on	F1	production.	However,	R108A	did	have	a	substantial	effect	reducing	F1	production	by	about	50%.	Attempts	to	construct	pACYCF1-RK100A	were	 not	 successful	 hence,	 the	 impact	 of	 this	DNA	 backbone	 interacting	 residue	 could	 not	 be	assessed.			A	 homology	 search	 revealed	 that	 Caf1R	 homologs	 are	 distributed	 throughout	 the	
Enterobacteriaceae	family	of	Gram-negative	bacteria	with	many	being	identifiable	within	whole	genome	 sequence	data	 of	 different	 strains	 of	E.	coli.	 The	 closest	 homologs	were	 an	AraC/XylS	family	 regulator	 of	 1)	 uropathogenic	 E.	 coli,	 strain-126	 (Salipante	 et	 al.,	 2015)	 and	 2)	 avian	pathogenic	 E.	 coli,	 strain-O08	 (Rojas	 et	 al.,	 2013).	 These	 shared	 61%	 and	 53%	 amino	 acid	identity	over	 the	entire	 length	of	Caf1R	and	>71%	amino	acid	 identity	with	Caf1R-DBD	alone,	reflecting	 high	 conservation	 of	 the	 DBD.	 Unexpectedly,	 the	 closest	 homologue	(WP_042110517.1)	 appeared	 to	 be	 linked	 to	 metabolism,	 specifically	 carbohydrate	 transport	and	 not	 associated	with	 any	 CU-system.	 This	 regulator	 has	 not	 been	 characterised.	 However,	
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based	on	the	ability	of	other	AraC/XylS-like	regulators	to	bind	small	substrates	via	the	‘sensing’	domain	(Gallegos	et	al.,	1997)	the	possibility	exists	that	Caf1R	may	bind	to	a	small	molecule.	No	information	 could	 be	 obtained	 regarding	 the	 genome	 context	 of	 the	 second	 top	 homolog	(WP_001697817.1).	 However	 phylogenetic	 analysis	 indicated	 a	 close	 relationship	 to	(WP_042110517.1),	 hence	 it	would	be	 interesting	 to	understand	more	about	 this	 regulator	 as	well.			The	 third	 top	 homolog	 (WP_024182496.1)	 was	 identified	 as	 a	 CU-linked	 regulator	 from	diarrheagenic	E.	coli,	strain-DEC11A	(Hazen	et	al.,	2012),	with	44%	amino	acid	identity	and	52%	similarity	 over	 89%	 coverage	 to	 Caf1R.	 An	 additional	 11	 further	 CU-linked	 regulators	 were	identified	with	≥	30%	amino	acid	identity	and	≥	38%	similarity	over	≥	85%	coverage	to	Caf1R.	Among	 these	 only	 two,	 LdaA	 (44%	 identity,	 52%	 similarity)	 and	 AfrR	 (42%	 identity,	 49%	similarity)	of	E.	coli	have	been	studied	so	 far	(Cantey	et	al.,	1999;	Scaletsky	et	al.,	2005).	LdaA	controls	expression	from	the	locus	of	diffusive	adherence	(lda)	fimbriae	of	enteropathogenic	E.	
coli	 and	 AfrR	 regulates	 the	 expression	 of	 AF/R1	 fimbriae	 of	 attaching/effacing	 E.	 coli.		Interestingly,	the	predicted	DBD	of	all	of	these	CU-linked	regulators	is	located	at	N-terminus	and	is	 highly	 conserved.	 Conservation	 of	 residues	 was	 particularly	 pronounced	 in	 the	 predicted	HTH1	 and	HTH2	motifs,	 and	 the	HTH2	 sequence	R97	E98	 F99	was	 invariant.	 This	 suggests	 a	very	similar	mode	of	DNA-protein	interaction	particularly	at	BS2	and	also	a	shared	requirement	for	E98.	Based	on	this,	one	would	expect	a	very	similar	DNA	binding	sequence	for	each	of	these	regulators.			In	 conclusion,	 through	 modelling,	 bioinformatic	 analysis	 and	 mutagenesis,	 this	 Chapter	 has	identified	 key	 residues	 involved	 in	 Caf1R-DNA	 interaction.	 The	 mutation	 Caf1R-	 E98G	 was	shown	 to	 drastically	 reduce	 Caf1R	 dependent	 activation	 of	 transcription	 at	 both	 PR	 and	 PM	promoters.	This	was	attributed	to	 loss	of	correct	orientation	of	HTH2	residues	due	to	reduced	helix-6	length	or	stability	combined	with	loss	of	a	bridge-type	interaction	with	R62	of	helix-4.		
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Chapter 4 
Recombinant expression and 
purification of tagged Caf1R
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4.1 Introduction 	Caf1R,	a	regulator	of	the	caf	locus,	belongs	to	the	AraC/XylS	family	of	transcriptional	regulators	(Gallegos	et	al.,	1997;	Karlyshev	et	al.,	1992;	Schuller	et	al.,	2012).	Many	proteins	of	this	family	are	expressed	in	low-level	and	when	overexpressed	often	make	inclusion	bodies	and	aggregates,	consequently	making	it	difficult	to	purify	the	soluble	active	protein	(Gallegos	et	al.,	1997;	Schleif,	2010).	The	problem	of	aggregates	can	be	prevented	to	a	certain	extent	before,	during	and	after	purification,	as	has	been	described	 in	a	comprehensive	study	by	Bondos	and	Bicknell	 (Bondos	and	 Bicknell,	 2003).	 Researchers	 have	 taken	 several	 different	 approaches	 to	 overexpress	 and	purify	the	active	 form	of	regulators	belonging	to	the	AraC/XylS	 family.	For	example,	MarA	and	Rob,	 the	 only	 proteins	 of	 this	 family	whose	 high-resolution	 crystal	 structure	 has	 been	 solved	with	their	cognate	promoter	DNA	(Kwon	et	al.,	2000;	Rhee	et	al.,	1998)	were	overexpressed	as	N-	 and	 C-terminal	 His6-tagged	 proteins	 in	 the	 pET15b	 and	 pET28b	 expression	 plasmids	(Novagen),	respectively	(Jair	et	al.,	1995;	Kwon	et	al.,	2000).	However,	MarA	was	purified	from	insoluble	inclusion	bodies	by	urea	solublisation	and	subsequently	refolding	to	obtain	the	active	form,	whereas	Rob	was	 purified	 as	 a	 soluble	 protein	 avoiding	 any	 treatment	with	 denaturant	like	 urea.	 Both	 proteins	 were	 purified	 by	 Ni2+	 affinity	 chromatography.	 Final	 preparations	 of	MarA	 were	 about	 0.6	 mg/ml	 whereas	 those	 of	 Rob	 were	 about	 19	 mg/ml.	 Likewise,	 XylR	(another	homologue	of	Caf1R	putative-structure;	36%	identity),	was	recently	overexpressed	and	purified	as	a	C-terminal	His6-tagged	recombinant	protein	from	the	pET28a	vector	(Novagen).	It	was	purified	in	the	soluble	form	by	growing	BL21	(DE3)	cells	containing	xylRpET28a	at	15°C/16	h	with	0.5	mM	IPTG	induction,	followed	by	Ni2+	affinity	chromatography	(Ni	et	al.,	2013).	SoxS,	a	protein	 closely	 related	 to	MarA	 (41%	 identity,	 67%	 similarity)	 (Duval	 and	 Lister,	 2013)	 was	overexpressed	 as	 a	 soluble	 maltose	 binding	 protein	 (MBP)	 fusion	 and	 purified	 by	 amylose	affinity	 chromatography	 (Fawcett	 and	Wolf,	 1994).	 	 These	 proteins	 share	 37%	 (MarA),	 27%	(Rob)	 and	 36%	 (XylR)	 identity	 with	 Caf1R.	 Therefore	 similar	 approaches	 were	 used	 to	overexpress	and	purify	functional	recombinant	Caf1R.		Hence,	 this	 chapter	 describes	 the	 different	 approaches	 taken	 to	 express	 and	 purify	 soluble	tagged	 Caf1R	 to	 be	 used	 initially	 in	 in	 vitro	 DNA	 binding	 studies	 (Chapter-5)	 and	 optimise	overexpression,	 irrespective	of	 solubility	 for	use	 in	 future	anti-Caf1R	antibody	production	and	structural	 analysis.	N-terminally	His6-tagged	Caf1R	 functionality	 in	 F1	production	had	 already	been	 confirmed	 using	 the	 pBADhCaf1R	 construct	 (Chapter-3).	 Therefore,	 initially	 expression,	purification	 and	 characterisation	 of	 His6-Caf1R	 (hCaf1R)	 was	 carried	 out	 from	 this	 construct.	Attempts	 were	 then	 made	 to	 maximise	 the	 level	 of	 soluble	 protein	 by	 cloning	 native	 and	synthetic	 caf1R	 into	 pET28a+	 and	 pMALc2x	 expression	 plasmid	 vectors.	 Expression	 was	monitored	in	a	range	of	E.	coli	strains	with	different	conditions	of	induction	and	cell	lysis.			
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Results and Discussion 
4.2 Expression and purification of tagged Caf1R from native gene 
4.2.1 Expression and purification of hCaf1R from pBADhCaf1R 	
i)	 Induction	and	solubility	of	hCaf1R			As	 functional	 His6-tagged	 Caf1R	 had	 already	 been	 shown	 by	 complementation	 of	 pACYCF1SpM	with	the	pBADhCaf1R	plasmid	construct	(Section	3.2.1),	this	plasmid	was	initially	tested	for	the	recovery	 of	 soluble	 hCaf1R.	 The	 final	 protein	 sequence	 and	 strategy	 that	 had	 been	 used	 to	prepare	this	construct	is	depicted	in	Fig.	4.1.	The	pBADhCaf1R	encodes	hCaf1R,	a	product	with	6	N-terminal	 Histidine	 (His)	 residues	 followed	 by	 the	 Xpress	 epitope	 and	 with	 a	 calculated	molecular	weight	of	40.98	kDa.			For	 testing	 induction,	 a	 small-scale	 (10	 ml)	 expression	 study	 (section	 2.5.1)	 was	 carried	 out	using	E.	coli	Top10/pBADhCaf1R	(pBADhR)	and	its	negative	control,	Top10/pBADHisA	(empty	vector,	C).	Expression	was	monitored	following	induction	with	a	range	of	L-ara	concentrations	(0.2-0.0002%)	at	37°C	for	4	h.	At	each	time	point,	one	OD	unit	of	bacterial	cells	was	recovered	and	 lysed	 by	 sonication	 (section	 2.5.2)	 in	 100	 μl	 PBS	 (137	 mM	 NaCl,	 2.7	 mM	 KCl,	 10	 mM	Na2HPO4,	2	mM	KH2PO4;	pH	7.4).		Supernatant	(S)	and	pellet	(P)	fractions	were	then	recovered	by	 centrifugation	 at	 15,000	 rpm/20	 min	 as	 described	 in	 section	 2.5.3.	 Both	 fractions	 were	analysed	by	 SDS-PAGE	 (Fig.	 4.2a).	 There	was	no	 clearly	distinguishable	band	at	 the	 expected	size	of	hCaf1R	(40.98	kDa)	in	either	S	or	P	fraction	following	coomassie	blue	(CB)	staining	(Fig.	
4.2a).	A	Western	blot	from	the	S	fraction	of	0.02%	L-ara	induced	sample	of	Top10/pBADhCaf1R	showed	a	clear	distinguishable	band	at	about	35-38	kDa	(slightly	smaller	than	the	expected	size	of	 40.98	 kDa),	 confirming	 expression	 of	 hCaf1R	 (Fig.	 4.2b).	 There	 was	 no	 such	 band	 at	 this	location	from	the	negative	control	(C),	which	validates	this	expression.			
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Figure 4.1| The pBADhCaf1R construct. 
a) Circular plasmid map of pBADhCaf1R (5024 bp). b) Sequence of pBADhCaf1R, gene encoding Caf1R had 
been amplified from pFS2 plasmid (Drozdov et al., 1995) using primers with SacI and BglII sites and cloned 
between SacI/BglII sites (red boxes) of pBADHisA plasmid (Invitrogen) to create pBADhCaf1R (Lopez-
Tolman, A. and MacIntyre, S., unpublished data). Translated sequence indicates the tagged Caf1R (hCaf1R)  
(345 aa; MWt 40.98 kDa). Coding sequence derived from caf1R is highlighted in blue and starts with a Leu start 
codon. Ribosomal binding site is enclosed in blue box.  
	
a 
b 
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Figure 4.2| Expression of native hCaf1R from E. coli Top10/pBADhCaf1R. 
a) SDS-PAGE (14% acrylamide) from the supernatant (S) and pellet (P) fractions of cells carrying 
pBADhCaf1R (pBADhR) or pBADHisA empty plasmid (C) induced (at 37°C/4 h) with a range of L-ara as 
indicated. Arrows, indicate the expected location of hCaf1R. b) Western blot (on NCM) from the supernatant (S) 
fractions of 0.02% L-ara induced sample of C (pBADHisA) and pBADhCaf1R. Arrow indicates hCaf1R, 
identified with antiHis-HRP monoclonal antibody (1:5000). L, protein size marker.   		In	order	 to	determine	solubility	a	 large-scale	 (100	ml)	preparation	(section	2.5.1)	was	carried	out	 to	 assess	 solubility	 of	 hCaf1R	 by	 ultracentrifugation	 and	 at	 the	 same	 time	 to	 test	 two	different	 lysis	 buffers,	 L1	 and	 L2.	 L1	 was	 the	 binding	 buffer	 from	 the	 HisTapFF	 column	 (GE	Healthcare)	 (20	mM	NaPO4	buffer,	500	mM	NaCl;	pH	7.4)	supplemented	with	3	mM	DTT,	10%	glycerol	and	1×	EDTA-free	protease	inhibitor	(Pierce).	L2	is	a	lysis	buffer	(20	mM	TrisHCl,	200	mM	KCl;	pH	7.4)	as	identified	by	Bondos	and	Bicknell	as	a	suitable	buffer	for	maintaining	a	range	of	prokaryotic	and eukaryotic	proteins,	including	LacI	regulator,	in	a	soluble	state	(Bondos	and	Bicknell,	2003).	Cells	of	E.	coli	Top10/pBADhCaf1R	(2	×	50	ml)	were	induced	with	0.02%	L-ara	at	37°C	for	4	h	(OD600,	1.94),	pelleted,	mixed	in	5	ml	of	either	L1	or	L2	and	lysed	by	sonication.	Unlysed	 cells	 were	 removed	 by	 centrifugation	 (5000	 rpm/5	 min/RT)	 and	 the	 resulting	supernatant	fractions	were	subjected	to	ultracentrifugation	at	50,000	rpm	for	60	min	at	4°C	to	separate	 soluble	 hCaf1R	 (supernatant	 fractions,	 S1	 and	 S2	 from	 Lysis	 buffer	 L1	 and	 L2,	respectively)	from	insoluble	hCaf1R	in	the	corresponding	pellet	fractions,	(P1	and	P2).	Despite	the	 higher	 volume	 of	 sample	 processed	 for	 this	 analysis,	 there	 was	 still	 no	 clearly	distinguishable	 hCaf1R	 band	 identifiable	 following	 CB	 staining	 of	 whole	 cells	 or	 lysed	 cell	fractions	(Fig.	 4.3a).	Western	blotting	confirmed	presence	of	hCaf1R	in	all	 induced	samples.	A	major	host-protein	band	in	the	pellet	samples	and	whole	cells	migrates	at	about	38	kDa	and	may	mask	 low	 levels	 of	 hCaf1R	 (Fig.	 4.3b).	 The	 results	 from	Western	 blot	 also	 indicated	 that	 the	supernatant	 fraction	S2,	 recovered	 in	L2	buffer	contained	relatively	more	soluble	hCaf1R	 than	L1	 recovered	 S1	 fraction	 (Fig.	 4.3b).	 This	 could	 be	 due	 to	 protein	 aggregation	 caused	by	 salt	components	of	L1.	The	 level	of	hCaf1R	 in	 the	P1	and	P2	 fractions	 (insoluble	 form)	was	higher	than	that	in	the	S1	and	S2	fractions	(soluble	form),	suggesting	either	initial	aggregation	into	the	insoluble	form	or	degradation	of	soluble	hCaf1R.				
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Figure 4.3| Solubility analysis of hCaf1R by ultracentrifugation and 2 different cell lysis buffers. 
CB stained SDS-PAGE (14% acrylamide) (a) and Western blot on NCM (b) of samples from E. coli 
Top10/pBADhCaf1R, induced with 0.02% L-ara for 4 h at 37°C and lysed by sonication in L1 (20 mM NaPO4 
buffer, 500 mM NaCl; pH 7.4 supplemented with 3 mM DTT, 10% glycerol and 1× EDTA-free protease 
inhibitor) or L2 (20 mM TrisHCl, 200 mM KCl; pH 7.4) lysis buffer.  S1 and S2, Supernatant (soluble) fractions 
recovered following ultracentrifugation at 50k/60 min of lysed cells in L1 and L2 lysis buffers, respectively. P1 
and P2, corresponding pellet fractions. WC, whole cells samples; C, sample from negative control 
(Top10/pBADHisA), NI and I, non-induced and L-ara induced whole cell samples from Top10/pBADhCaf1R. 
WC samples were directly mixed into 4× SDS-PAGE sample buffer (100 µl/OD). Identity of hCaf1R (in b) was 
confirmed by blotting with antiHis-HRP monoclonal antibody (1:5000, Roche). L, Protein size marker.  
 
 
ii)	 Ni2+	affinity	based	isolation	of	soluble	hCaf1R	from	E.	coli	Top10/pBADhCaf1R		It	 is	 well	 known	 that	 lowering	 the	 incubation	 temperature	 during	 induction	 enhances	 the	possibility	 of	 soluble	 protein	 recovery.	 The	 lower	 temperatures	 prolong	 the	 time	 of	 protein	folding	and	thus	decrease	the	chances	of	aggregation	which	is	favoured	at	high	temperature	due	to	 fast	 misfolding	 and	 temperature	 dependent	 hydrophobic	 interactions	 (Baldwin,	 1986;	Makhatadze	and	Privalov,	1995;	Noteborn,	1988;	Rosano	and	Ceccarelli,	2014;	Schellman,	1997;	Vasina	and	Baneyx,	1997;	Vera	et	al.,	2007).	Therefore	with	 the	aim	of	enhancing	solubility	of	recombinant	hCaf1R,	a	large	batch	(250	ml)	of	E.	coli	Top10/pBADhCaf1R	culture	was	induced	with	 0.02%	 L-ara	 at	 30°C	 for	 6	 h.	 Recovered	 cells	 were	 resuspended	 in	 20	 ml	 of	 HisTrapFF	column	binding	buffer	 (20	mM	NaPO4	buffer,	 500	mM	NaCl,	 5	mM	DTT,	20	mM	 imidazole;	pH	7.4),	supplemented	with	EDTA-free	proteases	inhibitor,	1×	(Thermo	Scientific,	Pierce)	and	lysed	by	French	press.	The	lysate	was	clarified	by	ultracentrifugation	and	the	supernatant	fractionated	by	Ni2+	affinity	chromatography	as	described	(section	2.5.4(i)).	The	elution	profile	following	Ni2+	affinity	purification	indicates	two	A280	peaks,	encompassing	fractions,	2-4	(small	peak)	and	17-22	(large	peak),	respectively	(Fig.	4.4a).	Fractions,	2-4	were	recovered	in	about	6%	of	buffer	B,	corresponding	to	about	15	mM	imidazole	whereas	fractions,	17-22	appeared	in	about	47%	of	B,	corresponding	 to	 117.5	 mM	 imidazole.	 Fractions	 19-22	 contained	 a	 large	 number	 of	 host	background	 protein	 (not	 shown).	 A	Western	 blot	 (Fig.	 4.4b)	 confirmed	 identity	 of	 hCaf1R	 at	about	38	kDa	primarily	 in	 fractions	18	and	19	with	a	 tail	 to	 fraction	22	and	very	 low	 level	 in	fractions	2-4.			
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Figure 4.4| Ni2+ affinity chromatography of soluble hCaf1R. 
Cells from 250 ml (438 OD units) induced culture of E. coli Top10/pBADhCaf1R were lysed and subjected to 
ultracentrifugation, as in text. Lysate supernatant (40 ml) was applied to a 1 ml HisTrapFF column. a) Elution 
profile (zoomed version) from HisTrapFF column with a linear gradient of 0-250 mM imidazole (100% buffer 
B, 20 mM NaPO4 buffer, 500 mM NaCl, 5 mM DTT, 250 mM imidazole; pH 7.4) over 20 ×1 ml fractions. b) 
Western blot analysis of peak-eluted fractions (2-4 and 17-22), blotted with monoclonal, antiHis-HRP conjugate 
(1:10,000). Arrowhead indicates the location and bands of hCaf1R.  
 	
iii)	 Estimation	of	oligomeric	state	of	recombinant	hCaf1R	by	size	exclusion	
chromatography			Size	 exclusion	 or	 gel	 filtration	 chromatography	 is	 a	 technique	 used	 to	 separate	 proteins	according	to	their	size	and	oligomeric	state.	In	order	to	estimate	the	size	and	form(s)	of	purified	hCaf1R,	 a	 sample	 was	 analysed	 by	 gel	 filtration	 on	 a	 Superose™12	 10/300GL	 column	 (GE	Healthcare)	 as	 described	 in	 section	 2.9.4.	 	 Initially,	 the	 elution	 profile	 of	 four	molecular	mass	standards	 (Blue	 dextran,	 2000	 kDa;	 albumin,	 67	 kDa;	 Ovalbumin,	 45	 kDa	 and	 RibonucleaseA,	13.7	 kDa)	 was	 monitored	 individually	 (data	 not	 shown)	 and	 then	 together	 (Fig.	 4.5a).	 To	analyse	hCaf1R,	fraction	18	(1	ml)	from	the	Ni2+	affinity	column	(Fig.	4.4)	was	concentrated	10-fold	and	buffer	exchanged	against	50	mM	NaPO4,	150	mM	NaCl,	5	mM	DTT;	pH	7.0	using	a	Viva	spin	 concentrator	 (10	 kDa	 MWCO)	 (sections	 2.9.1	 and	 2.9.2).	 Approximately	 150	 μl	 of	 the	concentrated	sample	was	applied	to	the	Superose™12	column	and	the	22	×1	ml	fractions	were	monitored	by	Western	blot	(Fig.	4.5b).	Fractions,	6-10,	correspond	to	the	column	void	volume	(V0)	and	hence	 likely	 contain	aggregated	 forms	of	hCaf1R	with	high	molecular	weight,	≥	2000	kDa.	The	bands	from	fractions	11	and	12	could	correspond	to	hCaf1R	dimer	(MWt	81.96	kDa).	Fractions,	14	and	15	are	 consistent	with	 a	 small	 amount	of	monomer	 (MWt	40.98	kDa).	Thus	
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this	 analysis	 indicates	 only	 a	 small	 proportion	 of	 hCaf1R	 was	 recovered	 in	 the	 soluble	monomeric	 state.	While	 there	may	also	be	some	dimeric	hCaf1R,	most	of	hCaf1R	was	 in	 some	higher	size	complex	or	aggregate.		
		
Figure 4.5| Molecular size determination of hCaf1R by gel filtration chromatography. 
a) Elution profile of molecular mass standards from Superose™12 10/300GL column. Standards (150 µl, 1 
mg/ml each), molecular weight and elution volumes are as indicated. Flow rate 0.8 ml/min, fraction size, 1 ml. 
V0: void volume, identified with blue dextran. b) Elution profile and confirmation of fractionated hCaf1R by 
Western blot (WB; on NCM) analysis, using antiHis-HRP monoclonal antibody (1:10,000). ATC, applied 
sample (150 µl) of Ni2+ affinity purified Fn-18 (Fig 4.4) that had been (concentrated and buffer exchanged as 
described in text). Elution conditions as in (a). Numbers corrospond to 1 ml fraction number. 6-10, pooled 
fractions 6 to 10. 
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4.2.2 Expression of hCaf1RT and hCaf1RTN from pET28a+ based vector 	
i)	 Construction	of	pEThCaf1R			As	recovery	of	hCaf1R	from	E.	coli	Top10/pBADhCaf1R	was	low,	to	enhance	the	level	of	hCaf1R	expression,	 the	 well-recognised	 expression	 plasmid,	 pET28a+	 (Novagen)	 was	 tested	 for	expression	 of	 caf1R.	 The	 strategy	 used	 to	 construct	 pEThCaf1R	 is	 depicted	 in	 Fig.	 4.6a.	 The	pEThCaf1R	 plasmid	 encodes	 hCaf1RT,	 a	 product	 with	 N-terminal	 His6-tag	 followed	 by	 a	thrombin	cleavage	site	and	a	calculated	molecular	weight	of	40	kDa.	Briefly,	the	caf1R	gene	(921	bp)	plus	either	side	pET28a+	vector	Infusion	joints	(19-	and	18	bp)	was	PCR-amplified	from	the	pBADhCaf1R	 construct	 using	 Infusion	 primers,	 pETcaf1Rf	 and	 pETcaf1Rr	 as	 described	 in	(section	2.2.4(i)).	The	gel	purified	PCR-product	was	Infused	into	EcoRI/NheI	linearised	pET28a+	plasmid	(Fig.	4.6b,	section	2.2.8(ii)).	The	resulting	Infusion	product	was	then	transformed	into	competent	 StellarTM	 cells.	 Twenty-six	 transformants	 were	 screened	 by	 colony	 PCR	 (Section	2.2.4(ii))	 using	 the	 same	 set	 of	 Infusion	primers.	 Colony	PCR-products	 from	23	 transformants	gave	 positive	 reaction	 with	 a	 band	 slightly	 smaller	 (≈	 800-900	 bp)	 than	 the	 expected	 PCR-product	 (958	bp)	(Fig.	 4.6c).	Plasmid	DNA	was	 isolated	 from	6	clearly	positive	 transformants	and	analysed	by	EcoRI	digestion	(Fig.	4.6d)	to	confirm	the	quality	of	isolated	DNA	and	the	linear	size	of	pEThCaf1R	construct.	All	digested	pEThCaf1R	transformants	showed	a	single	band	 just	below	 8.0	 kb	 while	 undigested	 transformants	 ran	 at	 about	 3.5	 kb,	 indicating	 the	 linear	pEThCaf1R	is	running	above	the	correct	size	(6.295	kb).	Two	transformants,	6	and	8	were	sent	for	DNA	sequencing	with	T7F	and	T7R	primers.	This	confirmed	the	correct	Infusion	of	caf1R	into	pET28a+	vector	with	intact	fusion	joints	at	both	ends	and	the	correct	caf1R	sequence	(Fig.	4.6e).	Both	 transformants	 were	 stocked	 and	 transformant	 8	 was	 used	 for	 overexpression	 and	purification	of	hCaf1RT.			
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Figure 4.6| Construction of pEThCaf1R. 
a) Circular plasmid map of pEThCaf1R (6295 bp). b) AGE analysis of caf1R+pET28a+ Infusion components 
and reaction mix. caf1R, gel purified PCR-product of caf1R with Infusion joints (100 ng; 958 bp), pET28a+, 
NheI/EcoRI digested and gel purified pET28a+ vector (50 ng). Infusion mixture, caf1R plus pET28a+ vector (2.5 
µl, ≈ 50 ng). c) AGE analysis of colony PCR-product, amplified with primers, pETcaf1Rf and pETcaf1Rr from 
transformants 1-26. *, Plasmids analysed in (d). d) EcoRI digestion. UD, undigested and D, digested plasmid 
from transformants 2, 5, 6, 7, 8 and 15. Transformants 6 and 8, selected for DNA sequencing. L, DNA Hyper 
ladder-I (20 ng). e) DNA sequence of transformant 8, showing fusion joints and encoded hCaf1RT fusion (338 
aa; 40.0 kDa). Deduced amino acids from caf1R are highlighted in blue. ><, Represents sequence not shown. 
Infusion primers are enclosed in red boxes. 
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ii)	 Expression	of	hCaf1RT	at	28	and	37°C	with	0.1	to	1.0	mM	IPTG			To	assess	expression	and	recovery	of	hCaf1RT,	small-scale	(10	ml)	expression	(section	2.5.1)	was	carried	out	with	E.	coli	BL21(DE3)	carrying	pEThCaf1R	(pEThR)	or	pET28a+	 (control,	C).	Cells	were	 induced	 with	 0.1	 mM	 to	 1	 mM	 IPTG	 at	 37	 or	 28°C.	 Induced	 cells	 were	 lysed	 by	 either	sonication	or	Bug-busting	as	described	in	Fig.	4.7	and	Section	2.5.2.	Following	lysis,	the	soluble	(S)	 and	 insoluble	 (P)	 fractions	 were	 isolated	 by	 centrifugation	 at	 16,	 000×g/20	 min	 and	analysed	 by	 SDS-PAGE	 and	 Western	 blot.	 	 At	 37°C/4	 h	 with	 1.0	 mM	 IPTG	 induction,	 no	distinguishable	band	of	hCaf1RT	was	observed	by	CB	staining	at	the	expected	location	of	about	40	kDa	in	either	soluble	or	pellet	fraction	(sonicated	samples)	(Fig.	4.7a;	CB).	WB	of	the	soluble	fractions	 confirmed	 presence	 of	 hCaf1RT	 at	 about	 38	 kDa	 from	 both	 non-induced	 (NI)	 and	induced	(I)	samples	of	BL21(DE3)/pEThR	(Fig.	 4.7a;	WB	 ).	A	prominent	band	at	 this	 location	from	NI	samples	suggests	a	high	basal	level	of	expression	(Fig.	4.7a;	WB).	A	faint	band	at	about	24	kDa	(⇠)	from	both	(NI)	and	(I)	samples,	and	a	strong	band	at	about	16	kDa	(⇜)	only	from	(I)	samples	 suggest	 truncation	 of	 hCaf1RT	 most	 likely	 at	 the	 His6-tagged	 N-terminal	 domain	(hCaf1RTN,	MWt	16.448	kDa).	Thus,	induction	with	1.0	mM	IPTG	at	37°C/4	h	showed	a	marked	deleterious	 effect	 on	 expression	 of	 full-length	 hCaf1RT	 as	 most	 of	 the	 recovered	 protein	 is	truncated.	Other	possible	reasons	 for	 this	 truncation	could	be	 the	 temperature	and	 incubation	time.	 Hence,	 the	 induction	 temperature	was	 reduced	 to	 28°C/16	 h	 and	 induction	 tested	with	both	1.0	mM	and	0.1	mM	 IPTG.	 	Under	both	conditions,	most	of	 the	blottable	hCaf1RT	protein	was	observed	in	the	insoluble	pellet	fractions	(Fig.	4.7b-c;	WB).	Moreover,	upon	induction	with	either	 1	 mM	 or	 0.1	 mM	 IPTG,	 a	 major	 proportion	 of	 hCaf1RT	 was	 degraded	 (⇝)	 or	 formed	aggregates	 (↣)	 (Fig.	 4.7b-c;	 WB).	 The	 presence	 of	 full-length	 hCaf1RT	 from	 (NI)	 samples	suggests	leaky	expression.	Further	analysis	at	shorter	induction	times	(28°C/6	h	and	37°C/3	h)	with	 0.35	 and	 0.5	 mM	 IPTG	 resulted	 in	 complete	 hCaf1RT	 recovery	 in	 the	 pellet	 fractions,	following	bug	buster	lysis,	irrespective	of	temperature/time	and	IPTG	concentrations	(Fig.	4.7d;	
WB).	 Throughout,	 no	 blottable	 band	 was	 detected	 from	 the	 negative	 control,	BL21(DE3)/pET28a+	(C)	validating	identification		of		hCaf1RT.		
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Figure 4.7| Expression of hCaf1RT from E. coli BL21(DE3)/pEThCaf1R at two different temperatures and 
IPTG concentrations. 
SDS-PAGE (14% acrylamide, CB) and Western blot (WB, on NCM) analysis of hCaf1RT expression from 
BL21(DE3)/pEThCaf1R. Cells were induced with 0.1-1.0 mM IPTG as indicated at 37°C/3-4 h or 28°C/6-16 h. 
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At the indicated time, cells (1 OD unit) were recovered and mixed in 100 µl of PBS supplemented with 1× 
proteases inhibitor (EDTA-free) and lysed by sonication (a-c), or in 100 µl bugbuster (d). S, soluble supernatant 
and P, insoluble pellet fractions isolated following centrifugation of cells lysate at 15k rpm/20 min. Identification 
of hCaf1RT on WB was confirmed by blotting with antiHis-HRP monoclonal antibody (1:10,000) and 
comparison with negative control (C, BL21(DE3)/pET28a+). IPTG induced and non-induced samples are 
indicated by (I) and (NI). ⟵, ⤎ & ⇜ and ↢ arrows show location (expected location in CB gels) of full-length, 
truncated version and aggregates forms of hCaf1RT, respectively. L, protein size marker indicating molecular 
mass in kDa.  	
iii)	 Construction	of	pEThCaf1RN			With	BL21(DE3)/pEThCaf1R,	degradation	and	aggregation	of	hCaf1RT	were	the	main	problems.	It	was	 considered	 that	 the	 C-terminal	 domain	 of	 Caf1R,	which	 putatively	 acts	 as	 a	 sensing	 or	oligomerisation	 domain,	 might	 be	 responsible	 for	 degradation	 and	 aggregation	 of	 hCaf1RT.	Therefore	 it	 was	 decided	 to	 express	 only	 the	 N-terminal	 DBD	 of	 hCaf1RT,	 with	 the	 aim	 of	enhancing	 recovery	 of	 soluble	 hCaf1RT.	 The	 construct,	 pEThCaf1RN	 contains	 the	 sequence	encoding	 the	 complete	N-terminal	DBD	 and	His6-tag	 in	 pET28a+	 vector	 (Fig.	 4.8).	 Briefly,	 the	
caf1RN	 fragment	 (377	 bp)	 was	 PCR	 amplified	 from	 pBADhCaf1R	 template	 using	 Infusion	primers,	 pETcaf1RNf*	 and	 pETcaf1RNr*	 as	 described	 in	 section	 2.2.4	 (i).	 The	 purified	 PCR	product	 was	 Infused	 into	 pre-linearised	 (NheI/EcoRI	 digestion)	 pET28a+	 vector	 and	transformed	 into	 competent	 E.	 coli	 StellarTM	 cells.	 	 Plasmid	 DNA	 was	 prepared	 from	 eight	individual	transformants	and	screened	by	sequencing	using	sequencing	primers,	T7F	and	T7R.	Successful	Infusion	was	confirmed	in	all	transformants.	All	were	stocked	and	plasmid	DNA	from	transformant	8	was	used	to	test	hCaf1RTN	expression	in	E.	coli	BL21(DE3)	cells.			
		
Figure 4.8| Construction of pEThCaf1RN. 
a) Circular plasmid map of pEThCaf1RN (5699 bp). b) AGE analysis (0.8% agarose). T, pBADhCaf1R template 
(50 ng); caf1RN, purified PCR-product of caf1RN (354 bp, 750 ng); pET28a+, NheI/EcoRI digested linearised 
plasmid (5369 bp, 300 ng) and L, DNA Hyper ladder-I (20ng). c) Confirmed sequence of hCaf1RTN (144 aa; 
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MWt 16.86 kDa). Translated sequence in blue is derived from caf1R.  Infusion primers and RBS are enclosed in 
red and blue boxes, respectively. The last α-helix (Helix-7) of Caf1R DBD is underlined.  	
iv)	 Expression	of	hCaf1RTN			at	27	and	37°C	with	1.0	mM	IPTG	induction			A	 small-scale	 (10	ml)	 expression	 trial	was	 carried	out	with	E.	coli	 BL21(DE3)	 cells	 containing	pEThCaf1RN	 	 (pETRN)	or	pET28a+	 (C)	plasmid.	Expression	was	 tested	at	27	and	37°C	with	1.0	mM	IPTG	induction.	Induced	cells	were	harvested	at	2,	4,	6,	8	and	22	h	post-induction.	One	set	of	recovered	cells	(1	OD)	was	mixed	in	100	μl	of	HisTrapFF	binding	buffer	and	sonicated.	The	other	set	was	 lysed	 by	 Bug-buster	master	mix.	 	 Following	 cell	 lysis,	 the	 S	 and	 P	 fractions	 from	 the	sonicated	 samples	 were	 recovered	 by	 ultracentrifugation	 and	 from	 bug-busted	 samples	 by	routine	 centrifugation	 at	 15,000	 rpm/20	min/RT.	WB	 identified	 a	 strong	 band	 of	 hCaf1RTN	 in	pellet	(P)	fractions	from	both	samples	(Fig.	4.9),	corresponding	to	a	possible	band	in	CB	stained	gel.	 However,	 there	 was	 negligible	 hCaf1RN	 in	 supernatant	 (S)	 from	 either	 set	 of	 samples	indicating	aggregation	of	the	N-terminus	alone.	Aggregation	was	evident	in	samples	treated	with	bug	buster	and	clarified	at	 low	speed	of	centrifugation.	Extensive	aggregation	of	hCaf1RN	 	was	visible	at	 the	 top	of	 the	gel.	 In	conclusion,	 the	production	of	 soluble	protein	was	no	better	 for	hCaf1RTN	compared	to	hCaf1RT,	irrespective	of	the	temperature	and	IPTG	concentration	tested.			
		
Figure 4.9| The hCaf1RTN is insoluble following expression at both 27 and 37°C.  
E. coli BL21(DE3)/pEThCaf1RN  was induced with 1 mM IPTG at either 27 or 37 for 0-8 h.  Samples were 
processed by sonication and ultracentrifugation (a) or by bugbuster and bench top centrifugation (b) See text for 
details. Coomassie Blue (CB) stained SDS-PAGE (14% acrylamide) and Western blot (on PVDF, WB) shown in 
(a) analysis of soluble (S) and insoluble (P) fractions; (b) WB only. NI, non-induced/0 h samples; C, negative 
control (BL21(DE3)/pET28a+) and pETRN, BL21(DE3)/pEThCaf1RN. →, ↣ and ⇝ arrow indicates full-length, 
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aggregates and degraded product of hCaf1RTN, respectively. Identification of hCaf1RTN on WB was confirmed by 
blotting with monoclonal antiHis-HRP conjugated antibody (1:5000).  
 
 
4.2.3  Expression of MBPCaf1R and MBPCaf1RN 	Only	 low-levels	 of	 hCaf1R/hCaf1RT	 or	 hCaf1RTN	 were	 recovered	 using	 the	 pBADHisA	 and	pET28a+	vectors.	Moreover,	the	recombinant	His6-tagged	Caf1R	was	mainly	in	the	insoluble	form	with	 aggregates	 and	 degraded	 product,	 especially	 using	 pET28a+.	 These	 problems	 could	 be	related	 to	misfolding	 of	 Caf1R	 or	 Caf1RN.	Therefore,	 it	 was	 decided	 to	 overexpress	 Caf1R	 and	Caf1RN	with	the	soluble	protein-tag,	maltose-binding	protein	(MBP).		The	MBP-fusion	expression	system	 has	 been	 widely	 used	 in	 the	 overexpression	 and	 purification	 of	 AraC/XylS	 family	regulators	 such	 as	 SoxS	 (Fawcett	 and	Wolf,	 1994),	 Rns	 (Munson	 and	 Scott,	 1999,	 2000)	 	 and	PchR	 (Lin	 et	 al.,	 2013;	Michel	 et	 al.,	 2005).	 It	 was	 hoped	 that	 the	MBPCaf1R	 and	MBPCaf1RN	fusion	 may	 enhance	 solubility	 and	 stability	 of	 Caf1R	 and	 Caf1RN.	 A	 cytoplasmic-expression	version	 of	 pMAL	 vector,	 pMALc2x	 (NEB)	 was	 used	 to	 In-fuse	 caf1R	 and	 caf1RN	 fragment	downstream	 of	 the	 MBP	 coding	 gene,	 malE	 thus	 constructing	 pMALc2-Caf1R	 and	 pMALc2-Caf1RN	 (Fig.	 4.10).	 Caf1R	 homology	 with	 AraC/XylS	 family	 regulators	 (Chapter-3)	 would	 be	consistent	with	the	ATG	(Met)	codon	being	the	start	codon	therefore	MBPCaf1R	was	constructed	assuming	 an	 MLKQ	 start.	 MBPCaf1RN	 fusion	 retained	 the	 additional	 6	 residues,	 starting	IWVIFMLKQ.			
i)	 Construction	of	pMALc2-Caf1R	and	pMALc2-Caf1RN		The	 906	 and	 376	 bp	 fragments	 of	 caf1R	 (coding	 from	 MLKQ…)	 and	 caf1RN	 (coding	 from	IWVIFMLKQ…)	were	PCR-amplified	from	pBADhCaf1R	plasmid	template	using	Infusion	primer	sets,	 pMALcaf1Rf	 and	 pMALcaf1Rr,	 and	 pMALCaf1RNifF	 and	 pMALCaf1RNifR,	 respectively	 as	described	 in	 section	 2.2.4	 (i).	 PCR	 products	were	 gel	 purified	 and	 Infused	 into	 pre-linearised	(BamHI/EcoRI	 digested)	 pMALc2x	 plasmid	 by	 Infusion	 cloning	 method	 (Section	 2.2.8(ii)).	Plasmid	DNA	 from	 three	 transformants	of	 each	 	 (23,	 24	 and	26	 in	 case	of	 pMALc2-MBPCaf1R	and	1-3	in	case	of	pMALc2-MBPCaf1RN)	was	sequenced	with	sequencing	primers,	malE	for	and	M13F,	 confirming	 Infusion	 of	 both	 caf1R	 and	 caf1RN	 with	 intact	 fusion	 joints.	 All	 of	 these	transformants	were	stocked	and	DNA	from	transformant	23	(pMALc2-Caf1R)	and	transformant	1	(pMALc2-Caf1RN)	was	used	to	monitor	expression	of	MBPCaf1R	and	MBPCaf1RN,	respectively.				
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Figure 4.10| Constructs, pMALc2-Caf1R and pMALc2-Caf1RN. 
a-b) Circular plasmid map of pMALc2-Caf1R (7582 bp) and pMALc2-Caf1RN (7009 bp).  c-d) Confirmed 
sequences of, pMALc2-Caf1R (696 aa; MWt 79.36 kDa) and pMALc2-Caf1RN  (512 aa; MWt 57.34 kDa), 
respectively. Translated sequence derived from caf1R and caf1RN (highlighted in blue); ><, Represents sequence 
not shown; Infuson primers on either end (red box). Residues of helix-6 and helix-7 of Caf1R DBD are 
underlined and annotated in (d).  
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ii)	 Expression	of	MBPCaf1R	in	E.	coli	BL21	at	37	and	25°C		A	small-scale	expression	(10	ml)	was	carried	out	from	BL21(DE3)	cells	carrying	pMALc2-Caf1R	or	pMALc2x	(empty	plasmid).	Induction	was	initially	at	37°C	and	later	at	25°C	to	test	the	impact	of	the	two	temperatures	on	recovery	of	soluble	MBPCaf1R.	Cells	were	induced	with	0.3	mM	IPTG	at	37°C/2	h	or	25°C/3-9	h.	Cells	(1	OD	unit)	were	lysed	by	sonication	in	100	μl	of	MPBTrapHP	column	buffer	 (20	mM	Tris-HCl,	 200	mM	NaCl,	 1	mM	EDTA	 and	10	mM	β-ME;	 pH	7.45)	with	protease	 inhibitor,	 followed	 by	 ultracentrifugation	 (134,877×g/60	 min/4°C).	 Production	 of	large	amounts	of	MBP	(migrating	at	MWt	48	kDa)	expressed	from	pMALc2x	was	evident	on	SDS-PAGE	 analysis	 of	 induced	whole	 cell	 samples	 (Fig.	 4.11a).	 Increased	 intensity	 of	 a	 band	 just	above	70	kDa	in	cells	carrying	pMALc2-Caf1R	would	correspond	with	presence	of	the	MBPCaf1R	fusion	(MWt	79.30	kDa).	The	SDS-PAGE	profile	of	the	lysed	cell	supernatant	and	pellet	fractions	indicated	that	 this	MBPCaf1R	fusion	was	primarily	 in	 the	pellet	 fraction	with	poor	recovery	of	MBPCaf1R	 in	 the	 soluble	 form.	 In	 addition,	 the	 appearance	 of	 MBP	 in	 the	 MBPCaf1R	 pellet	fraction	revealed	degradation	of	the	fusion	protein	at	37°C.			In	an	attempt	to	enhance	solubility	and	stability	of	the	fusion	protein,	constructs	were	induced	at	the	lower	temperature	of	25°C.	As	with	37°C	samples,	there	was	a	high	level	of	MBPCaf1R	in	pellet	fractions	at	all	time	points	tested.	Interestingly,	there	was	no	evidence,	on	CB	staining	or	immunoblots	 of	 degradation	 of	 the	 fusion	 (Fig.	 4.11b	 (iii-iv)).	 Immunoblotting	 of	 the	 lysate	supernatants	revealed	increasing	levels	of	soluble	MBPCaf1R	with	induction	time.	However,	all	samples	 showed	 evidence	 of	 degradation,	 suggesting	 that	 soluble	 MBPCaf1R	 fusion	 is	 more	susceptible	 to	 proteolysis.	 	 Hence,	 these	 results	 indicate	 that	 expression	 of	 Caf1R	 N-terminal	DBD	fusion	with	MBP	(MBPCaf1RN)	could	be	a	better	choice	to	avoid	degradation.			
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Figure 4.11| MBPCaf1R expression at 37°C and 25°C from E. coli BL21(DE3)/pMALc2-Caf1R. 
a) Expression at 37°C, SDS-PAGE (12.5% acrylamide) analysis from whole cells (WC), soluble supernatant (S) 
and insoluble pellet (P) fractions from 37°C/2 h samples. NI and I, non-induced and IPTG induced (0.3 mM) 
samples. b) Expression at 25°C, SDS-PAGE and WB (on NCM) analysis from (S) and (P) fractions, recovered 
after 3, 6 and 9 h induction with 0.3 mM IPTG as indicated. Band for full-length MBPCaf1R at about 79.3 kDa 
and MBP alone (C, BL21(DE3)/pMALc2x.) at about 48 kDa is indicated by ⟵ and ⤎ arrow, respectively. 
Degraded product in the pellet fraction from 37°C sample is indicated by arrowhead.  Identity of MBPCaf1R 
fusion on WB was confirmed by blotting with primary monoclonal antibody, antiMBP (1:10,000) followed by 
blotting with secondary polyclonal antibody, antiRabbit-HRP (1:10,000). 	
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iii)	 Expression	of	MBPCaf1RN	in	E.	coli	BL21	at	37	and	28°C		One	OD	unit	 cells	 of	E.	coli	 BL21	 (DE3)/pMALc2-Caf1RN	were	 recovered	before	 and	after	 IPTG	(0.3	mM)	 induction	at	37°C/2	and	3	h	and	at	28°C/4,	6	and	8	h.	Recovered	cells	were	mixed	 in	100	μl	of	MBPTrapHP	buffer	supplemented	with	1×	proteases	inhibitor	(EDTA-plus).	Soluble	(S)	and	 insoluble	 (P)	 fractions	 were	 then	 isolated	 by	 sonication	 followed	 by	 ultracentrifugation	(134,877×g/60	 min/4°C).	 Following	 SDS-PAGE	 and	 CB	 staining	 (Fig.	 4.12,	 CB)	 a	 very	 faint	distinguishing	band	was	observed	in	all	samples	 just	above	55	kDa,	consistent	with	the	size	of	MBPCaf1RN	fusion	(57.3	kDa).	This	was	confirmed	by	Western	blot	with	anti-MBP,	with	reaction	of	a	 small	band	at	approximately	57	kDa,	 running	 just	above	55	kDa	MBP	band	 in	 the	control	sample	(Fig.	4.12,	WB).	The	relative	level	of	MBPCaf1RN	fusion	was	slightly	higher	in	the	pellet	fractions	at	both	tested	temperatures,	suggesting	no	significant	effect	of	 lower	temperature	on	the	 recovery	 of	 more	 soluble	 MBPCaf1RN	 in	 the	 supernatant	 fractions.	 Although	 unlike	MBPCaf1R	 fusion,	 in	 above	 section	 there	 was	 no	 degradation	 of	 MBPCaf1RN,	 suggesting	MBPCaf1RN	fusion	is	more	stable	than	full-length	MBPCaf1R.			
	
 
Figure 4.12| MBPCaf1RN expression from E. coli BL21(DE3)/pMALc2-Caf1RN. 
SDS-PAGE (12.5% acrylamide; CB) and Western blot (on PVDF; WB) analysis of MBPCaf1RN expression at 
37°C and 28°C with 0.3 mM IPTG induction at various time points as indicated. Soluble (S) and insoluble (P) 
fractions were prepared by sonicating 1 OD unit cells in 100 µl of MBPTrapHP column buffer with proteases 
inhibitor followed by ultracentrifugation (50,000 rpm/60 min/4°C). Identity of MBPCaf1RN band in each case 
was confirmed by blotting with antiMBP-HRP monoclonal antibody (1:15,000; NEB) and comparison with 
MBP alone (C) from BL21(DE3)/pMALc2x empty plasmid. ⟵ indicates full-length MBP-RN. NI, non-induced 
sample and L, pre-stained protein marker.  
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iv)	 Expression	of	MBPCaf1R	and	MBPCaf1RN	in	E.	coli	K12-ER2508				In	order	 to	enhance	 the	 level	of	soluble	MBPCaf1R	and	MBPCaf1RN	and	to	relieve	degradation	problems,	 an	 alternate	 E.	 coli	 strain,	 K12-ER2508,	 recommended	 for	 MBP-fusion	 protein	expression	(NEB)	was	tested.	Briefly,	expression	of	soluble	 fusion	protein	 from	this	strain	was	tested	at	37°C	with	0.3	mM	IPTG	±1%	glucose10	induction	for	7	h.	At	hourly	intervals	one	OD	unit	cells	was	 resuspended	 in	 250	µl	 of	MBPTrapFF	 column	buffer	 supplemented	with	 1×	 cocktail	cOmplete	 protease	 inhibitor	 (Roche),	 sonicated	 and	 centrifuged	 (20,000	 rpm/30	min/4°C)	 in	order	to	isolate	soluble	supernatant	(S)	and	insoluble	pellet	(P)	fractions.	Both	S	and	P	fractions	were	analysed	by	SDS-PAGE	(Fig.	 4.13).	With	 this	 strain	of	E.	coli,	 the	 level	of	MBPCaf1R	and	MBPCaf1RN	 was	 much	 higher	 in	 the	 soluble	 (S)	 fractions	 than	 in	 insoluble	 fractions	 (P).	 In	addition,	 unlike	MBPCaf1R	 expression	 in	 BL21(DE3),	 no	 degradation	was	 observed	 from	 this	strain	 and	 the	 basal	 level	 of	 expression	 (in	 non-induced	 samples;	 NI)	 was	 found	 negligible	compared	 to	 BL21(DE3)	 both	 in	 the	 presence	 and	 absence	 of	 glucose.	 Inclusion	 of	 glucose	produced	better	 growth	 and	 slightly	more	 fusion-protein/OD,	 but	 also	more	 host	 background	protein.	 It	was	noticed	that	 the	 longer	the	 induction	time	the	more	fusion	protein	ended	up	 in	the	 insoluble	P	 fractions.	For	 large-scale	production	and	purification	of	soluble	MBPCaf1R	and	MBPCaf1RN,	the	shortest	convenient	induction	time	(i.e.	3-5	h)	is	probably	best	whether	with	or	without	 glucose.	 In	 conclusion,	 promising	 results	 for	 recovery	 of	 soluble	 MBPCaf1R	 and	MBPCaf1RN	were	obtained	by	using	the	recommended	host	strain.		
	
 
Figure 4.13| MBPCaf1R and MBPCaf1RN expression from E. coli K12-ER2508. 
CB stained SDS-PAGE (12.5% acrylamide) from 21k×g/30 min soluble (S) and insoluble (P) fractions of 
MBPCaf1R and MBPCaf1RN in ± glucose (1%). NI, non-induced and 2-7 h, samples harvested after 2-7 h of 
IPTG (0.3 mM) induction. ⟵ and ⤝ arrows indicate the corresponding location of MBPCaf1R and 
MBPCaf1RN fusion. Expression of MBP (C) from cells carrying empty pMALc2x plasmid can be seen at about 
45 kDa.   	
																																																								10	Plus	glucose	would	reduce	basal	level	of	expression	as	well	as	eliminate	IPTG-mediated	toxicity	if	any.		
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4.3 Expression and purification of tagged Caf1R from the synthetic gene  	Due	to	difficulties	faced	during	expression	of	native	tagged	Caf1R	it	was	thought	that	one	of	the	problems	could	be	related	to	the	presence	of	rare	codons	in	the	caf1R	open	reading	frame	(ORF).	If	 a	 protein	 ORF	 contains	 rare	 codons,	 not	 often	 used	 by	 E.	 coli,	 then	 overexpression	 of	 that	protein	 in	 E.	 coli	 may	 be	 severely	 diminished	 to	 a	 point	 of	 being	 undetectable	 (Rosano	 and	Ceccarelli,	 2009,	 2014).	 In	 particular,	 the	 codons	 for	 Arg	 (R)	 (AGG,	 AGA,	 and	 CGA),	 Leu	 (L)		(CTA),	Ile	(I)	(ATA)	and	Pro	(P)	(CCC)	can	be	a	problem	particularly	if	two	of	these	codons	are	present	 together	or	 in	a	 tandem	repeat	 (Rosano	and	Ceccarelli,	2009,	2014).	Analysis	of	caf1R	ORF	 (relative	 to	 MLKQ…	 start)	 by	 rare	 codons	 finder	 program,	 RaCC	(http://nihserver.mbi.ucla.edu/RACC/)	 identified	 32	 rare	 codons	 (Fig.	 4.14).	 Twenty	 out	 of	thirty	four	code	for	(R),	and	among	these	eight	make	a	tandem	double	repeat.	Similarly,	eleven	rare	 codons	 for	 Ile,	 two	 for	 Leu	 and	 one	 for	 Pro	 throughout	 caf1R	 ORF	 suggest	 this	 could	contribute	to	lower	level	of	expression	of	native	tagged	Caf1R	thus	far.	These	predictions	were	further	 confirmed	 by	 another	 rare	 codons	 analysis	 tool	 from	 GenScript,	 USA	(http://www.genscript.com/cgi-bin/tools/rare_codon_analysis).	The	codon	usage	frequency	for	the	 expression	 of	 native	 caf1R	 in	 E.	 coli	host	 strains	 was	 found	 to	 be	 0.6,	 nearly	 half	 of	 the	recommended	 1.0	 (GenScript,	 USA).	 Plasmid	 constructs,	 pEThCaf1Rgs,	 containing	 the	 codon	optimised	caf1R	gene	(caf1Rgs)	(Fig	4.14)	and	also	the	variant	E98G	mutant,	pEThCaf1RgsE98G	were	purchased	from	GeneScript,	USA.	In	total	162	codons	of	caf1R	were	optimised	to	obtain	the	recommended	codon	usage	frequency	and	optimum	GC	content	for	overexpression	in	E.	coli	host	strains.	 In	 this	 construct	 caf1Rgs	(starting	with	MLK...	 codons)	was	 subcloned	 downstream	of	the	 N-terminal	 His6-tag	 between	 NheI	 and	 EcoRI	 sites	 of	 the	 pET28a+	 vector.	 This	 codes	 for	hCaf1RTgs	(325	aa)	with	a	calculated	molecular	weight	of	38.5	kDa	(Fig.	4.15).		In	the	following	sections	only	the	WT	version	of	caf1Rgs	was	used	to	optimise	over-expression	of	tagged	Caf1Rgs	from	 pET28a+	 (hCaf1RTgs),	 pBADHisA	 (hCaf1Rgs)	 and	 pMALc2x	 (MBPCaf1Rgs)	 plasmids.	 For	subsequent	 purification,	 only	 the	 pEThCaf1Rgs	 (hCaf1RTgs)	 and	 pMALc2-MBPCaf1Rgs	(MBPCaf1Rgs)	were	used.	The	mutant	version	 (pEThCaf1RgsE98G)	was	used	 in	 the	 lysate	assay	for	binding	activity	as	described	in	Chapter-5.		
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Figure 4.14| Pairwise sequence alignment of native caf1R with synthetic gene (caf1Rgs). 
Rare codons identified by RaCC calculator are indicated by black underlines (32 amino acids). Changes made by 
GenScript, USA throughout caf1R ORF are indicated in pink (232 nucleotides encoding 162 amino acids). 
Consensus nucleotides are indicated by *. Deduced amino acid sequence is indicated underneath of alignment. 
DNADynamo was used to generate sequence alignment. 
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** ** ** ** *****  * ************** ** ** ******** ** *****  * ***** ** ** ***   ***
TCTCAGCAAACCTTCACGCGTGAATTTAAGAAAATTTTCGGCTATACCCCGCGTCAGTACCGCATGATTCCGTTCTGGAGTTTT
TCGCAACAGACATTCACCAGAGAATTTAAGAAAATATTTGGTTATACCCCACGGCAGTATAGGATGATCCCTTTTTGGTCCTTT
<S><Q><Q><T><F><T><R><E><F><K><K><I><F><G><Y><T><P><R><Q><Y><R><M><I><P><F><W><S><F>
*****  ** ***** *  * ***** ***** ***** ** ** ** ** ** ******** *****  * ** ** ** ***
AAAGGCCTGCTGGGTCGTCGCGAAATCAACTGCGAATATCTGCAGCCGCGTATTTGTTACCTGAAAGAACGCAACATTATCGGT
AAAGGTTTGTTGGGTAGAAGGGAAATTAACTGTGAATACCTTCAACCACGAATCTGTTACCTTAAAGAGAGAAATATAATTGGT
<K><G><L><L><G><R><R><E><I><N><C><E><Y><L><Q><P><R><I><C><Y><L><K><E><R><N><I><I><G>
******** ****** * *** * ** ** ** ** ** ** ** ** ****** *  *******  * ** ***    *****
CAATGCTTCAATTTTCGTGATCTGGTCTTTTATTCAGGCATCGACTCGAAATGTCGCCTGGGTAAACTGTACGATAGTCTGAAG
CAATGCTTTAATTTTAGGGATTTAGTGTTCTACTCTGGGATAGATTCAAAATGTAGATTGGGTAAGTTATATGATTCGTTGAAG
<Q><C><F><N><F><R><D><L><V><F><Y><S><G><I><D><S><K><C><R><L><G><K><L><Y><D><S><L><K>
***** ** ***** ** ** ** **  * ***** ************** ** ******** **  * ***** *********
AAAAACACCGCTATTACGGTTTCCAATCGTATCCCGTTTCATGATAAAACCAACGACATTATCGCGCGTACGGTGGTTTGGGAT
AAAAATACAGCTATAACAGTATCAAACAGAATCCCCTTTCATGATAAAACGAATGACATTATTGCAAGAACGGTTGTTTGGGAT
<K><N><T><A><I><T><V><S><N><R><I><P><F><H><D><K><T><N><D><I><I><A><R><T><V><V><W><D>
 * ** ** ** *********  ****** ** ** ** ************** ** ******** ** ***** ***** ***
CGCAACAAACACTTCAGCGATTCTGAAATCAAAGTGGACAAAGGCCTGTATGCCTACTTTTTCTTTAACGATACCTATGACCAG
AGGAATAAGCATTTCAGCGATAGTGAAATAAAGGTAGATAAAGGCCTGTATGCTTATTTTTTCTTCAATGATACATATGATCAG
<R><N><K><H><F><S><D><S><E><I><K><V><D><K><G><L><Y><A><Y><F><F><F><N><D><T><Y><D><Q>
** ******************** ** ** ****** **** ** *****  * ***** ** *********** ** ** ** 
TACGTTCATCACATGTACAACATCTACTACAACTCTCTGCCGATCTATAACCTGAATAAACGCGATGGTTACGACGTCGAAGTG
TATGTTCATCACATGTACAACATATATTATAACTCTTTGCCTATTTATAATTTAAATAAGCGGGATGGTTACGATGTGGAGGTC
<Y><V><H><H><M><Y><N><I><Y><Y><N><S><L><P><I><Y><N><L><N><K><R><D><G><Y><D><V><E><V>
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** *** * ** ** ** ***** ** ** ** *********** ***** ** ************** ******** ******
ATTAAACGTCGCAACGATAATACGATCGACTGCCATTATTTTCTGCCGATCTACTGTGATGACATGGAATTTTACAACGAAATG
ATAAAAAGACGAAATGACAATACTATTGATTGTCATTATTTTCTCCCGATTTATTGTGATGACATGGAGTTTTACAATGAAATG
<I><K><R><R><N><D><N><T><I><D><C><H><Y><F><L><P><I><Y><C><D><D><M><E><F><Y><N><E><M>
** ** ** ** ** ***** ** ** *********** ** **  * **  * ** **    ***
CAAGTGTACCATAACAATATCGTCAAACCGGAAATGTCTGTCACGCTGGGTCTGCCGAAATCATAA
CAGGTATATCACAATAATATTGTGAAGCCGGAAATGTCAGTAACATTAGGATTACCAAAGAGTTAA
<Q><V><Y><H><N><N><I><V><K><P><E><M><S><V><T><L><G><L><P><K><S><Z>
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Figure 4.15| The pEThCaf1Rgs construct.  
a) Circular plasmid map of synthetic Caf1R cloned in pET28a+ to create pEThCaf1Rgs (6241 bp). Plasmid 
purchased from GenScript, USA. b). Sequence of caf1Rgs in between NheI/EcoRI sites (red boxes) of pET28a+. 
The caf1Rgs derived amino acid sequence is highlighted in blue with upstream fusion to His6-tag (hCaf1Rgs, 
325 aa, MWt 38.5 kDa). Ribosomal binding site, RBS is indicated in blue box.  
 
4.3.1 Expression and purification of hCaf1Rgs  	
i)	 	Expression	of	hCaf1RTgs	from	pEThCaf1Rgs	with	different	temperatures,	IPTG	
concentrations	and	E.	coli	host	strains		Initially	 hCaf1RTgs	 expression	 was	 monitored	 at	 37°C	 using	 four	 different	 E.	 coli	 strains,	BL21(DE3),	Rosetta	gamiTM	2(DE3),	LOBSTR-BL21(DE3)	and	LOBSTR-BL21(DE3)-RIL	with	0.35	mM	IPTG	induction.	Cells	were	recovered	after	1.5,	3,	4.5,	6	and	18	h	induction.	Following	SDS-PAGE	and	WB	analysis,	 no	hCaf1RTgs	band	was	observed	at	 the	 expected	 location,	 about	38.5	kDa.	This	was	attributed	to	 IPTG-mediated	toxicity	(data	not	shown).	From	this	point	onward,	cells	with	plasmid	containing	the	synthetic	gene	caf1Rgs	were	always	grown	in	the	presence	of	1%	 (w/v)	 glucose	 irrespective	 of	 induction.	 Expression	 of	 hCaf1RTgs	 was	 re-tested	 in	BL21(DE3)/pEThCaf1Rgs	induced	with	glucose	plus	0.35	mM	IPTG	at	37°C	for	2-18	h.	A	clearly	induced	protein,	corresponding	to	the	expected	location	of	hCaf1RTgs	(38.5	kDa)	was	present	in	all	 induced	samples	of	whole	 cells	 carrying	pEThCaf1Rgs.	A	very	 thick	band	of	hCaf1RTgs	was	present	 in	 the	 lysed	 cell	 pellet	 (P)	 fractions	 (Fig.	 4.16,	 P),	 reflecting	 a	 very	 high	 level	 of	expression	 but	 again	 recovery	 primarily	 in	 the	 insoluble	 form.	 There	 was	 no	 distinguishable	
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difference	from	the	non-induced	and	induced	supernatant	samples,	although	any	soluble	protein	could	be	masked	by	a	host	protein	migrating	in	the	same	location	(38.5	kDa).			
	
 
Figure 4.16| Expression of hCaf1RTgs from E. coli BL21(DE3)/pEThCaf1Rgs. 
SDS-PAGE (14% acrylamide) analysis of hCaf1RTgs expression following induction with 0.35 mM IPTG + 1% 
glucose at 37°C (from 2-18 h). One OD unit of induced cells was mixed in 100 µl PBS for analysis of whole 
cells (WC) or in 100 µl Bugbuster master mix followed by centrifugation (20,000 rpm/15 min/4°C) to give 
soluble supernatant (S) and insoluble pellet (P) fractions.  NI, non-induced samples; L, protein size marker.  
Arrows indicate hCaf1RTgs (about 38.5 kDa).  All gels stained with Coomassie Blue. 		Because	 of	 the	 very	 high	 levels	 of	 insoluble	 hCaf1RTgs	 recovered	 following	 induction	 at	 37°C,	expression	of	soluble	hCaf1RTgs,	from	E.	coli	BL21(DE3)/pEThCaf1Rgs,	was	monitored	at	lower	temperatures	of	15	-	25°C	with	either	0.1	and	0.5	mM	IPTG,	and	1%	glucose.	Following	induction	at	21	or	25°C,	a	major	prominent	band	of	hCaf1RTgs	was	detected	on	SDS-PAGE	analysis	of	the	insoluble	pellet	fractions	of	all	samples	(Fig	4.17a).	As	before	no	hCaf1RTgs	specific	band	could	be	 identified	 in	 CB	 stained	 supernatant	 fractions	 and	 only	 a	 small	 band	 of	 hCaf1RTgs	 was	identified	by	immunoblotting.	 	Thus	at	21	or	25°C,	virtually	all	of	the	expressed	hCaf1RTgs	was	recovered	as	insoluble	protein.	However,	cells	 induced	with	0.1	mM	and	0.5	mM	IPTG	at	21	°C	for	6	h	did	appear	to	have	slightly	more	soluble	hCaf1RTgs	than	either	later	time	points	or	25°C	samples.	When	 the	 induction	 temperature	was	decreased	 further	 to	18	 and	15°C,	 as	 expected	protein	production	slowed	down	(Fig	4.17b,	CB-P),	but	while	hCaf1RTgs	was	the	major	protein	in	the	insoluble	pellet	fraction,	it	was	still	not	identifiable	in	CB	stained	supernatant	fractions.	As	with	 21°C	 induction,	 immunoblots	 identified	 slightly	 more	 soluble	 protein	 at	 the	 shortest	sampling	 time	 (4	 h),	 but	 aggregates	 also	 accumulated	 at	 the	 top	 of	 the	 gel.	 Hence,	 while	decreasing	 the	 rate	 of	 production	 of	 His6-tagged	 Caf1R	 from	 pEThCaf1Rgs	 substantially	improved	 relative	 recovery	 of	 soluble	 hCaf1R,	 it	 did	 not	 greatly	 enhance	 overall	 recovery	 of	soluble	protein.		
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Figure 4.17| Expression of hCaf1RTgs from E. coli BL21(DE3)/pEThCaf1Rgs at lower temperatures. 
SDS-PAGE (14% acrylamide) analysis of hCaf1RTgs expression at 15, 18, 21, 25 and 37°C with 0 to 0.5 mM 
IPTG, as indicated, in the presence of 1% glucose. Supernatant (S) and insoluble pellet (P) fractions were 
recovered from 1 OD unit induced cells, lysed in 100 µl Bugbuster master mix and fractionated by centrifugation 
(20,000 rpm/15 min/4°C). NI, not induced; C, BL21(DE3)/pET28a+; CB, Coomassie blue stained; WB, 
immunoblot on NCM using antiHis-HRP mAb (1:10,000; Roche) and L, protein size marker.  	
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Further	 two	 strains	 of	 E.	 coli,	 BL21	 StarTM	 (DE3)pLysS	 and	 SHuffle®	T7	 were	 tested	 for	 the	recovery	 of	 both	 soluble	 and	 insoluble	 level	 of	 hCaf1RTgs.	 Expression	 was	 tested	 from	 BL21	StarTM(DE3)pLysS	at	37°C	with	1.0	mM	IPTG	induction	and	from	SHuffle®	T7	at	37,	30	and	16°C	with	0.1	mM	IPTG	induction.	BL21	StarTM	(DE3)	pLysS	showed	very	tight	control	of	hCaf1RTgs	expression	with	no	expression	 in	non-induced	samples	(Fig.	 4.18a,	WB).	There	was	even	 less	expression	 from	 this	 strain,	 with	 product	 only	 visible	 in	 both	 soluble	 and	 insoluble	 pellet	fractions	by	immunoblotting.	Similarly,	with	the	SHuffle®	T7	strain	there	was	no	distinguishable	CB	stainable	product	at	the	expected	location	of	hCaf1RTgs,	 in	any	of	the	supernatant	fractions	tested	(Fig.	4.18b,	CB),	despite	a	large	amount	of	product	in	pellet	fractions	(Fig.	4.18b,	CB	and	
WB).	 During	 expression	 studies	 extensive	 aggregation	 of	 Caf1R	 in	 21,000×g/15	 min	supernatant	 fractions	 was	 often	 noticed.	 This	 appeared	 to	 be	 particularly	 prominent	 in	bugbuster	 lysed	 cells.	 Prior	 to	 purification,	 ultracentrifugation	 would	 remove	 much	 of	 this	aggregate.		
		
Figure 4.18| Expression of hCaf1RTgs from E. coli BL21 StarTM(DE3) pLysS and SHuffle® T7 carrying 
pEThCaf1Rgs plasmid. 
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SDS-PAGE (14% acrylamide; CB) and Western blot (WB, on NCM) of hCaf1RTgs expression from BL21 Star 
(DE3) pLysS at 37°C with 1.0 mM IPTG induction (a) and from SHuffle® T7 at 37, 30 and 16°C with 0.1 mM 
IPTG induction (b) at different time (h) as indicated. Soluble (S) and pellet (P) fractions were prepared by 
mixing 1 OD unit of recovered cells in 100 µl of Bugbuster master mix followed by centrifugation (20,000 
rpm/15 min/4°C). Identity of hCaf1RTgs on WB was validated by blotting with antiHis-HRP monoclonal 
antibody (1:10,000), and comparison with negative control, C (corresponding cells strain containing pET28a+ 
empty vector). ⟵, ↢ and ⤑ arrows indicate corresponding location and band of full-length hCaf1RTgs, 
aggregates and degradation products. L, protein size marker. 		
ii)	 Expression	of	hCaf1Rgs	from	E.	coli	Top10/pBADhCaf1Rgs	at	37°C			Expression	 of	 hCaf1R	 from	 the	 tightly	 regulated,	 low-copy	 number	 plasmid	 pBADhcaf1R	 had	resulted	 in	 soluble	 hCaf1R,	 but	 only	 low	 levels	 (Fig.	 4.3).	 Therefore	 expression	 from	 the	pBADHis	 vector	 was	 again	 tested	with	 the	 caf1Rgs	 gene.	 The	 gene	 caf1Rgs	 was	 excised	 from	pEThCaf1Rgs	 (by	 NheI/EcoRI	 digestion)	 and	 ligated	 between	 the	 NheI	 and	 EcoRI	 sites	 of	pBADHisA	plasmid	to	construct	pBADhCaf1Rgs.	This	construct	encodes	N-terminal	His6-tagged	
caf1Rgs	(hCaf1Rgs)	with	a	calculated	molecular	weight	37.55	kDa,	as	depicted	in	Fig.	4.19.	Small	scale	 (10	ml)	 expression	 of	 hCaf1Rgs	 from	 this	 construct,	 was	 tested	 in	E.	 coli	 Top10	with	 a	range	(0-0.2%)	of	L-ara	 induction	at	37°C	until	8	h	as	described	 in	section	2.5.1	and	shown	in	
Fig.	 4.20.	 Following	SDS-PAGE,	no	hCaf1Rgs	band	 could	be	 identified	by	CB	 staining	of	 either	supernatant	or	pellet	fractions	of	the	lysed	cells;	an	apparently	induced	protein	band	just	above	34	 kDa	 in	 supernatant	 fractions	 was	 also	 present	 in	 the	 induced	 negative	 control	 (C;	Top10/pBADHisA)	(Fig.	4.20,	CB),	suggesting	expression	of	hCaf1Rgs	(37.55	kDa)	is	masked	by	a	host	protein.	Western	blot	confirmed	recovery	of	reasonable	levels	of	hCaf1Rgs	in	supernatant	fractions	following	induction	at	all	L-ara	concentrations	tested.	The	0.02%	L-ara	induction	at	4	h	produced	a	 reasonably	good	amount	of	 full-length	hCaf1Rgs	with	 little	or	no	aggregate,	as	did	induction	with	 0.002%	 L-ara	 (Fig	 4.20,	 WB).	 Hence,	 production	 of	 soluble	 hCaf1R	 is	 slightly	improved	from	this	construct	when	compared	to	production	from	pBADhCaf1R	with	the	native	caf1R	sequence.	However,	the	level	of	soluble	product	is	still	low.			
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Figure 4.19| The pBADhCaf1Rgs construct. 
a) Circular plasmid map of pBADhCaf1Rgs (4913 bp). b) Confirmed sequence of pBADhCaf1Rgs encoding 
hCaf1Rgs. Cloning sites (NheI and EcoRI) and RBS are indicated in red and blue boxes, respectively. N-
terminal and C-terminal amino acid sequence of hCaf1Rgs (316 aa, MWt 37.55 kDa) is shown. ><, Indicates 
sequence not shown. Amino acids highlighted in blue indicate codons derived from caf1Rgs, those in black 
plasmid derived codons.  
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Figure 4.20| Expression of hCaf1Rgs from E. coli Top10/pBADhCaf1Rgs. 
SDS-PAGE (14% acrylamide, CB) and Western blot (WB, on NCM) analysis of hCaf1Rgs expression following 
induction of 10 ml culture with 0-0.2 % of L-ara at 37°C for 4-8 h, as shown.  S, supernatant and P, pellet 
fractions prepared following lysis of 1 OD unit cells in 100 µl of HisTrapFF column buffer (without imidazole), 
supplemented with 1× proteases inhibitor (EDTA-free, Pierce) and centrifugation (20,000 rpm/15 min/4°C). 
Identity of hCaf1Rgs on WB was confirmed by blotting with antiHis-HRP monoclonal antibody (1:10,000). ⟵ 
and ↢ arrows indicate the full-length and aggregated hCaf1Rgs. C, negative control (Top10/pBADHisA) and 
NI, not induced samples. L, protein size marker.  		
iii)	 IMAC	purification	of	soluble	hCaf1RTgs	from	E.	coli	BL21(DE3)/pEThCaf1Rgs				It	was	decided	that	highest	 levels	of	recovery	of	soluble	hCaf1R	would	most	 likely	be	obtained	from	 the	 pEThCaf1Rgs	 construct.	 Following,	 consideration	 of	 previous	 conditions	 tested	 and	time	constraints	soluble	hCaf1RTgs	was	prepared	by	sonication	and	ultracentrifugation	of	cells	of	E.	coli	BL21(DE3)/pEThCaf1RTgs	culture	(100	ml)	that	had	been	induced	with	0.35	mM	IPTG	+	1%	glucose	for	2.5	h	at	37°C.	Purification	was	carried	out	by	using	HisTrapFF	column	(1	ml)	with	 a	 linear	 gradient	 of	 0-250	mM	 imidazole	 as	 described	 in	 Fig.	 4.21	 and	 section	 2.5.4(i).	Elution	profile	of	HisTrapFF	column	(Fig.	4.21a)	indicates	two	very	small	peaks	at	Fns	3-5	and	14,	but	neither	correlated	with	hCaf1R,	which	was	eluted	mainly	between	Fn	7-12,	at	about	31%	of	 buffer	 B	 or	 77.5	 mM	 imidazole.	 Fns	 3-6	 contained	 high	 molecular	 weight	 (55-75	 kDa)	Histidine	 rich	 host	 proteins	 from	 host,	 which	 also	 contaminated	 Fn	 7	 and	 8.	 	 No	 visible	background	bands	were	present	in	Fn	9,	10	and	11	with	best	recovery	and	maximum	purity	in	fraction	10	(Fig.	4.21b).	A	Nano	drop	measurement	 from	this	 fraction	(10th)	showed	40	μg/ml	concentration	 of	 hCaf1RTgs,	 suggesting	 it	 would	 be	 sufficient	 for	 subsequent	 DNA-protein	binding	assays	upon	concentration.		
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Figure 4.21| IMAC purification of soluble hCaf1RTgs from E. coli BL21(DE3)/pEThCaf1Rgs. 
Induced cells of E. coli BL21(DE3)/pEThCaf1Rgs (100 ml culture) were lysed by sonication in 10 ml 
HisTrapFF column binding buffer (20 mM NaPO4 buffer, 500 mM NaCl, 5 mM DTT, 20 mM imidazole; pH 
7.4), supplemented with 1× proteases inhibitor (EDTA-free). The supernatant fraction following 
ultracentrifugation (50,000 rpm/60 min/4°C) was applied to a 1 ml HisTrapFF column. a) Elution profile with a 
linear gradient, 0-250 mM imidazole over 20 ×1 ml fractions, followed by wash with 250 mM imidazole (100% 
buffer B). b) SDS-PAGE (14% acrylamide) analysis of eluted fractions (1-15). ATC, applied sample to column, 
FT, flow through and W, wash fraction. ⟵ arrow indicates hCaf1RTgs. L, protein size marker. 
 	
iv)	 Urea	solublisation	of	hCaf1RTgs	from	the	inclusion	bodies				As	 most	 of	 the	 recombinant	 hCaf1RTgs	 was	 recovered	 as	 insoluble	 inclusion	 bodies,	solubilisation	of	hCaf1RTgs	with	urea	was	tested.	 	This	might	be	useful	for	anti-Caf1R	antibody	production	 or	 refolding	 of	 hCaf1R	 if	 recovery	 of	 soluble	 protein	 was	 too	 difficult.	 A	 batch	 of	hCaf1RTgs	 inclusion	 bodies	 was	 prepared	 from	 a	 50	 ml	 culture	 of	 E.	 coli	BL21(DE3)/pEThCaf1Rgs	 that	 had	 been	 induced	 with	 0.1	 mM	 IPTG	 at	 37°C/5	 h.	 Pelleted	inclusion	bodies	were	treated	with	a	0-8	M	urea	as	described	in	section	2.5.5	and	solubilisation	assessed	by	centrifugation.	The	highest	recovery	of	soluble	hCaf1RTgs	was	with	8	M	urea,	with	approximately	50-60%	solubilised	 (Fig.	 4.22).	 	Urea	 solubilisation	was	not	 taken	any	 further,	but	it	was	concluded	that	recovery	of	soluble	hCaf1RTgs	could	be	optimised	either	by	adjusting	the	 ratio	 of	 urea	 to	 protein	 or	 by	 using	 another	 method	 of	 solublisation	 such	 as	 Guanidine	hydrochloride,	if	needs	to	be,	and	optimising	refolding	conditions.		
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Figure 4.22| Solublisation of hCaf1RTgs from inclusion bodies. of E. coli BL21(DE3)/pEThCaf1Rgs by urea 
treatment. 
SDS-PAGE (14% acrylamide) analysis of hCaf1RTgs non-solubilised (P) and urea solubilised (S) Caf1R with a 
range of urea (M) as indicated. ⟵ and ↢ arrows indicate full-length hCaf1RTgs and aggregates, respectively. 
Inclusion bodies containing hCaf1RTgs were recovered from induced, lysed cells of E. coli 
BL21(DE3)/pEThCaf1Rgs and tested for solubilisation in urea as described in section 2.5.5.  
 
4.3.2  Expression and purification of MBPCaf1Rgs 	
i)	 Construction	of	pMALc2-Caf1Rgs	and	expression	of	MBPCaf1Rgs			To	 optimise	 the	 solubility	 and	 stability	 of	 tagged	 Caf1R,	 caf1Rgs	 was	 amplified	 from	pEThCaf1Rgs	 template,	 using	 Infusion	 primers,	 pMALCaf1R_GSf	 and	 pMALCaf1R_GSr	 and	subcloned	 into	 EcoRI/BamHI	 digested	 pMALc2x	 plasmid	 using	 Infusion	 cloning	 method.	 The	complete	 caf1Rgs	 sequence	 with	 intact	 fusion	 on	 either	 side	 was	 confirmed	 from	 three	transformants	 using	malE	 for	 and	M13F	 sequencing	 primers.	 All	were	 stocked	 and	 number	 1	was	assigned	as	pMALc2-Caf1Rgs	(Fig.	4.23)	and	used.					
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Figure 4.23| The pMALc2-Caf1Rgs construct. 
a) Circular plasmid map of pMALc2-Caf1Rgs (7551 bp). b) Confirmed sequence of pMALc2-Caf1Rgs. Encoded 
amino acid sequence derived from caf1Rgs is highlighted in blue, fused to N-terminal MBP (only a few linker 
residues (black) are shown). Infusion primers on either side are shown in red boxes. Complete fusion of 
MBPCaf1Rgs codes 693 aa with a calculated molecular weight, 78.98 kDa.  		A	small-scale	(10	ml)	 trial	of	recovery	of	soluble	MBPCaf1Rgs	over	7	h	 induction	with	0.3	mM	IPTG	±	1%	(w/v)	glucose	at	37°C	was	performed	from	E.	coli	K12-E2508/pMALc2-MBPCaf1Rgs.	Induced	 cells	 were	 lysed	 by	 sonication	 in	 MBPTrapHP	 column	 buffer	 and	 the	 supernatant	(soluble	 fraction)	 recovered	by	centrifugation	 (20,000	rpm/15	min/4°C).	Following	SDS-PAGE	analysis	 (Fig.	 4.24,	 CB),	 a	 clearly	 distinguishable	 band	 correlating	 with	 MBPCaf1Rgs	 fusion	(78.98	 kDa)	was	 observed	 between	 72	 and	 95	 kDa	 in	 all	 induced	 samples	 –	 supernatant	 and	pellet	 induced	 in	 presence	 and	 absence	 of	 glucose.	 Identity	 of	 this	 was	 confirmed	 by	immunoblotting	of	supernatant	samples.	This	also	highlighted	 the	higher	 levels	of	MBPCaf1Rgs	when	induced	in	the	presence	of	glucose.	However,	glucose	grown	cells	also	contained	a	much	higher	 level	 of	 background	 host	 proteins	 (Fig.	 4.24,	 WB).	 It	was	 also	 noticed	 that	 as	 culture	incubation	 time	 increased,	 the	 relative	 ratio	 of	 MBPCaf1Rgs	 in	 pellet	 fractions	 also	 increased.	Hence,	 for	maximum	 recovery	 of	 soluble	MBPCaf1Rgs,	 with	 less	 background,	 3-5	 h	 induction	time	in	the	absence	of	glucose	would	be	most	suitable.			
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Figure 4.24| Recovery of soluble MBPCaf1Rgs from E. coli K12-ER2508/pMALc2-Caf1Rgs. 
SDS-PAGE (12.5% acrylamide, CB) and Western blot (WB, on NCM)  analysis of MBPCaf1Rgs. Cultures were 
grown at 37°C following induction with 0.3 mM induction ± glucose (1%) with sampling over 2-7 h as 
indicated. S and P, Soluble and insoluble fractions, prepared from 1 OD unit cells, lysed in 100 µl MBPTrapHP 
column buffer with protease inhibitor (Roche) followed by centrifugation at 20,000 rpm/15 min at 4°C.   NI, 
non-induced, K12-ER2508/pMALc2-MBPCaf1Rgs; C, control with pMALc2x, expresses MBP only (48 kDa). ⟵ arrow, full-length MBPCaf1Rgs. MBP in negative control, WB (on NCM) was with 1:10,000 dilutions of 
both antiMBP (primary) and antiRabbit-HRP (secondary) antibodies.  
 
	
ii)	 Maltose	affinity	purification	of	MBPCaf1Rgs	from	E.	coli	K12-ER2508/pMALc2-
Caf1Rgs			Cell	 lysate	was	prepared	 from	500	ml	 culture	of	E.	coli	 K12-ER2508/pMALc2-Caf1Rgs	 induced	with	0.3	mM	IPTG	at	25°C	for	5	h	by	sonication	in	40	ml	of	MBPTrapHP	column	buffer	(20	mM	Tris-HCl,	 200	 mM	 NaCl,	 10	 mM	 β-ME,	 1	 mM	 EDTA;	 pH	 7.5)	 supplemented	 with	 1×	 protease	inhibitor	 (Thermo	 Scientific,	 Pierce).	 Sonicated	 lysate	 was	 ultra-centrifuged	 (134,877×g/60	min/4°C)	 and	 the	 supernatant	 was	 then	 fractionated	 on	 an	MBPTrapHP	 column.	 The	 Elution	profile	 from	 the	 MBPTrapHP	 column	 (Fig.	 4.25a)	 indicates	 a	 very	 sharp	 peak	 of	 A280	encompassing	 Fn	 2-4,	 eluting	 at	 about	 18%	 of	 B	 (1.8	 mM	maltose).	 This	 corresponds	 to	 the	correct	size	for	MBPCaf1Rgs	(MWt	78.98	kDa)	(Fig.	4.25b).	The	high	protein	background	in	the	flow	through	(FT)	sample	indicates	poor	binding	to	column	matrix,	which	could	be	improved	by	repeat	applications	of	smaller	volumes	or	using	a	 larger	column.	Protein	concentration	in	Fn	3	was	measured	by	Nanodrop	and	found	to	be	380	μg/ml.		
L      NI    4      NI    2      3      4      5     6      7  L      NI     4     NI     2      3      4      5      6      7 
   C                   MBPCaf1Rgs     C                   MBPCaf1Rgs 
(h) (h) 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!Glucose (+)                                                          Glucose (-) 
43 
55 
72 
95 
34 
43 
34 
55 
72 
95 
43 
43 
34 
55 
72 
95 
55 
72 
95 
kDa kDa 
34 
43 
55 
72 
26 
95 
26 
34 
43 
55 
72 
95 
S S 
S S 
P P 
CB 
CB CB 
CB 
WB WB 
	 146	
	
 
Figure 4.25| Purification of soluble MBPCaf1Rgs by maltose affinity chromatography.   
a) Elution profile from the MBPTrapHP column. Clarified lysate-supernatant (35 ml) was applied to a 
MBPTrapHP column (GE Healthcare) and the bound MBPCaf1Rgs was eluted with a linear gradient of 0-10 mM 
maltose (0-100% of B) over 10 ×1 ml fractions as described in section 2.5.4 (ii).  b) SDS-PAGE (12.5% 
acrylamide) analysis of the eluted fractions (1-11) along with sample applied to column , flow through (FT) and 
wash fraction (W). ⟵ arrow indicates expected location and protein band of MBPCaf1Rgs. L: Pre-stained 
protein size marker.   
 
4.4 Conclusion 	Caf1R	is	a	member	of	the	AraC/XylS	family	of	transcription	regulators.	Proteins	of	this	family	are	naturally	expressed	at	low	level	and	are	notoriously	difficult	to	purify	in	their	native	state.	This	is	 in	part	due	to	differences	 in	the	pI	of	 their	 two	domains	(conserved	DBD	and	highly	variant	sensing	 or	 oligomerisation	 domain)	 that	 can	 lead	 to	 protein	 aggregation	 and	 insolubility	(Gallegos	et	al.,	1997;	Schleif,	2010).	As	seen	in	this	study	the	DBD	alone	is	also	insoluble	when	overexpressed.	 Despite	 these	 problems,	 some	 proteins	 of	 this	 family	 have	 been	 successfully	overexpressed,	purified	and	characterised	 including	 the	putative-structural	homologs	of	Caf1R	MarA,	Rob	and	XylR	proteins	of	E.	coli	(Jair	et	al.,	1995;	Kwon	et	al.,	2000;	Ni	et	al.,	2013).	In	this	chapter	 expression	 of	 tagged	 Caf1R	 expression	 was	 monitored	 from	 both	 the	 native	 DNA	sequence	 (caf1R)	 and	 a	 synthetic	 codon	 optimised	 gene	 (caf1Rgs).	 Both	 native	 and	 synthetic	gene	were	subcloned	in	three	expression	plasmids,	two	contain	N-terminal	His6-tag,	pBADHisA	and	 pET28a+	 under	 control	 of	 the	 PBAD	 and	 T7	 promoter,	 respectively.	 The	 third	 plasmid,	pMALc2x	 contains	 a	 solubility	 enhancer	 tag	 (MBP)	 at	 N-terminal	 under	 control	 of	 the	 IPTG	inducible	 ptac	 promoter.	 Expression	 of	 hCaf1R	 from	pBADhCaf1R	 in	E.	coli	 Top10	 resulted	 in	recovery	 of	 soluble	 hCaf1R,	 but	 at	 very	 low	 levels	 only	 detectable	 by	 immunoblotting.	Optimising	 the	 caf1R	 codon	 sequence	 only	 slightly	 increased	 the	 level	 of	 recovery	 of	 soluble	
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hCaf1Rgs.	In	both	cases,	induction	with	0.02%	L-ara	for	37°C/4	h	was	found	to	be	optimum,	with	primarily	soluble	protein,	no	evidence	of	aggregates	but	only	very	low	levels	of	hCaf1R.			To	boost	the	level	of	expression	of	His6-tagged	Caf1R,	caf1R	and	caf1Rgs	were	subcloned	into	the	overexpression	 vector	 pET28a+,	 as	 pET	 vectors	 had	 been	 successfully	 used	 in	 the	overexpression	of	putative-structural	homologs	of	Caf1R,	MarA	(Jair	et	al.,	1995),	Rob	(Kwon	et	al.,	 2000)	 and	XylR	 (Ni	 et	 al.,	 2013).	 Surprisingly,	 levels	 of	 recovered	hCaf1RT	were	no	higher	from	 this	 vector	when	 induced	with	 IPTG.	 Detectable	 hCaf1R	was	 primarily	 recovered	 in	 the	insoluble	 fraction	 and	 degraded.	 Decreasing	 the	 temperature	 of	 incubation	 and	 IPTG	concentrations	 did	 not	 help.	 However,	 reducing	 the	 rate	 of	 induction	 from	 pETCaf1Rgs	 by	inclusion	 of	 1%	 glucose	with	 IPTG	 dramatically	 affected	 results.	 Under	 these	 conditions	 high	levels	 of	 Coomassie	 blue	 stainable	 hCaf1RTgs	 were	 recovered	 although	 this	 was	 virtually	 all	insoluble.	 	 Relief	 from	 IPTG-mediated	 toxicity	 by	 inclusion	 of	 glucose	 is	 linked	 to	 catabolite	repression	(Deutscher,	2008).		Induction	at	the	lower	temperatures	of	15	and	18°C	increased	the	ratio	 of	 soluble	 to	 insoluble	 protein,	 probably	 due	 to	 reduction	 in	 the	 rate	 of	 synthesis	 and	subsequent	 misfolding	 of	 protein	 (Rosano	 and	 Ceccarelli,	 2014;	 Vera	 et	 al.,	 2007),	 but	 the	majority	of	hCaf1RTgs	still	 aggregated,	Expression	of	 the	His6-tagged	N-terminal	DBD	of	Caf1R	(from	pEThCaf1RN)	was	 found	 to	be	even	worse.	 	Virtually	all	of	 the	protein	was	recovered	 in	insoluble	 inclusion	 bodies	 and	 aggregates,	 indicating	 that	 the	DBD	 domain	 of	 the	 regulator	 is	primarily	 responsible	 for	 aggregation.	 Hence,	 for	 production	 of	 soluble	 hCaf1R	 from	pETCaf1Rgs,	 a	higher	 ratio	of	 soluble	 to	aggregated	protein	 can	be	obtained	with	 induction	at	15°C			or	higher	levels	of	protein	(with	a	lower	ratio	of	soluble	to	insoluble)	can	be	obtained	with	short	 induction	 times	 at	 37°C.	 IMAC	 isolated	 and	 concentrated	 soluble	 hCaf1R	was	 primarily	large	aggregates	with	a	small	amount	of	monomer	(40.98	kDa),	and	possibly	dimer	(82	kDa)	as	determined	 by	 size	 exclusion	 chromatography.	 	 AraC/XylS	 regulators	 act	 as	 monomer,	 MarA	(Rhee	et	al.,	1998)	and	Rob	(Kwon	et	al.,	2000),	and	dimer,	XylR	(Jair	et	al.,	1995;	Kwon	et	al.,	2000;	 Ni	 et	 al.,	 2013).	 	 Further	 studies	 could	 focus	 on	 purification	 of	monomer	 and	 dimer	 of	hCaf1R	and	monitor	binding	activity	of	both.				To	 enhance	 the	 solubility	 of	 Caf1R,	 expression	 of	 Caf1R	was	monitored	 by	 fusion	 of	 Caf1R	 to	MBP.	 MBP	 has	 been	 shown	 to	 enhance	 the	 solubility	 of	 AraC/XylS	 regulators	 and	 their	subsequent	 characterisation	 without	 removing	 the	 MBP-tag;	 examples	 include	 SoxS	 (Fawcett	and	Wolf,	1994),	Rns	(Munson	and	Scott,	1999,	2000)	 	and	PchR	(Lin	et	al.,	2013;	Michel	et	al.,	2005).	MBPCaf1R	 and	MBPCaf1RN	was	 unstable	 and	 degraded	when	 expressed	 from	 BL21	 at	both	37°C	and	25°C.	The	NEB	recommended	strain,	E.	coli	K12-ER2508	worked	as	an	excellent	host	strain	for	the	expression	of	MBPCaf1R,	MBPCaf1Rgs	and	MBPCaf1RN.	This	is	a	lon	deficient	
E.	coli	K12	strain	that	enhances	protein	solubility	of	cytosolic	recombinant	proteins	(NEB).	High	levels	 of	 soluble	 MBPCaf1R	 were	 observed	 from	 all	 three	 versions	 of	 MBP-tagged	 Caf1R	constructs	 using	 this	 strain,	 with	 no	 degradation.	 Although	 there	 was	 still	 accumulation	 of	insoluble	 MBPCaf1R,	 the	 level	 of	 soluble	 protein	 recovered	 from	 K12-ER2508	 equalled	 the	amount	 of	 insoluble	 MBPCaf1R.	 Importantly,	 the	 level	 of	 soluble	 MBPCaf1R	 represented	 the	major	 protein	 in	 lysed	 cell	 supernatants	 in	 contrast	 to	 the	 soluble	 hCaf1R	 constructs,	 which	were	only	detectable	by	immunoblotting	of	cell	lysate	supernatants.		
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Coomassie	 blue	 stainable	 and	 soluble	 His6-	 and	 MBP-tagged	 Caf1R	 was	 purified	 from	 the	respective	 construct	 expressing	 codon	 optimised	 caf1Rgs.	 The	 hCaf1RTgs	was	 affinity	 purified	from	100	ml	culture	of	BL21(DE3)/pEThCaf1Rgs,	 induced	with	0.35	mM	IPTG	+1%	glucose	at	37°C	for	2.5	h.	The	hCaf1RTgs	protein	was	recovered	in	a	flat	peak	(about	40	μg/ml,	roughly	200	ug	 total).	 MBPCaf1Rgs	 was	 purified	 from	 500	 ml	 culture	 of	 K12-ER2508/pMALc2-Caf1Rgs,	induced	with	0.3	mM	IPTG	induction	(no	glucose)	at	25°C	for	5	h.	MBPCaf1Rgs	was	recovered	in	a	sharp	peak	from	maltose	affinity	chromatography	(about	380	μg/ml,	roughly	600-700	μg	total	MBPCaf1R	 fusion	 or	 300-350	 μg	 Caf1R).	 Activity	 of	 both	 fusion	 proteins	 is	 demonstrated	 in	Chapter-5.	 However,	 activity	 was	 clearly	 suboptimal	 and	 further	 studies	 should	 focus	 on	recovery	of	fully	active	protein.			MarA	was	purified	and	solubilised	from	inclusion	bodies	(Jair	et	al.,	1995)	and	successfully	used	to	 solve	 the	 mar-MarA	 cocrystal	 structure	 (Rhee	 et	 al.,	 1998).	 Insoluble	 hCaf1RTgs	 was	successfully	solubilised	from	inclusion	bodies	using	urea.	Further	manipulation	of	solublisation	conditions	and	studies	to	optimise	refolding	could	also	be	used	as	a	route	to	obtain	functional,	soluble	 hCaf1R	 for	 further	DNA	 binding	 studies,	 antibody	 production	 and	 even	 crystallization	studies.	
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 Chapter 5 
 Identification and localisation of 
caf locus promoters and Caf1R 
binding site(s) 		  
	 150	
5.1 Introduction 	 	The	F1	encoding	caf	 locus	 (5.128	kb)	 is	present	on	Y.	pestis	 specific	 largest	virulence	plasmid,	pFra	(≈100	kb).	It	codes	for	4	genes,	located	in	opposite	orientations	and	presumably	organised	into	 two	 or	 possibly	 three	 transcriptional	 units	 (Fig.	 5.1).	 One	 transcriptional	 unit	 (reverse	orientation)	 contains	 caf1R,	 a	 gene	 encoding	 a	 transcriptional	 regulator	 (Caf1R)	 of	 the	AraC/XylS	family	and	the	other	(forward	orientation)	includes	caf1M,	caf1A	and	caf1,	the	genes	coding	for	periplasmic	chaperone	(Caf1M),	an	outer	membrane	usher	(Caf1A)	and	F1	structural	subunit	 (Caf1),	 respectively	 (Karlyshev	 et	 al.,	 1992).	 Very	 little	 information	 is	 available	 on	regulation	of	this	locus.	It	has	been	suggested	that	it	may	contain	two	regulatory	regions,	one	the	intergenic	 region	 (327	 bp)	 between	 caf1R	 and	 caf1M,	which	 presumably	 contains	 divergent	promoters,	PR	and	PM,	and	Caf1R	binding	site(s)	(Fig.	5.1),	responsible	for	transcription	in	both	directions	(Karlyshev	et	al.,	1992).		The	possibility	of	a	second	regulatory	region	is	the	intergenic	region	(80	bp)	between	caf1A	and	caf1,	which	could	 influence	caf1	expression,	 leading	 to	high	levels	of	accumulation	of	F1,	possibly	 through	binding	of	 the	Caf1R	regulator	(Karlyshev	et	al.,	1992;	MacIntyre,	2004).			Bacterial	 RNAP	 holoenzyme	 (~460	 kDa)	 is	 the	 key	 determinant	 for	 transcription	 initiation,	made	 up	 of	 6	 subunits,	 2α,	 β,	 β',	 ω	 and	 σ	 (Browning	 and	 Busby,	 2004).	 The	 β'	 is	 the	 largest	subunit	(155.2	kDa),	encoded	by	the	rpoC	gene	(Ebright,	2000).	This	subunit	contains	the	region	of	 the	active	center	essential	 for	RNA	synthesis	and	also	contains	some	determinants	 for	non-sequence-specific	interactions	with	DNA	and	nascent	RNA	(Murakami	et	al.,	2002).	 	The	rest	of	the	 active	 center	 essential	 for	 RNA	 synthesis	 and	 determinants	 for	 non-sequence-specific	interactions	 (with	 DNA	 and	 nascent	 RNA)	 is	 contained	 within	 the	 second-largest	 subunit,	 β	(150.6	 kDa),	which	 is	 encoded	 by	 rpoB	gene.	 Third	 largest	 subunit	 of	 RNAP	 holoenzyme	 is	 α	subunit	(36.5	kDa)	(Ross	et	al.,	2001),	which	is	encoded	by	rpoA	gene	and	is	present	in	2	copies	(αI	and	αII)	per	molecule	of	RNAP.	Each	α	subunit	is	made	up	of	two	domains,	N-terminal	domain	(αNTD)	and	a	C-terminal	domain	(αCTD).	The	αCTD	contains	determinants	for	interaction	with	promoter	sequence	and	thus	makes	non-sequence-specific	 interactions	at	most	promoters	and	sequence-specific	 interactions	 at	 the	 UP-element	 containing	 promoters.	 It	 also	 contains	 the	determinants	 for	 interactions	with	 transcription	 factors	or	 regulators.	The	 smallest	 subunit	of	RNAP	is	ω	subunit	(10.2	kDa),	encoded	by	rpoZ	gene.	This	subunit	function	as	a	chaperone	and	thus	facilitates	assembly	of	RNAP	and	stabilizes	assembled	RNAP	(Mathew	and	Chatterji,	2006).	For	 binding	 to	 the	 target	 promoter,	 RNAP	 core	 initially	 interacts	 with	 the	 transcriptional	initiation	factor,	σ	subunit,	in	order	to	form	RNA	polymerase	holoenzyme.	The	σ	subunit	(factor)	decreases	 the	affinity	of	RNAP	for	nonspecific	DNA	interactions	and	thus	enhancing	specificity	for	 the	 target	 promoters,	 allowing	 transcription	 to	 begin	 at	 the	 correct	 site.	 To	 initiate	transcription,	 bacterial	 cell	 uses	 different	 sigma	 factors	 under	 different	 environmental	conditions,	 which	 bind	 the	 promoters	 of	 the	 target	 genes	 depending	 on	 the	 environmental	conditions	and	thus	enhance	the	transcription	of	those	genes	(Gruber	and	Gross,	2003).					
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All	bacterial	 cells	 contain	a	primary	or	housekeeping	σ	 factor	known	as	σ70	(70	kDa),	which	 is	encoded	by	rpoD	gene	and	transcribe	most	genes	in	the	growing	cells	and	thus	keeps	essential	genes	 and	 pathways	 operating	 (Gruber	 and	 Gross,	 2003).	 In	 Enterobacteriaceae,	 genes	recognised	 by	 σ70	 all	 have	 similar	 promoter	 consensus	 sequences,	 containing	 two	 hexamer	elements,	-10	(TATAAT)	and	-35	(TTGACA),	located	10	and	35	nt	upstream	of	the	transcription	start	site	(TSS;	+1).	Other	example	of	σ	 factors	 include,	σ19	(19	kDa),	σ24	(24	kDa),	σ28	(28	kDa)	σ32	 (32	 kDa)	 and	 σ38	 (38	 kDa)	 encoded	 by	 fecI,	 rpoE,	 rpoF,	 rpoH	 and	 rpoS	 gene.	 Factor	 σ19	regulates	fec	gene	involved	in	iron	transport,	σ24	is	a	factor	regulating	extracytoplasmic/extreme	heat	 stress,	 σ28	regulates	 gene	 involved	 in	 flagellar	 synthesis,	 σ32	 is	 turned	 on	when	 cells	 are	exposed	 to	 heat.	 Genes,	 whose	 expression	 is	 enhanced	 by	 σ32	 code	 for	 heat	 shock	 proteins,	chaperones,	 proteases	 and	 DNA-repair	 enzymes.	 Factor	 σ38	 is	 regulate	 genes	 in	 the	starvation/stationary	phage	of	growing	cells.		Sequence	 alignment	 of	 RNAP	 holoezyme	 of	 Y.	 pestis	 (strain	 CO92)	 and	 E.	 coli	 (strain	 K-12)	showed	a	great	degree	of	similarity	(Appendix	2a),	having	high	%	of	amino	acid	identity	in	the	respective	subunits.	For	examples,	RpoA	or	α	subunit	(99%),	RpoB	or	β	subunit	(95%),	RpoC	or	β'	subunit	(93%),	RpoZ	or	ω	subunit	(92%)	and	RpoD	or	σ70	(91%),	RpoH	or	σ32	(84%)	and	RpoS	or	σ38	(92%).	In	addition,	several	promoters	have	been	mapped	and	predicted	in	Y.	pestis,	containing	 the	 -10	 and	 -35	 elements	 quite	 similar	 to	 the	 σ70	 based	 promoters	 consensus	elements	 of	 E.	 coli.	 A	 tabulated	 summary	 of	 these	 promoters	 elements	 along	 with	 the	corresponding	regulated	gene	is	shown	in	Appendix	2b.	Hence,	the	aims	of	this	chapter	were	to	localise	the	core	or	basic	promoter	(σ70	type)	for	the	caf1R/M/1	genes	and	define	Caf1R	binding	within	 the	 caf	 locus,	 by	 combinatorial	 approaches	 of	 bioinformatics	 analysis,	 promoter-lacZ	fusions	and	an	in	vitro	DNA-binding	study	of	tagged	Caf1R.			
		
Figure 5.1| The caf locus of Yersinia pestis. 
Genes encoding Caf1R regulator, Caf1M periplasmic chaperone, Caf1A outer membrane usher and the F1 
subunit (Caf1) are presented according to their relative location and size. The main divergent promoters (PR and 
PM) within the caf1R-caf1M intergenic region and an additional putative promoter (P1), within caf1A-caf1 
intergenic region are indicated by black- solid and dotted arrows, respectively. Proposed binding of Caf1R to the 
suggested divergent and putative promoters is indicated by a solid and dotted red arrow, respectively. 	
Results and Discussion 
5.2 Analysis of caf1R-caf1M and caf1A-caf1 intergenic regions 	Three	 potential	 promoters	 had	 been	 predicted	 previously	 (Karlyshev	 et	 al.,	 1992)	 in	 the	intergenic	region	of	caf1R-caf1M;	one	 for	caf1R	(PRK)	 	and	the	other	 two	 for	caf1M	(PMK1/2).	No	such	 promoter	 had	 been	 predicted	 for	 the	 intergenic	 region	 of	 caf1A-caf1,	 suggesting	 the	
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intergenic	region	of	caf1R-caf1M	may	be	the	main	regulatory	region	of	the	caf	locus	controlling	the	 expression	 of	 caf1R	 in	 one	 direction	 and	 caf1MA1	 in	 the	 opposite	 direction.	 These	predictions	 raise	 the	 questions	 whether	 these	 are	 the	 active	 promoters	 of	 the	 caf	 locus	 and	where	 exactly	Caf1R	binds.	Alternatively,	 there	may	be	other	promoter(s),	which	 regulate	 the	expression	from	the	caf	 locus.	 	 In	order	to	 identify	potential	promoter	elements	(-10	and	-35),	Caf1R	binding	sites	and	possible	Shine-Dalgarno	(SD)	sequence	for	caf1R,	caf1M	and	caf1	genes,	the	 intergenic	 region	 of	 caf1R-caf1M	 and	 caf1A-caf1	 (Fig.	 5.2)	was	 analysed	bioinformatically	and	visually	as	described	in	section	2.11.2-5.	The	results	are	discussed	in	the	following	sections	and	properties	of	predicted	promoters	are	tabulated	in	Appendix	3.		
		
Figure 5.2| Sequence analysis of caf1R-caf1M and caf1A-caf1 intergenic regions of caf locus. 
pRS550(8-9)construct annotation: 
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CTATTTGtGCACGCGCATCAATATCAAAATTAGCTATTTGCGCAAcaAGCaAgTGGA 
                            R2     gtAGTT                     R3 
 
R4                                           -35PM                                                                                            -10PM-35PMB 
GTGCGCgAaAAGCTaaACTTTGTGTGCATTTTTAAATAaAATTGTTctCAGTGAGGC 
                        LrP                        TyR & IHF                              
              
                                     -10PMB                                                                      -10PMK2                                                   -35PMK1             -10PMK2 
TGTGCTACGGATATAAaAATCCCCTTCATTTGttACCCACCTTTTtACgCATATcgT 
          LexA & AgrR                                   SoxS                              HipB                           
   
   IR              -10PMK1                                                                                                                                SD 
CGATATGAaATgATGGGGAGGGGGTGGGAAGGTGTTGTCACCATTCCGTAAGGAGGT  
     
       caf1M 
TAAGCTCATGATTTTAAATAGATTAAGTACGTTAGGAATTATTACTTTCGGCATGCT       
TAGTTTTGCTGCGAACTCTGCTCAACCAGATATCAAATTCGCAAGCAAAGAGTATGG
CGTGACTATAGGTGAGAGTAGGATCATATACCCGTTAGATGCTGCTGGCGTT  
                                                  +158 
 
 
   
 
 
 
 
-259                                              -35P13                  R1a             -10P13 
CTGGCATTGTCGGAGATAATAGCGGTGTCTATTTGACtGGACTACCTAAAAAATCaAaAATA 
                
-35P12R1b-10P12 
CTTGTTAAGTGGGGGAgaGAtAAAAATCAATCATGTTCATcTAATGTAGTTCTACCAGAAAA 
                
                                                   caf1A
AACGGATATTTCTGGTGCTTATAGGTTATCCACAACCTGCATCTTAAATAACTGAAACGGAT 
            
  -35P11                    -10P11    -35P1B R2a 
GTTTATTTCAAACagGACACAAGCCCTCTCTACGAATtTgtTCGTgGAttGGATTATTCGAT   
            
     SD          -10P1B caf1               R1c                                                                                                                 R2b 
AGAGGTAatATATGAAAAAAATCAgTTCCGTTATCGCCATTGCATTATTTGGAACTATTGCA 
                                      +88 
ACTGCTAATGCGGCAGATTTAACTGCAAGCACCACTGC 
 
 
 
 
 
 
 
 
 
R4′
a 
PhoB 
b 
R3′ 
cC G a
t
35 
-10(PR1)# -10(PR2)#
-35(PR1)# -35(PR2)# -10(PRK)#
-35(PRK)#
-3 ( MB)#
-10(P B)# -35(PMK2)# -35( K1)# -10( K2)#
-10(P K1)#
-10(P13)#(P13)#
-35(P12)# ( 12)#
-35(P11)# -10(P11)# -35(P1B)#
-10(P1B)#
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a) The caf DNA fragment encompassing the complete intergenic region of caf1R-caf1M (327 bp) and 192 or 158 
bp (w.r.t. ATG start) of coding sequence of caf1R (fM1-A70 aa) and caf1M (M1-V53 aa), respectively. The two 
possible start codons, ATG (Met) (Karlyshev et al., 1992) and TTG (Leu or fMet) (Parkhill et al., 2001) (CAT 
and CCA in reverse complement) for caf1R and ATG (Met) for caf1M are highlighted in pink and green, 
respectively. Predicted Shine-Dalgarno (SD) sequences for caf1R and caf1M are highlighted in cyan and 
numbered SD1 and SD, respectively. Visually predicted SD sequence for caf1R w.r.t. TTG (fMet) start is also 
highlighted in cyan and indicated as SD2. Predicted and visually identified promoter elements (-10 and -35) are 
underlined and indicated in bold capital and small (non-consensus) letters. Previously predicted -10 and -35 
elements (Karlyshev et al., 1992) are designated as PRK1 and PMK1/2 while BPROM predicted elements are 
designated as -10(PMB) and -35(PMB) and visually identified PR and PM promoters, (PR1/2 ) and (PM), respectively. 
Repeated sequences, R1, R2 and R3 (for caf1R) and R3′ and R4′ (for caf1M) are shown by red and black arrows, 
respectively, with variant nucleotides in small letters. BPROM predicted binding site motifs for other 
transcriptional factors are highlighted in grey and discussed in text (section 5.2.5). An inverted repeat (IR), 
upstream of -10(PMK1) is highlighted in yellow. The +192 and +158 in blue at either end show the numbering 
from the caf1R and caf1M translation start sites (ATG; M), respectively. b) The caf DNA fragment 
encompassing the complete intergenic region of caf1A-caf1 (80 bp) plus 179 and 88 bp, respectively, from the 
caf1A end (TGA (Z), pink; S775-Z834 aa) and caf1 start (ATG, green; M1-A30 aa). BPROM predicted and visually 
identified putative P1 promoter’s elements are underlined, shown in bold capital and small (non-consensus) 
letters and indicated as -10/-35(P1B) and -10/-35(P11/2/3). Visually predicted SD sequence for caf1 is highlighted 
in cyan. Grey highlighted sequences with red and black arrows show repeat sequence motifs R1a/b/c and R2a/b, 
respectively. Variant nucleotide (G) of R1c is indicated as g. BPROM predicated PhoB binding site is indicated 
by dotted underline. The -259 and +88 indicated in blue at either end show the numbering from caf1 start (ATG).  
 
5.2.1 Identification of potential promoter elements in caf1R-caf1M intergenic region 	Previously	predicted	(Karlyshev	et	al.,	1992)	-10	and	-35	elements	of	PRK	and	PMK1/2	promoters	are	 indicated	 as	 -10/-35(PR/MK1/2)	(Fig.	 5.2a).	 The	 intergenic	 region	 of	 caf1R-caf1M	 (327	 bp,	relative	 to	 ATG	 start	 of	 both	 caf1R	 and	 caf1M)	 along	with	 first	 192	 and	 158	 bp	 of	 caf1R	 and	
caf1M	genes	was	initially	screened	by	BPROM	(Solovyev,	2011)	to	identify	potential	-10	and	-35	elements	of	possible	σ70	type	promoters	for	caf1R	and	caf1M.	A	single	promoter	was	predicted	within	this	DNA	fragment	with	close	proximity	to	caf1M,	-104	bp	upstream	of	caf1M	start	codon	(ATG)	to	the	beginning	of	-10	element.	Hence	this	was	assigned	as	PMB	promoter	with	predicted	-10	(TATAAa)	and	-35	(TTctCA)	elements	(Fig.	5.2a)	and	LDF	score	of	6.38,	suggesting	an	active	promoter.	The	 individual	 score	of	 -10(PMB)	and	 -35(PMB)	element	was	predicted	as	41	and	33,	indicating	a	better	prediction	of	 -10(PMB)	 element.	 In	 addition,	 the	 frequency	percentage	of	nt	within	 -10(PMB)	 element	 was	 found	 comparatively	 higher	 than	 that	 of	 -35(PMB),	 suggesting	 a	strong	-10	and	a	weak	-35	element	with	respect	to	optimum	-10	(TATAAT)	and	-35	(TTGACA)	elements	 of	 σ70	 type	 promoters	 (Fig.	 5.2a).	 This	 is	 in	 good	 agreement	 with	 an	 optimum	promoter	prediction	where	one	predicted	element	shows	a	higher	consensus	conservation	than	the	other	(Lisser	and	Margalit,	1993).	The	distance	between	the	predicted	-10(PMB)	and	-35(PMB)	elements	 was	 18	 nt,	 close	 to	 the	 optimum	 distance	 (17	 nt)	 for	 σ70	 type	 promoters	 of	 E.	 coli	(Lisser	and	Margalit,	1993).		Following	 visual	 analysis	 (section	 2.11.2-5)	 of	 both	 strands	 of	 this	 DNA	 fragment,	 three	additional	promoters	were	predicted	within	the	caf1R-caf1M	intergenic	region,	two	upstream	of	
caf1R,	(PR1)	and	(PR2)	and	another	for	caf1M,	PM		(Fig.	5.2a).	The	sequence	composition	of	these	predicted	elements,	was	TATtAT	(-10)	and	cgccgg	(-35)	for	(PR1)	and	TAgAAT	(-10)	and	aaGtCc	(-35)	for	(PR2),	indicating	a	strong	-10	element	with	5/6	consensus	nt	and	a	very	weak	-35	element	for	both.	Similarly,	 the	sequence	composition	of	 the	predicted	PM	promoter,	TAaAAT	(-10)	and	TaaACt	(-35),	indicated	a	strong	-10	element	with	5/6	consensus	nt	and	a	reasonable	good	-35	element	 with	 50%	 nt	 identity	 to	 the	 optimum	 -35	 element.	 The	 distance	 between	 visually	
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identified	-10	and	-35	promoter	elements	was	17	nt,	apart	from	(PR2)	which	has	18	nt	(Fig.	5.2).	Among	the	visually	identified	promoters,	the	predicted	PM	promoter	seems	the	most	promising	promoter.	The	first	two	and	last	three	nt	of	 its	predicted	-10	element	(TAaAAT)	correspond	to	the	%	frequency	of	consensus	residues	at	each	position	within	-10	element	(T80A95T45A50A60T96)	as	 do	 the	 first,	 fourth	 and	 fifth	 nt	 of	 its	 predicted	 -35	 element,	 TaaACt	 (T82T84G78A65C54A48)	(Lisser	and	Margalit,	1993).		
5.2.2 Identification of potential promoters elements in caf1A-caf1 intergenic region 	The	caf1A-caf1	 intergenic	 region	 (80	bp)	along	with	179	and	88	bp	 from	the	caf1A	 end	 (TGA)	and	caf1	start	(ATG),	respectively	was	also	screened	by	BPROM	and	then	analysed	visually	for	-10	and	-35	consensus	sequences	(Fig.	5.2b).	BPROM	predicted	a	single	promoter,	P1B		within	the	
caf1A-caf1	intergenic	region	with	an	LDF	score	of	4.25.	The	individual	score	of	the	predicted	-10	and	 -35	 elements	 was	 68	 and	 16,	 with	 17	 nt	 spacer	 suggesting	 a	 strong	 prediction	 for	 -10	element	 (Fig.	 5.2b).	 The	 nt	 composition	 of	 predicted	 -10(P1B)	 and	 -35(P1B)	 elements	 was	TAatAT	and	TgGAtt,	4/6	and	3/6	consensus	nt,	respectively	for	an	optimum	σ70	type	promoter.		However,	 the	 location	 of	 the	 predicted	 -10(P1B)	 element	 of	 this	 promoter	was	 adjacent	 to	 the	start	codon	(ATG)	of	caf1,	suggesting	 it	 is	unlikely	 to	be	 the	real	promoter	 for	 full-length	caf1.	The	 possibility	 was	 considered	 that	 there	 might	 be	 another	 open	 reading	 frame	 (ORF)	downstream,	 encoding	 a	 small	 fragment	 of	 Caf1	 controlled	 by	 this	 promoter.	 Therefore	 the	complete	caf	DNA	fragment	of	pRScaf1A′-1′-lacZ	promoter-lacZ	fusion	construct	was	analysed	by	an	 ORF	 finder	 program	 (http://www.bioinformatics.org/sms2/orf_find.html)	 in	 order	 to	identify	any	possible	ORF(s),	downstream,	starting	with	either	ATG	or	commonly	used	rare	but	alternate	codons,	TTG,	GTG	and	CTG	(Blattner	et	al.,	1997).	A	single	ORF,	with	a	CTG	start	codon	encoding	 a	 69-amino	 acids	 long	 peptide	 of	 7.817	 kDa	 was	 predicted	 (Fig.	 5.3).	 	 There	 is	 no	recognisable	strong	SD	sequence	for	this	ORF,	but	if	expressed,	the	BPROM	predicted	promoter,	P1B	would	control	the	expression	of	this	low-complexity	peptide	(Fig.	5.3).			Visual	 analysis	 of	 the	 caf1A-caf1	 DNA	 fragment	 (Fig.	 5.2b)	 showed	 three	 additional	 possible	promoters,	P11-3	with	17	nt	spacer	and	predicted	-10	and	-35	elements	(-10(P11-3)	and	-35(P11-3))	as	 shown	 in	Fig.	 5.2b	 and	Appendix	 2.	 The	 P11	was	 predicted	within	 the	 intergenic	 region	 of	
caf1A-caf1	 while	 P11-2	were	 predicted	within	 caf1A	 3′	 fragment.	 The	 sequence	 composition	 of	these	 predicted	 -10	 and	 -35	 elements	 were	 TtTgtT	 -10(P11)	 and	 agGACA	 -35(P11);	 TcTAAT	 -10(P12)	and	gaGAtA	-35(P12);	aAaAAT	-10(P13)	and	TTGACt	-35(P13),	indicating	3/6	and	4/6	(for	P11);	5/6	and	3/6	(for	P12);	and	4/6	and	5/6	(for	P13)	consensus	nt	(shown	in	capitals)	in	the	-10	and	-35	elements,	respectively.	Among	these	three	visually	identified	promoters,	P11	might	seem	to	be	the	logical	promoter	for	full-length	caf1	due	to	its	distance	from	the	caf1	start	codon,	ATG	(-31	 bp	 upstream	 from	ATG	 to	 the	 beginning	 of	 predicted	 -10(P11)	 and	 nt	 composition	 of	 the	predicted	-10(P11)	and		-35(P11)	elements	(Fig.	5.2b).	Alternatively,	the	other	two	promoters,	P12		and	 	 P13,	 predicted	 within	 caf1A	 3′	 fragment	 have	 as	 good	 	 predicted	 motif-sequence	compositions,	and	could	control	transcription	of	a	longer	5′	UTR		on	the	caf1	mRNA.		
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Figure 5.3| Additional predicted ORF within caf1. 
Nucleotide sequence of the full-length caf1 gene is indicated in blue text with upstream caf1A-caf1 intergenic 
region (in black). The deduced amino acids sequence of predicted ORF is indicated between the red and black 
arrows. BPROM predicted -10 and -35 elements of P1B promoter are under lined. A very weak predicted SD and 
TSS for this predicted ORF are thick underlined and shown in a box with +1, respectively.  
5.2.3 Identification of potential Caf1R-binding sites in caf1R-caf1M intergenic region 	Using	 both	 REPFIND	 and	 visual	 analysis	 (section	 2.11.2-5)	 of	 the	 caf1R-caf1M	 intergenic	fragment	(used	in	section	5.2.1),	five	repeat	motifs	(R1,	R2,	R3,	R3′	and	R4′)	of	15	nt	long	were	identified	with	few	variant	nt.	Repeat	motifs	R1,	R2	and	R3	(red	arrows)	were	identified	at	56-70	bp	(R1),	89-103	bp	(R2)	and	122-136	bp,	(R3)	upstream	from	ATG	start	codon	of	caf1R,	with	18	 nt	 spacer	 between	 each	 (Fig.	 5.2a).	 Repeat	motifs	 R3′	and	 R4′	 (black	 arrows)	 run	 in	 the	opposite	 orientation	 at	 163-177	 bp	 (R4′)	 and	 183-197	 bp	 (R3′)	 upstream	 from	 the	ATG	 start	
DNADynamo printout for caf1_ORF prediction
Page 1
AACGGATGTTTATTTCAAACAGGACACAAGCCCTCTCTACGA
ATTTGTTCGTGGATTGGATTATTCGATAGAGGTAATATATGA
AAAAAATCAGTTCCGTTATCGCCATTGCATTATTTGGAACTA
TTGCAACTGCTAATGCGGCAGATTTAACTGCAAGCACCACTG
CAACGGCAACTCTTGTTGAACCAGCCCGCATCACTCTTACAT
ATAAGGAAGGCGCTCCAATTACAATTATGGACAATGGAAACA
TCGATACAGAATTACTTGTTGGTACGCTTACTCTTGGCGGCT
ATAAAACAGGAACCACTAGCACATCTGTTAACTTTACAGATG
CCGCGGGTGATCCCATGTACTTAACATTTACTTCTCAGGATG
GAAATAACCACCAATTCACTACAAAAGTGATTGGCAAGGATT
CTAGAGATTTTGATATCTCTCCTAAGGTAAACGGTGAGAACC
TTGTGGGGGATGACGTCGTCTTGGCTACGGGCAGCCAGGATT
TCTTTGTTCGCTCAATTGGTTCCAAAGGCGGTAAACTTGCAG
CAGGTAAATACACTGATGCTGTAACCGTAACCGTATCTAACC
AATAA
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codon	of	caf1M,	with	a	5	nt	 spacer.	There	are	14	nt	between	R3	(caf1R	motif)	and	R4′	 (caf1M	motif).	 AraC/XylS	 family	 activators	 often	 bind	 immediately	 upstream	 of	 the	 promoter	 -35	element	(Egan,	2002;	Gallegos	et	al.,	1997).	This	would	be	consistent	with	Caf1R	binding	to	R4′,	immediately	 upstream	 and	 overlapping	 the	 -35	 element	 of	 PM	 promoter.	 Similarly	 R1	 lies	immediately	upstream	and	overlaps	-35	element	of	PR2	promoter.	R3	is	located	8	nt	upstream	of	the	 predicted	 PRK	 -35	 element.	 Repeat	 motif	 R3	 (upstream	 of	 caf1R)	 and	 R3′	 	 (upstream	 of	
caf1M)	overlap	each	other	by	6	nt.			The	 five	 potential	 Caf1R-binding	 sites	 or	 motifs	 were	 aligned	 and	 compared	 to	 predict	 a	consensus-binding	motif	 for	 Caf1R.	 They	 were	 also	 compared	 to	 the	 known	 binding	motif	 of	MarA	(Rhee	et	al.,	1998)	and	a	published	MarA/Rob/SoxS	binding	consensus	(Duval	and	Lister,	2013)	to	identify	key	nt	(Fig.	5.4).	The	15	nt	long	fragment	of	these	motifs	is	highly	conserved	with	9	identical	nt	and	only	a	few	point	variants.	R3′	is	the	most	variant;	R1-R3	and	R4′	share	12	identical	 nt.	 The	 flanking	 sequences	 of	 each	 repeat	 shows	 very	 poor	 conservation,	 although	interestingly	 an	 A	 base	 upstream	 of	 R4′	 and	 at	 position	 one	 of	 MarA/Rob/SoxS	 consensus	sequences	 is	 invariant	 (Duval	 and	 Lister,	 2013;	 Martin	 et	 al.,	 1999;	 Wood	 et	 al.,	 1999).	 	 A	mutagenesis	 study	 of	 this	 invariant	 A	 base	 in	 the	 SoxS	 consensus	 demonstrated	 a	 two-fold	reduction	in	transcription	following	substitution	with	any	other	base	(Griffith	and	Wolf,	2001).	In	the	mar-MarA	DNA-protein	cocrystal	structure	(PDB-1bl0)	this	base	was	not	contacted	by	any	amino	acid	residue	of	MarA	(Rhee	et	al.,	1998).	However,	the	first	eight	amino	acid	residues	of	MarA	are	not	visible	in	the	cocrystal	structure	of	mar-MarA	complex	and	thus	it	is	possible	that	one	or	more	of	these	amino	acids	make	base	specific	contact(s)	with	this	base.	This	is	supported	by	 an	NMR	 study	 of	 DNA-MarA	 complex,	where	 amino	 acid	 residues	 from	 the	N-terminal	 tail	were	shown	to	contact	DNA	(Dangi	et	al.,	2001).			Caf1R	 consensus	 from	 the	 aligned	 sequences	 of	 these	 potential	 Caf1R-binding	 motifs	 were	determined	 as	 (i)	 TGCRCBS1RAMWAGCWARDBS2,	 including	 all	 five	 and	 (ii)	TGCGCBS1RAAWAGCTAARBS2	 considering	 only	 R1	 and	 R4′	 (Fig.	 5.4).	 In	 the	 MarA/Rob/SoxS	consensus,	 the	BS1	sequence	 is	RGCAC	 (R:	A/G).	The	 first	nt	of	 this	BS1	 is	T	 in	all	5	potential	Caf1R-binding	motifs	whereas	 the	 last	 four	 nt	 are	GCGC	 except	 for	R2	which	has	 the	 same	 as	MarA/Rob/SoxS	 consensus	 (GCAC).	The	predicted	BS2	nt	of	 the	Caf1R-binding	motifs	 also	 fits	the	consensus	and	is	identical	over	6	nt	to	mar	BS2.	The	sequence	between	BS1	and	BS2	of	the	MarA/Rob/SoxS	consensus	 is	quite	variable	 (Egan,	2002;	Gallegos	et	 al.,	 1997)	but	 the	Caf1R-binding	motifs	show	a	greater	degree	of	conservation,	primarily	a	series	of	A	nt.				Often	 transcriptional	 regulators	bind	 to	DNA	as	multimeric	 forms	 to	a	 sequence	motif	 (Garvie	and	Wolberger,	 2001),	 which	 exhibit	 dyad	 symmetry.	 Examples	 of	 regulator	 binding	 to	 dyad	symmetry	sequence	include,	AraC	(Lu	et	al.,	1992),	AarP	(Macinga	et	al.,	1999),	ArsR	(Rosenstein	et	 al.,	 1994)	 and	 Fur	 (Pich	 et	 al.,	 2012).	 In	 this	 context,	 the	most	 likely	 binding	 of	 Caf1R	 as	 a	dimer	to	the	identified	repeat	motifs	would	be	at	R1	and	R4′,	which	seems	to	be	present	in	the	dyad	 symmetry	 (15-14-15)	 and	 thus	 might	 regulate	 the	 expression	 of	 caf1R	 and	 caf1M	 or	
caf1MA1	 operon.	 More	 so,	 one	 15	 nt	 sequence	 motif	 represented	 as	 ‘IR’	 in	 Fig.	 5.2a	 was	identified	 in	 the	 intergenic	 region	 of	 the	 caf1R-caf1M,	which	 seems	 to	 be	 present	 in	 the	 dyad	symmetry	(7-1-7)	and	there	might	be	possibility	of	Caf1R	or	other	regulator(s)	binding	to	this	
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region.	No	such	repeat	sequences	with	dyad	symmetry	were	 identified	 in	rest	of	 the	caf	locus,	reinforcing	the	potential	binding	site(s)	 for	Caf1R	 is/are	present	 in	 the	caf1R-caf1M	 intergenic	region.			
		
Figure 5.4| Potential Caf1R-binding motifs, within the caf1R-caf1M intergenic region of the caf locus. 
Sequence alignment of five potential Caf1R-binding repeat motifs (R1, R2, R3, R3′ and R4′) are highlighted in 
yellow with green highlight indicating variants. RC, repeat motifs in the reverse complement. Absolutely 
conserved nt within these repeat motifs are indicated by * and shown in the sequence logo generated using the 
WEBLOGO program (Crooks et al., 2004). The known binding sequence motif and nt interacting with helix-3 
(BS1) and helix-6 (BS2) of MarA in mar-MarA complex (Rhee et al., 1998) and the consensus-binding motif for 
MarA/Rob/SoxS (Duval and Lister, 2013) are shown above the potential Caf1R-binding repeat motifs using the 
degenerate nucleotide code (R: A/G, Y: C/T, W: A/T and N: A/T/G/C). Predicted sequences of R4′ interacting 
with helix-3 (BS1) and helix-6 (BS2) of Caf1R, as well as the corrosponding invariant A of MarA/Rob/SoxS 
consensus are bold underlined.  
 
5.2.4 Repeat sequences within the caf1A-caf1 intergenic region 	Five-repeated	sequences	with	2	different	motifs,	R1a-c	(9	nt)	and	R2a-b	(11	nt)	were	identified	in	this	region	(Fig.	5.2b).	R1a	and	R1b	are	identical	over	all	9	nt,	while	R1c	shares	eight	of	these	nt,	having	a	variant	G	base	(g)	at	the	end.	R2a			and	R2b	contain	a	single	nt	mismatch.	R1c	and	R2b	are	within	the	coding	sequence	of	caf1,	R1a	and	R1b	are	located	within	the	caf1A	gene	and	only	R2a	is	within	 the	 intergenic	 region.	 The	 nt	 composition	 of	 these	 repeats	 is	 unrelated	 to	 the	 repeat	sequences	identified	in	the	caf1R-caf1M	intergenic	region	(Fig.	5.2a),	suggesting	that	Caf1R	does	not	 bind	 to	 this	 region.	 Hence,	 the	 repeat	motifs	 of	 caf1A-caf1	 intergenic	 region	 could	 be	 the	remnant	of	phage	or	mobile	element	insertion	and	some	relic	of	horizontal	gene	transfer	(HGT).	In	addition,	these	could	contribute	to	stability	of	polycistronic	caf	mRNA.		
5.2.5 Predicted binding sites for additional transcription factors within the caf locus 	BPROM	 screening	 of	 caf1R-caf1M	 and	 caf1A-caf1	 intergenic	 regions,	 identified	 eight	 binding	motifs	 for	 additional	 transcription	 factors,	 seven	 between	 caf1R	 and	 caf1M	 and	 a	 single	 one	upstream	of	caf1	(Fig.	5.2).	A	potential	integration	host	factor	(IHF)	binding	site	(AAATAAAAT)	
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was	identified	overlapping	the	predicted	-10(PM)	element,	IHF	binds	to	the	minor	groove	of	DNA	in	 a	 sequence	 specific	 manner,	 recognising	 AT	 rich	 regions.	 The	 primary	 function	 of	 IHF	 is	architectural	as	it	introduces	a	>160°	bend	in	the	DNA	and	influences	transcription	(Rice	et	al.,	1996).	 A	 single	 binding	 motif	 of	 LrP	 (TCGATTTT)	 and	 TyrR	 (TAAATAAA)	 was	 indicated	upstream	 of	 the	 IHF	 binding	motif	 (Fig.	 5.2a).	 TyrR,	 a	metabolic	 virulence	 determinant	 of	Y.	
pestis,	 essential	 for	 extracellular	 survival	 and	 thus	 plays	 an	 important	 role	 in	 enhancing	 its	virulence	by	 regulating	29	genes	directly	or	 indirectly	 (Deng	et	 al.,	 2015).	These	 include,	nine	down	regulated,	5	(aroF,	tyrA,	aroP,	aroL,	and	tyrP)	from	aromatic-pathways,	2	(glnL	and	glnG)	of	two-component	system,	encoding	sensory	histidine	kinase	and	a	regulator	involved	nitrogen	assimilation	and	other	2	(hdeB	and	hdeD)	of	acid-stress.	The	remaining	20	genes	(up	regulated,	2.0–4.2-fold)	code	for	proteins	of	the	T3SS	(Deng	et	al.,	2015).			In	 the	caf1A-caf1	 intergenic	region	a	single	binding	motif	of	PhoB	(TAATATAT)	was	 identified,	which	overlaps	the	first	two	nt	of	the	caf1	start	codon	(ATG)	and	the	last	nt	of	the	predicted	SD	sequence	(Fig.	5.2b),	suggesting	binding	of	a	phosphate	regulon	transcriptional	regulator,	PhoB	of	 OmpR	 family.	 Prediction	 of	more	 transcription	 factor	 binding	 sites	within	 the	 caf1R-caf1M	intergenic	 region	 in	 comparison	 to	 the	 caf1A-caf1	 intergenic	 region	would	 be	 consistent	with	
caf1R-caf1M	intergenic	region	being	the	main	regulatory	region	of	the	caf	locus.		In	addition,	caf	expression	 is	 thermo-controlled	 (discussed	 in	 Chapter-6).	 There	 is	 likely	 to	 be	 a	 complex	mechanism	of	regulation	controlling	F1	expression.			
5.3 Promoter activity within the caf locus intergenic regions  	Following	 bioinformatic	 prediction	 of	 promoters,	 three	 promoter-lacZ	 fusion	 constructs,	pRScaf1M′-R′-lacZ,	 pRScaf1R′-M′-lacZ	 and	 pRScaf1R-M′-lacZ	 were	 used	 to	 monitor	 promoter	activity	within	the	intergenic	region	caf1R-caf1M,	by	monitoring	β-galactosidase	activity	(section	2.3,	Fig.	5.5).	The	pRScaf1R′-M′-lacZ	and	pRScaf1R-M′-lacZ	are	constructs	in	the	promoter	fusion	vector,	 pRS550,	 to	 test	 for	 caf1M	 promoter(s);	while,	 pRScaf1M′-R′-lacZ	 is	 in	 pRS415	 (reverse	orientation	of	 insert)	 to	 test	 for	caf1R	 promoter(s).	An	additional	 construct,	 pRScaf1A′-1′-lacZ,	also	 in	 pRS550	was	 used	 to	 monitor	 activity	 upstream	 of	 caf1.	 To	 test	 the	 impact	 of	 Caf1R	regulator	on	promoter	activity,	caf1R	was	supplied	either	 in	cis	orientation	 (on	 the	same	DNA	fragment	as	in	the	pRScaf1R-M′-lacZ	construct)	or	in	trans	by	co-transformation	with	pACYC-R.	Activity	was	routinely	monitored	from	three	individual	transformants	in	E.	coli	Top10.			
		
Figure 5.5| Promoter-lacZ fusion constructs of the caf locus intergenic regions.  
Fragments of the caf locus indicated in orange between dotted lines were PCR-amplified and subcloned 
upstream of lacZ (green) in pRS415 (construct pRScaf1M′-R′-lacZ) or pRS550 (all others) to create promoter-
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fusion plasmids (Simons et al., 1987). Three constructs, pRScaf1M′-R′-lacZ, pRScaf1R′-M′-lacZ and pRScaf1A′-
1′-lacZ were prepared to test promoter activity of DNA sequences upstream of caf1R, caf1M and caf1, 
respectively. The construct, pRScaf1R-M′-lacZ was prepared to monitor the impact of Caf1R (encoded in cis 
orientation) on expression from caf1M  promoter(s). 
 
5.3.1 Promoter activity upstream of caf1R  	Promoter-fusion	construct	pRScaf1M′-R′-lacZ,	encompassing	the	caf1R-caf1M	 intergenic	region,	192	bp	of	caf1R	and	158	bp	of	caf1M	(Fig.	5.5)	was	used	to	identify	caf1R	promoter(s)	activity.	β-galactosidase	 activity	 per	 OD	 cell	 density	 was	 monitored	 during	 growth	 of	 E.	 coli	 Top10	carrying	 pRScaf1M′-R′-lacZ,	 pRScaf1M′-R′-lacZ+pACYC-R	 (expressing	 Caf1R)	 or	 the	 negative	controls,	 pRS415	 and	 pRScaf1M′-R′-lacZ+pACYC	 (Fig.	 5.6).	 Promoter	 activity	was	 consistently	low	 throughout	 growth,	 in	 the	 absence	 of	 Caf1R	 (both	 E.	 coli/pRScaf1M′-R′-lacZ	 and	 E.	 coli/	pRScaf1M′-R′-lacZ+pACYC	empty	vector).	 In	 the	presence	of	Caf1R	 (pRScaf1M′-R′-lacZ+pACYC-R),	there	was	a	dramatic	increase	in	the	expression	of	lacZ	(β-galactosidase)	from	2	h	throughout	the	 exponential	 phase	 of	 growth.	 The	 activity	 from	 both	 tests,	 plus	 or	 minus	 Caf1R,	 was	maximum	 in	 the	 stationary	 phase	 of	 growth	 (at	 10	 h).	 At	 10	 h,	 without	 Caf1R	 the	maximum	activity	 was	 40.30	 ±	 1.65	 units,	 in	 cells	 carrying	 pRScaf1M′-R′-lacZ	 plus	 pACYC.	 Activity	increased	to	278.85	±	0.82	units	in	the	presence	of	Caf1R	(cells	carrying	both	pRScaf1M′-R′-lacZ	and	 pACYC-R	 plasmids).	 This	 suggests	 Caf1R	 dependent	 activation	 of	 a	 promoter	 within	 this	DNA	fragment,	with	about	a	6.9-fold	increase	in	the	activity.	Activity	from	pRScaf1M′-R′-lacZ	and	pRScaf1M′-R′-lacZ+pACYC	was	 almost	 identical,	 confirming	 that	 the	 enhanced	 activity	 of	 PR	promoter(s)	 in	 the	presence	of	Caf1R	 is	 from	Caf1R.	Comparison	of	β-galactosidase	activity	of	26°C-24	 h	 (0	 h,	 inoculum)	 and	 37°C-24	 h	 samples,	 indicated	 a	 substantial	 increase	 in	 activity	
(Fig.	5.6).	Without	Caf1R	(from	pRScaf1M′-R′-lacZ+pACYC),	the	temperature	induction	was	low,	2.9-fold;	 whereas	 when	 complemented	 with	 plasmid	 encoded	 Caf1R	 (from	 pRScaf1M′-R′-
lacZ+pACYC-R),	 induction	 was	 about	 8.3-fold,	 suggesting	 temperature-dependent,	 Caf1R-mediated	activation	of	PR	promoter(s).	This	is	consistent	with	thermoinduction	of	caf1R,	which	is	investigated	further	in	Chapter-6.		In	conclusion,	there	is	weak	promoter	activity	upstream	of	
caf1R	 and	 this	 was	 enhanced	 substantially	 in	 the	 presence	 of	 Caf1R	 provided	 in	 trans	 (from	pACYC-R),	 suggesting	 that	 there	 is	 a	Caf1R-dependent	promoter	 in	 the	caf1R-caf1M	 intergenic	region	 controlling	 expression	 of	 caf1R.	 This	 indicates	 caf1R-mediated	 autoregulation	 of	transcription	within	the	caf1R-caf1M	intergenic	region	of	the	caf	locus.				
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Figure 5.6| Promoter activity upstream of caf1R with and without Caf1R. 
Activity (per OD, solid lines) at 0-24 h in cells of E coli Top10 carrying pRScaf1M′-R′-lacZ (intergenic region 
alone), pRScaf1M′-R′-lacZ+pACYC-R (intergenic region +Caf1R) or the corresponding negative controls, 
pRS415 empty plasmid or pRScaf1M′-R′-lacZ+pACYC is presented on the primary Y-axis.  Growth scale 
(OD600, dotted lines) is on the secondary Y-axis. Error bars on the activity lines are based on ± SEM of activity 
from three separate cultures of each, processed from three individual colonies of each. 	
5.3.2 Promoter activity upstream of caf1M  	Promoter	activity	upstream	of	caf1M	was	monitored	in	a	similar	way	using	the	fusion	construct,	pRScaf1R′-M′-lacZ.	The	influence	of	Caf1R	on	β-galactosidase	activity	was	monitored	using	two	different	caf1R	encoding	constructs,	pRScaf1R-M′-lacZ	(cis	oriented	caf1R,	on	the	same	plasmid)	and	pRScaf1R′-M′-lacZ+pACYC-R	(trans	oriented	caf1R,	supplied	from	pACYC-R)	(Fig.	5.7).				
	
 
Figure 5.7| The cis and trans constructs used to test influence of Caf1R on PM promoter(s) activity.   		
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The	 β-galactosidase	 activity	 per	 OD	 cell	 density	 along	with	 growth	 (OD600)	 of	 test	 constructs,	pRScaf1R′-M′-lacZ	 (intergenic	 region	 alone),	 pRScaf1R-M′-lacZ	 (intergenic	 region	 plus	 cis	oriented	 caf1R),	 pRScaf1R′-M′-lacZ+pACYC-R	 (intergenic	 region	 plus	 caf1R	 supplied	 from	pACYC-R)	and	 the	 corresponding	negative	 controls,	 pRS550	empty	plasmid	and	pRScaf1R′-M′-
lacZ+pACYC	co-transformant	 is	presented	 in	Fig.	 5.8.	The	activity	of	caf1M	promoter(s)	 in	 the	absence	of	Caf1R,	from	pRScaf1R′-M′-lacZ	and	pRScaf1R′-M′-lacZ+pACYC	constructs	at	10	h	(the	time	point	of	maximum	activity)	was	7.38	±	0.56	and	8.82	±	0.65	units,	respectively	(Fig.	5.8),	indicating	 a	 much	 lower	 level	 of	 activity	 compared	 to	 the	 weak	 activity	 of	 the	 promoter(s)	upstream	 of	 caf1R	 in	 the	 absence	 of	 Caf1R	 (40	 ±	 0.61	 units)	 (Fig	 5.6).	 As	 with	 the	 caf1R	promoter-lacZ	 fusion	 construct,	 activity	 from	 the	 caf1M	 promoter-lacZ	 fusion	 construct,	pRScaf1R′-M′-lacZ	 was	 enhanced	 by	 trans	 expression	 of	 Caf1R	 from	 pACYC-R.	 Activity	 with	pRScaf1R′-M′-lacZ+pACYC-R	was	 283.49	 ±	 0.33	 units	 at	 10	 h,	 indicating	 about	 32-fold	 Caf1R-dependent	 activation	 (Fig.	 5.8).	 Almost	 identical,	 low-activity	 from	 pRScaf1R′-M′-lacZ	 and	pRScaf1R′-M′-lacZ+pACYC	confirms	that	the	increased	activity	from	pRScaf1R′-M′-lacZ+pACYC-R	is	solely	from	the	impact	of	Caf1R.			In	 spite	 of	 this	 dramatic	 activation,	 when	 caf1R	 was	 expressed	 in	 the	 trans	 orientation	 from	pACYC-R	 or	 when	 caf1R	 was	 expressed	 from	 the	 cis	 orientation	 in	 pRScaf1R-M′-lacZ,	 no	significant	 impact	was	observed	on	the	activity	of	PM	promoter(s)	(Fig.	 5.8).	Activity	was	only	3.95	±	0.07	units	(at	10	h),	even	lower	than	the	activity	from	pRScaf1R′-M′-lacZ	and	pRScaf1R′-
M′-lacZ+pACYC	constructs	at	10	h.	This	seems	very	strange	as	 the	same	oriented	of	caf1R	 and	intergenic	region	is	present	in	pACYCF1.	The	sequence	of	caf1R	and	intergenic	region	has	been	confirmed	 (Appendix	 4),	 but	 prior	 to	 speculation,	 functional	 β-galactosidase	 should	 be	confirmed	in	the	pRScaf1R-M′-lacZ	construct.	 If	expression	from	this	plasmid	carrying	caf1R	 in	
cis	 location	 is	 confirmed	 to	be	negligible,	 it	may	be	 related	 to	 the	 localised	architecture	of	 the	DNA.	 In	 conclusion,	 as	with	 the	 PR	 promoter(s),	 activity	 of	 PM	 promoter(s)	was	 stimulated	 by	
trans	supply	of	Caf1R,	suggesting	Caf1R	is	an	activator	with	multiple	modes	of	interaction	with	the	caf1R-caf1M	intergenic	DNA.			
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Figure 5.8| Promoter activity upstream of caf1M with and without Caf1R. 
Activity (per OD, solid lines) at 0-24 h in cells of E coli Top10 carrying pRScaf1R′-M′-lacZ (intergenic region 
alone), pRScaf1R-M′-lacZ (intergenic region plus caf1R on same plasmid), pRScaf1R′-M′-lacZ+pACYC-R 
(intergenic region +Caf1R) or the corresponding negative controls, pRS550 empty plasmid or pRScaf1R′-M′-
lacZ+pACYC is presented on the primary Y-axis. Growth scale (OD600 nm, dotted lines) is on the secondary Y-
axis. Error bars on the activity lines are based on ± SEM of activity from three separate cultures of each, 
processed from three individual colonies of each. 
 
5.3.3 Promoter activity upstream of caf1 	As	above,	the	activity	of	predicted	caf1	promoters	±	Caf1R	was	assayed	in	trans	using	pRScaf1A′-
1′-lacZ	 and	 pRScaf1A′-1′-lacZ+pACYC-R	 constructs	 along	 with	 the	 corresponding	 negative	controls,	 pRS550	 empty	 plasmid	 (pRS550)	 and	 pRScaf1A′-1′-lacZ+pACYC.	 Activity	 (β-galactosidase	activity	per	OD	cell	density)	and	growth	(OD600)	of	each	construct	is	presented	in	
Fig.	 5.9.	Activity	 in	the	 late	exponential	growth-phase	(6	h)	and	the	early	stationary	phase	(8-	and	10	h)	was	35.01	±	3.53	(6	h),	39.90	±	1.98	(8	h)	and	41.64	±	3.28	(10	h)	units	from	E.	coli	Top10/pRScaf1A′-1′-lacZ+pACYC.	 Activity	 was	 only	 modestly	 higher	 in	 samples	 with	 Caf1R,	(25.62	±	0.12	(6	h),	43.35	±	0.21	(8	h)	and	47.80	±	0.57	(10	h)	units)	in	E.	coli	Top10/pRScaf1A′-
1′-lacZ+pACYC-R,	indicating	no	detectable	effect	of	Caf1R	on	any	promoter	within	the	caf1A-caf1	intergenic	 fragment	 tested.	This	 in	 turn	suggests	 that	Caf1R	 is	 less	 likely	 to	bind	 to	caf1A-caf1	intergenic	 region.	 Unlike	 the	 very	 low	 activity	 from	 PM	 promoter(s)	 in	 the	 absence	 of	 Caf1R,	there	 was	 definite	 activity,	 throughout	 growth,	 in	 presence	 of	 caf1	 5′	 UTR	 DNA.	 At	 early	stationary	phase	 (10	h),	activity	was	49.82	±	0.12	units	versus	7.38	±	0.56	units	 for	promoter	activity	upstream	of	caf1M.	Comparison	of	26°C-24	h	(0	h	inoculum)	and	37°C-24	h,	revealed	a	temperature	 upshift	 from	 26	 to	 37°C	 of	 only	 2-fold	 increase	 in	 activity	 ±	 Caf1R.	 Hence,	 the	possibility	of	temperature-induced	transcription	effect	within	the	caf1A-caf1	intergenic	region	is	less	likely.	In	conclusion,	promoter	activity	upstream	of	caf1	was	low	and	not	activated	by	Caf1R.		
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Figure 5.9| Promoter activity upstream of caf1 with and without Caf1R. 
Activity (per OD, solid lines) at 0-24 h in cells of E coli Top10 carrying pRScaf1A′-1′-lacZ (intergenic region 
alone), pRScaf1A-1′-lacZ+pACYC-R (intergenic region +Caf1R) or the corresponding negative controls, 
pRS550 empty plasmid or pRScaf1A′-1′-lacZ+pACYC is presented on the primary Y-axis. Growth scale (OD, 
dotted lines) is on the secondary Y-axis. Error bars on the activity lines are based on ± SEM of activity from 
three separate cultures of each, processed from three individual colonies of each. 
 
5.4 Localisation of caf promoters and Caf1R-binding site(s) 	Following	 bioinformatic	 prediction	 and	 initial	 analysis	 of	 promoter	 activity	 within	 each	complete	 intergenic	 region,	 the	 next	 step	was	 to	 identify	 and	 localise	 which	 of	 the	 predicted	promoters	is	the	functional	promoter	for	each	gene.	Therefore,	a	series	of	promoter-lacZ	fusion	constructs	 were	 designed	 for	 each	 gene	 by	 Infusion	 cloning	 technology	 (section	 2.2.8(ii)	 and	2.3.1).	Each	 series	of	 constructs	 contained	 sequential	 loss	of	putative	promoter	and/or	 repeat	motif(s),	 shown	 in	 (Fig	 5.2).	 β-galactosidase	 activity	 from	 all	 of	 these	 promoter-lacZ	 fusion	constructs	was	measured	with	and	without	Caf1R	(encoded	from	pACYC-R).	The	numbering	of	all	promoter-lacZ	fusion	constructs	is	from	the	translation	start	site	(ATG)	of	the	corresponding	gene.			
5.4.1 Localisation of caf1R promoter and Caf1R-binding upstream of caf1R   	Five	 progressively	 shorter	 promoter-lacZ	 fusions,	 pRScaf1R′-137+192-lacZ,	 pRScaf1R′-114+192-lacZ,	pRScaf1R′-70+192-lacZ,	 pRScaf1R′-65+192-lacZ	 and	 pRScaf1R′-46+192-lacZ	 were	 created	 based	 on	predicted	promoters	and	repeats	(Fig.	5.10a).	The	putative	PR	promoters,	(PR1/2)	and	(PRK)	and	repeat	motifs	R1,	R2	and	R3	(possible	Caf1R	binding	sites)	were	lost	as	the	constructs	become	smaller	 (Fig.	 5.10b).	 The	 largest	 construct,	 pRScaf1R′-137+192-lacZ	 contained	 all	 the	 predicted	promoters	and	repeat	motifs	upstream	of	caf1R.	The	second	largest	construct,	pRScaf1R′-114+192-
lacZ	had	 lost	only	repeat	R3,	while	 in	the	third	and	fourth	constructs,	pRScaf1R′-70+192-lacZ	and	pRScaf1R′-65+192-lacZ,	 repeats	R3+R2	 and	 also	 PRK	 promoter	 had	 been	 deleted.	 The	 pRScaf1R′-65+192-lacZ	 construct	 was	 additionally	 missing	 half	 of	 repeat	 R1.	 In	 the	 smallest	 construct,	
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pRScaf1R′-46+192-lacZ,	all	repeat	motifs	and	predicted	promoters,	PRK	and	PR2	were	deleted	hence	this	 construct	 contained	 only	 PR1	predicted	promoter	 (Fig.	 5.10a-b).	 In	 the	 absence	 of	 Caf1R,	even	the	shortest	construct	(pRScaf1R′-46+192-lacZ),	had	promoter	activity	(Fig.	5.10c).	However,	the	pRScaf1R′-65+192-lacZ	construct,	which	includes	PR2	promoter,	showed	a	higher	level	of	basal	activity,	but	no	Caf1R	activation.	Inclusion	of	repeat	R1	in	construct	pRScaf1R′-70+192-lacZ	led	to	Caf1R	 activated	 transcription.	 As	 R1	 overlaps	 the	 -35	 element	 of	 PR2	 promoter,	 this	 provides	good	evidence	that	the	PR2	promoter	is	the	main	Caf1R	activated	promoter	for	transcription	of	
caf1R,	with	the	ATG	start	codon	as	shown	(Fig.	5.10a).	In	class	II	promoters	of	AraC/XylS	family	regulators,	the	transcriptional	regulator	binding	site	generally	overlaps	the	-35	motif	(Duval	and	Lister,	2013;	Egan,	2002;	Gallegos	et	 al.,	 1997).	The	pRScaf1R′-70+192-lacZ,	pRScaf1R′-114+192-lacZ	and	 pRScaf1R′-137+192-lacZ	 constructs	 contain	 repeats	 R1,	 R1+R2	 and	 R1+R2+R3,	 respectively.	Transcriptional	 activity	 of	 these	 constructs	 at	 8	 h	was	 enhanced	3.8-,	 7.6-	 and	2.5-fold,	 in	 the	presence	of	Caf1R	(Fig.	5.10c).		While	this	would	appear	to	suggest	that	R2	also	is	required	for	maximum	 Caf1R	mediated	 activation,	 the	 construct	 pRScaf1R′-70+192-lacZ	 lacks	 nt	 immediately	upstream	 of	 R1	 that	 may	 be	 required	 for	 efficient	 Caf1R	 binding.	 This	 requires	 further	investigation,	with	lacZ	fusion	construct	containing	a	further	10-15	nt	upstream	of	R1	to	ensure	optimum	 binding	 of	 Caf1R	 to	 R1.	 The	 low	 (2.5-fold)	 activation	 from	 the	 construct	 pRScaf1R′-137+192-lacZ	is	mainly	a	reflection	of	higher	basal	activity	in	the	absence	of	Caf1R,	suggesting	PRK	might	 function	 as	 a	 Caf1R	 independent	 promoter.	 A	 statistical	 comparison	 of	 the	 actual	 β-galactosidase	 activity	 from	 pRScaf1R′-137+192-lacZ	 and	 pRScaf1R′-114+192-lacZ	 in	 the	 presence	 of	Caf1R	at	each	time	point,	identified	a	statistically	decreased	level	of	β-galactosidase	production	throughout	growth	from	pRScaf1R′-137+192-lacZ	(P-value	<	0.05	at	each	time	point).	This	might	be	an	indication	of	different	modes	of	control	in	the	presence	of	the	3	repeat	sequences,	R1,	R2	and	R3.	 However,	 in	 the	 presence	 of	 the	 complete	 intergenic	 regionas	 in	 pRScaf1M′-R′-lacZ,	 full	Caf1R	mediated	activation	was	 restored	 (7.5-fold	activity	over	basal	 activity	 in	 the	absence	of	Caf1R).	 	
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Figure 5.10| Localisation of caf1R promoter and Caf1R-binding site(s) upstream of caf1R. 
a) Annotation of caf1M-caf1R intergenic DNA fragment (complement strand of the caf locus) as in 
pRS415caf1M′-R′-lacZ construct. Location of the putative promoter elements (-10 and -35) for caf1R (PR1/2, PRK) 
and for caf1M (PM) are underlined and indicated in bold; repeat motifs, R1, R2 and R3 (red arrows) and R4′ and 
R3′ (black arrows).  +158 and +192 indicate corresponding coding sequence of caf1M and caf1R with respect to 
ATG (Met) start sites. ↱ arrows indicate location of deletions, and number of bp (–xx) upstream from the caf1R 
start included in each construct. Start codons and SD sequences of caf1M and caf1R are shown, with both 
predicted starts (TTG and ATG) of caf1R highlighted. b) Deletion strategy and assigned promoter-lacZ fusions 
used to localise functional caf1R promoters and Caf1R binding site(s). c) β-galactosidase activity (± pACYC-R, 
encoding Caf1R) from promoter-lacZ fusions, sampled over 24 h as shown.  Activity (ΔA420/min/OD600nm) and 
Caf1R-mediated fold increase in activity at primary and secondary Y-axis, respectively. Standard error (± SEM) 
of activity was calculated from three individual colonies of each construct. The comparative P-value for activity 
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                                                                                                   caf1M     SD 
+158---------------AATCTATTTAAAATCATGAGCTTAACCTCCTTACGGAATGGTGA 
  
CAACACCTTCCCACCCCCTCCCCATCATTTCATATCGACGATATGCGTAAAAAGGTGGGTAA 
                                                -10PM 
CAAATGAAGGGGATTTTTATATCCGTAGCACAGCCTCACTGAGAACAATTtTATTTAAAAAT 
                                               TAAaAT  
-35PM                                                                                       
GCACACAAaGTttAGCTTtTcGCGCACTCCAcTtGCTtgTTGCGCAAATAGCTAATTTTGAT 
tCAaaT  -137 
-35PRK                                                          -10PRK                          -35PR2 
ATTGAtgCGCGTGCaCAAATAGCTAagATTGGTGTTGCTGGGTATGCGCAAATAGCTAagtc 
-114                                                                                                                                      -70           -65 
      -35PR1         -10PR2SD2   -10PR1caf1R2SD1caf1R1 
CcGGcgccggCCCACTATCTAgAATGCTATtATTTTGATTTGGGTTATATTCATGCTAAAAC 
     -46                                                                                                                                                   0  1  2 
AGAT------------+192  
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of pRScaf1R′-114+192-lacZ and pRScaf1R′-137+192-lacZ constructs +Caf1R were 0.014, 0.004, and 0.019 for 6 h, 8 h 
and 10 h respectively.  (Calculated using a Paired two-sample t-test, StatPlus software).   
5.4.2 Localisation of caf1M promoter and Caf1R-binding upstream of caf1M   	To	 localise	 the	 caf1M	 promoter,	 six	 progressively	 shorter	 promoter-lacZ	 fusions,	 pRScaf1M′-270+158-lacZ,	 pRScaf1M′-197+158-lacZ,	 pRScaf1M′-184+158-lacZ,	 pRScaf1M′-169+158-lacZ,	 pRScaf1M′-141+158-lacZ	and	pRScaf1M′-102+158-lacZ		(Fig	5.11)	were	created	based	on	the	analysis	of	caf1M	5′	UTR.	These	constructs	contain	the	sequential	removal	of	predicted	promoters,	(PMK1-2),	PMB	and	PM	for	caf1M	and	repeat	motifs.	Briefly,	the	largest	construct,	pRScaf1M′-270+158-lacZ	contains	13	of	the	15	nt	of	R1	and	intact	R2,	R3,	R3′	and	R4′	plus	all	4	predicted	promoters	for	caf1M.	The	second	 construct,	 pRScaf1M′-197+158-lacZ	 has	 essentially	 lost	 all	 3	 repeats	 (R1-R3),	 upstream	of	
caf1R	 but	 retained	 R3′	 and	 R4′,	 and	 all	 predicted	 promoters	 for	 caf1M.	 The	 third	 construct,	pRScaf1M′-184+158-lacZ	 contained	 only	 R4	 and	 all	 predicted	 promoters	 for	 caf1M.	 The	 fourth	construct,	pRScaf1M′-169+158-lacZ	contained	only	7	of	the	15	nt	of	R4′	repeat,	hence	essentially	no	repeat,	but	retained	all	predicted	promoters	for	caf1M.	Construct	number	five,	pRScaf1M′-141+158-
lacZ	had	lost	the	PM	promoter	but	retained	BPROM	predicted	PMB	promoter,	while	the	smallest	construct,	 pRScaf1M′-102+158-lacZ	 contained	 only	 the	 previously	 assigned	promoters	 (Karlyshev	et	al.,	1992)	PMK1-2		for	caf1M.		The	 results	 of	 the	 β-galactosidase	 assays	 with	 this	 series	 of	 caf1M	 promoter-lacZ	 fusion	constructs	showed	a	very	clear	indication	of	both	the	functional	promoter	and	the	Caf1R	binding	site	 (Fig.	 5.11c).	 Very	 low	 promoter	 activity	 (about	 2.8-3.9	 units)	 was	 observed	 from	 both	pRScaf1M′-102+158-lacZ	 and	 pRScaf1M′-141+158-lacZ	 constructs,	 with	 or	 without	 Caf1R.	 As	pRScaf1M′-141+158-lacZ	 contains	 both	 previously	 assigned	 promoters	 (Karlyshev	 et	 al.,	 1992),	PMK1-2	 and	 the	 BPROM	 predicted	 PMB	 promoter,	 this	 suggests	 that	 none	 of	 these	 predictions	represent	an	active	promoter	 for	caf1M.	 In	 contrast,	pRScaf1M′-169+158-lacZ,	which	contains	 the	visually	identified	promoter,	PM	showed	about	10-fold	higher	activity	(27.68	±	0.64,	28.97	±	0.62,	27.74	 ±	 0.08	 and	 32.55	 ±	 0.34	 units	 at	 6,	 8,	 10	 and	 24	 h,	 respectively)	 although	 no	 Caf1R-	mediated	 activation	 of	 transcription	 was	 observed.	 Inclusion	 of	 the	 repeat	 R4′,	 with	 an	additional	 15	 bp	 upstream	 in	 the	 construct	 pRScaf1M′-184+158-lacZ,	 resulted	 in	 clear	 Caf1R-mediated	activation.	 	About	7.5-	and	11.4-fold	increase	in	activity	was	observed	at	6	h	and	8	h	from	extracts	of	cells	transformed	with	pRScaf1M′-184+158-lacZ	and	pACYC-R	(Caf1R+)	compared	to	 cells	 transformed	 with	 pRScaf1M′-184+158-lacZ	 and	 pACYC	 plasmid	 (Caf1R-).	 Together	 these	results	 indicate	that	the	visually	 identified	promoter	assigned	as	PM	is	the	functional	promoter	for	the	transcription	of	caf1M.	The	results	also	show	that	inclusion	of	19	bp	upstream	of	the	-35	element	 of	 this	 promoter	 is	 sufficient	 for	 Caf1R	 mediated	 activation,	 consistent	 with	 Caf1R	binding	 to	 the	R4′	 repeat	motif.	 The	 fact	 that	 PM	promoter	 is	 the	 only	 predicted	 promoter	 for	
caf1M	 associated	 with	 a	 potential	 Caf1R	 binding	 motif	 is	 further	 evidence	 that	 this	 is	 the	functional	 promoter	 for	 Caf1R-mediated	 activation	 of	 transcription	 of	 caf1M.	 In	 contrast	 to	Caf1R-activated	transcription	at	the	PR2	promoter	(from	pRScaf1R′-70+192-lacZ+pACYC-R),	Caf1R-activated	transcription	at	PM	promoter	(from	pRScaf1M′-184+192-lacZ+pACYC-R)	showed	a	gradual	increase	in	activity	from	the	exponential	(6	h)	to	the	early	stationary	phase	(10	h)	followed	by	slight	reduction	at	24	h.	
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Figure 5.11| Localisation of caf1M promoter and Caf1R binding upstream of caf1M. 	a) Annotation of the caf1R-caf1M intergenic DNA fragment (sense strand) as in construct, pRScaf1R′-M′-lacZ. 
Location of the putative promoter elements (-10 and -35) of PM, PMB and PMK1/2 are underlined and indicated in 
bold; repeat motifs, R4′ and R3′ (black arrows), R1, R2 and R3 (red arrows). +158 and +192 indicate 
corresponding coding sequence of caf1M and caf1R with respect to ATG (Met) start sites. ↱ arrows indicate 
location of deletions, and number of bp (–xx) upstream from caf1M start included in each construct. Start codons 
and SD sequences of caf1M and caf1R are shown, with both predicted starts (TTG and ATG) of caf1R 
highlighted. b) Deletion strategy and assigned promoter-lacZ fusions constructs, used to localise functional 
promoters for caf1M and Caf1R binding. c) β-galactosidase activity (± pACYC-R, encoding Caf1R) from 
promoter-lacZ fusions, sampled over 24 h as shown.  Activity (ΔA420/min/OD600 nm) and Caf1R-mediated fold 
increase in activity at primary and secondary Y-axis, respectively. Standard error (± SEM) of activity was 
calculated from three individual colonies of each construct. The comparative P-value for activity of pRScaf1M′-
184+158-lacZ and pRScaf1R′-197+158-lacZ constructs +Caf1R were 0.006, 0.004, and 0.001 for 6 h, 8 h and 10 h 
respectively.  (Calculated using a Paired two-sample t-test, StatPlus software). 
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                                                             caf1R1       SD1              caf1R2                              SD2                         
+192---------TGTTTTAGCATGAATATAACCCAAATCAAAATAATAGCATTCTAGA           
                                                               GTA       TGG     GTT       CGTAAGA 
                                                                        
TAGTGGGCCGGCGCCGGGACTTAGCTATTTGCGCATACCCAGCAACACCAATCTTAG 
                                                                     -269                                                                                                                         
 
CTATTTGtGCACGCGCATCAATATCAAAATTAGCTATTTGCGCAAcaAGCaAgTGGA 
                                                                                                                       -196                                 -183                
                   
                            -35PM-10PM -35PMB   
GTGCGCgAaAAGCTaaACtTTGTGTGCATTTTTAAATAaAATTGTTctCAGTGAGGC 
        -168                               -140                
 
             -10PMB              -35PMK2           -35PMK1    -10PMK2 
TGTGCTACGGATATAAaAATCCCCTTCATTTGttACCCACCTTTTtACgCATATcgT 
                  -102 
         -10PMK1                                                                                                                                 SD              
CGATATGAaATgATGGGGAGGGGGTGGGAAGGTGTTGTCACCATTCCGTAAGGAGGT  
       caf1M 
TAAGCTCATGATTTTAAATAGATTAAGTACG-----------------------+158 
       0  1  2 
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5.4.3 Confirmation of PM promoter by mutagenesis in pACYCF1 	The	 predicted	 -10	 element	 (TAaAAT)	 of	 the	 PM	 promoter	 was	 substituted	 by	 GCcGGC	 in	 the	pACYCF1	plasmid	(carries	the	entire	WT	caf	locus),	using	SDM	and	the	Pcaf1M_2f	and	Pcaf1M_2r	mutagenic	 primers	 as	 described	 in	 section	 2.2.4(iv)(a).	 Plasmid	 size	 was	 monitored	 and	 the	GCCGGC	substitution	was	confirmed	in	plasmids	from	three	of	the	E.	coli	DH5α	transformants	by	sequencing	 the	 complete	 caf1R-caf1M	 intergenic	 region.	 Plasmids	 were	 assigned	 the	 name	ΔPM_pACYCF1.	Following	 confirmation,	 F1	expression	was	 tested	 from	all	 three	 transformants	(1-3)	 and	 compared	 to	 the	 level	 of	 expression	 from	 three	 transformants	 (1-3)	 of	 E.	 coli	DH5α/pACYCF1	 (wild	 type)	 (Fig.	 5.12).	 F1	 expression	was	monitored	 directly	 in	whole	 cells	(section	2.4.1),	after	4	and	6	h	thermo-induction	(Fig.	5.12).	 In	contrast	to	the	high	level	of	F1	produced	 in	 all	 three	 transformants	 of	 E.	 coli	 DH5α/pACYCF1,	 transformants	 of	DH5α/ΔPM_pACYCF1	produced	no	detectable	F1	(Caf1).	While	this	is	a	drastic	mutation	that	may	have	other	effects	including	loss	of	IHF	binding,	the	results	are	consistent	with	the	finding	that	the	visually	 identified	promoter,	PM,	 is	a	 strong	Caf1R	activated	promoter,	 controlling	 the	high	level	of	F1	expression	from	the	caf	locus.			
		
Figure 5.12| Loss of F1 production on mutation of PM promoter.  
Samples from three individual transformants of both wild type, DH5α/pACYCF1 and DH5α/ΔPM_pACYCF1 
mutant were harvested after 4 and 6 h thermo-induction at 37°C. Equivalent of 0.04 OD units of each sample of 
heat denatured cells (97.5°C for 15 min) were resolved on 16% acrylamide gels followed by CB staining.  	
5.4.4 Localisation of promoter(s) upstream of caf1  	Although	there	was	no	indication	of	Caf1R-binding	in	the	caf1A-caf1	 intergenic	region	in	either	the	 bioinformatics	 analysis	 (section	 5.2)	 or	 with	 the	 transcriptional	 fusion	 study	 of	 cells	transformed	 with	 pRScaf1A′-1′-lacZ	 and	 pACYC-R	 (section	 5.3.3),	 but	 there	 was	 evidence	 of	some	 promoter	 activity	 in	 this	 intergenic	 region	 (section	 5.3.3).	 Therefore,	 six	 deletion	constructs	 (Fig.	 5.13a-b)	 were	 designed	 within	 this	 region	 to	 localise	 any	 potential	 caf1	promoter.	 Four	 of	 these	 constructs,	 pRScaf1′-181+88-lacZ,	pRScaf1′-158+88-lacZ,	pRScaf1′-61+88-lacZ	and	 pRScaf1′-38+88-lacZ	 contained	 the	 first	 88	 bp	 of	 caf1	 (from	 ATG	 start)	 and	 progressively	larger	 fragments	of	caf1A-caf1	intergenic	region	with	or	without	bases	 from	caf1A	3′	terminus		(indicated	 as	 –xxx).	 The	 other	 two	 constructs,	 pRScaf1′-259-61-lacZ	and	pRScaf1′-259-22-lacZ	were	missing	the	first	61	or	22	bp	upstream	and	coding	bases	of	caf1.	They	contained	the	rest	of	the	
!!!!!!!!!pACYCF1               ΔPM_pACYCF1    
  1          2            3           1             2          3 
Caf1 
Caf1 
4h 
6h 
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caf1	5′	UTR	upstream	from	-61	and	-22	bp,	respectively,	plus	the	same	3′	fragment	of	caf1A	(179	bp),	 present	 in	 the	 pRScaf1A′-1′-lacZ	 construct.	 Thus	 the	 first	 construct,	 pRScaf1′-181+88-lacZ	encompassed	 the	DNA	 fragment	 containing	 repeat	 motifs,	 R1c,	 R2a	 and	 R2b	 and	 -10	 and	 -35	elements	of	P11,	P12	and	P1B	promoters.	The	second	construct,	pRScaf1′-158+88-lacZ	contained	R1b,	R1c,	R2a	and	R2b	repeat	motifs	and,	P11	and	P1B	predicted	promoters	plus	the	-10	consensus	of	P12.	The	third	construct,	pRScaf1′-61+88-lacZ	also	contained	R1c,	R2a	and	R2b	repeat	motifs,	and	P11	and	 P1B	 predicted	 promoters.	 The	 fourth	 construct,	 pRScaf1′-38+88-lacZ	 contained	R1c,	 R2a	 and	R2b	 repeat	 motifs,	 the	 BPROM	 predicted	 promoter,	 P1B	 plus	 the	 -10	 element	 of	 predicted	promoter,	P11.	The	other	 two	 constructs	 lacked	promoter	P1B	but	 contained	predicted	P13	 that	was	absent	from	the	other	constructs.	pRScaf1′-259-61-lacZ	contained	R1a	and	R1b	repeats	motifs	and	 P13	 and	 P12	 predicted	 promoters.	 pRScaf1′-259-22-lacZ	 contains	 R1a,	 R1b,	 part	 of	 R2a	repeat	motifs	and	P13,	P12,	P11	and	the	-35	element	of		P1B	predicted	promoter.				Negligible	activity	was	observed	with	inclusion	of	promoters,	P11-3	 in	constructs	pRScaf1′-259-61-
lacZ	and	pRScaf1′-259-22-lacZ	(Fig.	5.13c).	Thus,	P11-3	do	not	appear	to	be	functional	promoters	for	transcription	 of	 caf1.	 In	 contrast,	 all	 other	 constructs	 from	 the	 smallest	 (pRScaf1′-38+88-lacZ)	upwards	showed	a	low	level	of	promoter	activity	in	the	exponential	(6	h,	23.6	±	0.05	units)	and	stationary	(at	8	h,	36.6	±	0.07	units)	growth	phase	(Fig.	5.13c).	This	is	consistent	with	P1B	being	the	sole	active	promoter	in	this	region.	However	as	raised	earlier,	the	location	of	this	promoter	adjacent	to	the	start	of	caf1	means	that	it	cannot	be	the	promoter	responsible	for	transcription	of	full-length	caf1.	The	possibility	remains	that	it	might	function	as	a	promoter	for	the	putative	small	ORF	encoding	a	short	peptide	of	69-amino	acids	(Fig.	5.3).	Caf1R	had	negligible	effect	on	the	level	of	transcription	from	this	part	of	the	caf	locus.			In	conclusion,	no	promoter	was	identified	between	the	beginning	of	caf1	and	the	last	179	bp	of	
caf1A	that	could	be	responsible	for	transcription	of	full-length	caf1	and	there	was	no	evidence	to	support	Caf1R	binding	within	this	region.	BPROM	predicted	a	strong	promoter	(strongest	within	the	 caf	 locus)	 at	 192	 bp	 downstream	 from	 the	 beginning	 of	 caf1A.	 	 The	 LDF	 score	 of	 this	promoter	is	6.68	having	-10	(TAgAcT;	score	62)	and	-35	(TTaAtg;	score	29)	and	a	21	nucleotide	spacer.	 Activity	 of	 this	 promoter	was	 not	 tested.	While	 it	 could	 in	 theory	 promote	 additional	transcription	of	caf1,	the	transcript	would	have	a	leader	sequence	of	2375	bp.		
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Figure 5.13| Localisation of caf1 promoter and lack of effect of Caf1R.  
a) Annotation of caf1A-caf1 intergenic DNA as assigned in section 5.2.2 and included in pRScaf1A′-1′-lacZ. 
Location of the putative promoter elements (-10 and -35) for P11-3 and P1B are underlined and indicated in bold, 
repeat motifs, R1a-c and R2a-b are shaded in grey. -259 and +88, numbering of residues with respect to the A of 
caf1 ATG start codon (green). TGA stop codon of caf1A is in magenta. ↱, arrows indicate start of inserts in 
fusion constructs with sequence XX to +88; ↰, arrows indicate end of inserts in fusion constructs with insert -
269 to XX.  b) Deletion strategy and assigned promoter-lacZ fusions, used to localise functional promoters for 
caf1 and to test the impact of Caf1R. c) β-galactosidase activity (± pACYC-R, encoding Caf1R) from promoter-
lacZ fusions, sampled over 24 h as shown. Activity (ΔA420/min/OD600 nm) and Caf1R-mediated fold increase in 
activity at primary and secondary Y-axis, respectively. Standard error (± SEM) of activity was calculated from 
three individual colonies of each construct.  						
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c 
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-259                                             -35P13                   R1a          -10P13 
CTGGCATTGTCGGAGATAATAGCGGTGTCTATTTGACtGGACTACCTAAAAAATCaAaAATA 
                
-35P12R1b-10P12 
CTTGTTAAGTGGGGGAgaGAtAAAAATCAATCATGTTCATcTAATGTAGTTCTACCAGAAAA 
               -181                              -158 
                                                   caf1A
AACGGATATTTCTGGTGCTTATAGGTTATCCACAACCTGCATCTTAAATAACTGAAACGGAT 
            
 -35P11                  -10P11    -35P1B       R2a 
GTTTATTTCAAACagGACACAAGCCCTCTCTACGAATtTgtTCGTgGAttGGATTATTCGAT   
           -61                                -38                     -22 
     SD          -10P1)B caf1             R1c                                                                                                               R2b 
AGAGGTAatATATGAAAAAAATCAGTTCCGTTATCGCCATTGCATTATTTGGAACTATTGCA 
                                    0 1  2 
                              SD’                                   caf1’                                    +88 
ACTGCTAATGCGGCAGATTTAACTGCAAGCACCACTGC 
 
                                                                          
 
 
 
( 13)# -10(P13)#
- 5(P1 )# -10(P12)#
( 11)# -10(P1 )# ( B)#
-10( 1B)#
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5.5 In vitro confirmation of Caf1R binding to the R4′ repeat, upstream of PM  	Following	in	vivo	confirmation	of	PM	as	the	main	Caf1R-activated	promoter	within	the	caf	locus,	an	 in	vitro	protein-DNA	binding	approach,	electrophoretic	mobility	shift	assay	(EMSA)	(section	2.10),	 was	 used	 to	 decipher	 tagged	 Caf1R-PM	 interactions.	 Freshly	 prepared	 cell	 lysates	containing	 hCaf1RTgs,	 MBPCaf1Rgs	 or	 MBPCaf1RN	 as	 well	 as	 purified	 protein	 were	 used	 to	monitor	binding	of	Caf1R	to	oligonucleotides	containing	the	putative	Caf1R	binding	repeat	R4′.	The	 PM	 promoter	 specific	 and	 non-specific	 DNA	 probes	 were	 selected	 from	 the	 caf1R-caf1M	intergenic	 region.	The	specific	biotinylated	probe	 (F2-B)	was	designed	based	on	results	of	 the	promoter	fusion	assay	(Fig.	5.11)	and	the	Caf1R	consensus	sequence	(Fig.	5.4).	It	contained	47	bp	from	-140	to	-186	bp	upstream	of	caf1M	start	codon,	ATG	and	included	the		-35	element	of	PM	promoter	and	the	R4′	repeat	motif.	The	non-specific	biotinylated	probe	(F1-B),	also	47	bp	was	selected	from	-56	to	-102	bp	upstream	of	caf1M	start	codon,	ATG	and	includes	no	recognisable	predicted	Caf1R	binding	sequence	(Fig.	5.14).		
		Figure	5.14|	Biotin	tagged	specific	(F2-B)	and	non-specific	(F1-B)	EMSA	probes.		
F2-B (47 bp), contained predicted Caf1R-binding R4′ repeat motif (arrow) plus part of the downstream PM 
promoter (bold and underlined). BS1 and BS2 (underlined), putative binding site for Caf1R helix-3 and helix-6 
according to mar-MarA complex (Rhee et al., 1998). F1-B (47 bp) contains predicted but non-functional PMK1 
and PMK2 promoters upstream of caf1M. Small bold letters indicate non-consensus nucleotides in the predicted 
promoter elements. Numbers underneath of F1-B and F2-B are relative to ATG start codon of caf1M. See Figs. 
5.11 and 5.13 for confirmation of Caf1R dependent functional and non-functional promoters. F2-B and F1-B, 
biotin labeled probes; F2 and F1, corresponding unlabeled oligonucleotides. 
5.5.1 EMSAs with hCaf1RTgs 
i)	 In	vitro	binding	of	wild	type	and	mutated	hCaf1RT	from	cell	lysates			Initial	binding	studies	were	performed	using	 freshly	prepared	cell	 lysates	(4	and	6	μl)	 from	E.	
coli	 BL21(DE3)	 expressing	 wild	 type	 hCaf1RTgs	 (from	 pEThCaf1Rgs),	 mutated	 hCaf1RTgsE98G	(from	 pEThCaf1RgsE98G)	 or	 no	 Caf1R	 (negative	 control,	 from	 pET28a+)	 together	 with	 the	 test	(F2-B)	or	control	 (F1-B)	biotin-labeled	probes	(5-fmol	each).	Binding	reactions	were	set	up	as	described	 in	 section	 2.10.4	 and	 subjected	 to	 EMSA	 as	 detailed	 in	 section	 2.10.5.	 A	 prominent	shift	in	migration	of	the	biotinylated-F2-B	DNA	probe	was	observed	with	both	4	and	6	μl	lysates	containing	wild	type	hCaf1RTgs	(Fig.	5.15a,	 lanes	3	and	7)	 indicating	formation	of	a	hCaf1RT-F2-B	 complex	 (B).	 The	 6	 μl	 lysate	 produced	 a	 stronger	 shifted	 band	 than	 the	 4	 μl	 sample,	consistent	with	dependence	of	 the	 interaction	on	Caf1R	concentration.	A	competition	reaction,	with	100-fold	molar	excess	unlabeled	F2	probe	(500	fmol)	in	the	binding	reaction	of	wild	type	
          F2-B (Specific) 
                                                     
 R4    35PM  10PM  
5’GCAAGTGGAGTGCGCGAAAAGCTaaACtTTGTGTGCATTTTTAAATA-3’Biotin
                 3’Biotin-CGTTCACCTCACGCGCTTTTCGAttTGaAACACACGTAAAAATTTAT5’ 
                        -186             -180                         -170                         -160                         -150                          -140                                  
 
 
          F1-B (Non-specific) 
 
                                 35PMK2                               35PMK1                 10PMK2  
5’TCCCCTTCATTTGttACCCACCTTTTtACgCATATcgTCGATATGAA-3’Biotin 
3’Biotin-AGGGGAAGTAAACaaTGGGTGGAAAAaTGcGTATAgcAGCTATACTT5’
                    -102              -96                           -86                            -76                           -66                          -56                                   
 
BS1 BS2
R4′ 
-35( MK2) ! -35(PMK1) ! -10(PMK2) !
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hCaf1RTgs		lysate	and	F2-B	probe	showed	no	shift	in	the	labelled	F2-B	probe	(Fig.	5.15a,	lane	5	
and	 9),	 providing	 evidence	 for	 specificity	of	 binding.	 Specific	binding	of	hCaf1RTgs	 to	 the	 test	probe,	 F2-B	 was	 confirmed	 by	 the	 very	 faint	 shifted	 band	 of	 F1-B	 (control	 probe)	 with	 6	 μl	hCaf1RTgs	lysate	(Fig.	5.15a,	lane	10,	WT).	As	expected	no	shift	in	F2-B	was	observed	from	the	reactions	 containing	 no	 lysate	 (NL,	 lane	 1).	 This	 and	 the	 absence	 of	 any	 shift	 with	 lysates	obtained	from	cells	carrying	empty	pET28a+	vector	(C)	(Fig.	5.15a,	lane	2,	6	and	12)	supports	identity	of	the	shifted	band	as	a	complex	of	hCaf1RTgs-F2-B	rather	than	a	specific	interaction	of	this	DNA	sequence	with	some	other	cell	factor.	The	very	faint	complex	observed	with	4	μl	lysate	containing	the	mutated	regulator,	hCaf1RTgsE98G	(Fig.	5.15a,	lane	4,	E98G)	further	supports	the	identity	of	the	complex	as	hCaf1RTgs-F2-B.			Thus	this	initial	study	with	cell	lysates	provided	strong	evidence	that	wild	type	hCaf1RT	gs	binds	with	high	specificity	 to	the	F2-B	probe,	which	 includes	the	Caf1R	binding	consensus	sequence.	The	 very	 weak	 activity	 of	 hCaf1RTgsE98G	 mutant	 is	 interesting,	 as	 this	 would	 explain	 loss	 of	transcriptional	 activation	 by	 Caf1R	 possessing	 this	 G98	 residue.	 However,	 it	 could	 also	 be	explained	by	instability	of	the	mutated	protein.	Therefore,	an	immunoblot	was	performed	using	fresh	lysates	along	with	a	repeat	of	the	EMSA	(Fig.	5.15b-c).	It	was	observed	that	in	this	EMSA,	hCaf1RTgs-F2-B	 interaction	 resulted	 in	 two	 shifted	bands,	B1	and	B2,	 in	 contrast	 to	 the	 single	shift	 detected	 earlier	 (Fig.	 5.15b).	 	 Two	 different	 shifted	 complexes	 have	 been	 attributed	 by	others	to	monomeric	and	dimeric	protein-DNA	complexes	(Carolina	and	Celso,	2012;	Elliot	et	al.,	2003).	This	is	seen	with	AraC/XylS-type	regulators	that	function	as	both	activator	and	repressor	(Hollander	et	al.,	2011;	Ruiz	et	al.,	2003).	A	low	level	of	complex	only	at	position	B2	was	detected	with	 lysate	 from	 the	 hCaf1RTgsE98G	mutant.	 The	western	 blot	 analysis	 of	 these	 lysate	 samples	detected	both	hCaf1RTgsE98G	and	hCaf1RTgs	(Fig.	 5.15c).	The	 lower	 level	of	hCaf1RTgsE98G	may	suggest	 a	 greater	 instability	 of	 hCaf1RTgsE98G,	 but	 probably	 not	 sufficient	 to	 account	 for	 the	differences	in	binding	activity.	To	differentiate	the	impact	of	the	E98G	mutation	on	DNA	binding	versus	regulator	stability,	this	would	be	best	addressed	by	comparing	specific	binding	activity	of	both	purified	proteins.		 	
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Figure 5.15| EMSA with cell lysates of wild type and mutated hCaf1RTgs. 
a) EMSA blot. Lysates (4 or 6 µl) of BL21(DE3)/pEThCaf1Rgs (WT), pEThCaf1RgsE98G (E98G) or /pET28a+ 
(C, vector control) were incubated with 5-fmol biotinylated DNA probe. Reactions were analysed by DNA 
retardation gel electrophoresis and visualised using Streptavadin-HRP, as in methods, section 2.10.  b) Repeat 
EMSA analysis with hCaf1RTgs and hCaf1RTgsE98G (from fresh 6 µl cell lysate) using F2-B probe (10-fmol). c) 
Immunoblot of fresh lysates (6 µl) used in (b) with AntiHis-HRP monoclonal antibody (1:10,000) to detect His6-
tagged Caf1R. Probes: F2-B (test, includes proposed Caf1R binding R4′ repeat); F1-B (control, caf DNA 
without Caf1R-binding consensus); F2, non-biotinylated test (specific) probe. B/B1/B2: Retarded hCaf1RTgs-
F2-B complexes, D: degradation product and UB: unbound biotinylated probe. NL: no lysate. kDa: SDS-PAGE 
molecular weight markers. Arrow indicates hCaf1RTgs, at about 38 kDa.    					
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ii)	 In	vitro	binding	of	IMAC	purified	hCaf1RTgs		to	Caf1R	specific	F2-B	probe		To	confirm	hCaf1RTgs	binding	to	the	R4′	DNA	probe	(F2-B)	fresh	IMAC	purified	hCaf1RTgs	(Fig.	
4.21,	 Fn-10,	40	μg/ml)	was	concentrated	and	dialysed	against	20	mM	Tris,	300	mM	NaCl,	pH	8.0	and	the	final	preparation	(245	μg/ml,	6308.7	pmol/ml)	stored	at	4	°C	on	ice.	This	was	tested	in	EMSA	(section	2.10)	using	2.5	to	50	pmol	of	protein	and	10-fmol	of	F2-B	probe.	Again	2	band	shifts	(protein-F2-B	complexes),	B1	and	B2,	were	observed	(Fig.	5.16),	 indicating	that	purified	hCaf1RTgs	may	 bind	 as	 monomer	 and	 dimer.	 However,	 binding	 was	 irrespective	 of	 varying	protein	 concentrations	 and	 the	 unbound	 (UB)	 F2-B	 DNA	 was	 prominent,	 suggesting	 that	hCaf1RTgs	had	not	bound	optimally	to	F2-B	probe.			
	
 
Figure 5.16| In vitro binding of IMAC purified hCaf1RTgs to Caf1R specific F2-B probe. 
EMSA blot using purified hCaf1RTgs (6.3 pmol/µl in 20 mM Tris, 300 mM NaCl, pH 8.0) and F2-B biotinylated 
probe. Increasing amounts of hCaf1RTgs (2.5-55 pmol) as indicated, were incubated with the Caf1R specific F2-
B probe (10-fmol), non-specific competitor DNA Poly dI.dC (50 ng), 1× reaction-binding buffer (10 mM Tris, 
50 mM KCl and 1 mM DTT; pH 7.5) in a final reaction volume of 20 µl (section 2.10). B1 and B2: hCaf1RTgs-
F2-B complexes. UB: Unbound, F2-B probe and NP: negative control with no Caf1R protein.  
  
5.5.2 EMSAs with MBPCaf1R and MBPCaf1RN  	His6-tagged	Caf1R	consistently	bound	specifically	to	the	Caf1R	specific	F2-B	DNA	fragment,	but	binding	 of	 isolated	 protein	 was	 not	 optimal.	 Much	 higher	 levels	 of	 recombinant	 Caf1R	 were	recovered	with	MBPCaf1Rgs	fusions	(Chapter-4).	Therefore,	MBPCaf1Rgs	and	MBP	fused	to	the	N-terminal	DBD	of	Caf1R	(MBPCaf1RN)	also	were	tested	for	DNA	binding	capacity.	
i)	 In	vitro	binding	of	MBPCaf1Rgs	and	MBPCaf1RN	from	cell	lysate			Cell	 lysates	 of	 E.	 coli	 K12-ER2508	 carrying	 pMALc2-MBPCaf1Rgs,	 pMALc2-MBPCaf1RN	 or	pMALc2x	empty	vector	were	prepared	and	subjected	to	EMSA	using	6	μl	of	corresponding	cell	lysates	 and	10-fmol	of	F2-B	probe	as	described	 in	 section	2.10.	 	A	prominent	 shift	 of	protein-DNA	 complex	 (B)	 was	 observed	 from	 the	 lysates	 of	 both	 pMALc2-MBPCaf1Rgs	 (LMBP-R)	 and	
hCaf1RTgs  
 NP     55       50        45        35        30         25       10         5        2.5 pmol 
B2 
B1 
UB 
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pMALc2-MBPCaf1RN	 (LMBP-RN)	 (Fig.	 5.17a).	 The	 absence	 of	 any	 shifted	 band	 in	 the	 negative	control,	cell	lysate	containing	MBP	alone	from	pMALc2x	(LMBP),	confirmed	that	the	shifted	F2-B	band	 (B)	 is	 due	 to	 interaction	 of	 Caf1R/Caf1RN	 with	 F2-B.	 Both	 MBPCaf1Rgs	 and	 MBPCaf1RN	resulted	 in	 an	 intense	 band	 of	 the	 shifted	 complex,	 suggesting	 that	 the	 N-terminal	 domain	 of	Caf1R	alone	is	sufficient	to	mediate	DNA	binding.	The	ratio	of	F2-B	in	complex	(B)	to	unbound	F2-B	 (UB)	 was	much	 larger	 with	 the	MBP	 fusions	 (MBPCaf1Rgs	 and	MBPCaf1RN)	 than	 assays	using	hCaf1RTgs	lysates.	This	can	most	likely	be	attributed	to	the	fact	that	there	is	substantially	more	MBPCaf1Rgs	 and	MBPCaf1RN	 in	 these	 lysates	 than	 hCaf1RT.	MBPCaf1Rgs	 and	MBPCaf1RN	fusions	represented	the	strongest	CB	stainable	band	cell	 lysates	(Fig	5.17b),	whereas	hCaf1RT	was	only	visible	following	immunoblotting	of	cell	lysates	(Fig	5.15c).			 	
	
 
Figure 5.17| EMSA with cell lysates of MBPCaf1R and MBPCaf1RN. 
a) EMSA blot. b) CB stained SDS-PAGE gel from cell lysates of E. coli K12-ER2508 carrying pMALc2-
MBPCaf1Rgs (LMBP-R, full length Caf1R), pMALc2-MBPCaf1RN (LMBPR-RN, Caf1R N-terminus BDB) or 
pMALc2x (LMBP, vector control), induced with 0.3 mM IPTG for 2.5 h at 37°C. For EMSA, 6 µl of cell lysate, 
was tested with 10-fmol biotinylated F2-B probe as described, section 2.10. NL: no lysate, unbound F2-B 
control. B: retarded protein-DNA complex from MBP-R/RN- and F2-B probe. UB: unbound F2-B probe. For 
SDS-PAGE analysis, 6 µl of corresponding cell lysates or 100 pmol of purified/dialysed MBPCaf1Rgs (PMBP-R) 
was mixed in 5 mM DTT supplemented SDS-PAGE sample buffer (4×), heat denatured (97.5°C-15 min) and 
resolved on 12.5% polyacrylamide containing gel followed by CB staining. MBPCaf1Rgs (78.98 kDa) and 
MBPCaf1RN (57.35 kDa) are indicated by ⟹ and ↣ arrow, respectively. MBP alone (42.956 kDa) is indicated 
by → arrow. Identity of MBP and MBPCaf1R/RN fusions was confirmed by Western blotting using anti-MBP 
antibody (data not shown). 
 
ii)	 In	vitro	binding	of	purified	MBPCaf1Rgs	to	Caf1R	specific	F2-B	probe		As	 for	 purified	 wild	 type	 hCaf1RTgs,	 purified	 MBPCaf1Rgs	 (380	 μg/ml,	 Fig.	 4.25,	 Fn-3)	 was	concentrated	and	dialysed	against	20	mM	Tris,	300	mM	NaCl,	pH	8.0	and	the	final	preparation	(740	μg/ml	or	9366.8	pmol/ml)	stored	at	4°C	on	ice.	MBPCaf1Rgs	(2.5,	5.0,	10,	25,	30,	35,	45	and	50	 pmol)	 was	 tested	 with	 10-fmol	 F2-B	 probe	 in	 EMSA	 (section	 2.10).	 Despite	 the	 very	promising	 results	 with	 cell	 lysates,	 poor	 binding	 was	 observed	 with	 the	 purified	MBP	 fusion	
B 
UB 15 
25 
35 
40 
55 
70 
95 
130 
    a                                     b 
180 
kDa 
!
 
 
    
 
L MB
P-
R 
!!!!!
L MB
P-
R N!
!!!!!
L MB
P!
!!!!!
P M
BP
-R
!
    
 
L MB
P-
R 
!!!!!
L MB
P-
R N!
!!!!!
L MB
P!
     NL 
     
L 
	 176	
proteins	 irrespective	 of	 protein	 concentration	 (Fig.	 5.18).	 Consistent	 with	 purified	 wild	 type	hCaf1RTgs,	two	faint	shifted	complexes,	B1	and	B2	could	be	detected.			 	
		
Figure 5.18| In vitro binding of purified MBPCaf1Rgs to Caf1R specific F2-B probe.  
EMSA blot using purified and dialysed MBPCaf1Rgs (9.3 pmol/µl) with F2-B probe, as in section 2.10. B1 and 
B2: MBPCaf1Rgs-F2-B shifted complexes. UB: Unbound F2-B probe, NP: negative unbound DNA probe 
control, no protein and D: degradation product.   
5.5.3 Concentration-dependent binding of purchased hCaf1RP to F2-B probe  	In	 order	 to	 establish	 the	 concentration	 dependent	 effect	 of	 tagged	 Caf1R	 binding	 to	 the	 F2-B	DNA	 probe,	 EMSA	was	 repeated	 using	 purchased	 hCaf1R	 (hCaf1RP)	 (MyBiosource,	 USA).	 This	protein	was	provided	at	a	concentration	of	500	μg/ml	in	a	storage	buffer	containing	20	mM	Tris-HCl,	 500	 mM	 NaCl,	 50%	 Glycerol;	 pH	 8.0,	 stored	 at	 	 -20°C.	 This	 preparation	 of	 hCaf1RP	 was	shown	 to	 be	 free	 from	 large	 aggregates	 by	 centrifugation	 (16,000×g/40	 min/4°C).	 Prior	 to	setting	up	EMSA	binding	reactions,	 this	protein	was	also	dialysed,	as	above	and	then	used	at	a	broader	range	of	protein	(0.10,	0.25,	0.5,	25	and	50	pmol)	and	double	the	amount	of	F2-B	probe	(20-fmol).	Earlier	studies	used	purified	hCaf1RTgs	and	MBPCaf1Rgs	(2.5,	5.0,	10,	25,	30,	35,	45,	50	and	55	pmol)	and	F2-B	probe	(10-fmol).		Following	EMSA	(section	2.10),	an	equal	amount	of	both	 B1	 and	 B2	 complex	 were	 again	 seen,	 but	 unlike	 the	 previous	 assay,	 concentration	dependent	binding	of	hCaf1RP	to	the	F2-B	probe	was	obtained	as	can	be	seen	from	the	gradual	increase	 in	 intensity	 of	 B1	 and	 B2	 complexes	 from	 low	 (0.1	 pmol)	 to	 high	 (50	 pmol)	concentrations	 of	 hCaf1RP	 (Fig.	 5.19),	 Strangely,	 as	 protein	 concentration	 increased	 the	intensity	of	unbound	probe	at	the	bottom	also	appear	to	increase.	The	reason	for	this	increase	in	intensity	of	unbound	probe	is	unclear,	but	might	be	related	to	increasing	salt	concentrations	in	each	reaction,	as	the	amount	of	added	protein	increased.			
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Figure 5.19| Concentration-dependent binding of purchased hCaf1RP to Caf1R specific F2-B probe. 
EMSA blot with purchased/dialyzed hCaf1RP (12.8 pmol/µl) and F2-B probe. Increasing amounts of hCaf1RP 
(0.1-50 pmol) as indicated were mixed with 1× reaction-binding buffer (10 mM Tris, 50 mM KCl and 1 mM 
DTT; pH 7.5), non-specific competitor DNA Poly dI.dC (50 ng) and biotinylated F2-B specific probe (20-fmol) 
in a final reaction volume of 20 µl and subjected to EMSA (section 2.10). B1 and B2: hCaf1RP-F2-B shifted 
complexes, possibly representing monomer (B1) and dimers (B2) of HCaf1R.  UB: Unbound F2-B probe and 
NP: negative control with no protein and D: Degradation product.  
  
5.6 Conclusion  	The	 results	presented	 in	 this	 chapter	 show	 that	 the	caf1R-caf1M	 intergenic	 region	 (327	bp)	 is	the	main	 regulatory	 region	 of	 the	 caf	 locus	 and	 provides	 evidence	 for	 identification	 of	 Caf1R	activated	promoters	for	both	caf1R	and	caf1M.	Five	potential	Caf1R	binding	sites	of	15	nt	were	identified	in	this	region,	three,	R1-R3	upstream	of	caf1R	and	two,	R3′and	R4′	upstream	caf1M.	A	Caf1R-dependent	promoter,	PM	was	shown	to	activate	the	transcription	of	caf1M,	in	vivo,	using	
lacZ-promoter	fusions.	The	basal	expression	of	caf1M	from	PM,	in	the	absence	of	Caf1R	was	very	low	suggesting	that	PM	is	more	tightly	controlled	than	that	of	promoters	upstream	to	caf1R.	The	fusion	 study	 also	 provided	 preliminary	 evidence	 of	 Caf1R-binding	 upstream	 of	 PM	to	 the	 R4′	repeat,	which	overlaps	the	-35	promoter	element	by	3	nt.	Overlap	of	the	Caf1R-binding	site	with	the	 -35	element	 categorizes	 the	caf	 PM	promoter	as	 a	 class	 II	 activated	promoter	of	AraC/XylS	family	 regulators	 (Duval	 and	 Lister,	 2013;	 Egan,	 2002;	 Gallegos	 et	 al.,	 1997).	 With	 class	 II	promoters,	 RNA	 polymerase	 interacts	 with	 the	 DNA	 binding	 activator	 stabilizing	 the	 DNA-regulator	 interaction	(Martin	et	al.,	2002).	Binding	of	Caf1R	to	R4′	repeat	was	confirmed	by	 in	
vitro	EMSA	studies	using	cell	lysates	containing	hCaf1RTgs	or	MBPCaf1Rgs.	In	the	EMSA	studies,	Caf1R-binding	to	the	labelled	R4′	repeat	DNA	fragment	was	more	efficient	with	cell	lysates	than	with	the	isolated	proteins.	This	may	suggest	that	the	purified	versions	of	tagged	Caf1R	lack	some	important	cell	factors	(lost	during	purification),	essential	for	optimal	binding.	For	example,	RNA	polymerase	may	be	required	for	optimal	binding	of	regulator	to	the	cognate	DNA,	as	suggested	by	 others	 (Duval	 and	 Lister,	 2013;	 Martin	 et	 al.,	 2002).	 Alternately,	 recombinant	 Caf1R	 may	require	optimal	buffer	conditions	to	maintain	reduced	status	and	solubility	during	purification.	Optimisation	of	the	EMSA	would	permit	detailed	quantitative	comparison	of	binding	to	compare	specificity	of	binding	to	different	sequences.	The	impact	of	R3′	on	Caf1R	mediated	activation	is	
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unclear.	This	sequence	is	less	conserved	than	the	other	4	binding	sites.	The	promoter-lacZ	fusion	assay	 indicated	 slight	 enhancement	 of	 activation	 in	 the	 presence	 of	 both	 R3′	 and	R4′	 binding	sites.	Whether	this	is	an	indication	of	dimer	binding	could	be	investigated.			Comparison	of	R4′	with	the	other	4	repeats	within	the	caf1R-caf1M	intergenic	region	permitted	identification	 of	 a	 potential	 Caf1R	 binding	 consensus	 motif,	 5′TGCRCRAMWAGCWARD3′	(underlined	nt	indicate	BS1	and	BS2).	Within	BS1	(TGCRC),	both	C	nt	were	absolutely	conserved	when	 compared	 to	 the	MarA/Rob/SoxS	 consensus	 (Duval	 and	 Lister,	 2013)	 and	 the	 G	 varied	only	in	MarA.	Within	BS2,	MarA	(Rhee	et	al.,	1998)	and	Caf1R	binding	sites	were	identical	over	6	nt	(GCTAAA).	In	the	mar-MarA	crystal	structure	(Rhee	et	al.,	1998)	nt	of	both	binding	sites	are	involved	in	specific	recognition	and	binding	of	helix-3	and	6	amino	acids.	This	is	considered	in	more	depth	in	Chapter-7.		The	higher	level	of	conservation	of	residues	in	BS2	compared	to	BS1	has	been	attributed	to	a	shared	specificity	of	binding	in	BS2	among	this	subfamily	of	AraC/XylS-like	regulators	and	possibly	greater	specificity	of	BS1	binding	by	members	within	the	family.		Promoter	 localisation	 identified	 no	 active	 promoter	 upstream	 of	 caf1,	 responsible	 for	transcription	 of	 full-length	 caf1.	 The	 results	 were	 more	 consistent	 with	 polycistronic	transcription	of	 the	3	genes	caf1MA1.	 For	caf1R	 transcription,	 a	promoter	 assigned	as	PR2	was	identified	as	the	main	Caf1R-dependent	promoter	for	the	divergent	transcription	of	caf1R.	This	could	also	be	classified	as	a	class	II	Caf1R	activated	promoter.	The	R1	repeat	motif,	also	lies	just	upstream	of	 the	 -35	promoter	 element,	 overlapping	 it	 by	2	nt.	While	 transcription	of	 caf1R	 is	clearly	autoregulated,	the	significance	of	the	remaining	2	Caf1R	binding	sites	(R2	and	R3)	is	not	clear	at	this	stage	and	requires	further	study.	R2	is	located	between	the	-10	and	-35	elements	of	PRK	promoter.	The	statistically	significant	decrease	in	β-galactosidase	activity	upon	inclusion	of	repeats	R2	and	R3	might	suggest	that	as	levels	of	Caf1R	increase,	Caf1R	acts	as	a	repressor	at	R2	and/or	 R3.	 In	 addition,	 inclusion	 of	 an	 extended	 sequence	 (up	 to	 R3)	 encompassing	 the	 PRK	sequence	provided	an	indication	of	a	basal	level	of	Caf1R	independent	transcription	from	PRK.			Conclusively,	 two	 class	 II	 promoters,	 PR2	 and	 PM	 were	 identified,	 which	 activate	 divergent	expression	within	the	caf	locus	on	Caf1R	binding.	Caf1R-PR2	autoregulates	its	own	transcription	and	 Caf1R-PM	 controls	 transcription	 of	 caf1MA1.	 The	 role	 of	 PRK	 promoter	 in	 transcription	remained	to	be	clarified.				
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6.1 Introduction 	Following	entry	of	Y.	pestis	 into	 the	animal	host,	 the	host	body	 temperature	acts	 as	 a	decisive	signal	and	a	range	of	temperature	dependent	virulence	factors	are	expressed,	which	help	in	the	survival	of	bacteria	 in	 the	host.	F1	 is	one	such	 factor,	which	 is	expressed	at	a	high-level	 in	 the	host	 (Straley	 and	 Perry,	 1995).	 An	 early	 DNA	 microarray	 study	 of	 global	 changes	 in	 gene	expression	 in	Y.	pestis	 on	 temperature	 transition	 from	26	 to	37°C	 reported	upregulation	of	 all	genes	within	 the	 caf	 locus,	 caf1R	 (encodes	 regulator),	 caf1M	 (encodes	 periplasmic	 chaperone,	
caf1A	(encodes	outer	membrane	usher)	and	caf1	(encodes	F1	subunit)	(Motin	et	al.,	2004).	The	level	 of	 caf1	 alone	was	 increased	 about	 100-fold	 at	 10	 hours,	 and	 this	 was	 the	 highest	 fold	increase	 in	 transcript	 levels	 within	 the	 entire	 genome.	 	 A	 second	 study	 also	 reported	upregulation	of	the	caf	genes	in	LB	on	temperature	shift	from	28	to	37°C.	This	study	reported	a		22.7-fold	increase	for	caf1A	and	41.5-fold	increase	for	caf1,	but	only	4.3-fold	increase	for	caf1M	and	 2.3-fold	 increase	 for	 caf1R	 (Chauvaux	 et	 al.,	 2007).	 In	 the	 same	 year,	 one	 other	transcriptomic	study	confirmed	a	higher	level	of	expression	of	the	caf	genes	at	37°C	compared	to	growth	at	26°C,	after	 just	1	hour	shift	 in	 temperature.	However,	 the	 fold-	 increase	was	similar	for	 all	 genes	 3.16	 (caf1R),	 4.30	 (caf1M),	 3.28	 (caf1A)	 and	 2.96	 (caf1)	 (Han	 et	 al.,	 2007).	 The	increased	 level	 of	 caf1	 transcript	 relative	 to	 the	 level	 of	 caf1M	 and	 caf1A	with	 time	would	 be	consistent	 with	 high	 stability	 specifically	 of	 the	 caf1	 transcript	 or	 an	 additional	 promoter.	Recently	a	global	gene	expression	study	of	Y.	pestis	in	macrophages	revealed	a	gradual	increase	in	 the	 caf	 genes	 expression	 over	 8	 hours	 (Fukuto	 et	 al.,	 2010).	 A	 protein	 microarray	 study	containing	 218	 antigens	 of	 Y.	 pestis	 showed	 much	 higher	 F1	 antibody	 response	 in	 a	 pooled	plague	serum	which	was	adsorbed	by	Y.	pestis	grown	at	37°C	than	with	Y.	pestis	grown	at	26°C.	This	is	again	consistent	with	overexpression	of	F1	from	temperature	upshift	from	26	to	37°C	(Li	et	al.,	2011).	Hence	these	studies	all	confirm	that	expression	of	F1	is	highly	upregulated	at	37°C.	The	 mechanism	 of	 this	 thermoregulation	 within	 the	 caf	 locus	 has	 never	 been	 studied.	Thermoregulation	of	recombinant	F1	in	heterologous	systems	such	as	in	E.	coli	(Simpson	et	al.,	1990)	 and	 in	 Salmonella	 (Cao	 et	 al.,	 2012;	 Titball	 et	 al.,	 1997)	 provides	 good	 evidence	 that	thermoregulation	of	Y	pestis	F1	expression	can	be	studied	in	E.	coli.			A	 recent	 review	 has	 given	 a	 detailed	 account	 of	 both	 transcriptional	 and	 post-transcriptional	mechanisms	of	 thermoregulation	 in	Yersinia	 (Steinmann	and	Dersch,	 2013).	Examples	 include	temperature-induced	changes	in	DNA	topology	and	changes	in	stability	of	DNA	binding	proteins	(transcriptional	 level)	 and	 thermoregulation	 via	 thermosensitive	 RNA	 secondary	 structure	(post-transcriptional	 level).	 An	 example	 of	 transcriptional	 based	 thermoregulation	 in	Yersinia	occurs	 via	 concerted	 interplay	 of	 H-NS,	 YmoA	 and	 the	 DNA	 topology.	 H-NS	 binds	 to	 DNA	specifically	as	dimers	with	a	preference	for	AT	rich	regions	with	a	bend	in	the	DNA	(Amit	et	al.,	2003;	Dame	et	al.,	2000;	Spurio	et	al.,	1997).	YmoA	(18	kDa)	is	a	small	thermosensitive	protein	that	 interacts	 with	 H-NS	 and	 thus	 enhances	 downregulation	 of	 transcription	 (Madrid	 et	 al.,	2007).	At	 higher	 temperatures	 (37°C),	 YmoA	 is	 rapidly	degraded	by	host	proteases	 (ClpP	 and	Lon)	 and	 the	 ability	 of	 H-NS	 to	 bind	 its	 target	 sequence	 is	 decreased.	 This	 relieves	 the	repression,	permitting	transcription.	A	well-characterised	example	of	thermoregulation	at	both	the	 transcriptional	 and	 translational	 level	 is	 expression	 of	 lcrF,	 the	 gene	 encoding	 a	transcriptional	activator	(AraC/XylS	family)	of	the	Yersinia	Type	3	secretion	system	(Bohme	et	
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al.,	 2012;	 Hoe	 and	 Goguen,	 1993).	 At	 ambient	 temperature	 (25°C),	 the	 YmoA	 regulator	 binds	downstream	of	the	transcription	start	site	(TSS)	and	thus	represses	lcrF	transcription.		Upon	Y.	
pestis	 entry	 into	 the	 mammalian	 host,	 at	 the	 higher	 temperature	 YmoA	 is	 rapidly	 degraded	permitting	 transcription	 of	 lcrF	 (Bohme	 et	 al.,	 2012).	 At	 the	 post-transcriptional	 level,	translation	of	the	lcrF	transcript	is	blocked	by	a	two-stem	loop	RNA	structure,	located	within	the	yscW-lcrF	 intergenic	 region	 (Bohme	et	al.,	2012;	Hoe	and	Goguen,	1993).	This	RNA	secondary	structure	sequesters	the	RBS	(AGGA)	by	annealing	with	a	consecutive	4U	sequence	and	prevents	access	 of	 the	 ribosomes	 at	 lower	 temperature.	 On	 temperature	 increase,	 during	 infection,	structural	changes	in	this	RNA	secondary	structure	(melting	of	the	stem-loop	structure),	allows	access	 to	 ribosomes,	 synthesis	 of	 LcrF	 regulator	 and	 consequently	 induction	 of	 all	 LcrF-dependent	virulence	genes.				In	 general,	 bacterial	 pathogens	 often	 use	 these	 type	 of	 thermosensitive	 RNA	 secondary	structures	 to	 synthesis	 virulence	 factors	 only	 when	 required	 and	 respond	 to	 changes	 in	temperature	(Righetti	and	Narberhaus,	2014).	These	structures	are	usually	located	within	the	5′	untranslated	 region	 (UTR)	 of	 the	 transcript	 of	 virulence	 genes	 and	 are	 known	 as	 RNA	thermometers	(RNATs)	(Righetti	and	Narberhaus,	2014).	These	RNATs	modulate	the	expression	of	virulence	genes	in	response	to	temperature	changes	and	provide	a	control	mechanism	that	is	fast,	energy	saving	and	bypasses	the	requirement	for	expression	of	transcription	factors.	These	RNATs	generate	a	base-paired	structure	that	includes	the	ribosomal	binding	site	(Quade	et	al.)	and/or	 translation	 initiation	 codon	 (AUG)	 at	 the	 lower	 temperature	 (Fig.	 6.1),	 thus	 blocking	translation.	 Following	 temperature	 upshift	 to	 37°C,	 these	 RNATs	 melt	 in	 a	 zipper-like	mechanism	 and	 liberate	 the	 RBS	 and/or	 AUG	 initiation	 codon	which	 is	 then	 free	 to	 form	 the	translation	initiation	complex	with	ribosomes,	as	required	for	translation	(Fig.	6.1).			
		
Figure 6.1| General principle of RNAT mediated control of protein expression. 
At ambient temperature RNAT masks the RBS and the translation start site (AUG) by base pairing within a 
secondary structure. The increased temperature modulates the structure of RNAT and liberates RBS and AUG 
for subsequent translation. Picture adapted from (Righetti and Narberhaus, 2014).  		In	view	of	the	recognised	temperature	dependent	regulation	of	expression	of	the	caf	genes,	it	is	reasonable	 to	 hypothesize	 that	 post-transcriptional	 control	 via	 a	 thermosensitive	 RNA	secondary	 structure(s)	might	 contribute	 to	 control	of	 expression	of	F1.	Therefore,	 the	aims	of	this	chapter	were	specifically	 to	 localise	 the	site(s)	within	 the	caf	 locus	 that	 is/are	 involved	 in	
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thermoregulation	 and	 to	 explore	 potential	 RNATs	 upstream	 of	 caf1R	 and	 caf1M	 that	 could	contribute	to	thermoregulation	of	F1	expression.		
Results and Discussion 
6.2 Thermoinduction of F1 expression through Caf1R 	As	Chapter-5	provides	the	indirect	evidence	that	Caf1R	activates	F1	expression	by	binding	to	the	5′	UTR	of	both	caf1R	and	caf1M.	The	promoter-lacZ	fusions	and	EMSA	identified	binding	to	the	R4′	repeat,	located	upstream	of	the	PM	promoter.	Fusions	also	identified	autoregulation	of	Caf1R	and	 binding	 most	 likely	 at	 the	 R1	 repeat	 adjacent	 to	 the	 PR2	 promoter.	 As	 a	 first	 step	 to	investigate	 thermoinduction	 of	 F1	 expression,	 the	 impact	 on	 caf1R	 expression	 was	 tested.	 A	complementation	 assay	 was	 used	 that	 could	 test	 if	 the	 5′	 UTR	 of	 caf1R	 contributes	 to	 this	temperature	 dependent	 shift	 in	 expression	 of	 F1.	 Two	 complementing	 combinations	 of	constructs	used	were	pACYCF1+pBADHisA	(complete	caf	locus	+	pBADHisA	vector)	and	pACYC-MA1+pBADhCaf1R	(cafMA1	operon,	without	regulator	+	PBAD	controlled	hCaf1R)	(Fig.	6.2).	The	hypothesis	 was	 that	 Caf1R	 production	 from	 the	 caf	 locus	 within	 pACYCF1	 is	 controlled	 by	 a	thermosensitive	RNAT,	which	may	be	 located	at	5′	UTR	of	caf1R,	but	 that	expression	of	Caf1R	from	 pBADhCaf1R	 would	 not	 be	 thermosensitive	 because	 of	 its	 regulation	 by	 temperature	independent	PBAD	promoter	(L-ara	 inducible).	There	are	many	reports	of	successful	expression	from	pBADHis	vectors	at	lower	temperatures	(Bohme	et	al.,	2012;	Guzman	et	al.,	1995;	Hoe	and	Goguen,	 1993;	 Klinkert	 et	 al.,	 2012;	 Weber	 et	 al.,	 2014).	 In	 both	 pACYCF1	 and	 pACYC-MA1,	transcription	 of	 the	 caf	 operon,	 MA1	 is	 controlled	 by	 binding	 of	 Caf1R	 to	 repeat	 4	 (R4′),	upstream	 of	 caf1M	 (Chapter-5).	 Thus,	 in	 both	 cases	 cafMA1	 genes	 are	 only	 expressed	 and	 F1	only	 accumulates	 when	 Caf1R	 regulator	 is	 expressed.	 Hence,	 expression	 of	 Caf1R	 could	 be	monitored	by	production/loss	of	F1	assembly.			F1	 expression	 was	 monitored	 in	 whole	 cells	 of	 E.	 coli	 Top10,	 carrying	 either	pACYCF1+pBADHisA	or	pACYC-MA1+pBADhCaf1R	at	26,	28	and	30°C.	On	analysis	of	whole	cells	carrying	pACYCF1,	there	was	little	F1	after	9	h	at	26°C	and	F1	production	was	induced	following	temperature	upshift,	to	28	and	30°C	(Fig.	6.2a).	This	was	consistent	with	results	from	others	in	the	laboratory	where	only	low	levels	(blottable)	of	F1	were	detected	at	26°C	(data	not	shown).	In	contrast,	 in	cells	carrying	pACYC-MA1+pBADhCaf1R,	F1	was	expressed	at	 roughly	 the	same	level	 at	 all	 3	 temperatures	 tested,	 following	 induction	 with	 L-arabinose	 (Fig.	 6.2b).	Immunoblotting	of	whole	 cells	 carrying	pACYC-MA1+pBADhCaf1R	 confirmed	 that	 hCaf1R	was	expressed	 at	 all	 3	 temperatures	 from	 pBADhCaf1R	 (Fig.	 6.2c).	 As	 pACYC-MA1	 contains	 the	complete	5′	UTR	for	caf1M,	absence	of	thermo-control	when	pACYC-MA1	is	complemented	with	pBADhCaf1R	is	consistent	with	thermo-control	via	the	5′	UTR	of	caf1R.			An	 effect	 of	 growth	 temperature	 on	 the	 β-galactosidase	 activity	 of	 promoter-lacZ	 fusions,	described	 in	 Chapter-5,	 had	 also	 been	 noted.	 Therefore	 the	 results	 from	 Chapter-5	 were	analysed	in	more	detail	to	compare	activity	of	24	h	samples	grown	at	26°C	with	those	grown	at	37°C	(Fig	 6.3).	Each	construct	contains	 the	caf1R	promoters,	 start	 codon	and	192	bp	of	caf1R	(relative	 to	ATG	start	codon)	 fused	upstream	of	 the	promoterless	 lacZ	gene	(with	 its	own	RBS	and	 start	 codon).	 Activity	 of	 the	 caf1R	 promoter	 fusion	 constructs,	 pRScaf1R′-70+192-lacZ	
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(contains	PR2	promoter)	 and	pRScaf1R′-114+192-lacZ	 (contains	PRK	promoter)	was	 increased	2.5-fold	 and	3.3-fold	 following	 the	 temperature	 shift	 from	24°C	 to	37°C.	This	was	 in	 contrast	 to	 a	fusion	construct	containing	the	caf1A-caf1	intergenic	region	where	there	was	no	apparent	effect	of	 temperature.	 Thus	 the	 increase	 in	 β-galactosidase	 activity	 following	 growth	 at	 37°C	 is	consistent	 with	 temperature	 induced	 transcription	 of	 caf1R.	 Transcription	 of	 caf1R	 is	autoregulated,	therefore	the	impact	of	temperature	in	the	presence	of	complementing	pACYC-R	encoded	Caf1R	was	also	compared.	The	effect	was	amplified	substantially	due	to	expression	of	pACYC-R	 encoded	 Caf1R	 in	 a	 temperature	 dependent	 fashion.	 In	 the	 presence	 of	 Caf1R	 the	constructs	 pRScaf1R′-70+192-lacZ	 and	 pRScaf1R′-114+192-lacZ	 showed	 a	 7.5	 and	 12.7-fold	 higher	activity,	respectively,	following	growth	temperature	shift	from	26	to	37°C	(Fig.	6.3).		This	might	be	explained	by	additional	post-transcriptional	control	of	expression	from	the	caf1R	 transcript	encoded	on	pACYC-R.			The	PM	promoter	was	also	activated	by	Caf1R,	which	bound	at	R4′	repeat,	immediately	upstream	of	 PM	(Chapter-5;	Fig.	 5.11).	 Therefore,	 β-galactosidase	 activity	 of	 the	 caf1M	 promoter	 fusion	construct,	 pRScaf1M′-184+158-lacZ	 (contains	 PM	 promoter	 and	 complete	 R4′	 repeat)	 was	 also	reanalysed	in	the	context	of	temperature	shift.		Transformants	carrying	pACYC-R	together	with	pRScaf1M′-184+158-lacZ	already	showed	an	 increase	 in	activity	even	at	 the	 lower	 temperature	of	26°C.	 This	 may	 reflect	 sensitivity	 of	 PM	 to	 very	 low	 levels	 of	 Caf1R.	 Following	 growth	temperature	shift	from	26	to	37°C	there	was	a	4.0-fold	induction	of	activity	(presence	of	Caf1R)	whereas	 in	 the	 absence	 of	 Caf1R,	 the	 temperature-mediated	 increase	 in	 activity	was	 3.6-fold.	These	 results	 would	 be	 consistent	 with	 expression	 of	 caf1M	 being	 strictly	 dependent	 on	activation	 by	 Caf1R	 and	 the	 temperature	 requirement	 being	 for	 expression	 of	 caf1R	 (from	pACYC-R;	controlled	by	native	5′	UTR).	Hence	interpretation	of	this	data	reinforces	the	5′	UTR	of	
caf1R	appears	to	be	a	site	of	thermoinduction	within	the	caf	locus.	Expression	of	Caf1R	provides	an	indication	of	thermoregulation	of	basal	levels	of	transcription	of	both	caf1R	and	caf1M	in	the	absence	of	Caf1R.	The	 large	 impact	on	 the	presence	of	caf1R	might	readily	be	explained	by	an	RNAT	within	the	5′	UTR	of	caf1R	affecting	translation	from	pACYC-R.		 	
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Figure 6.2| Dependency of thermoregulation of F1 on caf1R 5′ UTR. 
a) caf1R expressed from native  5′ UTR in pACYCF1 b) caf1R expression controlled by pBADhCaf1R UTR. 
Schematic presentations show the plasmid combinations used in both tests to monitor the influence of caf1R 5’ 
UTR on thermoinduction of F1 expression. E. coli Top10, two or three different transformants co-transformed 
with both plasmids were grown (with 0.02% L-ara for (b)) at 26, 28 and 30°C for 9 h.  F1 production was 
monitored by analysing whole cells (0.07 OD units) by SDS PAGE (16% acrylamide). WT, positive control F1, 
from whole cell  (Top10/pACYCF1), recovered after 37°C/4 h. c) Immunoblot of samples shown in (b) with 
anti-His mAb (1:10,000). L, pre-stained protein ladder and C, negative control of hCaf1R (Top10/pBADHisA). 		
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Figure 6.3| Caf1R-mediated thermoinduction at PR2, PRK and PM promoters.  
β-galactosidase activity per OD following growth at 26 and 37°C for 24 h, from promoter-lacZ fusion constructs, 
pRScaf1R′-70+192-lacZ, pRScaf1R′-114+192-lacZ and pRScaf1M′-184+158-lacZ, which contain promoters PR2, PRK and 
PM, as indicated. Caf1R+ and Caf1R-, complemented with pACYC-R or pACYC vector. pRScaf1′-181+88-lacZ 
contains complete caf1A-caf1 intergenic region (80 bp), 101 bp from 3′ and 88 bp of caf1 and is included for 
comparison. Standard error on the activity bars is from ± SEM of the activity from three individual co- 
transformants of each. Note: Data presented are re-analysed data from Chapter-5; Figs. 5.10, 5.11 and 5.13. 
6.3 Prediction of RNATs within the 5′ UTR of caf1R and caf1M  	In	order	to	predict	RNATs	at	 the	5′	UTR	of	caf1R	and	caf1M,	 initially	 the	corresponding	mRNA	was	assigned	by	predicting	the	transcriptional	start	site	(TSS,	+1	site)	for	the	caf1R	and	caf1M	or	
caf1MA1	 transcript.	 This	was	 defined	 as	 10	 nt	 downstream	 from	 the	 first	 residue	 of	 the	 	 -10	element	(Ruff	et	al.,	2015).	 	Promoter	fusion	studies	had	identified	PR2	and	possibly	also	PRK	as	the	 promoter	 for	 caf1R	 and	 PM	 as	 the	 promoter	 for	 caf1M	 and	 possibly	 a	 single	 caf1MA1	transcript	(Fig.	6.4).	The	sequences	encompassing	a	few	residues	upstream	from	+1	to	a	tail	of	the	first	1-10	coding	amino	acids	of	caf1R	and	caf1M	(Fig.	6.4)	were	analysed	at	26,	28,	30	and	37°C	 by	 the	 RNA	 folding	 program,	 Mfold	 version	 2.3.	 Mfold	 is	 based	 on	 the	 algorithm	 of	minimum	 free	 energy	 	 (ΔG)	 of	 decomposition	 or	 destabilization	 (Zuker,	 2003).	 The	 selection	criteria	 for	 inclusion	 of	 1-10	 codons	 of	 the	 translated	 mRNA	 was	 based	 on	 studies	 from	previously	 identified	bacterial	RNATs	(Bohme	et	al.,	2012;	Kouse	et	al.,	2013;	Loh	et	al.,	2013;	Matsunaga	 et	 al.,	 2013;	 Righetti	 and	 Narberhaus,	 2014;	Weber	 et	 al.,	 2014).	 In	 each	 case	 the	most	 stable	 RNA	 secondary	 structure	with	 lowest	 free	 energy	 (most	 negative	 ΔG	 value),	 was	selected	and	 then	analysed	 for	 the	 extent	of	nucleotide	pairing	 at	 the	predicted	SD	 sequences	(RBSs)	and	translation	initiation	start	codons.		
Caf1R - Caf1R + Caf1R - Caf1R + Caf1R - Caf1R + Caf1R - Caf1R + 
[-70+192] PR2 [-114+192] PRK [-184+158] PRM [-181+88] 
26°C-24h 13.28 14.30 11.30 18.08 8.23 55.43 21.34 27.96 
37°C-24h 33.97 107.54 37.74 230.13 29.69 223.89 19.88 25.90 
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Figure 6.4| DNA fragment used to predict RNATs at 5′ UTR of caf1R and caf1M. 
Predicted +1 transcriptional start sites, corresponding to -10 elements of PR2, PRK and PM promoters are 
indicated. Only the first 5 amino acids of both Caf1M and Caf1R (with ATG start codon) are shown. fM 
indicates the alternate predicted start site for caf1R. Identification of promoters and other key features are 
described in Chapter-5.  
6.3.1 Predicted RNA secondary structure within 5′ UTR of caf1R  	As	 the	5′	UTR	from	PR2	promoter	 is	only	19	nt,	RNATs	were	predicted	by	 inclusion	of	 ten,	 five	and	one	codon	of	caf1R.	For	PRK	which	has	a	longer	5′	UTR	(78	nt),	only	the	first	five	codons	from	the	 translated	 sequence	 were	 included.	 For	 the	 mRNA	 corresponding	 to	 PR2,	 the	 predicted	structures	all	showed	an	identical	hairpin	stem-loop	structure	at	each	temperature	tested,	with	a	less	stable	structure	(less	negative	ΔG	values),	upon	increasing	temperature	(Fig.	6.5a	(i-iii)).		Upon	inclusion	of	only	a	single	caf1R	codon	(AUG),	an	identical	short	weak	stem-loop	(from	U11-A23	nt)	was	predicted	that	traps	only	the	putative	RBS1	(Fig.	6.5a	(i)).		ΔG	for	these	structures	varied	 from	 -2.11	 at	 26°C	 to	 -1.80	 at	 37°C.	 Upon	 inclusion	 of	 the	 first	 five	 and	 ten	 codons	 of	
caf1R,	 the	 resulting	 stem-loops	 became	 gradually	 longer	 and	 more	 stable	 with	 increasingly	negative	ΔG	values	(Fig.	 6.5a	 (i-ii)).	 Structures	predicted	on	 inclusion	of	 the	 first	5	codons	of	
caf1R	 trapped	the	RBS1	and	START1	within	the	loop	region	(Fig.	 6.5a	 (ii)).	On	inclusion	of	the	first	 10	 codons,	 RBS1	 and	 START1	 were	 trapped	 in	 an	 unstable	 internal	 loop	 and	 a	 bulge,	respectively.	Hence,	all	predicted	structures	from	a	PR2	transcript	are	in	a	CLOSED	conformation	(trapping	of	both	RBS	and	AUG)	at	each	temperature	tested.			If	PRK	 is	used	 for	 the	 transcription	of	caf1R,	the	 transcript	 includes	both	potential	start	codons	(START2	 (UUG)	 and	 START1	(AUG))	 and	 each	 respective	 RBS.	 Structures	 of	 the	 5′	 UTR	 of	 this	transcript	(59	and	77	nt	with	respect	to	START2	and	START1)	were	more	complex	(Fig.	6.5a	(i-
iv)).	Three	stem-loops	encompassing	nt	G3-C33,	G37-U74	and	nt	C80-G95	were	predicted	at	26,	28	 and	 30°C.	 At	 37°C	 the	 third	 stem-loop	 encompassing	 nt	 C80-G95	 including	 START1	 was	completely	 melted,	 forming	 a	 linear	 single	 stranded	 OPEN	 conformation.	 Notably,	 this	 third	stem-loop	was	dependent	on	the	presence	of	the	first	5	codons	of	caf1R.		If	this	stem-loop	exists	
pRS550(8-9)construct annotation: 
 
 
  
                  caf1R1        SD1             caf1R2   +1                    SD2   -10PR2                
   CAT CTG TTT TAG CATGAATATAACCCAAATCAAAATAATAGCATTCTAGA           
    M   Q   K   L   M                 fM  
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it	would	suggest	 thermosensing	within	 the	caf1R	 coding	sequence.	More	so,	within	 the	second	stem-loop,	at	each	 temperature	 the	predicted	RBS1,	GGU	was	paired	with	CCG	and	 located	 in	a	stable	stem	(G-C	paired	environment).	However,	RBS2	(AGAAUGC)	and	START2	(UUG)	spanned	the	 highly	 unstable	 external	 loop	 and	 internal	buge,	 respectively.	 First	 four	 nt	 of	 RBS2	paired	with	4U,	as	 in	a	 classic	4U	RNATs	 (Grosso-Becera	et	al.,	2015).	 Interestingly,	 in	 this	 transcript	from	 PRK,	 RBS1	 is	 preceded	 by	 a	 potential	 RNase	 E	 endoribonuclease	 cleavage	 site	 (GAUUU)	consistent	with	the	E.	coli	consensus	G/AAUUA/U	(Ehretsmann	et	al.,	1992).	This	may	indicate	particular	 sensitivity	 of	 this	 region	 to	 degradation	 driving	 the	 kinetics	 to	 an	 unstructured	 5′	UTR.			 	
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Figure 6.5| Predicted RNATs at 5′ UTR of caf1R. 
The Mfold program (Zuker, 2003) was used for the prediction of temperature modulated RNA secondary 
structures (RNATs) within the 5′ UTR of caf1R transcript from PR2 promoter (a) and PRK promoter (b).  The 
structure with the lowest predicted free energy (ΔG; kcal/mole) (indicated) at each temperature is shown. +1, 
predicted transcription start site (TSS) from each promoter. The two different predicted start codons for caf1R 
(AUG (START1) and UUG (START2) are encircled and corresponding RBSs (RBS1 and RBS2) are underlined. 
Red arrows indicate a potential RNase E cleavage site. Prediction of PR2 structure (a) was with inclusion of one 
(i), five (ii) and ten (iii) codons of caf1R (relative to AUG). RNATs corresponding to message from PRK were 
predicted only by inclusion of first five codons of caf1R.  OPEN and CLOSED indicate accessibility of the 
START and RBS site. ΔG values for all segments of each structure are tabulated in Appendix 5 and 6.  
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6.3.2 Predicted RNA secondary structure within 5′ UTR of caf1M 	The	5′	UTR	of	the	transcript	corresponding	to	PM	promoter	is	quite	long	(128	nt).		Potential	RNA	secondary	 structures	within	 this	 sequence	plus	 the	 first	5	 codons	of	caf1M	 showed	 four	 small	stem-loops	 encompassed	 nt	 G6-U14,	 G17-C30,	 G96-C107	 and	 U109-G120,	 connected	 by	 an	unstable	 internal	 stem	 (Fig.	 6.6).	 A	 fifth	 much	 longer	 structure	 (C44-G93)	 contained	 one	particularly	stable	stack	of	11	bp	separated	by	a	small	internal	loop	from	a	second	stack	of	9	bp	with	a	pentagonal	bulge,	one	non-paired	pair	and	a	classic	4	nt	hairpin.	This	structure	does	not	encompass	either	 the	RBS	or	AUG	and	hence	 is	 likely	 to	be	more	 important	 in	mRNA	stability	than	in	thermoregulation.	Structures	predicted	at	26,	28,	30°C	(Fig.	6.6a-c)	were	identical	while	a	dramatic	change	was	observed	between	30	and	37°C.	The	internal	stem,	trapping	the	START	codon,	melted	to	an	OPEN	conformation	(Fig.	6.6d).	However,	at	all	temperatures	the	putative	RBS	 (AGGAGGU)	 was	 trapped	 in	 a	 stem-loop.	 	 This	 long	 caf1M	 transcript	 (128	 nt)	 might	contribute	to	the	stability	of	the	mRNA,	although	the	single	RNase	E	site	(GAUUU)	following	the	AUG	start	codon	might	indicate	instability.				 	
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Figure 6.6| Predicted RNATs at 5′ UTR of caf1M. 
The Mfold program (Zuker, 2003) was used for the prediction of the RNA secondary structures (RNATs) at 26 
(a), 28 (b), 30 (c) and 37°C (d). The mRNA fragment (message) was selected from the predicted +1 transcription 
start site (indicated in red), corresponding predicted PM promoter of caf1M or caf1MA1. The putative RBS and 
translation initiation codon (AUG) for caf1M are underlined and encircled, respectively. Red arrows indicate 
RNase E cleavage site. RNATs at each selected temperature were predicted by inclusion of the first five codons 
of caf1M. Conformation (OPEN or CLOSED) relative to translation initiation codon (AUG; START) and RBS 
site is indicated. The most probable prediction with lowest free energy (ΔG; kcal/mole) at each temperature is 
shown.  ΔG for all segments of each structure is tabulated in Appendix 7.  		
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6.4 Conclusion  	The	results	presented	in	this	chapter	support	the	hypothesis	that	thermosensing	within	the	caf	locus	 is	 linked	 to	 the	 expression	 of	 caf1R.	 This	 was	 initially	 shown	 by	 complementation	 of	
caf1MA1	 operon	 with	 PBAD	 regulated	 hCaf1R.	 Thermosensing	 was	 lost	 when	 Caf1R	 was	expressed	 from	pBADhCaf1R,	 F1	was	 produced	 even	 at	 26°C.	 	 The	 fact	 that	 F1	was	 produced	means	that	the	PM	promoter	must	be	functional	at	26°C	as	the	Caf1M	chaperone	and	the	Caf1A	usher	are	 required	 for	F1	assembly.	This	 is	 in	 contrast	 to	 loss	of	F1	production	at	26°C	when	expressed	from	the	native	caf1R	promoter	(in	pACYCF1).	Some	evidence	of	thermoregulation	of	transcription	 of	 caf1R	 and	 caf1M	 was	 indicated	 by	 reanalysis	 of	 the	 data	 for	 β-galactosidase	activity	from	the	promoter-lacZ	fusion	study,	comparing	the	26°C/24	h	inoculum	with	37°C/24	h	samples	where	a	2-3	 fold	 increase	 in	activity	with	 the	37°C	samples	 in	 the	absence	of	Caf1R	was	noted.	This	was	in	contrast	to	fusion	of	the	caf1A-caf1	 intergenic	region	which	showed	no	enhanced	activity	with	the	37°C	samples.	In	the	presence	of	pACYC-R	encoded	Caf1R,	a	7.5-fold	and	 12.7-fold	 thermoinduction	 of	 β-galactosidase	 was	 obtained	 with	 PR2,	 PRK	 promoters,	respectively.	This	marked	increase	could	be	explained	by	an	additional	temperature	dependent	impact	on	translation	of	caf1R	from	pACYC-R.		While	caf1M	transcription	was	also	dependent	on	pACYC-R	 encoded	 Caf1R,	 moderate	 levels	 of	 transcription	 from	 pRScaf1M′-184+158-lacZ	 (PM)	+pACYC-R	 at	 26°C	 resulted	 in	 only	 a	 4.0-fold	 increase	 at	 37°C.	 This	 presumably	 reflects	 high	sensitivity	of	PM	to	Caf1R.		Together	these	results	provide	strong	evidence	for	thermoregulation	of	 the	 caf1MA1	 operon	 via	 expression	 of	 Caf1R,	 with	 possibilities	 for	 contributions	 of	 both	transcriptional	and	translational	control.		One	 common	 mechanism	 of	 thermoregulation	 of	 virulence	 factors	 from	 bacteria	 that	 live	 in	different	environments	is	translational	control	via	thermosensitive	structures	within	the	5′	UTR	of	 the	 transcript	 (Grosso-Becera	 et	 al.,	 2015;	 Hoe	 and	 Goguen,	 1993;	 Kouse	 et	 al.,	 2013;	Matsunaga	 et	 al.,	 2013).	 Of	 the	 2	 potential	 promoters	 upstream	 of	 caf1R,	 PR2	 produces	 the	shortest	5′	UTR	(19	nt)	with	a	small	stem-loop	structure	encompassing	the	RBS1	at	both	26	and	37°C	 and	 weak	 stability	 (ΔG	 value	 of	 -2.19	 and	 -1.30	 kcal/mole,	 respectively).	 More	 stable	structures	were	only	generated	with	inclusion	of	the	coding	sequence.	The	RBS	in	one	structure	(with	10	codons)	was	associated	with	a	bulge	within	the	stem	structure	similar	to	the	RNAT	of	the	PfrA	transcriptional	activator	of	L.	monocytogenes	(Loh	et	al.,	2009).	Location	of	the	RBS	in	the	external	loop,	as	in	the	other	structure	(with	5	codons)	would	be	unusual	(Grosso-Becera	et	al.,	 2015).	 Hence,	 the	most	 likely	 structure	within	 the	 PR2	 transcript	 5′	 UTR	would	 be	 of	 only	marginally	stable.	In	contrast	to	transcript	from	PR2,	the	5′	UTR	of	the	transcript	from	PRK	(78	nt)	includes	 both	 predicted	 start	 codons	 and	 the	 corresponding	 RBSs.	 Analysis	 of	 the	 5′	 UTR	produced	the	same	basic	structure	with	respect	to	RBS1,	RBS2	and	UUG	start,	with	and	without	additional	coding	sequence.	Only	the	AUG	start	codon	paired	with	additional	15	nt	of	the	coding	sequence	 forming	 an	 unstable	 structure	 that	was	 lost	 between	 30	 and	 37°C,	 to	 form	 a	 linear	single	stranded	OPEN	conformation	with	respect	to	this	start	codon.		RBS1	formed	a	stable	G-C	rich	base-pairing	stem	(ΔG	of	-10.10	kcal/mole).	In	contrast,	the	RBS2	was	located	in	a	less	stable	stem	(ΔG	of	-4.20	kcal/mole)	including	four	consecutive	A/G-U	pairs,	typical	of	the	4U	family	of	RNAT	as	seen	in	other	AraC/XylS	family	regulators	such	as	LcrF	regulator	of	Y.	pestis	(Bohme	et	al.,	2012;	Hoe	and	Goguen,	1993)	and	ToxT	of	V.	cholera	(Weber	et	al.,	2014).	Although,	the	4U	
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paired	RBS	was	still	at	the	same	position	at	37°C	it	spanned	a	highly	unstable	internal	buge	and	an	 external	 loop.	 This	 suggests	 that	 this	 region	 readily	 melts	 in	 vivo	at	 37°C	 with	 associated	destabilisation	 of	 the	 RBS1	 pairing	 sequence	 and	melting	 of	 the	 entire	 structure	 to	 an	 OPEN	conformation	accessible	for	translation.		RNA	secondary	structure	of	the	caf1M	5′	UTR	(128	nt)	was	longer	and	more	complex	than	that	of	caf1R.	It	 included	a	relatively	unstable	internal	stem	structure	connecting	two	large	internal	loops.	This	stem,	which	encompassed	 the	AUG	start	codon,	melted	between	30	and	37°C.	 	The	RBS	was	located	within	a	relatively	stable	stem-loop	structure	(ΔG	of	-4.9	kcal/mole)	with	a	4	nt	paired	 stem	 and	 a	 4	 nt	 loop.	 This	 may	 also	 indicate	 some	 thermosensing	 within	 the	 caf1M	transcript,	although	this	was	not	evident	from	the	complementation	study	using	PBAD	regulated	
caf1R.	A	 long	stable	G-C	rich	stem	structure	was	predicted	within	the	caf1M	5′	UTR	that	might	relate	to	mRNA	stability.		In	conclusion,	the	evidence	so	far	is	consistent	with	expression	of	caf1R	being	the	primary	site	for	thermoregulation	of	F1	production.	This	study	has	not	directly	addressed	factors	that	might	influence	thermoregulation	of	transcription	such	as	stability	of	additional	DNA	binding	proteins	as	 seen	 with	 Yersinia	 YmoA	 (Bohme	 et	 al.,	 2012)	 and	 its	 E.	 coli	 homolog	 Hha	 (Madrid	 et	 al.,	2002).	 The	 predicted	 RNA	 secondary	 structures	 presented	 provide	 a	 framework	 for	confirmation	 of	 the	 role	 of	 a	 caf1R	 5′	 RNAT	 in	 controlling	 F1	 expression.	 This	 would	 be	addressed	by	site-specific	mutagenesis	targeting	non-canonical	or	non-base	pairing	residues	to	increase	 stability	 and	 canonical	 base-pairing	 nt	 to	 decrease	 stability	 of	 predicted	 structures.	Primary	targets	would	be	nt	pairing	with	RBS1	in	the	PR2	transcript	and	both	RBS1	and	RBS2	in	the	PRK	transcript.			
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7.1 Introduction 	This	 study	 elucidated	 the	 primary	 regulatory	 mechanisms	 controlling	 the	 expression	 of	 key	surface	antigen	F1	of	Yersinia	pestis.	Despite	a	wealth	of	knowledge	on	other	aspects	of	F1,	such	as	 its	 assembly	 by	 the	 CU	 pathway,	 and	 its	 use	 in	 plague	 diagnostics	 and	 vaccine	 design,	understanding	the	regulation	of	this	key	antigen	was	untouched	prior	to	this	study.	The	caf	locus	is	controlled	by	a	divergently	linked	AraC/XylS	family	regulator,	Caf1R	(Karlyshev	et	al.,	1992).	CU	assembled	pili/fimbriae	have	acquired	a	diverse	range	of	regulatory	mechanisms	to	control	their	expression	(Clegg	et	al.,	2011).	An	AraC/XylS	family	regulator	is	one	such	mechanism,	but	this	has	received	little	attention	thus	far.	There	are	a	few	examples	of	AraC/XylS	type	regulators	which	 ‘globally’	 regulate	 several	 unlinked	CU	 system	 such	 as	Rns-mediated	 regulation	of	CS1-CS4,	CS14,	CS17	and	CS19	fimbriae	of	enterotoxigenic	E.	coli	(Basturea	et	al.,	2008;	Caron	et	al.,	1989;	Froehlich	et	al.,	1994;	Mahon	et	al.,	2010;	Munson	et	al.,	2002;	Munson	and	Scott,	1999,	2000);	 AggR-mediated	 expression	 of	 Agg3,	 Agg	 and	 AAf	 fimbriae	 of	 enteroaggregative	 E.	 coli	(Dudley	et	al.,	2006;	Morin	et	al.,	2013;	Nataro	et	al.,	1994)	but	there	has	been	no	in-depth	study	of	 a	 dedicated	 AraC/XylS	 family	 regulator	 controlling	 	 a	 linked	 CU	 system.	 This	 study	 has	highlighted	 key	 residues	 involved	 in	 DNA-Caf1R	 regulator	 interaction,	 including	 a	 bridge	interaction	likely	to	be	involved	in	stabilising	the	correct	orientation	of	BS2	residues.	Promoters	have	 been	 defined	 and	 an	 interesting	 model	 for	 thermo-control	 via	 expression	 of	 caf1R	 is	presented.	A	database	survey	identified	many	closely	related	regulators	controlling	CU	systems	within	the	Enterobacteriaceae.		From	consideration	of	conserved	residues,	many	features	appear	to	 be	 conserved	 among	 this	 CU	 family	 of	 regulators.	 This	 characterisation	 of	 Caf1R-mediated	regulation	 of	 F1	 provides	 the	 first	 fundamental	 model	 on	 regulation	 of	 CU	 pili/fimbriae,	controlled	by	a	directly	linked	AraC/XylS	type	regulator.		The	most	significant	and	novel	aspects	of	this	study	are	discussed	below.	
7.2 Caf1R-dependent and independent promoters of the caf locus 		Five	potential	Caf1R	binding	repeat	motifs,	R1,	R2,	R3,	R3′	and	R4′	(15	nt	long)	were	identified	within	 the	 caf1R-caf1M	 intergenic	 region.	 R1-R3	 are	 equally	 spaced	 (18	 nt)	 and	 located	upstream	of	caf1R,	while	repeats	R3′	and	R4′	(separated	by	5	nt)	run	in	the	opposite	orientation	upstream	of	caf1M.	Transcriptional	fusions,	designed	around	these	repeat	motifs,	identified	the	Caf1R	dependent	promoters,	PM	(for	caf1M)	and	PR2	(for	caf1R).	In	contrast	to	earlier	speculation	(Karlyshev	 et	 al.,	 1992;	 MacIntyre,	 2004),	 no	 Caf1R	 binding	 site	 or	 indication	 of	 promoter	activity	 was	 detected	 within	 246	 bp	 upstream	 of	 caf1	 SD	 sequence.	 This	 would	 suggest	 that	either	 there	 is	 another	 promoter	 further	 upstream	 leading	 to	 an	 exceptionally	 long	mRNA	 or	that	a	 single	polycistronic	mRNA,	encoding	Caf1M,	Caf1A	and	Caf1,	 is	 transcribed	 from	 the	PM	promoter.	 Transcriptomic	 studies	 have	 reported	 exceptionally	 high	 levels	 of	 caf1	 mRNA	compared	 to	 caf1M	 and	 caf1A	 mRNA,	 following	 several	 hours	 at	 37°C	 (Motin	 et	 al.,	 2004).	 A	feasible	explanation	for	this	would	be	differential	susceptibility	of	caf1M,	caf1A	and	caf1	mRNA	to	degradation,	leaving	highly	stable	mRNA	of	caf1.	This	would	then	contribute	to	the	high	level	of	F1	that	accumulates	on	the	cell	surface	of	Y.	pestis	(Amies,	1951;	Simpson	et	al.,	1990).						
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		For	transcription	of	caf1M	or	caf1MA1	operon,	PM	showed	a	strong	dependency	on	Caf1R.	An	 in	
vitro	protein-DNA	binding	study	confirmed	binding	of	Caf1R	at	R4′.		The	R4′	sequence	overlaps	this	 promoter	 -35	 element	 by	 3	 nt,	 and	 has	 a	 19	 nt	 spacer	 between	 the	 -10	 element	 and	predicted	R4′	BS2,	thus	classifying	PM	as	a	class	II	type	promoter	(Browning	and	Busby,	2004).	This	 is	 a	 common	mode	 of	 promoter	 activation	 by	AraC/XylS	 family	 regulators	 (Martin	 et	 al.,	2002;	 Martin	 et	 al.,	 1999;	 Martin	 and	 Rosner,	 2002).	 With	 class	 II	 promoters,	 the	 regulator	initially	binds	to	region	4	of	the	σ70	subunit	and	the	α-CTD	of	the	RNAP	and	then	scans	the	DNA	for	 subsequent	 transcription	 initiation	complex	 formation	 (Jair	et	al.,	1996a;	 Jair	et	al.,	1996b;	Martin	et	al.,	1999;	Shah	and	Wolf,	2004;	Zafar	et	al.,	2011;	Zafar	et	al.,	2010).		The	R3′	sequence	is	located	only	5	nt	upstream	of	R4′.	A	similar	short	space	between	2	binding	sites	was	found	to	be	critical	for	DNA-bending	by	98°	and	optimal	activation	by	a	dimer	of	XylS	(Dominguez-Cuevas	et	al.,	2010).	To	ensure	binding	of	Caf1R	HTH1	and	HTH	2	at	R4′,	caf	DNA	must	almost	certainly	bend,	 as	 seen	 in	 the	 cocrystal	 structure	of	mar-MarA	 (Rhee	et	 al.,	 1998)	 and	 in	 the	mar	DNA-Caf1R	model	 (Fig.	 3.18c).	 The	 promoter	 fusion	 studies	 indicated	 a	 slight	 enhancement	 of	 PM	activation	 on	 inclusion	 of	 R3′	 as	well	 as	 R4′	with	 PM	 promoter.	 	 It	 is	 possible	 that	 caf	 DNA	 is	additionally	bent	between	R3′and	R4′	as	Caf1R	binds	as	a	dimer	to	enhance	activation.	However,	as	yet	there	is	no	strong	evidence	of	dimerisation	of	Caf1R	and	R3′	has	diverged	more	than	the	other	 repeats.	 Any	 involvement	 of	 this	 sequence	 remains	 to	 be	 elucidated.	 A	model	 depicting	current	understanding	of	Caf1R-mediated	activation	at	PM	promoter	is	shown	in	Fig.	7.1.		
	
 
Figure 7.1| Caf1R-mediated transcription activation at the class II PM promoter.  
At 26°C, there is little caf1MA1 message (due to absence of thermo-inducible expression of caf1R). Following 
temperature transition to 37°C, mimicking Y. pestis transmission from flea vector to mammalian host, Caf1R 
regulator is synthesised (see Fig 7.2 for detail). Based on published evidence of RNAP-regulator interactions at 
class II promoters, it is proposed that Caf1R then interacts with region 4 of the σ70 subunit and the α-CTD of 
RNAP. RNAP-Caf1R complex would then scan the DNA, bind at R4′ and activate transcription of caf1MA1. 
This leads to high levels of surface F1, giving the appearance of encapsulated cells. Involvement of R3′ in 
enhancing Caf1R mediated activation is currently speculative. Depiction of class II activation adapted from 
(Browning and Busby, 2004) for the caf locus.  
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				Regulation	of	caf1R	expression	appears	more	complicated	with	3	repeat	sequences,	R1-3,	each	separated	 by	 18	 nt.	 PR2	can	 also	 be	 defined	 as	 a	 class	 II	 activated	 promoter,	 with	 the	 Caf1R	binding	site	overlapping	the	-35	consensus	by	2	nt.		PR2	clearly	mediates	autoactivation	of	caf1R.	When	Caf1R	 binds	 at	 R1	 there	 is	 a	 3.8-7.8-fold	 increase	 in	 transcription,	 leading	 to	 enhanced	production	of	Caf1R	(Fig	7.2).	Autoregulation	is	common	among	these	regulators.	Examples	of	autoactivation	include	Rns	(Munson	and	Scott,	2000),	PerA	(Porter	et	al.,	2004),	MarA	(Martin	et	al.,	1996)	and	AggR	(Morin	et	al.,	2010).	Unlike	caf1R	these	regulators	are	primarily	unlinked	to	the	target	operons.	 	Further	constructs	are	required	to	assess	the	 impact	of	 inclusion	of	R2	on	Caf1R	 mediated	 activation	 at	 PR2.	 However,	 results	 from	 the	 promoter	 fusion	 constructs	suggested	that	a	second	predicted	promoter,	PRK	may	work	at	a	slightly	higher	basal	level	in	the	absence	of	 Caf1R.	 	 The	 location	of	 the	R2	 repeat	 between	 the	PRK	 	 -10	 and	 -35	 elements	 then	resembles	a	classic	mode	of	transcriptional	repression	(Browning	and	Busby,	2004;	Sanchez	et	al.,	2011).	This	together	with	the	lower	fold	activation	observed	with	lacZ-fusions	containing	PRK,	R2	 and	R3	may	 reflect	 Caf1R	mediated	 repression	 at	 this	 PRK	 promoter.	 This	may	 or	may	not	involve	a	Caf1R	dimer.	Thus	far,	from	EMSA	with	cell	lysates	containing	either	MBPCaf1R	fusion	or	hCaf1R,	effective	binding	was	obtained	with	a	single	Caf1R	binding	repeat	(R4′).			F1	expression	is	known	to	be	temperature	controlled	with	expression	OFF	in	the	flea	and	ON	in	mammalian	hosts	(Chauvaux	et	al.,	2007;	Hinnebusch,	2005;	Straley	and	Perry,	1995;	Zhou	et	al.,	2006).	 Thermo-control	 of	 F1	 expression	 is	 known	 to	 be	maintained	 in	 recombinant	 plasmids	both	 in	E.	coli	 and	Salmonella	 (Cao	et	al.,	2012;	Simpson	et	al.,	1990;	Titball	 et	al.,	1997).	This	study	has	provided	 the	 first	 evidence	of	how	changes	 in	 temperature	 control	 expression	 from	the	caf	 locus.	Thermosensing	was	 localised	 to	expression	of	caf1R	 and	a	 thermosensitive	RNA	secondary	 structure	 (RNAT)	 was	 predicted	 within	 the	 transcript	 from	 PRK.	 	 This	 predicted	secondary	RNA	 structure	 trapped	both	 the	 ribosomal	 binding	 site	 (Quade	 et	 al.)	 and	 the	AUG	start	codon	of	Caf1R	 in	 two	stem-loop	structures	at	 lower	 temperatures	of	26°C.	Temperature	mediated	modifications	were	observed	 in	 this	predicted	structure	at	37°C,	with	melting	of	 the	stem-loop	encompassing	the	AUG	start	codon	and	destabilisation	of	the	structure	encompassing	the	RBS.		Interestingly,	an	RNase	E	site	was	located	directly	preceding	the	RBS	within	a	bulge	in	the	 stem	 structure.	 Cleavage	 at	 this	 site,	 in	 a	 partially	 unfolded	 structure,	 would	 drive	 the	reaction	towards	the	OPEN	structure	permitting	access	of	ribosomes	for	subsequent	translation	of	Caf1R.	This	model	of	thermoregulation	of	caf1R	is	depicted	in	Fig	7.2.	In	the	model,	an	RNAT	structure	within	 the	 leader	of	caf1R	 transcript	 synthesised	at	26°C	 remains	untranslated	until	the	 temperature	 increases.	 At	 37°C,	 on	 infection	 of	 the	 mammalian	 host,	 Caf1R	 regulator	 is	produced	 and	 binds	 at	 R4′	 to	 activate	 transcription	 of	 caf1MA1	 from	 the	PM	 promoter.	 Caf1R	would	also	bind	at	R1,	autoactivating	transcription	of	caf1R.	It	is	hypothesized	that	Caf1R	would	also	 bind	 at	 R2	 blocking	 further	 expression	 from	 PRK.	 	 The	 caf1R	 gene	 would	 then	 only	 be	transcribed	 from	 PR2.	 These	 features	 could	 be	 addressed	 by	 further	 lacZ-fusions,	 directed	mutagenesis	and	using	primer	extension,	or	RT-PCR	to	 identify	 temperature	dependent	 leader	sequence.						
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Figure 7.2| Working model of Caf1R- independent and dependent transcription of caf1R.  
At 26°C, caf1R mRNA is transcribed and mRNA leader sequence folds to form an RNAT (A), translation of 
Caf1R is blocked. At 37°C, the RNAT melts (A1) and Caf1R is translated. Low-level transcription from PRK 
may continue. Caf1R binds R1, activating transcription from PR2 promoter, in a class II type manner involving 
binding and optimum promoter RNAP complex formation as described in Fig. 7.1. This leads to a high level of 
Caf1R (B). A high level of Caf1R may also result in binding to R2 (possibly also involving R3 binding) 
resulting in repression of transcription (A2). The model of class II activation adapted from (Browning and 
Busby, 2004) for the caf locus.  		Activation	by	AraC/	XylS	 family	 regulators,	 as	 seen	with	PM,	 is	 common.	 In	many	well-studied	cases,	binding	of	a	 small	metabolite	 is	 required	 for	activation	 (Dominguez-Cuevas	et	al.,	2008;	Kolin	et	al.,	2008;	Lowden	et	al.,	2010;	Ni	et	al.,	2013;	Schleif,	2010).	Caf1R	also	possesses	a	C-terminal	 ‘sensing’-like	domain	but	it	remains	to	be	seen	if	this	binds	anything	or	is	 involved	in	dimerisation.	 The	 proposed	mode	 of	 regulation	 of	 caf1R	 is	more	 unusual.	 Two	promoters	 are	proposed;	one	involved	in	autoactivation	(PR2)	and	the	other	(PRK)	in	thermoregulation	of	basal	levels	 of	 Caf1R	 expression	 at	 low	 temperatures	 and	 autorepression	 at	 37°C.	 The	 best-studied	example	 of	 transcription	 repression	 by	 AraC/XylS	 family	 regulators	 is	 that	mediated	 by	 AraC	itself.	When	an	AraC	dimer	binds	 to	operator	 site	O1	 it	blocks	 self-transcription	 (Ogden	et	 al.,	1980).	 In	addition,	 it	represses	transcription	of	araBAD	via	a	DNA-looping	mechanism	(Schleif,	2000,	2010)	 involving	binding	of	AraC	dimer	to	 two	distant	sites,	O2	and	I1,	which	are	171	nt	apart.	 The	 working	 model	 presented	 for	 regulation	 by	 Caf1R	 is	 completely	 different.	 No	additional	distal	Caf1R	binding	site	 is	present,	R1-R4′	are	80	nt	apart.	 It	 remains	 to	be	seen	 if	other	CU	systems	are	controlled	in	a	similar	manner	proposed	here	for	Caf1R.				
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7.3 Caf1R residues involved in DNA binding 	The	Caf1R	binding	motif	(R4′)	showed	a	high	degree	of	similarity	with	the	MarA	binding	motif	(Rhee	et	al.,	1998)	(Fig.	 7.3).	 In	BS1	(binds	helix-3,	within	HTH1),	only	2	of	5	bp	are	 identical	between	 the	 2	 sequences,	 whereas	 in	 BS2	 (binds	 helix-6,	 within	 HTH2),	 6	 of	 the	 7	 bp	 are	identical.	 This	 is	 consistent	with	 the	 fact	 that	 bases	 in	 BS1	 contribute	 to	 regulator	 specificity	(Egan,	 2002;	 Gallegos	 et	 al.,	 1997).	 The	 high	 level	 of	 identity	 at	 BS2	 reflects	more	 conserved	DNA-protein	 interactions	within	this	subfamily	of	AraC/XylS	regulators.	This	 is	also	consistent	with	poor	amino	acid	 conservation	within	 the	 regulator	HTH1	motif	 in	 comparison	 to	a	much	higher	level	of	conservation	within	HTH2.	DNA-Caf1R	interactions	had	been	identified	using	the	
mar	 DNA-Caf1R	model.	 Having	 confirmed	 binding	 of	 Caf1R	 to	 R4′	 sequence,	 the	mar	 DNA	 nt	could	be	replaced	for	caf	DNA	as	shown	in	Fig.	7.3.		In	comparison	with	mar-MarA	interactions,	the	 key	 helix-6	 residues	 of	 Caf1R	 (Q93	 and	 R97)	 and	 MarA	 (Q92	 and	 R96)	 are	 involved	 in	virtually	identical	BS2	base	interactions	as	shown	for	Caf1R	in	Fig.	7.3.	MarA-Q92/	Caf1R-Q93	interacts	with	T-7	and	T-8	bases	while	MarA-R96/Caf1R-R97	showed	extensive	hydrogen	bonds	with	A-9,	 G-10	 and	G-40	 bases.	 The	 only	 exception	was	 the	 Caf1R-R97	 interaction	with	A-39,	which	 corresponds	 to	MarA-R96	 interaction	with	T-39.	 In	 the	modelled	Caf1R-DNA	 structure,	the	BS1	 interactions	are	very	different	 from	those	 in	the	mar-MarA	cocrystal	structure.	Caf1R-R43	was	the	only	residue	with	specific	base	interactions.	It	interacts	with	the	highly	conserved	nt,	G-31	and	C-32	 in	BS1.	Y44	 interacts	with	G-29	at	 the	border	of	 the	consensus	sequence.	 In	contrast,	 in	 MarA	 three	 residues,	 R46,	 W42	 and	 Q45	 all	 interact	 with	 nt	 of	 BS1.	 W42,	corresponding	 to	Caf1R-R43,	 interacts	with	T-18,	C-31	and	C-32	 (van	der	Waals	 interactions),	Q45	with	G-17	and	T-18	(van	der	Waals	interactions)	while	R46	forms	H-bonds	with	G-20,	G-30	and	C-31	(Rhee	et	al.,	1998).	These	differences	could	be	explained	by	the	very	different	residues	in	helix-3	of	both	regulators,	which	in	turn	could	contribute	to	differences	in	specificity.			Alanine	scanning	mutagenesis	of	all	Caf1R	residues	involved	in	DNA	binding	was	used	to	assess	the	 importance	 of	 these	 residues	 to	 Caf1R	 function.	 Comparison	 with	 published	 data	 on	mutations	in	MarA	is	summarised	in	Appendix	8.	Substitution	of	Q93	and	R97	in	Caf1R	indicated	an	equally	critical	role	of	both	of	these	invariant	residues	in	Caf1R	function.	The	corresponding	nt	to	Caf1R-R97	in	MarA	and	SoxS	was	also	found	to	be	critical	using	Ala	mutagenesis.	MarAR96A	had	a	lower	level	of	transcriptional	activity	at	both	class	I	and	class	II	promoters	(0-20%	on	fpr,	
zwf	 and	micF;	21-40%	 on	mar;	41-60%	on	 fumC)	 (Gillette	 et	 al.,	 2000).	 SoxSR90A	 had	 an	 even	greater	effect,	particularly	on	zwf	and	micF	promoters.	It	generated	only	2%	and	38%	activity	at	the	 class	 I	 promoters,	 zwf	 and	 fpr,	 respectively,	 and	 45%	 and	 8%	 activity	 at	 the	 class	 II	promoters,	 fumC	 and	 micF	 (Griffith	 and	 Wolf,	 2002).	 DNA-protein	 mobility	 shift	 assays	 also	highlighted	 the	 critical	 role	 of	 this	 BS2	 Arg	 residue	 in	 both	 MarA	 and	 SoxS	 for	 stable	 DNA	binding,	 consistent	 with	 the	 extensive	 nt	 interaction	 (Gillette	 et	 al.,	 2000;	 Griffith	 and	 Wolf,	2002;	Rhee	et	al.,	1998).	The	impact	of	loss	of	the	conserved	Gln	residue	was	less	pronounced.	With	 MarAQ92A,	 61-80%	 transcriptional	 activation	 remained	 at	 both	 class	 I	 (zwf)	 and	 class	 II	(fumC)	 promoters	 (Gillette	 et	 al.,	 2000).	 With	 SoxSQ86A	 there	 was	 no	 impact	 at	 any	 of	 the	promoters	tested	(Griffith	and	Wolf,	2002).			
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Figure 7.3| Modelled interactions of Caf1R residues at R4′ repeat.  
R4′ nt corresponding to mar BS1 and BS2 are numbered according to the mar DNA in the mar-MarA crystal 
structure (Rhee et al., 1998). BS1 and BS2 represent DNA residues involved in binding helix-3 and 6 of MarA 
regulator. The corresponding residues in caf R4′ sequence (red) are shown. Highlighted amino acids are Caf1R 
residues found to be involved in DNA binding in the mar DNA-Caf1R model (see Fig. 3.23). These amino acids 
are assumed to interact with the same corresponding position in the caf DNA. DNA-protein interactions 
identified in the mar DNA-Caf1R model that are different from those in the mar-MarA cocrystal structure are 
indicated by §.  		Ala	substitution	of	Caf1R-	R43	and	Y44	had	much	less	of	an	impact.	F1	production	was	reduced	by	 only	 25-35%.	 This	 suggests	 a	 lesser	 role	 of	 these	 residues	 in	 stabilizing	 the	 DNA-protein	interactions.	 	 In	 contrast,	 BS1	 interacting	 residues	 of	MarA	 and	 SoxS	were	 found	 to	 be	more	critical	 (Gillette	 et	 al.,	 2000;	 Griffith	 and	 Wolf,	 2002).	 Alanine	 substitution	 of	 W42	 in	 MarA	(corresponding	 to	R43)	resulted	 in	a	drastic	reduction	 in	 the	 transcription	activity	 (0-20%)	at	class	I	promoters	(fpr	and	zwf)	and	had	a	moderate	effect	on	class	II	promoters	(fumC	and	micF)	(Gillette	et	al.,	2000).	Similarly,	Ala	substitution	of	MarA-	H43	produced	a	severe	effect	(0-20%	of	WT)	on	both	class	I	and	class	II	promoters,	except	class	I	mar	promoter,	on	which	wild	type	phenotype	was	observed	(Gillette	et	al.,	2000).					
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			The	DNA	backbone	 interacting	 residues	 also	play	 an	 important	 role.	 	 Key	 residues	 are	Caf1R-	I31,	 D32,	 C33,	 F40	 and	R108,	which	 correspond	 to	MarA-	 L30,	 E31,	 K32,	 Y39	 and	H107.	 The	most	pronounced	effect	was	seen	with	F40A	mutation	in	Caf1R,	Y39A	mutation	in	MarA	(Gillette	et	 al.,	 2000)	 and	 Y33A	 in	 SoxS	 (Griffith	 and	 Wolf,	 2002).	 In	 all	 cases,	 regulator	 activity	 was	virtually	abolished.	Griffith	and	Wolf	suggested	that	the	Y39	residue	of	MarA	might	interact	with	highly	 conserved	 (invariant)	 A	 base	 (at	 position	 28	 in	 Fig.	 7.3)	 (Griffith	 and	Wolf,	 2002).	 A	similar	 conclusion	 was	 made	 from	 an	 NMR	 study	 of	 mar-MarA-RNAP	 complex	 (PDB-1xs9),	where	mar-MarA	contacts	were	shown	from	the	N-terminal	residues	of	MarA	(Dangi	et	al.,	2001)	that	are	absent	in	the	cocrystal	structure	of	mar-MarA	complex	(Rhee	et	al.,	1998).	At	the	other	end	of	the	regulator,	close	to	BS2,	Caf1R-R108	was	found	to	be	critical	as	was	SoxS-S101	(Griffith	and	Wolf,	2002),	suggesting	that	that	Caf1R-R108	together	with	F40	may	be	critical	in	anchoring	both	 ends	 of	 the	 protein-DNA	 interaction.	 However,	 Ala	 substitution	 of	 the	 corresponding	residue	in	MarA,	H107,	had	no	impact	(Gillette	et	al.,	2000).		A	spontaneous	mutation	(E98G),	within	Caf1R-DBD	virtually	abolished	F1	assembly	and	loss	of	Caf1R	binding	to	caf	DNA	in	an	in	vitro	EMSA	binding.	Strikingly,	the	analogous	position	of	Glu98	was	identical	in	all	of	the	analysed	regulators	linked	to	the	CU	system.	But	in	non-CU	regulators	such	 as	 Rob,	 MarA	 and	 SoxS	 this	 position	 was	 highly	 variable,	 containing	 Thr,	 Ala	 and	 Val,	respectively.	 DNA-Caf1R	modelling	 provided	 evidence	 that	 E98	 stabilizes	 the	 correct	 protein-DNA	 interaction	 through	 formation	 of	 a	 bridge	 between	 the	 BS2	 recognition	 helix-6	 and	 the	helix-4	residue	R62.	R62	and	helix-4	then	binds	to	the	DNA	backbone	and	connects	BS1	and	BS2.	R62	 and	 E98	 interact	 with	 an	 interatomic	 distance	 of	 3.2Å.	 Upon	 E98G	 substitution,	 the	proposed	 bridge	 interaction	 was	 completely	 lost	 (no	 interaction	 between	 R62	 and	 G98).	Moreover,	although	the	modelled	E98G	mutant	showed	no	disruption	of	the	R97	and	Q93/BS2	interactions,	 the	 small	 size	 and	 low	 helix	 propensity	 of	 G98	may	 disturb	 DNA	 interactions	 of	helix-6.	 This	 could	 explain	 the	 severe	 defect	 with	 Caf1RE98G.	This	 bridge-type	 interaction	 was	further	validated	by	site-specific	mutagenesis	of	R62	(R62A/S)	and	E98	(E98T/A/K)	with	which	significant	 reduction	 in	F1	assembly	 and	 loss	of	 the	modelled	bridge	was	observed.	R62	 is	 an	invariant	residue,	R61	in	MarA.		In	MarA,	R61	also	interacts	with	the	DNA	backbone	in	the	mar-MarA	 cocrystal	 structure	 (Rhee	 et	 al.,	 1998).	 However,	 Ala	 substitution	 of	 MarA-R61	 had	variable	results.	There	was	no	defect	in	transcription	from	the	class	II	promoters	fumC	and	micF,	but	a	marked	reduction	 in	 transcriptional	activity	at	 the	 class	 I	promoter	 fpr	 (21-40%	of	WT)	(Gillette	 et	 al.,	 2000).	 Mutation	 of	 SoxS	 gave	 similar	 results	 to	 Caf1R.	 A	 SoxS	 with	 an	 R55A	mutation	resulted	in	40-80%	reduction	in	transcriptional	activity	with	all	promoters	tested	(zwf,	
fpr,	micF	and	fumC)		(Griffith	and	Wolf,	2002).	There	was	less	impact	in	other	regulators	carrying	an	Ala	substitution	for	the	variable	residue	corresponding	to	Caf1R-E98.	In	contrast	to	Caf1RE98A	(58%	of	WT	F1),	MarA	T97A	showed	81-100%	activation	with	 class	 I	promoters	and	61-81%	activation	with	 class	 II	 promoters	 and	 SoxS	 V91A	 had	 only	 a	minor	 effect	 on	 fumC	 promoter	(Gillette	et	al.,	2000;	Griffith	and	Wolf,	2002).	No	T97	mediated	bridge	interaction	was	observed	in	 the	mar-MarA	 cocrystal	 structure	 (Rhee	 et	 al.,	 1998),	 suggesting	 the	 modelled	 Caf1R-DNA	bridge	interaction	may	be	a	special	feature	of	CU-associated	regulators,	which	contain	invariant	R62	and	E98	residues	of	this	subfamily.	Ultimately,	high	resolution	structural	studies	would	be	required	to	valid	these	interactions.			
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7.4 Future directions 	Initial	key	aspects	requiring	attention	include	confirmation	of	the	model	of	thermoregulation	at	the	 caf1R	 promoter	and	 optimisation	 of	 EMSA.	 This	 would	 permit	 a	 detailed	 analysis	 of	 the	significance	of	each	repeat	motif	and	consideration	of	whether	Caf1R	functions	as	a	monomer	or	dimer.	 This	 could	 include	mapping	 of	 transcription	 start	 site	 (TSS)	 for	 caf1R,	 caf1M	 and	 caf1	transcript.	 The	 question	 of	 whether	 the	 C-terminal	 domain	 of	 Caf1R	 functions	 as	 a	 sensor		domain	 is	 interesting,	 particularly	 in	 view	 of	 the	 fact	 that	 the	 closest	 relative	 appears	 to	 be	involved	in	carbohydrate	transport.	This	could	be	addressed	using	a	pull-down	assay	and	mass	spectrometry.	 	Another	possible	role	of	the	C-terminal	domain	is	for	dimerisation	as	with	AraC	(Soisson	et	al.,	1997),	XylR	(Ni	et	al.,	2013)	and	XylS	(Dominguez-Cuevas	et	al.,	2010)	and	Rns	(Mahon	 et	 al.,	 2012)	 regulators.	 All	 the	 constructs	 and	 optimised	 expression	 conditions	 for	recombinant	tagged	Caf1R	are	now	available.	Availability	of	purified	tagged	Caf1R	would	be	very	useful	for	further	EMSA	study,	preparation	of	anti-Caf1R	antibody	and	structural	analysis.			This	study	has	focused	on	the	role	of	Caf1R	in	regulation	of	the	caf	locus.	This	represent	a	good	model	for	studying	the	CU-system	controlled	by	a	dedicated	regulator.	There	will	be	many	other	factors	controlling	expression	of	the	caf	locus.	To	fully	understand	regulation	of	F1	expression	it	will	be	important	to	map	the	role	of	other	cellular	factors	onto	the	proposed	model.		Caf1R	is	a	dedicated	regulator	 linked	 to	 the	caf1MA1	operon.	Many	AraC/XylS	 like	regulators	 function	as	global	regulators,	however,	most	of	these	are	unlinked	to	the	target	operons.	Examples	include,	Rob,	MarA	and	SoxS	(Ariza	et	al.,	1995;	Barbosa	and	Levy,	2000;	Duval	and	Lister,	2013;	Jair	et	al.,	 1996a),	 Rns	 (Basturea	 et	 al.,	 2008;	 Caron	 et	 al.,	 1989;	 Froehlich	 et	 al.,	 1994;	Mahon	 et	 al.,	2010;	Munson	et	al.,	2002;	Munson	and	Scott,	1999,	2000)	and	AggR	(Dudley	et	al.,	2006;	Morin	et	al.,	2013;	Nataro	et	al.,	1994).	Virulence	of	Y.	pestis	is	still	not	well	understood	and	regulators	involved	 in	 global	 regulation	 may	 be	 critically	 important.	 Hence,	 despite	 the	 fact	 that	 Caf1R	appears	 to	 be	 a	 dedicated	 regulator,	 it	 is	 still	 important	 to	 review	 any	 possibility	 of	 global	regulation.	 A	 first	 step	 toward	 this	would	 be	 searching	Y.	pestis	 genome	 for	 Caf1R	 consensus	binding	sites.			In	 vaccine	 design,	 including	 anti-plague	 vaccines,	 there	 is	 a	 lot	 of	 interest	 in	 development	 of	attenuated	 vaccines	 and	 heterologous	 expression	 of	 F1	 (Derbise	 et	 al.,	 2012;	 Feodorova	 and	Motin,	2012).	In	this	type	of	vaccine	it	is	essential	to	retain	optimum	expression	of	F1.	For	this	reason	a	full	understanding	of	factors	controlling	expression	of	F1	is	essential.				 	
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1. Transcriptional fusion vectors used to construct promoter-lacZ fusions. 
	
	
	
Figure A.1| Transcriptional fusion vectors used to construct promoter-lacZ fusions. 
a) pRS415 used to design constructs for identification of promoters for caf1R. b) pRS550 used to design 
constructs for identification of promoters for caf1M and caf1. Key features of each vector are indicated along 
with reverse location of EcoRI and BamHI cloning site upstream of the promoterless lacZ gene. The 100 bp 
including SD sequence (AGGA) between the lacZ ATG start codon and multiple cloning sites are the same in 
both plasmids. This is in contrast to the available repository sequence 
(http://www.mimg.ucla.edu/faculty/simons/vectors/lac-based/lac-based.htm) of these vectors, where pRS550 
missing a G nt at position 23 (relative to BamHI site) within a sequence, ATCCxGACA; x is missing G. T1(4), 
four consecutive sequences of rrnB terminator (Simons et al., 1987). 
 
 
 
 
Site for Infusion or cloning  
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2a. Similarity between RNAP holoezyme of Y. pestis CO92 and E. coli K-12. 	
	
Sequences producing significant alignments:
unnamed protein product
Sequence ID: lcl|Query_40687 Length: 329 Number of Matches: 1
Range 1: 1 to 329
Score Expect Method Identities Positives Gaps Frame
659 bits(1701) 0.0() Compositional matrix adjust. 327/329(99%) 328/329(99%) 0/329(0%)
Features:
Query  1    MQGSVTEFLKPRLVDIEQVSSTHAKVTLEPLERGFGHTLGNALRRILLSSMPGCAVTEVE  60
            MQGSVTEFLKPRLVDIEQVSSTHAKVTLEPLERGFGHTLGNALRRILLSSMPGCAVTEVE
Sbjct  1    MQGSVTEFLKPRLVDIEQVSSTHAKVTLEPLERGFGHTLGNALRRILLSSMPGCAVTEVE  60
Query  61   IDGVLHEYSTKEGVQEDILEILLNLKGLAVRVQGKDEVILTLNKSGIGPVTAADITHDGD  120
            IDGVLHEYSTKEGVQEDILEILLNLKGLAVRVQGKDEVILTLNKSGIGPVTAADITHDGD
Sbjct  61   IDGVLHEYSTKEGVQEDILEILLNLKGLAVRVQGKDEVILTLNKSGIGPVTAADITHDGD  120
Query  121  VEIVKPQHVICHLTDENASINMRIKVQRGRGYVPASARIHSEEDERPIGRLLVDACYSPV  180
            VEIVKPQHVICHLTDENASI+MRIKVQRGRGYVPAS RIHSEEDERPIGRLLVDACYSPV
Sbjct  121  VEIVKPQHVICHLTDENASISMRIKVQRGRGYVPASTRIHSEEDERPIGRLLVDACYSPV  180
Query  181  ERIAYNVEAARVEQRTDLDKLVIEMETNGTIDPEEAIRRAATILAEQLEAFVDLRDVRQP  240
            ERIAYNVEAARVEQRTDLDKLVIEMETNGTIDPEEAIRRAATILAEQLEAFVDLRDVRQP
Sbjct  181  ERIAYNVEAARVEQRTDLDKLVIEMETNGTIDPEEAIRRAATILAEQLEAFVDLRDVRQP  240
Query  241  EVKEEKPEFDPILLRPVDDLELTVRSANCLKAEAIHYIGDLVQRTEVELLKTPNLGKKSL  300
            EVKEEKPEFDPILLRPVDDLELTVRSANCLKAEAIHYIGDLVQRTEVELLKTPNLGKKSL
Sbjct  241  EVKEEKPEFDPILLRPVDDLELTVRSANCLKAEAIHYIGDLVQRTEVELLKTPNLGKKSL  300
Query  301  TEIKDVLASRGLSLGMRLENWPPASIADE  329
            TEIKDVLASRGLSLGMRLENWPPASIADE
Sbjct  301  TEIKDVLASRGLSLGMRLENWPPASIADE  329
Dot Matrix View
Descriptions
Description Max
score
Total
score
Query
cover
E
value
Ident Accession
unnamed protein
product 659 659 100% 0.0 99% Query_40687
Alignments
NCBI Blast:RpoA (Alpha)
https://blast.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 11:13
Sequences producing significant alignments:
unnamed protein product
Sequence ID: lcl|Query_232963 Length: 1342 Number of Matches: 1
Range 1: 1 to 1342
Score Expect Method Identities Positives Gaps Frame
2620
bits(6792) 0.0()
Compositional matrix
adjust. 1270/1342(95%) 1321/1342(98%) 0/1342(0%)
Features:
Query  1     MVYSYTEKKRIRKDFGKRPQVLDIPYLLSIQLDSFQKFIEQDPEGQHGLEAAFRSVFPIQ  60
             MVYSYTEKKRIRKDFGKRPQVLD+PYLLSIQLDSFQKFIEQDPEGQ+GLEAAFRSVFPIQ
Sbjct  1     MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ  60
Query  61    SYSGNSELQYVSYRLGEPVFDVKECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ  120
             SYSGNSELQYVSYRLGEPVFDV+ECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
Sbjct  61    SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ  120
Query  121   EVYMGEIPLMTENGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR  180
             EVYMGEIPLMT+NGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
Sbjct  121   EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR  180
Query  181   GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNFTTAQILDLFFEKVVFEIRDNKLQME  240
             GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALN+TT QILDLFFEKV+FEIRDNKLQME
Sbjct  181   GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIFEIRDNKLQME  240
Query  241   LVPERLRGETASFDIEANGKVYVEKARRITARHIRQLEKDGIDRIEVPVEYIAGKVVAKD  300
             LVPERLRGETASFDIEANGKVYVEK RRITARHIRQLEKD +  IEVPVEYIAGKVVAKD
Sbjct  241   LVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDVKLIEVPVEYIAGKVVAKD  300
Query  301   YVDASTGELICAANMELSLDLLAKLSQAGHKQIETLFTNDLDHGAYISETLRVDPTSDRL  360
             Y+D STGELICAANMELSLDLLAKLSQ+GHK+IETLFTNDLDHG YISETLRVDPT+DRL
Sbjct  301   YIDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISETLRVDPTNDRL  360
Query  361   SALVEIYRMMRPGEPPTREAAENLFENLFFSEDRYDLSAVGRMKFNRSLLRDEIEGSGIL  420
             SALVEIYRMMRPGEPPTREAAE+LFENLFFSEDRYDLSAVGRMKFNRSLLR+EIEGSGIL
Sbjct  361   SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLREEIEGSGIL  420
Query  421   SKEDITEVMKKLIDIRNGRGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS  480
             SK+DI +VMKKLIDIRNG+GEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
Sbjct  421   SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS  480
Query  481   LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR  540
             LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
Sbjct  481   LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR  540
Query  541   ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRRVRDGVVT  600
             ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYR+V DGVVT
Sbjct  541   ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVTDGVVT  600
Query  601   DEINYLSAIEEGNFVIAQANSNLDDEGRFLEDLVTCRSKGESSLFSREQVDYMDVSTQQI  660
             DEI+YLSAIEEGN+VIAQANSNLD+EG F+EDLVTCRSKGESSLFSR+QVDYMDVSTQQ+
Sbjct  601   DEIHYLSAIEEGNYVIAQANSNLDEEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV  660
Query  661   VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTSVAKR  720
             VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVT+VAKR
Sbjct  661   VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR  720
Query  721   GGTVQYVDASRIVIKVNEDEMHPGEAGIDIYNLTKYTRSNQNTCINQMPCVNLGEPIERG  780
             GG VQYVDASRIVIKVNEDEM+PGEAGIDIYNLTKYTRSNQNTCINQMPCV+LGEP+ERG
Sbjct  721   GGVVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG  780
Query  781   DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS  840
             DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
Sbjct  781   DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS  840
Query  841   RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK  900
             RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
Sbjct  841   RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK  900
Query  901   LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL  960
Dot Matrix View
Descriptions
Description Max
score
Total
score
Query
cover
E
value
Ident Accession
unnamed protein
product 2620 2620 100% 0.0 95% Query_232963
Alignments
NCBI Blast:RpoC (B)
https://blast.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 11:00
        LEIEEMQLKQAKKDL
Sbjct  901   LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL  960
Query  961   TEELQILEAGLFARIHAVLVSGGIEAEKLSKLPRERWLELGLTDEDKQNQLEQLAEQYDE  1020
             +EELQILEAGLF+RI AVLV+GG+EAEKL KLPR+RWLELGLTDE+KQNQLEQLAEQYDE
Sbjct  961   SEELQILEAGLFSRIRAVLVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE  1020
Query  1021  MKSEFEKKMDAKRRKITQGDDLAPGVLKIVKVYLAVKRQIQPGDKMAGRHGNKGVISKIN  1080
             +K EFEKK++AKRRKITQGDDLAPGVLKIVKVYLAVKR+IQPGDKMAGRHGNKGVISKIN
Sbjct  1021  LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN  1080
Query  1081  PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGEKINAMLKKQEEVAK  1140
             PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIG+KINAMLK+Q+EVAK
Sbjct  1081  PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK  1140
Query  1141  LREFIQKAYDLGDNVCQKVDLSTFTDDEVLRLAENLKKGMPIATPVFDGATEKEIKELLQ  1200
             LREFIQ+AYDLG +V QKVDLSTF+D+EV+RLAENL+KGMPIATPVFDGA E EIKELL+
Sbjct  1141  LREFIQRAYDLGADVRQKVDLSTFSDEEVMRLAENLRKGMPIATPVFDGAKEAEIKELLK  1200
Query  1201  LGGLPTSGQITLFDGRTGEQFERQVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG  1260
             LG LPTSGQI L+DGRTGEQFER VTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
Sbjct  1201  LGDLPTSGQIRLYDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG  1260
Query  1261  GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGDHRMEPGMP  1320
             GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDG+H+MEPGMP
Sbjct  1261  GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP  1320
Query  1321  ESFNVLLKEIRSLGINIELEEE  1342
             ESFNVLLKEIRSLGINIELE+E
Sbjct  1321  ESFNVLLKEIRSLGINIELEDE  1342
NCBI Blast:RpoC (B)
https://blast.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 11:00
RpoA or α subunit  
RpoB or β subunit  
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Sequences producing significant alignments:
unnamed protein product
Sequence ID: lcl|Query_213457 Length: 1407 Number of Matches: 1
Range 1: 1 to 1404
Score Expect Method Identities Positives Gaps Frame
2680
bits(6948) 0.0()
Compositional matrix
adjust. 1304/1404(93%) 1358/1404(96%) 0/1404(0%)
Features:
Query  1     MKDLLKFLKAQTKTEEFDAIKIALASPDMIRSWSFGEVKKPETINYRTFKPERDGLFCAR  60
             MKDLLKFLKAQTKTEEFDAIKIALASPDMIRSWSFGEVKKPETINYRTFKPERDGLFCAR
Sbjct  1     MKDLLKFLKAQTKTEEFDAIKIALASPDMIRSWSFGEVKKPETINYRTFKPERDGLFCAR  60
Query  61    IFGPVKDYECLCGKYKRLKHRGVICEKCGVEVTQTKVRRERMGHIELASPTAHIWFLKSL  120
             IFGPVKDYECLCGKYKRLKHRGVICEKCGVEVTQTKVRRERMGHIELASPTAHIWFLKSL
Sbjct  61    IFGPVKDYECLCGKYKRLKHRGVICEKCGVEVTQTKVRRERMGHIELASPTAHIWFLKSL  120
Query  121   PSRIGLLLDMPLRDIERVLYFESYVVIEGGMTNLERRQILTEEQYLDALEEFGDEFDAKM  180
             PSRIGLLLDMPLRDIERVLYFESYVVIEGGMTNLER+QILTEEQYLDALEEFGDEFDAKM
Sbjct  121   PSRIGLLLDMPLRDIERVLYFESYVVIEGGMTNLERQQILTEEQYLDALEEFGDEFDAKM  180
Query  181   GAEAIQALLKNMDLEAECEILREELNETNSETKRKKLTKRIKLLEAFVQSGNKPEWMILT  240
             GAEAIQALLK+MDLE ECE LREELNETNSETKRKKLTKRIKLLEAFVQSGNKPEWMILT
Sbjct  181   GAEAIQALLKSMDLEQECEQLREELNETNSETKRKKLTKRIKLLEAFVQSGNKPEWMILT  240
Query  241   VLPVLPPDLRPLVPLDGGRFATSDLNDLYRRVINRNNRLKRLLDLAAPDIIVRNEKRMLQ  300
             VLPVLPPDLRPLVPLDGGRFATSDLNDLYRRVINRNNRLKRLLDLAAPDIIVRNEKRMLQ
Sbjct  241   VLPVLPPDLRPLVPLDGGRFATSDLNDLYRRVINRNNRLKRLLDLAAPDIIVRNEKRMLQ  300
Query  301   EAVDALLDNGRRGRAITGSNKRPLKSLADMIKGKQGRFRQNLLGKRVDYSGRSVITVGPY  360
             EAVDALLDNGRRGRAITGSNKRPLKSLADMIKGKQGRFRQNLLGKRVDYSGRSVITVGPY
Sbjct  301   EAVDALLDNGRRGRAITGSNKRPLKSLADMIKGKQGRFRQNLLGKRVDYSGRSVITVGPY  360
Query  361   LRLHQCGLPKKMALELFKPFIYGKLELRGLATTIKAAKKMVEREEAVVWDILDEVIREHP  420
             LRLHQCGLPKKMALELFKPFIYGKLELRGLATTIKAAKKMVEREEAVVWDILDEVIREHP
Sbjct  361   LRLHQCGLPKKMALELFKPFIYGKLELRGLATTIKAAKKMVEREEAVVWDILDEVIREHP  420
Query  421   VLLNRAPTLHRLGIQAFEPVLIEGKAIQLHPLVCAAYNADFDGDQMAVHVPLTLEAQLEA  480
             VLLNRAPTLHRLGIQAFEPVLIEGKAIQLHPLVCAAYNADFDGDQMAVHVPLTLEAQLEA
Sbjct  421   VLLNRAPTLHRLGIQAFEPVLIEGKAIQLHPLVCAAYNADFDGDQMAVHVPLTLEAQLEA  480
Query  481   RALMMSTNNILSPANGEPIIVPSQDVVLGLYYMTRDCVNAKGEGMVLTGPKEAERIYRAG  540
             RALMMSTNNILSPANGEPIIVPSQDVVLGLYYMTRDCVNAKGEGMVLTGPKEAER+YR+G
Sbjct  481   RALMMSTNNILSPANGEPIIVPSQDVVLGLYYMTRDCVNAKGEGMVLTGPKEAERLYRSG  540
Query  541   LASLHARVKVRITEEIRNTEGESITRTSIIDTTVGRAILWMIVPQGLPYSIVNQPLGKKA  600
             LASLHARVKVRITE  ++  GE + +TS+ DTTVGRAILWMIVP+GLPYSIVNQ LGKKA
Sbjct  541   LASLHARVKVRITEYEKDANGELVAKTSLKDTTVGRAILWMIVPKGLPYSIVNQALGKKA  600
Query  601   ISKMLNTCYRILGLKPTVIFADQIMYTGFAYAARSGASVGIDDMVIPEAKAGIIEEAETE  660
             ISKMLNTCYRILGLKPTVIFADQIMYTGFAYAARSGASVGIDDMVIPE K  II EAE E
Sbjct  601   ISKMLNTCYRILGLKPTVIFADQIMYTGFAYAARSGASVGIDDMVIPEKKHEIISEAEAE  660
Query  661   VAEIQEQFQSGLVTAGERYNKVIDIWAAANERVAKAMMDNLSVEDVVNRDGVVEQQVSFN  720
             VAEIQEQFQSGLVTAGERYNKVIDIWAAAN+RV+KAMMDNL  E V+NRDG  E+QVSFN
Sbjct  661   VAEIQEQFQSGLVTAGERYNKVIDIWAAANDRVSKAMMDNLQTETVINRDGQEEKQVSFN  720
Query  721   SIFMMADSGARGSAAQIRQLAGMRGLMAKPDGSIIETPITANFREGLNVLQYFISTHGAR  780
             SI+MMADSGARGSAAQIRQLAGMRGLMAKPDGSIIETPITANFREGLNVLQYFISTHGAR
Sbjct  721   SIYMMADSGARGSAAQIRQLAGMRGLMAKPDGSIIETPITANFREGLNVLQYFISTHGAR  780
Query  781   KGLADTALKTANSGYLTRRLVDVAQDLVVTEDDCGTHNGIVMTPVIEGGDVKEPLRDRVL  840
             KGLADTALKTANSGYLTRRLVDVAQDLVVTEDDCGTH GI+MTPVIEGGDVKEPLRDRVL
Sbjct  781   KGLADTALKTANSGYLTRRLVDVAQDLVVTEDDCGTHEGIMMTPVIEGGDVKEPLRDRVL  840
Query  841   GRVTAEEVIKPGSADILVPRNTLLDEKWCDLLEENSVDSVKVRSVVSCETDFGVCANCYG  900
             GRVTAE+V+KPG+ADILVPRNTLL E+WCDLLEENSVD+VKVRSVVSC+TDFGVCA+CYG
Sbjct  841   GRVTAEDVLKPGTADILVPRNTLLHEQWCDLLEENSVDAVKVRSVVSCDTDFGVCAHCYG  900
Query  901   RDLARGHIINKGEAVGVIAAQSIGEPGTQLTMRTFHIGGAASRAAAESSIQVKNKGSLKL  960
Dot Matrix View
Descriptions
Description Max
score
Total
score
Query
cover
E
value
Ident Accession
unnamed protein
product 2680 2680 99% 0.0 93% Query_213457
Alignments
NCBI Blast:RpoC (B') of Y.pestis and E.coli
https://blast.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 10:54
             RDLARGHIINKGEA+GVIAAQSIGEPGTQLTMRTFHIGGAASRAAAESSIQVKNKGS+KL
Sbjct  901   RDLARGHIINKGEAIGVIAAQSIGEPGTQLTMRTFHIGGAASRAAAESSIQVKNKGSIKL  960
Query  961   SNVKFVTNAAGKLVITSRNTELKLIDEFGRTKESYKVPYGAVMAKGDGAEVQGGETVANW  1020
             SNVK V N++GKLVITSRNTELKLIDEFGRTKESYKVPYGAV+AKGDG +V GGETVANW
Sbjct  961   SNVKSVVNSSGKLVITSRNTELKLIDEFGRTKESYKVPYGAVLAKGDGEQVAGGETVANW  1020
Query  1021  DPHIMPVVTEVSGFIRFADMVDGQTITRQTDELTGLSSLVVLDSAERTGSGKDLRPALKI  1080
             DPH MPV+TEVSGF+RF DM+DGQTITRQTDELTGLSSLVVLDSAERT  GKDLRPALKI
Sbjct  1021  DPHTMPVITEVSGFVRFTDMIDGQTITRQTDELTGLSSLVVLDSAERTAGGKDLRPALKI  1080
Query  1081  VDAKGNDVLIPGTDMPAQYFLPGKAIVQLEDGIQIGAGDTLARIPQESSGTKDITGGLPR  1140
             VDA+GNDVLIPGTDMPAQYFLPGKAIVQLEDG+QI +GDTLARIPQES GTKDITGGLPR
Sbjct  1081  VDAQGNDVLIPGTDMPAQYFLPGKAIVQLEDGVQISSGDTLARIPQESGGTKDITGGLPR  1140
Query  1141  VADLFEARRPKEPAILAEISGIISFGKETKGKRRLVISPLDGSDAYEEMIPKWRQLNVFE  1200
             VADLFEARRPKEPAILAEISGI+SFGKETKGKRRLVI+P+DGSD YEEMIPKWRQLNVFE
Sbjct  1141  VADLFEARRPKEPAILAEISGIVSFGKETKGKRRLVITPVDGSDPYEEMIPKWRQLNVFE  1200
Query  1201  GEVVERGDVVSDGPESPHDILRLRGVHAVTRYITNEVQEVYRLQGVKINDKHIEVIVRQM  1260
             GE VERGDV+SDGPE+PHDILRLRGVHAVTRYI NEVQ+VYRLQGVKINDKHIEVIVRQM
Sbjct  1201  GERVERGDVISDGPEAPHDILRLRGVHAVTRYIVNEVQDVYRLQGVKINDKHIEVIVRQM  1260
Query  1261  LRKGTIVDAGSTDFLEGEQAEMSRVKIANRKLAAEGKIEATFTRDLLGITKASLATESFI  1320
             LRK TIV+AGS+DFLEGEQ E SRVKIANR+L A GK+ AT++RDLLGITKASLATESFI
Sbjct  1261  LRKATIVNAGSSDFLEGEQVEYSRVKIANRELEANGKVGATYSRDLLGITKASLATESFI  1320
Query  1321  SAASFQETTRVLTEAAVAGKRDELRGLKENVIVGRLIPAGTGYAYHQDRMRRKAQGEAPV  1380
             SAASFQETTRVLTEAAVAGKRDELRGLKENVIVGRLIPAGTGYAYHQDRMRR+A GEAP 
Sbjct  1321  SAASFQETTRVLTEAAVAGKRDELRGLKENVIVGRLIPAGTGYAYHQDRMRRRAAGEAPA  1380
Query  1381  VPQVSADEATANLAELLNAGFGNN  1404
              PQV+A++A+A+LAELLNAG G +
Sbjct  1381  APQVTAEDASASLAELLNAGLGGS  1404
NCBI Blast:RpoC (B') of Y.pestis and E.coli
https://blast.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 10:54
poC or β' subunit  
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Sequences producing significant alignments:
unnamed protein product
Sequence ID: lcl|Query_164903 Length: 91 Number of Matches: 1
Range 1: 1 to 91
Score Expect Method Identities Positives Gaps Frame
131 bits(330) 1e-45() Compositional matrix adjust. 84/91(92%) 87/91(95%) 0/91(0%)
Features:
Query  1   MARVTVQDAVEKIGNRFDLVLVAARRARQIQSGGKDALVPEENDKVTVIALREIEEGLIT  60
           MARVTVQDAVEKIGNRFDLVLVAARRARQ+Q GGKD LVPEENDK TVIALREIEEGLI 
Sbjct  1   MARVTVQDAVEKIGNRFDLVLVAARRARQMQVGGKDPLVPEENDKTTVIALREIEEGLIN  60
Query  61  NQILDVRERQEQQEQQAAEIQAVTAIAEGRR  91
           NQILDVRERQEQQEQ+AAE+QAVTAIAEGRR
Sbjct  61  NQILDVRERQEQQEQEAAELQAVTAIAEGRR  91
Dot Matrix View
Descriptions
Description Max
score
Total
score
Query
cover
E
value
Ident Accession
unnamed protein
product 131 131 100% 1e-45 92% Query_164903
Alignments
NCBI Blast:RpoZ (W)
https://blast.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 11:06
Sequences producing significant alignments:
unnamed protein product
equence ID: lcl|Query_22573 Length: 613 Number of Matches: 1
Range 1: 1 to 613
Score Expect Method Identities Positives Gaps Frame
1106 bits(2861) 0.0() Compositional matrix adjust. 562/615(91%) 587/615(95%) 5/615(0%)
Features:
Query  1    MEQNPQSQLKLLVTRGKEQGYLTYAEVNDHLPEDIVDSDQIEDIIQMINDMGIQVLEEAP  60
            MEQNPQSQLKLLVTRGKEQGYLTYAEVNDHLPEDIVDSDQIEDIIQMINDMGIQV+EEAP
Sbjct  1    MEQNPQSQLKLLVTRGKEQGYLTYAEVNDHLPEDIVDSDQIEDIIQMINDMGIQVMEEAP  60
Query  61   DADDLMLAENTTDTDDDAAEAAAQVLSSVESEIGRTTDPVRMYMREMGTVELLTREGEID  120
            DADDLMLAENT D D  AAEAAAQVLSSVESEIGRTTDPVRMYMREMGTVELLTREGEID
Sbjct  61   DADDLMLAENTADED--AAEAAAQVLSSVESEIGRTTDPVRMYMREMGTVELLTREGEID  118
Query  121  IAKRIEDGINQVQCSVAEYPEAITYLLEQYDRVEAGESRLSDLITGFVDPNAEEDIAPTA  180
            IAKRIEDGINQVQCSVAEYPEAITYLLEQYDRVEA E+RLSDLITGFVDPNAEED+APTA
Sbjct  119  IAKRIEDGINQVQCSVAEYPEAITYLLEQYDRVEAEEARLSDLITGFVDPNAEEDLAPTA  178
Query  181  THVGSELS---TEEMDDEDEDEDEDDDAEDDNSIDPELARQKFSDLREQYENARMEIKKN  237
            THVGSELS    ++ +DEDE++ +DD A+DDNSIDPELAR+KF++LR QY   R  IK  
Sbjct  179  THVGSELSQEDLDDDEDEDEEDGDDDSADDDNSIDPELAREKFAELRAQYVVTRDTIKAK  238
Query  238  GRNHANAAAEILKLSEVFKQFRLVPKQFDYLVNNMRAMMDRVRTQERIIMKLCVEQCKMP  297
            GR+HA A  EILKLSEVFKQFRLVPKQFDYLVN+MR MMDRVRTQER+IMKLCVEQCKMP
Sbjct  239  GRSHATAQEEILKLSEVFKQFRLVPKQFDYLVNSMRVMMDRVRTQERLIMKLCVEQCKMP  298
Query  298  KKNFVTLFSSNETSDTWFNAAVAMGKPWSEKLKDVSEDVQRSLQKLRQIEEETGLTIEQV  357
            KKNF+TLF+ NETSDTWFNAA+AM KPWSEKL DVSE+V R+LQKL+QIEEETGLTIEQV
Sbjct  299  KKNFITLFTGNETSDTWFNAAIAMNKPWSEKLHDVSEEVHRALQKLQQIEEETGLTIEQV  358
Query  358  KDINRRMSIGEAKARRAKKEMVEANLRLVISIAKKYTNRGLQFLDLIQEGNIGLMKAVDK  417
            KDINRRMSIGEAKARRAKKEMVEANLRLVISIAKKYTNRGLQFLDLIQEGNIGLMKAVDK
Sbjct  359  KDINRRMSIGEAKARRAKKEMVEANLRLVISIAKKYTNRGLQFLDLIQEGNIGLMKAVDK  418
Query  418  FEYRRGYKFSTYATWWIRQAITRSIADQARTIRIPVHMIETINKLNRISRQMLQEMGREP  477
            FEYRRGYKFSTYATWWIRQAITRSIADQARTIRIPVHMIETINKLNRISRQMLQEMGREP
Sbjct  419  FEYRRGYKFSTYATWWIRQAITRSIADQARTIRIPVHMIETINKLNRISRQMLQEMGREP  478
Query  478  TPEELAERMLMPEDKIRKVLKIAKEPISMETPIGDDEDSHLGDFIEDTTLELPLDSATSE  537
            TPEELAERMLMPEDKIRKVLKIAKEPISMETPIGDDEDSHLGDFIEDTTLELPLDSAT+E
Sbjct  479  TPEELAERMLMPEDKIRKVLKIAKEPISMETPIGDDEDSHLGDFIEDTTLELPLDSATTE  538
Query  538  SLRSATHDVLAGLTAREAKVLRMRFGIDMNTDHTLEEVGKQFDVTRERIRQIEAKALRKL  597
            SLR+ATHDVLAGLTAREAKVLRMRFGIDMNTD+TLEEVGKQFDVTRERIRQIEAKALRKL
Sbjct  539  SLRAATHDVLAGLTAREAKVLRMRFGIDMNTDYTLEEVGKQFDVTRERIRQIEAKALRKL  598
Query  598  RHPSRSEVLRSFLDD  612
            RHPSRSEVLRSFLDD
Sbjct  599  RHPSRSEVLRSFLDD  613
Dot Matrix View
Descriptions
Description Max
score
Total
score
Query
cover
E
value
Ident Accession
unnamed protein
product 1106 1106 100% 0.0 91% Query_22573
Alignments
NCBI Blast:Protein Sequence (612 letters)
https://blast.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 10:21
poZ or ω subunit  
RpoD or σ70 factor  
	 207	
		
Figure A.2a| Similarity between RNAP holoezyme of Y. pestis CO92 and E. coli K-12.  
The amino acid sequence of the corresponding subunits and σ factors of RNAP holoezyme of Y. pestis CO92 
and E. coli K-12 were retrieved from NCBI with UniProtKB/Swiss-Prot accession numbers, Q8ZJ87 (RpoA or α 
subunit), Q8ZAP5 (RpoB or β subunit), A0A0B6NVW2 (RpoC or β' subunit), A0A0B6NRU2 (RpoZ or ω 
subunit), A0A0B6NX87 (RpoD or σ70 factor), A0A0B6NRK5 (RpoH or σ32 factor), A0A0B6NVW7 (RpoS or 
σ38 factor); Y. pestis CO92 and P0A7Z4 (RpoA or α subunit), P0A8V2 (RpoB or β subunit), P0A8T7 (RpoC or 
β' subunit), P0A800 (RpoZ or ω subunit), P00579 (RpoD or σ70 factor), P0AGB3 (RpoH or σ32 factor), P13445 
(RpoS or σ38 factor); E. coli K-12 and were analysed by pairwise sequence alignment using NCBP BLASTp 
service with default parameters. Query, Y. pestis and Subjct, E. coli. 
  			
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sequences producing significant alignments:
unnamed protein product
Sequence ID: lcl|Query_80113 Length: 284 Number of Matches: 1
Range 1: 1 to 284
Score Expect Method Identities Positives Gaps Frame
483 bits(1243) 2e-177() Compositional matrix adjust. 238/285(84%) 265/285(92%) 1/285(0%)
Features:
Query  1    MTKEMQTLALVPQGSLEAYIRAANAYPMLTAEEERELAERLHYQGDLGAAKQLILSHLRF  60
            MT +MQ+LAL P G+L++YIRAANA+PML+A+EER LAE+LHY GDL AAK LILSHLRF
Sbjct  1    MTDKMQSLALAPVGNLDSYIRAANAWPMLSADEERALAEKLHYHGDLEAAKTLILSHLRF  60
Query  61   VAHVARNYSGYGLPQADLIQEGNIGLMKAVRRFNPEVGVRLVSFAVHWIKAEIHEYVLRN  120
            V H+ARNY+GYGLPQADLIQEGNIGLMKAVRRFNPEVGVRLVSFAVHWIKAEIHEYVLRN
Sbjct  61   VVHIARNYAGYGLPQADLIQEGNIGLMKAVRRFNPEVGVRLVSFAVHWIKAEIHEYVLRN  120
Query  121  WRIVKVATTKAQRKLFFNLRKTKQRLGWFNQDEVELVAKELGVTSKDVREMESRMSAQDM  180
            WRIVKVATTKAQRKLFFNLRKTKQRLGWFNQDEVE+VA+ELGVTSKDVREMESRM+AQDM
Sbjct  121  WRIVKVATTKAQRKLFFNLRKTKQRLGWFNQDEVEMVARELGVTSKDVREMESRMAAQDM  180
Query  181  TFDPSPDDEARDGQFMAPVLYLQDKTSDFADGIEEDNWDSHAADKLSYALEGLDERSQHI  240
            TFD S  D+  D Q MAPVLYLQDK+S+FADGIE+DNW+  AA++L+ A++GLDERSQ I
Sbjct  181  TFDLSS-DDDSDSQPMAPVLYLQDKSSNFADGIEDDNWEEQAANRLTDAMQGLDERSQDI  239
Query  241  IRARWLDDENKSTLQELADQYGVSAERVRQLEKNAMKKLRMAIEA  285
            IRARWLD++NKSTLQELAD+YGVSAERVRQLEKNAMKKLR AIEA
Sbjct  240  IRARWLDEDNKSTLQELADRYGVSAERVRQLEKNAMKKLRAAIEA  284
Dot Matrix View
Descriptions
Description Max
score
Total
score
Query
cover
E
value
Ident Accession
unnamed protein
product 483 483 100% 2e-177 84% Query_80113
Alignments
NCBI Blast:RpoH of Y.pestis and E.coli
https://bla t.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 10:32
Sequences producing significant alignments:
unnamed protein product
Sequence ID: lcl|Query_250761 Length: 330 Number of Matches: 1
Range 1: 1 to 330
Score Expect Method Identities Positives Gaps Frame
615 bits(1587) 0.0() Compositional matrix adjust. 307/332(92%) 324/332(97%) 2/332(0%)
Features:
Query  1    MSQSTLKVNELHEDADFDENSTETEIFDEKALVDDEPTESELADDELLAQGVTQRVLDAT  60
            MSQ+TLKV++L+EDA+FDEN  E  +FDEKALV+ EP++++LA++ELL+QG TQRVLDAT
Sbjct  1    MSQNTLKVHDLNEDAEFDENGVE--VFDEKALVEQEPSDNDLAEEELLSQGATQRVLDAT  58
Query  61   QLYLGEIGYSPLLTAEEEVYFARRALRGDVSSRRRMIESNLRLVVKIARRYSNRGLALLD  120
            QLYLGEIGYSPLLTAEEEVYFARRALRGDV+SRRRMIESNLRLVVKIARRY NRGLALLD
Sbjct  59   QLYLGEIGYSPLLTAEEEVYFARRALRGDVASRRRMIESNLRLVVKIARRYGNRGLALLD  118
Query  121  LIEEGNLGLIRAVEKFDPERGFRFSTYATWWIRQTIERAIMNQTRTIRLPIHIVKELNVY  180
            LIEEGNLGLIRAVEKFDPERGFRFSTYATWWIRQTIERAIMNQTRTIRLPIHIVKELNVY
Sbjct  119  LIEEGNLGLIRAVEKFDPERGFRFSTYATWWIRQTIERAIMNQTRTIRLPIHIVKELNVY  178
Query  181  LRTARELSHKLDHEPSAEEIAEQLDKPVDDVSRMLRLNERITSVDTPLGGDSEKALLDIL  240
            LRTARELSHKLDHEPSAEEIAEQLDKPVDDVSRMLRLNERITSVDTPLGGDSEKALLDIL
Sbjct  179  LRTARELSHKLDHEPSAEEIAEQLDKPVDDVSRMLRLNERITSVDTPLGGDSEKALLDIL  238
Query  241  SDENENGPEDTTQDDDMKQSIVKWLFELNAKQREVLARRFGLLGYEAATLEDVGREIGLT  300
            +DE ENGPEDTTQDDDMKQSIVKWLFELNAKQREVLARRFGLLGYEAATLEDVGREIGLT
Sbjct  239  ADEKENGPEDTTQDDDMKQSIVKWLFELNAKQREVLARRFGLLGYEAATLEDVGREIGLT  298
Query  301  RERVRQIQVEGLRRLREILQTQGLSIEALFRE  332
            RERVRQIQVEGLRRLREILQTQGL+IEALFRE
Sbjct  299  RERVRQIQVEGLRRLREILQTQGLNIEALFRE  330
Dot Mat ix View
Descriptions
Description Max
score
Total
score
Query
cover
E
value
Ident Accession
unnamed protein
product 615 615 100% 0.0 92% Query_250761
Alignments
NCBI Blast:RpoS of Y.pestis and E.coli
https://blast.ncbi.nlm.nih.gov/Blast.cgi 04/12/2015 10:45
RpoH or σ32 factor  
RpoS or σ38 factor  
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2b. Promoters elements confirmed and predicted for some Y. pestis genes.  	
Gene	 -10	
TATAAT 
-35	
TTGACA 
Spacer	(nt)	 Reference		
	
yopN	 TATAAT TTGgCA 21	 (King	et	al.,	2013);	Regulated	by	LcrF/VirF		
lcrG	 TAgAAT cTGACA 21	 	
	
yscN	 TAaAAT cTacaA 21	 	
	
yscB	 TAaAAT TTtAaA 21	 	
	
pla	 TtTAAT acGAgA 19	 (Kim	et	al.,	2007);		Regulated	by	CRP		
	
fyu	 TATcAT TaGcac 16	 (Gao	et	al.,	2008);		Regulated	by	Fur	and	YbtA	
	
irp2	 TATtAT TaGcat 15	 	
	
ybtA	 ataAta TgGcgt 17	 	
	
pst	 TAattT TTGACA 17	 	(Rakin	et	al.,	1996);	Regulated	by	bacteriocin	
	
mgtC	 TATAcT TTtACA 17	 (Li	et	al.,	2008);		Regulated	by	PhoP		
	
katA	 TAcAAc TTGctg 17	 	
	
sodB	 TATggT TcGAtc 17	 	
	
sodC	 TAaAAc TTatCc 17	 	
	
uspB	 TAcAcT agGctA 17	 	
	
uspA	 TATAcT TcaACc 17	 	
	
pagP	 TATAga TTcAac 17	 	
	
oppA	 TATcAc TTGACc 17	 	
	
metJ	 TAaAAT TTGAgc 17	 	
	
furR	 TtagAT TTGctc 17	 	
	
phoP	 TATcgT TTtAtA 17	 	
	
slyA	 TATtAT TaaAgA 17	 	
	
astC	 TtatAT gTGgCA 17	 	
	
 
Figure A.2b| Promoter elements confirmed (light) and predicted (dark) for some Y. pestis genes. 
Consensus and non-consensus nt in each -10 and -35 are indicated by small and capital letters, respectively. 
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3. The caf locus promoters predicted upstream of caf1R, caf1M and caf1. 	
Promoter	
and	location	
relative	to	
ATG	start		
-10	element	
consensus	and	
frequency	%	at	each	
position	
(T80A95T45A50A60T96) 
-35	element	consensus		
and	frequency	%	at	
each	position	
(T82T84G78A65C54A48) 
	
Spacer		(nt)	
	
Source	
	
Upstream	of	caf1R	
	PR1		(-20	to	-48)	 TATtAT	(5)	 cgccgg (0)	 17	 Visual	PR2	(-28	to	-57)	 TAgAAT	(5)	 aaGtCc	(2)	 18	 Visual	PRK	(-86	to	-113)	 TAagAT	(4)	 TTGAtg	(4)	 16	 (Karlyshev	et	al.,	1992)	
	
Upstream	of	caf1M	
	PMK1	(-51	to	-78)	 aATgAT	(3)	 TTtACg	(4)	 16	 (Karlyshev	et	al.,	1992)	PMK2	(-65	to	-92)	 TATcgT	(4)	 TTGttA	(4)	 16	 (Karlyshev	et	al.,	1992)	PMB	(-105	to	-134)	LDF	score	6.38	 TATAAa	(5)	41		 TTctCA (4)	33		 18	 BPROM	PM	(-137	to	-165)	 TAaAAT	(5)	 TaaACt	(3)	 17	 Visual	
	
Upstream	of	caf1	
	P1B	(-1	to	-29)	LDF	score	4.25	 TAatAT	(4)	68	 TgGAtt	(3)	16	 17	 BPROM	P11	(-32	to	-60)	 TtTgtT	(3)	 agGACA	(4)	 17	 Visual	P12	(-153	to	-181)	 TcTAAT (5)	 gaGAtA	(3)	 17	 Visual	P13	(-199	to	-227)	 aAaAAT	(4)	 TTGACt	(5)	 17	 Visual	
 
Figure A.3| The caf locus promoters predicted upstream of caf1R, caf1M and caf1.  
Capital and small letters in both -10 and -35 elements represent the corresponding consensus and non-consensus 
nucleotides (nt) at the respective position. Number in bracket (x), at the end of each -10 and -35 element indicates 
the total number of consensus nt out of 6 nt for each element. (–xx to –xx) represent the upstream location (in bp) 
of each promoter relative to ATG start codon of the corresponding gene. LDF score of BPROM predicted 
promoters along with individual score of both -10 and -35 elements is shown underneath. BROM identified a 
strongest promoter within caf1A (at +192 to +219 bp, relative to ATG start) with LDF score 6.68, -10 (TAgAcT; 
score 62), -35 (TTaAtg; score 29) and 21 nt spacer. 											
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4. Sequencing result of pRScaf1R-caf1M′-lacZ.  
 
	
 
Figure A.4| Sequencing result of pRScaf1R-caf1M′-lacZ.   
Pairwise sequence alignment of designed construct, pRScaf1R-caf1M′-lacZ (annotated) with retrieved sequences 
from sequencing primers, F1_1, forward (a) and M13F, reverse (b). Repaired Glu98 residue (from E98G/K) is 
shown in the red boxes and annotated. Cloning sites (BamHI and EcoRI) on either side are in-boxed (black). 
Sequence accession number from MWG, Germany (for F1_1) and Source Bioscience (SB), Oxford (for M13F) 
is indicated on left side of each sequence. Alignment was generated using DNA dynamo via ClustalW interface. 
-----------------------------------------------------
-------------------------------------------TAAACCATGC
ACCTGTGA---TCAAAATAATTAACTCTTTGGTAATCCTAATGTTACTGACAT
TTCCGGCTTCACAATATTATTGTGATATACCTGCATTTCATTGTAAAACTCCA
TGTCATCACAATAAATCGGGAGAAAATAATGACAATCAATAGTATTGTCATTT
CGTCTTTTTATGACCTCCACATCGTAACCATCCCGCTTATTTAAATTATAAAT
AGGCAAAGAGTTATAATATATGTTGTACATGTGATGAACATACTGATCATATG
TATCATTGAAGAAAAAATAAGCATACAGGCCTTTATCTACCTTTATTTCACTA
TCGCTGAAATGCTTATTCCTATCCCAAACAACCGTTCTTGCAATAATGTCATT
CGTTTTATCATGAAAGGGGATTCTGTTTGATACTGTTATAGCTGTATTTTTCT
TCAACGAATCATATAACTTACCCAATCTACATTTTGAATCTATCCCAGAGTAG
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
0
10
60
113
166
219
272
325
378
431
484
CTGGATCCTGGGCAGCAGCCATCACCATCATCACCACAGCCAGGATCCGAATT
CTAGTGACTGATCAATATGTTGGGTCGAACATAAATCGGTTCAGTGGCCTCAA
CGCTGTGAAATCCAAAATAATTAACTCTTTGGTAATCCTAATGTTACTGACAT
TTCCGGCTTCACAATATTATTGTGATATACCTGCATTTCATTGTAAAACTCCA
TGTCATCACAATAAATCGGGAGAAAATAATGACAATCAATAGTATTGTCATTT
CGTCTTTTTATGACCTCCACATCGTAACCATCCCGCTTATTTAAATTATAAAT
AGGCAAAGAGTTATAATATATGTTGTACATGTGATGAACATACTGATCATATG
TATCATTGAAGAAAAAATAAGCATACAGGCCTTTATCTACCTTTATTTCACTA
TCGCTGAAATGCTTATTCCTATCCCAAACAACCGTTCTTGCAATAATGTCATT
CGTTTTATCATGAAAGGGGATTCTGTTTGATACTGTTATAGCTGTATTTTTCT
TCAACGAATCATATAACTTACCCAATCTACATTTTGAATCTATCCCAGAGTAG
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
53
106
159
212
265
318
371
424
477
530
583
pRScaf1R-caf1M'-lacZ
caf1R
pMT1 
pACYC 
F1_1
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!**!!!!
!!******!!!!*****************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
Score
Score
Score
Score
Score
Score
Score
Score
Score
Score
Score
P  1
AACACTAAATCCCTAAAATTAAAGCATTGACCAATTATATTTCTCTCTTTAAG
GTAACAGATTCGTGGTTGAAGGTATTCACAGTTAATTTCCCTTCTACCCAACA
AACCTTTAAAGGACCAAAAAGGGATCATCCTATACTGCCGTGGGGTATAACCA
AATATTTTCTTAAATTCTCTGGTGAATGTCTGTTGCGAATCATAAAAAAGCTT
TGCTGATATCTCTATTATTGTCAGCCTGGTAAGCCGTAATAGTGCAGCAGCTC
TACTAGCCCTTCTAACTCTAATATATGTTCCAATAGGCATTCCGACATATTCC
TTAAAGGAAATT---ATTTCCCTTCTACCCAAC-------AAACCTTTAAAGG
ACCAA---AAAGGGATC---ATCCTATACTGCC------GTGGGGGATAACCA
AATATTTTCTTAAATTCTCTGGTGAATGTCTGTTGCGAATCATAAAAA-AGCT
TTGCTGATATCTCTATTATTGTCAG--CCTGGTAAGCCGTAATAGTGCAGCAC
TCTACTAGCCCTTCTAACTCAAAAAAG---GTCCAAAAGGATTCCGACTATTC
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
F1_1_MWG_3437770
537
590
643
696
749
802
845
886
938
989
1039
AACACTAAATCCCTAAAATTAAAGCATTGACCAATTATATTTCTCTCTTTAAG
GTAACAGATTCGTGGTTGAAGGTATTCACAGTTAATTTCCCTTCTACCCAACA
AACCTTTAAAGGACCAAAAAGGGATCATCCTATACTGCCGTGGGGTATAACCA
AATATTTTCTTAAATTCTCTGGTGAATGTCTGTTGCGAATCATAAAAAAGCTT
TGCTGATATCTCTATTATTGTCAGCCTGGTAAGCCGTAATAGTGCAGCAGCTC
TACTAGCCCTTCTAACTCTAATATATGTTCCAATAGGCATTCCGACATATTCC
TTAAAGGAAATTTGCAAATACCTTCTGCTGAATCCTGAATACAAAACCAAACA
GTCAATGTTAATGAATTTCGACTCGAGATTCTCTTCTATATATTGAATAATTG
AATTTACAGTCATCTGTTTTAGCATGAATATAACCCAAATCAAAATAATAGCA
TTCTAGATAG-TGGGCCGGCGCCGGGACTTAGCTATTTGCGCATACCCAGCAA
C--ACCAATCTTAGCTATTTGTGCACGCGCATCAATATCAAAATTAGCTATTT
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
636
689
742
795
848
901
954
1007
1060
1112
1163
caf1R-caf1M
G98E
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
************!!!*!!*!******!*!!**!!!!!!!!*!*!!!!!***!!
!!***!!!!**!*!**!!!!*!!*!*!*!*!!*!!!!!!!*!!!*!****!!!
***!*!!!!*!*!!*!!*!*!*!!!!!!*!*!!!!*!*****!**!**!***!
**!!!****!!*!!!!!!!!*!*!*!!*!*!*!!*!!!*!!!!!!!!*****!
!!!**!*!!*!*!!!!*!*!!!!!*!*!!!!**!*!*!!!*!!!!!!*****!
Score
Score
Score
Score
Score
Score
Score
Score
Score
Score
Score
P 2
---------------------------------------------NNAATAGG
CNTTCCGACATATTNCTTAAAGGA-----AATTA-TTTCCNTTCTACCCAACA
AACCNTTTAAAGGACCCAAAAAGGGATCATCCTATACTGCCGTGGGGTATAAC
CAAATATTTTTCTTAAATTCTCTGGTGAATGTCTGTTGCGAATCATAAAAAAG
CTTTGCTGATATCTCTATTATTGTCAGCCTGGTAAGCCGTAATAGTGCAGCAG
CTCTACTAGCCCTTCTAACTCTAATATATGTTCCAATAGGCATTCCGACATAT
TCCTTAAAGGAAATTTGCAAATACCTTCTGCTGAATCCTGAATACAAAACCAA
ACAGTCAATGTTAATGAATTTCGACTCGAGATTCTCTTCTATATATTGAATAA
TTGAATTTACAGTCATCTGTTTTAGCATGAATATAACCCAAATCAAAATAATA
GCATTCTAGATAGTGGGCCGGCGCCGGGACTTAGCTATTTGCGCATACCCAGC
AACACCAATCTTAGCTATTTGTGCACGCGCATCAATATCAAAATTAGCTATTT
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
8
55
108
161
214
267
320
373
426
479
532
AACACTAAATCCCTAAAATTAAAGCATTGACCAATTATATTTCTCTCTTTAAG
GTAACAGATTCGTGGTTGAAGGTATTCACAGTTAATTTCCCTTCTACCCAACA
AACCTTT-AAAGGACC-AAAAAGGGATCATCCTATACTGCCGTGGGGTATAAC
CAAATATTTT-CTTAAATTCTCTGGTGAATGTCTGTTGCGAATCATAAAAAAG
CTTTGCTGATATCTCTATTATTGTCAGCCTGGTAAGCCGTAATAGTGCAGCAG
CTCTACTAGCCCTTCTAACTCTAATATATGTTCCAATAGGCATTCCGACATAT
TCCTTAAAGGAAATTTGCAAATACCTTCTGCTGAATCCTGAATACAAAACCAA
ACAGTCAATGTTAATGAATTTCGACTCGAGATTCTCTTCTATATATTGAATAA
TTGAATTTACAGTCATCTGTTTTAGCATGAATATAACCCAAATCAAAATAATA
GCATTCTAGATAGTGGGCCGGCGCCGGGACTTAGCTATTTGCGCATACCCAGC
AACACCAATCTTAGCTATTTGTGCACGCGCATCAATATCAAAATTAGCTATTT
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
636
689
740
792
845
898
951
1004
1057
1110
1163
caf1R-caf1M
G98E
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!**!*
!!!!*!**!!!!*!!!*!**!*!*!!!!!*!***!*****!************
****!**!********!************************************
**********!******************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
Score
Score
Score
Score
Score
Score
Score
Score
Score
Score
Score
P 2
GCGCAACAAGCAAGTGGAGTGCGCGAAAAGCTAAACTTTGTGTGCATTTTTAA
ATAAAATTGTTCTCAGTGAGGCTGTGCTACGGATATAAAAATCCCCTTCATTT
GTTACCCACCTTTTTACGCATATCGTCGATATGAAATGATGGGGAGGGGGTGG
GAAGGTGTTGTCACCATTCCGTAAGGAGGTTAAGCTCATGATTTTAAATAGAT
TAAGTACGTTAGGAATTATTACTTTCGGCATGCTTAGTTTTGCTGCGAACTCT
GCTCAACCAGATATCAAATTCGCAAGCAAAGAGTATGGCGTGACTATAGGTGA
GAGTAGGATCATATACCCGTTAGATGCTGCTGGCGTTGAATTCCGATCCGACA
ACCGATGAAAGCGGCGACGCGCAGTTAATCCCACAGCCGCCAGTTCCGCTGGC
GGCATTTTAACTTN--TTATCACACAGN-------------------------
-----------------------------------------------------
--------
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
M13F_SB_420724901
585
638
691
744
797
850
903
956
982
982
982
GCGCAACAAGCAAGTGGAGTGCGCGAAAAGCTAAACTTTGTGTGCATTTTTAA
ATAAAATTGTTCTCAGTGAGGCTGTGCTACGGATATAAAAATCCCCTTCATTT
GTTACCCACCTTTTTACGCATATCGTCGATATGAAATGATGGGGAGGGGGTGG
GAAGGTGTTGTCACCATTCCGTAAGGAGGTTAAGCTCATGATTTTAAATAGAT
TAAGTACGTTAGGAATTATTACTTTCGGCATGCTTAGTTTTGCTGCGAACTCT
GCTCAACCAGATATCAAATTCGCAAGCAAAGAGTATGGCGTGACTATAGGTGA
GAGTAGGATCATATACCCGTTAGATGCTGCTGGCGTTGAATTCCGATCCGACA
ACCGATGAAAGCGGCGACGCGCAGTTAATCCCACAGCCGCCAGTTCCGCTGGC
GGCATTTTAACTTTCTTTATCACACAGGAAACAGCTATGACCATGATTACGGA
TTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCC
AACTTAAT
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
pRScaf1R-caf1M'-lac
1216
1269
1322
1375
1428
1481
1534
1587
1640
1693
1701
caf1MN
5' UTR_lacZ 
lacZ
M13F
pACYC-R end
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*****************************************************
*************!!!***********!!!!!!!!!!!!!!!!!!!!!!!!!!
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!!!!!!!!
Score
Score
Score
Score
Score
Score
Score
Score
Score
Score
Score
P  3
a 
b 
EcoRI 
BamHI 
AAG
Glu98 
AAG
Glu98 
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5. ΔG of the predicted RNATs at 5′ UTR of caf1R relative to transcript from PR2. 	
		
Loop Free-Energy Decomposition Structure 2
RNAT_PR2_26C_Met
ΔG = -2.19
Structural element δG Information
External loop -0.87 12 ss bases & 1 closing helices.
Stack -2.11 External closing pair is U11-A23
Stack -1.54 External closing pair is G12-C22
Stack -0.51 External closing pair is G13-U21
Stack -1.11 External closing pair is G14-U20
Helix -5.27 5 base pairs.
Hairpin loop 3.95 Closing pair is U15-A19
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/15/15Sep27-15-46-04/1... 27/09/2015 20:51
Loop Free-Energy Decomposition Structure 2
PR2_28C_Met
ΔG = -2.02
Structural element δG Information
External loop -0.86 12 ss bases & 1 closing helices.
Stack -2.05 External closing pair is U11-A23
Stack -1.51 External closing pair is G12-C22
Stack -0.49 External closing pair is G13-U21
Stack -1.09 External closing pair is G14-U20
Helix -5.14 5 base pairs.
Hairpin loop 3.98 Closing pair is U15-A19
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/15/15Sep27-15-54-20/1... 27/09/2015 20:55
Loop Free-Energy Decomposition Structure 2
RNAT_PR2_30C_Met
ΔG = -1.87
Structural element δG Information
External loop -0.85 12 ss bases & 1 closing helices.
Stack -2.00 External closing pair is U11-A23
Stack -1.49 External closing pair is G12-C22
Stack -0.47 External closing pair is G13-U21
Stack -1.07 External closing pair is G14-U20
Helix -5.03 5 base pairs.
Hairpin loop 4.01 Closing pair is U15-A19
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/15/15Sep27-15-57-26/1... 27/09/2015 20:58
Loop Free-Energy Decomposition Structure 2
RNAT_PR2_37C_Met
ΔG = -1.30
Structural element δG Information
External loop -0.80 12 ss bases & 1 closing helices.
Stack -1.80 External closing pair is U11-A23
Stack -1.40 External closing pair is G12-C22
Stack -0.40 External closing pair is G13-U21
Stack -1.00 External closing pair is G14-U20
Helix -4.60 5 base pairs.
Hairpin loop 4.10 Closing pair is U15-A19
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/15/15Sep27-15-59-25/1... 27/09/2015 21:00
i) 
Loop Free-Energy Decomposition Structure 1
RNAT_PR2_28C_5 codons
ΔG = -5.33
Structural element δG Information
External loop -0.86 5 ss bases & 1 closing helices.
Stack -1.17 External closing pair is U4-A35
Stack -0.59 External closing pair is U5-G34
Stack -2.05 External closing pair is U6-A33
Helix -3.81 4 base pairs.
Interior loop 0.78 External closing pair is G7-C32
Stack -1.07 External closing pair is U9-A30
Stack -1.07 External closing pair is U10-A29
Stack -0.89 External closing pair is U11-A28
Stack -2.21 External closing pair is G12-U27
Helix -5.24 5 base pairs.
Hairpin loop 3.80 Closing pair is G13-C26
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-06-39/1... 27/09/2015 21:07
Loop Free-Energy Decomposition Structure 1
RNAT_PR2_30C_5 codons
ΔG = -5.00
Structural element δG Information
External loop -0.85 5 ss bases & 1 closing helices.
Stack -1.16 External closing pair is U4-A35
Stack -0.57 External closing pair is U5-G34
Stack -2.00 External closing pair is U6-A33
Helix -3.73 4 base pairs.
Interior loop 0.78 External closing pair is G7-C32
Stack -1.03 External closing pair is U9-A30
Stack -1.03 External closing pair is U10-A29
Stack -0.87 External closing pair is U11-A28
Stack -2.14 External closing pair is G12-U27
Helix -5.07 5 base pairs.
Hairpin loop 3.87 Closing pair is G13-C26
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-09-09/1... 27/09/2015 21:10
Loop Free-Energy Decomposition Structure 1
RNAT_PR2_37C_5 codons
ΔG = -3.80
Structural element δG Information
External loop -0.80 5 ss bases & 1 closing helices.
Stack -1.10 External closing pair is U4-A35
Stack -0.50 External closing pair is U5-G34
Stack -1.80 External closing pair is U6-A33
Helix -3.40 4 base pairs.
Interior loop 0.80 External closing pair is G7-C32
Stack -0.90 External closing pair is U9-A30
Stack -0.90 External closing pair is U10-A29
Stack -0.80 External closing pair is U11-A28
Stack -1.90 External closing pair is G12-U27
Helix -4.50 5 base pairs.
Hairpin loop 4.10 Closing pair is G13-C26
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-11-30/1... 27/09/2015 21:12
Loop Free-Energy Decomposition Structure 1
RNAT_PR2_26C_5 codons
ΔG = -5.67
Structural element δG Information
External loop -0.87 5 ss bases & 1 closing helices.
Stack -1.19 External closing pair is U4-A35
Stack -0.61 External closing pair is U5-G34
Stack -2.11 External closing pair is U6-A33
Helix -3.91 4 base pairs.
Interior loop 0.77 External closing pair is G7-C32
Stack -1.10 External closing pair is U9-A30
Stack -1.10 External closing pair is U10-A29
Stack -0.91 External closing pair is U11-A28
Stack -2.28 External closing pair is G12-U27
Helix -5.39 5 base pairs.
Hairpin loop 3.73 Closing pair is G13-C26
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/8/15Oct22-08-25-10/15O... 22/10/2015 13:29ii) 
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Figure A.5| ΔG of the predicted RNATs at 5′ UTR of caf1R relative to transcript from PR2. 
Using Mfold 2.3 program (Zuker, 2003) RNA secondary structures were predicted by inclusion of Caf1R first 
codon (i), first 5 codons (ii) and first 10 codons (iii) at 26, 28, 30 and 37°C. The most probable prediction with 
lowest free energy (ΔG; kcal/mole) at each temperature is indicated.  		
Loop Free-Energy Decomposition Structure 1
RNAT_PR2_26C_10 codons
ΔG = -11.61
Structural element δG Information
External loop -0.87 11 ss bases & 1 closing helices.
Stack -1.10 External closing pair is U10-A50
Stack -2.11 External closing pair is U11-A49
Stack -1.54 External closing pair is G12-C48
Helix -4.75 4 base pairs.
Interior loop 1.18 External closing pair is G13-U47
Stack -1.10 External closing pair is U15-A44
Stack -1.35 External closing pair is U16-A43
Stack -1.11 External closing pair is A17-U42
Stack -0.91 External closing pair is U18-G41
Helix -4.47 5 base pairs.
Interior loop 0.77 External closing pair is A19-U40
Stack -2.69 External closing pair is U21-A38
Stack -2.11 External closing pair is C22-G37
Stack -1.07 External closing pair is A23-U36
Helix -5.87 4 base pairs.
Bulge loop 1.07 External closing pair is U24-A35
Stack -1.91 External closing pair is C26-G34
Helix -1.91 2 base pairs.
Hairpin loop 3.24 Closing pair is U27-A33
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-13-48/1... 27/09/2015 21:15
Loop Free-Energy Decomposition Structure 1
RNAT_PR2_28C_10 codons
ΔG = -10.88
Structural element δG Information
External loop -0.86 11 ss bases & 1 closing helices.
Stack -1.07 External closing pair is U10-A50
Stack -2.05 External closing pair is U11-A49
Stack -1.51 External closing pair is G12-C48
Helix -4.63 4 base pairs.
Interior loop 1.28 External closing pair is G13-U47
Stack -1.07 External closing pair is U15-A44
Stack -1.30 External closing pair is U16-A43
Stack -1.09 External closing pair is A17-U42
Stack -0.89 External closing pair is U18-G41
Helix -4.35 5 base pairs.
Interior loop 0.78 External closing pair is A19-U40
Stack -2.62 External closing pair is U21-A38
Stack -2.05 External closing pair is C22-G37
Stack -1.04 External closing pair is A23-U36
Helix -5.71 4 base pairs.
Bulge loop 1.17 External closing pair is U24-A35
Stack -1.87 External closing pair is C26-G34
Helix -1.87 2 base pairs.
Hairpin loop 3.31 Closing pair is U27-A33
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27- 6-16-42/1... 27/09/2015 21:17
Loop Free-Energy Decomposition Structure 1
RNAT_PR2_30C_10 codons
ΔG = -10.20
Structural element δG Information
External loop -0.85 11 ss bases & 1 closing helices.
Stack -1.03 External closing pair is U10-A50
Stack -2.00 External closing pair is U11-A49
Stack -1.49 External closing pair is G12-C48
Helix -4.52 4 base pairs.
Interior loop 1.37 External closing pair is G13-U47
Stack -1.03 External closing pair is U15-A44
Stack -1.26 External closing pair is U16-A43
Stack -1.07 External closing pair is A17-U42
Stack -0.87 External closing pair is U18-G41
Helix -4.23 5 base pairs.
Interior loop 0.78 External closing pair is A19-U40
Stack -2.55 External closing pair is U21-A38
Stack -2.00 External closing pair is C22-G37
Stack -1.01 External closing pair is A23-U36
Helix -5.56 4 base pairs.
Bulge loop 1.26 External closing pair is U24-A35
Stack -1.83 External closing pair is C26-G34
Helix -1.83 2 base pairs.
Hairpin loop 3.38 Closing pair is U27-A33
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-18-52/1... 27/09/2015 21:19
Loop Free-Energy Decomposition Structure 1
RNAT_PR2_37C_10 codons
ΔG = -7.70
Structural element δG Information
External loop -0.80 11 ss bases & 1 closing helices.
Stack -0.90 External closing pair is U10-A50
Stack -1.80 External closing pair is U11-A49
Stack - .40 External closing pair is G12-C48
Helix -4.10 4 base pairs.
Interior loop 1.70 External closing pair is G13-U47
Stack -0.90 External closing pair is U15-A44
Stack -1.10 External closing pair is U16-A43
Stack -1.00 External closing pair is A17-U42
Stack -0.80 External closing pair is U18-G41
Helix -3.80 5 base pairs.
Interior loop 0.80 External closing pair is A19-U40
Stack -2.30 External closing pair is U21-A38
Stack -1.80 External closing pair is C22-G37
Stack -0.90 External closing pair is A23-U36
Helix -5.00 4 base pairs.
Bulge loop 1.60 External closing pair is U24-A35
Stack -1.70 External closing pair is C26-G34
Helix -1.70 2 base pairs.
Hairpin loop 3.60 Closing pair is U27-A33
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep 7-16-20-47/1... 27/09/2015 21:21
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6. ΔG of the predicted RNATs at 5′ UTR of caf1R relative to transcript from PRK. 	
	
Loop Free-Energy Decomposition Structure 1
RNAT_PRK_26C_5 codons
ΔG = -30.72
Structural element δG Information
External loop -3.63 10 ss bases & 3 closing helices.
Stack -2.11 External closing pair is C80-G95
Stack -1.07 External closing pair is A81-U94
Helix -3.18 3 base pairs.
Bulge loop 1.07 External closing pair is U82-A93
Stack -1.91 External closing pair is C84-G92
Helix -1.91 2 base pairs.
Hairpin loop 3.24 Closing pair is U85-A91
Stack -0.51 External closing pair is G37-U74
Stack -2.37 External closing pair is G38-U73
Stack -3.23 External closing pair is C39-G72
Stack -3.23 External closing pair is C40-G71
Stack -2.11 External closing pair is C41-G70
Helix -11.45 6 base pairs.
Interior loop 2.18 External closing pair is A42-U69
Stack -1.07 External closing pair is A45-U67
Stack -2.69 External closing pair is U46-A66
Helix -3.76 3 base pairs.
Bulge loop 1.65 External closing pair is C47-G65
Stack -0.61 External closing pair is A49-U64
Stack -1.19 External closing pair is G50-U63
Stack -1.10 External closing pair is A51-U62
Stack -1.07 External closing pair is A52-U61
Stack -0.91 External closing pair is U53-A60
Helix -4.88 6 base pairs.
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-32-13/1... 27/09/2015 21:34
Loop Free-Energy Decomposition Structure 1
RNAT_PRK_28C_5 codons
ΔG = -29.20
Structural element δG Information
External loop -3.56 10 ss bases & 3 closing helices.
Stack -2.05 External closing pair is C80-G95
Stack -1.04 External closing pair is A81-U94
Helix -3.09 3 base pairs.
Bulge loop 1.17 External closing pair is U82-A93
Stack -1.87 External closing pair is C84-G92
Helix -1.87 2 base pairs.
Hairpin loop 3.31 Closing pair is U85-A91
Stack -0.49 External closing pair is G37-U74
Stack -2.32 External closing pair is G38-U73
Stack -3.17 External closing pair is C39-G72
Stack -3.17 External closing pair is C40-G71
Stack -2.05 External closing pair is C41-G70
Helix -11.20 6 base pairs.
Interior loop 2.22 External closing pair is A42-U69
Stack -1.04 External closing pair is A45-U67
Stack -2.62 External closing pair is U46-A66
Helix -3.66 3 base pairs.
Bulge loop 1.74 External closing pair is C47-G65
Stack -0.59 External closing pair is A49-U64
Stack -1.17 External closing pair is G50-U63
Stack -1.07 External closing pair is A51-U62
Stack -1.04 External closing pair is A52-U61
Stack -0.89 External closing pair is U53-A60
Helix -4.76 6 base pairs.
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-37-16/1... 27/09/2015 21:38
Hairpin loop 3.97 Closing pair is G54-U59
Stack -3.78 External closing pair is G3-C33
Stack -2.28 External closing pair is C4-G32
Stack -1.22 External closing pair is U5-G31
Stack -3.23 External closing pair is G6-C30
Stack -3.23 External closing pair is G7-C29
Helix -13.74 6 base pairs.
Interior loop 1.04 External closing pair is G8-C28
Stack -3.78 External closing pair is G12-C22
Helix -3.78 2 base pairs.
Hairpin loop 2.46 Closing pair is C13-G21
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-32-13/1... 27/09/2015 21:34
Hairpin loop 4.01 Closing pair is G54-U59
Stack -3.71 External closing pair is G3-C33
Stack -2.21 External closing pair is C4-G32
Stack -1.22 External closing pair is U5-G31
Stack -3.17 External closing pair is G6-C30
Stack -3.17 External closing pair is G7-C29
Helix -13.48 6 base pairs.
Interior loop 1.14 External closing pair is G8-C28
Stack -3.71 External closing pair is G12-C22
Helix -3.71 2 base pairs.
Hairpin loop 2.54 Closing pair is C13-G21
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-37-16/1... 27/09/2015 21:38
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Figure A.6| ΔG of the predicted RNATs at 5′ UTR of caf1R relative to transcript from PRK.  
Using Mfold 2.3 program (Zuker, 2003) RNA secondary structures were predicted by inclusion of Caf1R first 5 
codons at 26°C (i), 28°C (ii), 30°C (iii) and 37°C (iv).	The most probable prediction with lowest free energy 
(ΔG; kcal/mole) at each temperature is indicated.  			
Loop Free-Energy Decomposition Structure 1
RNAT_PRK_30C_5 codons
ΔG = -27.74
Structural element δG Information
External loop -2.30 8 ss bases & 3 closing helices.
Stack -2.00 External closing pair is C80-G95
Stack -1.01 External closing pair is A81-U94
Helix -3.01 3 base pairs.
Bulge loop 1.26 External closing pair is U82-A93
Stack -1.83 External closing pair is C84-G92
Helix -1.83 2 base pairs.
Hairpin loop 3.38 Closing pair is U85-A91
Stack -0.47 External closing pair is G37-U74
Stack -2.27 External closing pair is G38-U73
Stack -3.11 External closing pair is C39-G72
Stack -3.11 External closing pair is C40-G71
Stack -2.00 External closing pair is C41-G70
Helix -10.96 6 base pairs.
Interior loop 2.26 External closing pair is A42-U69
Stack -1.01 External closing pair is A45-U67
Stack -2.55 External closing pair is U46-A66
Helix -3.56 3 base pairs.
Bulge loop 1.81 External closing pair is C47-G65
Stack -0.57 External closing pair is A49-U64
Stack -1.16 External closing pair is G50-U63
Stack -1.03 External closing pair is A51-U62
Stack -1.01 External closing pair is A52-U61
Stack -0.87 External closing pair is U53-A60
Helix -4.64 6 base pairs.
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-40-16/1... 27/09/2015 21:42
Loop Free-Energy Decomposition Structure 1
RNAT_PRK_37C_5 codons
ΔG = -23.30
Structural element δG Information
External loop -2.10 24 ss bases & 2 closing helices.
Stack -0.40 External closing pair is G37-U74
Stack -2.10 External closing pair is G38-U73
Stack -2.90 External closing pair is C39-G72
Stack -2.90 External closing pair is C40-G71
Stack -1.80 External closing pair is C41-G70
Helix -10.10 6 base pairs.
Interior loop 2.40 External closing pair is A42-U69
Stack -0.90 External closing pair is A45-U67
Stack -2.30 External closing pair is U46-A66
Helix -3.20 3 base pairs.
Bulge loop 2.10 External closing pair is C47-G65
Stack -0.50 External closing pair is A49-U64
Stack -1.10 External closing pair is G50-U63
Stack -0.90 External closing pair is A51-U62
Stack -0.90 External closing pair is A52-U61
Stack -0.80 External closing pair is U53-A60
Helix -4.20 6 base pairs.
Hairpin loop 4.20 Closing pair is G54-U59
Stack -1.20 External closing pair is U2-G34
Stack -3.40 External closing pair is G3-C33
Stack -1.90 External closing pair is C4-G32
Stack -1.20 External closing pair is U5-G31
Stack -2.90 External closing pair is G6-C30
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-43-52/1... 27/09/2015 21:44
Hairpin loop 05 Closing pair is G54-U59
Stack -1.21 External closing pair is U2-G34
Stack -3.64 External closing pair is G3-C33
Stack -2.14 External closing pair is C4-G32
Stack -1.21 External closing pair is U5-G31
Stack -3.11 External closing pair is G6-C30
Stack -3.11 External closing pair is G7-C29
Helix -14.42 7 base pairs.
Interior loop 1.23 External closing pair is G8-C28
Stack -3.64 External closing pair is G12-C22
Helix -3.64 2 base pairs.
Hairpin loop 2.63 Closing pair is C13-G21
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-40-16/1... 27/09/2015 21:42
Stack -2.90 External closing pair is G7-C29
Helix -13.50 7 base pairs.
Interior loop 1.60 External closing pair is G8-C28
Stack -3.40 External closing pair is G12-C22
Helix -3.40 2 base pairs.
Hairpin loop 2.90 Closing pair is C13-G21
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-43-52/1... 27/09/2015 21:44
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7. ΔG of the predicted RNATs at 5′ UTR of caf1M relative to transcript from PM. 	
		
Loop Free-Energy Decomposition Structure 1
RNAT_PM_26C_5 codons
ΔG = -47.38
Structural element δG Information
External loop -3.61 21 ss bases & 3 closing helices.
Stack -2.69 External closing pair is U34-A133
Stack -2.11 External closing pair is C35-G132
Stack -1.07 External closing pair is A36-U131
Helix -5.87 4 base pairs.
Interior loop 1.00 External closing pair is U37-A130
Stack -2.37 External closing pair is G40-C127
Stack -0.61 External closing pair is U41-G126
Helix -2.98 3 base pairs.
Multi-loop 2.35 External closing pair is U42-A1258 ss bases & 4 closing helices.
Stack -0.61 External closing pair is U109-G120
Stack -2.69 External closing pair is U110-A119
Stack -3.23 External closing pair is C111-G118
Helix -6.53 4 base pairs.
Hairpin loop 0.30 Closing pair is C112-G117
Stack -3.23 External closing pair is G96-C107
Stack -2.39 External closing pair is G97-C106
Stack -2.11 External closing pair is U98-A105
Helix -7.73 4 base pairs.
Hairpin loop 3.85 Closing pair is G99-C104
Stack -3.23 External closing pair is C44-G93
Stack -3.23 External closing pair is C45-G92
Stack -2.11 External closing pair is C46-G91
Stack -2.39 External closing pair is A47-U90
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-57-08/1... 27/09/2015 21:59
Stack -3.23 External closing pair is C48-G89
Stack -2.28 External closing pair is C49-G88
Stack -0.51 External closing pair is U50-G87
Stack -0.51 External closing pair is U51-G86
Stack -0.61 External closing pair is U52-G85
Stack -1.19 External closing pair is U53-A84
Helix -19.29 11 base pairs.
Interior loop -0.11 External closing pair is U54-G83
Stack -1.22 External closing pair is C56-G80
Helix -1.22 2 base pairs.
Bulge loop 1.39 External closing pair is G57-U79
Stack -2.11 External closing pair is C58-G77
Stack -1.07 External closing pair is A59-U76
Helix -3.18 3 base pairs.
Interior loop 0.77 External closing pair is U60-A75
Stack -2.69 External closing pair is U62-A73
Stack -1.22 External closing pair is C63-G72
Stack -1.11 External closing pair is G64-U71
Helix -5.02 4 base pairs.
Hairpin loop 4.18 Closing pair is U65-A70
Stack -3.23 External closing pair is G17-C30
Stack -2.69 External closing pair is G18-C29
Stack -1.07 External closing pair is A19-U28
Helix -6.99 4 base pairs.
Hairpin loop 3.42 Closing pair is U20-A27
Stack -2.28 External closing pair is G6-U14
Stack -3.78 External closing pair is G7-C13
Helix -6.06 3 base pairs.
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-57-08/1... 27/09/2015 21:59
Hairpin loop 3.95 Closing pair is C8-G12
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-57-08/1... 27/09/2015 21:59
Stack -3.23 External closing pair is C48-G89
Stack -2.28 External closing pair is C49-G88
Stack -0.51 External closing pair is U50-G87
Stack -0.51 External closing pair is U51-G86
Stack -0.61 External closing pair is U52-G85
Stack -1.19 External closing pair is U53-A84
Helix -19.29 11 base pairs.
Interior loop -0.11 External closing pair is U54-G83
Stack -1.22 External closing pair is C56-G80
Helix -1.22 2 base pairs.
Bulge loop 1.39 External closing pair is G57-U79
Stack -2.11 External closing pair is C58-G77
Stack -1.07 External closing pair is A59-U76
Helix -3.18 3 base pairs.
Interior loop 0.77 External closing pair is U60-A75
Stack -2.69 External closing pair is U62-A73
Stack -1.22 External closing pair is C63-G72
Stack -1.11 External closing pair is G64-U71
Helix -5.02 4 base pairs.
Hairpin loop 4.18 Closing pair is U65-A70
Stack -3.23 External closing pair is G17-C30
Stack -2.69 External closing pair is G18-C29
Stack -1.07 External closing pair is A19-U28
Helix -6.99 4 base pairs.
Hairpin loop 3.42 Closing pair is U20-A27
Stack -2.28 External closing pair is G6-U14
Stack -3.78 External closing pair is G7-C13
Helix -6.06 3 base pairs.
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/16/15Sep27-16-57-08/1... 27/09/2015 21:59
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Loop Free-Energy Decomposition Structure 1
RNAT_PM_28C_5 codons
ΔG = -45.14
Structural element δG Information
External loop -3.56 21 ss bases & 3 closing helices.
Stack -2.62 External closing pair is U34-A133
Stack -2.05 External closing pair is C35-G132
Stack -1.04 External closing pair is A36-U131
Helix -5.71 4 base pairs.
Interior loop 1.07 External closing pair is U37-A130
Stack -2.32 External closing pair is G40-C127
Stack -0.59 External closing pair is U41-G126
Helix -2.91 3 base pairs.
Multi-loop 2.53 External closing pair is U42-A1258 ss bases & 4 closing helices.
Stack -0.59 External closing pair is U109-G120
Stack -2.62 External closing pair is U110-A119
Stack -3.17 External closing pair is C111-G118
Helix -6.38 4 base pairs.
Hairpin loop 0.39 Closing pair is C112-G117
Stack -3.17 External closing pair is G96-C107
Stack -2.34 External closing pair is G97-C106
Stack -2.05 External closing pair is U98-A105
Helix -7.56 4 base pairs.
Hairpin loop 3.91 Closing pair is G99-C104
Stack -3.17 External closing pair is C44-G93
Stack -3.17 External closing pair is C45-G92
Stack -2.05 External closing pair is C46-G91
Stack -2.34 External closing pair is A47-U90
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/17/15Sep27-17-03-18/1... 27/09/2015 22:04
Stack -3.17 External closing pair is C48-G89
Stack -2.21 External closing pair is C49-G88
Stack -0.49 External closing pair is U50-G87
Stack -0.49 External closing pair is U51-G86
Stack -0.59 External closing pair is U52-G85
Stack -1.17 External closing pair is U53-A84
Helix -18.85 11 base pairs.
Interior loop 0.00 External closing pair is U54-G83
Stack -1.22 External closing pair is C56-G80
Helix -1.22 2 base pairs.
Bulge loop 1.47 External closing pair is G57-U79
Stack -2.05 External closing pair is C58-G77
Stack -1.04 External closing pair is A59-U76
Helix -3.09 3 base pairs.
Interior loop 0.78 External closing pair is U60-A75
Stack -2.62 External closing pair is U62-A73
Stack -1.22 External closing pair is C63-G72
Stack -1.09 External closing pair is G64-U71
Helix -4.93 4 base pairs.
Hairpin loop 4.22 Closing pair is U65-A70
Stack -3.17 External closing pair is G17-C30
Stack -2.62 External closing pair is G18-C29
Stack -1.04 External closing pair is A19-U28
Helix -6.83 4 base pairs.
Hairpin loop 3.47 Closing pair is U20-A27
Stack -2.21 External closing pair is G6-U14
Stack -3.71 External closing pair is G7-C13
Helix -5.92 3 base pairs.
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/17/15Sep27-17-03-18/1... 27/09/2015 22:04
Hairpin loop 3.98 Closing pair is C8-G12
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/17/15Sep27-17-03-18/1... 27/09/2015 22:04
Stack -3.17 External closing pair is C48-G89
Stack -2.21 External closing pair is C49-G88
Stack -0.49 External closing pair is U50-G87
Stack -0.49 External closing pair is U51-G86
Stack -0.59 External closing pair is U52-G85
Stack -1.17 External closing pair is U53-A84
Helix -18.85 11 base pairs.
Interior loop 0.00 External closing pair is U54-G83
Stack -1.22 External closing pair is C56-G80
Helix -1.22 2 base pairs.
Bulge loop 1.47 External closing pair is G57-U79
Stack -2.05 External closing pair is C58-G77
Stack -1.04 External closing pair is A59-U76
Helix -3.09 3 base pairs.
Interior loop 0.78 External closing pair is U60-A75
Stack -2.62 External closing pair is U62-A73
Stack -1.22 External closing pair is C63-G72
Stack -1.09 External closing pair is G64-U71
Helix -4.93 4 base pairs.
Hairpin loop 4.22 Closing pair is U65-A70
Stack -3.17 External closing pair is G17-C30
Stack -2.62 External closing pair is G18-C29
Stack -1.04 External closing pair is A19-U28
Helix -6.83 4 base pairs.
Hairpin loop 3.47 Closing pair is U20-A27
Stack -2.21 External closing pair is G6-U14
Stack -3.71 External closing pair is G7-C13
Helix -5.92 3 base pairs.
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/17/15Sep27-17-03-18/1... 27/09/2015 22:04
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Loop Free-Energy Decomposition Structure 1
RNAT_PM_30C_5 codons
ΔG = -42.91
Structural element δG Information
External loop -3.50 21 ss bases & 3 closing helices.
Stack -2.55 External closing pair is U34-A133
Stack -2.00 External closing pair is C35-G132
Stack -1.01 External closing pair is A36-U131
Helix -5.56 4 base pairs.
Interior loop 1.14 External closing pair is U37-A130
Stack -2.27 External closing pair is G40-C127
Stack -0.57 External closing pair is U41-G126
Helix -2.84 3 base pairs.
Multi-loop 2.71 External closing pair is U42-A1258 ss bases & 4 closing helices.
Stack -0.57 External closing pair is U109-G120
Stack -2.55 External closing pair is U110-A119
Stack -3.11 External closing pair is C111-G118
Helix -6.23 4 base pairs.
Hairpin loop 0.48 Closing pair is C112-G117
Stack -3.11 External closing pair is G96-C107
Stack -2.28 External closing pair is G97-C106
Stack -2.00 External closing pair is U98-A105
Helix -7.39 4 base pairs.
Hairpin loop 3.98 Closing pair is G99-C104
Stack -3.11 External closing pair is C44-G93
Stack -3.11 External closing pair is C45-G92
Stack -2.00 External closing pair is C46-G91
Stack -2.28 External closing pair is A47-U90
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/17/15Sep27-17-07-25/1... 27/09/2015 22:08
Stack -3.11 External closing pair is C48-G89
Stack -2.14 External closing pair is C49-G88
Stack -0.47 External closing pair is U50-G87
Stack -0.47 External closing pair is U51-G86
Stack -0.57 External closing pair is U52-G85
Stack -1.16 External closing pair is U53-A84
Helix -18.42 11 base pairs.
Interior loop 0.11 External closing pair is U54-G83
Stack -1.21 External closing pair is C56-G80
Helix -1.21 2 base pairs.
Bulge loop 1.54 External closing pair is G57-U79
Stack -2.00 External closing pair is C58-G77
Stack -1.01 External closing pair is A59-U76
Helix -3.01 3 base pairs.
Interior loop 0.78 External closing pair is U60-A75
Stack -2.55 External closing pair is U62-A73
Stack -1.21 External closing pair is C63-G72
Stack -1.07 External closing pair is G64-U71
Helix -4.83 4 base pairs.
Hairpin loop 4.26 Closing pair is U65-A70
Stack -3.11 External closing pair is G17-C30
Stack -2.55 External closing pair is G18-C29
Stack -1.01 External closing pair is A19-U28
Helix -6.67 4 base pairs.
Hairpin loop 3.52 Closing pair is U20-A27
Stack -2.14 External closing pair is G6-U14
Stack -3.64 External closing pair is G7-C13
Helix -5.78 3 base pairs.
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/17/15Sep27-17-07-25/1... 27/09/2015 22:08
Hairpin loop 4.01 Closing pair is C8-G12
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/17/15Sep27-17-07-25/1... 27/09/2015 22:08
Stack -3.11 External closing pair is C48-G89
Stack -2.14 External closing pair is C49-G88
Stack -0.47 External closing pair is U50-G87
Stack -0.47 External closing pair is U51-G86
Stack -0.57 External closing pair is U52-G85
Stack -1.16 External closing pair is U53-A84
Helix -18.42 11 base pairs.
Interior loop 0.11 External closing pair is U54-G83
Stack -1.21 External closing pair is C56-G80
Helix -1.21 2 base pairs.
Bulge loop 1.54 External closing pair is G57-U79
Stack -2.00 External closing pair is C58-G77
Stack -1.01 External closing pair is A59-U76
Helix -3.01 3 base pairs.
Interior loop 0.78 External closing pair is U60-A75
Stack -2.55 External closing pair is U62-A73
Stack -1.21 External closing pair is C63-G72
Stack -1.07 External closing pair is G64-U71
Helix -4.83 4 base pairs.
Hairpin loop 4.26 Closing pair is U65-A70
Stack -3.11 External closing pair is G17-C30
Stack -2.55 External closing pair is G18-C29
Stack -1.01 External closing pair is A19-U28
Helix -6.67 4 base pairs.
Hairpin loop 3.52 Closing pair is U20-A27
Stack -2.14 External closing pair is G6-U14
Stack -3.64 External closing pair is G7-C13
Helix -5.78 3 base pairs.
Loop Free-Energy Decomposition
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Figure A.7| ΔG of the predicted RNATs at 5′ UTR of caf1M relative to transcript from PM. 
Using Mfold 2.3 program (Zuker, 2003) RNA secondary structures were predicted by inclusion of Caf1M first 5 
codons at 26°C (i), 28°C (ii), 30°C (iii) and 37°C (iv). The most probable prediction with lowest free energy 
(ΔG; kcal/mole) at each temperature is indicated.  
 	
 
 
 
 
 
 
 
 
 
 
 
 		
Loop Free-Energy Decomposition Structure 1
RNAT_PM_37C_5 codons
ΔG = -35.70
Structural element δG Information
External loop -6.80 47 ss bases & 5 closing helices.
Stack -0.50 External closing pair is U109-G120
Stack -2.30 External closing pair is U110-A119
Stack -2.90 External closing pair is C111-G118
Helix -5.70 4 base pairs.
Hairpin loop 0.80 Closing pair is C112-G117
Stack -2.90 External closing pair is G96-C107
Stack -2.10 External closing pair is G97-C106
Stack -1.80 External closing pair is U98-A105
Helix -6.80 4 base pairs.
Hairpin loop 4.20 Closing pair is G99-C104
Stack -2.90 External closing pair is C44-G93
Stack -2.90 External closing pair is C45-G92
Stack -1.80 External closing pair is C46-G91
Stack -2.10 External closing pair is A47-U90
Stack -2.90 External closing pair is C48-G89
Stack -1.90 External closing pair is C49-G88
Stack -0.40 External closing pair is U50-G87
Stack -0.40 External closing pair is U51-G86
Stack -0.50 External closing pair is U52-G85
Stack -1.10 External closing pair is U53-A84
Helix -16.90 11 base pairs.
Interior loop 0.50 External closing pair is U54-G83
Stack -1.20 External closing pair is C56-G80
Loop Free-Energy Decomposition
http://unafold.rna.albany.edu/results/17/15Sep27-17-09-59/1... 27/09/2015 22:11
Helix -1.20 2 base pairs.
Bulge loop 1.80 External closing pair is G57-U79
Stack -1.80 External closing pair is C58-G77
Stack -0.90 External closing pair is A59-U76
Helix -2.70 3 base pairs.
Interior loop 0.80 External closing pair is U60-A75
Stack -2.30 External closing pair is U62-A73
Stack -1.20 External closing pair is C63-G72
Stack -1.00 External closing pair is G64-U71
Helix -4.50 4 base pairs.
Hairpin loop 4.40 Closing pair is U65-A70
Stack -2.90 External closing pair is G17-C30
Stack -2.30 External closing pair is G18-C29
Stack -0.90 External closing pair is A19-U28
Helix -6.10 4 base pairs.
Hairpin loop 3.70 Closing pair is U20-A27
Stack -1.90 External closing pair is G6-U14
Stack -3.40 External closing pair is G7-C13
Helix -5.30 3 base pairs.
Hairpin loop 4.10 Closing pair is C8-G12
mfold version 3.5   ●   Michael Zuker
Loop Free-Energy Decomposition
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8.  Comparison of Caf1R-DBD mutations with Ala scanning of MarA  	
	
 
Figure A.8| Site-specific mutagenesis of Caf1R-DBD with respect to MarA. 
F1 recovery from Caf1R-DBD mutants (in pACYCF1) and relatedness of mutagenesis targeted Caf1R-DBD 
residues with mar-MarA complex (Rhee et al., 1998) and alanine-scanning results of MarA (Gillette et al., 2000) 
is indicted. Interaction with DNA backbone (P), base specific hydrogen bond (H) and Van der Waals interactions 
(V) are indicated with corresponding mar DNA base in parentheses, (). Dark and light brown-shaded mutants 
indicate, F1 recovery from whole cell and cell surface with respective wild type (WT).  
 
 	
 
 
	
	
	
	
	
	
	
	
	
	
pACYCF1-R 
mutant 
 F1 recovery (%) at 37°C MarA 
mutant 
 Transcriptional activity at 
promoter 
Role Location 
  4 h 6 h Class I  Class II 
WT 100 ± 1.32 100 ± 1.57 mar fpr zwf fumC micF 
WT 100 ± 5.33 100 ± 3.43 
I31A   33.92 ± 1.31 73.22 ± 1.16 L30A  Helix-2 
D32A 61.25 ± 4.40 86.76 ± 1.83 E31A  P Helix-2 
C33A 59.50 ± 7.84 96.20 ± 9.44 K32A  Helix-2 
F40A 4.18 ± 0.33 5.53 ± 0.06 Y39A P Loop 2-3 
R42A 143.87 ± 3.51 85.19 ± 1.77 K41A  Helix-3 
R43A 79.48 ± 4.02 66.35 ± 0.66 W42A V (C,C) Helix-3 
Y44A 72.06 ± 1.39 76.44 ± 2.34 H43A  P Helix-3 
R62A 76.33 ± 3.66 96.55 ± 1.27 R61A  Helix-4 
 
R62S 58.85 ± 0.20 92.97 ± 2.94 
Q93A 6.99 ± 0.36 33.90 ± 1.77 Q92A  V (T, T) Helix-6 
R97A 4.79 ± 1.83 86.53 ± 4.78 R96A  H 
(G,G,A), 
V (T) 
Helix-6 
 
E98G 13.05 ± 0.62 14.16 ± 0.32 T97A  P Helix-6 
 
E98A% 58.85 ± 2.15% 95.24 ± 3.24 
E98T% 67.38 ± 1.57 73.12 ± 2.44 
E98K% 00%±%00% 00 ± 00 
T106A 125.12 ± 1.48 112.73 ± 1.84 P105A Loop 6-7 
R108A 57.22 ± 2.17 49.05 ± 0.63 H107A  P Helix-7 
Q109A 121.25 ± 5.73 112.74 ± 5.94 K108A P Helix-7 
WT or 
>100% 
96-100% 76-95% 46-75% 26-45% 0-25% 81-100
% 
61-80 
% 
41-60 
% 
21-40   
% 
0-20  
% 
	 220	
References 
Achtman,	M.,	Zurth,	K.,	Morelli,	G.,	Torrea,	G.,	Guiyoule,	A.,	and	Carniel,	E.	(1999).	Yersinia	pestis,	the	cause	of	 plague,	 is	 a	 recently	 emerged	 clone	 of	 Yersinia	 pseudotuberculosis.	 Proceedings	 of	 the	 National	Academy	of	Sciences	of	the	United	States	of	America	96,	14043-14048.	Alekshun,	M.N.,	Levy,	S.B.,	Mealy,	T.R.,	Seaton,	B.A.,	and	Head,	J.F.	(2001).	The	crystal	structure	of	MarR,	a	regulator	of	multiple	antibiotic	resistance,	at	2.3	A	resolution.	Nat	Struct	Biol	8,	710-714.	Amabile-Cuevas,	C.F.,	and	Demple,	B.	(1991).	Molecular	characterization	of	the	soxRS	genes	of	Escherichia	coli:	two	genes	control	a	superoxide	stress	regulon.	Nucleic	acids	research	19,	4479-4484.	Amies,	C.R.	(1951).	The	envelope	substance	of	Pasteurella	pestis.	Br	J	Exp	Pathol	32,	259-273.	Amit,	R.,	Oppenheim,	A.B.,	and	Stavans,	J.	(2003).	Increased	bending	rigidity	of	single	DNA	molecules	by	H-NS,	a	temperature	and	osmolarity	sensor.	Biophys	J	84,	2467-2473.	Andersen,	 K.R.,	 Leksa,	 N.C.,	 and	 Schwartz,	 T.U.	 (2013).	 Optimized	 E.	 coli	 expression	 strain	 LOBSTR	eliminates	common	contaminants	from	His-tag	purification.	Proteins	81,	1857-1861.	Andrews,	 G.P.,	 Heath,	 D.G.,	 Anderson,	 G.W.,	 Jr.,	 Welkos,	 S.L.,	 and	 Friedlander,	 A.M.	 (1996).	 Fraction	 1	capsular	 antigen	 (F1)	 purification	 from	Yersinia	 pestis	 CO92	 and	 from	an	Escherichia	 coli	 recombinant	strain	and	efficacy	against	lethal	plague	challenge.	Infection	and	immunity	64,	2180-2187.	Ariza,	 R.R.,	 Li,	 Z.,	 Ringstad,	 N.,	 and	 Demple,	 B.	 (1995).	 Activation	 of	 multiple	 antibiotic	 resistance	 and	binding	of	stress-inducible	promoters	by	Escherichia	coli	Rob	protein.	Journal	of	bacteriology	177,	1655-1661.	Associated	 Press	 in	 Antananarivo,	 M.	 (2013).	 Bubonic	 plague	 outbreak	 kills	 32	 in	 Madagascar.	 The	Guardian,	 United	 Kingdom.	 http://www.theguardian.com/world/2013/dec/20/bubonic-plague-outbreak-deaths-madagascar.	Azam,	 T.A.,	 Hiraga,	 S.,	 and	 Ishihama,	 A.	 (2000).	 Two	 types	 of	 localization	 of	 the	 DNA-binding	 proteins	within	the	Escherichia	coli	nucleoid.	Genes	Cells	5,	613-626.	Baga,	 M.,	 Goransson,	 M.,	 Normark,	 S.,	 and	 Uhlin,	 B.E.	 (1985).	 Transcriptional	 activation	 of	 a	 pap	 pilus	virulence	operon	from	uropathogenic	Escherichia	coli.	The	EMBO	journal	4,	3887-3893.	Baldwin,	 R.L.	 (1986).	 Temperature	 dependence	 of	 the	 hydrophobic	 interaction	 in	 protein	 folding.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	83,	8069-8072.	Barbosa,	T.M.,	and	Levy,	S.B.	(2000).	Differential	expression	of	over	60	chromosomal	genes	in	Escherichia	coli	by	constitutive	expression	of	MarA.	Journal	of	bacteriology	182,	3467-3474.	Bartra,	 S.S.,	 Styer,	 K.L.,	 O'Bryant,	 D.M.,	 Nilles,	M.L.,	 Hinnebusch,	 B.J.,	 Aballay,	 A.,	 and	 Plano,	 G.V.	 (2008).	Resistance	 of	 Yersinia	 pestis	 to	 complement-dependent	 killing	 is	mediated	 by	 the	 Ail	 outer	membrane	protein.	Infection	and	immunity	76,	612-622.	Basturea,	G.N.,	Bodero,	M.D.,	Moreno,	M.E.,	and	Munson,	G.P.	(2008).	Residues	near	the	amino	terminus	of	Rns	are	essential	for	positive	autoregulation	and	DNA	binding.	Journal	of	bacteriology	190,	2279-2285.	BBC,	 U.K.	 (2013).	 Madagascar	 bubonic	 plague	 warning.	 http://www.bbc.co.uk/news/world-africa-24461474.	Benedek,	 O.,	 Nagy,	 G.,	 and	 Emody,	 L.	 (2004).	 Intracellular	 signalling	 and	 cytoskeletal	 rearrangement	involved	in	Yersinia	pestis	plasminogen	activator	(Pla)	mediated	HeLa	cell	invasion.	Microb	Pathog	37,	47-54.	Bi,	Y.,	Du,	Z.,	Han,	Y.,	Guo,	Z.,	Tan,	Y.,	Zhu,	Z.,	and	Yang,	R.	(2009).	Yersinia	pestis	and	host	macrophages:	immunodeficiency	of	mouse	macrophages	induced	by	YscW.	Immunology	128,	e406-417.	
	 221	
Bianucci,	 R.,	 Rahalison,	 L.,	 Ferroglio,	 E.,	 Massa,	 E.R.,	 and	 Signoli,	 M.	 (2007).	 A	 rapid	 diagnostic	 test	 for	plague	detects	Yersinia	pestis	F1	antigen	in	ancient	human	remains.	C	R	Biol	330,	747-754.	Blattner,	F.R.,	Plunkett,	G.,	3rd,	Bloch,	C.A.,	Perna,	N.T.,	Burland,	V.,	Riley,	M.,	Collado-Vides,	J.,	Glasner,	J.D.,	Rode,	C.K.,	Mayhew,	G.F.,	et	al.	 (1997).	The	complete	genome	sequence	of	Escherichia	coli	K-12.	Science	
277,	1453-1462.	Blomfield,	I.C.	(2001).	The	regulation	of	pap	and	type	1	fimbriation	in	Escherichia	coli.	Adv	Microb	Physiol	
45,	1-49.	Bodero,	M.D.,	Harden,	E.A.,	 and	Munson,	G.P.	 (2008).	Transcriptional	 regulation	of	 subclass	5b	 fimbriae.	BMC	Microbiol	8,	180.	Bohme,	K.,	Steinmann,	R.,	Kortmann,	J.,	Seekircher,	S.,	Heroven,	A.K.,	Berger,	E.,	Pisano,	F.,	Thiermann,	T.,	Wolf-Watz,	H.,	Narberhaus,	F.,	et	al.	 (2012).	Concerted	actions	of	a	 thermo-labile	regulator	and	a	unique	intergenic	RNA	thermosensor	control	Yersinia	virulence.	PLoS	Pathog	8,	e1002518.	Bondos,	S.E.,	and	Bicknell,	A.	(2003).	Detection	and	prevention	of	protein	aggregation	before,	during,	and	after	purification.	Analytical	biochemistry	316,	223-231.	Botelho,	G.	(2015).	Second	case	of	plague-another	Yosemite	visitor-investigated	 in	California	(California,	USA:	CNN).	Braaten,	B.A.,	Nou,	X.,	Kaltenbach,	L.S.,	and	Low,	D.A.	(1994).	Methylation	patterns	in	pap	regulatory	DNA	control	pyelonephritis-associated	pili	phase	variation	in	E.	coli.	Cell	76,	577-588.	Brinkman,	A.B.,	Ettema,	T.J.,	de	Vos,	W.M.,	 and	van	der	Oost,	 J.	 (2003).	The	Lrp	 family	of	 transcriptional	regulators.	Molecular	microbiology	48,	287-294.	Brown,	 N.L.,	 Stoyanov,	 J.V.,	 Kidd,	 S.P.,	 and	 Hobman,	 J.L.	 (2003).	 The	 MerR	 family	 of	 transcriptional	regulators.	FEMS	microbiology	reviews	27,	145-163.	Browning,	 D.F.,	 and	 Busby,	 S.J.	 (2004).	 The	 regulation	 of	 bacterial	 transcription	 initiation.	 Nat	 Rev	Microbiol	2,	57-65.	Burns,	L.S.,	Smith,	S.G.,	and	Dorman,	C.J.	(2000).	Interaction	of	the	FimB	integrase	with	the	fimS	invertible	DNA	element	in	Escherichia	coli	in	vivo	and	in	vitro.	Journal	of	bacteriology	182,	2953-2959.	Busby,	S.,	and	Ebright,	R.H.	(1994).	Promoter	structure,	promoter	recognition,	and	transcription	activation	in	prokaryotes.	Cell	79,	743-746.	Busch,	A.,	and	Waksman,	G.	(2012).	Chaperone-usher	pathways:	diversity	and	pilus	assembly	mechanism.	Philos	Trans	R	Soc	Lond	B	Biol	Sci	367,	1112-1122.	Bustos,	S.A.,	and	Schleif,	R.F.	(1993).	Functional	domains	of	the	AraC	protein.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	90,	5638-5642.	Butler,	T.	(2009).	Plague	into	the	21st	century.	Clin	Infect	Dis	49,	736-742.	Campbell,	E.A.,	Muzzin,	O.,	Chlenov,	M.,	Sun,	J.L.,	Olson,	C.A.,	Weinman,	O.,	Trester-Zedlitz,	M.L.,	and	Darst,	S.A.	(2002).	Structure	of	the	bacterial	RNA	polymerase	promoter	specificity	sigma	subunit.	Molecular	cell	
9,	527-539.	Cantey,	 J.R.,	 Blake,	R.K.,	Williford,	 J.R.,	 and	Moseley,	 S.L.	 (1999).	 Characterization	 of	 the	Escherichia	 coli	AF/R1	 pilus	 operon:	 novel	 genes	 necessary	 for	 transcriptional	 regulation	 and	 for	 pilus-mediated	adherence.	Infection	and	immunity	67,	2292-2298.	Cao,	L.,	 Lim,	T.,	 Jun,	 S.,	Thornburg,	T.,	Avci,	R.,	 and	Yang,	X.	 (2012).	Vulnerabilities	 in	Yersinia	pestis	 caf	operon	are	unveiled	by	a	Salmonella	vector.	PLoS	One	7,	e36283.	
	 222	
Carolina,	A.,	 and	Celso,	 C.	 (2012).	Electrophoretic	Mobility	 Shift	Assay:	Analysing	Protein	 -	Nucleic	Acid	Interactions,	Gel	Electrophoresis	-	Advanced	Techniques,	Dr.	Samesh	Magdeldin	(Edn),	ISBN:	978-953-51-0457-5,	InTech,	Avialable	from:	http://cdn.intechopen.com/pdfs-wm/34920.pdf		Caron,	 J.,	 Coffield,	 L.M.,	 and	 Scott,	 J.R.	 (1989).	 A	 plasmid-encoded	 regulatory	 gene,	 rns,	 required	 for	expression	of	 the	CS1	and	CS2	adhesins	of	enterotoxigenic	Escherichia	coli.	Proceedings	of	 the	National	Academy	of	Sciences	of	the	United	States	of	America	86,	963-967.	Caron,	 J.,	 and	Scott,	 J.R.	 (1990).	A	 rns-like	 regulatory	gene	 for	 colonization	 factor	antigen	 I	 (CFA/I)	 that	controls	expression	of	CFA/I	pilin.	Infection	and	immunity	58,	874-878.	Cathelyn,	J.S.,	Crosby,	S.D.,	Lathem,	W.W.,	Goldman,	W.E.,	and	Miller,	V.L.	(2006).	RovA,	a	global	regulator	of	 Yersinia	 pestis,	 specifically	 required	 for	 bubonic	 plague.	 Proceedings	 of	 the	 National	 Academy	 of	Sciences	of	the	United	States	of	America	103,	13514-13519.	CDC	(2012).	Ecology	and	Transmission	of	Plague.	http://www.cdc.gov/plague/transmission/.	CDC	(2015).	Plague:	Resources	for	Clinicians.	http://www.cdc.gov/plague/healthcare/clinicians.html.	Chanteau,	S.,	Rahalison,	L.,	Ratsitorahina,	M.,	Mahafaly,	Rasolomaharo,	M.,	Boisier,	P.,	O'Brien,	T.,	Aldrich,	J.,	Keleher,	A.,	Morgan,	 C.,	et	al.	 (2000).	 Early	diagnosis	 of	 bubonic	plague	using	F1	 antigen	 capture	ELISA	assay	and	rapid	immunogold	dipstick.	Int	J	Med	Microbiol	290,	279-283.	Chapman,	D.A.,	Zavialov,	A.V.,	Chernovskaya,	T.V.,	Karlyshev,	A.V.,	Zav'yalova,	G.A.,	Vasiliev,	A.M.,	Dudich,	I.V.,	Abramov,	V.M.,	Zav'yalov,	V.P.,	and	MacIntyre,	S.	(1999).	Structural	and	functional	significance	of	the	FGL	sequence	of	 the	periplasmic	chaperone	Caf1M	of	Yersinia	pestis.	 Journal	of	bacteriology	181,	2422-2429.	Chauvaux,	S.,	Rosso,	M.L.,	Frangeul,	L.,	Lacroix,	C.,	Labarre,	L.,	Schiavo,	A.,	Marceau,	M.,	Dillies,	M.A.,	Foulon,	J.,	Coppee,	J.Y.,	et	al.	(2007).	Transcriptome	analysis	of	Yersinia	pestis	in	human	plasma:	an	approach	for	discovering	bacterial	genes	involved	in	septicaemic	plague.	Microbiology	153,	3112-3124.	Choudhury,	 D.,	 Thompson,	 A.,	 Stojanoff,	 V.,	 Langermann,	 S.,	 Pinkner,	 J.,	 Hultgren,	 S.J.,	 and	 Knight,	 S.D.	(1999).	 X-ray	 structure	 of	 the	 FimC-FimH	 chaperone-adhesin	 complex	 from	 uropathogenic	 Escherichia	coli.	Science	285,	1061-1066.	Chouikha,	 I.,	and	Hinnebusch,	B.J.	 (2012).	Yersinia--flea	 interactions	and	the	evolution	of	 the	arthropod-borne	transmission	route	of	plague.	Curr	Opin	Microbiol	15,	239-246.	Chubiz,	L.M.,	Glekas,	G.D.,	and	Rao,	C.V.	(2012).	Transcriptional	cross	talk	within	the	mar-sox-rob	regulon	in	Escherichia	coli	is	limited	to	the	rob	and	marRAB	operons.	Journal	of	bacteriology	194,	4867-4875.	Clegg,	 S.,	 Wilson,	 J.,	 and	 Johnson,	 J.	 (2011).	 More	 than	 one	 way	 to	 control	 hair	 growth:	 regulatory	mechanisms	in	enterobacteria	that	affect	fimbriae	assembled	by	the	chaperone/usher	pathway.	Journal	of	bacteriology	193,	2081-2088.	Clouthier,	 S.C.,	Muller,	 K.H.,	 Doran,	 J.L.,	 Collinson,	 S.K.,	 and	 Kay,	W.W.	 (1993).	 Characterization	 of	 three	fimbrial	genes,	sefABC,	of	Salmonella	enteritidis.	Journal	of	bacteriology	175,	2523-2533.	Cohn,	S.K.	(2003).	The	Black	Death	Transformed:	Disease	and	Culture	in	Early	Renaissance	Europe,	1	edn	(Hodder	Arnold	publication).	Cole,	S.T.,	and	Buchrieser,	C.	(2001).	Bacterial	genomics.	A	plague	o'	both	your	hosts.	Nature	413,	467,	469-470.	Costa,	 T.R.,	 Felisberto-Rodrigues,	 C.,	 Meir,	 A.,	 Prevost,	 M.S.,	 Redzej,	 A.,	 Trokter,	 M.,	 and	 Waksman,	 G.	(2015).	 Secretion	 systems	 in	 Gram-negative	 bacteria:	 structural	 and	 mechanistic	 insights.	 Nat	 Rev	Microbiol	13,	343-359.	Crooks,	 G.E.,	 Hon,	 G.,	 Chandonia,	 J.M.,	 and	 Brenner,	 S.E.	 (2004).	 WebLogo:	 a	 sequence	 logo	 generator.	Genome	research	14,	1188-1190.	
	 223	
Daber,	R.,	Stayrook,	S.,	Rosenberg,	A.,	and	Lewis,	M.	(2007).	Structural	analysis	of	lac	repressor	bound	to	allosteric	effectors.	Journal	of	molecular	biology	370,	609-619.	Dame,	R.T.,	Wyman,	C.,	 and	Goosen,	N.	 (2000).	H-NS	mediated	 compaction	of	DNA	visualised	by	atomic	force	microscopy.	Nucleic	acids	research	28,	3504-3510.	Dangi,	 B.,	 Gronenborn,	 A.M.,	 Rosner,	 J.L.,	 and	 Martin,	 R.G.	 (2004).	 Versatility	 of	 the	 carboxy-terminal	domain	of	the	alpha	subunit	of	RNA	polymerase	in	transcriptional	activation:	use	of	the	DNA	contact	site	as	a	protein	contact	site	for	MarA.	Molecular	microbiology	54,	45-59.	Dangi,	B.,	Pelupessey,	P.,	Martin,	R.G.,	Rosner,	J.L.,	Louis,	J.M.,	and	Gronenborn,	A.M.	(2001).	Structure	and	dynamics	of	MarA-DNA	complexes:	an	NMR	investigation.	Journal	of	molecular	biology	314,	113-127.	Davis,	 K.J.,	 Fritz,	 D.L.,	 Pitt,	M.L.,	Welkos,	 S.L.,	Worsham,	 P.L.,	 and	 Friedlander,	 A.M.	 (1996).	 Pathology	 of	experimental	pneumonic	plague	produced	by	fraction	1-positive	and	fraction	1-negative	Yersinia	pestis	in	African	green	monkeys	(Cercopithecus	aethiops).	Arch	Pathol	Lab	Med	120,	156-163.	De	Haan,	L.A.,	Willshaw,	G.A.,	 van	der	Zeijst,	B.A.,	 and	Gaastra,	W.	 (1991).	The	nucleotide	 sequence	of	 a	regulatory	gene	present	on	a	plasmid	 in	an	enterotoxigenic	Escherichia	coli	strain	of	serotype	O167:H5.	FEMS	microbiology	letters	67,	341-346.	deHaseth,	 P.L.,	 Zupancic,	M.L.,	 and	Record,	M.T.,	 Jr.	 (1998).	 RNA	polymerase-promoter	 interactions:	 the	comings	and	goings	of	RNA	polymerase.	Journal	of	bacteriology	180,	3019-3025.	Del	 Prete,	 G.,	 Santi,	 L.,	 Andrianaivoarimanana,	 V.,	 Amedei,	 A.,	 Domarle,	 O.,	 MM,	 D.E.,	 Arntzen,	 C.J.,	Rahalison,	 L.,	 and	 Mason,	 H.S.	 (2009).	 Plant-derived	 recombinant	 F1,	 V,	 and	 F1-V	 fusion	 antigens	 of	Yersinia	 pestis	 activate	 human	 cells	 of	 the	 innate	 and	 adaptive	 immune	 system.	 Int	 J	 Immunopathol	Pharmacol	22,	133-143.	Demple,	 B.	 (1996).	 Redox	 signaling	 and	 gene	 control	 in	 the	 Escherichia	 coli	 soxRS	 oxidative	 stress	regulon--a	review.	Gene	179,	53-57.	Deng,	 Z.,	 Liu,	 Z.,	 He,	 J.,	Wang,	 J.,	 Yan,	 Y.,	Wang,	 X.,	 Cui,	 Y.,	 Bi,	 Y.,	 Du,	 Z.,	 Song,	 Y.,	 et	al.	 (2015).	 TyrR,	 the	regulator	 of	 aromatic	 amino	 acid	 metabolism,	 is	 required	 for	 mice	 infection	 of	 Yersinia	 pestis.	 Front	Microbiol	6,	1-6.	Derbise,	 A.,	 Cerda	 Marin,	 A.,	 Ave,	 P.,	 Blisnick,	 T.,	 Huerre,	 M.,	 Carniel,	 E.,	 and	 Demeure,	 C.E.	 (2012).	 An	encapsulated	 Yersinia	 pseudotuberculosis	 is	 a	 highly	 efficient	 vaccine	 against	 pneumonic	 plague.	 PLoS	Negl	Trop	Dis	6,	e1528.	Deutscher,	J.	(2008).	The	mechanisms	of	carbon	catabolite	repression	in	bacteria.	Curr	Opin	Microbiol	11,	87-93.	Di	 Yu,	 X.,	 Dubnovitsky,	 A.,	 Pudney,	 A.F.,	 Macintyre,	 S.,	 Knight,	 S.D.,	 and	 Zavialov,	 A.V.	 (2012).	 Allosteric	mechanism	controls	traffic	in	the	chaperone/usher	pathway.	Structure	20,	1861-1871.	Dominguez-Cuevas,	P.,	Marin,	P.,	Busby,	S.,	Ramos,	J.L.,	and	Marques,	S.	(2008).	Roles	of	effectors	in	XylS-dependent	 transcription	 activation:	 intramolecular	 domain	 derepression	 and	 DNA	 binding.	 Journal	 of	bacteriology	190,	3118-3128.	Dominguez-Cuevas,	 P.,	 Ramos,	 J.L.,	 and	 Marques,	 S.	 (2010).	 Sequential	 XylS-CTD	 binding	 to	 the	 Pm	promoter	induces	DNA	bending	prior	to	activation.	Journal	of	bacteriology	192,	2682-2690.	Donato,	G.M.,	and	Kawula,	T.H.	 (1999).	Phenotypic	analysis	of	random	hns	mutations	differentiate	DNA-binding	activity	from	properties	of	fimA	promoter	inversion	modulation	and	bacterial	motility.	Journal	of	bacteriology	181,	941-948.	Donato,	G.M.,	Lelivelt,	M.J.,	and	Kawula,	T.H.	 (1997).	Promoter-specific	repression	of	 fimB	expression	by	the	Escherichia	coli	nucleoid-associated	protein	H-NS.	Journal	of	bacteriology	179,	6618-6625.	
	 224	
Dorman,	 C.J.,	 and	 Higgins,	 C.F.	 (1987).	 Fimbrial	 phase	 variation	 in	 Escherichia	 coli:	 dependence	 on	integration	host	factor	and	homologies	with	other	site-specific	recombinases.	Journal	of	bacteriology	169,	3840-3843.	Dorman,	C.J.,	and	Ni	Bhriain,	N.	 (1992).	Thermal	regulation	of	 fimA,	 the	Escherichia	coli	gene	coding	 for	the	type	1	fimbrial	subunit	protein.	FEMS	microbiology	letters	78,	125-130.	Dove,	S.L.,	Darst,	S.A.,	and	Hochschild,	A.	(2003).	Region	4	of	sigma	as	a	target	for	transcription	regulation.	Molecular	microbiology	48,	863-874.	Drozdov,	I.G.,	Anisimov,	A.P.,	Samoilova,	S.V.,	Yezhov,	I.N.,	Yeremin,	S.A.,	Karlyshev,	A.V.,	Krasilnikova,	V.M.,	and	 Kravchenko,	 V.I.	 (1995).	 Virulent	 non-capsulate	 Yersinia	 pestis	 variants	 constructed	 by	 insertion	mutagenesis.	J	Med	Microbiol	42,	264-268.	Drummelsmith,	 J.,	 and	 Whitfield,	 C.	 (2000).	 Translocation	 of	 group	 1	 capsular	 polysaccharide	 to	 the	surface	of	Escherichia	coli	requires	a	multimeric	complex	in	the	outer	membrane.	The	EMBO	journal	19,	57-66.	Du,	Y.,	Rosqvist,	R.,	and	Forsberg,	A.	 (2002).	Role	of	 fraction	1	antigen	of	Yersinia	pestis	 in	 inhibition	of	phagocytosis.	Infection	and	immunity	70,	1453-1460.	Dubnovitsky,	 A.P.,	 Duck,	 Z.,	 Kersley,	 J.E.,	 Hard,	 T.,	 MacIntyre,	 S.,	 and	 Knight,	 S.D.	 (2010).	 Conserved	hydrophobic	clusters	on	the	surface	of	 the	Caf1A	usher	C-terminal	domain	are	 important	 for	F1	antigen	assembly.	Journal	of	molecular	biology	403,	243-259.	Dudley,	 E.G.,	 Thomson,	 N.R.,	 Parkhill,	 J.,	Morin,	 N.P.,	 and	Nataro,	 J.P.	 (2006).	 Proteomic	 and	microarray	characterization	 of	 the	 AggR	 regulon	 identifies	 a	 pheU	 pathogenicity	 island	 in	 enteroaggregative	Escherichia	coli.	Molecular	microbiology	61,	1267-1282.	Duval,	 V.,	 and	 Lister,	 I.M.	 (2013).	 MarA,	 SoxS	 and	 Rob	 of	 -	 Global	 regulators	 of	 multidrug	 resistance,	virulence	and	stress	response.	Int	J	Biotechnol	Wellness	Ind	2,	101-124.	Ebright,	 R.H.	 (1993).	 Transcription	 activation	 at	 Class	 I	 CAP-dependent	 promoters.	 Molecular	microbiology	8,	797-802.	Ebright,	 R.H.	 (2000).	 RNA	 polymerase:	 structural	 similarities	 between	 bacterial	 RNA	 polymerase	 and	eukaryotic	RNA	polymerase	II.	Journal	of	molecular	biology	304,	687-698.	Egan,	S.M.	(2002).	Growing	repertoire	of	AraC/XylS	activators.	Journal	of	bacteriology	184,	5529-5532.	Ehretsmann,	C.P.,	Carpousis,	A.J.,	and	Krisch,	H.M.	(1992).	Specificity	of	Escherichia	coli	endoribonuclease	RNase	E:	in	vivo	and	in	vitro	analysis	of	mutants	in	a	bacteriophage	T4	mRNA	processing	site.	Genes	Dev	
6,	149-159.	Eidam,	O.,	Dworkowski,	F.S.,	Glockshuber,	R.,	Grutter,	M.G.,	and	Capitani,	G.	(2008).	Crystal	structure	of	the	ternary	 FimC-FimF(t)-FimD(N)	 complex	 indicates	 conserved	 pilus	 chaperone-subunit	 complex	recognition	by	the	usher	FimD.	FEBS	Lett	582,	651-655.	Eisenstein,	B.I.,	Sweet,	D.S.,	Vaughn,	V.,	and	Friedman,	D.I.	 (1987).	 Integration	host	 factor	 is	required	for	the	DNA	inversion	that	controls	phase	variation	in	Escherichia	coli.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	84,	6506-6510.	El-Labany,	 S.,	 Sohanpal,	 B.K.,	 Lahooti,	 M.,	 Akerman,	 R.,	 and	 Blomfield,	 I.C.	 (2003).	 Distant	 cis-active	sequences	and	sialic	acid	control	the	expression	of	fimB	in	Escherichia	coli	K-12.	Molecular	microbiology	
49,	1109-1118.	Elliot,	M.A.,	Locke,	T.R.,	Galibois,	C.M.,	and	Leskiw,	B.K.	(2003).	BldD	from	Streptomyces	coelicolor	is	a	non-essential	global	regulator	that	binds	its	own	promoter	as	a	dimer.	FEMS	microbiology	letters	225,	35-40.	Evans,	 D.G.,	 Silver,	 R.P.,	 Evans,	 D.J.,	 Jr.,	 Chase,	 D.G.,	 and	 Gorbach,	 S.L.	 (1975).	 Plasmid-controlled	colonization	factor	associated	with	virulence	in	Esherichia	coli	enterotoxigenic	for	humans.	Infection	and	immunity	12,	656-667.	
	 225	
Falkow,	S.	(1988).	Molecular	Koch's	postulates	applied	to	microbial	pathogenicity.	Rev	Infect	Dis	10	Suppl	
2,	S274-276.	Fawcett,	W.P.,	and	Wolf,	R.E.,	Jr.	(1994).	Purification	of	a	MalE-SoxS	fusion	protein	and	identification	of	the	control	sites	of	Escherichia	coli	superoxide-inducible	genes.	Molecular	microbiology	14,	669-679.	Feodorova,	V.A.,	and	Corbel,	M.J.	(2009).	Prospects	for	new	plague	vaccines.	Expert	Rev	Vaccines	8,	1721-1738.	Feodorova,	V.A.,	and	Motin,	V.L.	 (2012).	Plague	vaccines:	current	developments	and	future	perspectives.	Emerg	Microbes	Infect	1,	e36.	Fernandez,	L.A.,	and	Berenguer,	J.	(2000).	Secretion	and	assembly	of	regular	surface	structures	in	Gram-negative	bacteria.	FEMS	microbiology	reviews	24,	21-44.	Filippov,	A.A.,	Solodovnikov,	N.S.,	Kookleva,	L.M.,	and	Protsenko,	O.A.	(1990).	Plasmid	content	in	Yersinia	pestis	strains	of	different	origin.	FEMS	microbiology	letters	55,	45-48.	Ford,	B.,	Rego,	A.T.,	Ragan,	T.J.,	Pinkner,	J.,	Dodson,	K.,	Driscoll,	P.C.,	Hultgren,	S.,	and	Waksman,	G.	(2010).	Structural	 homology	 between	 the	 C-terminal	 domain	 of	 the	 PapC	 usher	 and	 its	 plug.	 Journal	 of	bacteriology	192,	1824-1831.	Forman,	S.,	Wulff,	C.R.,	Myers-Morales,	T.,	Cowan,	C.,	Perry,	R.D.,	and	Straley,	S.C.	(2008).	yadBC	of	Yersinia	pestis,	a	new	virulence	determinant	for	bubonic	plague.	Infection	and	immunity	76,	578-587.	Friedlander,	 A.M.,	Welkos,	 S.L.,	Worsham,	 P.L.,	 Andrews,	 G.P.,	 Heath,	 D.G.,	 Anderson,	 G.W.,	 Jr.,	 Pitt,	M.L.,	Estep,	J.,	and	Davis,	K.	(1995).	Relationship	between	virulence	and	immunity	as	revealed	in	recent	studies	of	the	F1	capsule	of	Yersinia	pestis.	Clin	Infect	Dis	21	Suppl	2,	S178-181.	Froehlich,	B.,	Husmann,	L.,	Caron,	J.,	and	Scott,	 J.R.	(1994).	Regulation	of	rns,	a	positive	regulatory	factor	for	pili	of	enterotoxigenic	Escherichia	coli.	Journal	of	bacteriology	176,	5385-5392.	Fukuto,	 H.S.,	 Svetlanov,	 A.,	 Palmer,	 L.E.,	 Karzai,	 A.W.,	 and	 Bliska,	 J.B.	 (2010).	 Global	 gene	 expression	profiling	of	Yersinia	pestis	replicating	 inside	macrophages	reveals	 the	roles	of	a	putative	stress-induced	operon	 in	 regulating	 type	 III	 secretion	 and	 intracellular	 cell	 division.	 Infection	 and	 immunity	78,	 3700-3715.	Gaastra,	W.,	and	Svennerholm,	A.M.	(1996).	Colonization	factors	of	human	enterotoxigenic	Escherichia	coli	(ETEC).	Trends	Microbiol	4,	444-452.	Galimand,	M.,	Guiyoule,	A.,	Gerbaud,	G.,	Rasoamanana,	B.,	Chanteau,	S.,	Carniel,	E.,	and	Courvalin,	P.	(1997).	Multidrug	resistance	 in	Yersinia	pestis	mediated	by	a	 transferable	plasmid.	The	New	England	 journal	of	medicine	337,	677-680.	Gallegos,	 M.T.,	 Marques,	 S.,	 and	 Ramos,	 J.L.	 (1996).	 Expression	 of	 the	 TOL	 plasmid	 xylS	 gene	 in	Pseudomonas	 putida	 occurs	 from	 a	 alpha	 70-dependent	 promoter	 or	 from	 alpha	 70-	 and	 alpha	 54-dependent	 tandem	promoters	according	 to	 the	 compound	used	 for	growth.	 Journal	of	bacteriology	178,	2356-2361.	Gallegos,	 M.T.,	 Michan,	 C.,	 and	 Ramos,	 J.L.	 (1993).	 The	 XylS/AraC	 family	 of	 regulators.	 Nucleic	 acids	research	21,	807-810.	Gallegos,	 M.T.,	 Schleif,	 R.,	 Bairoch,	 A.,	 Hofmann,	 K.,	 and	 Ramos,	 J.L.	 (1997).	 Arac/XylS	 family	 of	transcriptional	regulators.	Microbiology	and	molecular	biology	reviews	:	MMBR	61,	393-410.	Gally,	 D.L.,	 Bogan,	 J.A.,	 Eisenstein,	 B.I.,	 and	 Blomfield,	 I.C.	 (1993).	 Environmental	 regulation	 of	 the	 fim	switch	 controlling	 type	 1	 fimbrial	 phase	 variation	 in	 Escherichia	 coli	 K-12:	 effects	 of	 temperature	 and	media.	Journal	of	bacteriology	175,	6186-6193.	Galyov,	E.E.,	Karlishev,	A.V.,	Chernovskaya,	T.V.,	Dolgikh,	D.A.,	Smirnov,	O.,	Volkovoy,	K.I.,	Abramov,	V.M.,	and	Zav'yalov,	V.P.	 (1991).	 Expression	of	 the	 envelope	 antigen	F1	of	 Yersinia	 pestis	 is	mediated	by	 the	
	 226	
product	of	caf1M	gene	having	homology	with	the	chaperone	protein	PapD	of	Escherichia	coli.	FEBS	Lett	
286,	79-82.	Galyov,	 E.E.,	 Smirnov,	 O.,	 Karlishev,	 A.V.,	 Volkovoy,	 K.I.,	 Denesyuk,	 A.I.,	 Nazimov,	 I.V.,	 Rubtsov,	 K.S.,	Abramov,	 V.M.,	Dalvadyanz,	 S.M.,	 and	 Zav'yalov,	 V.P.	 (1990).	Nucleotide	 sequence	 of	 the	Yersinia	 pestis	gene	encoding	F1	antigen	and	the	primary	structure	of	the	protein.	Putative	T	and	B	cell	epitopes.	FEBS	Lett	277,	230-232.	Gao,	H.,	 Zhou,	D.,	 Li,	 Y.,	 Guo,	 Z.,	Han,	 Y.,	 Song,	 Y.,	 Zhai,	 J.,	 Du,	 Z.,	Wang,	 X.,	 Lu,	 J.,	 et	al.	 (2008).	 The	 iron-responsive	Fur	regulon	in	Yersinia	pestis.	Journal	of	bacteriology	190,	3063-3075.	Garvie,	C.W.,	and	Wolberger,	C.	(2001).	Recognition	of	specific	DNA	sequences.	Molecular	cell	8,	937-946.	Gillette,	W.K.,	Martin,	R.G.,	and	Rosner,	 J.L.	 (2000).	Probing	 the	Escherichia	coli	 transcriptional	activator	MarA	using	alanine-scanning	mutagenesis:	residues	important	for	DNA	binding	and	activation.	Journal	of	molecular	biology	299,	1245-1255.	Goransson,	M.,	 Forsman,	 P.,	 Nilsson,	 P.,	 and	 Uhlin,	 B.E.	 (1989).	 Upstream	 activating	 sequences	 that	 are	shared	 by	 two	 divergently	 transcribed	 operons	 mediate	 cAMP-CRP	 regulation	 of	 pilus-adhesin	 in	Escherichia	coli.	Molecular	microbiology	3,	1557-1565.	Goransson,	M.,	Sonden,	B.,	Nilsson,	P.,	Dagberg,	B.,	Forsman,	K.,	Emanuelsson,	K.,	 and	Uhlin,	B.E.	 (1990).	Transcriptional	 silencing	and	 thermoregulation	of	gene	expression	 in	Escherichia	 coli.	Nature	344,	 682-685.	Goransson,	M.,	and	Uhlin,	B.E.	(1984).	Environmental	 temperature	regulates	transcription	of	a	virulence	pili	operon	in	E.	coli.	The	EMBO	journal	3,	2885-2888.	Gourse,	R.L.,	Ross,	W.,	and	Gaal,	T.	(2000).	UPs	and	downs	in	bacterial	transcription	initiation:	the	role	of	the	alpha	subunit	of	RNA	polymerase	in	promoter	recognition.	Molecular	microbiology	37,	687-695.	Grewal,	H.M.,	Valvatne,	H.,	Bhan,	M.K.,	van	Dijk,	L.,	Gaastra,	W.,	and	Sommerfelt,	H.	(1997).	A	new	putative	fimbrial	colonization	factor,	CS19,	of	human	enterotoxigenic	Escherichia	coli.	Infection	and	immunity	65,	507-513.	Griffith,	K.L.,	Fitzpatrick,	M.M.,	Keen,	E.F.,	3rd,	and	Wolf,	R.E.,	 Jr.	(2009).	Two	functions	of	the	C-terminal	domain	 of	 Escherichia	 coli	 Rob:	 mediating	 "sequestration-dispersal"	 as	 a	 novel	 off-on	 switch	 for	regulating	Rob's	activity	as	a	transcription	activator	and	preventing	degradation	of	Rob	by	Lon	protease.	Journal	of	molecular	biology	388,	415-430.	Griffith,	K.L.,	Shah,	I.M.,	and	Wolf,	R.E.,	Jr.	(2004).	Proteolytic	degradation	of	Escherichia	coli	transcription	activators	 SoxS	 and	MarA	as	 the	mechanism	 for	 reversing	 the	 induction	of	 the	 superoxide	 (SoxRS)	 and	multiple	antibiotic	resistance	(Mar)	regulons.	Molecular	microbiology	51,	1801-1816.	Griffith,	K.L.,	 and	Wolf,	R.E.,	 Jr.	 (2001).	Systematic	mutagenesis	of	 the	DNA	binding	sites	 for	SoxS	 in	 the	Escherichia	 coli	 zwf	 and	 fpr	 promoters:	 identifying	 nucleotides	 required	 for	 DNA	 binding	 and	transcription	activation.	Molecular	microbiology	40,	1141-1154.	Griffith,	K.L.,	and	Wolf,	R.E.,	Jr.	(2002).	A	comprehensive	alanine	scanning	mutagenesis	of	the	Escherichia	coli	 transcriptional	activator	SoxS:	 identifying	amino	acids	 important	 for	DNA	binding	and	transcription	activation.	Journal	of	molecular	biology	322,	237-257.	Grosso-Becera,	M.V.,	Servin-Gonzalez,	L.,	and	Soberon-Chavez,	G.	 (2015).	RNA	structures	are	 involved	 in	the	thermoregulation	of	bacterial	virulence-associated	traits.	Trends	Microbiol	23,	509-518.	Gruber,	 T.M.,	 and	 Gross,	 C.A.	 (2003).	 Multiple	 sigma	 subunits	 and	 the	 partitioning	 of	 bacterial	transcription	space.	Annu	Rev	Microbiol	57,	441-466.	Guiyoule,	A.,	Gerbaud,	G.,	Buchrieser,	C.,	Galimand,	M.,	Rahalison,	L.,	Chanteau,	S.,	Courvalin,	P.,	and	Carniel,	E.	(2001).	Transferable	plasmid-mediated	resistance	to	streptomycin	in	a	clinical	isolate	of	Yersinia	pestis.	Emerg	Infect	Dis	7,	43-48.	
	 227	
Guzman,	L.M.,	Belin,	D.,	Carson,	M.J.,	and	Beckwith,	J.	(1995).	Tight	regulation,	modulation,	and	high-level	expression	by	vectors	containing	the	arabinose	PBAD	promoter.	Journal	of	bacteriology	177,	4121-4130.	Hachler,	 H.,	 Cohen,	 S.P.,	 and	 Levy,	 S.B.	 (1991).	 marA,	 a	 regulated	 locus	 which	 controls	 expression	 of	chromosomal	multiple	antibiotic	resistance	in	Escherichia	coli.	Journal	of	bacteriology	173,	5532-5538.	Haensch,	S.,	Bianucci,	R.,	Signoli,	M.,	Rajerison,	M.,	Schultz,	M.,	Kacki,	S.,	Vermunt,	M.,	Weston,	D.A.,	Hurst,	D.,	 Achtman,	M.,	 et	al.	 (2010).	 Distinct	 clones	 of	 Yersinia	 pestis	 caused	 the	 black	 death.	 PLoS	 Pathog	 6,	e1001134.	Halliwell,	C.M.,	Morgan,	G.,	Ou,	C.P.,	and	Cass,	A.E.	(2001).	Introduction	of	a	(poly)histidine	tag	in	L-lactate	dehydrogenase	 produces	 a	mixture	 of	 active	 and	 inactive	molecules.	 Analytical	 biochemistry	 295,	 257-261.	Han,	 Y.,	 Qiu,	 J.,	 Guo,	 Z.,	 Gao,	 H.,	 Song,	 Y.,	 Zhou,	 D.,	 and	 Yang,	 R.	 (2007).	 Comparative	 transcriptomics	 in	Yersinia	pestis:	a	global	view	of	environmental	modulation	of	gene	expression.	BMC	Microbiol	7,	96.	Hanahan,	 D.	 (1983).	 Studies	 on	 transformation	 of	 Escherichia	 coli	 with	 plasmids.	 Journal	 of	 molecular	biology	166,	557-580.	Hanahan,	 D.,	 Jessee,	 J.,	 and	 Bloom,	 F.R.	 (1991).	 Plasmid	 transformation	 of	 Escherichia	 coli	 and	 other	bacteria.	Methods	in	enzymology	204,	63-113.	Hancock,	K.	(2001).	Purification	of	(His)6-tagged	recombinant	proteins	expressed	as	inclusion	bodies	in	E.	coli	using	a	Ni2+		charged	HiTrap	Chelating	HP	column.	In	Life	Science	News,	Amersham	Biosciences,	pp.	1-3.	Hart,	M.K.,	Saviolakis,	G.A.,	Welkos,	S.L.,	and	House,	R.V.	(2012).	Advanced	Development	of	the	rF1V	and	rBV	A/B	Vaccines:	Progress	and	Challenges.	Adv	Prev	Med	2012,	731604.	Hartig,	 S.M.	 (2013).	 Basic	 image	 analysis	 and	manipulation	 in	 ImageJ.	 Curr	 Protoc	Mol	 Biol	Chapter	14,	Unit	14.15.	Hazen,	T.H.,	Sahl,	J.W.,	Redman,	J.C.,	Morris,	C.R.,	Daugherty,	S.C.,	Chibucos,	M.C.,	Sengamalay,	N.A.,	Fraser-Liggett,	 C.M.,	 Steinsland,	 H.,	 Whittam,	 T.S.,	 et	 al.	 (2012).	 Draft	 genome	 sequences	 of	 the	 diarrheagenic	Escherichia	coli	collection.	Journal	of	bacteriology	194,	3026-3027.	Heath,	D.G.,	 Anderson,	 G.W.,	 Jr.,	Mauro,	 J.M.,	Welkos,	 S.L.,	 Andrews,	 G.P.,	 Adamovicz,	 J.,	 and	 Friedlander,	A.M.	(1998).	Protection	against	experimental	bubonic	and	pneumonic	plague	by	a	recombinant	capsular	F1-V	antigen	fusion	protein	vaccine.	Vaccine	16,	1131-1137.	Hernday,	 A.,	 Krabbe,	 M.,	 Braaten,	 B.,	 and	 Low,	 D.	 (2002).	 Self-perpetuating	 epigenetic	 pili	 switches	 in	bacteria.	 Proceedings	 of	 the	 National	 Academy	 of	 Sciences	 of	 the	 United	 States	 of	 America	 99	 Suppl	 4,	16470-16476.	Hidalgo,	E.,	Leautaud,	V.,	and	Demple,	B.	(1998).	The	redox-regulated	SoxR	protein	acts	from	a	single	DNA	site	as	a	repressor	and	an	allosteric	activator.	The	EMBO	journal	17,	2629-2636.	Hinnebusch,	B.J.	 (2003).	Transmission	 factors:	Yersinia	pestis	genes	required	 to	 infect	 the	 flea	vector	of	plague.	Advances	in	experimental	medicine	and	biology	529,	55-62.	Hinnebusch,	B.J.	(2005).	The	evolution	of	flea-borne	transmission	in	Yersinia	pestis.	Curr	Issues	Mol	Biol	7,	197-212.	Hoe,	 N.P.,	 and	 Goguen,	 J.D.	 (1993).	 Temperature	 sensing	 in	 Yersinia	 pestis:	 translation	 of	 the	 LcrF	activator	protein	is	thermally	regulated.	Journal	of	bacteriology	175,	7901-7909.	Holden,	 N.J.,	 Totsika,	 M.,	 Mahler,	 E.,	 Roe,	 A.J.,	 Catherwood,	 K.,	 Lindner,	 K.,	 Dobrindt,	 U.,	 and	 Gally,	 D.L.	(2006).	Demonstration	of	regulatory	cross-talk	between	P	fimbriae	and	type	1	fimbriae	in	uropathogenic	Escherichia	coli.	Microbiology	152,	1143-1153.	
	 228	
Holden,	N.J.,	Uhlin,	B.E.,	and	Gally,	D.L.	(2001).	PapB	paralogues	and	their	effect	on	the	phase	variation	of	type	1	fimbriae	in	Escherichia	coli.	Molecular	microbiology	42,	319-330.	Hollander,	 A.,	 Mercante,	 A.D.,	 Shafer,	W.M.,	 and	 Cornelissen,	 C.N.	 (2011).	 The	 iron-repressed,	 AraC-like	regulator	MpeR	activates	expression	of	fetA	in	Neisseria	gonorrhoeae.	Infection	and	immunity	79,	4764-4776.	Hu,	 P.,	 Elliott,	 J.,	 McCready,	 P.,	 Skowronski,	 E.,	 Garnes,	 J.,	 Kobayashi,	 A.,	 Brubaker,	 R.R.,	 and	 Garcia,	 E.	(1998).	Structural	organization	of	virulence-associated	plasmids	of	Yersinia	pestis.	Journal	of	bacteriology	
180,	5192-5202.	Huang,	X.Z.,	and	Lindler,	L.E.	 (2004).	The	pH	6	antigen	 is	an	antiphagocytic	 factor	produced	by	Yersinia	pestis	independent	of	Yersinia	outer	proteins	and	capsule	antigen.	Infection	and	immunity	72,	7212-7219.	Huang,	Y.,	Smith,	B.S.,	Chen,	L.X.,	Baxter,	R.H.,	and	Deisenhofer,	J.	(2009).	Insights	into	pilus	assembly	and	secretion	 from	the	structure	and	 functional	 characterization	of	usher	PapC.	Proceedings	of	 the	National	Academy	of	Sciences	of	the	United	States	of	America	106,	7403-7407.	Hung,	 D.L.,	 Knight,	 S.D.,	 Woods,	 R.M.,	 Pinkner,	 J.S.,	 and	 Hultgren,	 S.J.	 (1996).	 Molecular	 basis	 of	 two	subfamilies	of	immunoglobulin-like	chaperones.	The	EMBO	journal	15,	3792-3805.	Hung,	D.L.,	Raivio,	T.L.,	Jones,	C.H.,	Silhavy,	T.J.,	and	Hultgren,	S.J.	(2001).	Cpx	signaling	pathway	monitors	biogenesis	and	affects	assembly	and	expression	of	P	pili.	The	EMBO	journal	20,	1508-1518.	Ibarra,	J.A.,	Perez-Rueda,	E.,	Segovia,	L.,	and	Puente,	J.L.	(2008).	The	DNA-binding	domain	as	a	functional	indicator:	the	case	of	the	AraC/XylS	family	of	transcription	factors.	Genetica	133,	65-76.	Inglesby,	T.V.,	Dennis,	D.T.,	Henderson,	D.A.,	Bartlett,	 J.G.,	Ascher,	M.S.,	Eitzen,	E.,	Fine,	A.D.,	Friedlander,	A.M.,	 Hauer,	 J.,	 Koerner,	 J.F.,	 et	 al.	 (2000).	 Plague	 as	 a	 biological	 weapon:	 medical	 and	 public	 health	management.	Working	Group	on	Civilian	Biodefense.	Jama	283,	2281-2290.	Iriarte,	M.,	and	Cornelis,	G.R.	(1995).	MyfF,	an	element	of	the	network	regulating	the	synthesis	of	fibrillae	in	Yersinia	enterocolitica.	Journal	of	bacteriology	177,	738-744.	Jair,	K.W.,	Fawcett,	W.P.,	Fujita,	N.,	Ishihama,	A.,	and	Wolf,	R.E.,	Jr.	(1996a).	Ambidextrous	transcriptional	activation	 by	 SoxS:	 requirement	 for	 the	 C-terminal	 domain	 of	 the	 RNA	 polymerase	 alpha	 subunit	 in	 a	subset	of	Escherichia	coli	superoxide-inducible	genes.	Molecular	microbiology	19,	307-317.	Jair,	 K.W.,	 Martin,	 R.G.,	 Rosner,	 J.L.,	 Fujita,	 N.,	 Ishihama,	 A.,	 and	Wolf,	 R.E.,	 Jr.	 (1995).	 Purification	 and	regulatory	properties	 of	MarA	protein,	 a	 transcriptional	 activator	 of	 Escherichia	 coli	multiple	 antibiotic	and	superoxide	resistance	promoters.	Journal	of	bacteriology	177,	7100-7104.	Jair,	K.W.,	Yu,	X.,	Skarstad,	K.,	Thony,	B.,	Fujita,	N.,	Ishihama,	A.,	and	Wolf,	R.E.,	Jr.	(1996b).	Transcriptional	activation	of	promoters	of	 the	 superoxide	and	multiple	antibiotic	 resistance	 regulons	by	Rob,	 a	binding	protein	of	the	Escherichia	coli	origin	of	chromosomal	replication.	Journal	of	bacteriology	178,	2507-2513.	Karlyshev,	 A.V.,	 Galyov,	 E.E.,	 Abramov,	 V.M.,	 and	 Zav'yalov,	 V.P.	 (1992).	 Caf1R	 gene	 and	 its	 role	 in	 the	regulation	of	capsule	formation	of	Y.	pestis.	FEBS	Lett	305,	37-40.	Ke,	Y.,	Chen,	Z.,	and	Yang,	R.	(2013).	Yersinia	pestis:	mechanisms	of	entry	into	and	resistance	to	the	host	cell.	Front	Cell	Infect	Microbiol	3,	106.	Kersley,	 J.E.,	Zavialov,	A.V.,	Moslehi,	E.,	Knight,	S.D.,	and	MacIntyre,	S.	(2003).	Mutagenesis	elucidates	the	assembly	pathway	and	structure	of	Yersinia	pestis	F1	polymer.	Advances	 in	experimental	medicine	and	biology	529,	113-116.	Kim,	 T.J.,	 Chauhan,	 S.,	 Motin,	 V.L.,	 Goh,	 E.B.,	 Igo,	 M.M.,	 and	 Young,	 G.M.	 (2007).	 Direct	 transcriptional	control	of	the	plasminogen	activator	gene	of	Yersinia	pestis	by	the	cyclic	AMP	receptor	protein.	Journal	of	bacteriology	189,	8890-8900.	
	 229	
King,	J.M.,	Schesser	Bartra,	S.,	Plano,	G.,	and	Yahr,	T.L.	(2013).	ExsA	and	LcrF	recognize	similar	consensus	binding	sites,	but	differences	in	their	oligomeric	state	influence	interactions	with	promoter	DNA.	Journal	of	bacteriology	195,	5639-5650.	Klaasen,	P.,	and	de	Graaf,	F.K.	(1990).	Characterization	of	FapR,	a	positive	regulator	of	expression	of	the	987P	operon	in	enterotoxigenic	Escherichia	coli.	Molecular	microbiology	4,	1779-1783.	Klinkert,	B.,	Cimdins,	A.,	Gaubig,	L.C.,	Rossmanith,	 J.,	Aschke-Sonnenborn,	U.,	 and	Narberhaus,	F.	 (2012).	Thermogenetic	tools	to	monitor	temperature-dependent	gene	expression	in	bacteria.	J	Biotechnol	160,	55-63.	Knight,	 S.D.	 (2007).	 Structure	 and	 assembly	 of	 Yersinia	 pestis	 F1	 antigen.	 Advances	 in	 experimental	medicine	and	biology	603,	74-87.	Kolin,	A.,	Balasubramaniam,	V.,	Skredenske,	J.M.,	Wickstrum,	J.R.,	and	Egan,	S.M.	(2008).	Differences	in	the	mechanism	of	the	allosteric	 l-rhamnose	responses	of	the	AraC/XylS	family	transcription	activators	RhaS	and	RhaR.	Molecular	microbiology	68,	448-461.	Korzheva,	 N.,	Mustaev,	 A.,	 Kozlov,	M.,	Malhotra,	 A.,	 Nikiforov,	 V.,	 Goldfarb,	 A.,	 and	 Darst,	 S.A.	 (2000).	 A	structural	model	of	transcription	elongation.	Science	289,	619-625.	Kouse,	 A.B.,	 Righetti,	 F.,	 Kortmann,	 J.,	 Narberhaus,	 F.,	 and	 Murphy,	 E.R.	 (2013).	 RNA-mediated	thermoregulation	of	iron-acquisition	genes	in	Shigella	dysenteriae	and	pathogenic	Escherichia	coli.	PLoS	One	8,	e63781.	Kukkonen,	 M.,	 and	 Korhonen,	 T.K.	 (2004).	 The	 omptin	 family	 of	 enterobacterial	 surface	proteases/adhesins:	from	housekeeping	in	Escherichia	coli	to	systemic	spread	of	Yersinia	pestis.	Int	J	Med	Microbiol	294,	7-14.	Kwon,	H.J.,	Bennik,	M.H.,	Demple,	B.,	and	Ellenberger,	T.	 (2000).	Crystal	structure	of	 the	Escherichia	coli	Rob	transcription	factor	in	complex	with	DNA.	Nat	Struct	Biol	7,	424-430.	Laemmli,	U.K.	 (1970).	Cleavage	of	 structural	proteins	during	 the	assembly	of	 the	head	of	bacteriophage	T4.	Nature	227,	680-685.	Lahteenmaki,	K.,	Kukkonen,	M.,	and	Korhonen,	T.K.	(2001).	The	Pla	surface	protease/adhesin	of	Yersinia	pestis	mediates	bacterial	invasion	into	human	endothelial	cells.	FEBS	Lett	504,	69-72.	Ledent,	P.,	Duez,	C.,	Vanhove,	M.,	Lejeune,	A.,	Fonze,	E.,	Charlier,	P.,	Rhazi-Filali,	F.,	Thamm,	I.,	Guillaume,	G.,	Samyn,	 B.,	 et	 al.	 (1997).	 Unexpected	 influence	 of	 a	 C-terminal-fused	 His-tag	 on	 the	 processing	 of	 an	enzyme	and	on	the	kinetic	and	folding	parameters.	FEBS	Lett	413,	194-196.	Lee,	 S.,	Nam,	D.,	 Jung,	 J.Y.,	Oh,	M.K.,	 Sang,	B.I.,	 and	Mitchell,	R.J.	 (2012).	 Identification	of	Escherichia	 coli	biomarkers	responsive	to	various	lignin-hydrolysate	compounds.	Bioresour	Technol	114,	450-456.	Li,	B.,	Tan,	Y.,	Guo,	J.,	Cui,	B.,	Wang,	Z.,	Wang,	H.,	Zhou,	L.,	Guo,	Z.,	Zhu,	Z.,	Du,	Z.,	et	al.	(2011).	Use	of	protein	microarray	 to	 identify	 gene	 expression	 changes	 of	 Yersinia	 pestis	 at	 different	 temperatures.	 Can	 J	Microbiol	57,	287-294.	Li,	Y.,	Gao,	H.,	Qin,	L.,	Li,	B.,	Han,	Y.,	Guo,	Z.,	Song,	Y.,	Zhai,	J.,	Du,	Z.,	Wang,	X.,	et	al.	(2008).	Identification	and	characterization	of	PhoP	regulon	members	in	Yersinia	pestis	biovar	Microtus.	BMC	Genomics	9,	143.	Lindler,	L.E.,	Plano,	G.V.,	Burland,	V.,	Mayhew,	G.F.,	and	Blattner,	F.R.	(1998).	Complete	DNA	sequence	and	detailed	 analysis	 of	 the	 Yersinia	 pestis	 KIM5	 plasmid	 encoding	 murine	 toxin	 and	 capsular	 antigen.	Infection	and	immunity	66,	5731-5742.	Lisser,	 S.,	 and	 Margalit,	 H.	 (1993).	 Compilation	 of	 E.	 coli	 mRNA	 promoter	 sequences.	 Nucleic	 acids	research	21,	1507-1516.	Livingstone,	 C.D.,	 and	 Barton,	 G.J.	 (1993).	 Protein	 sequence	 alignments:	 a	 strategy	 for	 the	 hierarchical	analysis	of	residue	conservation.	Comput	Appl	Biosci	9,	745-756.	
	 230	
Loh,	 E.,	 Dussurget,	 O.,	 Gripenland,	 J.,	 Vaitkevicius,	 K.,	 Tiensuu,	 T.,	Mandin,	 P.,	 Repoila,	 F.,	 Buchrieser,	 C.,	Cossart,	 P.,	 and	 Johansson,	 J.	 (2009).	 A	 trans-acting	 riboswitch	 controls	 expression	 of	 the	 virulence	regulator	PrfA	in	Listeria	monocytogenes.	Cell	139,	770-779.	Loh,	 E.,	 Kugelberg,	 E.,	 Tracy,	 A.,	 Zhang,	 Q.,	 Gollan,	 B.,	 Ewles,	 H.,	 Chalmers,	 R.,	 Pelicic,	 V.,	 and	 Tang,	 C.M.	(2013).	Temperature	triggers	immune	evasion	by	Neisseria	meningitidis.	Nature	502,	237-240.	Lowden,	M.J.,	Skorupski,	K.,	Pellegrini,	M.,	Chiorazzo,	M.G.,	Taylor,	R.K.,	and	Kull,	F.J.	 (2010).	Structure	of	Vibrio	cholerae	ToxT	reveals	a	mechanism	for	fatty	acid	regulation	of	virulence	genes.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	107,	2860-2865.	Lu,	Y.,	Flaherty,	C.,	and	Hendrickson,	W.	(1992).	AraC	protein	contacts	asymmetric	sites	in	the	Escherichia	coli	araFGH	promoter.	The	Journal	of	biological	chemistry	267,	24848-24857.	Lukaszewski,	R.A.,	Kenny,	D.J.,	Taylor,	R.,	Rees,	D.G.,	Hartley,	M.G.,	and	Oyston,	P.C.	(2005).	Pathogenesis	of	Yersinia	 pestis	 infection	 in	 BALB/c	 mice:	 effects	 on	 host	 macrophages	 and	 neutrophils.	 Infection	 and	immunity	73,	7142-7150.	Macinga,	 D.R.,	 Paradise,	 M.R.,	 Parojcic,	 M.M.,	 and	 Rather,	 P.N.	 (1999).	 Activation	 of	 the	 2'-N-acetyltransferase	 gene	 [aac(2')-Ia]	 in	 Providencia	 stuartii	 by	 an	 interaction	 of	 AarP	with	 the	 promoter	region.	Antimicrobial	agents	and	chemotherapy	43,	1769-1772.	MacIntyre,	S.,	Knight,	S.D.	and	Fooks,	L.J.	(2004).	Structure,	assembly	and	applications	of	the	polymeric	F1	antigen	of	Yersinia	pestis.	In	Yersinia:	Molecular	and	Cellular	Biology	ed		Carniel,	E	and	Hinnenbusch,	BJ	Norfolk,	UK:	Horizon	Bioscience,	363-407.	MacIntyre,	 S.,	 Zyrianova,	 I.M.,	 Chernovskaya,	 T.V.,	 Leonard,	 M.,	 Rudenko,	 E.G.,	 Zav'Yalov,	 V.P.,	 and	Chapman,	D.A.	(2001).	An	extended	hydrophobic	interactive	surface	of	Yersinia	pestis	Caf1M	chaperone	is	essential	for	subunit	binding	and	F1	capsule	assembly.	Molecular	microbiology	39,	12-25.	Madrid,	 C.,	 Balsalobre,	 C.,	 Garcia,	 J.,	 and	 Juarez,	 A.	 (2007).	 The	 novel	 Hha/YmoA	 family	 of	 nucleoid-associated	 proteins:	 use	 of	 structural	mimicry	 to	modulate	 the	 activity	 of	 the	 H-NS	 family	 of	 proteins.	Molecular	microbiology	63,	7-14.	Madrid,	 C.,	 Nieto,	 J.M.,	 and	 Juarez,	 A.	 (2002).	 Role	 of	 the	 Hha/YmoA	 family	 of	 proteins	 in	 the	thermoregulation	of	the	expression	of	virulence	factors.	Int	J	Med	Microbiol	291,	425-432.	Mahon,	V.,	Fagan,	R.P.,	and	Smith,	S.G.	(2012).	Snap	denaturation	reveals	dimerization	by	AraC-like	protein	Rns.	Biochimie	94,	2058-2061.	Mahon,	 V.,	 Smyth,	 C.J.,	 and	 Smith,	 S.G.	 (2010).	 Mutagenesis	 of	 the	 Rns	 regulator	 of	 enterotoxigenic	Escherichia	 coli	 reveals	 roles	 for	 a	 linker	 sequence	 and	 two	 helix-turn-helix	 motifs.	 Microbiology	 156,	2796-2806.	Makhatadze,	G.I.,	and	Privalov,	P.L.	(1995).	Energetics	of	protein	structure.	Adv	Protein	Chem	47,	307-425.	Marketon,	M.M.,	DePaolo,	R.W.,	DeBord,	K.L.,	 Jabri,	B.,	and	Schneewind,	O.	(2005).	Plague	bacteria	target	immune	cells	during	infection.	Science	309,	1739-1741.	Martin,	R.G.,	Gillette,	W.K.,	Martin,	N.I.,	and	Rosner,	J.L.	(2002).	Complex	formation	between	activator	and	RNA	 polymerase	 as	 the	 basis	 for	 transcriptional	 activation	 by	 MarA	 and	 SoxS	 in	 Escherichia	 coli.	Molecular	microbiology	43,	355-370.	Martin,	R.G.,	Gillette,	W.K.,	Rhee,	S.,	and	Rosner,	J.L.	(1999).	Structural	requirements	for	marbox	function	in	transcriptional	 activation	 of	mar/sox/rob	 regulon	 promoters	 in	 Escherichia	 coli:	 sequence,	 orientation	and	spatial	relationship	to	the	core	promoter.	Molecular	microbiology	34,	431-441.	Martin,	 R.G.,	 Jair,	 K.W.,	 Wolf,	 R.E.,	 Jr.,	 and	 Rosner,	 J.L.	 (1996).	 Autoactivation	 of	 the	 marRAB	 multiple	antibiotic	 resistance	 operon	 by	 the	 MarA	 transcriptional	 activator	 in	 Escherichia	 coli.	 Journal	 of	bacteriology	178,	2216-2223.	
	 231	
Martin,	R.G.,	and	Rosner,	 J.L.	 (1995).	Binding	of	purified	multiple	antibiotic-resistance	repressor	protein	(MarR)	to	mar	operator	sequences.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	92,	5456-5460.	Martin,	 R.G.,	 and	 Rosner,	 J.L.	 (1997).	 Fis,	 an	 accessorial	 factor	 for	 transcriptional	 activation	 of	 the	mar	(multiple	antibiotic	resistance)	promoter	of	Escherichia	coli	in	the	presence	of	the	activator	MarA,	SoxS,	or	Rob.	Journal	of	bacteriology	179,	7410-7419.	Martin,	R.G.,	and	Rosner,	J.L.	(2001).	The	AraC	transcriptional	activators.	Curr	Opin	Microbiol	4,	132-137.	Martin,	 R.G.,	 and	 Rosner,	 J.L.	 (2002).	 Genomics	 of	 the	 marA/soxS/rob	 regulon	 of	 Escherichia	 coli:	identification	 of	 directly	 activated	 promoters	 by	 application	 of	 molecular	 genetics	 and	 informatics	 to	microarray	data.	Molecular	microbiology	44,	1611-1624.	Martinez-Antonio,	 A.,	 and	 Collado-Vides,	 J.	 (2003).	 Identifying	 global	 regulators	 in	 transcriptional	regulatory	networks	in	bacteria.	Curr	Opin	Microbiol	6,	482-489.	Mathew,	R.,	and	Chatterji,	D.	(2006).	The	evolving	story	of	the	omega	subunit	of	bacterial	RNA	polymerase.	Trends	Microbiol	14,	450-455.	Matsunaga,	J.,	Schlax,	P.J.,	and	Haake,	D.A.	(2013).	Role	for	cis-acting	RNA	sequences	in	the	temperature-dependent	expression	of	the	multiadhesive	lig	proteins	in	Leptospira	interrogans.	Journal	of	bacteriology	
195,	5092-5101.	McGuffin,	L.J.,	Atkins,	J.D.,	Salehe,	B.R.,	Shuid,	A.N.,	and	Roche,	D.B.	(2015).	IntFOLD:	an	integrated	server	for	modelling	protein	structures	and	functions	from	amino	acid	sequences.	Nucleic	acids	research	43,	169-173.	McGuffin,	 L.J.,	 Bryson,	 K.,	 and	 Jones,	 D.T.	 (2000).	 The	 PSIPRED	 protein	 structure	 prediction	 server.	Bioinformatics	16,	404-405.	McMurry,	L.M.,	and	Levy,	S.B.	(2010).	Evidence	that	regulatory	protein	MarA	of	Escherichia	coli	represses	rob	by	steric	hindrance.	Journal	of	bacteriology	192,	3977-3982.	Merrick,	M.J.	(1993).	In	a	class	of	its	own--the	RNA	polymerase	sigma	factor	sigma	54	(sigma	N).	Molecular	microbiology	10,	903-909.	Michan,	 C.,	Manchado,	M.,	 and	Pueyo,	 C.	 (2002).	 SoxRS	down-regulation	of	 rob	 transcription.	 Journal	 of	bacteriology	184,	4733-4738.	Miller,	 J.,	Williamson,	E.D.,	Lakey,	 J.H.,	Pearce,	M.J.,	 Jones,	S.M.,	 and	Titball,	R.W.	 (1998).	Macromolecular	organisation	 of	 recombinant	 Yersinia	 pestis	 F1	 antigen	 and	 the	 effect	 of	 structure	 on	 immunogenicity.	FEMS	Immunol	Med	Microbiol	21,	213-221.	Miller,	V.L.,	Beer,	K.B.,	Heusipp,	G.,	Young,	B.M.,	and	Wachtel,	M.R.	(2001).	 Identification	of	regions	of	Ail	required	for	the	invasion	and	serum	resistance	phenotypes.	Molecular	microbiology	41,	1053-1062.	Morelli,	G.,	Song,	Y.,	Mazzoni,	C.J.,	Eppinger,	M.,	Roumagnac,	P.,	Wagner,	D.M.,	Feldkamp,	M.,	Kusecek,	B.,	Vogler,	 A.J.,	 Li,	 Y.,	 et	 al.	 (2010).	 Yersinia	 pestis	 genome	 sequencing	 identifies	 patterns	 of	 global	phylogenetic	diversity.	Nat	Genet	42,	1140-1143.	Morin,	 N.,	 Santiago,	 A.E.,	 Ernst,	 R.K.,	 Guillot,	 S.J.,	 and	 Nataro,	 J.P.	 (2013).	 Characterization	 of	 the	 AggR	regulon	in	enteroaggregative	Escherichia	coli.	Infection	and	immunity	81,	122-132.	Morin,	 N.,	 Tirling,	 C.,	 Ivison,	 S.M.,	 Kaur,	 A.P.,	 Nataro,	 J.P.,	 and	 Steiner,	 T.S.	 (2010).	 Autoactivation	 of	 the	AggR	regulator	of	enteroaggregative	Escherichia	coli	 in	vitro	and	in	vivo.	FEMS	Immunol	Med	Microbiol	
58,	344-355.	Motin,	V.L.,	Georgescu,	A.M.,	Fitch,	J.P.,	Gu,	P.P.,	Nelson,	D.O.,	Mabery,	S.L.,	Garnham,	J.B.,	Sokhansanj,	B.A.,	Ott,	 L.L.,	 Coleman,	M.A.,	 et	 al.	 (2004).	 Temporal	 global	 changes	 in	 gene	 expression	 during	 temperature	transition	in	Yersinia	pestis.	Journal	of	bacteriology	186,	6298-6305.	
	 232	
Motin,	 V.L.,	 Nakajima,	 R.,	 Smirnov,	 G.B.,	 and	 Brubaker,	 R.R.	 (1994).	 Passive	 immunity	 to	 yersiniae	mediated	by	anti-recombinant	V	antigen	and	protein	A-V	antigen	fusion	peptide.	Infection	and	immunity	
62,	4192-4201.	Muller-Hill,	B.	(1998).	Some	repressors	of	bacterial	transcription.	Curr	Opin	Microbiol	1,	145-151.	Munson,	G.P.,	Holcomb,	L.G.,	Alexander,	H.L.,	and	Scott,	J.R.	(2002).	In	vitro	identification	of	Rns-regulated	genes.	Journal	of	bacteriology	184,	1196-1199.	Munson,	 G.P.,	 and	 Scott,	 J.R.	 (1999).	 Binding	 site	 recognition	 by	 Rns,	 a	 virulence	 regulator	 in	 the	 AraC	family.	Journal	of	bacteriology	181,	2110-2117.	Munson,	G.P.,	 and	Scott,	 J.R.	 (2000).	Rns,	 a	 virulence	 regulator	within	 the	AraC	 family,	 requires	binding	sites	upstream	and	downstream	of	its	own	promoter	to	function	as	an	activator.	Molecular	microbiology	
36,	1391-1402.	Murakami,	 K.S.,	 Masuda,	 S.,	 Campbell,	 E.A.,	 Muzzin,	 O.,	 and	 Darst,	 S.A.	 (2002).	 Structural	 basis	 of	transcription	initiation:	an	RNA	polymerase	holoenzyme-DNA	complex.	Science	296,	1285-1290.	Murphy,	 J.R.,	 Donini,	 S.,	 and	 Kappock,	 T.J.	 (2015).	 An	 active	 site-tail	 interaction	 in	 the	 structure	 of	hexahistidine-tagged	 Thermoplasma	 acidophilum	 citrate	 synthase.	 Acta	 Crystallographica	 Section	 F:	Structural	Biology	Communications	71(10),	1292–1299.	Mycroft,	Z.	(2011).	The	role	of	the	Caf1A	outer	membrane	usher	in	the	production	of	F1	surface	fibres	of	Yersinia	pestis	In	School	of	Biological	Sciences	(University	of	Reading,	UK).	Nataro,	J.P.,	Yikang,	D.,	Yingkang,	D.,	and	Walker,	K.	(1994).	AggR,	a	transcriptional	activator	of	aggregative	adherence	 fimbria	 I	expression	 in	enteroaggregative	Escherichia	coli.	 Journal	of	bacteriology	176,	4691-4699.	Ni,	 L.,	 Tonthat,	 N.K.,	 Chinnam,	 N.,	 and	 Schumacher,	 M.A.	 (2013).	 Structures	 of	 the	 Escherichia	 coli	transcription	 activator	 and	 regulator	 of	 diauxie,	 XylR:	 an	 AraC	 DNA-binding	 family	 member	 with	 a	LacI/GalR	ligand-binding	domain.	Nucleic	acids	research	41,	1998-2008.	Ninh,	A.	(2011).	First	Case	of	Bubonic	Plague	in	2011	Appears	in	New	Mexico.	In	TIME	(TIME).	Noteborn,	 C.H.S.a.M.H.M.	 (1988).	 Formation	 of	 Soluble	 Recombinant	 Proteins	 in	 Escherichia	 Coli	 is	Favored	by	Lower	Growth	Temperature.	Nature	Biotechnology	6,	291	-	294.	Nou,	X.,	Braaten,	B.,	Kaltenbach,	L.,	and	Low,	D.A.	(1995).	Differential	binding	of	Lrp	to	two	sets	of	pap	DNA	binding	sites	mediated	by	Pap	I	regulates	Pap	phase	variation	 in	Escherichia	coli.	The	EMBO	journal	14,	5785-5797.	Nou,	 X.,	 Skinner,	 B.,	 Braaten,	 B.,	 Blyn,	 L.,	 Hirsch,	 D.,	 and	 Low,	 D.	 (1993).	 Regulation	 of	 pyelonephritis-associated	pili	phase-variation	in	Escherichia	coli:	binding	of	the	PapI	and	the	Lrp	regulatory	proteins	is	controlled	by	DNA	methylation.	Molecular	microbiology	7,	545-553.	Nuccio,	 S.P.,	 and	 Baumler,	 A.J.	 (2007).	 Evolution	 of	 the	 chaperone/usher	 assembly	 pathway:	 fimbrial	classification	goes	Greek.	Microbiology	and	molecular	biology	reviews	:	MMBR	71,	551-575.	Nunoshiba,	T.,	Hidalgo,	E.,	Amabile	Cuevas,	C.F.,	and	Demple,	B.	(1992).	Two-stage	control	of	an	oxidative	stress	 regulon:	 the	 Escherichia	 coli	 SoxR	 protein	 triggers	 redox-inducible	 expression	 of	 the	 soxS	regulatory	gene.	Journal	of	bacteriology	174,	6054-6060.	Nunoshiba,	T.,	Hidalgo,	E.,	 Li,	Z.,	 and	Demple,	B.	 (1993).	Negative	autoregulation	by	 the	Escherichia	 coli	SoxS	protein:	a	dampening	mechanism	for	the	soxRS	redox	stress	response.	 Journal	of	bacteriology	175,	7492-7494.	Ogden,	 S.,	 Haggerty,	 D.,	 Stoner,	 C.M.,	 Kolodrubetz,	 D.,	 and	 Schleif,	 R.	 (1980).	 The	 Escherichia	 coli	 L-arabinose	 operon:	 binding	 sites	 of	 the	 regulatory	 proteins	 and	 a	 mechanism	 of	 positive	 and	 negative	regulation.	 Proceedings	 of	 the	National	 Academy	 of	 Sciences	 of	 the	United	 States	 of	 America	77,	 3346-3350.	
	 233	
Okusu,	H.,	Ma,	D.,	and	Nikaido,	H.	(1996).	AcrAB	efflux	pump	plays	a	major	role	in	the	antibiotic	resistance	phenotype	 of	 Escherichia	 coli	multiple-antibiotic-resistance	 (Mar)	mutants.	 Journal	 of	 bacteriology	178,	306-308.	Olsen,	P.B.,	and	Klemm,	P.	(1994).	Localization	of	promoters	in	the	fim	gene	cluster	and	the	effect	of	H-NS	on	the	transcription	of	fimB	and	fimE.	FEMS	microbiology	letters	116,	95-100.	Olsen,	P.B.,	Schembri,	M.A.,	Gally,	D.L.,	and	Klemm,	P.	(1998).	Differential	temperature	modulation	by	H-NS	of	the	fimB	and	fimE	recombinase	genes	which	control	the	orientation	of	the	type	1	fimbrial	phase	switch.	FEMS	microbiology	letters	162,	17-23.	Otto,	K.,	and	Silhavy,	T.J.	(2002).	Surface	sensing	and	adhesion	of	Escherichia	coli	controlled	by	the	Cpx-signaling	pathway.	Proceedings	of	 the	National	Academy	of	Sciences	of	 the	United	States	of	America	99,	2287-2292.	Parkhill,	J.,	Wren,	B.W.,	Thomson,	N.R.,	Titball,	R.W.,	Holden,	M.T.,	Prentice,	M.B.,	Sebaihia,	M.,	James,	K.D.,	Churcher,	C.,	Mungall,	K.L.,	et	al.	(2001).	Genome	sequence	of	Yersinia	pestis,	the	causative	agent	of	plague.	Nature	413,	523-527.	Paul,	 B.J.,	 Berkmen,	 M.B.,	 and	 Gourse,	 R.L.	 (2005).	 DksA	 potentiates	 direct	 activation	 of	 amino	 acid	promoters	by	ppGpp.	Proceedings	of	 the	National	Academy	of	 Sciences	 of	 the	United	 States	 of	America	
102,	7823-7828.	Perez-Rueda,	E.,	and	Collado-Vides,	J.	(2000).	The	repertoire	of	DNA-binding	transcriptional	regulators	in	Escherichia	coli	K-12.	Nucleic	acids	research	28,	1838-1847.	Perez-Rueda,	E.,	Tenorio-Salgado,	S.,	Huerta-Saquero,	A.,	Balderas-Martinez,	Y.I.,	and	Moreno-Hagelsieb,	G.	(2015).	The	functional	landscape	bound	to	the	transcription	factors	of	Escherichia	coli	K-12.	Comput	Biol	Chem	58,	93-103.	Perry,	R.D.,	 and	Fetherston,	 J.D.	 (1997).	Yersinia	pestis--etiologic	agent	of	plague.	Clin	Microbiol	Rev	10,	35-66.	Peruski,	 L.F.,	 Jr.,	Kay,	B.A.,	 El-Yazeed,	R.A.,	 El-Etr,	 S.H.,	 Cravioto,	A.,	Wierzba,	T.F.,	Rao,	M.,	 El-Ghorab,	N.,	Shaheen,	H.,	Khalil,	S.B.,	et	al.	(1999).	Phenotypic	diversity	of	enterotoxigenic	Escherichia	coli	strains	from	a	 community-based	 study	 of	 pediatric	 diarrhea	 in	 periurban	 Egypt.	 Journal	 of	 clinical	microbiology	 37,	2974-2978.	Pettersson,	J.,	Holmstrom,	A.,	Hill,	J.,	Leary,	S.,	Frithz-Lindsten,	E.,	von	Euler-Matell,	A.,	Carlsson,	E.,	Titball,	R.,	Forsberg,	A.,	and	Wolf-Watz,	H.	(1999).	The	V-antigen	of	Yersinia	is	surface	exposed	before	target	cell	contact	and	involved	in	virulence	protein	translocation.	Molecular	microbiology	32,	961-976.	Phan,	G.,	Remaut,	H.,	Wang,	T.,	Allen,	W.J.,	Pirker,	K.F.,	Lebedev,	A.,	Henderson,	N.S.,	Geibel,	S.,	Volkan,	E.,	Yan,	J.,	et	al.	(2011).	Crystal	structure	of	the	FimD	usher	bound	to	its	cognate	FimC-FimH	substrate.	Nature	
474,	49-53.	Pich,	O.Q.,	Carpenter,	B.M.,	Gilbreath,	J.J.,	and	Merrell,	D.S.	(2012).	Detailed	analysis	of	Helicobacter	pylori	Fur-regulated	 promoters	 reveals	 a	 Fur	 box	 core	 sequence	 and	 novel	 Fur-regulated	 genes.	 Molecular	microbiology	84,	921-941.	Pichel,	 M.,	 Binsztein,	 N.,	 and	 Viboud,	 G.	 (2000).	 CS22,	 a	 novel	 human	 enterotoxigenic	 Escherichia	 coli	adhesin,	is	related	to	CS15.	Infection	and	immunity	68,	3280-3285.	Pilonieta,	 M.C.,	 Bodero,	 M.D.,	 and	 Munson,	 G.P.	 (2007).	 CfaD-dependent	 expression	 of	 a	 novel	extracytoplasmic	protein	from	enterotoxigenic	Escherichia	coli.	Journal	of	bacteriology	189,	5060-5067.	Plano,	G.V.,	 and	Schesser,	K.	 (2013).	The	Yersinia	pestis	 type	 III	 secretion	 system:	expression,	 assembly	and	role	in	the	evasion	of	host	defenses.	Immunol	Res	57,	237-245.	Plumbridge,	 J.	 (2002).	 Regulation	 of	 gene	 expression	 in	 the	 PTS	 in	 Escherichia	 coli:	 the	 role	 and	interactions	of	Mlc.	Curr	Opin	Microbiol	5,	187-193.	
	 234	
Pomposiello,	 P.J.,	 Bennik,	 M.H.,	 and	 Demple,	 B.	 (2001).	 Genome-wide	 transcriptional	 profiling	 of	 the	Escherichia	coli	responses	to	superoxide	stress	and	sodium	salicylate.	Journal	of	bacteriology	183,	3890-3902.	Porter,	 M.E.,	 Mitchell,	 P.,	 Roe,	 A.J.,	 Free,	 A.,	 Smith,	 D.G.,	 and	 Gally,	 D.L.	 (2004).	 Direct	 and	 indirect	transcriptional	 activation	 of	 virulence	 genes	 by	 an	 AraC-like	 protein,	 PerA	 from	 enteropathogenic	Escherichia	coli.	Molecular	microbiology	54,	1117-1133.	Prentice,	M.B.,	James,	K.D.,	Parkhill,	J.,	Baker,	S.G.,	Stevens,	K.,	Simmonds,	M.N.,	Mungall,	K.L.,	Churcher,	C.,	Oyston,	P.C.,	Titball,	R.W.,	et	al.	(2001).	Yersinia	pestis	pFra	shows	biovar-specific	differences	and	recent	common	ancestry	with	a	Salmonella	 enterica	 serovar	Typhi	plasmid.	 Journal	of	bacteriology	183,	 2586-2594.	Pujol,	 C.,	 and	 Bliska,	 J.B.	 (2005).	 Turning	 Yersinia	 pathogenesis	 outside	 in:	 subversion	 of	 macrophage	function	by	intracellular	yersiniae.	Clin	Immunol	114,	216-226.	Quade,	N.,	Mendonca,	C.,	Herbst,	K.,	Heroven,	A.K.,	Ritter,	C.,	Heinz,	D.W.,	and	Dersch,	P.	(2012).	Structural	basis	 for	 intrinsic	 thermosensing	 by	 the	 master	 virulence	 regulator	 RovA	 of	 Yersinia.	 The	 Journal	 of	biological	chemistry	287,	35796-35803.	Quenee,	L.E.,	Ciletti,	N.,	Berube,	B.,	Krausz,	T.,	Elli,	D.,	Hermanas,	T.,	and	Schneewind,	O.	(2011).	Plague	in	Guinea	pigs	and	its	prevention	by	subunit	vaccines.	Am	J	Pathol	178,	1689-1700.	Quenee,	L.E.,	Cornelius,	C.A.,	Ciletti,	N.A.,	Elli,	D.,	and	Schneewind,	O.	(2008).	Yersinia	pestis	caf1	variants	and	the	limits	of	plague	vaccine	protection.	Infection	and	immunity	76,	2025-2036.	Quinn,	B.	 (2012).	Oregon	man	 recovering	 from	 rare	 case	of	 the	plague.	The	Guardian,	United	Kingdom.	http://www.theguardian.com/world/2012/jul/18/oregon-man-case-plague.	Rakin,	A.,	Boolgakowa,	E.,	and	Heesemann,	J.	(1996).	Structural	and	functional	organization	of	the	Yersinia	pestis	bacteriocin	pesticin	gene	cluster.	Microbiology	142	(	Pt	12),	3415-3424.	Reed,	W.P.,	 Palmer,	 D.L.,	Williams,	 R.C.,	 Jr.,	 and	 Kisch,	 A.L.	 (1970).	 Bubonic	 plague	 in	 the	 Southwestern	United	States.	A	review	of	recent	experience.	Medicine	(Baltimore)	49,	465-486.	Remaut,	H.,	Tang,	C.,	Henderson,	N.S.,	Pinkner,	J.S.,	Wang,	T.,	Hultgren,	S.J.,	Thanassi,	D.G.,	Waksman,	G.,	and	Li,	H.	(2008).	Fiber	formation	across	the	bacterial	outer	membrane	by	the	chaperone/usher	pathway.	Cell	
133,	640-652.	Reuter,	S.,	Connor,	T.R.,	Barquist,	L.,	Walker,	D.,	Feltwell,	T.,	Harris,	S.R.,	Fookes,	M.,	Hall,	M.E.,	Petty,	N.K.,	Fuchs,	 T.M.,	 et	 al.	 (2014).	 Parallel	 independent	 evolution	 of	 pathogenicity	 within	 the	 genus	 Yersinia.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	111,	6768-6773.	Rhee,	S.,	Martin,	R.G.,	Rosner,	 J.L.,	and	Davies,	D.R.	 (1998).	A	novel	DNA-binding	motif	 in	MarA:	 the	 first	structure	for	an	AraC	family	transcriptional	activator.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	95,	10413-10418.	Rice,	 P.A.,	 Yang,	 S.,	 Mizuuchi,	 K.,	 and	 Nash,	 H.A.	 (1996).	 Crystal	 structure	 of	 an	 IHF-DNA	 complex:	 a	protein-induced	DNA	U-turn.	Cell	87,	1295-1306.	Righetti,	F.,	and	Narberhaus,	F.	(2014).	How	to	find	RNA	thermometers.	Front	Cell	Infect	Microbiol	4,	1-6.	Robichon,	 C.,	 Luo,	 J.,	 Causey,	 T.B.,	 Benner,	 J.S.,	 and	 Samuelson,	 J.C.	 (2011).	 Engineering	 Escherichia	 coli	BL21(DE3)	derivative	strains	to	minimize	E.	coli	protein	contamination	after	purification	by	immobilized	metal	affinity	chromatography.	Appl	Environ	Microbiol	77,	4634-4646.	Roche,	D.B.,	Buenavista,	M.T.,	Tetchner,	S.J.,	and	McGuffin,	L.J.	(2011).	The	IntFOLD	server:	an	integrated	web	 resource	 for	 protein	 fold	 recognition,	 3D	model	 quality	 assessment,	 intrinsic	 disorder	 prediction,	domain	prediction	and	ligand	binding	site	prediction.	Nucleic	acids	research	39,	W171-176.	
	 235	
Rocke,	T.E.,	Smith,	S.,	Marinari,	P.,	Kreeger,	J.,	Enama,	J.T.,	and	Powell,	B.S.	(2008).	Vaccination	with	F1-V	fusion	 protein	 protects	 black-footed	 ferrets	 (Mustela	 nigripes)	 against	 plague	 upon	 oral	 challenge	with	Yersinia	pestis.	J	Wildl	Dis	44,	1-7.	Rodgers,	M.E.,	 Holder,	 N.D.,	 Dirla,	 S.,	 and	 Schleif,	 R.	 (2009).	 Functional	modes	 of	 the	 regulatory	 arm	 of	AraC.	Proteins	74,	81-91.	Rojas,	T.C.,	Maluta,	R.P.,	Parizzi,	L.P.,	Koenigkan,	L.V.,	Yang,	J.,	Yu,	J.,	Pereira,	G.A.,	and	Dias	da	Silveira,	W.	(2013).	 Genome	 Sequences	 of	 Avian	 Pathogenic	 Escherichia	 coli	 Strains	 Isolated	 from	 Brazilian	Commercial	Poultry.	Genome	Announc	1,	e0011013.	Rollins,	S.E.,	Rollins,	S.M.,	and	Ryan,	E.T.	(2003).	Yersinia	pestis	and	the	plague.	Am	J	Clin	Pathol	119	Suppl,	S78-85.	Rosano,	G.L.,	and	Ceccarelli,	E.A.	(2009).	Rare	codon	content	affects	the	solubility	of	recombinant	proteins	in	a	codon	bias-adjusted	Escherichia	coli	strain.	Microb	Cell	Fact	8,	41.	Rosano,	 G.L.,	 and	 Ceccarelli,	 E.A.	 (2014).	 Recombinant	 protein	 expression	 in	 Escherichia	 coli:	 advances	and	challenges.	Front	Microbiol	5,	172.	Rosenberg,	E.Y.,	Bertenthal,	D.,	Nilles,	M.L.,	Bertrand,	K.P.,	and	Nikaido,	H.	(2003).	Bile	salts	and	fatty	acids	induce	the	expression	of	Escherichia	coli	AcrAB	multidrug	efflux	pump	through	their	interaction	with	Rob	regulatory	protein.	Molecular	microbiology	48,	1609-1619.	Rosenstein,	 R.,	 Nikoleit,	 K.,	 and	 Gotz,	 F.	 (1994).	 Binding	 of	 ArsR,	 the	 repressor	 of	 the	 Staphylococcus	xylosus	(pSX267)	arsenic	resistance	operon	to	a	sequence	with	dyad	symmetry	within	the	ars	promoter.	Molecular	&	general	genetics	:	MGG	242,	566-572.	Rosner,	 J.L.,	 Dangi,	 B.,	 Gronenborn,	 A.M.,	 and	 Martin,	 R.G.	 (2002).	 Posttranscriptional	 activation	 of	 the	transcriptional	activator	Rob	by	dipyridyl	in	Escherichia	coli.	Journal	of	bacteriology	184,	1407-1416.	Ross,	 W.,	 Ernst,	 A.,	 and	 Gourse,	 R.L.	 (2001).	 Fine	 structure	 of	 E.	 coli	 RNA	 polymerase-promoter	interactions:	alpha	subunit	binding	to	the	UP	element	minor	groove.	Genes	Dev	15,	491-506.	Ruff,	E.F.,	Record,	M.T.,	 Jr.,	and	Artsimovitch,	 I.	 (2015).	 Initial	events	 in	bacterial	 transcription	 initiation.	Biomolecules	5,	1035-1062.	Ruiz,	R.,	Marques,	S.,	and	Ramos,	J.L.	(2003).	Leucines	193	and	194	at	the	N-terminal	domain	of	the	XylS	protein,	 the	 positive	 transcriptional	 regulator	 of	 the	 TOL	 meta-cleavage	 pathway,	 are	 involved	 in	dimerization.	Journal	of	bacteriology	185,	3036-3041.	Runco,	L.M.,	Myrczek,	 S.,	Bliska,	 J.B.,	 and	Thanassi,	D.G.	 (2008).	Biogenesis	of	 the	 fraction	1	 capsule	and	analysis	of	the	ultrastructure	of	Yersinia	pestis.	Journal	of	bacteriology	190,	3381-3385.	Sakai,	T.,	Sasakawa,	C.,	Makino,	S.,	and	Yoshikawa,	M.	(1986).	DNA	sequence	and	product	analysis	of	the	virF	 locus	 responsible	 for	 congo	 red	 binding	 and	 cell	 invasion	 in	 Shigella	 flexneri	 2a.	 Infection	 and	immunity	54,	395-402.	Sakai,	T.,	Sasakawa,	C.,	and	Yoshikawa,	M.	(1988).	Expression	of	four	virulence	antigens	of	Shigella	flexneri	is	 positively	 regulated	 at	 the	 transcriptional	 level	 by	 the	 30	 kiloDalton	 virF	 protein.	 Molecular	microbiology	2,	589-597.	Salipante,	S.J.,	Roach,	D.J.,	Kitzman,	J.O.,	Snyder,	M.W.,	Stackhouse,	B.,	Butler-Wu,	S.M.,	Lee,	C.,	Cookson,	B.T.,	and	 Shendure,	 J.	 (2015).	 Large-scale	 genomic	 sequencing	 of	 extraintestinal	 pathogenic	 Escherichia	 coli	strains.	Genome	research	25,	119-128.	Sambrook,	 J.,	 and	 Russell,	 D.W.	 (2001).	Molecular	 cloning	 -	 a	 laboratory	manual,	 3rd	 edn	 (Cold	 Spring	Harbor	Laboratory	Press).	Sanchez,	A.,	Osborne,	M.L.,	 Friedman,	L.J.,	Kondev,	 J.,	 and	Gelles,	 J.	 (2011).	Mechanism	of	 transcriptional	repression	at	a	bacterial	promoter	by	analysis	of	single	molecules.	The	EMBO	journal	30,	3940-3946.	
	 236	
Sauer,	 F.G.,	 Remaut,	H.,	Hultgren,	 S.J.,	 and	Waksman,	G.	 (2004).	 Fiber	 assembly	by	 the	 chaperone-usher	pathway.	Biochim	Biophys	Acta	1694,	259-267.	Saviola,	 B.,	 Seabold,	 R.,	 and	 Schleif,	 R.F.	 (1998).	 Arm-domain	 interactions	 in	 AraC.	 Journal	 of	molecular	biology	278,	539-548.	Scaletsky,	 I.C.,	 Michalski,	 J.,	 Torres,	 A.G.,	 Dulguer,	 M.V.,	 and	 Kaper,	 J.B.	 (2005).	 Identification	 and	characterization	 of	 the	 locus	 for	 diffuse	 adherence,	 which	 encodes	 a	 novel	 afimbrial	 adhesin	 found	 in	atypical	enteropathogenic	Escherichia	coli.	Infection	and	immunity	73,	4753-4765.	Schellman,	J.A.	(1997).	Temperature,	stability,	and	the	hydrophobic	interaction.	Biophys	J	73,	2960-2964.	Schleif,	R.	 (2000).	Regulation	of	 the	L-arabinose	operon	of	Escherichia	 coli.	Trends	 in	genetics	 :	TIG	16,	559-565.	Schleif,	 R.	 (2010).	 AraC	 protein,	 regulation	 of	 the	 l-arabinose	 operon	 in	 Escherichia	 coli,	 and	 the	 light	switch	mechanism	of	AraC	action.	FEMS	microbiology	reviews	34,	779-796.	Schneiders,	T.,	and	Levy,	S.B.	(2006).	MarA-mediated	transcriptional	repression	of	the	rob	promoter.	The	Journal	of	biological	chemistry	281,	10049-10055.	Schuller,	A.,	 Slater,	A.W.,	Norambuena,	T.,	 Cifuentes,	 J.J.,	 Almonacid,	 L.I.,	 and	Melo,	 F.	 (2012).	 Computer-based	 annotation	 of	 putative	 AraC/XylS-family	 transcription	 factors	 of	 known	 structure	 but	 unknown	function.	J	Biomed	Biotechnol	2012,	103132.	Schwan,	W.R.	(2011).	Regulation	of	genes	in	uropathogenic.	World	J	Clin	Infect	Dis	1,	17-25.	Schwan,	W.R.,	 Lee,	 J.L.,	 Lenard,	 F.A.,	 Matthews,	 B.T.,	 and	 Beck,	M.T.	 (2002).	 Osmolarity	 and	 pH	 growth	conditions	regulate	fim	gene	transcription	and	type	1	pilus	expression	in	uropathogenic	Escherichia	coli.	Infection	and	immunity	70,	1391-1402.	Schwan,	W.R.,	Seifert,	H.S.,	and	Duncan,	J.L.	(1994).	Analysis	of	the	fimB	promoter	region	involved	in	type	1	pilus	phase	variation	in	Escherichia	coli.	Molecular	&	general	genetics	:	MGG	242,	623-630.	Sebbane,	F.,	 Jarrett,	C.,	Gardner,	D.,	 Long,	D.,	 and	Hinnebusch,	B.J.	 (2009).	The	Yersinia	pestis	 caf1M1A1	fimbrial	capsule	operon	promotes	transmission	by	flea	bite	in	a	mouse	model	of	bubonic	plague.	Infection	and	immunity	77,	1222-1229.	Servin,	A.L.	(2005).	Pathogenesis	of	Afa/Dr	diffusely	adhering	Escherichia	coli.	Clin	Microbiol	Rev	18,	264-292.	Sha,	J.,	Agar,	S.L.,	Baze,	W.B.,	Olano,	J.P.,	Fadl,	A.A.,	Erova,	T.E.,	Wang,	S.,	Foltz,	S.M.,	Suarez,	G.,	Motin,	V.L.,	et	
al.	(2008).	Braun	lipoprotein	(Lpp)	contributes	to	virulence	of	yersiniae:	potential	role	of	Lpp	in	inducing	bubonic	and	pneumonic	plague.	Infection	and	immunity	76,	1390-1409.	Shah,	I.M.,	and	Wolf,	R.E.,	Jr.	(2004).	Novel	protein--protein	interaction	between	Escherichia	coli	SoxS	and	the	DNA	binding	determinant	of	the	RNA	polymerase	alpha	subunit:	SoxS	functions	as	a	co-sigma	factor	and	 redeploys	 RNA	 polymerase	 from	 UP-element-containing	 promoters	 to	 SoxS-dependent	 promoters	during	oxidative	stress.	Journal	of	molecular	biology	343,	513-532.	Sheridan,	S.D.,	Opel,	M.L.,	and	Hatfield,	G.W.	(2001).	Activation	and	repression	of	 transcription	 initiation	by	a	distant	DNA	structural	transition.	Molecular	microbiology	40,	684-690.	Shin,	M.,	Kang,	S.,	Hyun,	S.J.,	Fujita,	N.,	Ishihama,	A.,	Valentin-Hansen,	P.,	and	Choy,	H.E.	(2001).	Repression	of	deoP2	in	Escherichia	coli	by	CytR:	conversion	of	a	transcription	activator	into	a	repressor.	The	EMBO	journal	20,	5392-5399.	Simons,	 R.W.,	 Houman,	 F.,	 and	 Kleckner,	 N.	 (1987).	 Improved	 single	 and	 multicopy	 lac-based	 cloning	vectors	for	protein	and	operon	fusions.	Gene	53,	85-96.	Simpson,	W.J.,	 Thomas,	 R.E.,	 and	 Schwan,	 T.G.	 (1990).	 Recombinant	 capsular	 antigen	 (fraction	 1)	 from	Yersinia	pestis	induces	a	protective	antibody	response	in	BALB/c	mice.	Am	J	Trop	Med	Hyg	43,	389-396.	
	 237	
Skurnik,	M.,	Peippo,	A.,	and	Ervela,	E.	(2000).	Characterization	of	the	O-antigen	gene	clusters	of	Yersinia	pseudotuberculosis	 and	 the	 cryptic	 O-antigen	 gene	 cluster	 of	 Yersinia	 pestis	 shows	 that	 the	 plague	bacillus	 is	most	closely	related	 to	and	has	evolved	 from	Y.	pseudotuberculosis	serotype	O:1b.	Molecular	microbiology	37,	316-330.	Smith,	 S.G.,	 and	Dorman,	C.J.	 (1999).	 Functional	 analysis	 of	 the	FimE	 integrase	of	Escherichia	 coli	K-12:	isolation	of	mutant	derivatives	with	altered	DNA	inversion	preferences.	Molecular	microbiology	34,	965-979.	Sohanpal,	B.K.,	El-Labany,	S.,	Lahooti,	M.,	Plumbridge,	J.A.,	and	Blomfield,	I.C.	(2004).	Integrated	regulatory	responses	of	fimB	to	N-acetylneuraminic	(sialic)	acid	and	GlcNAc	in	Escherichia	coli	K-12.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	101,	16322-16327.	Sohanpal,	 B.K.,	 Friar,	 S.,	 Roobol,	 J.,	 Plumbridge,	 J.A.,	 and	 Blomfield,	 I.C.	 (2007).	 Multiple	 co-regulatory	elements	 and	 IHF	 are	 necessary	 for	 the	 control	 of	 fimB	 expression	 in	 response	 to	 sialic	 acid	 and	 N-acetylglucosamine	in	Escherichia	coli	K-12.	Molecular	microbiology	63,	1223-1236.	Soisson,	S.M.,	MacDougall-Shackleton,	B.,	Schleif,	R.,	and	Wolberger,	C.	(1997).	The	1.6	A	crystal	structure	of	 the	 AraC	 sugar-binding	 and	 dimerization	 domain	 complexed	 with	 D-fucose.	 Journal	 of	 molecular	biology	273,	226-237.	Solovyev,	 V.,	 and	 	 Salamov,	 A.,	 (2011).	 Automatic	 Annotation	 of	 Microbial	 Genomes	 and	 Metagenomic	Sequences.	 In	 In	 Metagenomics	 and	 its	 Applications	 in	 Agriculture,	 Biomedicine	 and	 Environmental	Studies	R.W.	Li,	ed.	(Nova	Science	),	pp.	61-78.	Song,	 Y.,	 Tong,	 Z.,	 Wang,	 J.,	 Wang,	 L.,	 Guo,	 Z.,	 Han,	 Y.,	 Zhang,	 J.,	 Pei,	 D.,	 Zhou,	 D.,	 Qin,	 H.,	 et	 al.	 (2004).	Complete	genome	sequence	of	Yersinia	pestis	strain	91001,	an	isolate	avirulent	to	humans.	DNA	Res	11,	179-197.	Soto,	G.E.,	and	Hultgren,	S.J.	(1999).	Bacterial	adhesins:	common	themes	and	variations	in	architecture	and	assembly.	Journal	of	bacteriology	181,	1059-1071.	Spears,	P.A.,	Schauer,	D.,	and	Orndorff,	P.E.	(1986).	Metastable	regulation	of	type	1	piliation	in	Escherichia	coli	and	isolation	and	characterization	of	a	phenotypically	stable	mutant.	Journal	of	bacteriology	168,	179-185.	Spurio,	R.,	Falconi,	M.,	Brandi,	A.,	Pon,	C.L.,	and	Gualerzi,	C.O.	(1997).	The	oligomeric	structure	of	nucleoid	protein	H-NS	 is	 necessary	 for	 recognition	 of	 intrinsically	 curved	DNA	and	 for	DNA	bending.	 The	EMBO	journal	16,	1795-1805.	Starmer,	 J.,	 Stomp,	 A.,	 Vouk,	 M.,	 and	 Bitzer,	 D.	 (2006).	 Predicting	 Shine-Dalgarno	 sequence	 locations	exposes	genome	annotation	errors.	PLoS	computational	biology	2,	e57.	Steinmann,	 R.,	 and	 Dersch,	 P.	 (2013).	 Thermosensing	 to	 adjust	 bacterial	 virulence	 in	 a	 fluctuating	environment.	Future	Microbiol	8,	85-105.	Stenseth,	N.C.,	Atshabar,	B.B.,	Begon,	M.,	Belmain,	 S.R.,	Bertherat,	E.,	 Carniel,	E.,	Gage,	K.L.,	 Leirs,	H.,	 and	Rahalison,	L.	(2008).	Plague:	past,	present,	and	future.	PLoS	Med	5,	e3.	Stock,	 A.M.,	 Robinson,	 V.L.,	 and	 Goudreau,	 P.N.	 (2000).	 Two-component	 signal	 transduction.	 Annual	review	of	biochemistry	69,	183-215.	Straley,	 S.C.,	 and	Perry,	R.D.	 (1995).	 Environmental	modulation	of	 gene	 expression	 and	pathogenesis	 in	Yersinia.	Trends	Microbiol	3,	310-317.	Studier,	F.W.,	and	Moffatt,	B.A.	(1986).	Use	of	bacteriophage	T7	RNA	polymerase	to	direct	selective	high-level	expression	of	cloned	genes.	Journal	of	molecular	biology	189,	113-130.	Taliaferro,	L.P.,	Keen,	E.F.,	3rd,	Sanchez-Alberola,	N.,	and	Wolf,	R.E.,	Jr.	(2012).	Transcription	activation	by	Escherichia	coli	Rob	at	class	II	promoters:	protein-protein	interactions	between	Rob's	N-terminal	domain	and	the	sigma(70)	subunit	of	RNA	polymerase.	Journal	of	molecular	biology	419,	139-157.	
	 238	
Tanaka,	T.,	Horii,	T.,	 Shibayama,	K.,	 Sato,	K.,	Ohsuka,	S.,	Arakawa,	Y.,	Yamaki,	K.,	Takagi,	K.,	 and	Ohta,	M.	(1997).	RobA-induced	multiple	antibiotic	resistance	largely	depends	on	the	activation	of	the	AcrAB	efflux.	Microbiol	Immunol	41,	697-702.	Thanassi,	D.G.,	Bliska,	J.B.,	and	Christie,	P.J.	(2012).	Surface	organelles	assembled	by	secretion	systems	of	Gram-negative	bacteria:	diversity	in	structure	and	function.	FEMS	microbiology	reviews	36,	1046-1082.	Thanassi,	D.G.,	 Saulino,	 E.T.,	 and	Hultgren,	 S.J.	 (1998).	 The	 chaperone/usher	pathway:	 a	major	 terminal	branch	of	the	general	secretory	pathway.	Curr	Opin	Microbiol	1,	223-231.	Titball,	 R.W.,	 Howells,	 A.M.,	 Oyston,	 P.C.,	 and	Williamson,	 E.D.	 (1997).	 Expression	 of	 the	 Yersinia	 pestis	capsular	antigen	(F1	antigen)	on	the	surface	of	an	aroA	mutant	of	Salmonella	typhimurium	induces	high	levels	of	protection	against	plague.	Infection	and	immunity	65,	1926-1930.	Titball,	R.W.,	and	Williamson,	E.D.	(2001).	Vaccination	against	bubonic	and	pneumonic	plague.	Vaccine	19,	4175-4184.	Tobe,	T.,	Schoolnik,	G.K.,	Sohel,	I.,	Bustamante,	V.H.,	and	Puente,	J.L.	(1996).	Cloning	and	characterization	of	bfpTVW,	genes	required	for	the	transcriptional	activation	of	bfpA	in	enteropathogenic	Escherichia	coli.	Molecular	microbiology	21,	963-975.	Towbin,	H.,	Staehelin,	T.,	and	Gordon,	J.	(1979).	Electrophoretic	transfer	of	proteins	from	polyacrylamide	gels	 to	nitrocellulose	 sheets:	procedure	and	some	applications.	Proceedings	of	 the	National	Academy	of	Sciences	of	the	United	States	of	America	76,	4350-4354.	Tsujikawa,	L.,	Tsodikov,	O.V.,	and	deHaseth,	P.L.	(2002).	Interaction	of	RNA	polymerase	with	forked	DNA:	evidence	for	two	kinetically	significant	intermediates	on	the	pathway	to	the	final	complex.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	99,	3493-3498.	Valentin-Hansen,	P.,	Sogaard-Andersen,	L.,	and	Pedersen,	H.	(1996).	A	flexible	partnership:	the	CytR	anti-activator	and	the	cAMP-CRP	activator	protein,	comrades	in	transcription	control.	Molecular	microbiology	
20,	461-466.	Vasina,	 J.A.,	 and	 Baneyx,	 F.	 (1997).	 Expression	 of	 aggregation-prone	 recombinant	 proteins	 at	 low	temperatures:	 a	 comparative	 study	 of	 the	 Escherichia	 coli	 cspA	 and	 tac	 promoter	 systems.	 Protein	expression	and	purification	9,	211-218.	Vera,	 A.,	 Gonzalez-Montalban,	 N.,	 Aris,	 A.,	 and	 Villaverde,	 A.	 (2007).	 The	 conformational	 quality	 of	insoluble	 recombinant	 proteins	 is	 enhanced	 at	 low	 growth	 temperatures.	 Biotechnol	 Bioeng	 96,	 1101-1106.	Vinue,	 L.,	 McMurry,	 L.M.,	 and	 Levy,	 S.B.	 (2013).	 The	 216-bp	 marB	 gene	 of	 the	 marRAB	 operon	 in	Escherichia	 coli	 encodes	 a	 periplasmic	 protein	 which	 reduces	 the	 transcription	 rate	 of	 marA.	 FEMS	microbiology	letters	345,	49-55.	Waterhouse,	 A.M.,	 Procter,	 J.B.,	 Martin,	 D.M.,	 Clamp,	 M.,	 and	 Barton,	 G.J.	 (2009).	 Jalview	 Version	 2--a	multiple	sequence	alignment	editor	and	analysis	workbench.	Bioinformatics	25,	1189-1191.	Weber,	G.G.,	Kortmann,	J.,	Narberhaus,	F.,	and	Klose,	K.E.	(2014).	RNA	thermometer	controls	temperature-dependent	 virulence	 factor	 expression	 in	 Vibrio	 cholerae.	 Proceedings	 of	 the	 National	 Academy	 of	Sciences	of	the	United	States	of	America	111,	14241-14246.	Welch,	T.J.,	Fricke,	W.F.,	McDermott,	P.F.,	White,	D.G.,	Rosso,	M.L.,	Rasko,	D.A.,	Mammel,	M.K.,	Eppinger,	M.,	Rosovitz,	M.J.,	Wagner,	D.,	et	al.	 (2007).	Multiple	 antimicrobial	 resistance	 in	plague:	 an	 emerging	public	health	risk.	PLoS	One	2,	e309.	Weyand,	N.J.,	Braaten,	B.A.,	van	der	Woude,	M.,	Tucker,	J.,	and	Low,	D.A.	(2001).	The	essential	role	of	the	promoter-proximal	subunit	of	CAP	in	pap	phase	variation:	Lrp-	and	helical	phase-dependent	activation	of	papBA	transcription	by	CAP	from	-215.	Molecular	microbiology	39,	1504-1522.	
	 239	
White-Ziegler,	 C.A.,	 Angus	 Hill,	 M.L.,	 Braaten,	 B.A.,	 van	 der	 Woude,	 M.W.,	 and	 Low,	 D.A.	 (1998).	Thermoregulation	 of	 Escherichia	 coli	 pap	 transcription:	 H-NS	 is	 a	 temperature-dependent	 DNA	methylation	blocking	factor.	Molecular	microbiology	28,	1121-1137.	White-Ziegler,	 C.A.,	 Villapakkam,	 A.,	 Ronaszeki,	 K.,	 and	 Young,	 S.	 (2000).	 H-NS	 controls	 pap	 and	 daa	fimbrial	 transcription	 in	 Escherichia	 coli	 in	 response	 to	 multiple	 environmental	 cues.	 Journal	 of	bacteriology	182,	6391-6400.	Wood,	 T.I.,	 Griffith,	 K.L.,	 Fawcett,	 W.P.,	 Jair,	 K.W.,	 Schneider,	 T.D.,	 and	 Wolf,	 R.E.,	 Jr.	 (1999).	Interdependence	of	the	position	and	orientation	of	SoxS	binding	sites	in	the	transcriptional	activation	of	the	 class	 I	 subset	 of	 Escherichia	 coli	 superoxide-inducible	 promoters.	 Molecular	microbiology	 34,	 414-430.	Wosten,	M.M.	(1998).	Eubacterial	sigma-factors.	FEMS	microbiology	reviews	22,	127-150.	Wu,	J.,	and	Filutowicz,	M.	(1999).	Hexahistidine	(His6)-tag	dependent	protein	dimerization:	a	cautionary	tale.	Acta	Biochim	Pol	46,	591-599.	Xia,	Y.,	Gally,	D.,	Forsman-Semb,	K.,	and	Uhlin,	B.E.	(2000).	Regulatory	cross-talk	between	adhesin	operons	in	Escherichia	 coli:	 inhibition	of	 type	1	 fimbriae	expression	by	 the	PapB	protein.	The	EMBO	 journal	19,	1450-1457.	Xie,	 Y.,	 Yao,	 Y.,	 Kolisnychenko,	 V.,	 Teng,	 C.H.,	 and	 Kim,	 K.S.	 (2006).	 HbiF	 regulates	 type	 1	 fimbriation	independently	of	FimB	and	FimE.	Infection	and	immunity	74,	4039-4047.	Yang,	 Y.,	 and	 Isberg,	 R.R.	 (1997).	 Transcriptional	 regulation	 of	 the	 Yersinia	 pseudotuberculosis	 pH6	antigen	adhesin	by	two	envelope-associated	components.	Molecular	microbiology	24,	499-510.	Yu,	X.,	Visweswaran,	G.R.,	Duck,	 Z.,	Marupakula,	 S.,	MacIntyre,	 S.,	Knight,	 S.D.,	 and	Zavialov,	A.V.	 (2009).	Caf1A	usher	possesses	a	Caf1	subunit-like	domain	that	is	crucial	for	Caf1	fibre	secretion.	The	Biochemical	journal	418,	541-551.	Yu,	 X.D.,	 Fooks,	 L.J.,	 Moslehi-Mohebi,	 E.,	 Tischenko,	 V.M.,	 Askarieh,	 G.,	 Knight,	 S.D.,	 Macintyre,	 S.,	 and	Zavialov,	A.V.	(2012).	Large	is	fast,	small	is	tight:	determinants	of	speed	and	affinity	in	subunit	capture	by	a	periplasmic	chaperone.	Journal	of	molecular	biology	417,	294-308.	Zafar,	 M.A.,	 Sanchez-Alberola,	 N.,	 and	 Wolf,	 R.E.,	 Jr.	 (2011).	 Genetic	 evidence	 for	 a	 novel	 interaction	between	transcriptional	activator	SoxS	and	region	4	of	the	sigma(70)	subunit	of	RNA	polymerase	at	class	II	SoxS-dependent	promoters	in	Escherichia	coli.	Journal	of	molecular	biology	407,	333-353.	Zafar,	M.A.,	Shah,	I.M.,	and	Wolf,	R.E.,	Jr.	(2010).	Protein-protein	interactions	between	sigma(70)	region	4	of	 RNA	 polymerase	 and	 Escherichia	 coli	 SoxS,	 a	 transcription	 activator	 that	 functions	 by	 the	prerecruitment	 mechanism:	 evidence	 for	 "off-DNA"	 and	 "on-DNA"	 interactions.	 Journal	 of	 molecular	biology	401,	13-32.	Zav'yalov,	 V.,	 Zavialov,	 A.,	 Zav'yalova,	 G.,	 and	 Korpela,	 T.	 (2010).	 Adhesive	 organelles	 of	 Gram-negative	pathogens	 assembled	 with	 the	 classical	 chaperone/usher	 machinery:	 structure	 and	 function	 from	 a	clinical	standpoint.	FEMS	microbiology	reviews	34,	317-378.	Zavialov,	 A.,	 Zav'yalova,	 G.,	 Korpela,	 T.,	 and	 Zav'yalov,	 V.	 (2007).	 FGL	 chaperone-assembled	 fimbrial	polyadhesins:	anti-immune	armament	of	Gram-negative	bacterial	pathogens.	FEMS	microbiology	reviews	
31,	478-514.	Zavialov,	A.V.,	Batchikova,	N.V.,	Korpela,	T.,	Petrovskaya,	L.E.,	Korobko,	V.G.,	Kersley,	J.,	MacIntyre,	S.,	and	Zav'yalov,	V.P.	(2001).	Secretion	of	recombinant	proteins	via	the	chaperone/usher	pathway	in	Escherichia	coli.	Appl	Environ	Microbiol	67,	1805-1814.	Zavialov,	A.V.,	Berglund,	 J.,	Pudney,	A.F.,	Fooks,	L.J.,	 Ibrahim,	T.M.,	MacIntyre,	S.,	and	Knight,	S.D.	 (2003).	Structure	and	biogenesis	of	the	capsular	F1	antigen	from	Yersinia	pestis:	preserved	folding	energy	drives	fiber	formation.	Cell	113,	587-596.	
	 240	
Zavialov,	A.V.,	Kersley,	J.,	Korpela,	T.,	Zav'yalov,	V.P.,	MacIntyre,	S.,	and	Knight,	S.D.	(2002).	Donor	strand	complementation	mechanism	in	the	biogenesis	of	non-pilus	systems.	Molecular	microbiology	45,	983-995.	Zavialov,	 A.V.,	 Tischenko,	 V.M.,	 Fooks,	 L.J.,	 Brandsdal,	 B.O.,	 Aqvist,	 J.,	 Zav'yalov,	 V.P.,	 Macintyre,	 S.,	 and	Knight,	 S.D.	 (2005).	 Resolving	 the	 energy	 paradox	 of	 chaperone/usher-mediated	 fibre	 assembly.	 The	Biochemical	journal	389,	685-694.	Zhang,	 Y.,	 and	 Skolnick,	 J.	 (2005).	 TM-align:	 a	 protein	 structure	 alignment	 algorithm	 based	 on	 the	 TM-score.	Nucleic	acids	research	33,	2302-2309.	Zhang,	 Y.,	 Wang,	 L.,	 Fang,	 N.,	 Qu,	 S.,	 Tan,	 Y.,	 Guo,	 Z.,	 Qiu,	 J.,	 Zhou,	 D.,	 and	 Yang,	 R.	 (2013).	 Reciprocal	regulation	of	pH	6	antigen	gene	loci	by	PhoP	and	RovA	in	Yersinia	pestis	biovar	Microtus.	Future	Microbiol	
8,	271-280.	Zhou,	 D.,	 Han,	 Y.,	 and	 Yang,	 R.	 (2006).	 Molecular	 and	 physiological	 insights	 into	 plague	 transmission,	virulence	and	etiology.	Microbes	Infect	8,	273-284.	Zhou,	D.,	Tong,	Z.,	Song,	Y.,	Han,	Y.,	Pei,	D.,	Pang,	X.,	Zhai,	 J.,	Li,	M.,	Cui,	B.,	Qi,	Z.,	et	al.	 (2004).	Genetics	of	metabolic	variations	between	Yersinia	pestis	biovars	and	the	proposal	of	a	new	biovar,	microtus.	Journal	of	bacteriology	186,	5147-5152.	Zhou,	 L.,	 Ying,	 W.,	 Han,	 Y.,	 Chen,	 M.,	 Yan,	 Y.,	 Li,	 L.,	 Zhu,	 Z.,	 Zheng,	 Z.,	 Jia,	 W.,	 Yang,	 R.,	 et	 al.	 (2012).	 A	proteome	reference	map	and	virulence	factors	analysis	of	Yersinia	pestis	91001.	J	Proteomics	75,	894-907.	Zuker,	M.	 (2003).	Mfold	web	 server	 for	 nucleic	 acid	 folding	 and	 hybridization	 prediction.	Nucleic	 acids	research	31,	3406-3415.	
 
